Citrus Sinensis ID: 005111
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.610 | 0.762 | 0.600 | 1e-163 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.788 | 0.788 | 0.506 | 1e-159 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.467 | 0.651 | 0.491 | 9e-96 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.464 | 0.639 | 0.497 | 3e-95 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.467 | 0.661 | 0.489 | 5e-95 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.467 | 0.651 | 0.482 | 7e-93 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.408 | 0.235 | 0.455 | 2e-75 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.456 | 0.218 | 0.433 | 2e-75 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | yes | no | 0.492 | 0.232 | 0.411 | 2e-75 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.456 | 0.218 | 0.430 | 2e-75 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 575 bits (1482), Expect = e-163, Method: Compositional matrix adjust.
Identities = 269/448 (60%), Positives = 342/448 (76%), Gaps = 12/448 (2%)
Query: 87 MIYDQIERKKKVDEQIEKCEVNV-------INHHPAIGRLPKGVEGEQVAAGWPTWLATV 139
+I D +E+KK + +K + +P + K GEQVAAGWP+WL+
Sbjct: 43 VIADDVEKKKNEEANGDKERKSSKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDA 102
Query: 140 AGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFM 199
GEA+ GW+PR+A+TFEK+DKIGQGTYS+VY+A+D++ KIVALKKVRFDN +PESVKFM
Sbjct: 103 CGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFM 162
Query: 200 AREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCY 259
AREI +LR+LDHPN++KLEGL+TS+ SCSLYLVF+YM+HDL GLAS P +KF+ES+VKC
Sbjct: 163 AREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCL 222
Query: 260 MKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL 319
M+QL+SGLEHCHS GVLHRDIKGSNLL+D G+LKIADFGLA+ FDP PMTSRVVTL
Sbjct: 223 MRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTL 282
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY 379
WYR PELLLGA+ YG +DLWS GCIL EL +G+P++PG+TEVEQLH+I+KLCGSPSEDY
Sbjct: 283 WYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDY 342
Query: 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
W+K K H ++KP +PY+R I ETFKDFP S+L L++ L+SI+P R TA+ AL SEFF
Sbjct: 343 WKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFF 402
Query: 440 TTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG---GRDQKGDLHRSWRKEYLPIP 496
T++P AC P++LPKYPPSKEIDAK RDEE+RR A G + + HR LP P
Sbjct: 403 TSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARKNRHRDRSNRALPAP 462
Query: 497 APNRDAELSIMQKR--HHTNSRSKNEMF 522
N + + ++ ++R H N++SK+E F
Sbjct: 463 EANAELQSNVDRRRLITHANAKSKSEKF 490
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 304/600 (50%), Positives = 406/600 (67%), Gaps = 37/600 (6%)
Query: 116 IGRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDV 175
I + G G QV AGWP+WLA+VAGEAI GWIPR+A++FEKL+KIGQGTYSSVY+ARD+
Sbjct: 124 ICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDL 183
Query: 176 IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235
+++VALKKVRF N DP+SV+FMAREI ILR+LDHPN++KLEGLITS+ S S+YL+FEY
Sbjct: 184 ETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEY 243
Query: 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKI 295
MEHDL GLAS PG+ F+E+Q+KCYMKQLL GLEHCHS GVLHRDIKGSNLLLDHN LKI
Sbjct: 244 MEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKI 303
Query: 296 ADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV 355
DFGLA+F+ P+TSRVVTLWYRPPELLLG++ YG VDLWSTGCIL ELF+GKP+
Sbjct: 304 GDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPI 363
Query: 356 LPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRL 415
+PG+TEVEQLH+IFKLCGSPSE+YW+ SKL H+T+FKP QPY+R +AETFK P+SAL L
Sbjct: 364 MPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALAL 423
Query: 416 METLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVA 475
+E L++++P RGT AL SEFFTT PLA +PS+LPKY P KEID K ++EE++R
Sbjct: 424 VEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDT 483
Query: 476 GGRDQKGDLHRSWRKEYLPIPAPNRDAE-LSIMQKRHHTNSRSKNEMFISQKEAAHAINP 534
+ + +E +PAP+ +AE L+ +QKR +++ N + NP
Sbjct: 484 SSKQNDS---KQVSRESKAVPAPDSNAESLTSIQKRQGQHNQVSN---------SDKFNP 531
Query: 535 TKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGP-LIQGATWAKVGKGYNDPPA 593
G++A+ ++ + + G +G + V+ +G ++ G++ + +
Sbjct: 532 ------GEDAASFRIEPLKSGTAKDGHTRYGVSSVNRNGENVMMGSSRSPRKELRTQRSF 585
Query: 594 VS-GRSNLATLSGFVASR-----TVLPEDHREKSGPSYVGVGKQVGGSQRSYKDLVSTGK 647
V G + L+ S VA+R + E S + G SQR LV K
Sbjct: 586 VQRGTAQLSRFSNSVAARDGSHFAIANPRWFEDSYNNNNGRQNGGAWSQR----LVVKHK 641
Query: 648 QDCRQNIQKTAEPSLHGGGPRGNKIFVSGPLLPT-NNVDQLLKEHDQHIQEFARRARLEK 706
+ + + S+ G + ++ SGPL+ N+D++LKEH++ IQ R+AR++K
Sbjct: 642 EFTKH------KESITVNGEKKERMHCSGPLVSAGGNLDEMLKEHERQIQLAVRKARVDK 695
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 9e-96, Method: Compositional matrix adjust.
Identities = 172/350 (49%), Positives = 236/350 (67%), Gaps = 16/350 (4%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAIL 206
W R + FEKL++IG+GTY VY A++ ++IVALKK+R DN+ REI IL
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDNEREGFPITAIREIKIL 76
Query: 207 RKLDHPNIIKLEGLITS---------------QTSCSLYLVFEYMEHDLVGLASLPGMKF 251
+KL H N+I+L+ ++TS + S+Y+VFEYM+HDL GLA PGM+F
Sbjct: 77 KKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHDLTGLADRPGMRF 136
Query: 252 TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311
T Q+KCYM+QLL+GL +CH + VLHRDIKGSNLL+D+ G LK+ADFGLA F +
Sbjct: 137 TVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSSDHNGN 196
Query: 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL 371
+T+RV+TLWYRPPELLLG++ YG AVD+WS GCI EL +GKP+L GK E EQL +IF+L
Sbjct: 197 LTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGKNEPEQLSKIFEL 256
Query: 372 CGSPSEDYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
CG+P E W +K+ FKP +P +RR+ E+FK F AL L+E ++++DP+ R +A
Sbjct: 257 CGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEKMLTLDPSQRISA 316
Query: 431 TLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQ 480
AL++E+F T PL C+P +LPKY S E K + ++ R+ A R +
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQAEEAAKRQK 366
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (897), Expect = 3e-95, Method: Compositional matrix adjust.
Identities = 173/348 (49%), Positives = 232/348 (66%), Gaps = 16/348 (4%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAIL 206
W R + FEKL++IG+GTY VY AR+ +IVALKK+R DN+ REI IL
Sbjct: 17 WGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDNEREGFPITAIREIKIL 76
Query: 207 RKLDHPNIIKLEGLITS---------------QTSCSLYLVFEYMEHDLVGLASLPGMKF 251
+KL H N+I+L+ ++TS + S+Y+VFEYM+HDL GLA PGM+F
Sbjct: 77 KKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHDLTGLADRPGMRF 136
Query: 252 TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311
T Q+KCYMKQLL+GL +CH + VLHRDIKGSNLL+D+ G LK+ADFGLA F +
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFGLARSFSNDHNGN 196
Query: 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL 371
+T+RV+TLWYRPPELLLG++ YG AVD+WS GCI EL +GKP+LPGK E EQL +IF +
Sbjct: 197 LTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGKNEPEQLSKIFDV 256
Query: 372 CGSPSEDYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
CG+P E W +K+ FKP + +RR+ E FK F AL L+E ++++DPA R +A
Sbjct: 257 CGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEKMLTLDPAQRISA 316
Query: 431 TLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGR 478
AL++E+F + PL C+P +LPKY S E K + ++ R+ A R
Sbjct: 317 QDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQADEAAKR 364
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 349 bits (895), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 171/349 (48%), Positives = 233/349 (66%), Gaps = 15/349 (4%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAIL 206
W R + FEKL++IG+GTY VY A+++ +IVALKK+R DN+ REI IL
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKIL 77
Query: 207 RKLDHPNIIKLEGLITS--------------QTSCSLYLVFEYMEHDLVGLASLPGMKFT 252
+KL H N+I+L+ ++TS + +Y+VFEYM+HDL GLA PG++FT
Sbjct: 78 KKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFT 137
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312
Q+KCYMKQLL+GL +CH + VLHRDIKGSNLL+D+ G LK+ADFGLA + + +
Sbjct: 138 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNL 197
Query: 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLC 372
T+RV+TLWYRPPELLLGA+ YG A+D+WS GCI EL KP+LPGK E EQL++IF+LC
Sbjct: 198 TNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFELC 257
Query: 373 GSPSEDYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
GSP E W SK+ FKP +P +RR+ E F+ F AL L+E ++ +DPA R +A
Sbjct: 258 GSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISAK 317
Query: 432 LALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQ 480
AL++E+F T PL C+P +LP Y S E K + ++ R++ A R +
Sbjct: 318 DALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQNEEAAKRQK 366
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (877), Expect = 7e-93, Method: Compositional matrix adjust.
Identities = 169/350 (48%), Positives = 230/350 (65%), Gaps = 16/350 (4%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAIL 206
W R + FEKL++IG+GTY VY A+++ +IVALKK+R DN+ REI IL
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDNEREGFPITAIREIKIL 77
Query: 207 RKLDHPNIIKLEGLITS--------------QTSCSLYLVFEYMEHDLVGLASLPGMKFT 252
+KL H N+I L+ ++TS + +Y+VFEYM+HDL GLA PG++FT
Sbjct: 78 KKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRFT 137
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312
Q+KCYMKQLL+GL +CH + VLHRDIKGSNLL+D+ G LK+ADFGLA + + +
Sbjct: 138 VPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGNL 197
Query: 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLC 372
T+RV+TLWYRPPELLLGA+ YG A+D+WS GCI EL +GKP+LPGKTE EQL++I++LC
Sbjct: 198 TNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYELC 257
Query: 373 GSPSEDYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
GSP E W SK+ K +P +RR+ E ++ F AL L+E ++ +DP+ R A
Sbjct: 258 GSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICAK 317
Query: 432 LALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQK 481
AL++E+F T PL C+P +LP Y S E K + + RH + QK
Sbjct: 318 DALDAEYFWTDPLPCDPKSLPTYESSHEFQTK-KKRQQMRHNEEAAKKQK 366
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (727), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 138/303 (45%), Positives = 195/303 (64%), Gaps = 11/303 (3%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAI 205
W R + F+ + IG+GTY VY+A+D ++VALKKVR DN+ E A REI I
Sbjct: 702 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDNEK-EGFPITAIREIKI 760
Query: 206 LRKLDHPNIIKLEGLITSQTSC--------SLYLVFEYMEHDLVGLASLPGMKFTESQVK 257
LR+L H +++ ++ ++T + + YLVFEYM+HDL+GL ++F+E +K
Sbjct: 761 LRQLIHKSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIK 820
Query: 258 CYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317
+MKQL+ GLE+CH LHRDIK SN+LL+++G +K+ADFGLA + ++S P T++V+
Sbjct: 821 SFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVI 880
Query: 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377
TLWYRPPELLLG Y A+D+WS GCILGELF+ KP+ E+ QL I +LCGSP
Sbjct: 881 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 940
Query: 378 DYWRKS-KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436
W KL + KP + YRRR+ E F PT AL L++ ++++DP+ R TA L S
Sbjct: 941 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQS 1000
Query: 437 EFF 439
+F
Sbjct: 1001 DFL 1003
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 147/339 (43%), Positives = 213/339 (62%), Gaps = 13/339 (3%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAI 205
W R + F+ + IG+GTY VY+A+D ++VALKKVR DN+ E A REI I
Sbjct: 719 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDNEK-EGFPITAIREIKI 777
Query: 206 LRKLDHPNIIKLEGLITSQTSC--------SLYLVFEYMEHDLVGLASLPGMKFTESQVK 257
LR+L H +++ ++ ++T + + YLVFEYM+HDL+GL + F+E +K
Sbjct: 778 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 837
Query: 258 CYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317
+MKQL+ GLE+CH LHRDIK SN+LL+++G +K+ADFGLA ++ ++S P T++V+
Sbjct: 838 SFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 897
Query: 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377
TLWYRPPELLLG Y A+D+WS GCILGELF+ KP+ E+ QL I +LCGSP
Sbjct: 898 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 957
Query: 378 DYWRKS-KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436
W KL + KP + YRRR+ E F P++AL L++ ++++DP+ R TA L S
Sbjct: 958 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1017
Query: 437 EFFTTQPLA-CNPSNLPKYPPSKEIDAKLRDEESRRHGV 474
+F L+ P +LP + E+ +K R + R+ GV
Sbjct: 1018 DFLKDVELSKMAPPDLPHWQDCHELWSKKRRRQ-RQSGV 1055
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 155/377 (41%), Positives = 218/377 (57%), Gaps = 25/377 (6%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAIL 206
W R + F+ + IG+GTY VY+ARD ++VALKKVR DN+ REI IL
Sbjct: 697 WGKRCVDKFDIIGIIGEGTYGQVYKARDKDTGEMVALKKVRLDNEKEGFPITAIREIKIL 756
Query: 207 RKLDHPNIIKLEGLITSQTSC--------SLYLVFEYMEHDLVGLASLPGMKFTESQVKC 258
R+L H +II ++ ++T + + YLVFEYM+HDL+GL + F E+ +K
Sbjct: 757 RQLTHQSIINMKEIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKS 816
Query: 259 YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVT 318
+M+QL+ GL++CH LHRDIK SN+LL++ G +K+ADFGLA + ++S P T++V+T
Sbjct: 817 FMRQLMEGLDYCHKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVIT 876
Query: 319 LWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378
LWYRPPELLLG Y A+D+WS GCILGELF+ KP+ E+ QL I ++CGSP
Sbjct: 877 LWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPA 936
Query: 379 YWRKS-KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSE 437
W KL + KP + YRR++ E F P +AL L + ++++DP+ R TA AL E
Sbjct: 937 VWPDVIKLPYFNTMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCE 996
Query: 438 FF-TTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLPIP 496
F +P P +LP + E+ +K R RR G D DL I
Sbjct: 997 FLRDVEPSKMPPPDLPLWQDCHELWSKKR----RRQKQMGMTD---DLST--------IK 1041
Query: 497 APNRDAELSIMQKRHHT 513
AP +D L + R +T
Sbjct: 1042 APRKDLSLGLDDSRTNT 1058
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (725), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 146/339 (43%), Positives = 214/339 (63%), Gaps = 13/339 (3%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAI 205
W R + F+ + IG+GTY VY+A+D ++VALKKVR DN+ E A REI I
Sbjct: 720 WGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDNEK-EGFPITAIREIKI 778
Query: 206 LRKLDHPNIIKLEGLITSQTSC--------SLYLVFEYMEHDLVGLASLPGMKFTESQVK 257
LR+L H +++ ++ ++T + + YLVFEYM+HDL+GL + F+E +K
Sbjct: 779 LRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 838
Query: 258 CYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317
+MKQL+ GL++CH LHRDIK SN+LL+++G +K+ADFGLA ++ ++S P T++V+
Sbjct: 839 SFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVI 898
Query: 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377
TLWYRPPELLLG Y A+D+WS GCILGELF+ KP+ E+ QL I +LCGSP
Sbjct: 899 TLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCP 958
Query: 378 DYWRKS-KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436
W KL + KP + YRRR+ E F P++AL L++ ++++DP+ R TA L S
Sbjct: 959 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQS 1018
Query: 437 EFFTTQPLA-CNPSNLPKYPPSKEIDAKLRDEESRRHGV 474
+F L+ +P +LP + E+ +K R + R+ GV
Sbjct: 1019 DFLKDVELSKMDPPDLPHWQDCHELWSKKRRRQ-RQSGV 1056
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | ||||||
| 255553731 | 734 | ATP binding protein, putative [Ricinus c | 0.918 | 0.893 | 0.590 | 0.0 | |
| 225446376 | 710 | PREDICTED: probable serine/threonine-pro | 0.925 | 0.930 | 0.602 | 0.0 | |
| 224114928 | 713 | predicted protein [Populus trichocarpa] | 0.942 | 0.943 | 0.573 | 0.0 | |
| 356543323 | 710 | PREDICTED: probable serine/threonine-pro | 0.935 | 0.940 | 0.580 | 0.0 | |
| 224128322 | 713 | predicted protein [Populus trichocarpa] | 0.938 | 0.939 | 0.568 | 0.0 | |
| 356544039 | 708 | PREDICTED: probable serine/threonine-pro | 0.932 | 0.940 | 0.578 | 0.0 | |
| 225461467 | 713 | PREDICTED: probable serine/threonine-pro | 0.932 | 0.934 | 0.577 | 0.0 | |
| 302143004 | 712 | unnamed protein product [Vitis vinifera] | 0.932 | 0.935 | 0.577 | 0.0 | |
| 356517145 | 710 | PREDICTED: probable serine/threonine-pro | 0.935 | 0.940 | 0.572 | 0.0 | |
| 357452947 | 712 | Serine/threonine protein kinase cdk9 [Me | 0.932 | 0.935 | 0.570 | 0.0 |
| >gi|255553731|ref|XP_002517906.1| ATP binding protein, putative [Ricinus communis] gi|223542888|gb|EEF44424.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2138), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/731 (59%), Positives = 528/731 (72%), Gaps = 75/731 (10%)
Query: 15 RERLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLLIDKRVNGSNRYYDHHKIE 74
+ERL+RK SL++ VA V+SSRREE VR K K D DV+V+LIDK+ NGS R YD
Sbjct: 16 KERLSRKG-SLDRRVAHVNSSRREEGVRSKSKSDIGDVRVMLIDKKKNGSIRLYDD---- 70
Query: 75 KIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINH------------------HPAI 116
Q+EKK + Q+E KK +E CEV +H HP
Sbjct: 71 -------QIEKKQMESQVEIKK-----VENCEVAGDSHPQIEKNKKKENFDVTVRSHPDW 118
Query: 117 GRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
GR+PK + EQVAAGWP+WLA+ AGEAIKGW+PRRANTFEKLD+IGQGTYS+VY+ARDV
Sbjct: 119 GRVPKSMAAEQVAAGWPSWLASAAGEAIKGWVPRRANTFEKLDRIGQGTYSNVYKARDVT 178
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
HDK+VA+KKVRFD DP+SVKFMAREI ILR+LDHPNIIKLEGLITS TS SLYLVFEYM
Sbjct: 179 HDKVVAIKKVRFDINDPDSVKFMAREINILRRLDHPNIIKLEGLITSPTSSSLYLVFEYM 238
Query: 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
EHDL GL SLPG+KF E Q+KCYM+QLLSGL+HCHS GVLHRDIKGSNLL+D NGILKIA
Sbjct: 239 EHDLTGLISLPGIKFKEPQIKCYMQQLLSGLDHCHSRGVLHRDIKGSNLLVDDNGILKIA 298
Query: 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
DFGLA+FFDP S +TSRVVTLWYR PELLLGAS YG +VDLWS+GCILGEL++GKP+L
Sbjct: 299 DFGLATFFDPHSSGQLTSRVVTLWYRAPELLLGASRYGVSVDLWSSGCILGELYTGKPIL 358
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG+TEVEQLH+IFKLCGSPSEDYW+K KLRH +VFKP QPYRR IAETF + P A+ LM
Sbjct: 359 PGRTEVEQLHKIFKLCGSPSEDYWKKLKLRHQSVFKPQQPYRRCIAETFNNLPAPAVGLM 418
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
ETL+S+DPA+RGTA AL +FF ++P A +PSNLPKYPPSKEIDAK+RDEE+RR G
Sbjct: 419 ETLLSLDPANRGTAAFALKDKFFRSKPFASDPSNLPKYPPSKEIDAKMRDEEARRQEAVG 478
Query: 477 GRDQKGDLHRSWRKEYLPIPAPNRDAELSIM-QKRHHTNSRSKNEMFISQKE---AAHAI 532
+ R+ ++ L +PA N +++L+ M Q+R H+N+ S+ EMF S +E + +
Sbjct: 479 -------VGRNRTQQSLAVPASNANSKLAAMVQERRHSNANSRGEMFNSHREQTVSGFLV 531
Query: 533 NPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDPP 592
+P+KQ Q+ KE ++F +HQ RKVS+SGPLVH GA W K GK ++P
Sbjct: 532 DPSKQTQATKEGRREFQEHQLRKVSHSGPLVH-------------GAGWTKSGKDLDNPH 578
Query: 593 AVSGRSNLATLSGFVASRTVLPEDHREKSGPSYVGVGKQVGGSQRSYKDLVSTGKQDCRQ 652
+ R NL+T+SG VA+RT LP+D + + S V KQVG Q S L T KQ
Sbjct: 579 LLPARPNLSTISGLVATRTSLPDDRQGEPSTSQPEVVKQVGVFQGSSNGLEPTTKQGQSH 638
Query: 653 NIQK-------------TAEPSLHGGGPR-GNKIFVSGPLL-PTNNVDQLLKEHDQHIQE 697
++K T E SL+G GPR G+KI+VSGPLL P+NNV+Q+LKEHD+ IQE
Sbjct: 639 QVRKPAESHEAGGGKSTTREASLYGRGPRGGSKIYVSGPLLVPSNNVEQMLKEHDRKIQE 698
Query: 698 FARRARLEKIK 708
+AR+ RL+K K
Sbjct: 699 YARK-RLDKTK 708
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225446376|ref|XP_002274225.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2108), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/727 (60%), Positives = 524/727 (72%), Gaps = 66/727 (9%)
Query: 1 MGGKCAKPTAVEDSRERLNRK---EESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLLI 57
MG KP+A++DSRE + +ES R++S RREE + DVKV+LI
Sbjct: 1 MGCIVGKPSAIKDSRESPRERFPNKESAEARGQRLNSLRREE---------SGDVKVVLI 51
Query: 58 DKRVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAIG 117
D++ N S R YD +D+++EK E+ E+ EV +NH P +G
Sbjct: 52 DRKANSSVRVYD---------EDYKLEK--------------EKRERSEVGGVNH-PGMG 87
Query: 118 RLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIH 177
R+PK EGEQVAAGWP+WLA VAGEAIKGWIPRRA+TFEKLDKIGQGTYS+VY+ RDV
Sbjct: 88 RVPKASEGEQVAAGWPSWLAAVAGEAIKGWIPRRADTFEKLDKIGQGTYSNVYKGRDVTR 147
Query: 178 DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237
KIVALKKVRFD+ DPESVKFMAREI +LR+LDHPNIIKLEGL+TS+ S SLYLVFEYME
Sbjct: 148 GKIVALKKVRFDHLDPESVKFMAREILVLRRLDHPNIIKLEGLVTSRKSFSLYLVFEYME 207
Query: 238 HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIAD 297
HDL GLA+LPG KFTE Q+KCYM+QLLSGL+HCHSHGVLHRDIKGSNLL+D+NGILKIAD
Sbjct: 208 HDLTGLAALPGCKFTEPQIKCYMQQLLSGLDHCHSHGVLHRDIKGSNLLIDNNGILKIAD 267
Query: 298 FGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP 357
FGLASFFDP S+ MTSRVVTLWYRPPELLLGA+HYG +VDLWS GCILGEL++GKP++P
Sbjct: 268 FGLASFFDPHRSLSMTSRVVTLWYRPPELLLGATHYGVSVDLWSAGCILGELYAGKPIMP 327
Query: 358 GKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLME 417
G+TEVEQLHRIFKLCGSPSED+WRKSKL HS VFKP QPYR +AETFKDFP + + LME
Sbjct: 328 GRTEVEQLHRIFKLCGSPSEDFWRKSKLPHSAVFKPQQPYRCCVAETFKDFPAATVGLME 387
Query: 418 TLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGG 477
TL+SIDPAHRGTA AL SEFFTT+PLAC+PS+LPKYPPSKEIDAKLR+EE RR G GG
Sbjct: 388 TLLSIDPAHRGTAAAALKSEFFTTKPLACDPSSLPKYPPSKEIDAKLREEEVRRQGAGGG 447
Query: 478 RDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRH-HTNSRSKNEMFI-SQKEAAHA--I 532
R Q+ D R KE I APN +AEL++ MQKR NS+S++EMF +Q+EAA I
Sbjct: 448 RGQRVDPERRGSKESRAIAAPNANAELAMSMQKRQGQANSKSRSEMFYRNQEEAASGFPI 507
Query: 533 NPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDPP 592
+P +Q Q KE SK+ +H +A+VSHSGPL++ A W+K GK ++D P
Sbjct: 508 DPPRQSQGVKEVSKNLFEHH-------------SARVSHSGPLVRAAGWSKAGKKHDDLP 554
Query: 593 AVSGRSNLATLSGFVASRTVLPEDHREKSGPS----------YVGVGKQVGGSQRSYKDL 642
S R++LATLSG VA+RT ED REK GPS + G + G R + +
Sbjct: 555 MTSTRADLATLSGLVATRTS-SEDRREKPGPSKLEPRNQMSRFPGSMNESGKHDRKHHNK 613
Query: 643 VSTGKQDCRQNIQKTAEPSLHGGGPRGNKIFVSGPLLPT-NNVDQLLKEHDQHIQEFARR 701
S T EP L NK++ SGPLL T NNVDQ+LK+HD+ +QE RR
Sbjct: 614 FSEDSYLTEDGKGSTKEPILQSNRSNTNKMYFSGPLLVTSNNVDQMLKDHDRKVQELDRR 673
Query: 702 ARLEKIK 708
AR EK+K
Sbjct: 674 ARFEKMK 680
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114928|ref|XP_002316895.1| predicted protein [Populus trichocarpa] gi|222859960|gb|EEE97507.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 811 bits (2094), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/739 (57%), Positives = 525/739 (71%), Gaps = 66/739 (8%)
Query: 1 MGGKCAKPTAVEDS----RERLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLL 56
MG C KP+A+EDS RERL+ K S + V+R +SSRREE R K + D D + +L
Sbjct: 1 MGCLCCKPSAIEDSKESPRERLSSKASS-DLRVSRATSSRREEAYRAKDRCDGNDGRTML 59
Query: 57 IDKRVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAI 116
IDK+VNGS R + + +ERK+ +K E V+ HHP +
Sbjct: 60 IDKQVNGSLRVHGG-------------------EHVERKR------DKSEYAVV-HHPGM 93
Query: 117 GRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
G +PK EGEQVAAGWP+WLA VAGEAIKGW+PRRA++FEKLDKIGQGTYS+VYRARD+
Sbjct: 94 GSIPKATEGEQVAAGWPSWLAAVAGEAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLD 153
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
KIVALKKVRFDN +PESV+FMAREI ILR+LDHPN+IKLEGL+TS+ SCSLYLVFEYM
Sbjct: 154 QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYM 213
Query: 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
EHDL GLA+ PG+KFTE+QVKCYM+QLL GL+HCHS GVLHRDIKGSNLL+D+NGILKIA
Sbjct: 214 EHDLAGLAAHPGLKFTEAQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273
Query: 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
DFGLASF+DP P+TSRVVTLWYRPPELLLGA++YG AVDLWSTGCIL EL++GKP++
Sbjct: 274 DFGLASFYDPAHVQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 333
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG+TEVEQLH+IFKLCGSPSEDYWRKSKL H+T+FKP QPYRR +A+TFK+FP AL LM
Sbjct: 334 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVADTFKEFPPPALALM 393
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
ETL+SIDPA RG+A AL SEFF T+PL C+PS+ PKYPPSKE DAK+RDEE+RR G AG
Sbjct: 394 ETLLSIDPADRGSAASALRSEFFITKPLPCDPSSFPKYPPSKEFDAKMRDEEARRQGAAG 453
Query: 477 GRDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRH-HTNSRSKNEMFISQKE---AAHA 531
+ QK D+ R R+E +PAP+ +AEL + MQKRH +NS+S++E F E +
Sbjct: 454 SKGQKSDMERRGRRESRAVPAPDANAELVLSMQKRHGQSNSKSRSEKFNPHPEEVASGFP 513
Query: 532 INPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDP 591
I+P + Q+ + SN P H + SHSGPL A WAK + +D
Sbjct: 514 IDPPRPSQAAE--------------SNMDPQGHQHKRASHSGPLSHRAAWAKASRNPDDA 559
Query: 592 PAVSGRSNLATLSGFVAS-RTVLPEDHREKSGPSYVGVGKQVGGSQRSYKDLV-STGKQD 649
P +S ++L+T+S VA+ R++L ED E+SG + V K + S+K+ S +QD
Sbjct: 560 PKISTGADLSTISSLVAARRSLLSEDRNERSGLAQPEVPKLMARFPGSFKETSESFTQQD 619
Query: 650 CRQNIQKTA-------------EPSLHGGGPRGNKIFVSGPLL-PTNNVDQLLKEHDQHI 695
R Q A +P L G G +G+KI SGPL+ P+ NVDQ+LK+HD+ I
Sbjct: 620 PRHPSQGVAGFHQKEDGRNSSKDPVLLGYGSKGHKIHYSGPLIVPSGNVDQMLKDHDRQI 679
Query: 696 QEFARRARLEKIKPVKAHA 714
QE RRARL+K K K A
Sbjct: 680 QEAVRRARLDKEKVRKVQA 698
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543323|ref|XP_003540111.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 808 bits (2086), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/730 (58%), Positives = 519/730 (71%), Gaps = 62/730 (8%)
Query: 1 MGGKCAKPTAVEDS----RERLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLL 56
MGG C KP+A+EDS RER++ K SL+ V+R +S RRE+ R K + D DV+ L
Sbjct: 1 MGGVCCKPSAIEDSKESPRERMSTKAASLDSRVSRGASLRREDAYRGKDRYDGNDVRTAL 60
Query: 57 IDKRVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAI 116
IDK+ NGS R D + IERK+ E++E C V HP
Sbjct: 61 IDKQGNGSVRLQD--------------------ENIERKR---ERME-CVV-AAQQHPGA 95
Query: 117 GRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
G +PK +EGEQVAAGWP+WLA VAGEAIKGW+PRRA++FEKLDKIGQGTYS+VYRARD+
Sbjct: 96 GSVPKAMEGEQVAAGWPSWLAAVAGEAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLE 155
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
+KIVALKKVRFDN +PESV+FMAREI ILR+LDHPN+IKLEGL+TS+ SCSLYLVFEYM
Sbjct: 156 QNKIVALKKVRFDNLEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYM 215
Query: 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
EHDL GLAS P +KFTE+QVKCYM+QLL GL+HCH+ GVLHRDIKGSNLL+D+NGILKIA
Sbjct: 216 EHDLAGLASHPKLKFTEAQVKCYMQQLLQGLDHCHNCGVLHRDIKGSNLLIDNNGILKIA 275
Query: 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
DFGLAS FDP + P+TSRVVTLWYRPPELLLGA++YG AVDLWSTGCIL EL++GKP++
Sbjct: 276 DFGLASVFDPNQTQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 335
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG+TEVEQLH+IFKLCGSPSEDYWRKSKL H+T+FKP QPY R +A+TFKDFP AL LM
Sbjct: 336 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPRQPYWRCVADTFKDFPAPALALM 395
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
ETL+SIDPA RGTA AL S+FFTT+PL C+PS+LPKYPPSKE DAKLRDE++RR G G
Sbjct: 396 ETLLSIDPADRGTAASALKSDFFTTKPLPCDPSSLPKYPPSKEFDAKLRDEQARRQGATG 455
Query: 477 GRDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRH-HTNSRSKNEMFISQKEAAHA--I 532
R Q+ DL R KE +PAP+ +AEL + MQKR S+S++E F E A I
Sbjct: 456 SRGQRHDLERRGAKESRAVPAPDANAELPLSMQKRQSQAQSKSRSEKFNPHPEEASGFPI 515
Query: 533 NPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDPP 592
+P + Q+ E + Q ++ S+SGPL H TA WAK GK +D P
Sbjct: 516 DPPRSSQA-VEVGIETQVPQHKRASHSGPLAHRTA-------------WAKSGKNQDDAP 561
Query: 593 AVSGRSNLATLSGFVASRTVLPEDHREKSGPSYVGVGKQVGGSQRSYKDLV-STGKQDCR 651
+S +L+T+SG VA+R++L +D RE+SG S K S+KD S+ KQD R
Sbjct: 562 KISVGGDLSTISGLVAARSMLSDDRRERSGSSQTEASKLTNRFPGSFKDFSESSIKQDQR 621
Query: 652 QNIQKTAEPS-------------LHGGGPRGNKIFVSGPLLPTNNVDQLLKEHDQHIQEF 698
++Q S L G G G+KI SGPL ++N+DQ+LK+HD+ IQE
Sbjct: 622 HHVQGQVGTSQKEEGRSSNKDLVLVGYGSEGHKIHYSGPLT-SSNMDQVLKDHDRQIQEA 680
Query: 699 ARRARLEKIK 708
RRARL+K K
Sbjct: 681 VRRARLDKAK 690
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128322|ref|XP_002329133.1| predicted protein [Populus trichocarpa] gi|222869802|gb|EEF06933.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2078), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/742 (56%), Positives = 523/742 (70%), Gaps = 72/742 (9%)
Query: 1 MGGKCAKPTAVEDS----RERLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLL 56
MG C KP+A+EDS RERL+ K S + V+R +SSRREE R K + D+ D + +L
Sbjct: 1 MGCMCCKPSAIEDSKESPRERLSSKPSS-DLRVSRATSSRREEAYRAKDQYDSNDGRTML 59
Query: 57 IDKRVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAI 116
IDK+VNGS R H VE VD + +K E V+ HHP +
Sbjct: 60 IDKQVNGSLRV-------------HGVEH------------VDRKRDKSEYAVL-HHPGM 93
Query: 117 GRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
G +PK EGEQVAAGWP+WLA VAGEAIKGW+PRRA++FEKLDKIGQGTYS+VYRARD+
Sbjct: 94 GSIPKATEGEQVAAGWPSWLAAVAGEAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLD 153
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
KIVALKKVRFDN +PESV+FMAREI ILR+LDHPN+IKLEGL+TS+ SCSLYLVFEYM
Sbjct: 154 QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYM 213
Query: 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
EHDL GLAS PG+ FTE+QVKCYM+QLL GL+HCHS GVLHRDIKGSNLL+D+NGILKIA
Sbjct: 214 EHDLAGLASHPGLNFTEAQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 273
Query: 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
DFGLASF+DP P+TSRVVTLWYRPPELLLGA++YG AVDLWSTGCIL EL++GKP++
Sbjct: 274 DFGLASFYDPAQVQPLTSRVVTLWYRPPELLLGATYYGIAVDLWSTGCILAELYAGKPIM 333
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG+TEVEQLH+IFKLCGSPSEDYWRKSKL H+T+FKP QPYRR +AETFK+FP AL LM
Sbjct: 334 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVAETFKEFPAPALALM 393
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
ETL++IDP RG+A AL SEFFTT+PL C+PS+LP YPPSKE DAK+RDEE+RR G AG
Sbjct: 394 ETLLAIDPVDRGSAASALRSEFFTTKPLPCDPSSLPDYPPSKEFDAKMRDEEARRQGAAG 453
Query: 477 GRDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRH-HTNSRSKNEMFISQKE---AAHA 531
+ QK D+ R ++E +PAP+ +AEL + MQKRH NS+S++E F E +
Sbjct: 454 SKGQKPDMERRGQRESRAVPAPDANAELVLSMQKRHGRPNSKSRSEKFNPHPEEVASGFP 513
Query: 532 INPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDP 591
I+P + Q+ + SN P H + SHSGPL + WAK G+ +D
Sbjct: 514 IDPPRPSQAAE--------------SNMDPQGHQHKRASHSGPLSHRSGWAKAGRNPDDA 559
Query: 592 PAVSGRSNLATLSGF-VASRTVLPEDHREKSGPSYVGVGKQVGGSQRSYKDL-------- 642
P + ++L+T+S A R++L EDHRE+SG S V K + S+K+
Sbjct: 560 PKIYTGADLSTISSLEAARRSLLSEDHRERSGLSQPEVPKLMARFPGSFKETSESFAQQD 619
Query: 643 ---VSTG------KQDCRQNIQKTAEPSLHGGGPRGNKIFVSGPLL-PTNNVDQLLKEHD 692
+S G K+D R N + +P L G G + +KI SGPL+ P+ N+DQ+LK+HD
Sbjct: 620 PQRLSQGVAGSHQKEDGRNN---SKDPVLLGYGSKAHKIHYSGPLIVPSGNMDQMLKDHD 676
Query: 693 QHIQEFARRARLEKIKPVKAHA 714
+ IQE RRAR +K + K A
Sbjct: 677 RQIQEAVRRARFDKARVRKVQA 698
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356544039|ref|XP_003540463.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2067), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/730 (57%), Positives = 519/730 (71%), Gaps = 64/730 (8%)
Query: 1 MGGKCAKPTAVEDS----RERLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLL 56
MG C KP+A+EDS RERL+ K S + V+R +SSRREE R K + DN D + L
Sbjct: 1 MGCMCCKPSAIEDSKESPRERLSSKAVS-DLRVSRGASSRREEAFRVKDRYDNNDGRTAL 59
Query: 57 IDKRVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAI 116
IDK+ NGS R + ERK+ EK E V HP I
Sbjct: 60 IDKQGNGSVRVQG--------------------ESFERKR------EKMEYAVA-QHPGI 92
Query: 117 GRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
G +PK +EGEQVAAGWP+WLA VAGEAIKGW+PRRA++FEKLDKIGQGTYS+VYRARD+
Sbjct: 93 GSVPKAMEGEQVAAGWPSWLAAVAGEAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLE 152
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
K+VALKKVRFDN +PESV+FMAREI ILR+LDHPN+IKLEGL+TS+ SCSLYLVFEYM
Sbjct: 153 QRKVVALKKVRFDNLEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYM 212
Query: 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
EHDL GLAS PG+KFTE+QVKCYM+QLL GL+HCHS GVLHRDIKGSNLL+D+NGILKIA
Sbjct: 213 EHDLAGLASHPGLKFTEAQVKCYMQQLLRGLDHCHSCGVLHRDIKGSNLLIDNNGILKIA 272
Query: 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
DFGLASFFDP + P+TSRVVTLWYRPPELLLGA++YG AVDLWSTGCIL EL++GKP++
Sbjct: 273 DFGLASFFDPNQAQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 332
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG+TEVEQLH+IFKLCGSPSEDYWRKSKL H+T+FKP QPYRR ++ETFK+FP A+ L+
Sbjct: 333 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVSETFKEFPAPAIELI 392
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
ETL+SIDPA RGT+ ALNSEFF+T+PL C+PS+LPKYPPSKE DAK+RDEE+RR G AG
Sbjct: 393 ETLLSIDPADRGTSASALNSEFFSTKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQGAAG 452
Query: 477 GRDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRH-HTNSRSKNEMFISQKE---AAHA 531
+ Q+ DL R +E IPAP+ +AEL + MQKR NS+SK+E F E +
Sbjct: 453 SKGQRHDLERRGARESRAIPAPDANAELVLSMQKRQGQANSQSKSEKFNPHPEEVASGFP 512
Query: 532 INPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDP 591
I+P + Q+ + P VH + SHSGPL A WAK GK +D
Sbjct: 513 IDPPRPSQAAGLIAD--------------PPVHQHKRASHSGPLTHRAAWAKAGKNQDDA 558
Query: 592 PAVSGRSNLATLSGFVAS-RTVLPEDHREKSGPSYVGVGKQVGGSQRSYKDLV-STGKQD 649
P +S +L+T+SG VA+ R++L +D RE+SG S K + S+K+ S +QD
Sbjct: 559 PKISMVGDLSTVSGLVAARRSMLSDDRRERSGSSQTVAPKLINRFPGSFKEASESMMQQD 618
Query: 650 CRQNIQ----------KTAEPSLHGGGPRGNKIFVSGPLL-PTNNVDQLLKEHDQHIQEF 698
+ + + +L G G +G+KI SGPLL P++N DQ+LK+HD+ IQE
Sbjct: 619 QKYHAHVPQKEEGRGSSNKDSNLVGYGSKGHKIHHSGPLLVPSSNHDQMLKDHDRQIQEV 678
Query: 699 ARRARLEKIK 708
RRARL+K K
Sbjct: 679 VRRARLDKAK 688
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461467|ref|XP_002285008.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 797 bits (2058), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/733 (57%), Positives = 523/733 (71%), Gaps = 67/733 (9%)
Query: 1 MGGKCAKPTAVEDSRE----RLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLL 56
MG C KP+A+EDSRE RL+ K S N VA +SSRREE R K + D+ D + +L
Sbjct: 2 MGCICCKPSAIEDSRESPRERLSSKASS-NLRVAGPASSRREEAYRVKDRFDSNDGRTML 60
Query: 57 IDKRVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAI 116
I+K+ NGS R + + +ERK++ E V+ HP +
Sbjct: 61 IEKQANGSVRLHG--------------------ENVERKRERGEY-------VVAQHPGL 93
Query: 117 GRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
G +PK +EGEQVAAGWP WL+ VAGEAI+GW+PRRA++FEKLDKIGQGTYS+VYRARD+
Sbjct: 94 GSIPKAMEGEQVAAGWPAWLSAVAGEAIRGWLPRRADSFEKLDKIGQGTYSNVYRARDLD 153
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
KIVALKKVRFDN +PESV+FMAREI +LR+LDHPNIIKLEGL+TS+ SCSLYLVFEYM
Sbjct: 154 QRKIVALKKVRFDNLEPESVRFMAREIHVLRRLDHPNIIKLEGLVTSRMSCSLYLVFEYM 213
Query: 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
EHDL GLAS PG+KFTE QVKCYM+QLL GL+HCHS GVLHRDIKGSNLL+D++GILKIA
Sbjct: 214 EHDLAGLASHPGLKFTEPQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNSGILKIA 273
Query: 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
DFGLASFFDP P+TSRVVTLWYRPPELLLGA++YG AVDLWSTGCIL EL++GKP++
Sbjct: 274 DFGLASFFDPHQIQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 333
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG+TEVEQLH+IFKLCGSPSEDYWRKSKL H+T+FKP QPYRR +AETFKDFPT AL LM
Sbjct: 334 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVAETFKDFPTPALGLM 393
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
ETL+SIDPA RG+A AL SEFFT +PL C+PS+LPKYPPSKE DAK+RDEE+RR G A
Sbjct: 394 ETLLSIDPADRGSAASALKSEFFTVKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQG-AT 452
Query: 477 GRDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRH-HTNSRSKNEMFISQKE---AAHA 531
G+ Q+ D R +E +PAP+ +AEL + MQKR +NS+S++E F E +
Sbjct: 453 GKGQRLDHERKGIRESRAVPAPDANAELVLSMQKRQGQSNSKSRSEKFNPHPEEVASGFP 512
Query: 532 INPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDP 591
I+P + Q+ ++ S D GPL + SHSGPL A WAK GK +D
Sbjct: 513 IDPPRPSQAIEDGSID----------TQGPL---HKRASHSGPLAHRAVWAKAGKNLDDA 559
Query: 592 PAVSGRSNLATLSGFVAS-RTVLPEDHREKSGPSYVGVGKQVGGSQRSYKDLV-STGKQD 649
P VS ++L+T+S VA+ R++L ED REKSG S V K + S+K+ ST +QD
Sbjct: 560 PKVSTGADLSTMSSLVAARRSLLSEDRREKSGSSQPDVSKLIVRFPGSFKEASESTIQQD 619
Query: 650 CRQNIQ-------------KTAEPSLHGGGPRGNKIFVSGPLL-PTNNVDQLLKEHDQHI 695
+ +Q + +P L G G +G+KI SGPLL P+ VDQ+LK+HD+ I
Sbjct: 620 QKHQMQGAGRCTQKEDGRMTSKDPVLLGYGSKGHKIHYSGPLLVPSGKVDQMLKDHDRQI 679
Query: 696 QEFARRARLEKIK 708
Q+ RRARL++ K
Sbjct: 680 QDAERRARLDREK 692
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143004|emb|CBI20299.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/733 (57%), Positives = 523/733 (71%), Gaps = 67/733 (9%)
Query: 1 MGGKCAKPTAVEDSRE----RLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLL 56
MG C KP+A+EDSRE RL+ K S N VA +SSRREE R K + D+ D + +L
Sbjct: 1 MGCICCKPSAIEDSRESPRERLSSKASS-NLRVAGPASSRREEAYRVKDRFDSNDGRTML 59
Query: 57 IDKRVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAI 116
I+K+ NGS R + + +ERK++ E V+ HP +
Sbjct: 60 IEKQANGSVRLHG--------------------ENVERKRERGEY-------VVAQHPGL 92
Query: 117 GRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
G +PK +EGEQVAAGWP WL+ VAGEAI+GW+PRRA++FEKLDKIGQGTYS+VYRARD+
Sbjct: 93 GSIPKAMEGEQVAAGWPAWLSAVAGEAIRGWLPRRADSFEKLDKIGQGTYSNVYRARDLD 152
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
KIVALKKVRFDN +PESV+FMAREI +LR+LDHPNIIKLEGL+TS+ SCSLYLVFEYM
Sbjct: 153 QRKIVALKKVRFDNLEPESVRFMAREIHVLRRLDHPNIIKLEGLVTSRMSCSLYLVFEYM 212
Query: 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
EHDL GLAS PG+KFTE QVKCYM+QLL GL+HCHS GVLHRDIKGSNLL+D++GILKIA
Sbjct: 213 EHDLAGLASHPGLKFTEPQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNSGILKIA 272
Query: 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
DFGLASFFDP P+TSRVVTLWYRPPELLLGA++YG AVDLWSTGCIL EL++GKP++
Sbjct: 273 DFGLASFFDPHQIQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 332
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG+TEVEQLH+IFKLCGSPSEDYWRKSKL H+T+FKP QPYRR +AETFKDFPT AL LM
Sbjct: 333 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVAETFKDFPTPALGLM 392
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
ETL+SIDPA RG+A AL SEFFT +PL C+PS+LPKYPPSKE DAK+RDEE+RR G A
Sbjct: 393 ETLLSIDPADRGSAASALKSEFFTVKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQG-AT 451
Query: 477 GRDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRH-HTNSRSKNEMFISQKE---AAHA 531
G+ Q+ D R +E +PAP+ +AEL + MQKR +NS+S++E F E +
Sbjct: 452 GKGQRLDHERKGIRESRAVPAPDANAELVLSMQKRQGQSNSKSRSEKFNPHPEEVASGFP 511
Query: 532 INPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDP 591
I+P + Q+ ++ S D GPL + SHSGPL A WAK GK +D
Sbjct: 512 IDPPRPSQAIEDGSID----------TQGPL---HKRASHSGPLAHRAVWAKAGKNLDDA 558
Query: 592 PAVSGRSNLATLSGFVAS-RTVLPEDHREKSGPSYVGVGKQVGGSQRSYKDLV-STGKQD 649
P VS ++L+T+S VA+ R++L ED REKSG S V K + S+K+ ST +QD
Sbjct: 559 PKVSTGADLSTMSSLVAARRSLLSEDRREKSGSSQPDVSKLIVRFPGSFKEASESTIQQD 618
Query: 650 CRQNIQ-------------KTAEPSLHGGGPRGNKIFVSGPLL-PTNNVDQLLKEHDQHI 695
+ +Q + +P L G G +G+KI SGPLL P+ VDQ+LK+HD+ I
Sbjct: 619 QKHQMQGAGRCTQKEDGRMTSKDPVLLGYGSKGHKIHYSGPLLVPSGKVDQMLKDHDRQI 678
Query: 696 QEFARRARLEKIK 708
Q+ RRARL++ K
Sbjct: 679 QDAERRARLDREK 691
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517145|ref|XP_003527250.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2049), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/730 (57%), Positives = 518/730 (70%), Gaps = 62/730 (8%)
Query: 1 MGGKCAKPTAVEDS----RERLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLL 56
MGG C KP+A+EDS RER++ K SL+ V R +S RRE+ R K + D +V+ L
Sbjct: 1 MGGVCCKPSAIEDSKESPRERMSTKSASLDSCVPRGASLRREDAYRVKDRYDGNNVRTAL 60
Query: 57 IDKRVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAI 116
IDK+ NGS R + + +ERK+ E++E C V HP
Sbjct: 61 IDKQGNGSVR--------------------LQSENVERKR---ERME-CVV-AAQQHPGA 95
Query: 117 GRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
G +PK +EGEQVAAGWP+WLA VAGEAIKGW+PRRA++FEKLDKIGQGTYS+VYRARD+
Sbjct: 96 GSVPKALEGEQVAAGWPSWLAAVAGEAIKGWLPRRADSFEKLDKIGQGTYSNVYRARDLE 155
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
KIVALKKVRFDN +PESV+FMAREI ILR+LDHPN+IKLEGL+TS+ SCSLYLVFEYM
Sbjct: 156 QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYM 215
Query: 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
EHDL GLAS P +KFTE+QVKCYM+QLL GLEHCH+ GVLHRDIKGSNLL+D+NGILKIA
Sbjct: 216 EHDLAGLASHPKLKFTEAQVKCYMQQLLRGLEHCHNCGVLHRDIKGSNLLIDNNGILKIA 275
Query: 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
DFGLAS FDP + P+TSRVVTLWYRPPELLLGA++YG AVDLWSTGCIL EL++GKP++
Sbjct: 276 DFGLASVFDPNRTQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 335
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG+TEVEQLH+IFKLCGSPSEDYWRKSKL H+T+FKP QPYRR +A+TFKDF AL LM
Sbjct: 336 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVADTFKDFAAPALALM 395
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
ETL+SIDPA RGTA AL SEFFTT+PL C+PS+LPKYPPSKE+DAKLRDE++RR G G
Sbjct: 396 ETLLSIDPADRGTAASALKSEFFTTKPLPCDPSSLPKYPPSKELDAKLRDEQARRQGATG 455
Query: 477 GRDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRH-HTNSRSKNEMFISQKEAAHA--I 532
+ Q+ DL R +E +PAP+ +AEL + MQKR S+S++E F E A I
Sbjct: 456 SKGQRHDLERRGARESRAVPAPDANAELPLSMQKRQSQAQSKSRSEKFNPHLEEASGFPI 515
Query: 533 NPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDPP 592
+P + Q+ E + Q ++ S+SGPL H TA W K GK +D P
Sbjct: 516 DPPRPSQA-VEVGIEPQVPQHKRASHSGPLAHRTA-------------WGKAGKNQDDAP 561
Query: 593 AVSGRSNLATLSGFVASRTVLPEDHREKSGPSYVGVGKQVGGSQRSYKDLVSTG-KQDCR 651
+S +L+T+SG VA+R++L +D RE+SG S + K + S+KD+ KQD R
Sbjct: 562 KISVGGDLSTISGLVAARSMLSDDRRERSGSSQMEASKLMNRFPGSFKDISELLIKQDQR 621
Query: 652 QNIQKTAEPS-------------LHGGGPRGNKIFVSGPLLPTNNVDQLLKEHDQHIQEF 698
++ S L G G +G+KI SGPL ++N+DQ+LK+HD+ IQE
Sbjct: 622 HHVPGQVGTSQKEEGRSSNKDLVLVGYGSKGHKIHYSGPLT-SSNMDQVLKDHDRQIQEA 680
Query: 699 ARRARLEKIK 708
RRARL+K K
Sbjct: 681 VRRARLDKAK 690
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357452947|ref|XP_003596750.1| Serine/threonine protein kinase cdk9 [Medicago truncatula] gi|355485798|gb|AES67001.1| Serine/threonine protein kinase cdk9 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/734 (57%), Positives = 521/734 (70%), Gaps = 68/734 (9%)
Query: 1 MGGKCAKPTAVEDS----RERLNRKEESLNKHVARVSSSRREEVVRPKGKGDNT-DVKVL 55
MG C KP+A+EDS RERL+ K L+ V+R +SSRREE R K + DN D ++
Sbjct: 1 MGCMCCKPSAIEDSKDSPRERLSNKP-VLDSRVSRGASSRREEAYRVKDRNDNNNDARMA 59
Query: 56 LIDK--RVNGSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHH 113
LIDK + NGS R + D ERK+ EK E VI H
Sbjct: 60 LIDKHGQGNGSVRVHG--------------------DNFERKR------EKMEY-VIAPH 92
Query: 114 PAIGRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRAR 173
P IG +PK +EGE VAAGWP+WLA VAG+AIKGW+PRRA++FEKLDKIGQGTYS+VYRAR
Sbjct: 93 PGIGSVPKAMEGEHVAAGWPSWLAAVAGDAIKGWLPRRADSFEKLDKIGQGTYSNVYRAR 152
Query: 174 DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233
D+ KIVALKKVRFDN +PESV+FMAREI ILR+LDHPN+IKLEGL+TS+ SCSLYLVF
Sbjct: 153 DLEQRKIVALKKVRFDNLEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVF 212
Query: 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGIL 293
EYMEHDL GLAS PG+KFTESQVKCYM+QLL GL+HCHS GVLHRDIKGSNLL+D+NG+L
Sbjct: 213 EYMEHDLAGLASHPGLKFTESQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNNGVL 272
Query: 294 KIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK 353
KIADFGLASFFDP + P+TSRVVTLWYRPPELLLGA++YG AVDLWSTGCIL EL++GK
Sbjct: 273 KIADFGLASFFDPNLNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 332
Query: 354 PVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSAL 413
P++PG+TEVEQLH+IFKLCGSPSEDYWRKSKL H+T+FKP QPYRR +AETFK+FP A+
Sbjct: 333 PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVAETFKEFPAPAI 392
Query: 414 RLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHG 473
L+ETL+SIDPA RGT+ AL SEFF+T+PL C+PS+LPKYPPSKE DAK+RDEE+RR G
Sbjct: 393 ELIETLLSIDPADRGTSASALISEFFSTKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQG 452
Query: 474 VAGGRDQKGDLHRSWRKEYLPIPAPNRDAELSI-MQKRHHTN-SRSKNEMFISQKEAAHA 531
AG + Q+ D R +E +PAP+ +AEL + MQKR N S+S++E F E A +
Sbjct: 453 AAGSKGQRHDPERRGVRESRAVPAPDANAELVVSMQKRQGQNYSQSRSEKFNPHPEDAGS 512
Query: 532 ---INPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGY 588
I P + Q+ + +N P + + SHSGPL A WAK GK
Sbjct: 513 GFPIEPPRPSQAAE--------------ANVDPQANQHKRASHSGPLTHRAAWAKAGKNQ 558
Query: 589 NDPPAVSGRSNLATLSGFVAS-RTVLPEDHREKSGPSYVGVGKQVG---GSQRSYKDLVS 644
+D P +S +L+T+SG VA+ R++L +D RE SG S V K + GS + + +
Sbjct: 559 DDAPKISVGGDLSTMSGLVAARRSMLSDDRRESSGSSQVEAPKLITRFPGSFKEASESLM 618
Query: 645 TGKQDCRQNIQKTA---------EPSLHGGGPRGNKIFVSGPLL-PTNNVDQLLKEHDQH 694
Q+ + ++ + +P+ G G +G KI SGPLL P++N+DQ+LK+HD+
Sbjct: 619 QQNQNQKHHVHASQKEDAKGSNKDPNNVGYGSKGYKIHYSGPLLVPSSNMDQMLKDHDRQ 678
Query: 695 IQEFARRARLEKIK 708
IQE RRARL+K K
Sbjct: 679 IQEAVRRARLDKAK 692
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | ||||||
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.682 | 0.701 | 0.637 | 1.4e-172 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.728 | 0.702 | 0.568 | 4.6e-163 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.703 | 0.779 | 0.562 | 3.3e-158 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.656 | 0.656 | 0.580 | 1.9e-153 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.626 | 0.780 | 0.588 | 3e-149 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.549 | 0.638 | 0.618 | 1.4e-142 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.647 | 0.796 | 0.584 | 2.4e-140 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.634 | 0.638 | 0.559 | 4e-138 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.796 | 0.814 | 0.494 | 1.3e-137 | |
| TAIR|locus:2096199 | 593 | AT3G05050 [Arabidopsis thalian | 0.561 | 0.676 | 0.619 | 6e-135 |
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1636 (581.0 bits), Expect = 1.4e-172, Sum P(2) = 1.4e-172
Identities = 318/499 (63%), Positives = 389/499 (77%)
Query: 119 LPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHD 178
+ K EGE VAAGWP WLA+VAGEAI+GW+PRRA++FEKLDKIGQGTYS+VYRARD+
Sbjct: 98 IAKATEGEYVAAGWPPWLASVAGEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQK 157
Query: 179 KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH 238
KIVALKKVRFDN +PESV+FMAREI ILR+LDHPNIIKLEGL+TS+ SCSLYLVFEYMEH
Sbjct: 158 KIVALKKVRFDNLEPESVRFMAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEH 217
Query: 239 DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298
DL GLAS P +KF+ESQVKCY++QLL GL+HCHS GVLHRDIKGSNLL+D++G+LKIADF
Sbjct: 218 DLAGLASHPAIKFSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADF 277
Query: 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPG 358
GLASFFDP+ + P+TSRVVTLWYRPPELLLGA+ YGAAVDLWS GCIL EL++GKP++PG
Sbjct: 278 GLASFFDPRQTQPLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPG 337
Query: 359 KTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMET 418
+TEVEQLH+IFKLCGSP+EDYW KS+L H+T+FKP QPY+R + ETFK+FP AL L+ET
Sbjct: 338 RTEVEQLHKIFKLCGSPTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLET 397
Query: 419 LMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGR 478
L+S++P RGTAT AL SEFF+T+PL C+PS+LPKYPPSKE+DA++RDEESRR V G R
Sbjct: 398 LLSVNPDDRGTATAALKSEFFSTRPLPCDPSSLPKYPPSKELDARMRDEESRRQ-VGGNR 456
Query: 479 DQKGDLHRSWRKEYLPIPAPNRDAEL-SIMQKRH-HTNSRSKNEMFISQKEAAHAINPTK 536
DQ+ R KE IPAP+ +AEL + MQKR + +RS++E F E + P
Sbjct: 457 DQRHQERRG-TKESRAIPAPDANAELVASMQKRQSQSTNRSRSEKFNPHPEEVASGFPID 515
Query: 537 QRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYNDPPAVSG 596
+ +A + R N P H A SHSGPL + + AK + Y D VS
Sbjct: 516 PPRPSSQA----FEPNRESQGNIIP--HKRA--SHSGPLSRRSASAKGRRNYQDSQKVSS 567
Query: 597 RSNLATLSGFVASRTVLPE 615
++ + + GF A+RT P+
Sbjct: 568 IADYSAMPGFAATRTGAPQ 586
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1545 (548.9 bits), Expect = 4.6e-163, Sum P(2) = 4.6e-163
Identities = 308/542 (56%), Positives = 384/542 (70%)
Query: 78 IDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAIGRL---PKGVEGEQVAAGWPT 134
I+ ++ M + + +K V++ + V V++ G PK E +QVAAGWP+
Sbjct: 133 IESEKLSSSMFSEHHQIEKGVEKPEVEASVRVVHRELKRGSSIVSPKDAERKQVAAGWPS 192
Query: 135 WLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPE 194
WL +VAGE++ W PRRANTFEKL+KIGQGTYSSVYRARD++H+KIVALKKVRFD D E
Sbjct: 193 WLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSVYRARDLLHNKIVALKKVRFDLNDME 252
Query: 195 SVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTES 254
SVKFMAREI ++R+LDHPN++KLEGLIT+ S SLYLVFEYM+HDL+GL+SLPG+KFTE
Sbjct: 253 SVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSLYLVFEYMDHDLLGLSSLPGVKFTEP 312
Query: 255 QVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314
QVKCYM+QLLSGLEHCHS GVLHRDIKGSNLL+D G+LKIADFGLA+FFDP SV +TS
Sbjct: 313 QVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDSKGVLKIADFGLATFFDPAKSVSLTS 372
Query: 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGS 374
VVTLWYRPPELLLGASHYG VDLWSTGCILGEL++GKP+LPGKTEVEQLH+IFKLCGS
Sbjct: 373 HVVTLWYRPPELLLGASHYGVGVDLWSTGCILGELYAGKPILPGKTEVEQLHKIFKLCGS 432
Query: 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLAL 434
P+E+YWRK KL S FK PYRR+++E FKDFP S L L+ETL+SIDP HR +A AL
Sbjct: 433 PTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFPASVLSLLETLLSIDPDHRSSADRAL 492
Query: 435 NSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLP 494
SE+F T+P AC+PSNLPKYPPSKEIDAK+RDE R+ + + ++ D E
Sbjct: 493 ESEYFKTKPFACDPSNLPKYPPSKEIDAKMRDEAKRQQPMRAEKQERQDSMTRISHERKF 552
Query: 495 IPAPNRDAELSIMQKRHHTNSRSKNEMFISQKEAAHAINPTKQRQSGKEASKDFLDHQRR 554
+P + LS+ ++ + + RS+N+ F S KE P Q+ + H R
Sbjct: 553 VPPVKANNSLSMTMEKQYKDLRSRNDSFKSFKEERTPHGPVPDYQN--------MQHNRN 604
Query: 555 KVSNSGPLVHGTAKVSHSGPLIQGATWAKVGKGYND---PPAVSGRSNLATLSGFVASRT 611
+ +G ++SHSGPL+ AK + P R N LSG V+S+T
Sbjct: 605 --NQTG------VRISHSGPLMSNRNMAKSTMHVKENALPRYPPARVNPKMLSGSVSSKT 656
Query: 612 VL 613
+L
Sbjct: 657 LL 658
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1438 (511.3 bits), Expect = 3.3e-158, Sum P(2) = 3.3e-158
Identities = 293/521 (56%), Positives = 364/521 (69%)
Query: 22 EESLNKHVAXXXXXXXXXXXXPKGKGDNTDVKVLLIDKRVNGSNRYYDHHKIEKIAIDDH 81
+E+L K + K + D ++ KV LI+ S+R+ + H+ E I D
Sbjct: 18 KETLEKRSSRINSSRIDDSSQTKEEQDRSN-KVRLIESEKFSSSRFSEKHQ-EIAEIGDT 75
Query: 82 QVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAIGRLPKGVEGE-QVAAGWPTWLATVA 140
++ + E K+ E +V+ I P+ V E ++AAGWP WL +VA
Sbjct: 76 DEDEDDDHHPPEELKR--------EPSVV-----IPPSPETVSKEAELAAGWPAWLVSVA 122
Query: 141 GEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA 200
GEA+ W PRRA+TFEKL+KIGQGTYSSVY+ARD+ ++KIVALK+VRFD D ESVKFMA
Sbjct: 123 GEALVNWTPRRASTFEKLEKIGQGTYSSVYKARDLTNNKIVALKRVRFDLSDLESVKFMA 182
Query: 201 REIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYM 260
REI ++R+LDHPN++KLEGLIT+ S SLYLVFEYM+HDLVGLAS+PG+KF+E QVKCYM
Sbjct: 183 REIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDHDLVGLASIPGIKFSEPQVKCYM 242
Query: 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW 320
+QLLSGL HCHS GVLHRDIKGSNLL+D NG+LKIADFGLA+FFDP++ VP+TSRVVTLW
Sbjct: 243 QQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFGLATFFDPQNCVPLTSRVVTLW 302
Query: 321 YRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380
YRPPELLLGA HYG VDLWSTGCILGEL+SGKP+L GKTEVEQLH+IFKLCGSP+EDYW
Sbjct: 303 YRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGKTEVEQLHKIFKLCGSPTEDYW 362
Query: 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
RK KL S F+P PY RR+AE FKD PT+ L L+E L+SIDP RG+A AL SE+F
Sbjct: 363 RKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEALLSIDPDRRGSAARALESEYFR 422
Query: 441 TQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRD-QKGDLHRSWRKEYLPIPAPN 499
T+P AC+PS+LPKYPPSKEIDAK+RD+ R+ + Q RS ++ +P P
Sbjct: 423 TEPFACDPSSLPKYPPSKEIDAKIRDDAKRQRPTQEKHERQDSQTRRSHERKLIP-PVKA 481
Query: 500 RDAELSIMQKRHHTNSRSKNEMFISQKEAAHAINPTKQRQS 540
+ LS + + S Q + NPT R S
Sbjct: 482 NNPSLSTAVENPYLRSCVPGNSQ-RQMQDMTCNNPTSGRVS 521
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1418 (504.2 bits), Expect = 1.9e-153, Sum P(2) = 1.9e-153
Identities = 284/489 (58%), Positives = 357/489 (73%)
Query: 80 DHQVEKKMIYDQIERKKKVDEQIEKCEVNVIN----HHPAIGRL---PKGVEGEQVAAGW 132
D + EKK+ ++ + + EV N P + R+ G G QV AGW
Sbjct: 81 DDESEKKVNLERKSSRLVFQRRPTGIEVGANNIGTLQQPKMTRICSVSNGERGAQVMAGW 140
Query: 133 PTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD 192
P+WLA+VAGEAI GWIPR+A++FEKL+KIGQGTYSSVY+ARD+ +++VALKKVRF N D
Sbjct: 141 PSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKVRFANMD 200
Query: 193 PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFT 252
P+SV+FMAREI ILR+LDHPN++KLEGLITS+ S S+YL+FEYMEHDL GLAS PG+ F+
Sbjct: 201 PDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFS 260
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312
E+Q+KCYMKQLL GLEHCHS GVLHRDIKGSNLLLDHN LKI DFGLA+F+ P+
Sbjct: 261 EAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPL 320
Query: 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLC 372
TSRVVTLWYRPPELLLG++ YG VDLWSTGCIL ELF+GKP++PG+TEVEQLH+IFKLC
Sbjct: 321 TSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLC 380
Query: 373 GSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATL 432
GSPSE+YW+ SKL H+T+FKP QPY+R +AETFK P+SAL L+E L++++P RGT
Sbjct: 381 GSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTAS 440
Query: 433 ALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEY 492
AL SEFFTT PLA +PS+LPKY P KEID K ++EE++R + + +E
Sbjct: 441 ALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQNDS---KQVSRES 497
Query: 493 LPIPAPNRDAE-LSIMQKRH-HTNSRSKNEMFISQKEAAH-AINPTKQRQSGKEASKDFL 549
+PAP+ +AE L+ +QKR N S ++ F ++AA I P K SG +KD
Sbjct: 498 KAVPAPDSNAESLTSIQKRQGQHNQVSNSDKFNPGEDAASFRIEPLK---SG--TAKD-- 550
Query: 550 DHQRRKVSN 558
H R VS+
Sbjct: 551 GHTRYGVSS 559
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1457 (517.9 bits), Expect = 3.0e-149, P = 3.0e-149
Identities = 272/462 (58%), Positives = 347/462 (75%)
Query: 76 IAIDDHQVEKK--MIYDQIERKKKVDEQIEKCEVNV-------INHHPAIGRLPKGVEGE 126
+ + + V K +I D +E+KK + +K + +P + K GE
Sbjct: 30 VVVGESSVTKSNGVIADDVEKKKNEEANGDKERKSSKGDRRRSTKPNPRLSNPSKHWRGE 89
Query: 127 QVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV 186
QVAAGWP+WL+ GEA+ GW+PR+A+TFEK+DKIGQGTYS+VY+A+D++ KIVALKKV
Sbjct: 90 QVAAGWPSWLSDACGEALNGWVPRKADTFEKIDKIGQGTYSNVYKAKDMLTGKIVALKKV 149
Query: 187 RFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL 246
RFDN +PESVKFMAREI +LR+LDHPN++KLEGL+TS+ SCSLYLVF+YM+HDL GLAS
Sbjct: 150 RFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASS 209
Query: 247 PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306
P +KF+ES+VKC M+QL+SGLEHCHS GVLHRDIKGSNLL+D G+LKIADFGLA+ FDP
Sbjct: 210 PVVKFSESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDP 269
Query: 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366
PMTSRVVTLWYR PELLLGA+ YG +DLWS GCIL EL +G+P++PG+TEVEQLH
Sbjct: 270 NHKRPMTSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLH 329
Query: 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH 426
+I+KLCGSPSEDYW+K K H ++KP +PY+R I ETFKDFP S+L L++ L+SI+P
Sbjct: 330 KIYKLCGSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPED 389
Query: 427 RGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG---GRDQKGD 483
R TA+ AL SEFFT++P AC P++LPKYPPSKEIDAK RDEE+RR A G + +
Sbjct: 390 RQTASAALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARKN 449
Query: 484 LHRSWRKEYLPIPAPNRDAELSIMQKRH---HTNSRSKNEMF 522
HR LP P N + + ++ Q+R H N++SK+E F
Sbjct: 450 RHRDRSNRALPAPEANAELQSNVDQRRRLITHANAKSKSEKF 491
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1312 (466.9 bits), Expect = 1.4e-142, Sum P(2) = 1.4e-142
Identities = 245/396 (61%), Positives = 312/396 (78%)
Query: 76 IAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAIGRLPKGVEGEQVAAGWPTW 135
+ IDD K +I +ER + ++ + N I +P+ E E +AAGWP W
Sbjct: 66 VPIDDSHDGKTVI---VERPSR-SQRGRRVSDNGKGGGLIISNVPRSAEAELIAAGWPYW 121
Query: 136 LATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES 195
L +VAGEAIKGW+PRRA++FEKLDKIGQGTYS VY+ARD+ KIVA+KKVRF N DPES
Sbjct: 122 LTSVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLETGKIVAMKKVRFANMDPES 181
Query: 196 VKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQ 255
V+FMAREI ILRKLDHPN++KL+ L+TS+ S SL+LVFEYMEHDL GLA PG+KFTE Q
Sbjct: 182 VRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLSGLALRPGVKFTEPQ 241
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315
+KC+MKQLL GLEHCHS G+LHRDIKGSNLL++++G+LKI DFGLASF+ P P+TSR
Sbjct: 242 IKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQPLTSR 301
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375
VVTLWYR PELLLG++ YG A+DLWS GCIL ELF KP++PG+TEVEQ+H+IFKLCGSP
Sbjct: 302 VVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFKLCGSP 361
Query: 376 SEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
SE++W +K +T +KP PY+R + ETFK+ +S+L L++ L+S++P R +A+ L
Sbjct: 362 SEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSASSTLL 421
Query: 436 SEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRR 471
SEFFTT+PL C+ S+LPKYPPSKE+DAK+RDEE++R
Sbjct: 422 SEFFTTEPLPCHISSLPKYPPSKELDAKVRDEEAKR 457
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1373 (488.4 bits), Expect = 2.4e-140, P = 2.4e-140
Identities = 277/474 (58%), Positives = 345/474 (72%)
Query: 131 GWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN 190
GWP WL G++IK PRRA T+EKL+KIGQGTYS+VY+A+D++ KIVALKKVRFDN
Sbjct: 90 GWPPWLIAACGDSIKDLTPRRATTYEKLEKIGQGTYSNVYKAKDLLSGKIVALKKVRFDN 149
Query: 191 QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK 250
+ ESVKFMAREI +LR+L+HPN+IKL+GL+TS+ SCSLYLVFEYMEHDL GLA+ G+K
Sbjct: 150 LEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLK 209
Query: 251 FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310
F QVKC+MKQLLSGLEHCHS GVLHRDIKGSNLL+D++GILKIADFGLA+F+DPK
Sbjct: 210 FDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQ 269
Query: 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
MTSRVVTLWYRPPELLLGA+ YG VDLWS GCI+ EL +GKPV+PG+TEVEQLH+IFK
Sbjct: 270 TMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFK 329
Query: 371 LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
LCGSPS+ YW+K +L ++T+FKP PY+R +AE F F S++ L+ETL++IDPA RGT+
Sbjct: 330 LCGSPSDSYWKKYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTS 389
Query: 431 TLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRH-GVAG-GRDQKGDLHRSW 488
T ALNSEFFTT+PL C+PS+LPKYPPSKE++ KLRDEE RR G+AG G G +
Sbjct: 390 TSALNSEFFTTEPLPCDPSSLPKYPPSKELNVKLRDEELRRQKGLAGKGSGIDGARRIRY 449
Query: 489 RKEYL--PIPAPNRDAE----LSIMQKRHHTNSRSKNEMFISQKEAAHAINPTKQRQSGK 542
R + IPAP +AE L + TN +SK+E F + A+ + S K
Sbjct: 450 RGDRTGRAIPAPEANAESQANLDRWRSISQTNGKSKSEKFPPPHQDG-AVGYPLEDLSKK 508
Query: 543 EASKDFLDHQRRKVSNSGPLVHGTA--KVSHSGPLIQGATWAKVGKGYNDPPAV 594
+ +S S GT+ K+S+ +GA+ K G PPA+
Sbjct: 509 TSVFGAKTETSFGLSRSLKSGEGTSMRKISNKDGA-RGASSRKYIWGLKPPPAL 561
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1294 (460.6 bits), Expect = 4.0e-138, Sum P(2) = 4.0e-138
Identities = 265/474 (55%), Positives = 334/474 (70%)
Query: 116 IGRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDV 175
+G L K +E EQVAAGWP WL+ VAGEAI GW+P R++ FEKL+KIGQGTYSSV+RAR+
Sbjct: 92 LGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARET 151
Query: 176 IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235
+IVALKKVRFDN +PESV+FMAREI ILRKL+HPNIIKLEG++TS+ SCS++LVFEY
Sbjct: 152 ETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEY 211
Query: 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKI 295
MEHDL GL S P + FT Q+KCYMKQLLSGL+HCH+ GV+HRDIKGSNLL+++ GILK+
Sbjct: 212 MEHDLTGLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKV 271
Query: 296 ADFGLASFFDPK-DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKP 354
ADFGLA+F + + P+TSRVVTLWYRPPELLLGA+ YGA+VDLWS GC+ EL GKP
Sbjct: 272 ADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKP 331
Query: 355 VLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFK--DFPTSA 412
VL G+TEVEQLH+IFKLCGSP EDYW+KSKL H+ +FKP Q Y + ET K +
Sbjct: 332 VLQGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDAD 391
Query: 413 LRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRH 472
+ L+ETL+SI P RGTA+ AL S++FT++P AC+PS+LP Y PSKEIDAK R++ +R+
Sbjct: 392 INLIETLLSIQPHKRGTASTALVSQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKK 451
Query: 473 GVAGGRDQKGDLHRSWRKEYLPIPAPNRDAELSIMQK-RHHTNS-RSKNEMFISQK-EAA 529
GR +G R P P A+L+ + RHH+ + +N + ++
Sbjct: 452 ISGNGR--RGTESRK------PTRKPPAFAKLAPAEDVRHHSQKFQKRNGHSVHNSIDSD 503
Query: 530 HAINPTKQRQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPLIQGATWAK 583
+ Q+ S E KD H + P G +VS S G WAK
Sbjct: 504 STLFEKMQKPSNHE--KDEASHVKNASQGDVPF-SGPLQVSVSS----GFAWAK 550
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 1.3e-137, P = 1.3e-137
Identities = 311/629 (49%), Positives = 400/629 (63%)
Query: 116 IGRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDV 175
+G + + +E EQVAAGWP WL+ VAGEAI GW+P R++ FEKL+KIGQGTYS+V+RA +
Sbjct: 82 LGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFEKLEKIGQGTYSNVFRAVET 141
Query: 176 IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235
+IVALKKVRFDN +PESVKFMAREI ILR+L+HPNIIKLEGLITS+ SC++ LVFEY
Sbjct: 142 ETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSKLSCNIQLVFEY 201
Query: 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKI 295
MEHDL GL S P +KFT Q+KCYMKQLLSGL+HCHS GV+HRDIKGSNLLL + GILK+
Sbjct: 202 MEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVMHRDIKGSNLLLSNEGILKV 261
Query: 296 ADFGLASFFDPKD--SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK 353
ADFGLA+F + P+TSRVVTLWYRPPELLLGA+ YGA+VDLWS GC+ EL GK
Sbjct: 262 ADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSVGCVFAELLLGK 321
Query: 354 PVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSAL 413
P+L G+TEVEQLH+IFKLCGSP EDYW+KSKL H+ +FKP Q Y + ET KD + +
Sbjct: 322 PILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQTYDSCLRETLKDLSETEI 381
Query: 414 RLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHG 473
L+ETL+SIDP RGTA+ AL S++FTT+P AC+PS+LP YPPSKEID K RDE +R+
Sbjct: 382 NLIETLLSIDPHKRGTASSALVSQYFTTKPFACDPSSLPIYPPSKEIDTKHRDEAARKKI 441
Query: 474 VAGGRDQKG-DLHRSWRKEYLPIPAPNRDAELSIMQKRHHTNSRSKNEMFISQKEAAHAI 532
GR +G D + RK + + NR A RH T E F QK H +
Sbjct: 442 SGNGR--RGIDPRKPSRKAH----SFNRLAP----DVRHQT------ETF--QKRIGHLV 483
Query: 533 NPTKQ---RQSGKEASKDFLDHQRRKVSNSGPLVHGTAKVSHSGPL----IQGATWAK-- 583
+ + + R GK + LDH++ + S+ G V SGPL WAK
Sbjct: 484 HSSIESDARLCGKLQNP--LDHKKDEASHVKHASQGD--VPFSGPLQVSKSNSFAWAKRE 539
Query: 584 ------------VGKGYNDPPAVSGRSNLATLSGFVASRTVLPE--DHREKSGP-SYVGV 628
+ +GY P++SG S V S+ E D + G SY V
Sbjct: 540 KDDVCVRVHNRSLSRGYI--PSLSGHSPAFNGKSDVESKINKDEKEDKTDSRGEESYEMV 597
Query: 629 GKQVGGSQRSYKDLVSTG------KQDCRQNIQKTAEPSLHGGGPRGN--KIFVSGPLLP 680
+ + R + S G Q+ + + E + G G+ KI SGPLL
Sbjct: 598 KRSMLKQWRQLERPDSFGASDEYHSQELSLGLYQRDEMAKKMGNNLGDGDKIEFSGPLLS 657
Query: 681 TN-NVDQLLKEHDQHIQEFARRARLEKIK 708
+ VD+LL+ H+++I++ R+ +K++
Sbjct: 658 QSYGVDELLERHERNIRKLIRKPWFQKVQ 686
|
|
| TAIR|locus:2096199 AT3G05050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1322 (470.4 bits), Expect = 6.0e-135, P = 6.0e-135
Identities = 256/413 (61%), Positives = 314/413 (76%)
Query: 120 PKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDK 179
PK + GEQVAAGWP+WL+ V GEA+ GW+PR+A++FEK+DKIG GTYS+VY+A+D +
Sbjct: 103 PKNLLGEQVAAGWPSWLSEVCGEALSGWLPRKADSFEKIDKIGSGTYSNVYKAKDSLTGN 162
Query: 180 IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239
IVALKKVR D + ES+KFMAREI ILR+LDHPN+IKLEGL+TS+ S SLYLVF YM+HD
Sbjct: 163 IVALKKVRCDVNERESLKFMAREILILRRLDHPNVIKLEGLVTSRMSSSLYLVFRYMDHD 222
Query: 240 LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFG 299
L GLA+ P +KFTE QVKCYMKQLLSGLEHCH+ GVLHRDIKGSNLL+D G+L+I DFG
Sbjct: 223 LAGLAASPEIKFTEQQVKCYMKQLLSGLEHCHNRGVLHRDIKGSNLLIDDGGVLRIGDFG 282
Query: 300 LASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK 359
LA+FFD MT+RVVTLWYR PELL G Y VDLWS GCIL EL +G+ ++PG+
Sbjct: 283 LATFFDASKRQEMTNRVVTLWYRSPELLHGVVEYSVGVDLWSAGCILAELLAGRAIMPGR 342
Query: 360 TEVEQLHRIFKLCGSPSEDYWRKSKL--RHSTVF-KPVQPYRRRIAETFKDFPTSALRLM 416
EVEQLHRI+KLCGSPSE+YW+K +L H KP+ Y+RRI E +KDF AL L+
Sbjct: 343 NEVEQLHRIYKLCGSPSEEYWKKIRLPSTHKHAHHKPLPQYKRRIREVYKDFSPEALSLL 402
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAG 476
+TL+++DPA R TAT L S+FFTT+PLAC PS+LPKYPPSKEIDAK RDEE RR A
Sbjct: 403 DTLLALDPAERQTATDVLMSDFFTTEPLACQPSDLPKYPPSKEIDAKRRDEEYRRQREA- 461
Query: 477 GRDQKGDLHRSWR-KEYLP--IPAPNRDAE----LSIMQKRHHTNSRSKNEMF 522
R +G+ R R +E P +PAP +AE + M+ H N++SK+E F
Sbjct: 462 -RKAQGESGRRMRPRERAPRAMPAPEANAENQSNIDRMRMITHANAKSKSEKF 513
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 714 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-150 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-119 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-108 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-106 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-103 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-103 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-96 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-92 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-91 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-88 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-86 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-84 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-84 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-81 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-79 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-79 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-79 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-76 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-76 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-76 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-74 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-72 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-72 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-71 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-70 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-67 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-67 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-62 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-61 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-60 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-60 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-59 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-59 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-59 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-59 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-58 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-57 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-56 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-56 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-56 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-55 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-54 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-52 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-51 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-51 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-50 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-50 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-48 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-48 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-47 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-46 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-45 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-45 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-45 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-44 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-43 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-41 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-40 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-39 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-39 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-38 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-36 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-35 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-35 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-33 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-29 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-27 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-27 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-27 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-27 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-26 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-26 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-22 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-21 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-21 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-20 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-20 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-19 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-19 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-19 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-19 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-19 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-15 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-14 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-14 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-14 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-06 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 436 bits (1125), Expect = e-150
Identities = 154/287 (53%), Positives = 213/287 (74%), Gaps = 2/287 (0%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+EK+ +IG+GTY VY+AR+ ++VALKK+R +N+ REI +L+KL HPNI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
++L+ ++TS+ S+Y+VFEYM+HDL GL P +KFTESQ+KCYMKQLL GL++ HS+G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYG 334
+LHRDIKGSN+L++++G+LK+ADFGLA + ++S T+RV+TLWYRPPELLLGA+ YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 335 AAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHSTVFKP 393
VD+WS GCIL ELF GKP+ G TE+EQL +IF+LCGSP+++ W SKL KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 394 VQPYRRRIAETFKDFPT-SALRLMETLMSIDPAHRGTATLALNSEFF 439
+PY+RR+ E FK SAL L++ L+++DP R +A AL E+F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 358 bits (922), Expect = e-119
Identities = 124/290 (42%), Positives = 183/290 (63%), Gaps = 13/290 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
+EKL+K+G+GTY VY+ARD +IVALKK+R DN++ E + A REI++L++L HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPN 59
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I+KL +I ++ LYLVFEY + DL + + +K M QLL GL +CHSH
Sbjct: 60 IVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELLLGA 330
+LHRD+K N+L++ +G+LK+ADFGLA F +P+ T VVTLWYR PE+LLG+
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAF----GIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHST 389
HY AVD+WS GCI E+ +GKP+ PG +E++QL +IF++ G+P+E+ W +KL
Sbjct: 174 KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233
Query: 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
P P + + + + L+ ++ +PA R +A AL +F
Sbjct: 234 PTFPKFPP-KDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 331 bits (851), Expect = e-108
Identities = 126/302 (41%), Positives = 183/302 (60%), Gaps = 9/302 (2%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMA-REIAILRKLDH 211
+EK K+G+GTY+ VY+ARD +IVA+KK++ + + + F A REI +L++L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
PNII L + +++ + LVFE+ME DL + + T + +K YM L GLE+ H
Sbjct: 62 PNIIGLLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
S+ +LHRD+K +NLL+ +G+LK+ADFGLA F + MT +VVT WYR PELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVVTRWYRAPELLFGAR 178
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHSTV 390
HYG VD+WS GCI EL P LPG ++++QL +IF+ G+P+E+ W + L
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE 238
Query: 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSN 450
FKP P + + F AL L++ L++++P R TA AL +F+ P PS
Sbjct: 239 FKPFPPTPLK--QIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296
Query: 451 LP 452
LP
Sbjct: 297 LP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 326 bits (837), Expect = e-106
Identities = 150/311 (48%), Positives = 194/311 (62%), Gaps = 10/311 (3%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRK 208
R FEKL++IG+GTY VYRARD +IVALKKVR DN+ D + + REI +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL-REITLLLN 62
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK--FTESQVKCYMKQLLSG 266
L HPNI++L+ ++ + S++LV EY E DL L L M F+ESQVKC M QLL G
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASL--LDNMPTPFSESQVKCLMLQLLRG 120
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
L++ H + ++HRD+K SNLLL G LKIADFGLA + PMT +VVTLWYR PEL
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPEL 179
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKL 385
LLG + Y A+D+W+ GCIL EL + KP+LPGK+E+EQL I +L G+P+E W S L
Sbjct: 180 LLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239
Query: 386 RHSTVFK-PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444
F P QPY + F + LRL+ L+ DP R TA AL S +F +PL
Sbjct: 240 PLVGKFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298
Query: 445 ACNPSNLPKYP 455
C P +P +P
Sbjct: 299 PCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 318 bits (817), Expect = e-103
Identities = 133/297 (44%), Positives = 184/297 (61%), Gaps = 12/297 (4%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRK 208
R + +EKL++I +GTY VYRARD +IVALKK++ + + E + REI IL K
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLK 60
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK--FTESQVKCYMKQLLSG 266
L HPNI+ ++ ++ +Y+V EY+EHDL L + MK F +S+VKC M QLLSG
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL--METMKQPFLQSEVKCLMLQLLSG 118
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-DPKDSVPMTSRVVTLWYRPPE 325
+ H H + +LHRD+K SNLLL++ GILKI DFGLA + P P T VVTLWYR PE
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPE 176
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SK 384
LLLGA Y A+D+WS GCI EL + KP+ PGK+E++QL++IFKL G+P+E W S+
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTS--ALRLMETLMSIDPAHRGTATLALNSEFF 439
L + + ++ + F S L+ L++ DPA R +A AL +F
Sbjct: 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 316 bits (811), Expect = e-103
Identities = 144/302 (47%), Positives = 197/302 (65%), Gaps = 11/302 (3%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAI 205
W R + F+ + +IG+GTY VY+ARD ++VALKKVR DN+ E A REI I
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKI 59
Query: 206 LRKLDHPNIIKLEGLITSQTSC--------SLYLVFEYMEHDLVGLASLPGMKFTESQVK 257
LR+L+H NI+ L+ ++T + + YLVFEYM+HDL+GL + F+E +K
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 258 CYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317
+MKQLL GL +CH LHRDIK SN+LL++ G +K+ADFGLA ++ ++S P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377
TLWYRPPELLLG YG A+D+WS GCILGELF+ KP+ E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 378 DYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436
W KL + KP + YRRR+ E F PT AL L++ ++++DP+ R TA ALNS
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 437 EF 438
+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 4e-96
Identities = 131/303 (43%), Positives = 182/303 (60%), Gaps = 19/303 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
+E L K+G+GT+ VY+AR + ++VALKK+ N+ + A REI IL+KL HPN
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPN 68
Query: 214 IIKLEGLI------TSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
++ L + + + S+Y+V YM+HDL GL P +K TESQ+KCYM QLL G+
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM----------TSRVV 317
+ H + +LHRDIK +N+L+D+ GILKIADFGLA +D P T+ VV
Sbjct: 129 NYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377
T WYRPPELLLG Y AVD+W GC+ E+F+ +P+L GK++++QLH IFKLCG+P+E
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248
Query: 378 DYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436
+ W L Y R + E F L L+ L+S+DP R TA+ AL
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308
Query: 437 EFF 439
+F
Sbjct: 309 PYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 290 bits (743), Expect = 2e-92
Identities = 133/300 (44%), Positives = 185/300 (61%), Gaps = 14/300 (4%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDH 211
+ +EKL KIGQGT+ V++AR +IVALKKV +N+ E A REI IL+ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKH 70
Query: 212 PNIIKL------EGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLS 265
N++ L + ++ S YLVFE+ EHDL GL S +KFT S++K MK LL+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVP--MTSRVVTLWYR 322
GL + H + +LHRD+K +N+L+ +GILK+ADFGLA +F K+S P T+RVVTLWYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382
PPELLLG YG +D+W GCI+ E+++ P++ G TE QL I +LCGS + + W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 383 -SKLRHSTVFKPVQPYRRRIAETFKDFPTS--ALRLMETLMSIDPAHRGTATLALNSEFF 439
KL + Q +R++ E K + AL L++ L+ +DPA R A ALN +FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 6e-91
Identities = 125/286 (43%), Positives = 171/286 (59%), Gaps = 4/286 (1%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++KL KIG+GTY VY+ARD + +IVA+KK++ + K REI +L++L+HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
IKL + + LYLVFE+M+ DL L ES +K Y+ QLL GL CHSHG
Sbjct: 61 IKLLDVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYG 334
+LHRD+K NLL++ G+LK+ADFGLA F P T VVT WYR PELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 335 AAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHSTVFKP 393
VD+WS GCI EL S +P+ PGK+E++QL +IF+ G+P + W K + L + F
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ + + F + AL L+ ++ DP R TA AL +F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 278 bits (712), Expect = 3e-88
Identities = 127/293 (43%), Positives = 184/293 (62%), Gaps = 18/293 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
++K++KIG+GTY VY+ARD + +IVALKK+R + +D E V A REI++L++L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPN 59
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I++L ++ S+ LYLVFE+++ DL + S P +K Y+ QLL G+ +CHS
Sbjct: 60 IVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELLLG 329
H VLHRD+K NLL+D G LK+ADFGLA F VP+ T VVTLWYR PE+LLG
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEILLG 173
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHS 388
+ Y VD+WS GCI E+ + +P+ PG +E++QL RIF+ G+P ED W + L
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD- 232
Query: 389 TVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+KP P R+ +++ + L L+ ++ DPA R +A AL +F
Sbjct: 233 --YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 272 bits (698), Expect = 1e-86
Identities = 110/286 (38%), Positives = 154/286 (53%), Gaps = 33/286 (11%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E L+K+G+G++ VY ARD K+VA+K ++ + + + REI IL+KL HPNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
++L + + LYLV EY E DL L G + +E + + Y++Q+LS LE+ HS
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSK 116
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
G++HRD+K N+LLD +G +K+ADFGLA DP + +T+ V T Y PE+LLG Y
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGY 173
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
G AVD+WS G IL EL +GKP PG +QL +FK G P +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP----------- 219
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
D A L+ L+ DP R TA AL FF
Sbjct: 220 -----------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 268 bits (686), Expect = 2e-84
Identities = 111/300 (37%), Positives = 164/300 (54%), Gaps = 27/300 (9%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV---RFDNQDPESVKFMAREIAILRKLD 210
++ L +IG+G + V++A+D + VALKKV R + P REI L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA---LREIKALQACQ 57
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDL---VGLASLPGMKFTESQVKCYMKQLLSGL 267
HP ++KL + + LV EYM DL + P E+QVK YM+ LL G+
Sbjct: 58 HPYVVKLLDVFPHGSGF--VLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGV 112
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
+ H++G++HRD+K +NLL+ +G+LKIADFGLA F ++ + +V T WYR PELL
Sbjct: 113 AYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW------- 380
GA Y VDLW+ GCI EL +G P+ PG+ ++EQL +F+ G+P+E+ W
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
+K+ F +P E F D AL L++ L+ DP+ R +A AL +FT
Sbjct: 233 DYNKIT----FPESKPIPLE--EIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 4e-84
Identities = 114/299 (38%), Positives = 170/299 (56%), Gaps = 26/299 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD---PESVKFMAREIAILRKLD- 210
+E+L +IG+G Y +VY+ARD+ + VALKKVR + P S REIA+L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 211 --HPNIIKLEGL---ITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYMKQLL 264
HPNI++L + + L LVFE+++ DL L+ P +K M+QLL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPP 324
G++ HSH ++HRD+K N+L+ +G +KIADFGLA + + +TS VVTLWYR P
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAP 175
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
E+LL +S Y VD+WS GCI ELF +P+ G +E +QL +IF + G PSE+ W +
Sbjct: 176 EVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR-- 232
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTS----ALRLMETLMSIDPAHRGTATLALNSEFF 439
V P + +FK F L L++ +++ +P R +A AL +F
Sbjct: 233 ----NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 2e-81
Identities = 123/325 (37%), Positives = 182/325 (56%), Gaps = 32/325 (9%)
Query: 155 FEKLDK-IGQGTYSSVYRARDVIHDKIVALKKVR------FDNQDPESV-----KFMA-R 201
+ + +G+GTY V +A D + KIVA+KKV+ +D + V F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 202 EIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMK 261
E+ I+ ++ H NI+ L + + LV + M DL + ++ TESQVKC +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVD-RKIRLTESQVKCILL 126
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-------------DPKD 308
Q+L+GL H +HRD+ +N+ ++ GI KIADFGLA + +
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
MTS+VVTLWYR PELL+GA Y AVD+WS GCI EL +GKP+ PG+ E++QL RI
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 369 FKLCGSPSEDYW-RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
F+L G+P+ED W + KL T F P +P + + F + A+ L+++L+ ++P R
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKP--KDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 428 GTATLALNSEFFTTQPLACNPSNLP 452
+A AL E+F + PL C+PS LP
Sbjct: 305 ISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 2e-79
Identities = 108/287 (37%), Positives = 150/287 (52%), Gaps = 29/287 (10%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E L K+G G++ +VY+A+ KIVA+K ++ ++ + + REI ILR+L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
++L + LYLV EY E DL S G +E + K Q+L GLE+ HS+
Sbjct: 61 VRLID--AFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSN 117
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
G++HRD+K N+LLD NG++KIADFGLA K S +T+ V T WY PE+LLG + Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK-LCGSPSEDYWRKSKLRHSTVFK 392
G VD+WS G IL EL +GKP G+ ++QL I + L D
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE------------- 223
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
P +E KD L DP+ R TA L +F
Sbjct: 224 ---PKWSSGSEEAKDLIKKCLNK-------DPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 2e-79
Identities = 122/292 (41%), Positives = 175/292 (59%), Gaps = 16/292 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
F+K++KIG+GTY VY+AR+ + ++VALKK+R D + E V A REI++L++L+HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPN 60
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I+KL +I ++ LYLVFE++ DL + + P +K Y+ QLL GL CHS
Sbjct: 61 IVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELLLG 329
H VLHRD+K NLL++ G +K+ADFGLA F VP+ T VVTLWYR PE+LLG
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF----GVPVRTYTHEVVTLWYRAPEILLG 174
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389
+Y AVD+WS GCI E+ + + + PG +E++QL RIF+ G+P E W +
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW--PGVTSLP 232
Query: 390 VFKPVQPY--RRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+KP P R+ ++ L+ ++ DP R +A AL FF
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 254 bits (652), Expect = 8e-79
Identities = 107/287 (37%), Positives = 159/287 (55%), Gaps = 10/287 (3%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGL 220
IG G Y V A D + VA+KK+ D K + REI +LR L H NII L +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 221 ITSQTSCS---LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277
+ + +Y+V E ME DL + P T+ ++ ++ Q+L GL++ HS V+H
Sbjct: 68 LRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIH 126
Query: 278 RDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP--MTSRVVTLWYRPPELLLGASHYGA 335
RD+K SN+L++ N LKI DFGLA DP + +T VVT WYR PELLL +S Y
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED---YWRKSKLRHSTVFK 392
A+D+WS GCI EL + KP+ PG+ ++QL+ I ++ G+PSE+ + K R+
Sbjct: 187 AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSL 246
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
P +P ++ +++ F A+ L+E ++ DP R TA AL +
Sbjct: 247 PKKP-KKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 7e-76
Identities = 127/299 (42%), Positives = 175/299 (58%), Gaps = 21/299 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDH-P 212
+EKL+KIG+GTY VY+ARD K+VALKK R + + E + A REI++L+ L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESI 61
Query: 213 NIIKL---EGLITSQTSCSLYLVFEYMEHDL----VGLASLPGMKFTESQVKCYMKQLLS 265
I++L E + SLYLVFEY++ DL PG +K +M QLL
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLASFFDPKDSVPM---TSRVVTLWY 321
G+ HCH HGV+HRD+K NLL+D G+LKIAD GL F S+P+ T +VTLWY
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF----SIPVKSYTHEIVTLWY 177
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
R PE+LLG++HY VD+WS GCI E+ +P+ PG +E++QL IFKL G+P+E W
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 382 K-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
SKLR F +P + ++ D L L++ ++ DPA R +A AL +F
Sbjct: 238 GVSKLRDWHEFPQWKP--QDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 8e-76
Identities = 119/290 (41%), Positives = 168/290 (57%), Gaps = 12/290 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+EKL+KIG+GTY +V++A++ +IVALK+VR D+ D REI +L++L H NI
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
++L ++ S L LVFEY + DL VK +M QLL GL CHSH
Sbjct: 62 VRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELLLGAS 331
VLHRD+K NLL++ NG LK+ADFGLA F +P+ ++ VVTLWYRPP++L GA
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 332 HYGAAVDLWSTGCILGELF-SGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHST 389
Y ++D+WS GCI EL +G+P+ PG +QL RIF+L G+P+E+ W SKL
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ + K T L++ L+ +P R +A AL +F
Sbjct: 236 PYPMYPATTSLVNVVPKLNST-GRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 8e-76
Identities = 120/294 (40%), Positives = 186/294 (63%), Gaps = 19/294 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
+ K++KIG+GTY VY+ R+ +IVA+KK+R ++++ E V A REI++L++L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPN 60
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQ-VKCYMKQLLSGLEHCH 271
I+ L+ ++ ++ LYL+FE++ DL L SLP ++ +++ VK Y+ Q+L G+ CH
Sbjct: 61 IVCLQDVLMQESR--LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELLL 328
S VLHRD+K NLL+D+ G++K+ADFGLA F +P+ T VVTLWYR PE+LL
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF----GIPVRVYTHEVVTLWYRAPEVLL 174
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRH 387
G+ Y VD+WS G I E+ + KP+ G +E++QL RIF++ G+P+ED W + L
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234
Query: 388 STVFKPVQPYRRR--IAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+K P ++ + K+ L L+E ++ DPA R +A ALN +F
Sbjct: 235 ---YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 1e-74
Identities = 120/293 (40%), Positives = 184/293 (62%), Gaps = 17/293 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
+EK++KIG+GTY VY+ARD + ++ +ALKK+R + +D E V A REI++L+++ H N
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGN 62
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I++L+ ++ S+ LYLVFEY++ DL + S P +K Y+ Q+L G+ +CHS
Sbjct: 63 IVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 273 HGVLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELLL 328
H VLHRD+K NLL+D LK+ADFGLA F +P+ T VVTLWYR PE+LL
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF----GIPVRTFTHEVVTLWYRAPEILL 176
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR--KSKLR 386
G+ HY VD+WS GCI E+ + KP+ PG +E+++L +IF++ G+P+E+ W S
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236
Query: 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ + F P + +A + + L+ ++ +DP+ R TA AL E+F
Sbjct: 237 YKSAFPKWPP--KDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 1e-72
Identities = 105/292 (35%), Positives = 158/292 (54%), Gaps = 9/292 (3%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
N +E L +G+G Y V + R+ +IVA+KK + D + K RE+ +LR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGL--ASLPGMKFTESQVKCYMKQLLSGLEHC 270
NI+ L+ LYLVFEY+E L+ L AS G+ V+ Y+ QLL + +C
Sbjct: 61 NIVNLKEAFRR--KGRLYLVFEYVERTLLELLEASPGGL--PPDAVRSYIWQLLQAIAYC 116
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
HSH ++HRDIK N+L+ +G+LK+ DFG A + + P+T V T WYR PELL+G
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD 176
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG--SPSEDYWRKSKLRHS 388
++YG VD+W+ GCI+ EL G+P+ PG ++++QL+ I K G PS S R +
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 389 TVFKPVQPYRRRIAETF-KDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
V P + + + AL ++ + +DP R T L +F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 1e-72
Identities = 112/299 (37%), Positives = 173/299 (57%), Gaps = 20/299 (6%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKL 209
+ T++KLDK+G+G+Y++VY+ R + ++VALK++R + E F A RE ++L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRL--EHEEGAPFTAIREASLLKDL 60
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
H NI+ L +I ++ + L LVFEY++ DL G + V+ ++ QLL GL +
Sbjct: 61 KHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPEL 326
CH VLHRD+K NLL+ G LK+ADFGLA SVP ++ VVTLWYRPP++
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLAR----AKSVPSKTYSNEVVTLWYRPPDV 174
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV-EQLHRIFKLCGSPSEDYWRK-SK 384
LLG++ Y ++D+W GCI E+ +G+P+ PG T+V +QLH+IF++ G+P+E+ W S
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234
Query: 385 L----RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+S F P +P D L + +P R +A A+ +F
Sbjct: 235 NPEFKPYSFPFYPPRPLINHAPRL--DRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 3e-71
Identities = 108/294 (36%), Positives = 174/294 (59%), Gaps = 20/294 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD--PESVKFMAREIAILRKLDHP 212
F++L+K+G+GTY++VY+ R+ +IVALK++ D ++ P + REI+++++L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHE 58
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK--FTESQVKCYMKQLLSGLEHC 270
NI++L +I T L LVFEYM+ DL G++ + VK + QLL G+ C
Sbjct: 59 NIVRLHDVI--HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELL 327
H + VLHRD+K NLL++ G LK+ADFGLA F +P+ ++ VVTLWYR P++L
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAF----GIPVNTFSNEVVTLWYRAPDVL 172
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387
LG+ Y ++D+WS GCI+ E+ +G+P+ PG +QL +IF++ G+P+E W +
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW--PGISQ 230
Query: 388 STVFKPVQPYRRR--IAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+KP P + + F + L+ L+ ++P R +A AL +F
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 6e-70
Identities = 109/295 (36%), Positives = 170/295 (57%), Gaps = 22/295 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKV--RFDNQDPESVKFMAREIAILRKL-DH 211
++ + ++G GT+ SVY AR+ ++VA+KK+ +F + + E + RE+ LRKL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 212 PNIIKL-EGLITSQTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEH 269
PNI+KL E + LY VFEYME +L L G F+ES ++ + Q+L GL H
Sbjct: 58 PNIVKLKEVFRENDE---LYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
H HG HRD+K NLL+ ++KIADFGLA + P T V T WYR PE+LL
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PYTDYVSTRWYRAPEILLR 172
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-----SK 384
++ Y + VD+W+ GCI+ EL++ +P+ PG +E++QL++I + G+P++ W + SK
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
L F P + + + A+ L++ ++ DP R TA+ AL +F
Sbjct: 233 LGFR--FPQFAPT--SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 1e-67
Identities = 121/316 (38%), Positives = 175/316 (55%), Gaps = 28/316 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHP 212
+E L K+G+G Y V++A D ++VALKK+ FD ++ + REI L++L DHP
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDL--VGLASLPGMKFTESQVKCY-MKQLLSGLEH 269
NI+KL +I ++ +YLVFEYME DL V A++ E K Y M QLL L++
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-----LEDVHKRYIMYQLLKALKY 122
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP----MTSRVVTLWYRPPE 325
HS V+HRD+K SN+LL+ + +K+ADFGLA + P +T V T WYR PE
Sbjct: 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR--KS 383
+LLG++ Y VD+WS GCILGE+ GKP+ PG + + QL +I ++ G PS + KS
Sbjct: 183 ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242
Query: 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN----SEFF 439
+ + R+ + E AL L++ L+ +P R TA AL ++F
Sbjct: 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302
Query: 440 TTQPLACNPSNLPKYP 455
NPS+ P P
Sbjct: 303 -------NPSDEPVLP 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 223 bits (570), Expect = 4e-67
Identities = 106/327 (32%), Positives = 158/327 (48%), Gaps = 52/327 (15%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHD--KIVALKKVRFDNQDPESVKFMA-REIAILRKLD 210
+E IG+GTY VY+A+ K A+KK + D + + A REIA+LR+L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGL---------ASLPGMKFTESQVKCYMK 261
H N++ L + S+YL+F+Y EHDL + S+P S VK +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIP-----PSMVKSLLW 115
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASFFDPKDSVPMTSR-- 315
Q+L+G+ + HS+ VLHRD+K +N+L+ G++KI D GLA F+ P+
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPLADLDP 174
Query: 316 -VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---------VEQL 365
VVT+WYR PELLLGA HY A+D+W+ GCI EL + +P+ G+ +QL
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234
Query: 366 HRIFKLCGSPSED---------YWRKSKLRHSTVFKP----VQPYRRRIAETFKDFPTSA 412
RIF++ G+P+E + T P + + +
Sbjct: 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD-----SQG 289
Query: 413 LRLMETLMSIDPAHRGTATLALNSEFF 439
L+ L+ DP R TA AL +F
Sbjct: 290 FDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 1e-62
Identities = 111/292 (38%), Positives = 172/292 (58%), Gaps = 15/292 (5%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
T+ KLDK+G+GTY++V++ R + + +VALK++R ++++ + RE+++L+ L H N
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHAN 64
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I+ L +I T L LVFEY++ DL G + VK +M QLL GL +CH
Sbjct: 65 IVTLHDII--HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELLLGA 330
+LHRD+K NLL++ G LK+ADFGLA SVP ++ VVTLWYRPP++LLG+
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGS 178
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390
+ Y +D+W GCIL E+ +G+P+ PG T E+LH IF+L G+P+E+ W + +
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW--PGITSNEE 236
Query: 391 FKPVQPYRRRIAETFKDFP---TSALRLMETLMSIDPAHRGTATLALNSEFF 439
F+ + R P T + L+ +L+ + R +A AL +F
Sbjct: 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 206 bits (524), Expect = 9e-61
Identities = 100/233 (42%), Positives = 151/233 (64%), Gaps = 10/233 (4%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
+ T+ KLDK+G+GTY++VY+ R + D +VALK++R ++++ + RE+++L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
H NI+ L +I ++ S L LVFEY++ DL G VK ++ QLL GL +C
Sbjct: 63 HANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELL 327
H VLHRD+K NLL++ G LK+ADFGLA S+P ++ VVTLWYRPP++L
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380
LG++ Y +D+W GCI E+ +G+P+ PG T EQLH IF++ G+P+E+ W
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 1e-60
Identities = 98/297 (32%), Positives = 148/297 (49%), Gaps = 25/297 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+EKL KIG+G+Y V++ R+ +IVA+KK DP K REI +L++L HPN+
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
+ L + + L+LVFEY +H ++ E +K + Q L + CH H
Sbjct: 63 VNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYG 334
+HRD+K N+L+ G +K+ DFG A T V T WYR PELL+G + YG
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD-YTDYVATRWYRAPELLVGDTQYG 179
Query: 335 AAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL--RHSTVFK 392
VD+W+ GC+ EL +G+P+ PGK++V+QL+ I K G L RH +F
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG----------DLIPRHQQIFS 229
Query: 393 ----------PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
P R + F + + AL ++ + +DP R + L +F
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 4e-60
Identities = 102/290 (35%), Positives = 154/290 (53%), Gaps = 19/290 (6%)
Query: 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIK 216
L KIG+GT+S V +A+ K A+K ++ + E V + REI LR+L HPNI++
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILR 62
Query: 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK-----FTESQVKCYMKQLLSGLEHCH 271
L ++ + + L LVFE M+ +L L +K E +VK YM QLL L+H H
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYEL-----IKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
+G+ HRDIK N+L+ + ILK+ADFG K P T + T WYR PE LL
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKP--PYTEYISTRWYRAPECLLTDG 174
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
+YG +D+W+ GC+ E+ S P+ PG E++Q+ +I + G+P + K R S
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV--LKKFRKSRHM 232
Query: 392 KPVQPYRR--RIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
P ++ + + + L L++ L++ DP R TA AL +F
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 203 bits (517), Expect = 1e-59
Identities = 98/233 (42%), Positives = 151/233 (64%), Gaps = 10/233 (4%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
+ T+ KL+K+G+GTY++V++ R + + +VALK++R ++++ + RE+++L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
H NI+ L ++ T SL LVFEY++ DL G + VK ++ Q+L GL +C
Sbjct: 63 HANIVTLHDIV--HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM---TSRVVTLWYRPPELL 327
H VLHRD+K NLL++ G LK+ADFGLA SVP ++ VVTLWYRPP++L
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380
LG+S Y +D+W GCI E+ SG+P+ PG T ++LH IF+L G+P+E+ W
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 2e-59
Identities = 116/305 (38%), Positives = 161/305 (52%), Gaps = 19/305 (6%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVR--FDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
IG+G Y V A++ ++ VA+KK+ FDN+ K REI +LR LDH N+I ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR--IDAKRTLREIKLLRHLDHENVIAIK 70
Query: 219 GLIT---SQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
++ + +Y+V+E M+ DL + ++ + ++ QLL GL++ HS V
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANV 129
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
LHRD+K SNLLL+ N LKI DFGLA K MT VVT WYR PELLL S Y
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTT 188
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE---DYWRKSKLRHSTVFK 392
A+D+WS GCI EL KP+ PGK V QL I +L GSPSE + R K R
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF------TTQPLAC 446
P P R+ A F A+ L+E ++ DP+ R T AL + + +P+
Sbjct: 249 PYTP-RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQ 307
Query: 447 NPSNL 451
P +
Sbjct: 308 TPFSF 312
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-59
Identities = 104/312 (33%), Positives = 162/312 (51%), Gaps = 19/312 (6%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ ++ L +G G Y V A D + VA+KK+ Q K RE+ +L+ +DH
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 213 NIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
N+I L + T +S +YLV M DL + + K ++ ++ + Q+L GL+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNI--VKCQKLSDDHIQFLVYQILRGLK 132
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
+ HS G++HRD+K SN+ ++ + LKI DFGLA D + MT V T WYR PE++L
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIML 188
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
HY VD+WS GCI+ EL +GK + PG ++QL RI L G+P E+ +K +
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248
Query: 389 TVFKPVQPYRRRIAETFKD-FPTS---ALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444
+ P + + FK+ F + A+ L+E ++ +DP R TA AL +
Sbjct: 249 RNYIQSLPQMPK--KDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL--AEY 304
Query: 445 ACNPSNLPKYPP 456
+P + P PP
Sbjct: 305 H-DPEDEPVAPP 315
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 199 bits (509), Expect = 9e-59
Identities = 103/296 (34%), Positives = 171/296 (57%), Gaps = 19/296 (6%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDH 211
+E L +G+G+Y V + + +IVA+KK +++D + VK +A REI +L++L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRH 59
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
N++ L + + LYLVFE+++H ++ ES+V+ Y+ Q+L G+E CH
Sbjct: 60 ENLVNL--IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD-PKDSVPMTSRVVTLWYRPPELLLGA 330
SH ++HRDIK N+L+ +G++K+ DFG A P + T V T WYR PELL+G
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YTDYVATRWYRAPELLVGD 175
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY---WRKSKL-- 385
+ YG AVD+W+ GC++ E+ +G+P+ PG ++++QL+ I K G+ + ++K+ L
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235
Query: 386 --RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
R V K ++P +R F L L + + IDP R +++ L+ EFF
Sbjct: 236 GMRLPEV-KEIEPLEKR----FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 2e-58
Identities = 78/191 (40%), Positives = 112/191 (58%), Gaps = 6/191 (3%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGL 220
+G+G + +VY ARD K VA+K ++ ++ + + REI IL+KL+HPNI+KL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYG- 58
Query: 221 ITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRD 279
+ LYLV EY E L L K +E ++ + Q+L GLE+ HS+G++HRD
Sbjct: 59 -VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 280 IKGSNLLLDH-NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVD 338
+K N+LLD NG +K+ADFGL+ S + + V T Y PE+LLG +Y D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 339 LWSTGCILGEL 349
+WS G IL EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 2e-57
Identities = 117/340 (34%), Positives = 170/340 (50%), Gaps = 37/340 (10%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKF---MAREIAILRKL 209
++ L IG+G Y V A VA+KK+ F++Q F REI ILR+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-----TFCQRTLREIKILRRF 60
Query: 210 DHPNIIKLEGLITSQTSCSL---YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSG 266
H NII + +I + S Y+V E ME DL L + + ++ ++ Q+L G
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKL--IKTQHLSNDHIQYFLYQILRG 118
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYRPP 324
L++ HS VLHRD+K SNLLL+ N LKI DFGLA DP + +T V T WYR P
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS-EDYWRKS 383
E++L + Y A+D+WS GCIL E+ S +P+ PGK + QL+ I + G+PS ED
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238
Query: 384 KLR-----HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
LR S FKP P+ + F + AL L++ +++ +P R T AL +
Sbjct: 239 SLRARNYIKSLPFKPKVPW----NKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
Query: 439 FTT------QPLACNPSNLPKYPPSKEIDAKLRDEESRRH 472
+P+A P +P E+ L E+ +
Sbjct: 295 LEQYHDPSDEPVAEEP-----FPFDFELFDDLPKEKLKEL 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 1e-56
Identities = 111/293 (37%), Positives = 162/293 (55%), Gaps = 14/293 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL---DH 211
+E + +IG G Y +VY+ARD VALK VR + RE+A+L++L DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 212 PNIIKLEGLI-TSQT--SCSLYLVFEYMEHDL-VGLASLPGMKFTESQVKCYMKQLLSGL 267
PNI++L + TS+T + LVFE+++ DL L +P +K M+Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
+ H++ ++HRD+K N+L+ G +K+ADFGLA + + + +T VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVL 179
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW-RKSKLR 386
L S Y VD+WS GCI E+F KP+ G +E +QL +IF L G P ED W R L
Sbjct: 180 L-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
F P P R + + S +L+ +++ +P R +A AL FF
Sbjct: 239 RGA-FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-56
Identities = 116/297 (39%), Positives = 170/297 (57%), Gaps = 18/297 (6%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLD 210
A ++ L+K+G+G+Y++VY+ I+ ++VALK + + E V F A RE ++L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLK 61
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYMKQLLSGLEH 269
H NI+ L +I T +L VFEYM DL + PG V+ +M QLL GL +
Sbjct: 62 HANIVLLHDII--HTKETLTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAY 118
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVVTLWYRPPEL 326
H +LHRD+K NLL+ + G LK+ADFGLA S+P +S VVTLWYRPP++
Sbjct: 119 IHGQHILHRDLKPQNLLISYLGELKLADFGLAR----AKSIPSQTYSSEVVTLWYRPPDV 174
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV-EQLHRIFKLCGSPSEDYWRK-SK 384
LLGA+ Y +A+D+W GCI E+ G+P PG ++V EQL +I+ + G P+ED W SK
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234
Query: 385 LRH--STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
L + F P +P + R+ P A L ++ + P R +A AL +F
Sbjct: 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 4e-56
Identities = 111/321 (34%), Positives = 161/321 (50%), Gaps = 23/321 (7%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV--RFDNQDPESVKFMAREIAILRKLDH 211
++ ++ IG G Y V A D K VA+KK+ FD P K RE+ ILR H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKH 63
Query: 212 PNIIKLEGLITSQTS--CSLYLVFEYMEHDLVGL--ASLPGMKFTESQVKCYMKQLLSGL 267
NII + ++ + +Y+V + ME DL + + P TE ++ ++ QLL GL
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP---LTEEHIRYFLYQLLRGL 120
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD--PKD-SVPMTSRVVTLWYRPP 324
++ HS V+HRD+K SNLL++ + L+I DFG+A P + MT V T WYR P
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
ELLL Y A+D+WS GCI E+ + + PGK V QL I + GSPSE+ ++
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL--NR 238
Query: 385 LRHSTVFKPVQPYRRRIAETFKD-FPTS---ALRLMETLMSIDPAHRGTATLALNSEFFT 440
+ V K +Q R+ + FP + AL L+ ++ DP R T AL F
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
Query: 441 TQPLACNPSNLPKYPPSKEID 461
+P + P PP + D
Sbjct: 299 QYH---DPDDEPTCPPPFDFD 316
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 7e-56
Identities = 90/291 (30%), Positives = 142/291 (48%), Gaps = 36/291 (12%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
+ + + +G+G++ SVY A D +++A+K V E ++ + REI IL L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVG--LASLPGM--KFTESQVKCYMKQLLSGLEH 269
I++ G + +L + EY+ G L+SL K E ++ Y +Q+L GL +
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVS----GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLL 328
HS+G++HRDIKG+N+L+D +G++K+ADFG A ++ T V T ++ PE++
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
G YG A D+WS GC + E+ +GKP ++K+ S
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA--LYKIGSSGE------------ 221
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
P P ++E KDF L + L DP R TA L F
Sbjct: 222 ---PPEIP--EHLSEEAKDF------LRKCL-RRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 4e-55
Identities = 108/302 (35%), Positives = 155/302 (51%), Gaps = 17/302 (5%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
N + L +G G + V ARD + + VA+KK+ P K RE+ +L+ L H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQ-VKCYMKQLLSGLEHCH 271
NII L + S +Y V E + DL L + E Q ++ ++ Q+L GL++ H
Sbjct: 70 NIISLSDIFISPLE-DIYFVTELLGTDL---HRLLTSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
S GV+HRD+K SN+L++ N LKI DFGLA DP+ MT V T +YR PE++L
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQ 181
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
Y VD+WS GCI E+ GKP+ PGK V Q I L G+P +D ++ F
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241
Query: 392 KPVQPYRRR--IAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF------TTQP 443
P R +E FK+ SA+ L+E ++ DP R +A AL + T +P
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP 301
Query: 444 LA 445
+A
Sbjct: 302 VA 303
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 2e-54
Identities = 117/304 (38%), Positives = 170/304 (55%), Gaps = 22/304 (7%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKL 209
+A+++EKL+K+G+G+Y++VY+ + ++ K+VALK +R Q+ E F A RE ++L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRL--QEEEGTPFTAIREASLLKGL 60
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
H NI+ L +I T +L LVFEY+ DL VK ++ QLL GL +
Sbjct: 61 KHANIVLLHDII--HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVVTLWYRPPEL 326
H +LHRD+K NLL+ G LK+ADFGLA SVP ++ VVTLWYRPP++
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLAR----AKSVPSHTYSNEVVTLWYRPPDV 174
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDYWRK-SK 384
LLG++ Y +D+W GCI E+ G PG +++ QL RIF + G+P+ED W
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234
Query: 385 LRHSTVFKP-----VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
L H FKP P R A + A L L+ P +R +A AL+ E+F
Sbjct: 235 LPH---FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291
Query: 440 TTQP 443
+ P
Sbjct: 292 SDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-52
Identities = 113/331 (34%), Positives = 172/331 (51%), Gaps = 17/331 (5%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+P R + L ++G G Y SV A D + VA+KK+ Q K RE+ +L+
Sbjct: 13 LPER---YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLK 69
Query: 208 KLDHPNIIKLEGLITSQTSC----SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H N+I L + TS S YLV YM+ DL + G +E +V+ + Q+
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQM 126
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L GL++ HS G++HRD+K NL ++ + LKI DFGLA D + MT VVT WYR
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRA 182
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK- 382
PE++L HY VD+WS GCI+ E+ +GK + GK ++QL +I K+ G P ++ +K
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242
Query: 383 -SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
K S + + R+ + F A+ L+E ++ +D R TAT AL +F +
Sbjct: 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302
Query: 442 QPLACNPSNLPKYPPSKEIDAKLRDEESRRH 472
A + Y S E + KL +E ++H
Sbjct: 303 FRDADEETEQQPYDDSLE-NEKLSVDEWKKH 332
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 113/295 (38%), Positives = 157/295 (53%), Gaps = 16/295 (5%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDH 211
N FE L +G+G Y V + R +IVA+KK + D+++ E VK RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
NI++L+ + LYLVFEY+E +++ L +V+ Y+ QL+ + CH
Sbjct: 60 ENIVELKEAFRRRGK--LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
+ ++HRDIK NLL+ HN +LK+ DFG A + T V T WYR PELLLGA
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGS-PSEDYW------RKSK 384
YG AVD+WS GCILGEL G+P+ PG++E++QL I K+ G P+E R
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
LR V P Q RR L LM+ L+ ++P R LN F
Sbjct: 237 LRFPAVNHP-QSLERRYLGILSGV---LLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 2e-51
Identities = 110/295 (37%), Positives = 165/295 (55%), Gaps = 17/295 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHD-KIVALKKVRFDNQDPESVKFMAREIAILRKLD--- 210
+E + +IG+G Y V++ARD+ + + VALK+VR + RE+A+LR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 211 HPNIIKLEGLIT---SQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYMKQLLSG 266
HPN+++L + T + L LVFE+++ DL L +P +K M QLL G
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
L+ HSH V+HRD+K N+L+ +G +K+ADFGLA + + + +TS VVTLWYR PE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEV 180
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
LL +S Y VDLWS GCI E+F KP+ G ++V+QL +I + G P E+ W +
Sbjct: 181 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239
Query: 387 HSTVF--KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
F K QP I + D L+ ++ +PA R +A AL+ +F
Sbjct: 240 PRQAFHSKSAQP----IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 8e-51
Identities = 89/285 (31%), Positives = 136/285 (47%), Gaps = 34/285 (11%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
FE L+KIG+G + VY+AR K VA+K ++ +++ E + + EI IL+K HPNI
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNI 59
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+K G + L++V E+ L L TESQ+ K+LL GLE+ HS+
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
G++HRDIK +N+LL +G +K+ DFGL++ D+ + V T ++ PE++ G Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL--SDTKARNTMVGTPYWMAPEVING-KPY 174
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
D+WS G EL GKP ++ L +I P + + S
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGLRNPE---KWSDE--- 226
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
FKDF ++ + +P R TA L F
Sbjct: 227 -----------FKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 101/292 (34%), Positives = 152/292 (52%), Gaps = 15/292 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDV--IHDKIVALKKVR--FDNQDPESVKFMAREIAILRKL- 209
+E + ++GQG Y V AR+ ++ VA+KK+ F + K RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK--ILAKRALRELKLLRHFR 59
Query: 210 DHPNIIKLEGL--ITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
H NI L + + LYL E ME DL + G T++ + ++ Q+L GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGL 118
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP---KDSVPMTSRVVTLWYRPP 324
++ HS VLHRD+K NLL++ + LKI DFGLA F +++ MT V T WYR P
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-- 382
E++L Y A+D+WS GCIL EL KPV GK V+QL++I ++ G+P E+ +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLAL 434
S + + ++ F + AL L+E L++ DP R + AL
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 9e-50
Identities = 116/349 (33%), Positives = 170/349 (48%), Gaps = 49/349 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ L +G G+ V+ A D DK VA+KK+ DP+SVK REI I+R+LDH NI
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL--TDPQSVKHALREIKIIRRLDHDNI 64
Query: 215 IK-----------LEGLITSQTSC-SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQ 262
+K L + S T S+Y+V EYME DL + L +E + +M Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANV--LEQGPLSEEHARLFMYQ 122
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKDSVP--MTSRVVTL 319
LL GL++ HS VLHRD+K +N+ ++ +LKI DFGLA DP S ++ +VT
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK--------- 370
WYR P LLL ++Y A+D+W+ GCI E+ +GKP+ G E+EQ+ I +
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 371 ----LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH 426
L P S +R+ +P RR + + AL +E +++ +P
Sbjct: 243 RNELLNVIP-------SFVRNDG----GEP-RRPLRDLLPGVNPEALDFLEQILTFNPMD 290
Query: 427 RGTATLALNSEFFTTQPLAC---NPSNLPKYPPSKEIDAKLRDEESRRH 472
R TA AL + +C P +L + E+D L E
Sbjct: 291 RLTAEEALMHPYM--SCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 1e-48
Identities = 107/328 (32%), Positives = 171/328 (52%), Gaps = 19/328 (5%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+P R ++ L +G G Y SV A D + VA+KK+ Q + RE+ +L+
Sbjct: 13 VPER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H N+I L + T TS +YLV M DL + K ++ V+ + QL
Sbjct: 70 HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQL 127
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L GL++ HS G++HRD+K SN+ ++ + L+I DFGLA D + MT V T WYR
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRA 183
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
PE++L HY VD+WS GCI+ EL GK + PG ++QL RI ++ G+PS + +K
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243
Query: 384 KLRHSTVFKPVQPY--RRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
H+ + P+ ++ + + F+ A+ L+E ++ +D R +A+ AL +F+
Sbjct: 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303
Query: 442 QPLACNPSNLPKYPPSKE-IDAKLRDEE 468
+P + P+ P E + K R E
Sbjct: 304 YH---DPEDEPEAEPYDESPENKERTIE 328
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 8e-48
Identities = 107/299 (35%), Positives = 165/299 (55%), Gaps = 21/299 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR--FDN-QDPESVKFMAREIAILRKLDH 211
++ + IG+G+Y V A D + VA+KK+ F++ D + REI +LR L H
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRI---LREIKLLRLLRH 58
Query: 212 PNIIKLEGLI---TSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
P+I++++ ++ + + +Y+VFE ME DL + T + ++ QLL L+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALK 117
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA--SFFDPKDSVPMTSRVVTLWYRPPEL 326
+ H+ V HRD+K N+L + + LKI DFGLA +F D ++ T V T WYR PEL
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 327 LLGA--SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
G+ S Y A+D+WS GCI E+ +GKP+ PGK V QL I L G+PS + S+
Sbjct: 178 C-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE--TISR 234
Query: 385 LRHSTVFKPVQPYRRRIAETF-KDFPTS---ALRLMETLMSIDPAHRGTATLALNSEFF 439
+R+ + + R++ F + FP + ALRL+E L++ DP R TA AL +F
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-47
Identities = 98/280 (35%), Positives = 144/280 (51%), Gaps = 7/280 (2%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK-LEG 219
IG G + V+ D K VALKK+ Q+ S K + RE+ +L H N++ L+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 220 LITSQTSC--SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277
L +Y+V E M+ DL + P + VK ++ Q+L GL++ HS G+LH
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILH 126
Query: 278 RDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAV 337
RDIK NLL++ N +LKI DFGLA +P +S MT VVT +YR PE+L+G+ HY +AV
Sbjct: 127 RDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAV 186
Query: 338 DLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS-ED--YWRKSKLRHSTVFKPV 394
D+WS GCI EL + + ++ ++QL I L G+PS E + H
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK 246
Query: 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLAL 434
P + A+ L+ ++ DP R +A AL
Sbjct: 247 PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 9e-47
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E + +IG+G++ VY R K+ LK++ N + + E+ IL+KL+HPNI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
IK + + L +V EY + + G F E Q+ + QL L++
Sbjct: 62 IKYYE--SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLG 329
HS +LHRDIK N+ L NG++K+ DFG++ +V + VV T +Y PEL
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS--STVDLAKTVVGTPYYLSPELCQN 177
Query: 330 ASHYGAAVDLWSTGCILGELFSGKP 354
Y D+WS GC+L EL + K
Sbjct: 178 KP-YNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 2e-46
Identities = 111/318 (34%), Positives = 167/318 (52%), Gaps = 46/318 (14%)
Query: 160 KIGQGTYSSVYRAR--DVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPNIIK 216
K+G+GTY VY+A+ D D+ ALK++ + + A REIA+LR+L HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELKHPNVIS 62
Query: 217 LEGLITSQTSCSLYLVFEYMEHDL--------VGLASLPGMKFTESQVKCYMKQLLSGLE 268
L+ + S ++L+F+Y EHDL A+ ++ VK + Q+L G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 269 HCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYR 322
+ H++ VLHRD+K +N+L+ G +KIAD G A F+ K + VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---------VEQLHRIFKLCG 373
PELLLGA HY A+D+W+ GCI EL + +P+ + E +QL RIF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
Query: 374 SPSEDYWR--KSKLRHSTVFKPVQPYRR---------RIAETFKDFPTS-ALRLMETLMS 421
P++ W K HST+ K +RR + E K P S A L++ L++
Sbjct: 243 FPADKDWEDIKKMPEHSTLMK---DFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 299
Query: 422 IDPAHRGTATLALNSEFF 439
+DP R T+ A+ +F
Sbjct: 300 MDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 169 bits (427), Expect = 3e-46
Identities = 97/334 (29%), Positives = 146/334 (43%), Gaps = 40/334 (11%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHP- 212
+ L K+G+G++ VY ARD K+VALK + + V+ REI IL L+HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME-HDLVGLASLPG--MKFTESQVKCYMKQLLSGLEH 269
NI+KL Q SLYLV EY++ L L G +ES+ + Q+LS LE+
Sbjct: 59 NIVKLYDFF--QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 270 CHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKDS-----VPMTSRVVTLWYRP 323
HS G++HRDIK N+LLD +G ++K+ DFGLA S ++ V T Y
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 324 PELLLGAS--HYGAAVDLWSTGCILGELFSGKPVLPGKTE---VEQLHRIFKLCGSPSED 378
PE+LLG S + ++ D+WS G L EL +G P G+ Q +I +PS
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
+A L++ L++ DP +R +++ L+ +
Sbjct: 237 SPLSPSNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 439 FTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRH 472
L + + P
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEAL 311
|
Length = 384 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 1e-45
Identities = 110/317 (34%), Positives = 165/317 (52%), Gaps = 44/317 (13%)
Query: 160 KIGQGTYSSVYRAR--DVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPNIIK 216
K+G+GTY VY+A+ D +K ALK++ + + A REIA+LR+L HPN+I
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELKHPNVIA 62
Query: 217 LEGLITSQTSCSLYLVFEYMEHDL--------VGLASLPGMKFTESQVKCYMKQLLSGLE 268
L+ + S + ++L+F+Y EHDL A+ M+ S VK + Q+L G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 269 HCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYR 322
+ H++ VLHRD+K +N+L+ G +KIAD G A F+ K + VVT WYR
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---------VEQLHRIFKLCG 373
PELLLGA HY A+D+W+ GCI EL + +P+ + E +QL RIF + G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
Query: 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIA----------ETFKDFPTS-ALRLMETLMSI 422
P++ W +R + +Q RR E K P S L++ L+++
Sbjct: 243 FPADKDWE--DIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTM 300
Query: 423 DPAHRGTATLALNSEFF 439
DP R T+ AL +F
Sbjct: 301 DPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 6e-45
Identities = 77/199 (38%), Positives = 118/199 (59%), Gaps = 10/199 (5%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
D IG+G + VY+ ++ VA+K++ + E++K + +EI +L+ L HPNI+K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 219 GLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277
G I +TS SLY++ EY E+ L + G F ES V Y+ Q+L GL + H GV+H
Sbjct: 66 GSI--ETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 278 RDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL--GASHYGA 335
RDIK +N+L +G++K+ADFG+A+ + S S V T ++ PE++ GAS
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMSGAS---T 178
Query: 336 AVDLWSTGCILGELFSGKP 354
A D+WS GC + EL +G P
Sbjct: 179 ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 7e-45
Identities = 105/328 (32%), Positives = 166/328 (50%), Gaps = 23/328 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ L ++G G Y +V A D VA+KK+ Q K RE+ +L+ + H N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 215 IKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I L + T S YLV +M DL L K +E +++ + Q+L GL++
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYI 134
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
H+ G++HRD+K NL ++ + LKI DFGLA D + MT VVT WYR PE++L
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNW 190
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390
HY VD+WS GCI+ E+ +GKP+ G ++QL I K+ G+PS+++ +K + +
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250
Query: 391 FKPVQPYRRRIAETFKDFPT-------SALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
+ P R+ KDF + A+ ++E ++ +D R TA AL +F
Sbjct: 251 YVKKLPRFRK-----KDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
Query: 444 LACNPSNLPKYPPSKEIDAKLRDEESRR 471
+ + P Y S + + EE +R
Sbjct: 306 DPEDETEAPPYDDSFD-EVDQSLEEWKR 332
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 103/326 (31%), Positives = 157/326 (48%), Gaps = 24/326 (7%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+P R ++ L +G G Y SV A D VA+KK+ Q K RE+ +L+
Sbjct: 15 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H N+I L + T S +YLV M DL + K T+ V+ + Q+
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQI 129
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L GL++ HS ++HRD+K SNL ++ + LKI DFGLA D + MT V T WYR
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRA 185
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
PE++L HY VD+WS GCI+ EL +G+ + PG ++QL I +L G+P + +K
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245
Query: 384 KLRHSTVFKPVQPY--RRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
+ + + A F A+ L+E ++ +D R TA AL +F
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305
Query: 442 QPLACNPSNLPKYPP------SKEID 461
+P + P P S+++
Sbjct: 306 YH---DPDDEPVADPYDQSFESRDLL 328
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 96/312 (30%), Positives = 157/312 (50%), Gaps = 33/312 (10%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+ +R ++ L IG G V A D + + VA+KK+ Q+ K RE+ +++
Sbjct: 14 VLKR---YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK 70
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
++H NII L + T Q S +YLV E M+ +L + M ++ + Q+
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQM 127
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L G++H HS G++HRD+K SN+++ + LKI DFGLA S MT VVT +YR
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 185
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
PE++LG Y VD+WS GCI+GE+ G + PG ++Q ++I + G+PS+++ +
Sbjct: 186 PEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244
Query: 384 KLRHSTVFKPVQPYRRRIAETFKD-FPTS----------------ALRLMETLMSIDPAH 426
+ TV V+ + +F++ FP A L+ ++ IDP
Sbjct: 245 Q---PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301
Query: 427 RGTATLALNSEF 438
R + AL +
Sbjct: 302 RISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 79/243 (32%), Positives = 119/243 (48%), Gaps = 28/243 (11%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV--RFDNQDPESVKFMAREIAILRKLD 210
+ F+ IG+G++S+V A++ +K A+K + R ++ + VK++ E +L +L+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLN 59
Query: 211 -HPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
HP IIKL T Q +LY V EY + +L+ G E + Y ++L LE
Sbjct: 60 GHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS---------------VPMT 313
+ HS G++HRD+K N+LLD + +KI DFG A DP S
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 314 SR----VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIF 369
R V T Y PELL G + DLW+ GCI+ ++ +GKP G E +I
Sbjct: 177 RRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
Query: 370 KLC 372
KL
Sbjct: 236 KLE 238
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 4e-41
Identities = 88/290 (30%), Positives = 144/290 (49%), Gaps = 36/290 (12%)
Query: 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
++ +KIG GT+ VY A ++ +++A+K++R + DP+++K +A E+ +L L HPN++
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 216 KLEGLITSQTSCSLYLVFEY-MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
K G+ + +Y+ EY L L G E ++ Y QLL GL + HSHG
Sbjct: 63 KYYGVEVHREK--VYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVVTLWYRPPELLLGA- 330
++HRDIK +N+ LDHNG++K+ DFG A + + S T Y PE++ G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 331 -SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI-FKLCGSPSEDYWRKSKLRHS 388
+G A D+WS GC++ E+ +GK E++ +I F +
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVGAGH------------- 223
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
KP P +++ KDF ++ + DP R TA+ L F
Sbjct: 224 ---KPPIPDSLQLSPEGKDF-------LDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 88/303 (29%), Positives = 137/303 (45%), Gaps = 43/303 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++ L+KIG+G VY+A D K VA+KK+R Q+ E + EI I++ HPNI
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNI 77
Query: 215 IKLEG--LITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
+ L+ L++V EYM+ L + + ++ E Q+ +++L GLE+ H
Sbjct: 78 VDYYDSYLVGD----ELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLGA 330
S V+HRDIK N+LL +G +K+ADFG A+ + + VV T ++ PE++
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--KSKRNSVVGTPYWMAPEVIKR- 190
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390
YG VD+WS G + E+ G+P + + L I G P L++
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP--------PLKNPEK 241
Query: 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSN 450
+ P FKDF + + DP R +A L F AC
Sbjct: 242 WSPE----------FKDF-------LNKCLVKDPEKRPSAEELLQHPFLKK---ACPKEE 281
Query: 451 LPK 453
Sbjct: 282 FAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 2e-39
Identities = 106/338 (31%), Positives = 171/338 (50%), Gaps = 32/338 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+++L IG G V A D + VA+KK+ Q+ K RE+ +L+ ++H NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 215 IKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I L + T Q S +YLV E M+ +L + M+ ++ + Q+L G++H
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHL 139
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
HS G++HRD+K SN+++ + LKI DFGLA + MT VVT +YR PE++LG
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK--SKLRHS 388
Y VD+WS GCI+GEL G + G ++Q +++ + G+PS ++ + +R+
Sbjct: 198 G-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256
Query: 389 TVFKPVQPYRRRIAETFKD--FPTSALR----------LMETLMSIDPAHRGTATLALNS 436
+P P E F D FP+ + R L+ ++ IDP R + AL
Sbjct: 257 VENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315
Query: 437 EFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGV 474
+ T + +P+ + PP + DA+L E R H +
Sbjct: 316 PYIT---VWYDPAE-AEAPPPQIYDAQL---EEREHAI 346
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 3e-39
Identities = 105/334 (31%), Positives = 171/334 (51%), Gaps = 33/334 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++ L IG G V A D + D+ VA+KK+ Q+ K RE+ +++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 215 IKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I L + T Q S +YLV E M+ +L + M+ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL 135
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
HS G++HRD+K SN+++ + LKI DFGLA S MT VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390
Y VD+WS GCI+GE+ K + PG+ ++Q +++ + G+P ++ +K + TV
Sbjct: 194 G-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ---PTV 249
Query: 391 FKPVQPYRRRIAETF-KDFPTS---------------ALRLMETLMSIDPAHRGTATLAL 434
V+ + TF K FP S A L+ ++ IDPA R + AL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309
Query: 435 NSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEE 468
+ + +P+ + + PP + D +L + E
Sbjct: 310 QHPYIN---VWYDPAEV-EAPPPQIYDKQLDERE 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 13/213 (6%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRKLDHPNIIK 216
+G+G++ V R K+ A+K ++ ++ E E IL +++HP I+K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL---TERNILSRINHPFIVK 57
Query: 217 LEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
L QT LYLV EY +L S G F+E + + Y +++ LE+ HS G+
Sbjct: 58 L--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGR-FSEERARFYAAEIVLALEYLHSLGI 114
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
++RD+K N+LLD +G +K+ DFGLA + + T Y PE+LLG YG
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPEVLLGKG-YGK 172
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
AVD WS G +L E+ +GKP + E +I
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 75/224 (33%), Positives = 121/224 (54%), Gaps = 20/224 (8%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP---ESVKFMAREIAILRKLDHPNIIKL 217
+G G++ SVY ++ A+K+V + E+VK + +EIA+L KL HPNI++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 218 EGLITSQTSCSLYLVFEYMEHDLVGLASLPGM--KFTESQVKCYMKQLLSGLEHCHSHGV 275
G T + +LY+ E + LA L F E ++ Y +Q+L GLE+ H
Sbjct: 68 LG--TEREEDNLYIFLELVPGG--SLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLA---SFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
+HRDIKG+N+L+D NG++K+ADFG+A F S + ++ PE++
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYWMAPEVIAQQGG 178
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376
YG A D+WS GC + E+ +GKP +++E + +FK+ S
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKE 219
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 93/289 (32%), Positives = 148/289 (51%), Gaps = 37/289 (12%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKV--------RFDNQDPESVKFMAREIAILRKLDHP 212
IG+GTY VY A +V +++A+K+V R D++ + VK + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYMKQLLSGLEHCH 271
NI++ G T++ S++L EY+ +G G +F E V+ + +Q+L GL + H
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH 125
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-DPKDSVPMTSRVVTLWYRPPELLLGA 330
S G+LHRD+K NLL+D +GI KI+DFG++ D D+ S ++++ PE++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 331 SH-YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389
S Y A VD+WS GC++ E+F+G+ P E E + +FKL S
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRR--PWSDE-EAIAAMFKLGNKRSA------------ 230
Query: 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
P+ P + + AL + +I+P +R TA L F
Sbjct: 231 --PPIPP------DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 8e-38
Identities = 102/334 (30%), Positives = 168/334 (50%), Gaps = 33/334 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++ L IG G V A D I ++ VA+KK+ Q+ K RE+ +++ ++H NI
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 215 IKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I L + T Q S +Y+V E M+ +L + M+ ++ + Q+L G++H
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL 142
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
HS G++HRD+K SN+++ + LKI DFGLA S MT VVT +YR PE++LG
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390
Y VD+WS GCI+GE+ G + PG ++Q +++ + G+P ++ +K + TV
Sbjct: 201 G-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ---PTV 256
Query: 391 FKPVQPYRRRIAETF-KDFP---------------TSALRLMETLMSIDPAHRGTATLAL 434
V+ + +F K FP + A L+ ++ ID + R + AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 435 NSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEE 468
+ + +PS + PP K D +L + E
Sbjct: 317 QHPYIN---VWYDPSE-AEAPPPKIPDKQLDERE 346
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 93/290 (32%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
E++ +GQG+ VY+ R KI ALKK+ D D E K + RE+ LR + P +
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYV 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHS 272
+K G + +V EYM D LA L K E + +Q+L GL++ H+
Sbjct: 62 VKCYGAFYK--EGEISIVLEYM--DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 273 -HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
++HRDIK SNLL++ G +KIADFG++ + T V T+ Y PE + G S
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGES 176
Query: 332 HYGAAVDLWSTGCILGELFSGK-PVLPGKTE--VEQLHRIFKLCGSPSEDYWRKSKLRHS 388
Y A D+WS G L E GK P LP E + I C P
Sbjct: 177 -YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPP------------ 220
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
P P E F+DF ++ L+ DP R +A L F
Sbjct: 221 ----PSLPAEEFSPE-FRDFISACLQK-------DPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 17/226 (7%)
Query: 155 FEKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
E K+G+G + VY+ + VA+K ++ + E +F+ E +I++KL
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
HPNI++L G+ T LY+V EYM DL+ G K T + Q+ G+E+
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL----WYRPPE 325
S +HRD+ N L+ N ++KI+DFGL+ D R W PE
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY--YRKRGGGKLPIKWM-APE 174
Query: 326 LLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370
L + + D+WS G +L E+F+ G+ PG + E L +
Sbjct: 175 SLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 71/218 (32%), Positives = 112/218 (51%), Gaps = 11/218 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E L+ IG+G++ +V + R KI+ K++ + N + + + E+ ILR+L HPNI
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGL---ASLPGMKFTESQVKCYMKQLLSGLEHC 270
++ I +++ +LY+V EY E DL L E + + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 271 H-----SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
H + VLHRD+K +N+ LD N +K+ DFGLA DS + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE 363
L S Y D+WS GC++ EL + P + +++
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 72/203 (35%), Positives = 109/203 (53%), Gaps = 11/203 (5%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAILRKLDH 211
F+ KIG+G +S VY+A ++ ++VALKKV+ F+ D ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 212 PNIIK-LEGLITSQTSCSLYLVFEYMEH-DLVGL---ASLPGMKFTESQVKCYMKQLLSG 266
PN+IK L I + L +V E + DL + E + Y QL S
Sbjct: 62 PNVIKYLASFIENN---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
LEH HS ++HRDIK +N+ + G++K+ D GL FF K + S V T +Y PE
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPER 177
Query: 327 LLGASHYGAAVDLWSTGCILGEL 349
+ Y D+WS GC+L E+
Sbjct: 178 IHENG-YNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-35
Identities = 110/326 (33%), Positives = 165/326 (50%), Gaps = 37/326 (11%)
Query: 148 IPRRANTFEKL-DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAIL 206
I R N KL + IG G++ VY A + + VA+KKV QDP+ + RE+ I+
Sbjct: 60 INRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL---QDPQ---YKNRELLIM 113
Query: 207 RKLDHPNIIKL------EGLITSQTSCSLYLVFE--------YMEHDLVGLASLPGMKFT 252
+ L+H NII L E ++ + L +V E YM+H +LP
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF--- 170
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLA-SFFDPKDSV 310
VK Y QL L + HS + HRD+K NLL+D N LK+ DFG A + + SV
Sbjct: 171 --LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV 228
Query: 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
S + + +YR PEL+LGA++Y +DLWS GCI+ E+ G P+ G++ V+QL RI +
Sbjct: 229 ---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
Query: 371 LCGSPSEDYWRKSKLRHSTV-FKPVQPYRRRIAETF-KDFPTSALRLMETLMSIDPAHRG 428
+ G+P+ED ++ ++ + F V+P + + + F K P A+ + + +P R
Sbjct: 286 VLGTPTEDQLKEMNPNYADIKFPDVKP--KDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343
Query: 429 TATLALNSEFFTTQPLACNPSNLPKY 454
AL FF C LPKY
Sbjct: 344 NPIEALADPFFDDLRDPC--IKLPKY 367
|
Length = 440 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 156 EKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
K+G+G + VY+ + VA+K ++ D + + +F+ RE I+RKLDH
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
PN++KL G+ T + LY+V EYME DL+ K + S + + Q+ G+E+
Sbjct: 61 PNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL-WYRPPELLLG 329
S +HRD+ N L+ N ++KI+DFGL+ D + + W PE L
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLK- 176
Query: 330 ASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
+ + D+WS G +L E+F+ G+ PG + E L +
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 72/213 (33%), Positives = 104/213 (48%), Gaps = 15/213 (7%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEG 219
I +G Y V+ A+ I A+K ++ + V + E IL + P ++KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58
Query: 220 LITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
+ Q +LYLV EY+ DL L G E + Y+ +++ LE+ HS+G++HR
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 279 DIKGSNLLLDHNGILKIADFGLASF-------FDPKDSVPMTSRVV-TLWYRPPELLLGA 330
D+K N+L+D NG LK+ DFGL+ D R+V T Y PE++LG
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDYIAPEVILGQ 176
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE 363
H VD WS GCIL E G P G+T E
Sbjct: 177 GH-SKTVDWWSLGCILYEFLVGIPPFHGETPEE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 156 EKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
K+G+G + VY+ + VA+K ++ ++ + ++ RE I+RKLDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-EDASEQQIEEFLREARIMRKLDH 60
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQLLSGLEH 269
PNI+KL G+ T + L +V EYM DL+ L + + S + + Q+ G+E+
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL-WYRPPELLL 328
S +HRD+ N L+ N ++KI+DFGL+ D + + + W PE L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK 177
Query: 329 GASHYGAAVDLWSTGCILGELFS 351
+ + D+WS G +L E+F+
Sbjct: 178 -EGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 82/309 (26%), Positives = 134/309 (43%), Gaps = 58/309 (18%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F L+ IG+G++ VY+A D +++VA+K + + + + ++ + +EI L + P I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-EAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
K G + L+++ EY DL+ PG K E+ + ++++L GLE+
Sbjct: 62 TKYYGSFLKGSK--LWIIMEYCGGGSCLDLL----KPG-KLDETYIAFILREVLLGLEYL 114
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR-------VVTLWYRP 323
H G +HRDIK +N+LL G +K+ADFG++ +TS V T ++
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSG--------QLTSTMSKRNTFVGTPFWMA 166
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
PE++ + Y D+WS G EL G+P L + L I K
Sbjct: 167 PEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN------------ 213
Query: 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
P + ++ FKDF + L DP R +A L +F
Sbjct: 214 --------NPPSLEGNKFSKPFKDFVSLCLNK-------DPKERPSAKELLKHKFIKK-- 256
Query: 444 LACNPSNLP 452
A S L
Sbjct: 257 -AKKTSYLT 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 159 DKIGQGTYSSVYRAR---DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
K+G+G + VY+ + VA+K ++ D + E F+ +E +++KL HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPNVV 59
Query: 216 KLEGLITSQTSCSLYLVFEYMEH-DLVG--------LASLPGMKFTESQVKCYMKQLLSG 266
+L G+ T + LYLV EYME DL+ S + + + Q+ G
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RVVTLWYRPP 324
+E+ S +HRD+ N L+ + ++KI+DFGL+ D + ++ W P
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-AP 176
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFS 351
E L + + D+WS G +L E+F+
Sbjct: 177 ESLKD-GIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 74/210 (35%), Positives = 111/210 (52%), Gaps = 20/210 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPN 213
F L +IG G++ +VY ARDV +++VA+KK+ + Q E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 214 IIKLEGLITSQTSCSLYLVFEYM---EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I+ +G + + +LV EY D++ + P E ++ L GL +
Sbjct: 77 TIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYL 131
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG- 329
HSH +HRDIK N+LL G +K+ADFG AS P +S V T ++ PE++L
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VGTPYWMAPEVILAM 186
Query: 330 -ASHYGAAVDLWSTG--CILGELFSGKPVL 356
Y VD+WS G CI EL KP L
Sbjct: 187 DEGQYDGKVDVWSLGITCI--ELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 65/212 (30%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ +E ++ IG G + VY A + +++ VA+K++ + + SV + +E+ + + +HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE-KCQTSVDELRKEVQAMSQCNHP 59
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
N++K L+LV Y+ D++ +S P E+ + +K++L GLE
Sbjct: 60 NVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGL-ASFFDPKDSVPMTSR-----VVTLWYR 322
+ HS+G +HRDIK N+LL +G +KIADFG+ AS D D T + V T +
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD---RTRKVRKTFVGTPCWM 173
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFSGKP 354
PE++ Y D+WS G EL +G
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-31
Identities = 68/210 (32%), Positives = 108/210 (51%), Gaps = 23/210 (10%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
F+ L+K+G+G+Y SVY+A ++VA+K V + E +K EI+IL++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK----EISILKQCDSP 58
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
I+K G T L++V EY D++ + + TE ++ + Q L GLE
Sbjct: 59 YIVKYYGSYFKNTD--LWIVMEYCGAGSVSDIMKITNKT---LTEEEIAAILYQTLKGLE 113
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFG----LASFFDPKDSVPMTSRVVTLWYRPP 324
+ HS+ +HRDIK N+LL+ G K+ADFG L +++V + T ++ P
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV-----IGTPFWMAP 168
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKP 354
E++ Y D+WS G E+ GKP
Sbjct: 169 EVIQE-IGYNNKADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 71/232 (30%), Positives = 130/232 (56%), Gaps = 22/232 (9%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES-------VKFMAREIAILRKLDHPN 213
IG G++ SVY + +++A+K+V + S + +AREIA+L++L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLV-GLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I++ G +++L EY+ V L + G F E+ V+ +++Q+L GL + H+
Sbjct: 68 IVQYLGSSLDADHLNIFL--EYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHN 124
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV------TLWYRPPEL 326
G++HRDIKG+N+L+D+ G +KI+DFG++ + +S+ + ++++ PE+
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA-NSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378
+ S+ A D+WS GC++ E+ +GK P + QL IFK+ + S +
Sbjct: 184 VKQTSYTRKA-DIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 73/235 (31%), Positives = 124/235 (52%), Gaps = 30/235 (12%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRF----DNQDPESVKFMAREIAILRKLDHPNIIK 216
+G G +SS Y+ARDV ++A+K+V + ++ E V+ + +EI ++ +L+HP+II+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
+ G + +L++ E+M V F E+ + Y +QLL GL + H + ++
Sbjct: 68 MLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 277 HRDIKGSNLLLDHNG-ILKIADFGLASFFDPKDSVPMTSRVV-----------TLWYRPP 324
HRD+KG+NLL+D G L+IADFG A + ++ T+ + P
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAA--------ARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLC---GSPS 376
E+L G YG + D+WS GC++ E+ + KP + L IFK+ +PS
Sbjct: 178 EVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 17/218 (7%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-D 210
FE ++ IG+GTY VY+AR ++VA+K + + E +K E ILRK +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSN 61
Query: 211 HPNIIKLEGLITSQTSCS----LYLVFEYMEH----DLVGLASLPGMKFTESQVKCYMKQ 262
HPNI G + L+LV E DLV G + E + +++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
L GL + H + V+HRDIKG N+LL N +K+ DFG+++ D T + T ++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWM 180
Query: 323 PPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVL 356
PE++ + Y A D+WS G EL GKP L
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E + +IG GTY VY+ARD+ ++VA+K ++ + D + + +EI++L++ HPNI
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNI 62
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDL--VGLASLPGMKFTESQVKCYMKQLLSGLE 268
+ G + L++V EY D+ V L E Q+ ++ L GL
Sbjct: 63 VAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-----ELQIAYVCRETLKGLA 115
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
+ H G +HRDIKG+N+LL +G +K+ADFG+++ S + T ++ PE+
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIAKRKSFIGTPYWMAPEVAA 174
Query: 329 GASH--YGAAVDLWSTGCILGELFSGKP 354
Y D+W+ G EL +P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 72/226 (31%), Positives = 115/226 (50%), Gaps = 19/226 (8%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES---VKFMAREIAILRKLDHPNIIKL 217
+GQG + VY DV + +A+K+V FD PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 218 EGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
G + + S+++ EYM D + TE+ + Y +Q+L G+E+ HS+
Sbjct: 70 YGCLRDDETLSIFM--EYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN 123
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYRPPELLLGAS 331
++HRDIKG+N+L D G +K+ DFG + M S T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377
YG D+WS GC + E+ + KP E E + IFK+ P+
Sbjct: 184 -YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 84/304 (27%), Positives = 132/304 (43%), Gaps = 50/304 (16%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ KIG+G+ V A D + VA+KK+ Q + F E+ I+R HPNI
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF--NEVVIMRDYQHPNI 78
Query: 215 IKLEG--LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+++ L+ + L++V E++E D+V + E Q+ +L L
Sbjct: 79 VEMYSSYLVGDE----LWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALS 129
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM-TSRVVTLWYRPPELL 327
H+ GV+HRDIK ++LL +G +K++DFG + VP S V T ++ PE +
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPE-V 186
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387
+ YG VD+WS G ++ E+ G+P + ++ + RI R +
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------------RDNLPPK 234
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACN 447
V P R S L M + DPA R TA LN F A
Sbjct: 235 LKNLHKVSPRLR-----------SFLDRM---LVRDPAQRATAAELLNHPFLA---KAGP 277
Query: 448 PSNL 451
PS++
Sbjct: 278 PSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
E L ++G G V + KI+A+K +R + + K + RE+ IL K + P I
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLAS-LPGMK--FTESQVKCYMKQLLSGLEHCH 271
+ G + + + EYM D L L ++ E + +L GL + H
Sbjct: 62 VGFYG--AFYNNGDISICMEYM--DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 272 S-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
H ++HRD+K SN+L++ G +K+ DFG++ +S+ T V T Y PE + G
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTF-VGTSSYMAPERIQG- 173
Query: 331 SHYGAAVDLWSTGCILGELFSGK-----PVLPGKTEVEQLHRI 368
+ Y D+WS G L EL +G+ P E L I
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 73/236 (30%), Positives = 110/236 (46%), Gaps = 25/236 (10%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILRKLDH 211
FE L IG+G + V + K+ A+K K + + SV+ + E IL++L+H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK--GSVRNVLNERRILQELNH 59
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL-----PGMKFTESQVKCYMKQLLSG 266
P ++ L + Q ++YLV DL+ L +KF+E QVK ++ +++
Sbjct: 60 PFLVNLW--YSFQDEENMYLVV-----DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
LE+ HS G++HRDIK N+LLD G + I DF +A+ TS T Y PE+
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPGYMAPEV 170
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGK--TEVEQLHRIFKLCGSPSEDYW 380
L Y AVD WS G E GK G T +Q+ + + Y
Sbjct: 171 LCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---TADVLYP 222
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 73/205 (35%), Positives = 114/205 (55%), Gaps = 22/205 (10%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGL 220
+G+GTY VY ARD+ +A+K++ +D V+ + EIA+ L H NI++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 221 ITSQTSCSLYLVFE-YMEHDLVG-LASL------PGMKFTESQVKCYMKQLLSGLEHCHS 272
S S F+ +ME G L++L P +K E + Y KQ+L GL++ H
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHD 126
Query: 273 HGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELL-LG 329
+ ++HRDIKG N+L++ ++G++KI+DFG + + P T TL Y PE++ G
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKG 184
Query: 330 ASHYGAAVDLWSTGCILGELFSGKP 354
YGA D+WS GC + E+ +GKP
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 71/217 (32%), Positives = 109/217 (50%), Gaps = 10/217 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPN 213
F L +IG G++ +VY ARDV + ++VA+KK+ + Q E + + +E+ L+KL HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I+ G + + +LV EY L + E ++ L GL + HSH
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG--AS 331
++HRD+K N+LL G++K+ DFG AS P + V T ++ PE++L
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMDEG 189
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
Y VD+WS G EL KP L + L+ I
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 84/252 (33%), Positives = 124/252 (49%), Gaps = 33/252 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAILRKLDHPN 213
F+ KIG+G +S VYRA ++ K VALKKV+ F+ D ++ + +EI +L++L+HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 214 IIK-LEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMK---FTESQVKCYMKQLLSGLE 268
+IK L+ I L +V E + DL + + E V Y QL S +E
Sbjct: 64 VIKYLDSFIEDN---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H HS V+HRDIK +N+ + G++K+ D GL FF K + S V T +Y PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPE-RI 178
Query: 329 GASHYGAAVDLWSTGCILGEL------FSGK----------------PVLPGKTEVEQLH 366
+ Y D+WS GC+L E+ F G P LP + E+L
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238
Query: 367 RIFKLCGSPSED 378
+ +C P D
Sbjct: 239 ELVSMCIYPDPD 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 71/221 (32%), Positives = 114/221 (51%), Gaps = 9/221 (4%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAR---EIAILRKLDHPNIIKL 217
+GQG + VY DV + +A K+V+FD + PE+ K ++ EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 218 EGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277
G + + +L + EYM V TES + Y +Q+L G+ + HS+ ++H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 278 RDIKGSNLLLDHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYRPPELLLGASHYGA 335
RDIKG+N+L D G +K+ DFG + + S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGR 188
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376
D+WS GC + E+ + KP E E + IFK+ P+
Sbjct: 189 KADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F+ L K+G+G+Y SVY+ + + ++ ALK+V + + + EI IL ++HPNI
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 215 IKL-EGLITSQTSCSLYLVFEYME-HDLVGLASLPGMK---FTESQVKCYMKQLLSGLEH 269
I E + L +V EY DL S K E ++ QLL GL+
Sbjct: 62 ISYKEAFLDG---NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-----TLWYRPP 324
H +LHRD+K +N+LL N ++KI D G++ + + T Y P
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKV--------LKKNMAKTQIGTPHYMAP 170
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
E+ G Y D+WS GC+L E+ + P ++ + +++
Sbjct: 171 EVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 80/248 (32%), Positives = 115/248 (46%), Gaps = 41/248 (16%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
KIG+G +S VYRA ++ VALKKV+ FD D ++ +EI +L++L+HPN+IK
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPGM---------KFTESQVKCYMKQLLSGLEH 269
++ L +L L M E V Y QL S LEH
Sbjct: 69 ASFIEDNELNIVL-------ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
HS V+HRDIK +N+ + G++K+ D GL FF K + S V T +Y PE +
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPE-RIH 179
Query: 330 ASHYGAAVDLWSTGCILGEL------FSGK----------------PVLPGKTEVEQLHR 367
+ Y D+WS GC+L E+ F G P LP E+L +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 239
Query: 368 IFKLCGSP 375
+ +C +P
Sbjct: 240 LVNMCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 64/203 (31%), Positives = 112/203 (55%), Gaps = 8/203 (3%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH--- 211
+++L+ IG+G Y +VYR + V ++VALK + D D + V + RE+A+L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
PNI K G L+++ EY E V G E + ++++L L++ H
Sbjct: 62 PNITKYYGSYLKGPR--LWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIH 118
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
GV+HRDIK +N+L+ + G +K+ DFG+A+ + ++S ++ V T ++ PE++
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN-QNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 332 HYGAAVDLWSTGCILGELFSGKP 354
+Y D+WS G + E+ +G P
Sbjct: 178 YYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 76/235 (32%), Positives = 118/235 (50%), Gaps = 15/235 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPN 213
F L +IG G++ +VY ARDV +++VA+KK+ + Q E + + +E+ L+++ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I+ +G + + +LV EY L + E ++ L GL + HSH
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG--AS 331
++HRDIK N+LL G +K+ADFG AS P +S V T ++ PE++L
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPYWMAPEVILAMDEG 199
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK-----LCGSPSEDYWR 381
Y VD+WS G EL KP L + L+ I + L + DY+R
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 84/308 (27%), Positives = 137/308 (44%), Gaps = 56/308 (18%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
P++ T + +KIGQG +VY A DV + VA+K++ Q + + + EI ++R+
Sbjct: 17 PKKKYT--RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMRE 72
Query: 209 LDHPNIIK-LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFT---------ESQVKC 258
HPNI+ L+ + L++V EY L G T E Q+
Sbjct: 73 NKHPNIVNYLDSYLVGD---ELWVVMEY----------LAGGSLTDVVTETCMDEGQIAA 119
Query: 259 YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVT 318
++ L LE HS+ V+HRDIK N+LL +G +K+ DFG + P+ S ++ V T
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGT 178
Query: 319 LWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378
++ PE++ YG VD+WS G + E+ G+P + + L+ I
Sbjct: 179 PYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---------- 227
Query: 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
+T P +++ F+DF L +D RG+A L F
Sbjct: 228 ---------ATNGTPELQNPEKLSAIFRDFLNRCL-------EMDVEKRGSAKELLQHPF 271
Query: 439 FT-TQPLA 445
+PL+
Sbjct: 272 LKIAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 67/221 (30%), Positives = 113/221 (51%), Gaps = 10/221 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E + KIG+G++ +Y A+ + +K++ + + +E+ +L K+ HPNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHS 272
+ + Q + L++V EY + DL+ + G+ F+E Q+ + Q+ GL+H H
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 273 HGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
+LHRDIK N+ L NG + K+ DFG+A + + T V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLC 372
Y D+WS GC+L EL + K G + QL + K+C
Sbjct: 179 -YNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 68/221 (30%), Positives = 112/221 (50%), Gaps = 9/221 (4%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES---VKFMAREIAILRKLDHPNIIKL 217
+GQG + VY D + +A+K+V+FD + PE+ V + EI +L+ L H I++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 218 EGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277
G + +L + E+M + TE+ + Y +Q+L G+ + HS+ ++H
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 278 RDIKGSNLLLDHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYRPPELLLGASHYGA 335
RDIKG+N+L D G +K+ DFG + M S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGR 188
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376
D+WS GC + E+ + KP E E + IFK+ P+
Sbjct: 189 KADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 75/245 (30%), Positives = 107/245 (43%), Gaps = 36/245 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDHP 212
FE + IG+G + V+ RD ++ A+K +R + + + A E IL D P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA-ERDILADADSP 61
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
I+KL + Q LYLV EYM DL+ L + F E + Y+ +L+ L+ H
Sbjct: 62 WIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDSVH 118
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLAS-FFDPKDSVPMTSRVVTLWYRP------- 323
G +HRDIK N+L+D +G +K+ADFGL KD + L +R
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 324 --------------------PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE 363
PE+L G YG D WS G IL E+ G P T E
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
Query: 364 QLHRI 368
++I
Sbjct: 238 TYNKI 242
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 81/289 (28%), Positives = 121/289 (41%), Gaps = 43/289 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
FE L+KIG+G++ V++ ++ A+K++ + + E +L KLD I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 215 IK-LEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
I+ E + L +V EY E H L L G E QV + Q+L GL H
Sbjct: 62 IRYYESFLDKG---KLNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
HS +LHRDIK NL LD +KI D G+A + T V T +Y PEL
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCED 175
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389
Y D+W+ G +L E +GK + + +I +
Sbjct: 176 KP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR------------------G 216
Query: 390 VFKPV-QPYRRRIAETFKDFPTSALRLMETLMSIDPAHR-GTATLALNS 436
VF PV Q Y +++A+ L++ ++ D R T L N
Sbjct: 217 VFPPVSQMYSQQLAQ-----------LIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 79/287 (27%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 155 FEKLDKIGQGTYSS--VYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ + +G+G + +YR + D +V K+V + + EI IL L HP
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 213 NIIK-LEGLITSQTSCSLYLVFEYMEHDLVG--LASLPGMKFTESQVKCYMKQLLSGLEH 269
NII + T L + EY + + G F E V Y+ Q++S + +
Sbjct: 60 NIIAYYNHFMDDNT---LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLL 328
H G+LHRDIK N+ L G++K+ DFG++ + S M VV T +Y PEL
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQ 174
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
G Y D+W+ GC+L EL + L R F +P + + ++
Sbjct: 175 GVK-YNFKSDIWALGCVLYELLT-------------LKRTFD-ATNPLNLVVKIVQGNYT 219
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALR-LMETLMSIDPAHRGTATLAL 434
V V Y +S L L+ +L+ DP R TA L
Sbjct: 220 PV---VSVY------------SSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRKLDHPNIIK 216
+G G + V + ++ ALK V+ + E + E IL + +HP I+K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGM----------KFTESQVKCYMKQLLSG 266
L T + +Y++ EY G F E + Y+ ++
Sbjct: 58 LYR--TFKDKKYIYMLMEYC----------LGGELWTILRDRGLFDEYTARFYIACVVLA 105
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
E+ H+ G+++RD+K NLLLD NG +K+ DFG A K + T Y PE+
Sbjct: 106 FEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEI 163
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKP 354
+L Y +VD WS G +L EL +G+P
Sbjct: 164 ILN-KGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD---PESVKFMAREIAILRKL 209
+ FE + +G G++ V R K ALK + V+ + E IL+ +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALK--ILSKAKIVKLKQVEHVLNEKRILQSI 58
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYME-------HDLVGLASLPGMKFTESQVKCYMKQ 262
HP ++ L G + Q +LYLV EY+ G +F E + Y Q
Sbjct: 59 RHPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQ 109
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW-- 320
++ LE+ HS +++RD+K NLLLD +G +KI DFG A R TL
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--------RTYTLCGT 161
Query: 321 --YRPPELLLGASHYGAAVDLWSTGCILGELFSGKP 354
Y PE++L + G AVD W+ G ++ E+ +G P
Sbjct: 162 PEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 10/217 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPN 213
F L +IG G++ +VY A + +++VA+KK+ + Q E + + +E+ L++L HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I+ +G + + +LV EY L + E ++ L GL + HSH
Sbjct: 83 TIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG--AS 331
++HRDIK N+LL G +K+ADFG AS P +S V T ++ PE++L
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF-----VGTPYWMAPEVILAMDEG 195
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
Y VD+WS G EL KP L + L+ I
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 157 KLDKIGQGTYSSVYRAR-DVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ ++G+G + V R D + D VA+K + ++ F REI ILR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF-EREIEILRTLDHE 66
Query: 213 NIIKLEGLITSQTSCSLYLVFEY-----MEHDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
NI+K +G+ SL L+ EY + L + ++ + Q+ G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGM 122
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR----VVTLWYRP 323
++ S +HRD+ N+L++ ++KI+DFGLA P+D + WY P
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL-PEDKDYYYVKEPGESPIFWYAP 181
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFS 351
L A D+WS G L ELF+
Sbjct: 182 ECLRTSKFSS--ASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 79/277 (28%), Positives = 118/277 (42%), Gaps = 45/277 (16%)
Query: 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES-VKFMAREIAILR-KLDHPNII 215
L I +G + SVY A+ A+K ++ + ++ V + E AI+ + + P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 216 KLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
KL + Q+ LYLV EY+ D L G E K Y+ +++ G+E H G
Sbjct: 61 KL--YYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLGASHY 333
++HRDIK NLL+D G LK+ DFGL+ + + V T Y PE +LG
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVGD- 170
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
D WS GC++ E G P +T P VF
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAET--------------PDA------------VFDN 204
Query: 394 VQPYRRRI---AETFKDFPTSALRLMETLMSIDPAHR 427
+ RRI E + A+ L+ L+ +DPA R
Sbjct: 205 IL--SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 77/284 (27%), Positives = 132/284 (46%), Gaps = 34/284 (11%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F KL++IG+G++ V++ D ++VA+K + + + E ++ + +EI +L + D P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
K G T L+++ EY+ L L F E Q+ +K++L GL++ HS
Sbjct: 65 TKYYGSYLKGTK--LWIIMEYLGGG-SALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYG 334
+HRDIK +N+LL G +K+ADFG+A + + V T ++ PE ++ S Y
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPE-VIQQSAYD 179
Query: 335 AAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV 394
+ D+WS G EL G+P P+ D L P
Sbjct: 180 SKADIWSLGITAIELAKGEP--------------------PNSDMHPMRVLFLIPKNNP- 218
Query: 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
++ FK+F ++ ++ DP+ R TA L +F
Sbjct: 219 PTLTGEFSKPFKEF-------IDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 1e-22
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 9/222 (4%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES---VKFMAREIAILRKLDHPNIIKL 217
+G+G + VY D + +A+K+V FD E+ V + EI +L+ L H I++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 218 EGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277
G + L + EYM + TE+ + Y +Q+L G+ + HS+ ++H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 278 RDIKGSNLLLDHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYRPPELLLGASHYGA 335
RDIKG+N+L D G +K+ DFG + + S T ++ PE++ G YG
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGR 188
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377
D+WS C + E+ + KP E E + IFK+ P++
Sbjct: 189 KADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 79/293 (26%), Positives = 142/293 (48%), Gaps = 36/293 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + +KIGQG +V+ A DV + VA+K++ Q + + + EI ++++L +PNI
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK--ELIINEILVMKELKNPNI 78
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ L + L++V EY+ L + + M E+Q+ ++ L LE H++
Sbjct: 79 VNF--LDSFLVGDELFVVMEYLAGGSLTDVVTETCMD--EAQIAAVCRECLQALEFLHAN 134
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
V+HRDIK N+LL +G +K+ DFG + P+ S ++ V T ++ PE++ + Y
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA-Y 192
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
G VD+WS G + E+ G+P + + L+ I G+P +L++ P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP--------ELQNPEKLSP 243
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT-TQPLA 445
+ F+DF + + +D RG+A L F +PL+
Sbjct: 244 I----------FRDF-------LNRCLEMDVEKRGSAKELLQHPFLKLAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRF-DNQDPESVKFMAREIAILRKLDHPN 213
E++ +G GT+ V+ RD I + ALK + + + + + E +L+++ HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG----------MKFTESQVKCYMKQL 263
II+L T LY++ EY +PG +F+ S Y ++
Sbjct: 63 IIRLFW--TEHDQRFLYMLMEY----------VPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW--- 320
+ LE+ HS +++RD+K N+LLD G +K+ DFG A + R TL
Sbjct: 111 VCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK--------KLRDRTWTLCGTP 162
Query: 321 -YRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
Y PE++ H AVD W+ G ++ E+ G P +I
Sbjct: 163 EYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (244), Expect = 2e-22
Identities = 78/293 (26%), Positives = 138/293 (47%), Gaps = 36/293 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + +KIGQG +VY A DV + VA++++ Q + + + EI ++R+ +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKNPNI 79
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ L + L++V EY+ L + + M E Q+ ++ L LE HS+
Sbjct: 80 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLHSN 135
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
V+HRDIK N+LL +G +K+ DFG + P+ S ++ V T ++ PE++ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA-Y 193
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
G VD+WS G + E+ G+P + + L+ I +T P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------------ATNGTP 234
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT-TQPLA 445
+++ F+DF + + +D RG+A L +F +PL+
Sbjct: 235 ELQNPEKLSAIFRDF-------LNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+L ++G+G SV + R I ALK + D +P+ K + RE+ I + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL------PGMKFTESQVKCYMKQLLSG 266
I+K G ++S S+ + EY E L S+ G + E + + +L G
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGG--SLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
L + HS ++HRDIK SN+LL G +K+ DFG++ +S+ T T +Y PE
Sbjct: 118 LSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL--VNSLAGTF-TGTSFYMAPER 174
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGK 353
+ G Y D+WS G L E+ +
Sbjct: 175 IQGKP-YSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 6/201 (2%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ K+ KIG+G++ + K +K++ P+ + +E+A+L + HPNI
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
++ + + + + +LY+V +Y E DL + + G+ F E Q+ + Q+ L+H H
Sbjct: 62 VQYQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
+LHRDIK N+ L +G +K+ DFG+A + + T + T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRP- 177
Query: 333 YGAAVDLWSTGCILGELFSGK 353
Y D+W+ GC+L E+ + K
Sbjct: 178 YNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 2e-22
Identities = 66/204 (32%), Positives = 113/204 (55%), Gaps = 14/204 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F KL+KIG+G++ V++ D K+VA+K + + + E ++ + +EI +L + D P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHC 270
K G T L+++ EY L G ++L PG E+Q+ ++++L GL++
Sbjct: 65 TKYYGSYLKDTK--LWIIMEY----LGGGSALDLLEPG-PLDETQIATILREILKGLDYL 117
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
HS +HRDIK +N+LL +G +K+ADFG+A + + V T ++ PE ++
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPE-VIKQ 175
Query: 331 SHYGAAVDLWSTGCILGELFSGKP 354
S Y + D+WS G EL G+P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 2e-22
Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 36/293 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + +KIGQG +VY A D+ + VA+K++ Q + + + EI ++R+ +PNI
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKNPNI 78
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ L + L++V EY+ L + + M E Q+ ++ L L+ HS+
Sbjct: 79 VNY--LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALDFLHSN 134
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
V+HRDIK N+LL +G +K+ DFG + P+ S ++ V T ++ PE++ + Y
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKA-Y 192
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
G VD+WS G + E+ G+P + + L+ I +T P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNGTP 233
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT-TQPLA 445
R++ F+DF + + +D RG+A L F +PL+
Sbjct: 234 ELQNPERLSAVFRDF-------LNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-22
Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 25/226 (11%)
Query: 140 AGEAIKGWIPRRANTFEKLDK---IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESV 196
+ + G P A + +L++ IG G +VY+ ++ ALK V + N +
Sbjct: 58 SSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVR 116
Query: 197 KFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFT-ESQ 255
+ + REI ILR ++HPN++K + + + ++ E+M+ SL G E
Sbjct: 117 RQICREIEILRDVNHPNVVKCHDMF--DHNGEIQVLLEFMDG-----GSLEGTHIADEQF 169
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFG----LASFFDPKDSVP 311
+ +Q+LSG+ + H ++HRDIK SNLL++ +KIADFG LA D P
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-----P 224
Query: 312 MTSRVVTLWYRPPELL---LGASHY-GAAVDLWSTGCILGELFSGK 353
S V T+ Y PE + L Y G A D+WS G + E + G+
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 7/197 (3%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ L +G+G++ + V D+ A+K++R + +V+ +E +L K+ HPNI
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHS 272
+ + + + LY+V EY + DL+ L G F E + + Q+ G++H H
Sbjct: 61 VAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
VLHRDIK N+ L NG +K+ DFG A + T V T +Y PPE+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMP- 176
Query: 333 YGAAVDLWSTGCILGEL 349
Y D+WS GCIL EL
Sbjct: 177 YNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDH 211
F+ L ++GQG Y V+ A+ +IVALK+++ V+ + E IL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
++KL L Q LYL EY+ D L + G+ +E + YM ++ ++
Sbjct: 61 EWLVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDAL 117
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
H G +HRD+K N L+D +G +K+ DFGL+ S V + Y PE+L G
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY----ANSVVGSPDYMAPEVLRG- 172
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKT 360
Y VD WS GC+L E G P G T
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 73/224 (32%), Positives = 112/224 (50%), Gaps = 23/224 (10%)
Query: 158 LDKIGQGTYSSVYRARDVIHDK------IVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
L +GQG++ V+ R + + LKK +D K M R+I L +++H
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK-MERDI--LAEVNH 57
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
P I+KL QT LYL+ +++ DL S M FTE VK Y+ +L L+H
Sbjct: 58 PFIVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHL 114
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV----TLWYRPPEL 326
HS G+++RD+K N+LLD G +K+ DFGL+ K+S+ + T+ Y PE+
Sbjct: 115 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSFCGTVEYMAPEV 169
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
+ H +A D WS G ++ E+ +G GK E + I K
Sbjct: 170 VNRRGHTQSA-DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-21
Identities = 67/223 (30%), Positives = 98/223 (43%), Gaps = 9/223 (4%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDH 211
F+ +G+G + V R+ I A+K ++ E+V F E IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
P I +L Q +LYLV EY DL+ L + +F E + Y+ +L+ +
Sbjct: 61 PWIPQL--QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL-- 328
H G +HRDIK N+L+D G +K+ADFG A+ V V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 329 ---GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
G YG D WS G I E+ G+ T + + I
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 62/203 (30%), Positives = 110/203 (54%), Gaps = 12/203 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F KL++IG+G++ VY+ D ++VA+K + + + E ++ + +EI +L + D P I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK---FTESQVKCYMKQLLSGLEHCH 271
+ G + L+++ EY L G ++L +K E+ + ++++L GL++ H
Sbjct: 65 TRYYG--SYLKGTKLWIIMEY----LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
S +HRDIK +N+LL G +K+ADFG+A + + V T ++ PE ++ S
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPE-VIKQS 176
Query: 332 HYGAAVDLWSTGCILGELFSGKP 354
Y D+WS G EL G+P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILRKLDHPN 213
F+K+ +G+G V+ R K+ ALK + + + VK + E IL LDHP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 214 IIKLEGLITSQTSCSLYLVFEY-MEHDLVG-LASLPGMKFTESQVKCYMKQLLSGLEHCH 271
+ L + QT L LV +Y +L L PG +E + Y ++L LE+ H
Sbjct: 63 LPTLYA--SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM------------------- 312
G+++RD+K N+LL +G + ++DF L+ D +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 313 ---------TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG 352
S V T Y PE++ G H G+AVD W+ G +L E+ G
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 77/294 (26%), Positives = 130/294 (44%), Gaps = 56/294 (19%)
Query: 160 KIGQGTYSSVYRARD---VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216
++G+G++ +VY +D V +++ LK++ +P +E +L KLDHP I+K
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 217 LEGLITSQTSCSLYLVFEYME-HDL---VGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
+ + ++ EY E DL + G +E+QV + QLL G+ + H
Sbjct: 67 FHASFLERDA--FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
+LHRD+K N+ L +N +LKI DFG++ + T+ T +Y PE L H
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLA-TTFTGTPYYMSPEAL---KH 179
Query: 333 --YGAAVDLWSTGCILGEL------FSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
Y + D+WS GCIL E+ F G+ L
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---------------------------- 211
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
S V + V+ + ET + +M+++++ DP+ R +A L + F
Sbjct: 212 ---SVVLRIVEGPTPSLPET---YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 39/288 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
E KIG+G+ V AR+ + VA+K + Q + F E+ I+R H N+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNV 80
Query: 215 IKL--EGLITSQTSCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
+++ L+ + L+++ E+++ L + S + E Q+ + +L L + H
Sbjct: 81 VEMYKSYLVGEE----LWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLH 134
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
S GV+HRDIK ++LL +G +K++DFG + KD S V T ++ PE ++ +
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGTPYWMAPE-VISRT 192
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
YG VD+WS G ++ E+ G+P + V+ + R L SP KL+++
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR---LRDSPP------PKLKNAHKI 243
Query: 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
PV +DF +E +++ +P R TA L+ F
Sbjct: 244 SPV----------LRDF-------LERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 69/247 (27%), Positives = 125/247 (50%), Gaps = 26/247 (10%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E + ++G GTY VY+AR++ ++ A+K ++ + D S+ + +EI ++++ H NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNI 68
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGM-----KFTESQVKCYMKQLLSGLEH 269
+ G S+ L++ EY G SL + +E Q+ ++ L GL +
Sbjct: 69 VAYFGSYLSREK--LWICMEY-----CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR---VVTLWYRPPEL 326
HS G +HRDIKG+N+LL NG +K+ADFG+A+ K + + R + T ++ PE+
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAA----KITATIAKRKSFIGTPYWMAPEV 177
Query: 327 LLGASH--YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
+ Y D+W+ G EL +P + ++ + +F + S + K K
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPM---FDLHPMRALFLMSKSNFQPPKLKDK 234
Query: 385 LRHSTVF 391
+ S+ F
Sbjct: 235 TKWSSTF 241
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 44/291 (15%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL-EG 219
+G G + VY+A+ A K ++ ++++ E FM EI IL + HPNI+ L E
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-ELEDFMV-EIDILSECKHPNIVGLYEA 70
Query: 220 LITSQTSCSLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
L+++ E+ + + L TE Q++ +Q+L L HSH V+HR
Sbjct: 71 YFYEN---KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 279 DIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR---VVTLWYRPPELLLGASH--- 332
D+K N+LL +G +K+ADFG+++ K+ + R + T ++ PE++ +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSA----KNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 333 -YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
Y D+WS G L EL +P P E+ + + K+ S T+
Sbjct: 184 PYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP-----------PTLD 229
Query: 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442
+P + + +F DF S L DP R TA L F + Q
Sbjct: 230 QP-----SKWSSSFNDFLKSCL-------VKDPDDRPTAAELLKHPFVSDQ 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD--NQDPESVKF--MAREIAILRKLDHPNIIK 216
+G+G Y +VY +++A+K+V D N ++ + E+ +L+ L H NI++
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 217 LEGLITSQTSCSLYLVF---EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
G + S+++ F + L LP F + Y KQ+L G+ + H++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK-----YTKQILDGVAYLHNN 121
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLA------SFFDPKDSVPMTSRVVTLWYRPPELL 327
V+HRDIKG+N++L NGI+K+ DFG A ++ + W P +
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE--V 179
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVL 356
+ S YG D+WS GC + E+ +GKP L
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+EK+ +G+G + V+ R K+V +K++ + + E +L+ L HPNI
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 215 IK-LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK----FTESQVKCYMKQLLSGLEH 269
I+ E + + +L +V EY LA + E + + Q+L L H
Sbjct: 62 IEYYENFLEDK---ALMIVMEYAPGGT--LAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 270 CHSHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H+ +LHRD+K N+LLD H ++KI DFG++ K + V T Y PEL
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA--YTVVGTPCYISPELCE 174
Query: 329 GASHYGAAVDLWSTGCILGELFSGK 353
G Y D+W+ GC+L EL S K
Sbjct: 175 GKP-YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 24/219 (10%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD----NQDPESVKFMAREIAILRKLDHPNIIK 216
+G+G++ V A D++ A+K ++ D + D E R +A+ K HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLTQ 60
Query: 217 LEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
L QT L+ V EY+ DL+ G +F E + + Y +++ GL+ H G+
Sbjct: 61 LHS--CFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGI 117
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW------YRPPELLLG 329
++RD+K N+LLD G +KIADFG+ K+ + V T Y PE+L
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMC-----KEG--ILGGVTTSTFCGTPDYIAPEILSY 170
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
YG AVD W+ G +L E+ +G+ G E E I
Sbjct: 171 QP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 7e-20
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK---- 216
IG+GT+ VY+ R +I A+K + S K + + + + NI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL--------SKKEIVAKKEVAHTIGERNILVRTLL 52
Query: 217 -----LEGLITS-QTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+ GL S QT LYLV +YM + +F+E + K Y+ +L+ LEH
Sbjct: 53 DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
H + +++RD+K N+LLD G + + DFGL S + D+ + T Y PE+LL
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGL-SKANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 331 SHYGAAVDLWSTGCILGELFSG 352
Y VD WS G ++ E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 20/223 (8%)
Query: 158 LDKIGQGTYSSVYRA--RDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
L ++G G + V+ R I I +++ D F+ E ++ KL HPN++
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD-----FI-EEAKVMMKLSHPNLV 62
Query: 216 KLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+L G+ T Q +++V EYM + L L G K + + +E+ S+
Sbjct: 63 QLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASF-FDPKDSVPMTSRVVTLWYRPPELLLGASH 332
G +HRD+ N L+ + ++K++DFGLA + D + + ++ W PPE+ S
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKW-APPEVFD-YSR 177
Query: 333 YGAAVDLWSTGCILGELFS-GKPVLPGKTE---VEQLHRIFKL 371
+ + D+WS G ++ E+FS GK + VE + ++L
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
FE + +IG GTY VY+AR+V ++ A+K ++ + E + +EI +++ H NI
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL--EPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGM-----KFTESQVKCYMKQLLSGLEH 269
+ G + L++ E+ G SL + +ESQ+ ++ L GL +
Sbjct: 69 VAYFGSYLRRDK--LWICMEF-----CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR---VVTLWYRPPEL 326
HS G +HRDIKG+N+LL NG +K+ADFG+++ + + + R + T ++ PE+
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSA----QITATIAKRKSFIGTPYWMAPEV 177
Query: 327 --LLGASHYGAAVDLWSTGCILGELFSGKP 354
+ Y D+W+ G EL +P
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 9e-20
Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 161 IGQGTYSSVYRARDVI-HD--KIVALK-----KVRFDNQDPESVKFMAREIAILRKLDHP 212
+G+G Y V++ R V D KI A+K + + +D K E IL + HP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK---AERNILEAVKHP 60
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
I+ L + QT LYL+ EY+ +L G+ F E Y+ ++ LEH H
Sbjct: 61 FIVDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLH 117
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
G+++RD+K N+LLD G +K+ DFGL + +V T T+ Y PE+L+ +
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-CGTIEYMAPEILMRSG 176
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
H G AVD WS G ++ ++ +G P + + + +I K
Sbjct: 177 H-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 58/202 (28%), Positives = 105/202 (51%), Gaps = 21/202 (10%)
Query: 161 IGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
IG G + V R R + K VA+K ++ + D + + F+ E +I+ + DHPNII+L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNIIRL 70
Query: 218 EGLITSQTSCSLYLVFEYMEHDLVGLASLPGM------KFTESQVKCYMKQLLSGLEHCH 271
EG++T S + ++ EYME+ SL KFT Q+ ++ + SG+++
Sbjct: 71 EGVVTK--SRPVMIITEYMEN-----GSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RVVTLWYRPPELLLG 329
+HRD+ N+L++ N + K++DFGL+ + ++ T ++ W P +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA--IA 181
Query: 330 ASHYGAAVDLWSTGCILGELFS 351
+ +A D+WS G ++ E+ S
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
A FE ++ +G GTY VY+ R V ++ A+K + + E +K EI +L+K H
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSH 71
Query: 212 -PNIIKLEGLITSQTSC----SLYLVFEYMEH----DLVGLASLPGMKFTESQVKCYMKQ 262
NI G ++ L+LV E+ DLV + G E + ++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYICRE 129
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
+L GL H H+H V+HRDIKG N+LL N +K+ DFG+++ D + + + T ++
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWM 188
Query: 323 PPELLL----GASHYGAAVDLWSTGCILGELFSGKPVL 356
PE++ + Y D+WS G E+ G P L
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 66/209 (31%), Positives = 96/209 (45%), Gaps = 9/209 (4%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILRKL 209
+A F+ + IG+G + V R ++ A+K + +F+ F E I+
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+ I++L Q LY+V EYM DLV L S E + Y +++ L+
Sbjct: 101 NSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALD 156
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
HS G +HRD+K N+LLD +G LK+ADFG D V + V T Y PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLK 216
Query: 329 ---GASHYGAAVDLWSTGCILGELFSGKP 354
G +YG D WS G L E+ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 90/318 (28%), Positives = 135/318 (42%), Gaps = 45/318 (14%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES-VKFMAREIAILRKLDHPNIIKLEG 219
IG+G++ V + R +I ALK +R + S V E +L +++ P I+ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 220 LITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
+ Q+ LYLV ++ +L G +F S+ + Y +LL LE+ H V++R
Sbjct: 60 -FSFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 279 DIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVD 338
D+K N+LLD+ G + + DFGL + KD + T Y PELLLG Y AVD
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVD 175
Query: 339 LWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYR 398
W+ G +L E+ +G P + E +I + +P R
Sbjct: 176 WWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ------------------------EPLR 211
Query: 399 RRIAETFKD-FPTSALRLMETLMSIDPAHR---GTATLALNSEFFTTQPLA--CNPSNLP 452
F D F A L+ L+S DP R A N FF+ P
Sbjct: 212 ------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQP 265
Query: 453 KYPPSKE--IDAKLRDEE 468
+ P+ ID DEE
Sbjct: 266 PFKPAVSSAIDTSNFDEE 283
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 74/264 (28%), Positives = 110/264 (41%), Gaps = 61/264 (23%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAILRKLDH 211
+ FE + IG+G + V + I A+KK+R + + E V + E IL + D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG-------MK---FTESQVKCYMK 261
P ++KL + Q LYL+ EY LPG MK FTE + + Y+
Sbjct: 61 PWVVKL--YYSFQDENYLYLIMEY----------LPGGDMMTLLMKKDTFTEEETRFYIA 108
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD---------------P 306
+ + ++ H G +HRDIK NLLLD G +K++DFGL + P
Sbjct: 109 ETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 307 KDSV-----PMTS-RVVTLW----------------YRPPELLLGASHYGAAVDLWSTGC 344
+ + PM+S R W Y PE+ L + Y D WS G
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGV 227
Query: 345 ILGELFSGKPVLPGKTEVEQLHRI 368
I+ E+ G P E +I
Sbjct: 228 IMYEMLVGYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 60/197 (30%), Positives = 84/197 (42%), Gaps = 30/197 (15%)
Query: 180 IVALKKVR-FDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME- 237
I ALKK + ES+ R HP ++ L QT + V EY
Sbjct: 29 IKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF--QTEDHVCFVMEYAAG 86
Query: 238 -------HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN 290
H V F+E + Y ++ GL++ H + +++RD+K NLLLD
Sbjct: 87 GDLMMHIHTDV---------FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE 137
Query: 291 GILKIADFGLASFFDPKDSVPMTSRVVTLWYRP----PELLLGASHYGAAVDLWSTGCIL 346
G +KIADFGL K+ + R T P PE+L S Y AVD W G ++
Sbjct: 138 GFVKIADFGLC-----KEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLI 191
Query: 347 GELFSGKPVLPGKTEVE 363
E+ G+ PG E E
Sbjct: 192 YEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 69/245 (28%), Positives = 118/245 (48%), Gaps = 27/245 (11%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIA--- 204
+ +T+E ++ IG+GTY VY+ + + A+K + DP + + EI
Sbjct: 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-----DP--ISDVDEEIEAEY 69
Query: 205 -ILRKL-DHPNIIKLEGLITSQTSCS---LYLVFEYME----HDLVGLASLPGMKFTESQ 255
IL+ L +HPN++K G+ L+LV E +LV + G + E+
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315
+ + L GL+H H++ ++HRD+KG+N+LL G +K+ DFG+++ TS
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 316 VVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL 371
V T ++ PE++ Y A D+WS G EL G P L ++ + +FK+
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL---FDMHPVKTLFKI 245
Query: 372 CGSPS 376
+P
Sbjct: 246 PRNPP 250
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 18/216 (8%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD----NQDPESVKFMAREIAILRKLDHPNIIK 216
+G+G++ V+ A ++ A+K ++ D + D E R +++ +HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL--AWEHPFLTH 60
Query: 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
L T QT +L+ V EY+ + KF + Y +++ GL+ HS G++
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP----PELLLGASH 332
+RD+K N+LLD +G +KIADFG+ K+++ ++ T P PE+LLG
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMC-----KENMLGDAKTCTFCGTPDYIAPEILLG-QK 172
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
Y +VD WS G +L E+ G+ G E E I
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-19
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILRKL 209
+A ++ + IG+G + V R K+ A+K + +F+ F E I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+ P +++L Q LY+V EYM DLV L S E K Y +++ L+
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALD 156
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
HS G++HRD+K N+LLD +G LK+ADFG D V + V T Y PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 329 ---GASHYGAAVDLWSTGCILGELFSG 352
G +YG D WS G L E+ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 20/217 (9%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIH-DKIVALKKVRFDN--------QDPESVKFMAREIA 204
+ L+ +G G + VY+ R + ++ALK++ N + +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 205 ILRK-LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVG--LASLP--GMKFTESQVKCY 259
I+++ L HPNI++ LY+V + +E +G SL +FTE ++
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDR--LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 260 MKQLLSGLEHCHSHG-VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVT 318
Q++ L + H ++HRD+ +N++L + + I DFGLA P+ +TS V T
Sbjct: 119 FVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176
Query: 319 LWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV 355
+ Y PE++ YG D+W+ GCIL ++ + +P
Sbjct: 177 ILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 161 IGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
IG G + V R R + K VA+K ++ + + F++ E +I+ + DHPNII L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQFDHPNIIHL 70
Query: 218 EGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
EG++T S + ++ E+ME+ L +FT Q+ ++ + +G+++ +
Sbjct: 71 EGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFF-----DPKDSVPMTSRVVTLWYRPPELLLGAS 331
HRD+ N+L++ N + K++DFGL+ F DP + + ++ W P +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--R 186
Query: 332 HYGAAVDLWSTGCILGELFS 351
+ +A D+WS G ++ E+ S
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 6e-19
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
A FE ++ +G GTY VY+ R V ++ A+K + + E +K +EI +L+K H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 212 -PNIIKLEGLITSQTSC----SLYLVFEYMEHDLVG--LASLPGMKFTESQVKCYMKQLL 264
NI G + L+LV E+ V + + G E + +++L
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPP 324
GL H H H V+HRDIKG N+LL N +K+ DFG+++ D + + + T ++ P
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVGRRNTFIGTPYWMAP 180
Query: 325 ELLLGASH----YGAAVDLWSTGCILGELFSGKPVL 356
E++ + Y DLWS G E+ G P L
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 28/223 (12%)
Query: 159 DKIGQGTYSSVYRARDVIHDKI-VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
+KIG+G + VY+ + VA+K R KF+ +E IL++ DHPNI+KL
Sbjct: 1 EKIGKGNFGDVYKGV--LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKL 57
Query: 218 EGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLL-------SGLEHC 270
G+ + +Y+V E + G + L ++ ++++ +K+LL +G+E+
Sbjct: 58 IGVCVQKQP--IYIVMELVP----GGSLLTFLRKKKNRLT--VKKLLQMSLDAAAGMEYL 109
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS----RVVTLWYRPPEL 326
S +HRD+ N L+ N +LKI+DFG++ + + + S ++ W P L
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEAL 167
Query: 327 LLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
G Y + D+WS G +L E FS G PG + + RI
Sbjct: 168 NYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVI---HDKIVA---LKKVRFDNQDPESVKFMAREIAILRK 208
FE L +G G Y V+ R V K+ A LKK + + +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
P ++ L QT L+L+ +Y+ + FTES+V+ Y+ +++ L+
Sbjct: 62 RRCPFLVTLH--YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H H G+++RDIK N+LLD G + + DFGL+ F ++ S T+ Y PE++
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 329 GASH-YGAAVDLWSTGCILGELFSG 352
G S + AVD WS G + EL +G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 73/231 (31%), Positives = 115/231 (49%), Gaps = 13/231 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVI-HD--KIVALKKVRFDN--QDPESVKFMAREIAILRKL 209
FE L +G G Y V+ R V HD K+ A+K ++ Q ++V+ E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 210 -DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
P ++ L QT L+L+ +Y+ + F+E +V+ Y +++ LE
Sbjct: 62 RQSPFLVTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H H G+++RDIK N+LLD G + + DFGL+ F ++ S T+ Y PE++
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 329 GASHYGAAVDLWSTGCILGELFSGKP--VLPGK--TEVEQLHRIFKLCGSP 375
G +G AVD WS G ++ EL +G L G+ T+ E RI K C P
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPP 229
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 72/256 (28%), Positives = 117/256 (45%), Gaps = 31/256 (12%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAI 205
W IPR + E+ K+G G + V+ K VA+K ++ PE+ +E I
Sbjct: 1 WEIPRESLKLER--KLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQI 54
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQL 263
++KL H +++L + + + +Y+V EYM L L S G K Q+ Q+
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI 112
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
G+ + S +HRD+ N+L+ N + KIADFGLA + + + +
Sbjct: 113 AEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA 172
Query: 324 PELLLGASHYGA---AVDLWSTGCILGELFS-GKPVLPGKT------EVEQLHRIFKLCG 373
PE A++YG D+WS G +L E+ + G+ PG T +VE+ +R+ +
Sbjct: 173 PE----AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN 228
Query: 374 SPSEDY------WRKS 383
P E Y W K
Sbjct: 229 CPEELYDLMLQCWDKD 244
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 70/239 (29%), Positives = 117/239 (48%), Gaps = 19/239 (7%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
P ++T+E ++ IG+GTY V++ + + A+K + + E ++ E IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE---AEYNILKA 70
Query: 209 L-DHPNIIKLEGLITSQ---TSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYM 260
L DHPN++K G+ + L+LV E DLV G + E + +
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW 320
+ L GL+H H + +HRD+KG+N+LL G +K+ DFG+++ TS V T +
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPF 189
Query: 321 YRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375
+ PE++ S Y A D+WS G EL G P L ++ + +FK+ +P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 70/279 (25%), Positives = 115/279 (41%), Gaps = 51/279 (18%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKV---RFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
+G+G + V + K+ A KK+ R + E + ++I L K+ I+ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 218 EGLITSQTSCSLYLV--------FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
++ L + + G F E++ Y Q++ GLEH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIFYAAQIICGLEH 110
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
H +++RD+K N+LLD +G ++I+D GLA K + R T Y PE+L G
Sbjct: 111 LHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGRAGTPGYMAPEVLQG 168
Query: 330 ASHYGAAVDLWSTGCILGELFSGK-PVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
Y +VD ++ GC L E+ +G+ P K +VE K +L+
Sbjct: 169 -EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE------------------KEELKRR 209
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
T+ V+ Y + + KD E L+ DP R
Sbjct: 210 TLEMAVE-YPDKFSPEAKDL-------CEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVI-HD--KIVALKKVRFDN--QDPESVKFMAREIAILRKL 209
FE L +G G Y V+ R V HD K+ A+K ++ Q ++ + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 210 DH-PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
P ++ L QT L+L+ +Y+ + +F E +V+ Y +++ LE
Sbjct: 62 RQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H H G+++RDIK N+LLD NG + + DFGL+ F + S T+ Y P+++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 329 GA-SHYGAAVDLWSTGCILGELFSG 352
G + AVD WS G ++ EL +G
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEG 219
K+G G Y VY + VA+K ++ D V+ +E A+++++ HPN+++L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 220 LITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYM-KQLLSGLEHCHSHGVLH 277
+ T + Y++ E+M + +L+ + + V YM Q+ S +E+ +H
Sbjct: 70 VCTREPP--FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 278 RDIKGSNLLLDHNGILKIADFGLASFF-DPKDSVPMTSRVVTLWYRPPELLLGASHYGAA 336
RD+ N L+ N ++K+ADFGL+ + ++ W P L + +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES--LAYNKFSIK 185
Query: 337 VDLWSTGCILGEL 349
D+W+ G +L E+
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 158 LDKIGQGTYSSVYRAR-DVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
+ ++G+G + SV R D + D ++VA+KK++ E ++ REI IL+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I+K +G+ S +L LV EY+ + L + ++ Y Q+ G+E+ S
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS----VPMTSRVVTLWYRPPELLL 328
+HRD+ N+L++ +KI DFGL P+D V WY P L
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIFWYAPES--L 183
Query: 329 GASHYGAAVDLWSTGCILGELFS 351
S + A D+WS G +L ELF+
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILRKL 209
+A +E + IG+G + V R K+ A+K + +F+ F E I+
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+ P +++L Q LY+V EYM DLV L S E + Y +++ L+
Sbjct: 101 NSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALD 156
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
HS G +HRD+K N+LLD +G LK+ADFG + + V + V T Y PE+L
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 329 ---GASHYGAAVDLWSTGCILGELFSG 352
G +YG D WS G L E+ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 83/306 (27%), Positives = 129/306 (42%), Gaps = 44/306 (14%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAR-EIAILRKLDHPNIIK 216
IG+G + VY R K+ A+K K R + E++ R ++++ D P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 217 LEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
+ T L + + M DL S G+ F+E++++ Y +++ GLEH H+ V
Sbjct: 62 MS--YAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
++RD+K +N+LLD +G ++I+D GLA F K P S V T Y PE+L Y +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS-VGTHGYMAPEVLQKGVAYDS 175
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395
+ D +S GC+L +L G SP + K K + +
Sbjct: 176 SADWFSLGCMLFKLLRGH--------------------SPFRQHKTKDKHEIDRMTLTMA 215
Query: 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHR-----GTATLALNSEFFTTQPLACNPSN 450
E F L+E L+ D R A FF + L
Sbjct: 216 V------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS--LDWQMVF 267
Query: 451 LPKYPP 456
L KYPP
Sbjct: 268 LQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEG 219
+IG G + V+ + K VA+K +R E E ++ KL HP +++L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHPKLVQLYG 66
Query: 220 LITSQTSCSLYLVFEYMEHDLVG--LASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277
+ T ++ + LVFE+MEH + L + G KF++ + + G+ + S V+H
Sbjct: 67 VCTERSP--ICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 278 RDIKGSNLLLDHNGILKIADFGLASF-FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAA 336
RD+ N L+ N ++K++DFG+ F D + + ++ W P + S Y +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE--VFSFSKYSSK 181
Query: 337 VDLWSTGCILGELFS-GKPVLPGKTE---VEQL---HRIFK 370
D+WS G ++ E+FS GK ++ VE + R++K
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 50/296 (16%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEG 219
KIG+G+ V A K+VA+KK+ Q + F E+ I+R H N++++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVEMYN 84
Query: 220 LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
+ L++V E++E D+V + E Q+ +L L H+ GV
Sbjct: 85 --SYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQGV 137
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
+HRDIK ++LL H+G +K++DFG + K+ S V T ++ PE L+ YG
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPE-LISRLPYGP 195
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395
VD+WS G ++ E+ G+P Y+ + L+ + +
Sbjct: 196 EVDIWSLGIMVIEMVDGEP-----------------------PYFNEPPLKAMKMIRDNL 232
Query: 396 PYR----RRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ-PLAC 446
P + +++ + K F ++ L+ DPA R TA L F P +C
Sbjct: 233 PPKLKNLHKVSPSLKGF-------LDRLLVRDPAQRATAAELLKHPFLAKAGPPSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E + ++G G + VY+A++ ++A KV D + E ++ EI IL DHPNI
Sbjct: 7 WEIIGELGDGAFGKVYKAQNK-ETGVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK-FTESQVKCYMKQLLSGLEHCHSH 273
+KL + + L+++ E+ V L + TE Q++ KQ L L + H +
Sbjct: 65 VKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR---VVTLWYRPPELLLGA 330
++HRD+K N+L +G +K+ADFG+++ K++ + R + T ++ PE+++
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 331 SH----YGAAVDLWSTGCILGELFSGKP 354
+ Y D+WS G L E+ +P
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRA--RDVIHDK---IVALKKVRFDNQDPESVKFMARE 202
+ R ++G+G + V+ + + +VA+K ++ + ++ K RE
Sbjct: 2 VQRDTIVL--KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFERE 58
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH------------DLVGLASLPGMK 250
+L H NI+K G+ T +VFEYMEH D L S
Sbjct: 59 AELLTNFQHENIVKFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116
Query: 251 F--TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308
T SQ+ Q+ SG+ + S +HRD+ N L+ ++ ++KI DFG++ D
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176
Query: 309 SVPMT-SRVVTLWYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GK 353
+ ++ + + PPE ++ Y D+WS G +L E+F+ GK
Sbjct: 177 YYRVGGHTMLPIRWMPPESIM----YRKFTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 31/214 (14%)
Query: 155 FEKLDKIGQGTYSSVYRAR-DVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
+K+ +G+G + V D +D ++VA+K ++ + ++ +EI IL+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSG 266
H NI+K +G + Q L L+ EY V L SL P K +Q+ + +Q+ G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEY-----VPLGSLRDYLPKHKLNLAQLLLFAQQICEG 119
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVV------ 317
+ + HS +HRD+ N+LLD++ ++KI DFGLA +VP RV
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK------AVPEGHEYYRVREDGDSP 173
Query: 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
WY L + + A D+WS G L EL +
Sbjct: 174 VFWYAVE--CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVA---LKK-VRFDNQDPESVKFMAREIAILRKLD 210
F L +G+G++ V A D++ A LKK V + D E R +A+ K
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK-- 59
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
P + +L QT LY V EY+ DL+ G KF E Y ++ GL
Sbjct: 60 PPFLTQLHS--CFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFF 116
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLA--SFFDPKDSVPMTSRVV--TLWYRPPE 325
HS G+++RD+K N++LD G +KIADFG+ + F K T+R T Y PE
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-----TTRTFCGTPDYIAPE 171
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
++ YG +VD W+ G +L E+ +G+P G+ E E I
Sbjct: 172 IIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 48/238 (20%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRAR--DVIHDK---IVALKKVRFDNQDPESVKFMAREI 203
PR N E + IGQG + V++AR ++ + +VA+K ++ + F RE
Sbjct: 3 PR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 59
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL---------------------V 241
A++ + DHPNI+KL G+ + L+FEYM + DL
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 242 GLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGL- 300
L + + ++ C KQ+ +G+ + +HRD+ N L+ N ++KIADFGL
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 301 -----ASFF--DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
A ++ D++P+ + PPE + Y D+W+ G +L E+FS
Sbjct: 178 RNIYSADYYKASENDAIPIR-------WMPPESIFYN-RYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 59/202 (29%), Positives = 107/202 (52%), Gaps = 11/202 (5%)
Query: 157 KLDK-IGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
K++K IG G + V R + K VA+K ++ + + F++ E +I+ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
NII LEG++T S + +V EYME+ L +FT Q+ ++ + SG+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFF--DPKDSVPMTSRVVTLWYRPPELLLG 329
G +HRD+ N+L++ N + K++DFGL+ DP+ + + + + PE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 182
Query: 330 ASHYGAAVDLWSTGCILGELFS 351
+ +A D+WS G ++ E+ S
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 70/244 (28%), Positives = 123/244 (50%), Gaps = 25/244 (10%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+PR T + + K+G G + V+ H K VA+K ++ + PE+ F+A E +++
Sbjct: 3 VPR--ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMK 56
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQLLS 265
+L HP +++L ++T + +Y++ EYME+ LV L + G+K T +++ Q+
Sbjct: 57 QLQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
G+ +HRD++ +N+L+ KIADFGLA + + + + PE
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 326 LLLGASHYGA---AVDLWSTGCILGELFS-GKPVLPGKT--EV----EQLHRIFKLCGSP 375
A +YG D+WS G +L E+ + G+ PG T EV E+ +R+ + P
Sbjct: 174 ----AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCP 229
Query: 376 SEDY 379
E Y
Sbjct: 230 EELY 233
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 17/195 (8%)
Query: 180 IVALKK-VRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH 238
I ALKK V ++ D E R +A+ + HP + L T QT L+ V EY+
Sbjct: 25 IKALKKDVVLEDDDVECTMVERRVLALAWE--HPFLTHL--FCTFQTKEHLFFVMEYLNG 80
Query: 239 -DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIAD 297
DL+ G +F E++ + Y +++ GL+ H G+++RD+K N+LLD +G +KIAD
Sbjct: 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIAD 139
Query: 298 FGLASFFDPKDSVPMTSRVVTLW----YRPPELLLGASHYGAAVDLWSTGCILGELFSGK 353
FG+ K+++ + T Y PE+L G Y +VD WS G +L E+ G+
Sbjct: 140 FGMC-----KENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQ 193
Query: 354 PVLPGKTEVEQLHRI 368
G+ E E I
Sbjct: 194 SPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 7/155 (4%)
Query: 202 EIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYM 260
E ++ KL H +++L G+ T Q +Y+V EYM + L+ G +F SQ+
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF-FDPKDSVPMTSRVVTL 319
K + G+ + S +HRD+ N L+D G +K++DFGL+ + D + + + S+
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFS-GK 353
W PPE+LL S + + D+W+ G ++ E++S GK
Sbjct: 167 W-SPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 23/225 (10%)
Query: 137 ATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD---P 193
W + + FE + +G G++ V A+ + A+K ++ ++
Sbjct: 5 YMFTKPDTSSW---KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK--KREILKM 59
Query: 194 ESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTE 253
+ V+ +A+E +IL +L HP I+ + + + Q +Y + E++ + +F
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN 117
Query: 254 SQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313
K Y +L+ E+ HS +++RD+K NLLLD+ G +K+ DFG A +
Sbjct: 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK--------KVP 169
Query: 314 SRVVTLW----YRPPELLLGASHYGAAVDLWSTGCILGELFSGKP 354
R TL Y PE++ H G AVD W+ G +L E +G P
Sbjct: 170 DRTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEG 219
KIG+G+ V A + K VA+KK+ Q + F E+ I+R H N++ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVDMYN 86
Query: 220 LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
+ L++V E++E D+V + E Q+ +L L + H+ GV
Sbjct: 87 --SYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLGASHYG 334
+HRDIK ++LL +G +K++DFG + VP +V T ++ PE ++ YG
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPE-VISRLPYG 196
Query: 335 AAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
VD+WS G ++ E+ G+P + ++ + RI
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 77/304 (25%), Positives = 122/304 (40%), Gaps = 52/304 (17%)
Query: 168 SVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227
V+ A+ + +VA+KK+ D+ E +K + +EI R+L HPNI+ +
Sbjct: 15 IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-- 72
Query: 228 SLYLVFEYMEH----DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGS 283
LY+V M + DL+ G+ E + +K +L+ L++ HS G +HR +K S
Sbjct: 73 ELYVVSPLMAYGSCEDLLKTHFPEGLP--ELAIAFILKDVLNALDYIHSKGFIHRSVKAS 130
Query: 284 NLLLDHNGILKIA-----------DFGLASFFDPKDSVPMTSRVVTLWYRPPEL---LLG 329
++LL +G + ++ D P +S W P L L G
Sbjct: 131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF----PKSSVKNLPWLSPEVLQQNLQG 186
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP-----------SED 378
Y D++S G EL +G +P K + K+ G+ ED
Sbjct: 187 ---YNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 379 YWRK--SKLRHSTVFKPVQ-PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
+ S H V PY R +E F F +E + DP R +A+ LN
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQF-------VELCLQRDPESRPSASQLLN 294
Query: 436 SEFF 439
FF
Sbjct: 295 HSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV---RFDNQDPESVKFMAREIAILRKLD 210
TF +G+G + V + K+ A KK+ R + E++ E IL K++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL--NEKQILEKVN 58
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DL-VGLASLPGMKFTESQVKCYMKQLLSGLE 268
++ L +T +L LV M DL + ++ F E + Y ++ GLE
Sbjct: 59 SRFVVSLA--YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H +++RD+K N+LLD G ++I+D GLA + + + RV T+ Y PE ++
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAV--EIPEGETIRGRVGTVGYMAPE-VV 173
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTE 361
Y + D W GC++ E+ GK + E
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD----NQDPESVKFMAREIAILRKLDHPNIIK 216
+G+G++ V A D++ A+K ++ D + D + R +A+ K HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTA 60
Query: 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
L QT L+ V EY+ + KF E + + Y ++ L H HGV+
Sbjct: 61 LHC--CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAA 336
+RD+K N+LLD G K+ADFG+ T+ T Y PE +L YG +
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-TTTFCGTPDYIAPE-ILQELEYGPS 176
Query: 337 VDLWSTGCILGELFSGKP 354
VD W+ G ++ E+ +G+P
Sbjct: 177 VDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEG 219
+G+GT+ V R+ K A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61
Query: 220 LITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
+ QT L V EY +L S + F+E + + Y +++S L + HS V++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 279 DIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVD 338
D+K NL+LD +G +KI DFGL D M + T Y PE +L + YG AVD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 177
Query: 339 LWSTGCILGELFSGKPVLP 357
W G ++ E+ G+ LP
Sbjct: 178 WWGLGVVMYEMMCGR--LP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPE-SVKFMAREIAILRKLDHPNIIKL 217
++IG+G + V+ R + VA+K R + P+ KF+ +E IL++ HPNI++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFL-QEARILKQYSHPNIVRL 58
Query: 218 EGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
G+ T + +Y+V E ++ D + G + ++ ++ +G+E+ S +
Sbjct: 59 IGVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS----RVVTLWYRPPELLLGASH 332
HRD+ N L+ +LKI+DFG++ + +D V ++ ++ W P L G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYG--R 172
Query: 333 YGAAVDLWSTGCILGELFS 351
Y + D+WS G +L E FS
Sbjct: 173 YSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 70/226 (30%), Positives = 110/226 (48%), Gaps = 20/226 (8%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD----NQDPESVKFMAREIAILRKL 209
F L +G+G++ V A D++ A+K ++ D + D E R +A+ K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
P + +L QT LY V EY+ DL+ G KF E Q Y ++ GL
Sbjct: 60 -PPFLTQLHSCF--QTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLF 115
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV--PMTSRVV--TLWYRPP 324
H G+++RD+K N++LD G +KIADFG+ K+ + +T+R T Y P
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KEHMVDGVTTRTFCGTPDYIAP 170
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
E ++ YG +VD W+ G +L E+ +G+P G+ E E I +
Sbjct: 171 E-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 14/219 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F K+G G + V+ + VA+K ++ D+ + +E+ L++L H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDL--LKQQDFQKEVQALKRLRHKHL 64
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I L + + +Y++ E ME L L S G + + Q+ G+ +
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RVVTLWYRPPELLLGA 330
+HRD+ N+L+ + + K+ADFGLA K+ V ++S ++ W P G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHG- 179
Query: 331 SHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
+ D+WS G +L E+F+ G+ PG E +I
Sbjct: 180 -TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 68/226 (30%), Positives = 115/226 (50%), Gaps = 30/226 (13%)
Query: 161 IGQGTYSSVYRARDVIHDKI-VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEG 219
+G+G + V++ + DK VA+K + D +KF++ E IL++ DHPNI+KL G
Sbjct: 3 LGKGNFGEVFKG--TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIG 59
Query: 220 LITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLL-------SGLEHCHS 272
+ T + +Y+V E + G L ++ + ++K KQL+ +G+ + S
Sbjct: 60 VCTQRQP--IYIVMELVP----GGDFLSFLRKKKDELK--TKQLVKFALDAAAGMAYLES 111
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS---RVVTLWYRPPELLLG 329
+HRD+ N L+ N +LKI+DFG++ D D + +S ++ W P L G
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 330 ASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEV---EQLHRIFKL 371
Y + D+WS G +L E FS G PG T EQ+ + +++
Sbjct: 170 --RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 5e-16
Identities = 72/261 (27%), Positives = 107/261 (40%), Gaps = 54/261 (20%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRKLD 210
F K+ IG G + V R V + + A+K +R VK E IL + D
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVK---AERDILAEAD 59
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
+ ++KL + Q +LY V +Y+ D++ L G+ F E + Y+ +L +E
Sbjct: 60 NEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIES 116
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF----DPK------------------ 307
H G +HRDIK N+L+D +G +K+ DFGL + F D K
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 308 ----DSVPMT----------------SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILG 347
D + S V T Y PE+LL + Y D WS G IL
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILY 235
Query: 348 ELFSGKPVLPGKTEVEQLHRI 368
E+ G+P T E ++
Sbjct: 236 EMLVGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 12/213 (5%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV---RFDNQDPESVKFMAREIAILRKLD 210
TF + +G+G + V + K+ A K++ R + ES+ E IL K++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL--NEKQILEKVN 58
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DL-VGLASLPGMKFTESQVKCYMKQLLSGLE 268
++ L +T +L LV M DL + ++ F E + Y ++L GLE
Sbjct: 59 SQFVVNLA--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H ++RD+K N+LLD G ++I+D GLA +S+ RV T+ Y PE +L
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI--RGRVGTVGYMAPE-VL 173
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTE 361
Y + D W GC++ E+ G+ G+ E
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 10/197 (5%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKL-DHPNIIKLE 218
IG+G+Y+ V R ++I A+K V+ + D E + ++ E + + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
QT L+ V EY+ + K E + Y ++ L + H G+++R
Sbjct: 63 SCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 279 DIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVV-TLWYRPPELLLGASHYGAA 336
D+K N+LLD G +K+ D+G+ P D+ TS T Y PE+L G YG +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGED-YGFS 176
Query: 337 VDLWSTGCILGELFSGK 353
VD W+ G ++ E+ +G+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 21/230 (9%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI-VALKKVRFDNQDPESVKFMAREIA 204
W I R + + K+G G + V+ + ++ VA+K ++ DP+ F+ E
Sbjct: 1 WEIDRTSIQLLR--KLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKD--FL-AEAQ 53
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQ 262
I++KL HP +I+L + T + +Y+V E M++ L L G Q+ Q
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP--IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQ 111
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
+ SG+ + + +HRD+ N+L+ N I K+ADFGLA + +
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171
Query: 323 PPELLLGASHYGA---AVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
PE A+ Y D+WS G +L E+ + G+ PG T E L ++
Sbjct: 172 APE----AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 12/224 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
E ++++G+G Y V + R V I+A+K++R E + + +R +D P
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGL---ASLPGMKFTESQVKCYMKQLLSGLEHCH 271
+ G + + +++ E M+ L G+ E + ++ LE+ H
Sbjct: 63 VTFYGALFREGD--VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 272 SH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL--- 327
S V+HRD+K SN+L++ NG +K+ DFG++ + DSV T Y PE +
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPE 178
Query: 328 LGASHYGAAVDLWSTGCILGELFSGK-PVLPGKTEVEQLHRIFK 370
L Y D+WS G + EL +G+ P KT +QL ++ +
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E + ++G G + VY+A++ + A K + +++ E +M EI IL +HP I
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYMV-EIEILATCNHPYI 71
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSH 273
+KL G L+++ E+ V L TE Q++ +Q+L L++ HS
Sbjct: 72 VKLLGAFYWDGK--LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR---VVTLWYRPPELL--- 327
++HRD+K N+LL +G +K+ADFG+++ K+ + R + T ++ PE++
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 328 -LGASHYGAAVDLWSTGCILGELFSGKP 354
+ + Y D+WS G L E+ +P
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAR-EIAILRKLDHPNIIK 216
IG+G + VY R K+ A+K K R + E++ R ++++ D P I+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 217 LEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
+ T L + + M DL S G+ F+E +++ Y +++ GLEH H+ V
Sbjct: 62 MT--YAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFV 118
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
++RD+K +N+LLD +G ++I+D GLA F K P S V T Y PE+L + Y +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS-VGTHGYMAPEVLQKGTAYDS 175
Query: 336 AVDLWSTGCILGELFSG 352
+ D +S GC+L +L G
Sbjct: 176 SADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 10/214 (4%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD----NQDPESVKFMAREIAILRKLDHPNIIK 216
+G+G++ V AR ++ A+K ++ D + D E R +++ R +HP + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFLTQ 60
Query: 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
L QT L+ V E++ + +F E++ + Y ++ S L H G++
Sbjct: 61 L--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAA 336
+RD+K N+LLDH G K+ADFG+ + ++ T Y PE +L YG +
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPS 176
Query: 337 VDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
VD W+ G +L E+ G + E + I
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 8/196 (4%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLD-HPNIIKLE 218
IG+G+Y+ V R +D+I A+K V+ + D E + ++ E + + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
QT+ L+LV EY+ + K E + Y ++ L H G+++R
Sbjct: 63 SCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 279 DIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAV 337
D+K N+LLD +G +K+ D+G+ P D+ ++ T Y PE+L G YG +V
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPEILRG-EEYGFSV 177
Query: 338 DLWSTGCILGELFSGK 353
D W+ G ++ E+ +G+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 61/194 (31%), Positives = 93/194 (47%), Gaps = 5/194 (2%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEG 219
+G+GT+ V R+ + A+K +R + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 61
Query: 220 LITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRD 279
QT L V EY + FTE + + Y +++S LE+ HS V++RD
Sbjct: 62 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 280 IKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDL 339
IK NL+LD +G +KI DFGL D M + T Y PE +L + YG AVD
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 340 WSTGCILGELFSGK 353
W G ++ E+ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-15
Identities = 63/257 (24%), Positives = 107/257 (41%), Gaps = 26/257 (10%)
Query: 202 EIAILRKLDHPNIIKL-EGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYM 260
E +L+ ++HP++I++ + L++ +C +V + DL + Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF--FDPKDSVPMTSRVVT 318
KQ+L GL + H+ ++HRD+K N+ ++ + I D G A F P + + V T
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF-LGLAGTVET 222
Query: 319 LWYRPPELLLGASHYGAAVDLWSTGCILGE-------LFSGKPVLPG---KTEVEQLHRI 368
PE+L Y + D+WS G +L E +F P P K+ L +I
Sbjct: 223 ---NAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
Query: 369 FKLCGSPSEDYWRK--SKLRHSTVFKPV---QPYRRRIAETFKDFPTSALRLMETLMSID 423
E++ R S+L + QPY R + P L+ +++ D
Sbjct: 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD 338
Query: 424 PAHRGTATLALNSEFFT 440
A R +A LN F
Sbjct: 339 AAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 7/213 (3%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGL 220
+G+G+Y V R K +KK+ N K +E +L +L HPNI+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 221 ITSQTSCSLYLVFEYMEH-DLV-GLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
+ LY+V + E DL L G E+QV + Q+ L++ H +LHR
Sbjct: 68 WEGE-DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHR 126
Query: 279 DIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLGASHYGAAV 337
D+K N+ L I+K+ D G+A + + M S ++ T +Y PE L Y
Sbjct: 127 DLKTQNVFLTRTNIIKVGDLGIARVLE--NQCDMASTLIGTPYYMSPE-LFSNKPYNYKS 183
Query: 338 DLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
D+W+ GC + E+ + K K ++RI +
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 159 DKIGQGTYSSVYRAR------DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
K+G G++ V R VI VA+K ++ D F+ +E AI+ LDH
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIP---VAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHE 56
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL------PGMKFTESQVKC-YMKQLLS 265
N+I+L G++ + L +V E L L SL + C Y Q+ +
Sbjct: 57 NLIRLYGVVLTH---PLMMVTE-----LAPLGSLLDRLRKDALGHFLISTLCDYAVQIAN 108
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMT-SRVVTLWYRP 323
G+ + S +HRD+ N+LL + +KI DFGL + +D M V +
Sbjct: 109 GMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168
Query: 324 PELL--LGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
PE L SH A D+W G L E+F+ G+ G + + L +I
Sbjct: 169 PESLRTRTFSH---ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 20/203 (9%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK-----KVRFDNQDPESVKFMAREIAILRKLDHPNII 215
IG+G++ V A+ K A+K + E MA +L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK---EQKHIMAERNVLLKNVKHPFLV 59
Query: 216 KLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
L + QT+ LY V +Y+ + F E + + Y ++ S L + HS +
Sbjct: 60 GLH--YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW----YRPPELLLGAS 331
++RD+K N+LLD G + + DFGL K+ + + T Y PE+L
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLC-----KEGIEHSKTTSTFCGTPEYLAPEVLR-KQ 171
Query: 332 HYGAAVDLWSTGCILGELFSGKP 354
Y VD W G +L E+ G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 15/225 (6%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
IPR + E K+GQG + V+ + VA+K ++ PE+ +E +++
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMK 56
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQLLS 265
KL H +++L +++ + +Y+V EYM L L G Q+ Q+ S
Sbjct: 57 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-DPKDSVPMTSRVVTLWYRPP 324
G+ + +HRD++ +N+L+ N + K+ADFGLA D + + ++ W P
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
L G + D+WS G +L EL + G+ PG E L ++
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 68/231 (29%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKK-VRFDNQDPESVKFMAREIAILRKLDH 211
N E L +IG GT VY+ R ++A+K+ R N++ M ++ +L+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTE--------SQVKC--YMK 261
P I+K G + + +++ E M L L E + VK Y+K
Sbjct: 74 PYIVKCYGYFITDSD--VFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWY 321
+ HGV+HRD+K SN+LLD +G +K+ DFG++ DS T Y
Sbjct: 132 E---------KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAY 180
Query: 322 RPPELL---LGASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQLHRI 368
PE + Y D+WS G L EL +G+ KTE E L +I
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 67/221 (30%), Positives = 106/221 (47%), Gaps = 12/221 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD----NQDPESVKFMAREIAILRKLD 210
F L +G+G++ V A D++ A+K ++ D + D E R +A+ K
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK-- 59
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
P + +L QT LY V EY+ DL+ G +F E Y ++ GL
Sbjct: 60 PPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFF 116
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
HS G+++RD+K N++LD G +KIADFG+ + D V + T Y PE ++
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPE-IIA 174
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
YG +VD W+ G +L E+ +G+ G+ E E I +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 18/231 (7%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
IPR + + + K+G G + V+ + K VA+K ++ PES E I++
Sbjct: 3 IPR--ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMK 56
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQLLS 265
KL H +++L +++ + +Y+V EYM L L G + Q+ +
Sbjct: 57 KLRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-DPKDSVPMTSRVVTLWYRPP 324
G+ + +HRD++ +N+L+ + KIADFGLA D + + ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPG---KTEVEQLHRIFKL 371
L G + D+WS G +L EL + G+ PG + +EQ+ R +++
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 19/222 (8%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
IPR + EK K+G G + V+ A H K VA+K ++ + SV+ E +++
Sbjct: 3 IPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMK 56
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQLLS 265
L H ++KL ++T + +Y++ E+M L L S G K ++ + Q+
Sbjct: 57 TLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
G+ +HRD++ +N+L+ + + KIADFGLA + + + + PE
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 326 LLLGASHYGAAV---DLWSTGCILGELFS-GKPVLPGKTEVE 363
A ++G+ D+WS G +L E+ + G+ PG + E
Sbjct: 174 ----AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-15
Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 5/194 (2%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEG 219
+G+GT+ V R+ K A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 220 LITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRD 279
+ QT L V EY+ + F+E + + Y +++S L++ HS +++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 280 IKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDL 339
+K NL+LD +G +KI DFGL D+ M + T Y PE +L + YG AVD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGTPEYLAPE-VLEDNDYGRAVDW 178
Query: 340 WSTGCILGELFSGK 353
W G ++ E+ G+
Sbjct: 179 WGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 8e-15
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 8/220 (3%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILRKLDHPN 213
FE L IG+G + V + ++ A+K + +++ E +L D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 214 IIKLEGLITSQTSCSLYLVFEY-MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I L Q +LYLV +Y + DL+ L S + E + Y+ +++ ++ H
Sbjct: 63 ITNLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL---- 328
G +HRDIK N+LLD NG +++ADFG +V V T Y PE+L
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
G YG D WS G + E+ G+ ++ VE +I
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-15
Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 14/182 (7%)
Query: 198 FMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTES--- 254
+ EI L +L+H NI+K+E ++ S+ + Y++ + + DL + +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANT--YMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 255 -QVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313
Q + MKQLL +E+ H ++HRDIK N+ L+ +G + + DFG A F+ K+
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE-KEREAFD 325
Query: 314 -SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP----GKTEVEQLHRI 368
V T+ PE+L G Y D+WS G IL ++ S P G +QL +I
Sbjct: 326 YGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKI 383
Query: 369 FK 370
Sbjct: 384 ID 385
|
Length = 501 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 66/222 (29%), Positives = 111/222 (50%), Gaps = 38/222 (17%)
Query: 158 LDKIGQGTYSSVYRAR-----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
L+++G+G + VY+ + + VA+K ++ +N +P+ + +E ++ L HP
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHP 68
Query: 213 NIIKLEGLIT-SQTSCSLYLVFEYMEH-DL------------VGLASLPGMKFTESQVKC 258
NI+ L G+ T Q +C L FEY+ H DL VG S G + +S + C
Sbjct: 69 NIVCLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAES--GDETVKSSLDC 123
Query: 259 -----YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313
Q+ +G+E+ SH +HRD+ N L+ +KI+DFGL+ D +
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 314 SR-VVTLWYRPPELLLGASHYG---AAVDLWSTGCILGELFS 351
S+ ++ + + PPE +L YG D+WS G +L E+FS
Sbjct: 184 SKSLLPVRWMPPEAIL----YGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 36/232 (15%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYR--------------ARDVIHDK--IVALKKVRFDNQD 192
PR+ TF+ +K+G+G + V+ + DV ++ +VA+K +R D
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 193 PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME----------HDLVG 242
F+ +EI I+ +L PNII+L L TS L ++ EYME H+
Sbjct: 61 NARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 243 LASLPGMKFTESQVKCYMK-QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
A + +M Q+ SG+++ S +HRD+ N L+ N +KIADFG++
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 302 SFFDPKDSVPMTSRVV--TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
D + R V W +LLG + A D+W+ G L E+ +
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 11/212 (5%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
TF K ++G G + V+ + K VA+K + E F+ E ++ KL HP
Sbjct: 7 TFMK--ELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED--FI-EEAKVMMKLSHPK 60
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
+++L G+ T Q LY+V E+ME+ L+ K ++ + + + G+E+
Sbjct: 61 LVQLYGVCTQQKP--LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER 118
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
+ +HRD+ N L+ G++K++DFG+ + + + + + PPE+ S
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN-FSK 177
Query: 333 YGAAVDLWSTGCILGELFS-GKPVLPGKTEVE 363
Y + D+WS G ++ E+F+ GK K+ E
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 58/186 (31%), Positives = 93/186 (50%), Gaps = 19/186 (10%)
Query: 180 IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH- 238
+VA+K +R D F+ +EI I+ +L +PNII+L G+ S L ++ EYME+
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 239 DLVGLASLPGM--KFTESQ-VKC-------YMK-QLLSGLEHCHSHGVLHRDIKGSNLLL 287
DL S + FT + + YM Q+ SG+++ S +HRD+ N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 288 DHNGILKIADFGLASFFDPKDSVPMTSRVV--TLWYRPPELLLGASHYGAAVDLWSTGCI 345
++ +KIADFG++ D + R V W +LLG + A D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVT 220
Query: 346 LGELFS 351
L E+F+
Sbjct: 221 LWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 63/230 (27%), Positives = 109/230 (47%), Gaps = 23/230 (10%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
+ IG+G + +V + + VA+K ++ D + F+ E A++ KL H N+++L
Sbjct: 12 EIIGEGEFGAVLQGEYT--GQKVAVKNIKCD---VTAQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 219 GLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTE-SQVKCYMKQLLSGLEHCHSHGVL 276
G+I LY+V E M +LV G Q+ + + G+E+ S ++
Sbjct: 66 GVILHN---GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAA 336
HRD+ N+L+ +G+ K++DFGLA S++ W P L + +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLAR-VGSMGV--DNSKLPVKWTAPEALKHK--KFSSK 177
Query: 337 VDLWSTGCILGELFS-GKPVLPG------KTEVEQLHRIFKLCGSPSEDY 379
D+WS G +L E+FS G+ P K VE+ +R+ G P++ Y
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKL-DHPNIIKLE 218
IG+G+Y+ V +I A+K ++ + D E + ++ E + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
QT L+ V E++ + K E + Y ++ L H G+++R
Sbjct: 63 SCF--QTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 279 DIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVV-TLWYRPPELLLGASHYGAA 336
D+K N+LLD G +K+ D+G+ P D+ TS T Y PE+L G YG +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TSTFCGTPNYIAPEILRG-EDYGFS 176
Query: 337 VDLWSTGCILGELFSGK 353
VD W+ G ++ E+ +G+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
+ IG+G + V + VA+K ++ D+ ++ F+A E +++ L HPN++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 216 KLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+L G++ LY+V EYM LV L S T +Q + + G+E+
Sbjct: 64 QLLGVVL--QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS-RVVTLWYRPPELLLGASH 332
+HRD+ N+L+ + + K++DFGLA + S S ++ W P L
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKK-- 175
Query: 333 YGAAVDLWSTGCILGELFS 351
+ D+WS G +L E++S
Sbjct: 176 FSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 74/268 (27%), Positives = 114/268 (42%), Gaps = 60/268 (22%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-----FDNQDPESVKFMAREIAILRKL 209
F K+ +G G + V AR V + A+K +R NQ V + E IL +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ----VAHVKAERDILAEA 58
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
D+ +++L + Q +LY V +Y+ D++ L G+ F E + Y+ +L +E
Sbjct: 59 DNEWVVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVE 115
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF----DPK----------DSV---- 310
H G +HRDIK N+L+D +G +K+ DFGL + F D K DS+
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 311 ---------------PMTSR-------------VVTLWYRPPELLLGASHYGAAVDLWST 342
P+ R V T Y PE+LL + Y D WS
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSV 234
Query: 343 GCILGELFSGKPVLPGKTEVEQLHRIFK 370
G IL E+ G+P +T +E ++
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-14
Identities = 69/269 (25%), Positives = 117/269 (43%), Gaps = 41/269 (15%)
Query: 200 AREIAILRKLDHPNIIKLEGLIT-SQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKC 258
A E ILR ++HP+II+L+G T ++ +C L+ + DL + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLA-AKRNIAICDILA 186
Query: 259 YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVT 318
+ +L +++ H + ++HRDIK N+ ++H G + + DFG A F V + +
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF-----PVDINANKYY 241
Query: 319 LW-----YRPPELLLGASHYGAAVDLWSTGCILGELFSG------KPVLPGKTEVE-QLH 366
W PE LL YG AVD+WS G +L E+ + K L G + + Q+
Sbjct: 242 GWAGTIATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300
Query: 367 RIFKLCGS-PSE-----------DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALR 414
I + G+ P+E Y +K + S +P R + + P
Sbjct: 301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAK-KSSR-----KPGSRPLWTNLYELPIDLEY 354
Query: 415 LMETLMSIDPAHRGTATLALNSEFFTTQP 443
L+ +++ D HR +A L+ F P
Sbjct: 355 LICKMLAFDAHHRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD----NQDPESVKFMAREIAILRKLDHPNIIK 216
+G+G++ V A + A+K ++ D + D E R +A+ ++P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL--AWENPFLTH 60
Query: 217 LEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
L T QT L+ V E++ DL+ G +F + Y +++ GL+ HS G+
Sbjct: 61 L--YCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP----PELLLGAS 331
++RD+K N++LD +G +KIADFG+ K++V +R T P PE+L G
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMC-----KENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
Y +VD WS G +L E+ G+ G E E I
Sbjct: 173 -YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 155 FEKLDKIGQGTYSSV----YRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
+++ +G+G + V Y + VA+K ++ ++ + + +EI ILR L
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLY 64
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLE 268
H NI+K +G+ T + L+ E++ + LP K Q Y Q+ G++
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLK-EYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA-------SFFDPKDSVPMTSRVVTLWY 321
+ S +HRD+ N+L++ +KI DFGL ++ KD + S V WY
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD--LDSPV--FWY 179
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFS 351
PE L+ + Y A+ D+WS G L EL +
Sbjct: 180 -APECLIQSKFYIAS-DVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 161 IGQGTYSSVYRAR----------DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
IG+G++ V A+ V+ K + KK E MA +L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKK--------EQNHIMAERNVLLKNLK 54
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
HP ++ L + QT+ LY V +Y+ + F E + + Y ++ S + +
Sbjct: 55 HPFLVGLH--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYL 112
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVVTLWYRPPELLLG 329
HS +++RD+K N+LLD G + + DFGL +P+++ ++ T Y PE +L
Sbjct: 113 HSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPE-VLR 169
Query: 330 ASHYGAAVDLWSTGCILGELFSGKP 354
Y VD W G +L E+ G P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 20/226 (8%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
A + L +IG+G + +V + I+A+K++R + E + + ++R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLS------ 265
P I+K G + + C ++ E M+ L E +++L
Sbjct: 63 PYIVKFYGALFREGDC--WICMELMDISLDKFY----KYVYEVLKSVIPEEILGKIAVAT 116
Query: 266 --GLEHC-HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
L + ++HRD+K SN+LLD NG +K+ DFG++ DS+ T Y
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYM 174
Query: 323 PPELLL--GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV-EQL 365
PE + Y D+WS G L E+ +GK P V +QL
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 25/204 (12%)
Query: 160 KIGQGTYSSVYRA--RDVIHDKI-VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216
IG+G + VY+ ++KI VA+K + KF+ E I+R+ DHP+I+K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 217 LEGLITSQTS------CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
L G+IT L + Y++ + L + + Y QL + L +
Sbjct: 72 LIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTALAYL 123
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL---WYRPPELL 327
S +HRDI N+L+ +K+ DFGL+ + + D + L W P
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE--DESYYKASKGKLPIKWMAPES-- 179
Query: 328 LGASHYGAAVDLWSTGCILGELFS 351
+ + +A D+W G + E+
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKV---RFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
+G+G + V + K+ A KK+ R + E + + +EI L K++ P I+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 218 EGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTE-SQVKCYMKQLLSGLEHCHSHGV 275
S+T L LV M DL G + E +V Y Q+ G+ H HS +
Sbjct: 59 AYAFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
++RD+K N+LLD G +++D GLA + KD +T R T Y PE+L Y
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP-YSY 173
Query: 336 AVDLWSTGCILGELFSGK 353
VD ++ GC + E+ +G+
Sbjct: 174 PVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 9e-14
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 8/221 (3%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILRKLDHPN 213
FE L IG+G + V + DK+ A+K + +++ E +L D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 214 IIKLEGLITSQTSCSLYLVFEY-MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I L Q +LYLV +Y + DL+ L S + E + Y+ +++ ++ H
Sbjct: 63 ITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL---- 328
+HRDIK N+L+D NG +++ADFG +V + V T Y PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIF 369
G YG D WS G + E+ G+ ++ VE +I
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 71/289 (24%), Positives = 117/289 (40%), Gaps = 56/289 (19%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAILRKLDHPN 213
FE L IG+G + V + + A+K +R D + E V + E IL + D
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
++K+ + Q +LYL+ E++ + + TE + + Y+ + + ++ H
Sbjct: 63 VVKM--FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLAS----------FFDPKDSVPM--------TSR 315
G +HRDIK NLLLD G +K++DFGL + + + S+P + R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 316 VVTLWYR----------------PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK 359
W R PE+ + + Y D WS G I+ E+ G P +
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 360 TEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDF 408
T P E Y + + + +F P P I+E KD
Sbjct: 240 T--------------PQETYKKVMNWKETLIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 15/177 (8%)
Query: 181 VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD- 239
VA+ +R D + F+A E L + DH NI++LEG+IT ++ +V EYM +
Sbjct: 36 VAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVIT--RGNTMMIVTEYMSNGA 92
Query: 240 LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFG 299
L + Q+ + L SG+++ G +H+ + +L++ + + KI+ F
Sbjct: 93 LDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
Query: 300 LASFFDPKDSV-----PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
+D M+ + LW P + H+ +A D+WS G ++ E+ S
Sbjct: 153 RL----QEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-13
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 34/194 (17%)
Query: 249 MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308
+ F E +V Q++ L+ HS ++HRD+K +N+ L GI+K+ DFG + + D
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY--SD 221
Query: 309 SVPM---TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQL 365
SV + +S T +Y PE L Y D+WS G IL EL + L
Sbjct: 222 SVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLT-------------L 267
Query: 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPA 425
HR FK PS+ ++ ++ P+ ++ K L++ L+S +PA
Sbjct: 268 HRPFK---GPSQ-----REIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPA 312
Query: 426 HRGTATLALNSEFF 439
R T L++EF
Sbjct: 313 LRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
+ +G G +VY+A ++ +I+A+K + D E K + E+ IL K D P II
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 218 EGLITSQTSCSLYLVFEYMEH---DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
G + S+ E+M+ D+ K E + ++ GL + S
Sbjct: 65 YGAFFVENRISI--CTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYG 334
+LHRD+K SN+L++ G +K+ DFG+++ +S+ T V T Y PE + G YG
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKT-YVGTNAYMAPERISG-EQYG 171
Query: 335 AAVDLWSTGCILGELFSGK 353
D+WS G EL G+
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 32/233 (13%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN---QDPESVKFMAREIAILRKL 209
FE + I G Y +VY R + A+KK+ N ++ F+ R+I L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI--LTFA 58
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEHD-----LVGLASLPGMKFTESQVKCYMKQLL 264
++P ++ + + +T L +V EY+E L + +LP + Y + +
Sbjct: 59 ENPFVVSMFC--SFETKRHLCMVMEYVEGGDCATLLKNIGALP-----VDMARMYFAETV 111
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF------------FDPKDSVPM 312
LE+ H++G++HRD+K NLL+ G +K+ DFGL+ KD+
Sbjct: 112 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 313 TSRVV--TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE 363
+ V T Y PE++L YG VD W+ G IL E G G T E
Sbjct: 172 LDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK----KVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216
IG+G++ V A+ + K A+K K+ + ++ + + MA +L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
L + QT+ LY V +++ + F E + + Y ++ S L + HS ++
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW----YRPPELLLGASH 332
+RD+K N+LLD G + + DFGL K+ + + T Y PE++
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLC-----KEGIAQSDTTTTFCGTPEYLAPEVIR-KQP 172
Query: 333 YGAAVDLWSTGCILGELFSGKP 354
Y VD W G +L E+ G P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 15/214 (7%)
Query: 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
E LD++G+G Y SVY+ +A+K++R + D + E+ IL K P I+
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIV 62
Query: 216 KLEGLITSQTSCSLYLVFEYMEH---DLVGLASLPGMKFTESQVKCYMKQLLSGLEHC-H 271
G + + +Y+ EYM+ D + + E ++ ++ GL+
Sbjct: 63 DFYGAFFIEGA--VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL---- 327
H ++HRD+K +N+L++ NG +K+ DFG++ + S+ T+ + Y PE +
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTN-IGCQSYMAPERIKSGG 177
Query: 328 -LGASHYGAAVDLWSTGCILGELFSGKPVLPGKT 360
Y D+WS G + E+ G+ P +T
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 14/215 (6%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDHPNIIKLE 218
IG+G++ V AR +K A+K ++ + E M+ +L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
+ QT+ LY V +Y+ + F E + + Y ++ S L + HS +++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 279 DIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW----YRPPELLLGASHYG 334
D+K N+LLD G + + DFGL K+++ T Y PE +L Y
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC-----KENIEHNGTTSTFCGTPEYLAPE-VLHKQPYD 174
Query: 335 AAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIF 369
VD W G +L E+ G P + E I
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 52/295 (17%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAILRKLDH 211
+ FE L IG+G + V + I A+K +R D + E V + E IL + D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
++K+ + Q +LYL+ E++ + + +E + Y+ + + ++ H
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLAS---------FFDPKDSVP--------MTS 314
G +HRDIK NLLLD G +K++DFGL + F+ P M S
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 315 -RVVTLW----------------YRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP 357
R W Y PE+ + + Y D WS G I+ E+ G P
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 358 GKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSA 412
+T P E Y + + + VF P P + + F T +
Sbjct: 238 SET--------------PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDS 278
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 149 PRRANT-----FEKLDKIGQGTYSSV----YRARDVIHDKIVALKKVRFDNQDPESVKFM 199
P+R N F + +G G++ V Y+ D I +K + Q + V +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ--KQVDHV 78
Query: 200 AREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVG---LASLPGMKFTESQV 256
E IL ++HP + L G ++ LYLV E+ ++G L K + V
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESY--LYLVLEF----VIGGEFFTFLRRNKRFPNDV 132
Query: 257 KC-YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315
C Y Q++ E+ S +++RD+K NLLLD +G +K+ DFG A D +R
Sbjct: 133 GCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--------TR 184
Query: 316 VVTLWYRP----PELLLGASHYGAAVDLWSTGCILGELFSGKP 354
TL P PE+LL H G A D W+ G + E+ G P
Sbjct: 185 TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 160 KIGQGTYSSVYRARDV----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
++G+G + V+ A DKI+ K D D F RE +L L H +I+
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH-REAELLTNLQHEHIV 70
Query: 216 KLEGLITSQTSCSLYLVFEYMEH------------DLVGLAS-LPGMKFTESQVKCYMKQ 262
K G+ L +VFEYM+H D V +A + T+SQ+ +Q
Sbjct: 71 KFYGVCVEGDP--LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR-VVTLWY 321
+ +G+ + S +HRD+ N L+ N ++KI DFG++ D + ++ + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFS 351
PPE ++ + D+WS G +L E+F+
Sbjct: 189 MPPESIM-YRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 74/279 (26%), Positives = 123/279 (44%), Gaps = 37/279 (13%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV---RFDNQDPESVKFMAREIAILRKLD 210
TF + +G+G + V + K+ A KK+ R + ES+ E IL K++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL--NEKQILEKVN 58
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DL-VGLASLPGMKFTESQVKCYMKQLLSGLE 268
++ L +T +L LV M DL + + F E + Y ++ GLE
Sbjct: 59 SRFVVSLA--YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H +++RD+K N+LLD +G ++I+D GLA P+ + RV T+ Y PE++
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQT-IKGRVGTVGYMAPEVVK 174
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
Y + D W+ GC+L E+ +G+ SP + RK K++
Sbjct: 175 N-ERYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQ--RKKKIKRE 211
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
V + V+ + +E F A L + L+ DP R
Sbjct: 212 EVERLVKEVQEEYSEKFSP---DARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 53/219 (24%), Positives = 106/219 (48%), Gaps = 32/219 (14%)
Query: 158 LDKIGQGTYSSVYRARDVI----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
++++G+ + +Y+ + H ++VA+K ++ D +P+ +E +++ +L HPN
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPN 68
Query: 214 IIKLEGLITS-QTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMK----------- 261
I+ L G++T Q C ++FEY+ L M+ S V C
Sbjct: 69 IVCLLGVVTQEQPVC---MLFEYLNQG--DLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 262 --------QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313
Q+ +G+E+ SH +H+D+ N+L+ +KI+D GL+ D +
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ 183
Query: 314 SR-VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
+ ++ + + PPE ++ + + D+WS G +L E+FS
Sbjct: 184 PKSLLPIRWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 50/198 (25%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 161 IGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
IG G + V+R + + VA+K ++ + + F++ E +I+ + H NII+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 218 EGLITSQTSCSLYLVFEYMEHDLVG--LASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
EG++T ++ EYME+ + L G +F+ Q+ ++ + +G+++
Sbjct: 72 EGVVTKFKP--AMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMNY 128
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFF--DPKDSVPMTSRVVTLWYRPPELLLGASHY 333
+HRD+ N+L++ N K++DFGL+ DP+ + + + + + PE + +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKF 187
Query: 334 GAAVDLWSTGCILGELFS 351
+A D+WS G ++ E+ S
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 15/225 (6%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
IPR + + K+GQG + V+ K VA+K ++ PE+ +E I++
Sbjct: 3 IPRESLRLDV--KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMK 56
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQLLS 265
KL H ++ L +++ + +Y+V E+M L L G Q+ Q+
Sbjct: 57 KLRHDKLVPLYAVVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-DPKDSVPMTSRVVTLWYRPP 324
G+ + +HRD++ +N+L+ N + KIADFGLA D + + ++ W P
Sbjct: 114 GMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
L G + D+WS G +L EL + G+ PG E L ++
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 35/238 (14%)
Query: 161 IGQGTYSSVYRARDVIHDK-------IVALKKVRFDNQDPESVKFMAREIAILRKL-DHP 212
+G+G + V A + DK VA+K ++ D+ + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 213 NIIKLEGLITSQTSCSLYLVFEY-----------------MEHDLVGLASLPGMKFTESQ 255
NII L G T LY++ EY ME+ +A +P + T
Sbjct: 82 NIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSY-DIARVPDEQMTFKD 138
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS- 314
+ Q+ G+E+ S +HRD+ N+L+ N ++KIADFGLA + D T+
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 315 -RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370
R+ W P L Y D+WS G ++ E+F+ G PG VE+L ++ K
Sbjct: 199 GRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 15/298 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
FE++ ++G G V + + I+A K + + + P + RE+ +L + + P I
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYI 65
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC-HSH 273
+ G S S+ + E+M+ + + E + +L GL + H
Sbjct: 66 VGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
++HRD+K SN+L++ G +K+ DFG++ DS+ S V T Y PE L G +HY
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMA-NSFVGTRSYMSPERLQG-THY 179
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
D+WS G L EL G+ +P + ++L IF G P D + HS +P
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIP-PPDAKELEAIF---GRPVVD--GEEGEPHSISPRP 233
Query: 394 VQPYRRRIAETFKDFPTSAL-RLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSN 450
P R P A+ L++ +++ P + + F + L NP+
Sbjct: 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 291
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 8/220 (3%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILRKLDHPN 213
FE + IG+G + V + ++I A+K + +++ E +L D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 214 IIKLEGLITSQTSCSLYLVFEY-MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I L Q LYLV +Y + DL+ L S + E + Y+ +++ + H
Sbjct: 63 ITTLH--YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL---- 328
+HRDIK N+LLD NG +++ADFG + +V + V T Y PE+L
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
G YG D WS G + E+ G+ ++ VE +I
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 155 FEKLDKIGQGTYSSVYRA------RDVIHDKI-VALKKVRFDNQDPESVKFMAREIAILR 207
EK+ +G G + +VY+ V KI VA+K +R + P++ K + E ++
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKV---KIPVAIKVLR-EETSPKANKEILDEAYVMA 64
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSG 266
+DHP++++L G+ S L+ + M L+ + + Q+ G
Sbjct: 65 SVDHPHVVRLLGICLSSQVQ---LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RVVTLWYRPP 324
+ + ++HRD+ N+L+ +KI DFGLA D + +V W
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 325 ELLLGASHYGAAVDLWSTGCILGEL--FSGKPV--LPGKTEVEQL 365
+L Y D+WS G + EL F KP +P E+ L
Sbjct: 182 SILHRI--YTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-EIPDL 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 6/195 (3%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEG 219
+G+GT+ V ++ + A+K ++ + + V E +L+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 220 LITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHR 278
+ QT L V EY + F+E + + Y +++S L++ HS V++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 279 DIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVD 338
D+K NL+LD +G +KI DFGL KD M + T Y PE +L + YG AVD
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-VLEDNDYGRAVD 178
Query: 339 LWSTGCILGELFSGK 353
W G ++ E+ G+
Sbjct: 179 WWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
PN++ L I S+ S ++LV ++ E + + E VK + +++ L+ H
Sbjct: 45 PNMVCLHKYIVSEDS--VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH 102
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
G++ RD+ +N+LLD G +++ F + + +DS V Y PE + G S
Sbjct: 103 REGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSC--DGEAVENMYCAPE-VGGIS 157
Query: 332 HYGAAVDLWSTGCILGELFSGKPVL 356
A D WS G IL EL +GK ++
Sbjct: 158 EETEACDWWSLGAILFELLTGKTLV 182
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 5e-12
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 33/233 (14%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
R N +E + KIG G + V+ + + K + + + E+ ++R+L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEY-----MEHDLVGLASLPGMKFTESQVKCYMKQLLS 265
H NI++ ++ + LY++ E+ + ++ + G K E + +QLL
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG-KIEEHAIVDITRQLLH 129
Query: 266 GLEHCHS-------HGVLHRDIKGSNLLL---------------DHNG--ILKIADFGLA 301
L +CH+ VLHRD+K N+ L + NG I KI DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASH-YGAAVDLWSTGCILGELFSGK 353
+ S V T +Y PELLL + Y D+W+ GCI+ EL SGK
Sbjct: 190 KNIGIESMA--HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-12
Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 18/200 (9%)
Query: 181 VALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKL--EGLITSQTSCSLYLVFEYME 237
VA+K +R D ++ RE A+ +L HPNI+ L G L+ VFEY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAVFEYVP 62
Query: 238 -HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI---L 293
L + + G + M Q+L L H+ G++HRD+K N+++ G+
Sbjct: 63 GRTLREVLAADGALPAGETGR-LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 294 KIADFGLASF---FDPKDSVPMTSR---VVTLWYRPPELLLGASHYGAAVDLWSTGCILG 347
K+ DFG+ + D +T + T Y PE L G DL++ G I
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFL 180
Query: 348 ELFSGKPVLPGKTEVEQLHR 367
E +G+ V+ G + E L++
Sbjct: 181 ECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 70/259 (27%), Positives = 108/259 (41%), Gaps = 54/259 (20%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRF-DNQDPESVKFMAREIAILRKLDHPN 213
F K+ +G G + V A V + A+K +R D + V + E IL + D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
++KL + Q +LY V +Y+ D++ L + F E + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFF--------------------DPKD---- 308
G +HRDIK N+L+D +G +K+ DFGL + F +P D
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 309 --SVPMTSRVVTLWYR--------------------PPELLLGASHYGAAVDLWSTGCIL 346
+ R+ TL R PE+LL Y D WS G IL
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL 238
Query: 347 GELFSGKP--VLPGKTEVE 363
E+ G+P + P TE +
Sbjct: 239 FEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 161 IGQGTYSSV----YRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216
+G G + SV Y + + VA+K ++ K RE +++ +LDHP I++
Sbjct: 3 LGHGNFGSVVKGVYLMKSG-KEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKF-------TESQVKCYMKQLLSGLEH 269
L G+ + L LV E L L L +K+ S +K Q+ G+ +
Sbjct: 61 LIGVCKGE---PLMLVME-----LAPLGPL--LKYLKKRREIPVSDLKELAHQVAMGMAY 110
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS---VPMTSRVVTLWYRPPEL 326
S +HRD+ N+LL + KI+DFG++ R WY P +
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 327 LLGASHYGAAVDLWSTGCILGELFS--GKP 354
G + + D+WS G L E FS KP
Sbjct: 171 NYGK--FSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 55/179 (30%), Positives = 72/179 (40%), Gaps = 18/179 (10%)
Query: 201 REIAILRKLDHPNIIKL-EGLITSQTSCSLYLVFEYMEHDLV----GLASLPGMKFTESQ 255
REI IL+ + H II L T C +V + DL LP Q
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVC---MVMPKYKCDLFTYVDRSGPLP-----LEQ 186
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT-S 314
++LL L + H G++HRD+K N+ LD + DFG A D P
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK---TEVEQLHRIFK 370
TL PE LL Y A D+WS G +L E+ L GK + QL I +
Sbjct: 247 WSGTLETNSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304
|
Length = 392 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 31/182 (17%)
Query: 247 PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306
PG F E + Y Q++SGLEH H +++RD+K N+LLD++G ++I+D GLA +
Sbjct: 92 PG--FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA--VEL 147
Query: 307 KDSVPMTSRVV-TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQL 365
KD T T + PELL G Y +VD ++ G L E+ + + P + E++
Sbjct: 148 KDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARG--PFRARGEKV 204
Query: 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPA 425
+L+ + V Y + + K F E L++ DP
Sbjct: 205 ---------------ENKELKQRILNDSVT-YPDKFSPASKSF-------CEALLAKDPE 241
Query: 426 HR 427
R
Sbjct: 242 KR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 161 IGQGTYSSVYRARDVIHDK-------IVALKKVRFDNQDPESVKFMAREIAILRKL-DHP 212
+G+G + V A + DK VA+K ++ D D + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-KDLSDLVSEMEMMKMIGKHK 78
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFT-------ESQVKCYMK 261
NII L G T LY++ EY + + PGM ++ E Q+ K
Sbjct: 79 NIINLLGACTQDGP--LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF--K 134
Query: 262 QLLS-------GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314
L+S G+E+ S +HRD+ N+L+ + ++KIADFGLA D T+
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 315 --RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370
R+ W P L Y D+WS G +L E+F+ G PG VE+L ++ K
Sbjct: 195 NGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 202 EIAILRKLDHPNIIKLEGL-ITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYM 260
E +LR+L HP ++ L + + +C LV DL +QV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TL 319
+QLLS +++ H G++HRDIK N+L++ + + DFG A F S P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGE 348
PE+L G Y +VD+WS G ++ E
Sbjct: 327 DTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 52/176 (29%), Positives = 79/176 (44%), Gaps = 10/176 (5%)
Query: 181 VALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH- 238
VA+K ++ E M+ E+ I+ L +H NI+ L G T + ++ EY +
Sbjct: 68 VAVKMLKPTAHSSEREALMS-ELKIMSHLGNHENIVNLLGACTI--GGPILVITEYCCYG 124
Query: 239 DLVGLASLPGMKF-TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIAD 297
DL+ F T + + Q+ G+ S +HRD+ N+LL H I+KI D
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184
Query: 298 FGLAS--FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
FGLA D V +R+ W P + Y D+WS G +L E+FS
Sbjct: 185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV--YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 73/257 (28%), Positives = 112/257 (43%), Gaps = 48/257 (18%)
Query: 161 IGQGTYSSVYRARDVIHDK-------IVALKKVRFDNQDPESVKFMAREIAILRKLD-HP 212
+G+G + V RA DK VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFT-------ESQ------ 255
NII L G+ T + LY++ EY + + PG +T E Q
Sbjct: 79 NIINLLGVCTQEGP--LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS- 314
V C Q+ G+E+ S +HRD+ N+L+ + ++KIADFGLA D TS
Sbjct: 137 VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 315 -RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELF----SGKPVLPGKTEVEQL---- 365
R+ W P L Y D+WS G ++ E+F S P +P VE+L
Sbjct: 196 GRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP----VEELFKLL 249
Query: 366 ---HRIFKLCGSPSEDY 379
HR+ K E Y
Sbjct: 250 REGHRMDKPSNCTHELY 266
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 73/303 (24%), Positives = 134/303 (44%), Gaps = 21/303 (6%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
+ + FEK+ ++G G V++ I+A K + + + P + RE+ +L + +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECN 61
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
P I+ G S S+ + E+M+ + + E + ++ GL +
Sbjct: 62 SPYIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 271 -HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
H ++HRD+K SN+L++ G +K+ DFG++ DS+ S V T Y PE L G
Sbjct: 120 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMA-NSFVGTRSYMSPERLQG 176
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIF--KLCGSPSEDYWRKSKLRH 387
+HY D+WS G L E+ G+ +P + ++L +F + G P+E
Sbjct: 177 -THYSVQSDIWSMGLSLVEMAIGRYPIP-PPDAKELELMFGCPVEGDPAES--------- 225
Query: 388 STVFKPVQPYRRRIAETFKDFPTSAL-RLMETLMSIDPAHRGTATLALNSEFFTTQPLAC 446
T +P P R + P A+ L++ +++ P + + F + L
Sbjct: 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK 285
Query: 447 NPS 449
NP+
Sbjct: 286 NPA 288
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 10/215 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
FEKL ++G G V + I+A K + + + P + RE+ +L + + P I
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-H 273
+ G S S+ + E+M+ + + E+ + +L GL + H
Sbjct: 62 VGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
++HRD+K SN+L++ G +K+ DFG++ DS+ S V T Y PE L G +HY
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMA-NSFVGTRSYMSPERLQG-THY 175
Query: 334 GAAVDLWSTGCILGELFSGK-PV-LPGKTEVEQLH 366
D+WS G L E+ G+ P+ P E+E +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 181 VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-D 239
VA+K +R D D F+ +E+ IL +L PNI +L G+ T ++ EYME+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTVDPPL--CMIMEYMENGD 105
Query: 240 L---------VGLASLPGMKFTESQVKCYM-KQLLSGLEHCHSHGVLHRDIKGSNLLLDH 289
L K YM Q+ SG+ + S +HRD+ N L+
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 290 NGILKIADFGLAS------FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTG 343
N +KIADFG++ ++ + P+ R W +LLG + D+W+ G
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLG--KFTTKSDVWAFG 219
Query: 344 CILGELFS---GKP--VLPGKTEVEQLHRIFK 370
L E+ + +P L + +E F+
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVIENAGHFFR 251
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 60/244 (24%), Positives = 115/244 (47%), Gaps = 24/244 (9%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
IPR + + + K+G G + V+ K VA+K ++ SV+ E +++
Sbjct: 3 IPR--ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMK 56
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD--LVGLASLPGMKFTESQVKCYMKQLLS 265
L H +++L ++T + +Y++ EYM L L S G K ++ + Q+
Sbjct: 57 TLQHDKLVRLYAVVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAE 114
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
G+ + +HRD++ +N+L+ + + KIADFGLA + + + + PE
Sbjct: 115 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
Query: 326 LLLGASHYGAAV---DLWSTGCILGELFS-GKPVLPGKTE------VEQLHRIFKLCGSP 375
A ++G+ D+WS G +L E+ + GK PG + +++ +R+ ++ P
Sbjct: 175 ----AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCP 230
Query: 376 SEDY 379
E Y
Sbjct: 231 DELY 234
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 59/223 (26%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 161 IGQGTYSSV----YRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216
IG+G + V YR VA+K ++ D + F+A E +++ +L H N+++
Sbjct: 14 IGKGEFGDVMLGDYRG------NKVAVKCIK---NDATAQAFLA-EASVMTQLRHSNLVQ 63
Query: 217 LEGLITSQTSCSLYLVFEYM-EHDLVGLASLPGMKFTESQVKCYMK---QLLSGLEHCHS 272
L G+I + LY+V EYM + LV G C +K + +E+ +
Sbjct: 64 LLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGD--CLLKFSLDVCEAMEYLEA 120
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
+ +HRD+ N+L+ + + K++DFGL S T ++ W P L
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALR--EKK 175
Query: 333 YGAAVDLWSTGCILGELFS-GK---PVLPGKTEVEQLHRIFKL 371
+ D+WS G +L E++S G+ P +P K V ++ + +K+
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV---RFDNQDPESVKFMAREIAILRKLD 210
TF +G+G + V + K+ A KK+ R + E++ E IL K++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL--NEKRILEKVN 58
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DL-VGLASLPGMKFTESQVKCYMKQLLSGLE 268
++ L +T +L LV M DL + ++ F E + Y +L GLE
Sbjct: 59 SRFVVSLA--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
+++RD+K N+LLD G ++I+D GLA ++V RV T+ Y PE++
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV--RGRVGTVGYMAPEVIN 174
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHR 367
Y + D W GC++ E+ G+ P + E++ R
Sbjct: 175 NEK-YTFSPDWWGLGCLIYEMIQGQS--PFRKRKERVKR 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 67/236 (28%), Positives = 106/236 (44%), Gaps = 33/236 (13%)
Query: 161 IGQGTYSSVYRARDVIHDK-----IVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNI 214
+G+G + V +A V D VA+K ++ D + + ++ E+ +++ + H NI
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNI 78
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH----DLVGLASLPGMKF-------TESQVKCY---- 259
I L G+ T + LY+V EY H D + PG E +
Sbjct: 79 INLLGVCTQEGP--LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 260 -MKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RV 316
Q+ G+E S +HRD+ N+L+ + ++KIADFGLA D T+ R+
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKPVLPGKTEVEQLHRIFK 370
W P L Y D+WS G +L E+F+ G P PG VE+L ++ K
Sbjct: 197 PVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 68/262 (25%), Positives = 100/262 (38%), Gaps = 76/262 (29%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRK 208
F + IG+G + V + KI A+K + F VK E +L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVK---AERDVLAE 57
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG---MK-------FTESQVKC 258
D P ++ L + Q + LYL+ E+ LPG M F+E +
Sbjct: 58 SDSPWVVSL--YYSFQDAQYLYLIMEF----------LPGGDLMTMLIKYDTFSEDVTRF 105
Query: 259 YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK----------- 307
YM + + +E H G +HRDIK N+L+D G +K++DFGL++ F +
Sbjct: 106 YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 308 ----------------DSVPMT-------------------SRVVTLWYRPPELLLGASH 332
DS+ +T S V T Y PE+ L
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG- 224
Query: 333 YGAAVDLWSTGCILGELFSGKP 354
YG D WS G I+ E G P
Sbjct: 225 YGQECDWWSLGAIMFECLIGWP 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 43/159 (27%), Positives = 76/159 (47%), Gaps = 14/159 (8%)
Query: 157 KLDKI-GQGTYSSVYRARDVIHDKI---VALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
KL KI G+G + SV + D VA+K ++ D ++ E A ++ DHP
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 213 NIIKLEGL-ITSQTSCSL---YLVFEYMEH-DLVG--LASLPGM---KFTESQVKCYMKQ 262
N++KL G+ + + + ++ +M+H DL L S G K + +M
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
+ G+E+ + +HRD+ N +L + + +ADFGL+
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-11
Identities = 65/222 (29%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVK--FMAREIAILRKLDHP 212
++ + IG+G VY A D + + VALKK+R D + +K F+ RE I L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME-HDLVGL-------ASLPGMKFTESQVKCYMK--- 261
I+ + I S +Y Y+E + L L SL ++ V ++
Sbjct: 63 GIVPVYS-ICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD------SVPMTS- 314
++ + +E+ HS GVLHRD+K N+LL G + I D+G A F ++ V +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 315 ---------RVV-TLWYRPPELLLGASHYGAAVDLWSTGCIL 346
++V T Y PE LLG + D+++ G IL
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVIL 221
|
Length = 932 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 160 KIGQGTYSSVYRAR--DVIHDKIVALKKVRFDNQDPESVKF-MAREIAILRKLDHPNIIK 216
++G+G + V+ A +++ ++ L V+ + ES + RE +L L H +I++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 217 LEGLITSQTSCSLYLVFEYMEHD---------------LVGLASLPGMKFTESQVKCYMK 261
G+ T L +VFEYM H L G + + T Q+
Sbjct: 72 FYGVCTEGRP--LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR-VVTLW 320
Q+ SG+ + S +HRD+ N L+ ++KI DFG++ D + R ++ +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 321 YRPPELLLGASHYGAAVDLWSTGCILGELFS 351
+ PPE +L + D+WS G +L E+F+
Sbjct: 190 WMPPESIL-YRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 8/204 (3%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
R E + +G G SV + + + ++A KKV K + RE+ I+ +
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
P I+ G ++ + + + E+M+ + G + ++ GL +
Sbjct: 62 SPYIVSFYGAFLNENNICMCM--EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 271 HS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
++ H ++HRDIK SN+L++ G +K+ DFG++ + +S+ T V T Y PE + G
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADTF-VGTSTYMSPERIQG 176
Query: 330 ASHYGAAVDLWSTGCILGELFSGK 353
Y D+WS G + EL GK
Sbjct: 177 GK-YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 160 KIGQGTYSSV----YRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
++G G + +V Y+ + K VA+K ++ DN DP + RE ++++LD+P I+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSE--KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIV 59
Query: 216 KLEGLITSQTSCSLYLVFEYMEHDLVGLASL-PGMKF-------TESQVKCYMKQLLSGL 267
++ G+ ++ S LV E LA L P KF TE + + Q+ G+
Sbjct: 60 RMIGICEAE---SWMLVME--------LAELGPLNKFLQKNKHVTEKNITELVHQVSMGM 108
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS---VPMTSRVVTLWYRPP 324
++ +HRD+ N+LL KI+DFGL+ ++ + WY P
Sbjct: 109 KYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFS 351
+ + + D+WS G ++ E FS
Sbjct: 169 --CMNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 35/238 (14%)
Query: 161 IGQGTYSSVYRARDVIHDK-------IVALKKVRFDNQDPESVKFMAREIAILRKL-DHP 212
+G+G + V A + DK VA+K ++ D + + ++ E+ +++ + H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS-EMEMMKMIGKHK 84
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFT-------------ESQ 255
NII L G T LY++ EY + + PGM++ +
Sbjct: 85 NIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS- 314
V C Q+ G+E+ S +HRD+ N+L+ + ++KIADFGLA D T+
Sbjct: 143 VSCAY-QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 315 -RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370
R+ W P L Y D+WS G +L E+F+ G PG VE+L ++ K
Sbjct: 202 GRLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 161 IGQGTYSSVYRARDV------IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
IG+G + VY + IH + +L ++ D E V+ +E I++ HPN+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI----TDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ L G+ L +V YM+H DL T + + Q+ G+E+ S
Sbjct: 59 LSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVVTLWYRPPELL----L 328
+HRD+ N +LD + +K+ADFGLA +D + L P + + L
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL---PVKWMALESL 174
Query: 329 GASHYGAAVDLWSTGCILGELFS-GKPVLP 357
+ D+WS G +L EL + G P P
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 35/241 (14%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVY----RARDVIHDKI-VALKKVRFDNQDPESVKFMARE 202
+PR + L +G G + VY R RD ++ VA+K + + + F+ E
Sbjct: 3 VPRD--SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-ME 59
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMK 261
I+ K +H NI++L G+ S +++ E M DL E MK
Sbjct: 60 ALIMSKFNHQNIVRLIGV--SFERLPRFILLELMAGGDLKSFLRE-NRPRPERPSSLTMK 116
Query: 262 QLL-------SGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLA------SFFD 305
LL G ++ + +HRDI N LL G + KIADFG+A S++
Sbjct: 117 DLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176
Query: 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQ 364
+ + + PPE L + + D+WS G +L E+FS G PG+T E
Sbjct: 177 KGGRAMLPIK-----WMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
Query: 365 L 365
+
Sbjct: 231 M 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 9/162 (5%)
Query: 216 KLEGLITSQTSCSLYLVFEY----MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
+L+ + +SQ+S S V E +E + L T + CY Q+ G+E
Sbjct: 137 RLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA 196
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLAS--FFDPKDSVPMTSRVVTLWYRPPELLLG 329
S +HRD+ N+LL N ++KI DFGLA + DP +R+ W P +
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF-- 254
Query: 330 ASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370
Y D+WS G +L E+FS G PG E+ R K
Sbjct: 255 DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 160 KIGQGTYSSVYRAR----DVIHDK-IVALKKVRFDNQDP--ESVKFMAREIAILRKLDHP 212
++G+G + V+ A DK +VA+K ++ DP + K RE +L L H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQREAELLTNLQHE 67
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPG---MKFTE------------SQV 256
+I+K G+ L +VFEYM+H DL G M + SQ+
Sbjct: 68 HIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 257 KCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR- 315
Q+ SG+ + S +HRD+ N L+ N ++KI DFG++ D +
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
++ + + PPE ++ + D+WS G IL E+F+
Sbjct: 186 MLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 40/104 (38%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 258 CYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLAS--FFDPKDSVPMTSR 315
CY Q+ G+E S +HRD+ N+LL N ++KI DFGLA + DP D V S
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGSA 236
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPG 358
+ L + PE + Y D+WS G +L E+FS G PG
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 44/143 (30%), Positives = 75/143 (52%), Gaps = 5/143 (3%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAILRKLDHPNIIKLEG 219
I +G + VY R + K+ A+K V+ D + V + E L P I+ L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL-- 69
Query: 220 LITSQTSCSLYLVFEYM-EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
+ Q++ ++YLV EY+ D+ L + G F E Y+ ++ L++ H HG++HR
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 279 DIKGSNLLLDHNGILKIADFGLA 301
D+K N+L+ + G +K+ DFGL+
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 34/206 (16%)
Query: 181 VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM---- 236
VA+K ++ +N ++ + E +L++++HP++IKL G + L L+ EY
Sbjct: 33 VAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGPLLLIVEYAKYGS 89
Query: 237 ------EHDLVGLASL-------------PGMK-FTESQVKCYMKQLLSGLEHCHSHGVL 276
E VG + L P + T + + Q+ G+++ ++
Sbjct: 90 LRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV 149
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RVVTLWYRPPELLLGASH-Y 333
HRD+ N+L+ +KI+DFGL+ +DS S R+ W L H Y
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL---FDHIY 206
Query: 334 GAAVDLWSTGCILGELFS-GKPVLPG 358
D+WS G +L E+ + G PG
Sbjct: 207 TTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 14/219 (6%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL-EG 219
+G G +V A+ V + A+K V + E+ L D +I+K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 220 LITS-----QTSCSLYLVFEYMEH-DL---VGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+ + LV +Y DL + + F E + Q+L + H
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHV 159
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYRPPELLL 328
HS ++HRDIK +N+LL NG++K+ DFG + + D V T T +Y PE+
Sbjct: 160 HSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF-CGTPYYVAPEIWR 218
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHR 367
Y D++S G +L EL + K G+ E +H+
Sbjct: 219 RKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 160 KIGQGTYSSV----YRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
++G G + V Y+ R D VA+K ++ +N+ + M RE I+ +LD+P I+
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID--VAIKVLKNENEKSVRDEMM-REAEIMHQLDNPYIV 58
Query: 216 KLEGLITSQTSCSLYLVFEYMEHDLVGLASL-PGMKF--------TESQVKCYMKQLLSG 266
++ G+ ++ +L LV E +AS P KF T S V M Q+ G
Sbjct: 59 RMIGVCEAE---ALMLVME--------MASGGPLNKFLSGKKDEITVSNVVELMHQVSMG 107
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW---YRP 323
+++ +HRD+ N+LL + KI+DFGL+ DS +R W +
Sbjct: 108 MKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYA 166
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFS--GKP 354
PE + + + D+WS G + E FS KP
Sbjct: 167 PECIN-FRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 161 IGQGTYSSVYR--ARDVIHDKI----VALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+G G + VY A D++ VA+K +R D E +F+ E ++ +HPNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVG------LASLPGMKFTESQVKCYMKQLLSGL 267
+KL G+ Y++ E ME DL+ + T ++ + G
Sbjct: 62 VKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNG-----ILKIADFGLASFFDPKD--SVPMTSRVVTLW 320
+ +HRD+ N L+ G ++KI DFGLA D + W
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 321 YRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
P LL G + D+WS G ++ E+ + G+ P E L +
Sbjct: 180 MAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 48/154 (31%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 161 IGQGTYSSVYRARDVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
+G+G + SV A+ D + VA+K ++ D ++ RE A +++ DHPN+IKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 218 EGL-ITSQTSCSL---YLVFEYMEH-DLVG--LASLPGMK-FTESQVKC--YMKQLLSGL 267
G+ + S+ L ++ +M+H DL L S G + FT +M + SG+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
E+ S +HRD+ N +L+ N + +ADFGL+
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 28/197 (14%)
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236
+VA+K +R D F+ +E+ IL +L PNII+L G+ + L ++ EYM
Sbjct: 45 RPLLVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVDEDP--LCMITEYM 101
Query: 237 E--------------------HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
E +D V A + S + Q+ SG+++ S +
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAH-CLPAISYSSLLHVALQIASGMKYLSSLNFV 160
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV--TLWYRPPELLLGASHYG 334
HRD+ N L+ N +KIADFG++ D + R V W +L+G +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG--KFT 218
Query: 335 AAVDLWSTGCILGELFS 351
A D+W+ G L E+
Sbjct: 219 TASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 161 IGQGTYSSVYRARDVIHDKI--VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
+G+G + SV + D I VA+K ++ ++ E +++ DHPN+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 219 GLITSQTSCSLY----LVFEYMEH-DLVG------LASLPGMKFTESQVKCYMKQLLSGL 267
G+ Y ++ +M+H DL L P T+ VK +M + SG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
E+ S +HRD+ N +L+ N + +ADFGL+
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 29/218 (13%)
Query: 159 DKIGQGTYSSVYRARDVIHDKI---VALKKVRFDNQDPESVKFMAREIAILRKL-DHPNI 214
D IG+G + V +AR + D + A+K+++ + + + A E+ +L KL HPNI
Sbjct: 13 DVIGEGNFGQVLKAR-IKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH----DLV------------GLASLPGMKFTESQVKC 258
I L G + LYL EY H D + +A+ + Q+
Sbjct: 71 INLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 259 YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVT 318
+ + G+++ +HRD+ N+L+ N + KIADFGL+ + M R+
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPV 187
Query: 319 LWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKP 354
W L S Y D+WS G +L E+ S G P
Sbjct: 188 RWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 47/219 (21%), Positives = 95/219 (43%), Gaps = 21/219 (9%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDKI---VALKKVRFDNQDPESVKFMAR 201
W R + ++GQG++ VY A+ V+ + VA+K V + E ++F+
Sbjct: 1 WELPR-EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN- 58
Query: 202 EIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASL--------PGMKF 251
E +++++ + ++++L G+++ T +V E M DL L S
Sbjct: 59 EASVMKEFNCHHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 252 TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV- 310
T + ++ G+ + + +HRD+ N ++ + +KI DFG+ D
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGEL 349
++ + + PE L + D+WS G +L E+
Sbjct: 177 KGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 41/116 (35%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 258 CYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLAS--FFDPKDSVPMTSR 315
Y Q+ G+E S +HRD+ N+LL N ++KI DFGLA + DP D V
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-DYVRKGDA 235
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370
+ L + PE + Y D+WS G +L E+FS G PG E+ R K
Sbjct: 236 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+T ++++G+ + VY+ + VA+K ++ + P +F + A++R
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEF--KHEAMMR 62
Query: 208 -KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD-------LVGLASLPGMKFTESQVKCY 259
+L HPNI+ L G++T + S+ +F Y H + S G + VK
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSM--IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 260 MK---------QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310
++ Q+ +G+E SH V+H+D+ N+L+ +KI+D GL D
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180
Query: 311 PM--TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
+ S + W P ++ G + D+WS G +L E+FS
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 160 KIGQG--TYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
+IG+G +SVY AR +V ++ +N E +K + E+ + HPNI+
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 218 EGLITSQTSCSLYLVFEYMEH----DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ T T L+++ +M + L+ GM +E+ + + L GL + H +
Sbjct: 65 WTVFT--TGSWLWVISPFMAYGSANSLLKTYFPEGM--SEALIGNILFGALRGLNYLHQN 120
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFD-----PKDSV----PMTSRVVTLWYRPP 324
G +HR+IK S++L+ +G++ ++ GL+ + K V P S V W P
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGK 353
L Y D++S G EL +G+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 49/225 (21%), Positives = 82/225 (36%), Gaps = 62/225 (27%)
Query: 163 QGTYSSVYRA----RDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
+GT+ ++ ++ V +K V+ D+ V + +E +L L H NI+ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPIL 74
Query: 219 GLITSQTSCSLYLVFEYM------------------------EHDLVGLASLPGMKFTES 254
+ L + YM LV +A
Sbjct: 75 HVCIEDGEPPFVL-YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI--------- 124
Query: 255 QVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM-- 312
Q+ G+ + H GV+H+DI N ++D +KI D L+ +D PM
Sbjct: 125 -------QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS-----RDLFPMDY 172
Query: 313 ------TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
+R V W L+ Y +A D+WS G +L EL +
Sbjct: 173 HCLGDNENRPVK-WMALESLV--NKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPES-VKFMAREIAIL 206
+ +++ +G G + +VY+ V + V + K+ + P++ V+FM E I+
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIM 63
Query: 207 RKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLS 265
+DHP++++L G+ S T + LV + M H L+ + + Q+
Sbjct: 64 ASMDHPHLVRLLGVCLSPT---IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF--DPKDSVPMTSRVVTLWYRP 323
G+ + ++HRD+ N+L+ +KI DFGLA D K+ ++ W
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW--- 177
Query: 324 PELLLGASHYGAAV---DLWSTGCILGEL--FSGKP 354
+ L HY D+WS G + EL F GKP
Sbjct: 178 --MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 15/209 (7%)
Query: 151 RANTFEKLDKIGQGTYSSVYRA-----RDVIHDKIVALKKVRFDNQDPESVKFMAREIAI 205
+ KL +G G + +V++ D I KI K D ++ + + +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSI--KIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLL 264
+ LDH I++L G+ SL LV + L+ ++ + Q+
Sbjct: 63 MGSLDHAYIVRLLGICPGA---SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVT--LWYR 322
G+ + H ++HR++ N+LL + I++IADFG+A P D S T W
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFS 351
+L G Y D+WS G + E+ S
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 79/330 (23%), Positives = 128/330 (38%), Gaps = 66/330 (20%)
Query: 156 EKLDKIGQG--TYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
E L IG+G +V AR + V ++++ + E V F+ E+ + + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH----DLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
I+ + L++V +M + DL+ + GM +E + ++ +L L++
Sbjct: 61 IVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGM--SELAIAYILQGVLKALDY 116
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD--------------PKDSVPMTSR 315
H G +HR +K S++L+ +G K+ GL S PK SV
Sbjct: 117 IHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVK---- 170
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGS- 374
V W P L Y A D++S G EL +G +P K + KL G+
Sbjct: 171 -VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKLNGTV 227
Query: 375 ---------PSEDYWRK----------------SKLRHSTVFKPVQPYRRRIAETFKDFP 409
P+E+ K S R S PY R + F F
Sbjct: 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF- 286
Query: 410 TSALRLMETLMSIDPAHRGTATLALNSEFF 439
+E + +P R +A+ LN FF
Sbjct: 287 ------VEQCLQRNPDARPSASTLLNHSFF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 45/150 (30%), Positives = 64/150 (42%), Gaps = 18/150 (12%)
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF--DPKDSVPMTSRVVTL 319
Q+ G+ S +HRD+ N+LL H I KI DFGLA D V +R+
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGK-------TEVEQLHRIFKL 371
W P + Y D+WS G +L E+FS G PG +++ +R+
Sbjct: 282 WMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339
Query: 372 CGSPSEDY------WRKSKLRHSTVFKPVQ 395
+PSE Y W L+ T + VQ
Sbjct: 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 17/207 (8%)
Query: 159 DKIGQGTYSSVY--RARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216
D+IG G + V A + V +K++R E + F+ +E+ R+L+HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 217 LEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMK---QLLSGLEHCH 271
G LV E+ DL L S GM +Q + ++ SGL H
Sbjct: 60 CLGQCIESIP--YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELL--- 327
+H D+ N L + +KI D+GLA P+D + V L + PEL+
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 328 ---LGASHYGAAVDLWSTGCILGELFS 351
L ++WS G + ELF+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 65/229 (28%), Positives = 94/229 (41%), Gaps = 43/229 (18%)
Query: 154 TFEKLDKIGQGTYSSVYRAR-----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
FE D IG+G + V RA ++ I LK+ +N + A E+ +L K
Sbjct: 5 KFE--DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD----FAGELEVLCK 58
Query: 209 L-DHPNIIKLEGLITSQTSCSLYLVFEY---------------MEHDLV-----GLASLP 247
L HPNII L G + LY+ EY +E D G AS
Sbjct: 59 LGHHPNIINLLG--ACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS-- 114
Query: 248 GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307
T Q+ + + +G+++ +HRD+ N+L+ N KIADFGL+ +
Sbjct: 115 --TLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY 172
Query: 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKP 354
M R+ W L S Y D+WS G +L E+ S G P
Sbjct: 173 VKKTM-GRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 39/119 (32%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 242 GLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
GL +L + FT Q+ G+E S +HRD+ N+LL I+KI DFGLA
Sbjct: 233 GLTTLDLLSFT--------YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA 284
Query: 302 -SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPG 358
+ V S + + + PE + + Y D+WS G +L E+FS G PG
Sbjct: 285 RDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 25/57 (43%), Positives = 37/57 (64%)
Query: 245 SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
++P K + +K M+Q+L+GL H G++HRDIK NLL+ +G +KI DFG A
Sbjct: 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 48/222 (21%), Positives = 95/222 (42%), Gaps = 17/222 (7%)
Query: 161 IGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216
+G+G + V+ A+ + + + L K +D RE+ + RKL H N+++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 217 LEGLITSQTSCSLYLVFEYME-HDL--------VGLASLPGMKFTESQVKCYMKQLLSGL 267
L GL Y++ EY + DL L + Q Q+ G+
Sbjct: 73 LLGLCREAE--PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
+H + +HRD+ N L+ +K++ L+ + + + ++ L + PE +
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV 190
Query: 328 LGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
+ D+WS G ++ E+F+ G+ G ++ E L+R+
Sbjct: 191 Q-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 50/204 (24%), Positives = 77/204 (37%), Gaps = 37/204 (18%)
Query: 166 YSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLI--TS 223
Y ++ ++VI I KK F + EI LR++D NI+K+ G I
Sbjct: 37 YKGIFNNKEVI---IRTFKK--FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 224 QTSCSLYLVFEY-----------MEHDLVGLASLPGMKFTESQVKCYMK-QLLSGLEHCH 271
L L+ EY E DL + K M GL + +
Sbjct: 92 DDLPRLSLILEYCTRGYLREVLDKEKDL------------SFKTKLDMAIDCCKGLYNLY 139
Query: 272 -SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
++++ + L+ N LKI GL S P V + Y ++L
Sbjct: 140 KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDI 195
Query: 331 -SHYGAAVDLWSTGCILGELFSGK 353
S Y D++S G +L E+F+GK
Sbjct: 196 FSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 56/215 (26%), Positives = 87/215 (40%), Gaps = 32/215 (14%)
Query: 207 RKLDHPNIIKLEGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMK---Q 262
R L HPNI++ G + LVFEY E DL S SQ+ + +
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RVVTLW 320
+ +G+ H H H LH D+ N L + +K+ D+G+ K+ T + V L
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLR 166
Query: 321 YRPPELL------LGASHYGAAVDLWSTGCILGELF-SGKPVLPGKTEVEQLHRIFKLCG 373
+ PEL+ L + ++W+ G L ELF + ++ E L+ + K
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD-- 224
Query: 374 SPSEDYWRKSKLRHSTVFKP--VQPYRRRIAETFK 406
++ KL FKP PY R E +
Sbjct: 225 -------QQVKL-----FKPQLELPYSERWYEVLQ 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 5/100 (5%)
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLAS--FFDPKDSVPMTSRVVTL 319
Q+ G++ S +HRD+ N+LL + KI DFGLA D V +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPG 358
W P + Y D+WS G +L E+FS GK PG
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 52/218 (23%), Positives = 103/218 (47%), Gaps = 22/218 (10%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDKI---VALKKVRFDNQDPESVKFMARE 202
+ R T + ++GQG++ VY A+ V+ D+ VA+K V E ++F+ E
Sbjct: 3 VAREKITMSR--ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NE 59
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVG-LASL-PGMKFTESQVKCYM 260
+++++ + ++++L G++ SQ +L ++ DL L SL P M+ Q +
Sbjct: 60 ASVMKEFNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 261 KQLLS-------GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313
K+++ G+ + +++ +HRD+ N ++ + +KI DFG+ D
Sbjct: 119 KKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 314 SR--VVTLWYRPPELLLGASHYGAAVDLWSTGCILGEL 349
+ + W P L G + D+WS G +L E+
Sbjct: 179 GKGLLPVRWMSPESLKDGV--FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 23/59 (38%), Positives = 34/59 (57%), Gaps = 8/59 (13%)
Query: 254 SQVKCY--------MKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304
++KC MK +L+ LE+ H HG+ H DIK N+++D N I D+G+AS F
Sbjct: 118 KRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 60/224 (26%), Positives = 91/224 (40%), Gaps = 41/224 (18%)
Query: 159 DKIGQGTYSSVYRA---RD--VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHP 212
D IG+G + V +A +D + I +K+ + + A E+ +L KL HP
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD----FAGELEVLCKLGHHP 56
Query: 213 NIIKLEGLITSQTSCSLYLVFEY---------------MEHDLV-----GLASLPGMKFT 252
NII L G + LYL EY +E D AS +
Sbjct: 57 NIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS----TLS 110
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312
Q+ + + G+++ +HRD+ N+L+ N + KIADFGL+ + M
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 170
Query: 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKP 354
R+ W L S Y D+WS G +L E+ S G P
Sbjct: 171 -GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 52/209 (24%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 155 FEKLDKIGQGTYSSVYRA---RDVIHDKI-VALKKVRFDNQDPESVKFMAREIAILRKLD 210
F+K+ +G G + +VY+ + KI VA+K++R + P++ K + E ++ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 67
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
+P++ +L G+ + T + L+ + M L+ + + Q+ G+ +
Sbjct: 68 NPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF--DPKDSVPMTSRVVTLWYRPPELL 327
++HRD+ N+L+ +KI DFGLA D K+ +V W +L
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 328 LGASHYGAAVDLWSTGCILGEL--FSGKP 354
Y D+WS G + EL F KP
Sbjct: 185 --HRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 8e-06
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 31/172 (18%)
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYM-EHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
D+PN IKL +T+ L+ +Y+ + DL L G K +E++VK ++QL+ L
Sbjct: 67 DNPNFIKLYYSVTTLKG--HVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALN 123
Query: 269 HCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDSVPMTSRVV--------TL 319
H H ++H DIK N+L D + + D+GL +++ TL
Sbjct: 124 DLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-------------CKIIGTPSCYDGTL 170
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGK-PVLPGKTE---VEQLHR 367
Y PE + G +Y + D W+ G + EL +GK P + E +E L +
Sbjct: 171 DYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 48/232 (20%), Positives = 91/232 (39%), Gaps = 41/232 (17%)
Query: 161 IGQGTYSSVYRAR------DVIHDKIVALKKVRFDNQDPESVKFMA--REIAILRKLDHP 212
+GQGT++++Y+ I + V + +A +++ +L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDHRDSLAFFETASLMSQLSHK 61
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKC--------YMKQLL 264
+++KL G+ + +V EY++ P F + KQL
Sbjct: 62 HLVKLYGVCVRDENI---MVEEYVKFG-------PLDVFLHREKNNVSLHWKLDVAKQLA 111
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGI-------LKIADFGLASFFDPKDSVPMTSRVV 317
S L + ++H ++ G N+L+ G+ +K++D G+ P + RV
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI-----PITVLSREERVE 166
Query: 318 TLWYRPPELL-LGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHR 367
+ + PE + G + A D WS G L E+ S G+ L + E+
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYR--ARDVIH---DKIVALKKVRFDNQDPESVKFMARE 202
+ R T L ++GQG++ VY ARD+I + VA+K V E ++F+ E
Sbjct: 3 VSREKITL--LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NE 59
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASL-PGMKFTESQVKCY 259
++++ ++++L G++ S+ +L +V E M H DL L SL P + +
Sbjct: 60 ASVMKGFTCHHVVRLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 260 MKQLLS-------GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312
+++++ G+ + ++ +HRD+ N ++ H+ +KI DFG+ D
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 313 TSR--VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
+ + W P L G + + D+WS G +L E+ S
Sbjct: 178 GGKGLLPVRWMAPESLKDGV--FTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 10/112 (8%)
Query: 252 TESQVKCYMK------QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFF 304
ES YM Q+ +G+E S +HRD+ N+L+ ++KI DFGLA
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKP 354
+ + S + L + PE + + Y D+WS G +L E+F+ G P
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 26/77 (33%), Positives = 40/77 (51%), Gaps = 8/77 (10%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGL 220
I +G + Y+ + + + +K++ N P S EIA + KL HPNI+KL GL
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS------EIADMGKLQHPNIVKLIGL 751
Query: 221 ITSQTSCSLYLVFEYME 237
S+ YL+ EY+E
Sbjct: 752 CRSEKGA--YLIHEYIE 766
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 55/224 (24%), Positives = 86/224 (38%), Gaps = 29/224 (12%)
Query: 181 VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS-------CSLYLVF 233
V +K++R E +KF+ E R L H N+++ G T T C L +
Sbjct: 25 VVVKELRVSASVQEQMKFLE-EAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGIL 293
Y+ P T ++ C ++ GL H H + +H D+ N LL + +
Sbjct: 84 GYLRSCRKAELMTPDPT-TLQRMAC---EIALGLLHLHKNNFIHSDLALRNCLLTADLTV 139
Query: 294 KIADFGLASFFDPKDSVPMTSRV-VTLWYRPPELL------LGASHYGAAVDLWSTGCIL 346
KI D+GL+ +D ++ V L + PEL+ L ++WS G +
Sbjct: 140 KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199
Query: 347 GELF----------SGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380
ELF S + VL +QL P D W
Sbjct: 200 WELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRW 243
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 23/134 (17%)
Query: 262 QLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGI----------------LKIADFGLASFF 304
Q L++ H+ ++H D+K N+L++ + ++I D G
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC-- 296
Query: 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ 364
D + S T+ V T YR PE++LG + + D+WS GCI+ EL++GK + +E
Sbjct: 297 DERHS--RTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 365 LHRIFK-LCGSPSE 377
LH + K L PSE
Sbjct: 354 LHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 13/208 (6%)
Query: 155 FEKLDKIGQGTYSSVYR---ARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
+K+ +G G + +VY+ D + KI KV +N P++ K + E ++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
P + +L G+ + T + LV + M + L+ + + + Q+ G+ +
Sbjct: 69 PYVCRLLGICLTST---VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF--DPKDSVPMTSRVVTLWYRPPELLL 328
++HRD+ N+L+ +KI DFGLA D + +V W +L
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL- 184
Query: 329 GASHYGAAVDLWSTGCILGEL--FSGKP 354
+ D+WS G + EL F KP
Sbjct: 185 -HRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 16/96 (16%)
Query: 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH 289
Y V Y+ + L G++ ++ M+Q+L L+ HS G++HRD+K N++
Sbjct: 233 YNVEPYLLGKVQDLP--KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 290 -NGILKIADFGLAS-------------FFDPKDSVP 311
+G KI D G A+ DP+ + P
Sbjct: 291 GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAP 326
|
Length = 566 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 29/138 (21%), Positives = 56/138 (40%), Gaps = 10/138 (7%)
Query: 169 VYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228
VY D ++ + + + RE+AIL+ L + + L + ++
Sbjct: 14 VYLLGTKDEDYVL-----KINPSREKGADR-EREVAILQLLARKGLPVPKVLASGESDGW 67
Query: 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD 288
YL+ E++E G + + + + +LL+ L + H D+ N+L+D
Sbjct: 68 SYLLMEWIE----GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123
Query: 289 HNGILKIADFGLASFFDP 306
IL I D+ A + P
Sbjct: 124 DGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.95 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.49 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.45 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.02 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.89 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.88 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.85 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.55 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.44 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.34 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.32 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.26 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.25 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.18 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.16 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.05 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.02 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.92 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.76 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.55 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.42 | |
| PLN02236 | 344 | choline kinase | 96.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.98 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.93 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.57 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.45 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.93 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.89 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.81 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.7 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.7 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 94.64 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.11 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.85 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.48 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-86 Score=708.24 Aligned_cols=419 Identities=63% Similarity=1.056 Sum_probs=388.2
Q ss_pred CCCcCCCCCCCchhhhhcCCCchhhhhhhhhhcccccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC
Q 005111 113 HPAIGRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD 192 (714)
Q Consensus 113 ~~~i~~~p~~~~~~~~~~~~p~~~~~~~g~~~~~~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~ 192 (714)
....++.+...+.++.+++||.|+..++|+.+.+|.++..+.|+.+++||+|+||.||+|++..+|+.||+|+++++..+
T Consensus 77 ~~~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~ 156 (560)
T KOG0600|consen 77 GSRPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK 156 (560)
T ss_pred ccCCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC
Confidence 44556677777889999999999999999999999999999999999999999999999999999999999999999888
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh
Q 005111 193 PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272 (714)
Q Consensus 193 ~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~ 272 (714)
++....+.|||.||++|+||||++|.+++++...+.+|||||||+++|..++...+..|++.++++||+||+.||+|||.
T Consensus 157 ~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~ 236 (560)
T KOG0600|consen 157 EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS 236 (560)
T ss_pred CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh
Confidence 89999999999999999999999999999988777899999999999999999999999999999999999999999999
Q ss_pred cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC
Q 005111 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG 352 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG 352 (714)
+||+|||||.+|||||.+|.+||+|||||+++.......+++++.|+||+|||+|+|...|+.++|+||+||||.||++|
T Consensus 237 ~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~g 316 (560)
T KOG0600|consen 237 RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLG 316 (560)
T ss_pred cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcC
Confidence 99999999999999999999999999999999988888899999999999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHH
Q 005111 353 KPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATL 432 (714)
Q Consensus 353 ~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e 432 (714)
+|+|+|.++++|+++|+++||+|.+++|...++++...+++.++|.+++.+.++.+|..+++|+..||+.||.+|.||.+
T Consensus 317 kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~ 396 (560)
T KOG0600|consen 317 KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASS 396 (560)
T ss_pred CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHcCcCCCCCCCCCCCCCCCCCCCChhHHHhhhhHHhhhcCCCCCCCCCCCccccccccCCCCCCCCchhhh-hhhcccc
Q 005111 433 ALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLPIPAPNRDAEL-SIMQKRH 511 (714)
Q Consensus 433 ~L~Hp~f~~~~~~~~~~~~p~~~p~~~~~~k~r~~~~rr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 511 (714)
+|+|+||++.|.+|+|+.+|.|++++|+++|.|+++.|+.....+. .....+..+...++|++..+++. +..+..
T Consensus 397 aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~---~~~~~~~~~~~r~~p~~~~~~~~~~~~~~~- 472 (560)
T KOG0600|consen 397 ALQSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGGASK---RRIRERGDRGSRAIPAQPANAESQASPQRR- 472 (560)
T ss_pred HhcCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccccccc---cccccccccccCCCCCCCCCHHHhcccccc-
Confidence 9999999999999999999999999999999999988877622222 22222335567788888888877 666666
Q ss_pred ccCCCCccccccCcccccccCCCCC
Q 005111 512 HTNSRSKNEMFISQKEAAHAINPTK 536 (714)
Q Consensus 512 ~~~~~~~~~~~~~~~~~~~~~~~~~ 536 (714)
.+|..+.++.|.++++++ .++|..
T Consensus 473 ~~n~~~~s~kf~p~~~~~-~~~~~~ 496 (560)
T KOG0600|consen 473 KSNSRSNSEKFPPPEQDG-VGFPIG 496 (560)
T ss_pred ccCCcCcccCCCCccccc-cCcccC
Confidence 788899999999998887 445554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-60 Score=487.67 Aligned_cols=307 Identities=44% Similarity=0.759 Sum_probs=269.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|+.+..|++|+||.||+|+|+.|++.||+|.++.+......--.-.|||.+|.+++|||||.+..++.......+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 45789999999999999999999999999999999987743322223356999999999999999999998877777799
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||||++++..++..-..+|...++++++.|+|.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.++.. ..
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k 232 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LK 232 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-cc
Confidence 99999999988877766678999999999999999999999999999999999999999999999999999998755 44
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc-Cc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH-ST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~-~~ 389 (714)
+++..+.|+||+|||+|+|...|+.++|+||+|||+.||++++|+|+|.++.+|+.+|++++|.|.+..|....... ..
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 67888999999999999999999999999999999999999999999999999999999999999999998754333 22
Q ss_pred -cccCCchhhhhhhhhccC--CcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCCCCCCCCCCCCChh
Q 005111 390 -VFKPVQPYRRRIAETFKD--FPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKE 459 (714)
Q Consensus 390 -~~~~~~p~~~~i~~~~~~--~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~p~~~p~~~ 459 (714)
...+.+||. .+...|.. ++....+|+..+|.+||.+|.||.++|+|+||...|.|++|..+|.||...+
T Consensus 313 ~~~f~~~pyn-~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 313 KMTFSEHPYN-NLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred ccccCCCCch-hhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 122333432 33444444 4599999999999999999999999999999999999999999999987443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-58 Score=463.12 Aligned_cols=297 Identities=40% Similarity=0.747 Sum_probs=263.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|..+++||+|+||.||+|+|..||+.||||+++..+..........|||..|+.++|+||+.|+++|...+. +.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~--l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN--LSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc--eEEE
Confidence 57899999999999999999999999999999999876554555667899999999999999999999987765 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
+|||+.++...+......|+..+++.|+.+++.||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+.+.....
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 9999999999888888999999999999999999999999999999999999999999999999999999998665543
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh-hcccCccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS-KLRHSTVF 391 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~-~~~~~~~~ 391 (714)
+..+.|.||+|||+|.|...|+..+||||+|||++||+-|.|.|+|.++.+|+..|+..+|+|.++.|... .++....+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 33488999999999999999999999999999999999999999999999999999999999999999763 33333333
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCCCCCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKY 454 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~p~~ 454 (714)
... | .......|...+.++.+|+.+||.+||.+|+||.|+|.|+||++.|.|+.+..+|..
T Consensus 239 ~~~-P-~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 239 QQF-P-KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP 299 (318)
T ss_pred hcC-C-CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence 211 1 112233778889999999999999999999999999999999999999888888753
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=461.36 Aligned_cols=285 Identities=32% Similarity=0.599 Sum_probs=250.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.|+.+.++|+|+||.||+|+++.||+.||||++.....++...+...|||.+|++|.|+|+|.|+++|..... ++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk--lhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK--LHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce--eEEE
Confidence 57999999999999999999999999999999998777777788888999999999999999999999987665 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||||++..|..+......++...++.|++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+.. .....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999999988877666799999999999999999999999999999999999999999999999999999874 34457
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh---hhhcccCc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR---KSKLRHST 389 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~---~~~~~~~~ 389 (714)
+.++.|.||+|||++.|...|+.++||||+||++.||++|.|+|+|.++.+++..|.+.+|.....-.. ...+-+..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 788999999999999998889999999999999999999999999999999999999999988765322 11111111
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
. -|..+-...+...+++++.-+.+|+.+||..||++|++.+++|.|+||..
T Consensus 239 ~-lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 239 R-LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred e-cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1 12222234455667888999999999999999999999999999999954
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-57 Score=484.27 Aligned_cols=287 Identities=38% Similarity=0.669 Sum_probs=258.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|.++++||.|+||.||+|+.+.+|..||||.++.....-+..-. .||+..|++|+ |||||+|.+++.+.+. .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 46899999999999999999999999999999999876544444433 48999999998 9999999999988775 599
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+|||||+.++..++...+..|++..++.|+.||+.||+|+|.+|+.||||||+||||.....|||+|||+|+.+. ...
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--Skp 164 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR--SKP 164 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--cCC
Confidence 999999999999999889999999999999999999999999999999999999999988899999999999885 445
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh-hhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~-~~~~~~~ 389 (714)
+.+.++.|.||+|||+|+....|+.++|||++|||++|+.+-+|+|+|.++.+++.+|+.++|+|..+.|.. ..+....
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 688999999999999999999999999999999999999999999999999999999999999999999977 4455555
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.|...+-....+..+++..+.++.+||.+||.+||.+||||.++|+||||+..
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 55444444456677788899999999999999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-55 Score=458.28 Aligned_cols=264 Identities=31% Similarity=0.459 Sum_probs=227.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH-----HHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP-----ESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~-----~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
..+.|.+.+.||+|+||.|-+|.++.||+.||||++....... .....+.+|++||++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3567899999999999999999999999999999998653211 12334679999999999999999999998776
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC---CcEEEeecCccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN---GILKIADFGLAS 302 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~---g~vKL~DFGla~ 302 (714)
. .||||||++||.|......++.+.+...+.+++||+.||.|||++||+||||||+|||++.+ ..+||+|||+|+
T Consensus 250 s--~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 S--SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred c--eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 5 89999999998888888788899999999999999999999999999999999999999876 689999999999
Q ss_pred ccCCCCCCCcccccccccccCcccccCCC--CCCccccccchhHHHHHHhhCCCCCCCCChHH-HHHHHHHhhCCCChhH
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLGAS--HYGAAVDLWSTGCILGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDY 379 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g~~--~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~~I~k~~G~p~~~~ 379 (714)
..+ ....+.+.||||.|.|||++.+.. .|..++||||||||||-+|+|.+||.+..... ...+|.+.-..+-..+
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 986 345577889999999999996543 34558999999999999999999999876555 6667765444443444
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
| ..++.++++||.+||.+||+.|||++|+|+||||+..+
T Consensus 406 w-------------------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 W-------------------------DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred h-------------------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 4 35899999999999999999999999999999999765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-54 Score=445.60 Aligned_cols=291 Identities=37% Similarity=0.609 Sum_probs=250.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc---cCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS---QTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~---~~~~~ 228 (714)
...|..++.||.|+||.|+.|.++.+|+.||||++.......-..++..||+.+|+.++|+||+.+.+++.. .....
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 456777899999999999999999999999999998554556778889999999999999999999999876 23345
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC-
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK- 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~- 307 (714)
+|+|+|+|+.++...+. .+..|++.++..+++|||.||.|+|+.+|+||||||.|+|++.+..+||||||+|+..+..
T Consensus 101 vYiV~elMetDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHhhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99999999777665544 4456999999999999999999999999999999999999999999999999999988542
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
....++.++.|.||+|||+++....|+.++||||+||||+|||+|+++|+|.+..+|+..|+..+|+|+++.+....-..
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 23346888999999999999988889999999999999999999999999999999999999999999998876644222
Q ss_pred CccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+....| -+..+...|++.++.+++||++||..||.+|+|++|+|+||||...-
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 111111111 12345678899999999999999999999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=458.43 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=231.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+|+..+.||+|||+.||.+++..+|+.||+|++... -......+.+.+||+|.++|+|||||+++++|++... +||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n--VYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN--VYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc--eEE
Confidence 6799999999999999999999999999999999875 3355678889999999999999999999999987655 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|+|+|..+++..+......|+|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||..+..... .
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-r 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-R 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-c
Confidence 999999999988888888999999999999999999999999999999999999999999999999999999874433 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
-.+.||||.|+|||++.... +++.+||||+|||||-||+|+|||...+-.+.+.+|...-..
T Consensus 175 k~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~----------------- 236 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS----------------- 236 (592)
T ss_pred cceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-----------------
Confidence 34569999999999999777 699999999999999999999999999999999998542211
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+..++.++.+||.+||..||.+|||++++|.|+||++.
T Consensus 237 ------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 237 ------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 123689999999999999999999999999999999654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=437.78 Aligned_cols=292 Identities=40% Similarity=0.734 Sum_probs=247.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeccccccCC----
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN-IIKLEGLITSQTS---- 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-IVkl~~~~~~~~~---- 226 (714)
...|+.+++||+|+||+||+|+++.+|+.||+|+++.....+..-....||+.+|+.|+|+| ||.|++++.....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688889999999999999999999999999999987553334455679999999999999 9999999876551
Q ss_pred ceEEEEEeeccccccccccCCC---CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPG---MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~---~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
..+||||||++.++...+.... ..++...++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 3599999999988766554433 3578899999999999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
+.-... ..+..++|.||+|||+|+|...|+..+||||+|||++||++++++|+|.++.+++..|++.+|+|.++.|...
T Consensus 170 ~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 763332 3566789999999999999988999999999999999999999999999999999999999999999999764
Q ss_pred h-cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 384 K-LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 384 ~-~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
. ++.....-+.......+....+...+.+.+|+.+||+++|.+|.||..+|.||||...+.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 3 222221111111133445556667789999999999999999999999999999998654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=438.08 Aligned_cols=279 Identities=31% Similarity=0.467 Sum_probs=238.8
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
....++|++++.||+|+||.||+|+.+.||..||+|++++..+ ....++++..|-.+|...++|+||+|+..|.+...
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~- 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY- 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe-
Confidence 3467899999999999999999999999999999999988743 45678899999999999999999999888876554
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+||||||++||.+.-++.....|++..++.|+.+++.||+.||++|+|||||||+|+|||..|++||+||||+.-+...
T Consensus 216 -LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 216 -LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred -eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999888777777779999999999999999999999999999999999999999999999999999543210
Q ss_pred ----------------------CCC------------------------CcccccccccccCcccccCCCCCCccccccc
Q 005111 308 ----------------------DSV------------------------PMTSRVVTLWYRPPELLLGASHYGAAVDLWS 341 (714)
Q Consensus 308 ----------------------~~~------------------------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWS 341 (714)
+.. ...+.+|||.|+|||+|++.+ |+..+|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHH
Confidence 000 012468999999999999988 899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh-hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhc
Q 005111 342 TGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS-KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLM 420 (714)
Q Consensus 342 LG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~-~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL 420 (714)
|||||||||.|.|||.+++..++..+|+. |+.. .++ . -..++.+++|||.+||
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP------~-----------~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFP------E-----------EVDLSDEAKDLITRLL 427 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCC------C-----------cCcccHHHHHHHHHHh
Confidence 99999999999999999999999999965 4321 111 0 1246789999999999
Q ss_pred ccCcCCCCC---HHHHHcCcCCCCCCCCCCCCCCCCCCCC
Q 005111 421 SIDPAHRGT---ATLALNSEFFTTQPLACNPSNLPKYPPS 457 (714)
Q Consensus 421 ~~DP~kRpT---a~e~L~Hp~f~~~~~~~~~~~~p~~~p~ 457 (714)
+ ||++|.. ++|+..||||+...|-......|.|.|.
T Consensus 428 ~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~ 466 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQ 466 (550)
T ss_pred c-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCC
Confidence 9 9999975 9999999999998887666666666663
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-51 Score=426.04 Aligned_cols=258 Identities=29% Similarity=0.420 Sum_probs=227.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..+.+.++.||+|..|+||+|+|+.|++.+|+|++.. ..++...+++.+|+++|+.++||+||.+|+.|..... .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 3567889999999999999999999999999999954 4567888999999999999999999999999987764 5999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+++.|+.+....+.++|.....++.+|+.||.|||+ ++||||||||+||||+..|.|||||||.+..+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999999888877889999999999999999999995 99999999999999999999999999999987543
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC-----ChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK-----TEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~-----~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
...+.+||..|||||.+.+.. |+.++||||||++++||++|+.||... ...+++..|+. +.|+
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP--------- 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPP--------- 300 (364)
T ss_pred hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCC---------
Confidence 456789999999999999976 899999999999999999999999874 45566666642 1111
Q ss_pred ccCccccCCchhhhhhhhhcc-CCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFK-DFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~-~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.. +. .+++++.+||..||.+||.+|+|+.|+|+|||++...
T Consensus 301 --------~l---------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 301 --------RL---------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred --------CC---------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 11 12 3899999999999999999999999999999999754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=427.54 Aligned_cols=262 Identities=30% Similarity=0.445 Sum_probs=231.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||+||.++.+.+++.||+|++++... .....+.+..|..||..++||+||+++..|.+... +
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k--L 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK--L 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe--E
Confidence 45789999999999999999999999999999999987632 33467889999999999999999999887776655 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||+||+.||.|...+...+.|+|..++.|+.+|+.||.|||++|||||||||+|||||.+|+++|+|||+++..-. ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~-~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK-DG 179 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc-CC
Confidence 99999999999988888888999999999999999999999999999999999999999999999999999986433 23
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+.|||+.|||||++.+.+ |+.++|+||||+++|||++|.+||.+.+....+.+|.+.-.
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~---------------- 242 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL---------------- 242 (357)
T ss_pred CccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC----------------
Confidence 3455679999999999999886 89999999999999999999999999999999988865210
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC----CHHHHHcCcCCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG----TATLALNSEFFTTQPL 444 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp----Ta~e~L~Hp~f~~~~~ 444 (714)
......++.++++||.++|..||++|. .+.++-+||||....|
T Consensus 243 ------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 243 ------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred ------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 111123789999999999999999995 7999999999998654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=426.60 Aligned_cols=282 Identities=38% Similarity=0.634 Sum_probs=238.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc---eE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC---SL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~---~l 229 (714)
-.|+..+.+|.|+||.||.|....+++.||||++..+... -.+|+.+|+.++|||||+|.-+|...... ++
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3588899999999999999999999999999998765321 23799999999999999998887654443 46
Q ss_pred EEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-CcEEEeecCcccccC
Q 005111 230 YLVFEYMEHDLVGLAS---LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLASFFD 305 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~-g~vKL~DFGla~~~~ 305 (714)
.+|||||+.++...+. ..+..++.-.++-|+.||++||.|||+.||+||||||.|||||.+ |.+||||||.|+.+.
T Consensus 98 nlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 7899999988766544 346689999999999999999999999999999999999999975 999999999999986
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... +..++..|..|+|||++.|...|+.++||||.|||++||+.|+|+|+|++..+|+..|++.+|.|+.+.+...+.
T Consensus 178 ~~e--pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 178 KGE--PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred cCC--CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 554 457788999999999999999999999999999999999999999999999999999999999999988765443
Q ss_pred ccCccccCCchhhhhhh-hhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIA-ETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~-~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
... .++..+-...... -.+...++++.+|+.++|.++|.+|.++.++|.||||....
T Consensus 256 ~y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 256 NYT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred ccc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 321 1111111011111 24567899999999999999999999999999999998754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-50 Score=436.07 Aligned_cols=263 Identities=33% Similarity=0.485 Sum_probs=232.7
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCc
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~ 227 (714)
+..++|.+.+.||.|+|++||+|+++.+++.||||++.+.. ..+.-++.+.+|-.+|.+| .||.||+|+..|.++..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s- 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES- 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc-
Confidence 45689999999999999999999999999999999987652 2334567788999999999 89999999877766554
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|+|+||+++|.|-.++..-+.|++..++.|+.||+.||+|||++|||||||||+|||||.||++||+|||.|+.+.+.
T Consensus 149 -LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 -LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred -eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999998777777777789999999999999999999999999999999999999999999999999999988654
Q ss_pred CCC------------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCC
Q 005111 308 DSV------------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375 (714)
Q Consensus 308 ~~~------------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p 375 (714)
... ...++|||-.|.+||+|.... .++.+|||+||||||.|+.|.|||.+.++.-.+++|+++...+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF 306 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence 322 125689999999999888765 7999999999999999999999999999999999998864333
Q ss_pred ChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 376 SEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 376 ~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.+++|+.+.+||+++|..||.+|+|+.++.+||||....|
T Consensus 307 -----------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 307 -----------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred -----------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 2478999999999999999999999999999999998654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=379.18 Aligned_cols=285 Identities=41% Similarity=0.745 Sum_probs=250.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|...++||+|+||+||+|++..+++.||+|.++.+..++..-....|||-+|+.|.|.|||+++++...+.. +-+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk--ltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK--LTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce--eEEeH
Confidence 5777889999999999999999999999999999987666666678899999999999999999999877665 89999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
|||..++...+..-++.++.+.++.++.|++.||.|||+++++||||||.|+||+.+|.+||+|||+++.++-.-.. ..
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrc-ys 159 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YS 159 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-ee
Confidence 99999887777777788999999999999999999999999999999999999999999999999999988654332 23
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh-hcccCccc
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS-KLRHSTVF 391 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~-~~~~~~~~ 391 (714)
..+.|.||++|.++.|..-|+...|+||.|||++|+.. |.|+|+|.+..+++.+|+..+|.|.++.|... +++. ...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd-yk~ 238 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD-YKP 238 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC-Ccc
Confidence 44779999999999999999999999999999999986 89999999999999999999999999999753 2322 122
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
-|.-|....+..+.+.+.....+|++++|.-+|..|++|+++|+||||+..
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 233333445566778888999999999999999999999999999999863
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=416.32 Aligned_cols=266 Identities=30% Similarity=0.472 Sum_probs=234.0
Q ss_pred cccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 147 ~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
+......+|++.+.||.|+||+||+|+++.++..||||.+.......+.++.+..||.+|+.++|||||.|++++...+.
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 44556789999999999999999999999999999999999887778889999999999999999999999999876654
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC------CcEEEeecCc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN------GILKIADFGL 300 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~------g~vKL~DFGl 300 (714)
+|||||||.||.|..++...+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+
T Consensus 84 --i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 84 --IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred --EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999999999988899999999999999999999999999999999999999865 4689999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 301 ASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 301 a~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
|+.+.+... ..+.||++.|||||++.... |+.++|+||+|+|||+|++|++||...+..+.+..|.+.....
T Consensus 162 AR~L~~~~~--a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~----- 233 (429)
T KOG0595|consen 162 ARFLQPGSM--AETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV----- 233 (429)
T ss_pred hhhCCchhH--HHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc-----
Confidence 999975443 45679999999999997554 9999999999999999999999999999998888664321110
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
+ .....++....+|+..+|..+|..|.+..+-+.|+++...|
T Consensus 234 ------------~---------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 234 ------------P---------VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ------------C---------chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 0 11123566778999999999999999999999999998765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=403.03 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=231.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+|++++.||.|+||.|.+++++.+|..||+|++.+. ......+++..+|..+|+.+.||++++|++.+.+.. .+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~--~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS--NLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC--eEE
Confidence 47899999999999999999999999999999999775 334567888999999999999999999988776554 499
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||||++|+.+..+++..++|++..++.|+.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999987533
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
+.+.||||.|+|||++...+ |+.++|+|||||++|||++|.+||...+....+++|+..--.
T Consensus 198 -T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~---------------- 259 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK---------------- 259 (355)
T ss_pred -EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc----------------
Confidence 45679999999999998877 899999999999999999999999999999999999763211
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCC-----CCHHHHHcCcCCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR-----GTATLALNSEFFTTQPL 444 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kR-----pTa~e~L~Hp~f~~~~~ 444 (714)
.+..+++++++||.++|+.|-.+| ....++..||||....|
T Consensus 260 -------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 260 -------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred -------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 123578999999999999999999 35779999999997654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=401.62 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=231.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|++.+.||+|.|+.||++.+..+|+.+|+|++..........+.+.+|+.|.+.|+|||||+|++.+.+.. ..|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~--~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc--eeE
Confidence 457799999999999999999999999999999999876555567788999999999999999999999886654 489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCcccccCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLASFFDPK 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla~~~~~~ 307 (714)
||||+|+|+.+..-+-....++|..+..+++||+.+|.|||.+||||||+||+|+|+-. ..-+||+|||+|..+.
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999998766544444467899999999999999999999999999999999999953 3469999999999887
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
......+++|||.|||||++...+ |+..+|||+.|+|||.||.|++||.+++....+..|.+.-...+..+|
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w------- 236 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW------- 236 (355)
T ss_pred CccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc-------
Confidence 445567889999999999998876 899999999999999999999999999999999999876655555555
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+.+++++++||++||..||.+|+|+.|+|+|||+..
T Consensus 237 ------------------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 237 ------------------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ------------------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 468999999999999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=418.37 Aligned_cols=260 Identities=30% Similarity=0.451 Sum_probs=226.3
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC--C-HHHHHHHHHHHHHHHhCC-CCCeeeeeccccccC
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--D-PESVKFMAREIAILRKLD-HPNIIKLEGLITSQT 225 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--~-~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~ 225 (714)
...+.|++.+.||+|+||+|++|.+..+|..||+|++..... . ....+.+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 346789999999999999999999999999999998765411 1 234567779999999998 999999999998776
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-CcEEEeecCccccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLASFF 304 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~-g~vKL~DFGla~~~ 304 (714)
. +|||||||.|+.|..++...+++.|..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~--~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 K--IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred e--EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 6 99999999986666666558899999999999999999999999999999999999999999 99999999999987
Q ss_pred CCCCCCCcccccccccccCcccccCCC-CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGAS-HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~-~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
. .......+.+||+.|+|||++.+.. +-+.++||||+|+|||.|++|..||...+....+.+|.+..-
T Consensus 172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~---------- 240 (370)
T KOG0583|consen 172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF---------- 240 (370)
T ss_pred C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc----------
Confidence 4 2334566789999999999999877 557899999999999999999999999888888888754211
Q ss_pred hcccCccccCCchhhhhhhhhccCC-cHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDF-PTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~-p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.....+ +.++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 241 -------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 -------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 111235 899999999999999999999999999999997
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=423.93 Aligned_cols=281 Identities=30% Similarity=0.519 Sum_probs=232.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC------CCCeeeeeccccccCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD------HPNIIKLEGLITSQTS 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~------HpnIVkl~~~~~~~~~ 226 (714)
.+|++++.||+|+||+|.+|.|..|++.||||+++.. .....+...|+.+|..|+ --|||+++++|.....
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3799999999999999999999999999999999854 355666778999999996 3689999999988776
Q ss_pred ceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC--cEEEeecCcccc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG--ILKIADFGLASF 303 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g--~vKL~DFGla~~ 303 (714)
+|||+|+++.+|.+++...+ ..|+...++.|+.||+.||.+||+.||||+|||||||||.+-+ .|||+|||.|..
T Consensus 263 --lciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 263 --LCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred --eeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999999999888776543 4589999999999999999999999999999999999997644 799999999998
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
.... ...++-+..|+|||+++|.+ |+.++||||||||++||++|.|+|+|.++.+|+..|+.++|.|+..+....
T Consensus 341 ~~q~----vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQR----VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCc----ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 6433 23678899999999999987 899999999999999999999999999999999999999999998876553
Q ss_pred hcccCcccc-C-----C--------------------------ch-hhhhhhhhcc-CCcHHHHHHHHHhcccCcCCCCC
Q 005111 384 KLRHSTVFK-P-----V--------------------------QP-YRRRIAETFK-DFPTSALRLMETLMSIDPAHRGT 429 (714)
Q Consensus 384 ~~~~~~~~~-~-----~--------------------------~p-~~~~i~~~~~-~~p~~l~~LI~~mL~~DP~kRpT 429 (714)
+-.+...-. . . .| ..+.+...+. .-...+.+||.+||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 222111000 0 0 00 0011111111 12346899999999999999999
Q ss_pred HHHHHcCcCCCCCC
Q 005111 430 ATLALNSEFFTTQP 443 (714)
Q Consensus 430 a~e~L~Hp~f~~~~ 443 (714)
+.++|+||||+...
T Consensus 496 p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 496 PAQALNHPFLTGTS 509 (586)
T ss_pred HHHHhcCccccccc
Confidence 99999999999654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=402.07 Aligned_cols=284 Identities=37% Similarity=0.695 Sum_probs=233.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||.|+||.||+|++..++..||+|+++..... .....+.+|+.+|+.++||||+++++++.... .+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTER--CLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC--eEEE
Confidence 46799999999999999999999999999999999754322 22345678999999999999999999887654 4899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 999999877665555555689999999999999999999999999999999999999999999999999976543222 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc-c
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST-V 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~-~ 390 (714)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.+.|......... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 334578999999999887666899999999999999999999999999999999999999999999988653221100 0
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
+................++.++.+||.+||.+||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0000000111223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=398.89 Aligned_cols=284 Identities=36% Similarity=0.620 Sum_probs=235.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|++..+++.||+|++..........+.+.+|+.+++.++||||+++++++.... .+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG--KLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC--EEEEE
Confidence 4799999999999999999999999999999999866444455677889999999999999999999887654 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++++..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999998887766556799999999999999999999999999999999999999999999999999987654433334
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC---c
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS---T 389 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~---~ 389 (714)
....||+.|+|||++.+.. ++.++|||||||++|+|++|++||++.+..+.+..+....|..+.+.|........ .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 4557899999999998766 79999999999999999999999999998888888888888887766543211100 0
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.+................++..+.+||.+||.+||++|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000011112234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=424.82 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=233.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.+-|++.+.||.|+.|.|-+|++..||+.+|||+|... .........+.+||-||+.+.||||+.||++++.... +|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~--ly 88 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH--LY 88 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce--EE
Confidence 45679999999999999999999999999999999876 4445556778999999999999999999999987665 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+|+||++||.|+.++...++|++.++..+++||+.|+.|||..+|+||||||+|+||+..++|||+|||+|..-.+..
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-- 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-- 166 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence 999999999888888888899999999999999999999999999999999999999999999999999998754332
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
-+.+.||+|.|.|||++.|.++.+.++||||+|||||.||+|+.||.+.+....+.++.+.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G------------------- 227 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG------------------- 227 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC-------------------
Confidence 3456699999999999999998899999999999999999999999988877777777442
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
..+.+..+|.++.+||.+||.+||++|+|.++++.|||+...+-.
T Consensus 228 ----------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 228 ----------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred ----------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 123345799999999999999999999999999999999876533
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=395.86 Aligned_cols=292 Identities=38% Similarity=0.659 Sum_probs=238.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHD----KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
..|+++..||+|+||.||+|....++ +.+|||.++-.......-....|||.+++.++||||+.|..+|...+ ..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d-~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD-KK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC-ce
Confidence 56899999999999999999665553 37999999766333333445669999999999999999999988753 44
Q ss_pred EEEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC----CcEEEeecCc
Q 005111 229 LYLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN----GILKIADFGL 300 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~----g~vKL~DFGl 300 (714)
++|+|||.+++++..+.. ....++...++.|+.||+.|+.|||++-|+||||||.||||..+ |.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999999999999886543 22458999999999999999999999999999999999999887 8999999999
Q ss_pred ccccCCCCCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC---------hHHHHHHHH
Q 005111 301 ASFFDPKDSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT---------EVEQLHRIF 369 (714)
Q Consensus 301 a~~~~~~~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~---------~~e~l~~I~ 369 (714)
++.+...-.. .....+.|.||+|||+|+|..+|+.++|||++|||+.|||+-.|+|.+.. ..+++.+|+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9988643221 23456789999999999999999999999999999999999999999864 458999999
Q ss_pred HhhCCCChhHHhhh-hcccC-ccccCCc-hh-----hhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 370 KLCGSPSEDYWRKS-KLRHS-TVFKPVQ-PY-----RRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 370 k~~G~p~~~~w~~~-~~~~~-~~~~~~~-p~-----~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+++|.|.+..|... ++++. ....... .+ -.......+.-++.+.+||.+||.+||.+|+||+++|+|+||+.
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 99999999999763 34433 1111111 01 11123344445677999999999999999999999999999999
Q ss_pred CCCC
Q 005111 442 QPLA 445 (714)
Q Consensus 442 ~~~~ 445 (714)
.+.|
T Consensus 343 d~lp 346 (438)
T KOG0666|consen 343 DPLP 346 (438)
T ss_pred CCCC
Confidence 8765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=396.25 Aligned_cols=249 Identities=31% Similarity=0.509 Sum_probs=217.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|+++++||.|+||.||++.+..+|..||.|.+.+...+....+.+..|+.+|++|+|||||++++.-..++...++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 56999999999999999999999999999999999998999999999999999999999999999984334444458999
Q ss_pred Eeecccccccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhh--cC--eeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 233 FEYMEHDLVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHS--HG--VLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 233 ~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~--~g--IiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
||||++|.|..++ .....++|..++.++.|++.||.+||. .. |+||||||.||+|+.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999987776443 356679999999999999999999998 45 999999999999999999999999999998
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... ....+.+|||.||+||.+.+.+ |++++|||||||++|||+.-++||.|++-.+.-.+|.+.--+|-.+
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~------ 250 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD------ 250 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH------
Confidence 7543 4466789999999999999877 8999999999999999999999999998777777775532111000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa 430 (714)
..+|.++..||..|+++||+.||+.
T Consensus 251 ---------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ---------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ---------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2468899999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=405.96 Aligned_cols=265 Identities=32% Similarity=0.468 Sum_probs=225.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC------------CHHHHHHHHHHHHHHHhCCCCCeeeee
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ------------DPESVKFMAREIAILRKLDHPNIIKLE 218 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~------------~~~~~~~~~rEi~iL~~L~HpnIVkl~ 218 (714)
..++|++++.||+|.||.|-+|++..+++.||||++..... .....+.+.+||.||++|.|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 35899999999999999999999999999999999964321 111246788999999999999999999
Q ss_pred ccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 219 ~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
++..+.....+|||+|||..+.+...-.....|++.+++.|++.++.||+|||.+|||||||||.|+||+.+|++||+||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeecc
Confidence 99988888889999999998877655444444999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCC----CCCCcccccccccccCcccccC---CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHh
Q 005111 299 GLASFFDPK----DSVPMTSRVVTLWYRPPELLLG---ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL 371 (714)
Q Consensus 299 Gla~~~~~~----~~~~~~~~~gT~~Y~APE~l~g---~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~ 371 (714)
|.+..+... ....+...+|||.|+|||++.+ ....+.+.|||||||+||.|+.|+.||.+....++..+|...
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 999876322 1122334689999999999987 333578999999999999999999999999999999999652
Q ss_pred hCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 372 CGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 372 ~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
- ..| ...+++...+++||.+||++||++|++..++..|||.+..
T Consensus 335 p----------------L~f-----------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 335 P----------------LEF-----------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred c----------------ccC-----------CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 1 111 1123578899999999999999999999999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=390.42 Aligned_cols=294 Identities=42% Similarity=0.751 Sum_probs=248.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC------
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT------ 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~------ 225 (714)
.+.|+.+.+||+|.||.||+|+...+|+.||+|++-.++.....-....+|+.+|..|.|+|++.++++|....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 46789999999999999999999999999999988776544444455679999999999999999999875432
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
...+||||.+|++++..++.....+|+..+++.++++++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 23489999999999999998888899999999999999999999999999999999999999999999999999997765
Q ss_pred CCCC---CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 306 PKDS---VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 306 ~~~~---~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
.... ...+.++.|+||++||.++|...|+++.|||..|||+.||++|.|.|.+.++..+++.|-.+||+...+.|..
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 4322 2356788999999999999999999999999999999999999999999999999999999999999999976
Q ss_pred h-hccc--CccccCCc-hhhhhhhhhccC--CcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 383 S-KLRH--STVFKPVQ-PYRRRIAETFKD--FPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 383 ~-~~~~--~~~~~~~~-p~~~~i~~~~~~--~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
. +++. +....|.. .-.+.+.+..+. -.+++.+||++||.+||.+|+++.++|+|.||-.+|.|
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 3 2221 11112111 111222222221 25689999999999999999999999999999988755
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=396.88 Aligned_cols=289 Identities=35% Similarity=0.634 Sum_probs=231.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.... .+|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 79 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLT 79 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--eEE
Confidence 457899999999999999999999999999999999754322 22345678999999999999999999887654 499
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 158 (303)
T cd07869 80 LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H 158 (303)
T ss_pred EEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence 999999998877766656679999999999999999999999999999999999999999999999999997653222 2
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC-hHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT-EVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~-~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..++...+.+....|.........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 23445789999999998876668999999999999999999999998754 45677888888888888777543211000
Q ss_pred cc-cCCchhhhhhhhhcc--CCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 390 VF-KPVQPYRRRIAETFK--DFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 390 ~~-~~~~p~~~~i~~~~~--~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.. .........+...+. .++..+.+||.+||++||.+|||+.++|+||||+..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 00 000000111111121 3567899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=411.38 Aligned_cols=255 Identities=33% Similarity=0.500 Sum_probs=228.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+........+.+.+|++|++.|+|||||.+++.|+.... +++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~--~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH--LWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce--EEEE
Confidence 67889999999999999999999999999999999887778889999999999999999999999999987655 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
.|||.|++ ..++..++.++|+.++.++.+++.||.|||+++|+|||+||.|||+...|.+|+||||+|+.+..+. ...
T Consensus 80 te~a~g~L-~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-~vl 157 (808)
T KOG0597|consen 80 TEYAVGDL-FTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-SVL 157 (808)
T ss_pred ehhhhhhH-HHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-eee
Confidence 99999955 4555666799999999999999999999999999999999999999999999999999999887543 346
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
++..|||.|||||++.+.+ |+..+|+||||||+|||++|+|||....-......|.+---.+
T Consensus 158 tsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----------------- 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----------------- 219 (808)
T ss_pred eeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-----------------
Confidence 6778999999999998766 8999999999999999999999999888777777775411110
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+..++..+.+||+.+|.+||.+|.|=.++|.|||.+.
T Consensus 220 ------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 220 ------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred ------------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 1257889999999999999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=388.47 Aligned_cols=282 Identities=38% Similarity=0.665 Sum_probs=226.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeccccc---cC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI-HDKIVALKKVRFDNQDPESVKFMAREIAILRKL---DHPNIIKLEGLITS---QT 225 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~-~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIVkl~~~~~~---~~ 225 (714)
.+|++++.||+|+||.||+|++.. ++..||+|+++...........+.+|+.+++.+ .||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999864 478999999986543333344566788877766 69999999998742 22
Q ss_pred CceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
...+++||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 335899999999876655433 2345899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..|+..++.+....|....
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 433 2234457899999999987765 7999999999999999999999999999999999999999988877765432
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
......+.... ...+....+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCC--CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 11111111111 112234446789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=396.86 Aligned_cols=290 Identities=33% Similarity=0.542 Sum_probs=231.8
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC---CceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT---SCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~---~~~l~ 230 (714)
+|++.+.||+|+||.||+|++..+|..||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 589999999999999999999999999999998754333344567889999999999999999999875432 13489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS- 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~- 309 (714)
+|||||++++...+ .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 lv~e~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVI-KANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHH-HhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 99999987665544 3445799999999999999999999999999999999999999999999999999986532221
Q ss_pred -CCcccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 -VPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 -~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+...++..+....|.++...+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 122345789999999988652 347899999999999999999999999999999999999999988877654422110
Q ss_pred Cccc-cC-CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 388 STVF-KP-VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 388 ~~~~-~~-~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
...+ .. .......+...++.+++.+.+||.+||+.||++|||+.++|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 00 000011223445678899999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=392.23 Aligned_cols=303 Identities=48% Similarity=0.810 Sum_probs=249.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||.|+||.||+|.+..+|+.||+|+++...........+.+|+.++++++|+||+++++++.......+|
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 35789999999999999999999999999999999986543333333456899999999999999999988765545689
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+.+++...+......+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 9999999876665554456799999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc-cCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR-HST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~-~~~ 389 (714)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|...... ...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 2233356889999999887666899999999999999999999999999999999999999999988877653221 111
Q ss_pred ccc-CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCCCCCCCCCCC
Q 005111 390 VFK-PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYP 455 (714)
Q Consensus 390 ~~~-~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~p~~~ 455 (714)
.+. +..++ ..+...+..+++.+.+||.+||+.||.+|||+.++|.||||...+.++.|..+|.+|
T Consensus 244 ~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 244 KFTLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred cccccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 111 11111 122334455789999999999999999999999999999999999999888888775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=411.82 Aligned_cols=262 Identities=26% Similarity=0.379 Sum_probs=229.6
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCC
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTS 226 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~ 226 (714)
+...++|.++++||+|+||+|++|..+.+++.||||+++++ ....+.++.+..|..|+.... ||+++.|+..|...+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34568999999999999999999999999999999999987 345567888899999999885 9999999998876655
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+|+||||+.||.+..+.. ...|++..++.|+..|+.||.|||++||||||||.+|||||.+|.+||+|||+++..-.
T Consensus 444 --l~fvmey~~Ggdm~~~~~-~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 --LFFVMEYVAGGDLMHHIH-TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred --EEEEEEecCCCcEEEEEe-cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999999998555544 45899999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
....+.+.||||.|||||+|.+.. |+.++|+|||||+|||||.|.+||+|+++.+....|+..--.
T Consensus 521 -~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~------------ 586 (694)
T KOG0694|consen 521 -QGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVR------------ 586 (694)
T ss_pred -CCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC------------
Confidence 233567789999999999999877 899999999999999999999999999999999998642110
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQPL 444 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~~ 444 (714)
.+..++.++.++|++||.++|++|.. ++++..||||....|
T Consensus 587 -----------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 587 -----------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred -----------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 11357999999999999999999975 588999999998765
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=413.83 Aligned_cols=282 Identities=32% Similarity=0.529 Sum_probs=228.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc------C
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ------T 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~------~ 225 (714)
...|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 467999999999999999999999999999999886432 2245799999999999999998876332 2
Q ss_pred CceEEEEEeeccccccccc---cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcc
Q 005111 226 SCSLYLVFEYMEHDLVGLA---SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLA 301 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~---~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla 301 (714)
...+++||||+++++...+ ......+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 2347899999998765433 23456799999999999999999999999999999999999999665 7999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
+.+.... .....+||+.|+|||++.+...|+.++|||||||+||||++|.+||.+.+..+++.++.+.+|.|..+.+.
T Consensus 219 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 8765332 23345789999999998877668999999999999999999999999999999999999999999887665
Q ss_pred hhhcccC-ccccCCchhhhhhhhh-ccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 382 KSKLRHS-TVFKPVQPYRRRIAET-FKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 382 ~~~~~~~-~~~~~~~p~~~~i~~~-~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
....... ..+....+ ..+... ....|.++.+||.+||.+||.+|||+.++|+||||....
T Consensus 297 ~~~~~~~~~~~~~~~~--~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 297 EMNPNYADIKFPDVKP--KDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HhchhhhcccCCccCc--hhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 4221111 01111111 111112 235788999999999999999999999999999998754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=404.17 Aligned_cols=289 Identities=33% Similarity=0.500 Sum_probs=236.6
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC---ceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---CSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---~~l~ 230 (714)
+|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++|+||+++++++..... ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4789999999999999999999999999999987554444556778899999999999999999998865441 2489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 lv~e~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 999999987665544 3457999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc---c
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR---H 387 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~---~ 387 (714)
.....++|+.|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|...+|.++.+.+...... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 4455678999999999988766899999999999999999999999999999999999999999887655332100 0
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
........+....+.......+.++.+||.+||+.||.+|||+.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000011111112223345688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=391.02 Aligned_cols=289 Identities=35% Similarity=0.678 Sum_probs=237.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|.++++||+|+||.||+|++..+++.||+|.++..... .....+.+|+.+++.++||||+++++++..... +|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~ 80 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS--LT 80 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe--EE
Confidence 347899999999999999999999999999999999765322 223456789999999999999999999876554 89
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||++++++..+...+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 9999999887776655556789999999999999999999999999999999999999999999999999976543222
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..+|.+..+.|..........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 22334679999999998876668999999999999999999999999999999999999999999998886532211100
Q ss_pred ccCCchh-hhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 391 FKPVQPY-RRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~-~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......+ ........+.++.++.+||.+||..||.+|||+.++|+||||+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000000 0111233456889999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=393.10 Aligned_cols=277 Identities=27% Similarity=0.363 Sum_probs=236.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||.|.-|+||+|+...++..+|+|++..... ......+...|-+||..++||.++.||..|+.... +|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~--~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY--SC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce--eE
Confidence 4679999999999999999999999999999999977633 24556677889999999999999999999976554 99
Q ss_pred EEEeecccccccccc--CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC--
Q 005111 231 LVFEYMEHDLVGLAS--LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-- 306 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~--~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~-- 306 (714)
||||||.|+.|..+. +++..|++..++.|+.+|+.||+|||-.|||+|||||+||||.++|+|.|+||.|+.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999998887554 3567799999999999999999999999999999999999999999999999999843210
Q ss_pred ---------------------------------C--------------------CCCCcccccccccccCcccccCCCCC
Q 005111 307 ---------------------------------K--------------------DSVPMTSRVVTLWYRPPELLLGASHY 333 (714)
Q Consensus 307 ---------------------------------~--------------------~~~~~~~~~gT~~Y~APE~l~g~~~y 333 (714)
. ......+++||-.|+|||++.|.++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH- 312 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH- 312 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC-
Confidence 0 0012345789999999999999985
Q ss_pred CccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHH
Q 005111 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSAL 413 (714)
Q Consensus 334 ~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~ 413 (714)
+.++|+|+||++|||||.|..||.|.+..+++.+|+..--.++. .+.++..++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~---------------------------~~~vs~~ak 365 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE---------------------------EPEVSSAAK 365 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC---------------------------CCcchhHHH
Confidence 99999999999999999999999999999999998642111111 125678999
Q ss_pred HHHHHhcccCcCCCCC----HHHHHcCcCCCCCCCCCCCCCCCCCCCCh
Q 005111 414 RLMETLMSIDPAHRGT----ATLALNSEFFTTQPLACNPSNLPKYPPSK 458 (714)
Q Consensus 414 ~LI~~mL~~DP~kRpT----a~e~L~Hp~f~~~~~~~~~~~~p~~~p~~ 458 (714)
|||+++|.+||.+|.. |+|+-+||||....|+......|.+.|..
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~ 414 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKP 414 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCc
Confidence 9999999999999999 99999999999999988777777776643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=392.78 Aligned_cols=261 Identities=31% Similarity=0.452 Sum_probs=214.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|...+.||+|+||.||++.+..+|..+|||.+...... ..+.+.+|+.+|.+|+|||||+++|.........++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 4578889999999999999999999999999998775322 27779999999999999999999997444332358999
Q ss_pred EeeccccccccccCCCC-CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeecCcccccCC--CC
Q 005111 233 FEYMEHDLVGLASLPGM-KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADFGLASFFDP--KD 308 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~-~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla~~~~~--~~ 308 (714)
|||+.++.+..++...+ .|++..++.+++||+.||.|||++|||||||||+||||+. ++.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999998887776554 8999999999999999999999999999999999999999 79999999999988763 22
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC-ChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK-TEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........||+.|||||++......+.++|||||||++.||+||.+||..- ...+.+-.|....
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------------- 239 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------------- 239 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------------
Confidence 223446789999999999985322345999999999999999999999873 3333333332100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
. ....+..+|.++.+||.+||..||.+||||+++|.|||.+..
T Consensus 240 ---~---------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 240 ---S---------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ---C---------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0 012334689999999999999999999999999999999864
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.95 Aligned_cols=281 Identities=37% Similarity=0.670 Sum_probs=226.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeeecccccc---CCc
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL---DHPNIIKLEGLITSQ---TSC 227 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIVkl~~~~~~~---~~~ 227 (714)
+|++++.||+|+||.||+|++..+++.||+|.++...........+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48999999999999999999999999999999876532222233455677777665 799999999987542 223
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+++||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 4899999999876654433 234589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.. ......+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+....+.+.+++...+.+....|......
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 QM--ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cc--cCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 22 223457799999999998765 899999999999999999999999999999999999999998887777532111
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
....+.+. ....+....+.++..+.+||.+||++||++|||+.++|.||||
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPR--GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCC--CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 11111111 1122344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=400.32 Aligned_cols=262 Identities=34% Similarity=0.508 Sum_probs=230.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~ 228 (714)
....|++.+.||.|.||.||+|+++.+|+.+|+|++..... .......+.+|+.||+++. |||||.++++|.....
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~-- 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS-- 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe--
Confidence 45679999999999999999999999999999999987633 2335678899999999998 9999999999987765
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC----CcEEEeecCccccc
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN----GILKIADFGLASFF 304 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~----g~vKL~DFGla~~~ 304 (714)
+|||||+|.|+.|.+.+... .+++..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999987776655544 49999999999999999999999999999999999999643 57999999999988
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.. .......+||+.|+|||++.+.. |+..+||||+||++|.|++|.+||.+.+......+|...-..+..++|
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w---- 262 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPW---- 262 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCc----
Confidence 65 44567789999999999998765 899999999999999999999999999999888888765444444444
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..++..+.+||..||..||.+|+||.++|+|||++...
T Consensus 263 ---------------------~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 263 ---------------------DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred ---------------------cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 57899999999999999999999999999999998754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=403.59 Aligned_cols=256 Identities=28% Similarity=0.517 Sum_probs=225.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
..|....+||+|+.|.||.|+...+++.||||.+...... ..+-+.+|+.+|+.++|+|||.+++.|...+. +|+|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de--LWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDE--LWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccce--eEEE
Confidence 5689999999999999999999999999999999876443 34558899999999999999999998887755 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||||+|+.|.++.... .++|.++..+++++|.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 9999999988777554 699999999999999999999999999999999999999999999999999999876654 34
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
.+.+|||.|||||++.... |++++||||||+++.||+-|+|||-.++....+..|.. .|.|.-.
T Consensus 427 ~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk-------------- 490 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK-------------- 490 (550)
T ss_pred ccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC--------------
Confidence 5669999999999988766 89999999999999999999999998888777776643 3333211
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
....+++.+++||.+||+.|+.+|++|.|+|+||||..
T Consensus 491 -----------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 491 -----------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -----------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 12468999999999999999999999999999999964
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=394.73 Aligned_cols=284 Identities=32% Similarity=0.537 Sum_probs=230.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
.++|++++.||+|+||.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999999999999999997654455566778899999999999999999998765432 2
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 479999999998776543 35899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+++.+|.+..+++.......
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 2234457899999999998766 7999999999999999999999999999999999999999998877654321100
Q ss_pred ------CccccCCchhhh--------hhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 ------STVFKPVQPYRR--------RIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ------~~~~~~~~p~~~--------~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
...+. ...+.. .........+..+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 254 RNYVENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHhhCCCCC-CcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 00000 000000 0001112346789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=394.87 Aligned_cols=286 Identities=31% Similarity=0.529 Sum_probs=230.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC----Cc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----SC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----~~ 227 (714)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 57899999999999999999999999999999999765444555677889999999999999999998875432 13
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 479999999988766553 35889999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+.+++..+|.+..+++.......
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred --CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2234457899999999998765 8999999999999999999999999999999999999999998876654421110
Q ss_pred C------ccccCC-----ch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 S------TVFKPV-----QP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~------~~~~~~-----~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
. ..+... .+ ............+..+.+||.+||..||.+|||+.++|+||||....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 0 000000 00 00000111123456899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=384.62 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=218.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++.+.. .+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR--FLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC--eEEE
Confidence 47999999999999999999999999999999997542 22344567889999999999999999999877654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++.+..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+...
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999888777666678999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~--~---------------- 215 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK--L---------------- 215 (291)
T ss_pred cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--c----------------
Confidence 22357899999999988766 7999999999999999999999999988777666664310 0
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQP 443 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~ 443 (714)
.....++..+.+||.+||+.||.+|++ +.+++.||||+...
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 111346789999999999999999995 99999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=390.54 Aligned_cols=286 Identities=34% Similarity=0.578 Sum_probs=231.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC----Cc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----SC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----~~ 227 (714)
.+.|++++.||.|+||+||+|.+..+++.||||++..........+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 47899999999999999999999999999999998765433445566789999999999999999999875432 13
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|++||++.+++.. +.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~~~~~~~~~~l~~-~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLMGADLNN-IVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecCCCCHHH-HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 479999999665543 332 346999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|.+..+.+.......
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 3355789999999999876668999999999999999999999999999999999999998888776654321111
Q ss_pred CccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+....+ ....+...+...++.+.+||.+||..||.+|||+.++|.||||....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 110000000 01122334456778899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=389.65 Aligned_cols=264 Identities=27% Similarity=0.408 Sum_probs=221.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|..++||||+++++++.... .+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~--~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE--YLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC--EEEE
Confidence 479999999999999999999999999999999975421 2334567889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999999988887777667899999999999999999999999999999999999999999999999999987643 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+........
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 218 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------------- 218 (333)
T ss_pred cCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------------
Confidence 34457899999999998775 89999999999999999999999999887777666543211100
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.+. .......++.++.+||.+||..+|.+|||+.+++.||||....+
T Consensus 219 ~~~------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 219 RPV------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred CCC------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 000 00001357889999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=378.10 Aligned_cols=283 Identities=40% Similarity=0.699 Sum_probs=232.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|++++.||.|+||.||+|++..+|+.||+|.++...........+.+|+.++++++||||+++++++..... +|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~--~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK--LTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc--eEEEE
Confidence 4899999999999999999999999999999997654433444567789999999999999999999876554 99999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
||++++++..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+..... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-CcC
Confidence 9999887776655556799999999999999999999999999999999999999999999999999987643322 223
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCC-CCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV-LPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~p-F~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
...+++.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+++.++.+....|............
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 346789999999988766679999999999999999998755 6777888889999999999888777543211111111
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
+..+.........+.++..+.+||.+||..||.+|||++++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11111122234445788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=402.06 Aligned_cols=282 Identities=24% Similarity=0.358 Sum_probs=220.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|++++.||+|+||.||+|.+..+++.||||... ...+.+|+.+|++|+|||||++++++..... .+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--~~ 159 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKF--TC 159 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCe--eE
Confidence 3467999999999999999999999999999999753 2346789999999999999999999876544 89
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+.++++..+. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|.........
T Consensus 160 lv~e~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 160 LILPRYKTDLYCYLA-AKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEEecCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 999999877665443 3457899999999999999999999999999999999999999999999999999764333333
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC-------ChHHHHHHHHHhhCCCChhHHhhh
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK-------TEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~-------~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+. ....++..++...|.++.+++...
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 334568999999999998765 899999999999999999999776543 234677888888887765442110
Q ss_pred hcccCccc------cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 384 KLRHSTVF------KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 384 ~~~~~~~~------~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.......+ ....+...........+|.++.+||.+||++||.+||||.|+|+||||...+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~ 384 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPD 384 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCC
Confidence 00000000 00000000011112346788999999999999999999999999999987653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=390.43 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=219.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++..... +
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR--V 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE--E
Confidence 3578999999999999999999999999999999997542 223455678899999999999999999998876554 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 9999999998877776666789999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
...+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+... .+
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~-------------- 232 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RL-------------- 232 (329)
T ss_pred ---ceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--Cc--------------
Confidence 2457899999999998766 799999999999999999999999988877666665321 00
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~ 442 (714)
.....++..+.+||.+||+.||.+|++ ++++|.||||...
T Consensus 233 -------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 233 -------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred -------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 011236788999999999999999997 7999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=385.91 Aligned_cols=273 Identities=25% Similarity=0.400 Sum_probs=226.9
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
+....+|++...||.|..++||+|+.+.+++.||||++..+....+ ++.+.+|+..|+.++||||++++..|..+..
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-- 98 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-- 98 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecce--
Confidence 5567899999999999999999999999999999999998765544 8899999999999999999999999887665
Q ss_pred EEEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 229 LYLVFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+|+||.||.+|.+..++... ..|.|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+-.
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 99999999988776555421 2499999999999999999999999999999999999999999999999998876543
Q ss_pred CCCC---CcccccccccccCcccc-cCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 307 KDSV---PMTSRVVTLWYRPPELL-LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 307 ~~~~---~~~~~~gT~~Y~APE~l-~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
.... .....+||++|||||++ .....|++++||||||++..||++|..||..-.....+..- +-|.|+...
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t--Lqn~pp~~~--- 253 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT--LQNDPPTLL--- 253 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH--hcCCCCCcc---
Confidence 3211 11445899999999995 34445999999999999999999999999988777665443 344443211
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
....+ .+..+.++..+..+|..||++||.+||||+++|.|+||+...
T Consensus 254 ---------t~~~~-----~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 254 ---------TSGLD-----KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ---------cccCC-----hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 00011 123356788999999999999999999999999999998753
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=395.01 Aligned_cols=263 Identities=28% Similarity=0.426 Sum_probs=218.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|..++||||+++++++..... +||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~--~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY--LYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe--EEE
Confidence 47999999999999999999999999999999997542 233455678899999999999999999998876554 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC-
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV- 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~- 310 (714)
||||+.++.|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.+|.++|+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999998887777666678999999999999999999999999999999999999999999999999998765321110
Q ss_pred ------------------------------------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCC
Q 005111 311 ------------------------------------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKP 354 (714)
Q Consensus 311 ------------------------------------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~ 354 (714)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCC
Confidence 011346899999999987765 8999999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC---HH
Q 005111 355 VLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT---AT 431 (714)
Q Consensus 355 pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT---a~ 431 (714)
||.+.+..+.+..+....... .+ + ....+++.+.+||.+||. +|.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~--------------~~----~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETL--------------QF----P-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCcc--------------CC----C-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 999988777766664311000 00 0 001468899999999997 9999998 99
Q ss_pred HHHcCcCCCCCCC
Q 005111 432 LALNSEFFTTQPL 444 (714)
Q Consensus 432 e~L~Hp~f~~~~~ 444 (714)
++|.||||....+
T Consensus 292 ~ll~h~~~~~~~~ 304 (364)
T cd05599 292 EIKSHPFFKGVDW 304 (364)
T ss_pred HHhcCCCcCCCCH
Confidence 9999999987543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=388.64 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=213.0
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
+.||+|+||.||+|.+..+|+.||||+++... ........+.+|+.+|+.++||||+++++++.... .+||||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD--RLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC--EEEEEEeCCC
Confidence 36999999999999999999999999997542 23345567789999999999999999999887655 4999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccc
Q 005111 238 HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317 (714)
Q Consensus 238 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 317 (714)
++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 9888777766778999999999999999999999999999999999999999999999999999754222 122344579
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchh
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPY 397 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~ 397 (714)
|+.|+|||++.+.. |+.++|||||||++|||++|..||.+.+.......+....
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~------------------------- 211 (323)
T cd05571 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------------------- 211 (323)
T ss_pred CccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 99999999998765 8999999999999999999999998877665555543210
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 398 RRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 398 ~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
......++.++.+||.+||+.||++|| ++.++|+||||....
T Consensus 212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 212 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 011235788999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=372.42 Aligned_cols=262 Identities=29% Similarity=0.435 Sum_probs=230.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC------CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN------QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~------~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
+.|+--+.||.|..+.|.++.++.+|..+|+|++.... ...+..+...+|+.||+++ .||+|++|.++|....
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 55777788999999999999999999999999997542 1123345567899999999 6999999999997654
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
- +++|||+|..|.|.+++.....++|...+.||+||+.|+.|||.++||||||||+|||++++.++||+|||+|..+.
T Consensus 97 F--~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 F--VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred h--hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 4 89999999999999999888899999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCcccccccccccCcccccC-----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLG-----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g-----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
+.. .+...||||.|+|||.+.+ .+.|+..+|+|++|+|||-||.|.|||......-.+..|+..-..+..+.|
T Consensus 175 ~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 175 PGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred Cch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence 654 4667899999999999853 445889999999999999999999999998888888888876655555555
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+++...++||.+||++||.+|+|++|+|.||||....
T Consensus 253 -------------------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 253 -------------------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred -------------------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 46899999999999999999999999999999996543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=376.04 Aligned_cols=283 Identities=39% Similarity=0.714 Sum_probs=230.3
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++++.||+|+||.||+|.+..++..||||+++...........+.+|+.+++.++||||+++++++..... +|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR--LYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe--EEEEE
Confidence 5899999999999999999999999999999997654444445677899999999999999999999876544 89999
Q ss_pred eeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||+.+++...... .+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ .
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-V 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-c
Confidence 9999766554432 235789999999999999999999999999999999999999999999999999986543321 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23346789999999987766678999999999999999999999999999999999998888888777754221110000
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.........+......++.++.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000001112233345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=394.37 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=217.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||+||+|.+..+++.||||+++... ........+.+|+.++..++|+||+++++.+.... .+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~--~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL--NLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC--eEEE
Confidence 47999999999999999999999999999999997542 23345567889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC--
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-- 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-- 309 (714)
|||||+++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999988877776667899999999999999999999999999999999999999999999999999976532110
Q ss_pred --------------------------------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCC
Q 005111 310 --------------------------------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP 357 (714)
Q Consensus 310 --------------------------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~ 357 (714)
......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0012457999999999998766 8999999999999999999999999
Q ss_pred CCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcC---CCCCHHHHH
Q 005111 358 GKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPA---HRGTATLAL 434 (714)
Q Consensus 358 g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~---kRpTa~e~L 434 (714)
+.+..+.+.+|....... .+.+ ...++..+.+||.+||. +|. .||++++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------------~~p~-----------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETL--------------IFPP-----------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCcc--------------cCCC-----------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 988887777775421110 0000 11368899999999876 455 458999999
Q ss_pred cCcCCCCCCC
Q 005111 435 NSEFFTTQPL 444 (714)
Q Consensus 435 ~Hp~f~~~~~ 444 (714)
+||||....+
T Consensus 292 ~hp~f~~~~~ 301 (363)
T cd05628 292 TNPFFEGVDW 301 (363)
T ss_pred CCCCCCCCCH
Confidence 9999997643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=384.89 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=231.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+|++.+.||+|+||.|-+|.+...|+.||||.|+.+. .+...+-++.|||+||..|+||||+.+|++|...+. ++
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK--Iv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK--IV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce--EE
Confidence 357999999999999999999999999999999999873 466778889999999999999999999999988776 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||||..++.|.+++...+.|++.+++.|++||..|+.|||.++++|||||.+|||+|.++++||+|||++..+.. ..
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KK 207 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc--cc
Confidence 9999999999999999899999999999999999999999999999999999999999999999999999998854 44
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.+.++||+|-|.+||++.|.++-++.+|.||||++||.|+.|..||.|.+-...+.+|-.....
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---------------- 271 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---------------- 271 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc----------------
Confidence 5778899999999999999997799999999999999999999999999988777777432110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
.+.-|.++.-||+.||-++|++|.|++++-.|=|..
T Consensus 272 --------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 --------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 134578899999999999999999999999998875
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=378.41 Aligned_cols=288 Identities=36% Similarity=0.675 Sum_probs=235.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||.|+||.||+|.+..+++.||+|.++..... .....+.+|+.+++.++||||+++++++..... +|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~--~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS--LT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCe--EE
Confidence 357899999999999999999999999999999998765322 223456789999999999999999999876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred EEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 9999999877766655556789999999999999999999999999999999999999999999999999976543222
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
......+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+...++.+....|..........
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 22334678999999998876668899999999999999999999999999999999999999999888886532111000
Q ss_pred -ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 391 -FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 391 -~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+....-....+......+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0000000111223335688999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=381.00 Aligned_cols=278 Identities=35% Similarity=0.643 Sum_probs=216.5
Q ss_pred EeEEeccCceEEEEEEEc--cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEee
Q 005111 158 LDKIGQGTYSSVYRARDV--IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~--~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
..+||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.+|+.++||||+++++++.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 357999999999999865 4678999999865432 2346789999999999999999998876656668999999
Q ss_pred ccccccccccC--------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE----cCCCcEEEeecCcccc
Q 005111 236 MEHDLVGLASL--------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASF 303 (714)
Q Consensus 236 ~~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl----~~~g~vKL~DFGla~~ 303 (714)
+++++...... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 99876554321 12358999999999999999999999999999999999999 4567899999999987
Q ss_pred cCCCCC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh---------HHHHHHHHHhh
Q 005111 304 FDPKDS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---------VEQLHRIFKLC 372 (714)
Q Consensus 304 ~~~~~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---------~e~l~~I~k~~ 372 (714)
+..... ......++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+... .+++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 643221 1233457899999999998876689999999999999999999999976442 46788899999
Q ss_pred CCCChhHHhhhhc-ccCcc-ccC-------CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 373 GSPSEDYWRKSKL-RHSTV-FKP-------VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 373 G~p~~~~w~~~~~-~~~~~-~~~-------~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
|.+....|..... +.... ... .......+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9998888865321 11000 000 0000001111112345679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=393.50 Aligned_cols=262 Identities=27% Similarity=0.391 Sum_probs=214.7
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++.... .+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~--~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--EEEEE
Confidence 6899999999999999999999999999999997642 23445677899999999999999999999987654 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC---
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS--- 309 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~--- 309 (714)
|||++++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999988777766667899999999999999999999999999999999999999999999999999864321000
Q ss_pred -------------------------------------------CCcccccccccccCcccccCCCCCCccccccchhHHH
Q 005111 310 -------------------------------------------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCIL 346 (714)
Q Consensus 310 -------------------------------------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iL 346 (714)
......+||+.|+|||++.+.. |+.++||||||||+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHH
Confidence 0012357999999999998765 79999999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhccc--Cc
Q 005111 347 GELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSI--DP 424 (714)
Q Consensus 347 yeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~--DP 424 (714)
|||++|.+||...+..+...++........ + .....+++++.+||.+||.. +|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------~-----------~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH--------------I-----------PPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHccccccC--------------C-----------CCCCCCCHHHHHHHHHHccCcccc
Confidence 999999999998877666655542111000 0 01124788999999997654 55
Q ss_pred CCCCCHHHHHcCcCCCCCC
Q 005111 425 AHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 425 ~kRpTa~e~L~Hp~f~~~~ 443 (714)
..|+|+.++|.||||+...
T Consensus 294 ~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 294 LGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred cCCCCHHHHhcCcccCCCC
Confidence 5599999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=389.47 Aligned_cols=263 Identities=31% Similarity=0.457 Sum_probs=220.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|..++||||+++++++.... .+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE--HLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC--eEEE
Confidence 479999999999999999999999999999999975422 2245567889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC---
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD--- 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~--- 308 (714)
||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999988777666666789999999999999999999999999999999999999999999999999998765433
Q ss_pred -------------------------CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH
Q 005111 309 -------------------------SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE 363 (714)
Q Consensus 309 -------------------------~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e 363 (714)
.......+||+.|+|||++.+.. ++.++||||||||||+|++|..||.+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 11233457899999999998775 8999999999999999999999999988777
Q ss_pred HHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-HHHHHcCcCCCCC
Q 005111 364 QLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-ATLALNSEFFTTQ 442 (714)
Q Consensus 364 ~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-a~e~L~Hp~f~~~ 442 (714)
...++........ + .....+++.+.+||..||. ||.+|++ +.++|+||||...
T Consensus 238 ~~~~i~~~~~~~~--------------~-----------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESLR--------------F-----------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCccc--------------C-----------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 7666644111000 0 0012368999999999997 9999999 9999999999875
Q ss_pred CC
Q 005111 443 PL 444 (714)
Q Consensus 443 ~~ 444 (714)
.+
T Consensus 292 ~~ 293 (350)
T cd05573 292 DW 293 (350)
T ss_pred CH
Confidence 44
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=388.18 Aligned_cols=285 Identities=32% Similarity=0.551 Sum_probs=230.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++..... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 478999999999999999999999999999999997655555566778899999999999999999998754322 3
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 479999999988766543 35899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..++..++.+..++|....-..
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 2234457899999999998765 8999999999999999999999999999999999999999988777654421100
Q ss_pred C------cccc-----CCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 S------TVFK-----PVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~------~~~~-----~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
. ..+. ...+ ............+..+.+||.+||..||++|||+.|+|+||||...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 0000 0000 0000011122346788999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=376.65 Aligned_cols=260 Identities=23% Similarity=0.359 Sum_probs=213.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+|..++|+||+++++++..... +++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~--~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA--LCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe--EEEE
Confidence 48899999999999999999999999999999875432 22334567789999999999999999998876554 9999
Q ss_pred EeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+.++.+..... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999887754432 33468999999999999999999999999999999999999999999999999998764322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.........+...+....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 233457899999999998765 89999999999999999999999988765433333322111110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||+.||.+||| ++++++||||....
T Consensus 222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 1122457889999999999999999997 99999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=393.38 Aligned_cols=262 Identities=28% Similarity=0.405 Sum_probs=216.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|+++++||+|+||.||+|++..+++.||||++.... ........+.+|+.+|++++|||||++++++.... .+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~--~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD--NLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--EEEEE
Confidence 6899999999999999999999999999999987542 23345677889999999999999999999987654 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC----
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD---- 308 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~---- 308 (714)
||||+++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999988777666656679999999999999999999999999999999999999999999999999975331100
Q ss_pred ------------------------------------------CCCcccccccccccCcccccCCCCCCccccccchhHHH
Q 005111 309 ------------------------------------------SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCIL 346 (714)
Q Consensus 309 ------------------------------------------~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iL 346 (714)
.......+||+.|+|||++.+.. |+.++|||||||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHH
Confidence 00012347899999999998766 89999999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC
Q 005111 347 GELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH 426 (714)
Q Consensus 347 yeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k 426 (714)
|||++|.+||.+.+..+...++........ + .....+++++.+||.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------------~-----------p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLH--------------I-----------PPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcC--------------C-----------CCcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999999887776666643111100 0 011357889999999986 59999
Q ss_pred CCC---HHHHHcCcCCCCCCC
Q 005111 427 RGT---ATLALNSEFFTTQPL 444 (714)
Q Consensus 427 RpT---a~e~L~Hp~f~~~~~ 444 (714)
|++ +.++++||||....+
T Consensus 293 R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred cCCCCCHHHHhcCCCcCCcCh
Confidence 997 999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=393.10 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=215.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+|+.++|||||++++++.... .+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~--~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ--YLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--eeEE
Confidence 47999999999999999999999999999999987542 23345677889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC-
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV- 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~- 310 (714)
||||++++.|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999998887777666678999999999999999999999999999999999999999999999999999643211000
Q ss_pred ---------------------------------------------CcccccccccccCcccccCCCCCCccccccchhHH
Q 005111 311 ---------------------------------------------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCI 345 (714)
Q Consensus 311 ---------------------------------------------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~i 345 (714)
.....+||+.|+|||++.+.. |+.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchh
Confidence 001247899999999998765 8999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcC
Q 005111 346 LGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPA 425 (714)
Q Consensus 346 LyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~ 425 (714)
+|||++|.+||.+.+..+.+..|....... .+ + ....++..+.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------~~----p-------~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETL--------------YF----P-------DDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCcc--------------CC----C-------CCCCCCHHHHHHHHHHhc-CHh
Confidence 999999999999888777776664311000 00 0 012468899999999997 777
Q ss_pred CC---CCHHHHHcCcCCCCCC
Q 005111 426 HR---GTATLALNSEFFTTQP 443 (714)
Q Consensus 426 kR---pTa~e~L~Hp~f~~~~ 443 (714)
+| +|+.++|.||||....
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCCC
Confidence 75 5999999999998643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=386.40 Aligned_cols=264 Identities=26% Similarity=0.367 Sum_probs=219.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++.+.||+|+||.||+|++..+|+.||||+++.... ..+..+.+.+|+.+++.++|+||+++++++.... .+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~--~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD--NLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--eEEE
Confidence 479999999999999999999999999999999986532 3345677889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999987776665443 67999999999999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccccccCcccccC-----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 311 PMTSRVVTLWYRPPELLLG-----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g-----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.....+||+.|+|||++.+ ...++.++||||||||+|+|++|..||...+....+.++.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---------- 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL---------- 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc----------
Confidence 2334478999999999863 3347899999999999999999999999888877777665421100
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.+ .....++..+.+||..||. ||.+|||+.+++.||||....+
T Consensus 229 ----~~-----------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~ 271 (330)
T cd05601 229 ----KF-----------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW 271 (330)
T ss_pred ----CC-----------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence 00 0112478899999999998 9999999999999999987544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=393.15 Aligned_cols=262 Identities=27% Similarity=0.382 Sum_probs=215.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++|+||+++++++.... .+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~--~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD--NLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC--EEEE
Confidence 47999999999999999999999999999999986432 12234567889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC---
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD--- 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~--- 308 (714)
|||||+++.|..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+....
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999998887777666789999999999999999999999999999999999999999999999999985331100
Q ss_pred ---------------------------------------CCCcccccccccccCcccccCCCCCCccccccchhHHHHHH
Q 005111 309 ---------------------------------------SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGEL 349 (714)
Q Consensus 309 ---------------------------------------~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeL 349 (714)
.......+||+.|+|||++.+.. ++.++||||||||+|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeeh
Confidence 00112357999999999998766 79999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-
Q 005111 350 FSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG- 428 (714)
Q Consensus 350 ltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp- 428 (714)
++|++||.+.+..+....+........ ......++..+.+||.+|+ .+|.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTLH-------------------------IPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCcccc-------------------------CCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999999887766665532110000 0011357889999999987 5999999
Q ss_pred --CHHHHHcCcCCCCCC
Q 005111 429 --TATLALNSEFFTTQP 443 (714)
Q Consensus 429 --Ta~e~L~Hp~f~~~~ 443 (714)
|+.++|+||||....
T Consensus 292 ~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 292 KNGADEIKAHPFFKGID 308 (376)
T ss_pred CCCHHHHhCCCCcCCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=387.19 Aligned_cols=258 Identities=26% Similarity=0.348 Sum_probs=219.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCC-eEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHD-KIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|++++.||+|+||.||+|.+..++ ..||+|++.... ......+.+.+|+.+|+.++||||+++++++.... .
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES--Y 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC--E
Confidence 3578999999999999999999876655 789999987542 23345667889999999999999999999987654 4
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 9999999999888777766778999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+....+..+.....
T Consensus 185 ---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------------- 245 (340)
T PTZ00426 185 ---TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------------- 245 (340)
T ss_pred ---cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------------
Confidence 23457899999999998765 79999999999999999999999999887766666643110
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
.....++..+.+||.+||+.||.+|+ |+.++++||||....+
T Consensus 246 --------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 246 --------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 01234688999999999999999995 8999999999987543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=399.39 Aligned_cols=283 Identities=22% Similarity=0.316 Sum_probs=220.1
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC------CCeeeeeccccc
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH------PNIIKLEGLITS 223 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H------pnIVkl~~~~~~ 223 (714)
...++|+++++||+|+||+||+|.+..+++.||||+++... .....+..|+.++..+.| .+|+.+++++..
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 34678999999999999999999999999999999996432 233445667777777654 458888888765
Q ss_pred cCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCC-----------
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNG----------- 291 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g----------- 291 (714)
.. ..+|||||++.+.++..+.. ...+++..++.|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 203 ~~-~~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 203 ET-GHMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred CC-ceEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 43 35899999998777665543 4579999999999999999999997 5999999999999998765
Q ss_pred -----cEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHH
Q 005111 292 -----ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366 (714)
Q Consensus 292 -----~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 366 (714)
.+||+|||++..... .....+||+.|+|||++.+.. |+.++|||||||+||||++|++||.+.+..+++.
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 499999998864321 234568899999999998876 8999999999999999999999999999999999
Q ss_pred HHHHhhCCCChhHHhhhhcccC-------ccccCCchhhhhhhh-----hcc--CCcHHHHHHHHHhcccCcCCCCCHHH
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHS-------TVFKPVQPYRRRIAE-----TFK--DFPTSALRLMETLMSIDPAHRGTATL 432 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~-------~~~~~~~p~~~~i~~-----~~~--~~p~~l~~LI~~mL~~DP~kRpTa~e 432 (714)
.|.+.+|.++..++........ ....+... ...+.. .+. .....+.+||.+||.+||.+|||++|
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTD-PKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCC-HHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 9999999988765433211100 00000000 000000 000 11456889999999999999999999
Q ss_pred HHcCcCCCCCC
Q 005111 433 ALNSEFFTTQP 443 (714)
Q Consensus 433 ~L~Hp~f~~~~ 443 (714)
+|+||||....
T Consensus 435 ~L~Hp~~~~~~ 445 (467)
T PTZ00284 435 MTTHPYVLKYY 445 (467)
T ss_pred HhcCccccccC
Confidence 99999998753
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=388.65 Aligned_cols=267 Identities=25% Similarity=0.369 Sum_probs=221.3
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
...++|++++.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+|+.++||||+++++++.... .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~--~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK--Y 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--E
Confidence 34578999999999999999999999999999999997532 22334556789999999999999999999887554 4
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||++++.|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999998877766543 468999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccccCcccccCCC---CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGAS---HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~---~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.......+||+.|+|||++.+.. .++.++|||||||++|||++|.+||.+.+....+.+|........
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 267 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT--------- 267 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---------
Confidence 33334557999999999986532 378999999999999999999999999888777777643211100
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC--CCCHHHHHcCcCCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH--RGTATLALNSEFFTTQPL 444 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k--RpTa~e~L~Hp~f~~~~~ 444 (714)
+ .....++..+.+||.+||..+|.+ |+|++++|+||||+...+
T Consensus 268 -----~-----------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~ 312 (370)
T cd05596 268 -----F-----------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW 312 (370)
T ss_pred -----C-----------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence 0 011247899999999999999988 999999999999997543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=367.32 Aligned_cols=285 Identities=37% Similarity=0.651 Sum_probs=234.4
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++.+.||.|+||.||+|.+..+|..||+|++............+.+|+.++++++||||+++++++.... .+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS--GFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC--eeEEEe
Confidence 589999999999999999999999999999999876544455677889999999999999999999887654 489999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
||+.+++...+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99944444444344467999999999999999999999999999999999999999999999999999877544332334
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc-cCcccc
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR-HSTVFK 392 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~-~~~~~~ 392 (714)
...++.+|+|||++.+...++.++|||||||++|+|++|.++|.+.+..+.+..+...++.+....|...... ......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 4578999999999877666789999999999999999999999999999999999999998888777542211 000000
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
........+.+.+++++..+.+||.+||..||.+|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 001111123445567889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=382.47 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=212.2
Q ss_pred CeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCc
Q 005111 154 TFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDN--QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~--~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~ 227 (714)
+|++++.||+|+||.||+|++. .+++.||+|++.... ......+.+.+|+.+|..+ +|+||+++++++.....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~- 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK- 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE-
Confidence 5899999999999999999864 478999999997532 2234456788999999999 59999999988865544
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|+||||+.++.+..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 80 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 80 -LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred -EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 8999999999887776666678999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........+||+.|+|||++.+...++.++||||||||+|+|++|..||...........+....-.
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------------- 225 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------------- 225 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-------------
Confidence 3333445679999999999987655789999999999999999999999754322111111110000
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
.. ......++..+.+||.+||..||++|| +++++|+||||+...
T Consensus 226 ---~~---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 226 ---CD---------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred ---CC---------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 00 011235788999999999999999999 889999999998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=378.75 Aligned_cols=249 Identities=30% Similarity=0.432 Sum_probs=211.3
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
||+|+||.||+|++..+++.||+|++.... ........+.+|+.+|.+++||||+++++++.... .+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE--KLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC--eEEEEEcCCCCC
Confidence 799999999999999999999999997542 23445667889999999999999999999887654 499999999998
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccc
Q 005111 240 LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL 319 (714)
Q Consensus 240 ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~ 319 (714)
.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 887777666789999999999999999999999999999999999999999999999999998643222 2233457899
Q ss_pred cccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhh
Q 005111 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRR 399 (714)
Q Consensus 320 ~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~ 399 (714)
.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 ~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------------------------- 209 (312)
T cd05585 158 EYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--------------------------- 209 (312)
T ss_pred ccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------------------------
Confidence 999999998765 7999999999999999999999999887766665553210
Q ss_pred hhhhhccCCcHHHHHHHHHhcccCcCCCC---CHHHHHcCcCCCCC
Q 005111 400 RIAETFKDFPTSALRLMETLMSIDPAHRG---TATLALNSEFFTTQ 442 (714)
Q Consensus 400 ~i~~~~~~~p~~l~~LI~~mL~~DP~kRp---Ta~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..||.+|| ++.++|.||||...
T Consensus 210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 011235788999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=381.63 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=212.2
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
+.||+|+||.||+|++..+|+.||+|++.... ........+.+|+.+|+.++||||+++++++..... +||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR--LCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE--EEEEEeCCC
Confidence 36999999999999999999999999997642 233456678899999999999999999998876554 999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccc
Q 005111 238 HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317 (714)
Q Consensus 238 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 317 (714)
++.+..++.....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 9888777666678999999999999999999999999999999999999999999999999998754322 122334578
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchh
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPY 397 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~ 397 (714)
|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~------------------------- 211 (328)
T cd05593 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED------------------------- 211 (328)
T ss_pred CcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-------------------------
Confidence 99999999998765 7999999999999999999999998877665555442100
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 398 RRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 398 ~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||..||.+|+ ++.++|+|+||....
T Consensus 212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 212 ----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred ----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 011235788999999999999999997 899999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=359.47 Aligned_cols=256 Identities=32% Similarity=0.447 Sum_probs=225.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++.+.||+|-||.||+|+.+.++-.||+|++.+... ......++.||++|...|+||||+++|++|.+... +
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r--i 97 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR--I 97 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce--e
Confidence 45889999999999999999999999999999999976532 23345678999999999999999999999987765 9
Q ss_pred EEEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 230 YLVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
||++||...+.+...+. ....|++..+..|+.|++.||.|||..+||||||||+|+|++.+|.+||+|||.+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999877665554 66789999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.....+.|||..|++||++.+.. ++..+|+|++|++.||++.|.+||...+..+++.+|.+.--..
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~------------ 241 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF------------ 241 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC------------
Confidence 22345669999999999999887 6999999999999999999999999999999999997632111
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
...++..+.|||.+||.++|.+|.+..|++.|||+..
T Consensus 242 -----------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 242 -----------------PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -----------------CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 1368999999999999999999999999999999864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=385.81 Aligned_cols=265 Identities=25% Similarity=0.356 Sum_probs=218.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|++..+++.||+|++... .........+.+|+.+++.++||||+++++++.... .+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK--YL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EE
Confidence 457899999999999999999999999999999998653 222334566789999999999999999999887654 49
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+|||||+++.|..++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999998877766644 3689999999999999999999999999999999999999999999999999987654333
Q ss_pred CCcccccccccccCcccccCCC---CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 310 VPMTSRVVTLWYRPPELLLGAS---HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~---~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
......+||+.|+|||++.+.. .++.++|||||||+||+|++|.+||.+.+....+.+|.........
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--------- 268 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--------- 268 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCC---------
Confidence 3334567999999999987542 3788999999999999999999999998887777777542211100
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC--CCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH--RGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k--RpTa~e~L~Hp~f~~~~ 443 (714)
.....++..+.+||..||..++.+ |+|+.++|+||||+...
T Consensus 269 ----------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 269 ----------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred ----------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence 001246889999999999865543 89999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=385.99 Aligned_cols=264 Identities=26% Similarity=0.385 Sum_probs=218.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|.+..+++.||||+++... ........+.+|+.+|..++||||+++++.+.... .+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~--~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR--NLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEE
Confidence 47999999999999999999999999999999997532 23345677889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC--
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-- 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-- 309 (714)
|||||+++.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.++|+|||++..+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999988877776667899999999999999999999999999999999999999999999999999875532110
Q ss_pred --------------------------------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCC
Q 005111 310 --------------------------------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP 357 (714)
Q Consensus 310 --------------------------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~ 357 (714)
......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCC
Confidence 0012357899999999998766 8999999999999999999999999
Q ss_pred CCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC---CHHHHH
Q 005111 358 GKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG---TATLAL 434 (714)
Q Consensus 358 g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp---Ta~e~L 434 (714)
+.+..+.+.++....... .+.+ ...++..+.+||.+|+ .||.+|+ ++.+++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------------~~p~-----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETL--------------VFPP-----------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCce--------------ecCC-----------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence 988877776664311000 0000 1136889999999987 5999998 489999
Q ss_pred cCcCCCCCCCC
Q 005111 435 NSEFFTTQPLA 445 (714)
Q Consensus 435 ~Hp~f~~~~~~ 445 (714)
+||||....+.
T Consensus 292 ~hp~f~~~~~~ 302 (360)
T cd05627 292 SHPFFEGVDWG 302 (360)
T ss_pred cCCCCCCCCHH
Confidence 99999986543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=379.57 Aligned_cols=252 Identities=27% Similarity=0.379 Sum_probs=212.6
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
+.||+|+||.||+|++..+|..||+|+++... ........+.+|+.+|+.++||||+++++++.... .+||||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD--RLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC--EEEEEEeCCC
Confidence 36999999999999999999999999997642 23345567788999999999999999999887654 4999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccc
Q 005111 238 HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317 (714)
Q Consensus 238 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 317 (714)
++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-CccccccC
Confidence 98887776666789999999999999999999999999999999999999999999999999987542221 22334578
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchh
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPY 397 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~ 397 (714)
|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (323)
T cd05595 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------------ 212 (323)
T ss_pred CcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 99999999998765 79999999999999999999999988877666655532100
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 398 RRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 398 ~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
.....+++.+.+||.+||..||.+|+ ++.++|+|+||....
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 01235788999999999999999998 999999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=366.41 Aligned_cols=283 Identities=40% Similarity=0.720 Sum_probs=229.4
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|++++.||.|+||.||+|++..+|..||||++............+.+|+.++++++||||+++++++..... +|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK--LYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc--EEEEe
Confidence 4899999999999999999999999999999987654444445678899999999999999999999876544 99999
Q ss_pred eeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 234 EYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 234 Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||+.+++...+.. ....+++..++.++.||+.||+|||+.|++|+||+|+|||++.++.+||+|||++..+..... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 9998765544332 345789999999999999999999999999999999999999999999999999986643322 22
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.++.+.+.+++...+.+....|............
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 33456889999999887665688999999999999999999999999999999999999998887766532110000000
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
........+....+.++..+.+||.+||..||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00000112233345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=376.92 Aligned_cols=256 Identities=27% Similarity=0.379 Sum_probs=215.5
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCC-CeeeeeccccccCCceEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHP-NIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~Hp-nIVkl~~~~~~~~~~~l~L 231 (714)
+|++++.||+|+||.||+|.+..+++.||||++.... ......+.+..|+.++..+.|+ +|+.+++++..... +|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~--~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR--LYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE--EEE
Confidence 5899999999999999999999999999999997642 2334566788899999999765 57888888766544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999998887776666789999999999999999999999999999999999999999999999999987542222 12
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (324)
T ss_pred eeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 33457899999999998766 79999999999999999999999999888777776643110
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH-----HHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA-----TLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa-----~e~L~Hp~f~~~ 442 (714)
.....++..+.+||.+||..||.+|+++ .++++||||...
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 219 -----------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 1113578899999999999999999986 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=376.71 Aligned_cols=266 Identities=24% Similarity=0.334 Sum_probs=216.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|++..+++.||+|++... .......+.+.+|+.++..++|+||+++++++.... .+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN--NLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC--eEEE
Confidence 4799999999999999999999999999999999753 223344566889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||+.++.|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999998777655543 557999999999999999999999999999999999999999999999999999776543332
Q ss_pred CcccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 311 PMTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.....+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF----------- 227 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-----------
Confidence 2333578999999999863 3447889999999999999999999999888777766664321100
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC--CCCHHHHHcCcCCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH--RGTATLALNSEFFTTQPL 444 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k--RpTa~e~L~Hp~f~~~~~ 444 (714)
.+......++..+.+||.+||+.++.. |+++.++|+||||....+
T Consensus 228 -------------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 228 -------------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred -------------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 001112347899999999999765544 789999999999987544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=380.17 Aligned_cols=259 Identities=27% Similarity=0.467 Sum_probs=232.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++-|.+.+.||+|-|+.|-+|++..||..||||+|.+..++.....++.+|+..|+.++|||||+||+++..+.. +||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK--lyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK--LYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce--EEE
Confidence 567999999999999999999999999999999999888887788889999999999999999999999987776 999
Q ss_pred EEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc-CCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLV-GLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~-~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+|+-+++.+ +.++.....+.|..++.|+.||+.|+.|||+..+|||||||+||.+- .-|-|||+|||++..+.+...
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 9999998555 45555556799999999999999999999999999999999998765 678999999999999876654
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
+++.||++.|.|||+|+|..+..+++||||||||||.|+||++||...++.+.+..|+..-.+
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--------------- 237 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--------------- 237 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc---------------
Confidence 667799999999999999996678999999999999999999999999999999999753221
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+..++.++++||..||..||.+|.|.+++..|+|++...
T Consensus 238 --------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 238 --------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred --------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 2246789999999999999999999999999999998653
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.80 Aligned_cols=288 Identities=44% Similarity=0.802 Sum_probs=235.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC------
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT------ 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~------ 225 (714)
.++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999999999999998765333223345678999999999999999998765433
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
...+|+||||+.++++..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23479999999998877766666689999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCC----------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCC
Q 005111 306 PKDSV----------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375 (714)
Q Consensus 306 ~~~~~----------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p 375 (714)
..... ..+...+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......++..++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 32211 12334678999999998776668899999999999999999999999999999999999999988
Q ss_pred ChhHHhhhhcccCcc-ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 376 SEDYWRKSKLRHSTV-FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 376 ~~~~w~~~~~~~~~~-~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
....|..+....... ..........+...+..++..+.+||.+||..||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 877665433211111 0111112233344556677899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=370.06 Aligned_cols=277 Identities=36% Similarity=0.649 Sum_probs=214.8
Q ss_pred eEEeccCceEEEEEEEcc--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVI--HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~--~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
.+||+|+||.||+|++.. ++..||+|.+..... ...+.+|+.+|+.++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999998654 568999999865432 23467899999999999999999988665556689999999
Q ss_pred cccccccccC--------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE----cCCCcEEEeecCccccc
Q 005111 237 EHDLVGLASL--------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASFF 304 (714)
Q Consensus 237 ~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl----~~~g~vKL~DFGla~~~ 304 (714)
+++++..+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 9876654321 22358999999999999999999999999999999999999 56679999999999876
Q ss_pred CCCCC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh---------HHHHHHHHHhhC
Q 005111 305 DPKDS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---------VEQLHRIFKLCG 373 (714)
Q Consensus 305 ~~~~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---------~e~l~~I~k~~G 373 (714)
..... ......++|+.|+|||++.+...++.++|||||||++|||++|.+||....+ ..++..++..+|
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43322 1233457899999999998766689999999999999999999999976432 466788899999
Q ss_pred CCChhHHhhhhcccCc-----ccc----CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 374 SPSEDYWRKSKLRHST-----VFK----PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 374 ~p~~~~w~~~~~~~~~-----~~~----~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.+..+.|......... .+. ................+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 9888888653211000 000 00000001111112346679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=361.68 Aligned_cols=281 Identities=35% Similarity=0.588 Sum_probs=227.5
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEEEE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
|++++.||+|+||.||+|.+..++..||+|+++......... ...+|+.++.++. |+||+++++++.......+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 788999999999999999999999999999987643333333 3457999999885 99999999998776435599999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
||++++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+|||++. +.+||+|||++..+.... ...
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcC
Confidence 99998887766655567999999999999999999999999999999999999999 999999999998764332 223
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|.+....+..........+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 34678999999987665557899999999999999999999999999999999999988888775533221111111111
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.......+......++..+.+||.+||.+||++|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111122333445679999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=365.69 Aligned_cols=288 Identities=39% Similarity=0.676 Sum_probs=233.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD---PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.|++.+.||+|+||.||+|.+..+++.||||.++..... ......+..|+.+++.++|+||+++++++.... .+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS--NIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC--EEE
Confidence 488999999999999999999999999999999865432 334456778999999999999999999987643 499
Q ss_pred EEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
+||||+ ++.+..++... ..+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........
T Consensus 79 lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 79 LVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred EEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999999 54444444433 3799999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.+..+.+.+++..++.+....|....... .
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 235 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP-D 235 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc-c
Confidence 22334568899999998766667899999999999999999999999999999999999888888877765421110 0
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLAC 446 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~ 446 (714)
...........+...+..++..+.+||.+||..||.+|||+.++|.|+||+..+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 011111111222344566789999999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=374.50 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=212.4
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHH---HhCCCCCeeeeeccccccCCceEE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAIL---RKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL---~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
|++++.||+|+||.||+|.+..+++.||||+++... ......+.+.+|+.++ +.++||||+++++++..... +|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~--~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH--VC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE--EE
Confidence 789999999999999999999999999999997542 2233455677776665 45689999999998876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+.++.+...... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-D 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC-C
Confidence 99999999887766544 479999999999999999999999999999999999999999999999999987543222 2
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~----------------- 218 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV----------------- 218 (324)
T ss_pred cccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 233457899999999998765 79999999999999999999999999887777766643110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
.....++..+.+||.+||..||.+|| ++.++++||||....
T Consensus 219 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 219 ------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 01135788999999999999999999 799999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=377.55 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=211.2
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.++..++||||+++++++..... +||||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~--~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR--LCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE--EEEEEeCCC
Confidence 36999999999999999999999999997642 223445667889999999999999999998876554 999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 238 HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 238 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
++.+..++.....+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 98887777666789999999999999999999997 79999999999999999999999999998754322 22233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....-
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05594 158 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------------- 213 (325)
T ss_pred CCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 899999999998765 79999999999999999999999988776655555422100
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
.....+++++.+||.+||+.||++|+ ++.++|+|+||....
T Consensus 214 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 214 ------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 01135788999999999999999997 999999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=376.52 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=212.0
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||||++.... ........+..|+.++..+ +||||+++++++..... +||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~--~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR--LFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE--EEEEEcCC
Confidence 36999999999999999999999999997542 2234456677899999877 79999999998876544 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
+++.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccccc
Confidence 998887766666789999999999999999999999999999999999999999999999999987643222 2233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..|.....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (320)
T cd05590 158 GTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------------------- 213 (320)
T ss_pred cCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 899999999988765 79999999999999999999999999888777776643110
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH------HHHHcCcCCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA------TLALNSEFFTTQP 443 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa------~e~L~Hp~f~~~~ 443 (714)
.....++.++.+||.+||+.||.+|+++ ++++.||||....
T Consensus 214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 0112468899999999999999999998 9999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.91 Aligned_cols=287 Identities=44% Similarity=0.744 Sum_probs=235.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.++++++||||+++++++.......+||
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46799999999999999999999999999999999865443334445678999999999999999999887664456999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999986655554444569999999999999999999999999999999999999999999999999998765432 22
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc-ccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL-RHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~-~~~~~ 390 (714)
.....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++..++.+....|..... +....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 23446789999999988766578999999999999999999999999999999999999999998888865322 11111
Q ss_pred ccCCchhhhhhhhhccC--CcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 391 FKPVQPYRRRIAETFKD--FPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~--~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
..........+...++. ++..+.+||.+||+.||++|||+.|+|.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111111222333444 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=385.00 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=223.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
...|..++.||+|+||.||+|.+..+++.||||++..+.. ...++.+.+|+.+|.+++++||.++|+.|..... +++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~g~~--Lwi 88 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK--LWI 88 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheeeccc--HHH
Confidence 3568888999999999999999999999999999988744 3456778999999999999999999999887666 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
+||||.|+.+...+..+..+.|..+..++++++.||.|||.++.+|||||+.||||..+|.+||+|||.+..+.......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999988888888788999999999999999999999999999999999999999999999999998876555444
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.+.+|||.|||||++.+.. |+.++||||||++.|||++|.||+....+...+..|-+ ..
T Consensus 169 -~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------------------~~ 227 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------------------SA 227 (467)
T ss_pred -ccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-------------------CC
Confidence 6779999999999999655 89999999999999999999999987765322222211 11
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.| . .-..+++.+++||..||.+||+.||+|.++|.|+|++..
T Consensus 228 PP------~---L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 228 PP------R---LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred CC------c---cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 11 0 112688999999999999999999999999999999873
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=360.82 Aligned_cols=285 Identities=53% Similarity=0.971 Sum_probs=239.1
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|++++.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+|++++++++.......+|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78999999999999999999999999999999876433445567889999999999999999999987663345999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccc
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 314 (714)
|+++++...+......+++..++.++.||+.||+|||+.|++|+||+|+|||+++++.++|+|||++.............
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99987766665554689999999999999999999999999999999999999999999999999998776544323344
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc-ccCccccC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL-RHSTVFKP 393 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~-~~~~~~~~ 393 (714)
..++..|+|||.+.+...++.++|||||||++|+|++|.+||...+....+..+...++.+....|..... .....+.+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 56788999999887766689999999999999999999999999999999999999999988877754321 12222233
Q ss_pred CchhhhhhhhhccCC-cHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 394 VQPYRRRIAETFKDF-PTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~-p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.......+.+.+..+ +..+.++|.+||..||.+|||+.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 333344445555565 9999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.90 Aligned_cols=283 Identities=33% Similarity=0.625 Sum_probs=227.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++|+||+++++++.... .+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR--KLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--EEEEE
Confidence 4699999999999999999999999999999998755333334456789999999999999999999887654 38999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++++..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999998887776666799999999999999999999999999999999999999999999999999987654332 22
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhH---HhhhhcccCc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY---WRKSKLRHST 389 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~---w~~~~~~~~~ 389 (714)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+...... |....+....
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 3346789999999988766688999999999999999999999999988888877776665543321 1110000000
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.... ......+...+..++..+.+||.+||..||++|||+.++|.||||
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPE-PETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCC-cccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 011111223455789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=373.96 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=212.3
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||||++.... ........+..|+.++..+ +||||+++++++..... +||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~--~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR--LFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe--EEEEEeCC
Confidence 36999999999999999999999999997642 2334556677899999876 79999999999876554 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
+++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .....+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccccc
Confidence 9988776666667899999999999999999999999999999999999999999999999999976432222 233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....-
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (321)
T cd05591 158 GTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV----------------------- 213 (321)
T ss_pred cCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 899999999988765 89999999999999999999999999988877777643110
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-------CHHHHHcCcCCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRG-------TATLALNSEFFTTQP 443 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-------Ta~e~L~Hp~f~~~~ 443 (714)
.....++.++.+||.+||+.||.+|+ ++.++++||||....
T Consensus 214 ------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 214 ------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 00123678999999999999999999 999999999997643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=372.71 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=215.7
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~L 231 (714)
+|++++.||+|+||.||+|++..+++.||||++.... ........+..|+.++..+ .|++|+++++++...+. +||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~--~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR--LYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE--EEE
Confidence 5899999999999999999999999999999998642 2233455677788888887 58999999998876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++.+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999988777666666689999999999999999999999999999999999999999999999999997543222 22
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..|.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred cccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 33457899999999998765 89999999999999999999999999888777776643110
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQP 443 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~ 443 (714)
.....++.++.+||.+||+.||.+|++ ..++++|+||....
T Consensus 219 -----------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 219 -----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred -----------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 011357889999999999999999998 48999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=364.82 Aligned_cols=290 Identities=48% Similarity=0.867 Sum_probs=237.9
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC----
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT---- 225 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~---- 225 (714)
...++|++.+.||+|+||.||+|.+..+|+.||+|+++...........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999999999999999999999865433334456778999999999999999999876543
Q ss_pred ----CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 226 ----SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 226 ----~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
...+||||||++++++..+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 2358999999999777666655557999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
..+............++..|+|||++.+...++.++|||||||++|+|++|++||...+..+.+..+.+.++.+....|.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP 243 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 87654433333334568889999988765557899999999999999999999999999999999999999988877665
Q ss_pred hhhc-ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 382 KSKL-RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 382 ~~~~-~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.... +..............+...+..+|..+.+||..||..||.+|||+.++|.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 3211 111111111222234445556789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=359.67 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=227.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|+.++.||+|+||.|.+|+.+.+++.||||+++++. ...+.+.+...|-++|....||.+..|...|...+. +
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr--l 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR--L 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce--E
Confidence 4588999999999999999999999999999999998773 345667788899999999999999988766665554 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
++||||..|+.|...+.....|++..++.|..+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++.- -...
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc-cccc
Confidence 999999999998888887788999999999999999999999999999999999999999999999999999753 2344
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
..+.+.||||.|+|||++.... |+.++|+|.+||++|||+||+.||...+....+..|+-.--
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~---------------- 385 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL---------------- 385 (516)
T ss_pred ceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc----------------
Confidence 4566789999999999998765 89999999999999999999999998887766666643110
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQPL 444 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~~ 444 (714)
..+..++++++.||..+|.+||.+|.. |.|+++|+||....|
T Consensus 386 -------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 386 -------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred -------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 112468999999999999999999964 899999999998765
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=373.41 Aligned_cols=280 Identities=23% Similarity=0.332 Sum_probs=217.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|++..++..||+|++.... .......+.+|+.+|+.++||||+++++++..... +|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--ISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE--EEE
Confidence 478999999999999999999999999999999997642 34556779999999999999999999998876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||++++.|..++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999988887776667799999999999999999999986 6999999999999999999999999999866432
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCCh----hHHhhh-hc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE----DYWRKS-KL 385 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~----~~w~~~-~~ 385 (714)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+ +.+.. ..+... ..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF----GRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----cccccccccCCccccCcc
Confidence 223457899999999998765 899999999999999999999999877654433222 21110 000000 00
Q ss_pred ccC---------ccccCCc---hhhhhhh-h-----hccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 386 RHS---------TVFKPVQ---PYRRRIA-E-----TFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 386 ~~~---------~~~~~~~---p~~~~i~-~-----~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
... ....+.. .....+. . ....++.++.+||.+||.+||++|||+.++|+||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 0000000 0000000 0 012367899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=379.65 Aligned_cols=265 Identities=26% Similarity=0.367 Sum_probs=217.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|++..+++.||+|++... .........+.+|+.+++.++||||+++++++.... .+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~--~~ 118 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR--YL 118 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC--EE
Confidence 457899999999999999999999999999999998653 222334556789999999999999999999887544 49
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||++++.|..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 999999998877766543 3689999999999999999999999999999999999999999999999999987654333
Q ss_pred CCcccccccccccCcccccCCC---CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 310 VPMTSRVVTLWYRPPELLLGAS---HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~---~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
......+||+.|+|||++.+.. .++.++|||||||++|+|++|.+||.+.+....+.+|........
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------- 267 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---------- 267 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 3334567999999999987532 378999999999999999999999999888777777653211100
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC--CCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH--RGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k--RpTa~e~L~Hp~f~~~~ 443 (714)
+ .....++..+.+||..||..++.+ |++++++++|+||....
T Consensus 268 ----~-----------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 268 ----F-----------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ----C-----------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 0 011357899999999999844433 78999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=376.50 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=208.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
...+|+++++||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++|+||+++++++..... +|
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~ 148 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE--IQ 148 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe--EE
Confidence 3467899999999999999999999999999999986542 34456778899999999999999999998876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+.++.+... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D 223 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence 99999999876533 245788899999999999999999999999999999999999999999999998764322 2
Q ss_pred CcccccccccccCcccccCC----CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 311 PMTSRVVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~----~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.....+||..|+|||++... ..++.++|||||||++|||++|+.||......+....+.......
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 292 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----------- 292 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-----------
Confidence 23345789999999987432 224578999999999999999999997433222111111100000
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.......++..+.+||.+||..||++|||+.|+|+||||....
T Consensus 293 --------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 --------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred --------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0011235788999999999999999999999999999998753
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=372.93 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=216.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|+++++||+|+||.||++++..+++.||+|++... .........+.+|+.++..++|+||+++++++..... +||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~--~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN--LYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE--EEE
Confidence 4799999999999999999999999999999998643 1223344567889999999999999999998876544 999
Q ss_pred EEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||+.++.|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999998777666543 467999999999999999999999999999999999999999999999999999765433332
Q ss_pred CcccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 311 PMTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||.+.+..+.+.++.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------- 227 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-----------
Confidence 3334578999999999863 3447899999999999999999999999988777777764311000
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC--CCCHHHHHcCcCCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH--RGTATLALNSEFFTTQPL 444 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k--RpTa~e~L~Hp~f~~~~~ 444 (714)
.+......++..+.+||.+||+.++.. |++++++++||||....+
T Consensus 228 -------------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 228 -------------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred -------------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 011112457899999999999765554 689999999999987543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=359.02 Aligned_cols=282 Identities=36% Similarity=0.707 Sum_probs=231.3
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++++.||.|++|.||+|.+..+|..||||+++..... .....+.+|+.++++++|+||+++++++..... +||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENK--LMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc--EEEEE
Confidence 589999999999999999999999999999999865332 234567789999999999999999999876654 89999
Q ss_pred eeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||+++++...+.... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........ .
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 999987665543322 4689999999999999999999999999999999999999999999999999986643322 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....++..|++||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++...+.+....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23346789999999987766578999999999999999999999999999999999999999998888865442111111
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.............++.++..+.++|.+||+.||.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 100001112233445678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=371.51 Aligned_cols=251 Identities=25% Similarity=0.391 Sum_probs=208.2
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||||+++... ......+.+..|..++..+ +||||+++++++.... .+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~--~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE--HLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 36999999999999999999999999997642 2223445566777777754 8999999999887654 499999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
+++.|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 998887776666789999999999999999999999999999999999999999999999999998653322 2234457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (316)
T cd05592 158 GTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP----------------------- 213 (316)
T ss_pred CCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 899999999998766 79999999999999999999999999887766665532100
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH-HHHHcCcCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA-TLALNSEFFTTQ 442 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa-~e~L~Hp~f~~~ 442 (714)
.....++.++.+||.+||..||.+||++ .++++||||...
T Consensus 214 ------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 214 ------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 0113468899999999999999999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=371.76 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=211.1
Q ss_pred EeEEeccCceEEEEEEEc---cCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 158 LDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++.||+|+||.||+|++. .+++.||||++.... ........+.+|+.+|+.++||||+++++++..... +|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~--~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK--LYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe--EEEE
Confidence 367999999999999864 478999999997532 122344567899999999999999999998876544 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 99999988877776667899999999999999999999999999999999999999999999999999875432222 22
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
...+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+....+..+....
T Consensus 158 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------------- 216 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------------- 216 (323)
T ss_pred cccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence 3457899999999998765 7899999999999999999999999888776666654310
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQ 442 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..||++|| ++.+++.||||...
T Consensus 217 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 217 ---------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 011235788999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=360.03 Aligned_cols=284 Identities=35% Similarity=0.664 Sum_probs=226.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++.+.||.|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.++|+||+++++++.... ..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKK--TLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCC--eEEE
Confidence 47899999999999999999999989999999998764322 12234568999999999999999999987654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-T 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-c
Confidence 999999876665554455789999999999999999999999999999999999999999999999999876532221 1
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC-hHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT-EVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~-~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+++..+....+.+..+.|..........
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2223568899999998876557899999999999999999999998776 667888888999998888776543211110
Q ss_pred c-cCCchhhhhhhhhccCCc--HHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 391 F-KPVQPYRRRIAETFKDFP--TSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 391 ~-~~~~p~~~~i~~~~~~~p--~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
. .........+...+..++ ..+.+||.+||+.||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000000111223333455 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=363.22 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=213.5
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|++.+.||+|+||+||++.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+..... +|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA--LCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe--EEEE
Confidence 48999999999999999999999999999999875422 22334557789999999999999999998876554 9999
Q ss_pred EeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+.++.+..+.. ....+++..+..++.||+.||.|||+.||+||||||+|||+++++.++|+|||++..+....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 99999877764432 23469999999999999999999999999999999999999999999999999998764222
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence 223457899999999998765 79999999999999999999999988765544433322111000
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
......++..+.+||.+||..||.+|| +++++++||||....+
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05605 222 -----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269 (285)
T ss_pred -----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence 011235788999999999999999999 9999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=362.53 Aligned_cols=289 Identities=43% Similarity=0.723 Sum_probs=228.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC-----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----- 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----- 225 (714)
..++|+++++||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 346799999999999999999999999999999998765333333345668999999999999999999875432
Q ss_pred -CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 226 -SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 226 -~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
....|+||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 2347999999998777766655567999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCC---CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 305 DPKDSV---PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 305 ~~~~~~---~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
...... ......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+...+|..+.+.|.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP 249 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 433221 12334678899999998776657899999999999999999999999999888888899999888777654
Q ss_pred hhhcccC-ccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 382 KSKLRHS-TVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 382 ~~~~~~~-~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
....... ............+.... ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 3211100 00000111111111111 1235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=371.97 Aligned_cols=285 Identities=31% Similarity=0.536 Sum_probs=229.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
.+.|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++|+||+++++++..... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 478999999999999999999999999999999987554445556677899999999999999999998764332 2
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+.+++...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 4799999999876665432 2899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.. .....+++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....+..+...+|.++.+++.......
T Consensus 172 ~~--~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 FM--MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CC--CCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 22 23446789999999998765 7999999999999999999999999999999999999999999877654422110
Q ss_pred CccccCC-----chhhhh---------hhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 STVFKPV-----QPYRRR---------IAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~~~~~~~-----~p~~~~---------i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
....... .++... ........+..+.+||.+||..||++|||+.++|.||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 0000000 000000 000112356789999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=359.73 Aligned_cols=284 Identities=33% Similarity=0.619 Sum_probs=229.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+|+.++||||+++++++.... .+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK--RLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--eEEEE
Confidence 4799999999999999999999989999999998765433345567889999999999999999999987554 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+.++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999998888776655679999999999999999999999999999999999999999999999999998764433 223
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc--Ccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH--STV 390 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~--~~~ 390 (714)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......-....... ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 345678999999998876657889999999999999999999999998888888888776655432111000000 000
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
..+...........++.++..+.+||.+||..||++|||+.++|+|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0011111122333456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=370.82 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=208.1
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHH-HHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIA-ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~-iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||+||+|++..+|+.||||++.... ........+..|.. +++.++||||+++++++.... .+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~--~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD--KLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC--EEEEEEcCC
Confidence 36999999999999999999999999997542 12223344555555 567899999999999887654 499999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 99888777766778999999999999999999999999999999999999999999999999998754222 12233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (323)
T cd05575 158 GTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------ 212 (323)
T ss_pred CChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 899999999998765 8999999999999999999999999887776666654310
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH----HHHHcCcCCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA----TLALNSEFFTTQP 443 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa----~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||+.||.+||++ .+++.||||....
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 213 -----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 01123578899999999999999999998 6999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=409.47 Aligned_cols=281 Identities=28% Similarity=0.385 Sum_probs=240.4
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
+....++|++++.||+|+||.|.+++++.+++.||+|++.+-. ........|..|-.||.--+.+.||.|+..|.+..
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~- 148 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER- 148 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc-
Confidence 3446789999999999999999999999999999999997632 22344567889999999999999999988776655
Q ss_pred ceEEEEEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 227 CSLYLVFEYMEHDLV-GLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
++|||||||+||.+ .++.... ++++..+++|+..|+.||..||+.|+|||||||+|||||..|+|||+|||.+..++
T Consensus 149 -~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 149 -YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred -ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 49999999997654 4444444 89999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCcccccccccccCccccc----CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLL----GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~----g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
..........+|||.|++||+|. +...|+..+|+|||||++||||.|..||..++-++++.+|+..-..
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~------- 299 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES------- 299 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh-------
Confidence 77777777889999999999984 2256899999999999999999999999999999999999764111
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC---HHHHHcCcCCCCCCCCCCCCCCCCCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT---ATLALNSEFFTTQPLACNPSNLPKYPPS 457 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT---a~e~L~Hp~f~~~~~~~~~~~~p~~~p~ 457 (714)
..|++ ..++|..+++||+++|+ +|+.|.. ++++..||||...+|..-....|+|.|.
T Consensus 300 -------l~FP~-----------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 300 -------LSFPD-----------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred -------cCCCc-----------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 11110 12589999999999986 7889988 9999999999999997777788888774
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=362.55 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=205.9
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
||+|+||+||+|.+..+++.||+|++..... .....+.+..|+.+|+.++|+||+++++++..... +|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~--~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD--LCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe--EEEEEeCCCCC
Confidence 7999999999999999999999999875422 22344667889999999999999999998876544 89999999988
Q ss_pred cccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccc
Q 005111 240 LVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315 (714)
Q Consensus 240 ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 315 (714)
.+...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+..... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 775443 2345799999999999999999999999999999999999999999999999999987644322 22345
Q ss_pred cccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCc
Q 005111 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395 (714)
Q Consensus 316 ~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~ 395 (714)
.||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+....-..
T Consensus 158 ~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------- 216 (280)
T cd05608 158 AGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-------------------- 216 (280)
T ss_pred CCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--------------------
Confidence 7899999999998765 7999999999999999999999998754322222221110000
Q ss_pred hhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 396 p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
.......++..+.+||.+||+.||++|| |++++++||||+...+
T Consensus 217 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~ 265 (280)
T cd05608 217 -----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW 265 (280)
T ss_pred -----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence 0011235788999999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=360.89 Aligned_cols=287 Identities=39% Similarity=0.743 Sum_probs=231.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||.|++|.||+|.+..+|+.||+|.+............+.+|+.++++++||||+++++++.... .+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK--RLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--eEEEE
Confidence 5799999999999999999999999999999998765444444567889999999999999999999987654 49999
Q ss_pred EeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+++++....... ...+++..++.++.||+.||+|||++||+|+||+|+|||++. ++.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 999988766554332 234688999999999999999999999999999999999985 5679999999997654321 1
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc-ccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL-RHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~-~~~~ 389 (714)
......+++.|+|||++.+...++.++|||||||++|+|++|.+||...+..+.+.+++...+.+....|..... +...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 223446789999999987765578999999999999999999999999999999999999999998888864211 1100
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+.. .........+.++..+.++|.+||+.||++||++.++|.||||...+
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 239 SAFPKW-PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhcccC-CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 000000 00112233456889999999999999999999999999999998754
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=369.85 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=207.8
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+|+.||+|+++.... .......+..|+.++..+ +||||+++++++.... .+||||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~--~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE--HLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC--EEEEEECCC
Confidence 469999999999999999999999999976421 123445667788888765 8999999999887654 499999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.+..++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-CceeccC
Confidence 998877666666789999999999999999999999999999999999999999999999999987532221 2234567
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~--------------------- 213 (316)
T cd05620 158 GTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--P--------------------- 213 (316)
T ss_pred CCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C---------------------
Confidence 899999999998765 8999999999999999999999999887766655553210 0
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH-HHHHcCcCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA-TLALNSEFFTTQ 442 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa-~e~L~Hp~f~~~ 442 (714)
.....++.++.+||.+||..||.+|+++ +++++||||...
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 214 ------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 0112367899999999999999999998 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=370.70 Aligned_cols=253 Identities=22% Similarity=0.378 Sum_probs=205.6
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||||+++... ........+.+|+.++..+ +||||+++++++..... +|||||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~--~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR--LFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE--EEEEEeCC
Confidence 36999999999999999999999999998652 2334566788999999998 79999999998876544 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
+++.|..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 99887766666678999999999999999999999999999999999999999999999999998753221 12233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh--------HHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE--------VEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~--------~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .+.+...+.
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~------------------ 218 (329)
T cd05588 158 GTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL------------------ 218 (329)
T ss_pred CCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH------------------
Confidence 899999999998765 79999999999999999999999963211 111111100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC------HHHHHcCcCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT------ATLALNSEFFTTQP 443 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT------a~e~L~Hp~f~~~~ 443 (714)
.........++..+.+||.+||..||.+|+| +.++++||||....
T Consensus 219 ----------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 219 ----------EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred ----------cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 0000112357889999999999999999987 79999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=370.23 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=216.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||++++..+++.||+|++... .........+.+|+.++..++|+||+++++++.... .+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~--~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN--YLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC--EEEE
Confidence 5799999999999999999999999999999998753 222334556788999999999999999999887654 4999
Q ss_pred EEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||+.|+.|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999998877766544 467999999999999999999999999999999999999999999999999999876543332
Q ss_pred CcccccccccccCcccccCC----CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 311 PMTSRVVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~----~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.....+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+..+.+.++......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF----------- 227 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-----------
Confidence 23345789999999998652 347889999999999999999999999888777666664311000
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC--CCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH--RGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k--RpTa~e~L~Hp~f~~~~ 443 (714)
.+.....+++..+.+||.+||+.++.+ |+++++++.|+||....
T Consensus 228 -------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 228 -------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred -------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 011122457899999999999976655 56999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=373.39 Aligned_cols=252 Identities=31% Similarity=0.414 Sum_probs=211.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeE-EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKI-VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~-VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
....+.+.||.|+||+||+|.. .|.. ||+|++.....+....+.|.+|+.+|.+|+|||||+++|++..... .+.|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEE
Confidence 3445556699999999999964 4666 9999998765555558899999999999999999999999987652 3899
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcC-eeeccCCCccEEEcCCC-cEEEeecCcccccCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHG-VLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPK 307 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~g-IiHrDLKP~NILl~~~g-~vKL~DFGla~~~~~~ 307 (714)
||||+++|+|..++.. ...|+...+..|+.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999877765 678999999999999999999999999 99999999999999998 9999999999876543
Q ss_pred CCCCcccccccccccCcccccC-CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLG-ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g-~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. ...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||.+.........+....-.|
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp----------- 265 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP----------- 265 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 2 33455689999999999985 2459999999999999999999999999998855554443211111
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......++.+..||..||..||.+||+..+++.
T Consensus 266 ----------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 ----------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 112347899999999999999999999999875
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.69 Aligned_cols=284 Identities=34% Similarity=0.644 Sum_probs=234.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||+|+||.||+|.+..+++.||+|+++.........+.+.+|+.+++.++|+||+++++++.... .+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG--RLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC--EEEEE
Confidence 4699999999999999999999999999999998765444555678899999999999999999999987644 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++++..+......+++.++..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999988887766666799999999999999999999999999999999999999999999999999988765543344
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc---
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST--- 389 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~--- 389 (714)
...+++.+|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.....++.........
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 45678999999999987745899999999999999999999999999888888888888887776554332111000
Q ss_pred cccCCchhhhhhhhhcc-CCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 390 VFKPVQPYRRRIAETFK-DFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~-~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.+.+.. ....+...++ .++..+.+||.+||..||++|||+.+++.||||
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPS-QPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCC-CcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000000 0011122222 358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=371.64 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=211.4
Q ss_pred eEEeccCceEEEEEEEc---cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEee
Q 005111 159 DKIGQGTYSSVYRARDV---IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
+.||+|+||.||++++. .+|+.||+|++............+.+|+.+|++++||||+++++++.... .+||||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG--KLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC--EEEEEEcC
Confidence 57999999999999864 57899999999765333334556778999999999999999999887654 49999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccc
Q 005111 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315 (714)
Q Consensus 236 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 315 (714)
+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceecc
Confidence 9988777666666679999999999999999999999999999999999999999999999999998654332 223345
Q ss_pred cccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCc
Q 005111 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395 (714)
Q Consensus 316 ~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~ 395 (714)
+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 159 ~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~---------------------- 215 (318)
T cd05582 159 CGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL---------------------- 215 (318)
T ss_pred cCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 7899999999988765 78999999999999999999999998887777666643110
Q ss_pred hhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCC
Q 005111 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQ 442 (714)
Q Consensus 396 p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~ 442 (714)
.....++..+.+||.+||+.||.+||| ..+++.|+||...
T Consensus 216 -------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 216 -------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 112357889999999999999999999 7889999999874
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=379.63 Aligned_cols=259 Identities=28% Similarity=0.465 Sum_probs=232.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++++++|+|+||.+++++++..++.|++|.+..........+...+|+.+++++.|||||.+.+.|..+ .+.++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 4689999999999999999999999999999999999877767777889999999999999999999988754 455999
Q ss_pred EEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||+||+|+++...+. .+..|++..+..|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+.+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999988876553 34679999999999999999999999999999999999999999999999999999987665
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+.+||+.|++||++.+.+ |+.++|||||||++|||++-+++|.+.+....+.+|+.....|-
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------------- 226 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------------- 226 (426)
T ss_pred hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------------
Confidence 2456679999999999998876 89999999999999999999999999999999999987654332
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
...++.++..||..||..+|..||+|.++|.+|.+..
T Consensus 227 ---------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 227 ---------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ---------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 2357889999999999999999999999999988764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.13 Aligned_cols=285 Identities=41% Similarity=0.744 Sum_probs=228.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCC---ce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTS---CS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~---~~ 228 (714)
+.|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+++.+. ||||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4699999999999999999999999999999998765433334456788999999995 6999999988754332 23
Q ss_pred EEEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeecCcccc
Q 005111 229 LYLVFEYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADFGLASF 303 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla~~ 303 (714)
+|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||+|+|||++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 7999999998766544322 346899999999999999999999999999999999999998 88999999999986
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
+..... ......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|...
T Consensus 161 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543222 2233466899999999877666799999999999999999999999999999999999998888887766432
Q ss_pred hcccC-ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 384 KLRHS-TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 384 ~~~~~-~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
..... ..+.... ...+....+.++..+.+||.+||..||.+|||+.++|.||||.
T Consensus 240 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWK--PQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCccc--chhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 11111 1111101 1122334457899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=369.09 Aligned_cols=292 Identities=34% Similarity=0.557 Sum_probs=235.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc--CCceE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ--TSCSL 229 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~--~~~~l 229 (714)
.+.|++.+.||.|+||.||+|.+..+|..||+|++............+.+|+.+|+.++||||+++++++... ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3689999999999999999999999999999999876543344567788899999999999999999887543 23458
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||+.+++...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~lv~e~~~~~l~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhhhhHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 999999987655544 3445699999999999999999999999999999999999999999999999999976643222
Q ss_pred C---CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 310 V---PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 310 ~---~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .....+++.+|+|||++.+...++.++|||||||++|+|++|++||.+.+...++..+....|.++...+......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 1234578999999999876555899999999999999999999999999999999999999999887765432111
Q ss_pred cCccccCCchh--hhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 387 HSTVFKPVQPY--RRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 387 ~~~~~~~~~p~--~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.........+. .......++.++.++.+||.+||+.||.+|||+.++|.||||...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~ 302 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence 00000000000 01122344667999999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=367.47 Aligned_cols=257 Identities=27% Similarity=0.391 Sum_probs=214.6
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~L 231 (714)
+|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+..|+.++..+. |++|+++++++..... +||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~--~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR--LYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE--EEE
Confidence 5889999999999999999999999999999997542 22334566778999998885 5777888888766544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++.|..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-T 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-c
Confidence 999999888877776667899999999999999999999999999999999999999999999999999876432221 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+....+..+.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred ccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 23456899999999988765 79999999999999999999999999887776666643110
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQP 443 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~ 443 (714)
.....++..+.+||.+||+.||.+|++ ..++++||||....
T Consensus 219 -----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 219 -----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred -----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 011356889999999999999999997 58999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.64 Aligned_cols=282 Identities=41% Similarity=0.758 Sum_probs=227.7
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|++++.||.|++|.||+|.+..+|..||+|++............+.+|+.+++.++||||+++++++.... ..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~--~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN--KLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC--eEEEEEe
Confidence 67889999999999999999999999999999866443344456788999999999999999999987654 4999999
Q ss_pred eccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 235 YMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 235 y~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
|+++.+...+.... ..+++..+..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++..+..... ...
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-ccC
Confidence 99865544433222 3689999999999999999999999999999999999999999999999999976543322 123
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
...++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+.++++..+.+....|.............
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 33568899999988776557899999999999999999999999999999999999999988887775432211000000
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
............+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0000112223356788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=368.71 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=211.4
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||+||+|.+..++..||||+++... ........+.+|+.++..+ +||||+++++++.... .+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~--~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD--RLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 36999999999999999999999999998642 2234456677899999888 7999999999887655 499999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.|.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 998887776666789999999999999999999999999999999999999999999999999987532222 2233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 158 g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (318)
T cd05570 158 GTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV----------------------- 213 (318)
T ss_pred cCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 899999999998766 79999999999999999999999998877666555532100
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH-----HHHHcCcCCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA-----TLALNSEFFTTQP 443 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa-----~e~L~Hp~f~~~~ 443 (714)
.....++..+.+||.+||..||.+|||+ .+++.||||....
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 0113478899999999999999999999 9999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=354.15 Aligned_cols=260 Identities=30% Similarity=0.462 Sum_probs=212.8
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|++++.||+|+||+||+|.+..+++.||+|++..............+|+.++++++||||+++++++..... +++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~--~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNY--LYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE--EEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccc--cccccc
Confidence 899999999999999999999999999999998765444444455679999999999999999999877544 899999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccc
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 314 (714)
|+.++.+..++.....+++..+..++.||+.||.+||++||+|+||||+|||++.++.++|+|||++..+. ........
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNP 157 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99997776555555689999999999999999999999999999999999999999999999999998642 22233445
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV 394 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~ 394 (714)
..++..|+|||++.....++.++|||||||++|+|++|..||......+....+.+.........+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 223 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-------------- 223 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--------------
Confidence 678999999999873344799999999999999999999999987544444444332211111000
Q ss_pred chhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 395 ~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
......+..+.+||..||+.||++|||+.++++||||
T Consensus 224 --------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 --------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001234799999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=368.33 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=205.5
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.++.++ +||||+++++++..... +||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~--~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR--LFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE--EEEEEeCC
Confidence 36999999999999999999999999998652 2344566788899999877 89999999998876544 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccccccc
Confidence 998887766666789999999999999999999999999999999999999999999999999997543222 2233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh--------HHHH-HHHHHhhCCCChhHHhhhhccc
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE--------VEQL-HRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~--------~e~l-~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .+.+ ..+..
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~----------------- 219 (329)
T cd05618 158 GTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----------------- 219 (329)
T ss_pred CCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc-----------------
Confidence 899999999998765 79999999999999999999999953110 1111 11110
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC------HHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT------ATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT------a~e~L~Hp~f~~~~ 443 (714)
.....+..++..+.+||.+||..||.+|+| +.++++||||....
T Consensus 220 ------------~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 220 ------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred ------------CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 000122457889999999999999999998 58999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=372.08 Aligned_cols=274 Identities=22% Similarity=0.320 Sum_probs=211.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
..|++++.||+|+||.||+|++..++..||+|+.... ....|+.+|++++||||+++++++..... .|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI--TCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCe--eEEE
Confidence 5799999999999999999999999999999985432 13469999999999999999999876554 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+.++++..+......+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 136 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 213 (357)
T PHA03209 136 LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAF 213 (357)
T ss_pred EEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--ccc
Confidence 999998887777666678999999999999999999999999999999999999999999999999999754322 122
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCC-CCCCCCC---------hHHHHHHHHHhhCCCChhHHhh
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK-PVLPGKT---------EVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~-~pF~g~~---------~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
....||+.|+|||++.+.. |+.++|||||||++|||+++. ++|.... ....+..++..++..+..+...
T Consensus 214 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 3457899999999998765 899999999999999999854 5554322 1234555555555544332210
Q ss_pred hh-------cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 383 SK-------LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 383 ~~-------~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.. +..... ...++..........++..+.+||.+||+.||.+||||.|+|+||||+.
T Consensus 293 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 293 PGSRLVRGFIEYASL--ERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CccHHHHHHHhhccc--CCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00 000000 0001111111112356788999999999999999999999999999985
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=368.52 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=207.7
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHH-HHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIA-ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~-iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||+||+|++..+|+.||+|++.... ........+.+|.. +++.++||||+++++++..... +|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~--~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK--LYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE--EEEEEcCC
Confidence 36999999999999999999999999997542 22233445556655 4677899999999998876544 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccccc
Confidence 998887777667789999999999999999999999999999999999999999999999999987542221 2234557
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------ 212 (325)
T cd05604 158 GTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------ 212 (325)
T ss_pred CChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 899999999998765 7999999999999999999999999887776666553210
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH----HHHHcCcCCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA----TLALNSEFFTTQP 443 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa----~e~L~Hp~f~~~~ 443 (714)
....+.++..+.+||.+||..||.+||++ .+++.||||....
T Consensus 213 -----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 213 -----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred -----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 01123578899999999999999999987 5999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.00 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=208.3
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||||+++.... .......+..|..++..+ +||||+++++++..... +||||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~--~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN--LFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE--EEEEEeCC
Confidence 469999999999999999999999999976421 123345566788888764 89999999998876554 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
+++.|..++.....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 988887776666689999999999999999999999999999999999999999999999999987543222 1233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+... .+
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~--------------------- 213 (316)
T cd05619 158 GTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP--------------------- 213 (316)
T ss_pred CCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC---------------------
Confidence 899999999998765 899999999999999999999999988776665554221 00
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHH-HHHcCcCCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT-LALNSEFFTTQP 443 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~-e~L~Hp~f~~~~ 443 (714)
.....++..+.+||.+||+.||.+||++. ++++||||....
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 214 ------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred ------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 00123678899999999999999999996 899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=370.16 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=206.0
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC---CCCCeeeeeccccccCCceEEEEEeec
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL---DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L---~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
||+|+||+||+|++..+++.||||++.... ........+..|..++..+ .||||+++++++..... +||||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~--~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD--LYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe--EEEEEcCC
Confidence 799999999999999999999999986532 1223344556677777765 69999999998876554 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.+..++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 988777666666789999999999999999999999999999999999999999999999999997643222 2233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.... . .+ +
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~--------------~~----~ 217 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--V--------------RF----P 217 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--C--------------CC----C
Confidence 89999999999876658999999999999999999999999887766655553210 0 00 0
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCC----CHHHHHcCcCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRG----TATLALNSEFFTTQ 442 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp----Ta~e~L~Hp~f~~~ 442 (714)
...++..+.+||.+||..||.+|| ++.++++||||...
T Consensus 218 --------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 218 --------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred --------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 013688999999999999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=366.61 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=207.3
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHH-HHHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREI-AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi-~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||+|++..... .......+..|. .+++.++||||+++++++..... +|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~--~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK--LYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe--EEEEEeCC
Confidence 369999999999999999999999999975321 112233344444 45678899999999998876554 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccccc
Confidence 998887777666789999999999999999999999999999999999999999999999999997543222 2234457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (325)
T cd05602 158 GTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------ 212 (325)
T ss_pred CCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC------------------------
Confidence 899999999998765 8999999999999999999999999888777766664310
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHH----HHHcCcCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT----LALNSEFFTTQ 442 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~----e~L~Hp~f~~~ 442 (714)
....+.++..+.+||.+||+.||.+|+++. ++++|+||...
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 213 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred -----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 011236789999999999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=353.72 Aligned_cols=284 Identities=35% Similarity=0.606 Sum_probs=223.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|.+++.||+|+||.||+|.+..+|..||+|++...... .....+.+|+.+|+.++|+||+++++++.... ..|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKE--TLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--eEEE
Confidence 47899999999999999999999999999999998754322 22335678999999999999999999887554 4899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++++..+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ .
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-T 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-C
Confidence 999999887776655555688999999999999999999999999999999999999999999999999976533221 1
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC-hHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT-EVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~-~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+....|.|....|..........
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2334678999999998776557889999999999999999999997654 456777788888888777664432111000
Q ss_pred cc-CCchhhhhhhhhcc--CCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 391 FK-PVQPYRRRIAETFK--DFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 391 ~~-~~~p~~~~i~~~~~--~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.. ........+...+. ..+..+.+||.+||..||.+|||+.++|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 00000011111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=364.30 Aligned_cols=296 Identities=40% Similarity=0.713 Sum_probs=237.2
Q ss_pred CCCeeEE-eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHH------------HHHHHHHHHHHHHhCCCCCeeeee
Q 005111 152 ANTFEKL-DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPE------------SVKFMAREIAILRKLDHPNIIKLE 218 (714)
Q Consensus 152 ~~~Y~~~-~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~------------~~~~~~rEi~iL~~L~HpnIVkl~ 218 (714)
.++|..+ +.||.|+||+||+|.+..+++.||||+++....... ....+.+|+.+|+.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 4567654 679999999999999999999999999875432210 012467899999999999999999
Q ss_pred ccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 219 ~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
+++..... +|+||||+.+++...+ .....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+||
T Consensus 87 ~~~~~~~~--~~lv~e~~~~~l~~~l-~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVEGDF--INLVMDIMASDLKKVV-DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEecCCc--EEEEEeccccCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99876554 8999999998665544 34457999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCC-------------CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHH
Q 005111 299 GLASFFDPKD-------------SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQL 365 (714)
Q Consensus 299 Gla~~~~~~~-------------~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l 365 (714)
|++..+.... ........+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9998764111 112233456889999999987666789999999999999999999999999999999
Q ss_pred HHHHHhhCCCChhHHhhhhc-ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 366 HRIFKLCGSPSEDYWRKSKL-RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~-~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
..++..++.+....|..... +....+... ....+...+...+..+.+||.+||..||++|||++++|.||||...+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcC--CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 99999999988776654311 111111111 112233445667899999999999999999999999999999999887
Q ss_pred CCCCCCCC
Q 005111 445 ACNPSNLP 452 (714)
Q Consensus 445 ~~~~~~~p 452 (714)
++.+..+|
T Consensus 322 ~~~~~~~~ 329 (335)
T PTZ00024 322 PCDPSQLP 329 (335)
T ss_pred CCCcccCC
Confidence 77766554
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=363.87 Aligned_cols=291 Identities=37% Similarity=0.583 Sum_probs=233.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC---ce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---CS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---~~ 228 (714)
.+.|.+++.||+|+||+||+|++..+++.||||.+............+.+|+.+|+.++|+||+++++++..... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999999999999999987543334445667789999999999999999998764322 34
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||+.+++...+. ....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 89999999876655443 44679999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....|.+..+.|........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2233456799999999987654589999999999999999999999999998888999999999887766532111100
Q ss_pred ccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 389 TVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 389 ~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
..+....+ ........++.++..+.+||.+||+.||++|||+.++|+||||.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 00000000 001122345678999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=378.19 Aligned_cols=280 Identities=25% Similarity=0.328 Sum_probs=218.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc--cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV--IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~--~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+.++|||||++++++..... +
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~--~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST--V 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE--E
Confidence 357999999999999999999754 45688999987532 234589999999999999999998876544 8
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||+.++++..+ .....+++..++.|+.||+.||.|||++||+||||||+||||+.++.++|+|||++..+.....
T Consensus 162 ~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999999998777655 4456799999999999999999999999999999999999999999999999999987654332
Q ss_pred C-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC---hHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 310 V-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT---EVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 310 ~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~---~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
. .....+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+.. ....+..|++.++..+.++......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 2 223457899999999998765 8999999999999999999999997753 4567777888777655443221000
Q ss_pred cc-----CccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 386 RH-----STVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 386 ~~-----~~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.. ........++ .+...+ ..++.++.+||.+||..||++|||+.++|.||||...|.
T Consensus 320 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPY--TIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hHHHHHHhhcccccCCc--cccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00 0000000000 000111 246778999999999999999999999999999997653
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=348.60 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=213.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD---PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
+.|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.... .+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE--TL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC--eE
Confidence 4689999999999999999999999999999998765322 223567889999999999999999999987665 49
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||+.++.+..+......+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999887776666566799999999999999999999999999999999999999999999999999986643322
Q ss_pred CCc--ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 VPM--TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 ~~~--~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
... ....++..|+|||++.+.. ++.++|||||||++|+|++|++||...+..+....+.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------- 224 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-------------- 224 (263)
T ss_pred ccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--------------
Confidence 111 2346788999999998766 79999999999999999999999987665554444321100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.......++..+.+||.+||..+|.+|||+.++|.|+||
T Consensus 225 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 -------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 001123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.83 Aligned_cols=286 Identities=37% Similarity=0.639 Sum_probs=224.7
Q ss_pred CeeEEeEEeccCceEEEEEEEcc--CCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVI--HDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~--~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.|+++++||+|+||.||+|.+.. ++..||||.+.... ........+.+|+.++..++||||+++++++.......+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 89999999998642 1223345677899999999999999999998877445699
Q ss_pred EEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC----CCcEEEeecCccc
Q 005111 231 LVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH----NGILKIADFGLAS 302 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~----~g~vKL~DFGla~ 302 (714)
+||||++++++..+.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999999877654422 2237899999999999999999999999999999999999999 8999999999998
Q ss_pred ccCCCCC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChH---------HHHHHHHHh
Q 005111 303 FFDPKDS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV---------EQLHRIFKL 371 (714)
Q Consensus 303 ~~~~~~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~---------e~l~~I~k~ 371 (714)
....... ......+++++|+|||++.+...++.++|||||||++|+|++|.+||.+.... ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 7643322 11233467899999999887666899999999999999999999999876532 467788888
Q ss_pred hCCCChhHHhhhh-cccCcc---ccCCchhh----hhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 372 CGSPSEDYWRKSK-LRHSTV---FKPVQPYR----RRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 372 ~G~p~~~~w~~~~-~~~~~~---~~~~~p~~----~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
++.+....|.... ++.... ......+. ....+.....+..+.++|.+||..||++|||+.+++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 8888777664321 111110 00000010 11112223678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.03 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=205.2
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIA-ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~-iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||+|++..... .......+.+|+. +++.++||||+++++++.... .+||||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~--~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE--KLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC--EEEEEEcCC
Confidence 369999999999999999999999999875421 2223344555554 678899999999999886554 499999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
+++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccccc
Confidence 998887666666789999999999999999999999999999999999999999999999999987542222 1233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+....+..+... +
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~--------------------- 212 (321)
T cd05603 158 GTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P--------------------- 212 (321)
T ss_pred CCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C---------------------
Confidence 899999999988765 899999999999999999999999988766655555320 0
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH----HHHHcCcCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA----TLALNSEFFTTQ 442 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa----~e~L~Hp~f~~~ 442 (714)
.......+..+.+||.+||+.||.+|+++ .++++|+||...
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 01123567889999999999999999876 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=361.87 Aligned_cols=289 Identities=34% Similarity=0.553 Sum_probs=230.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC---Cce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT---SCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~---~~~ 228 (714)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++|+||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 478999999999999999999999999999999986432 2234566778999999999999999998765432 234
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|+||||+++++...+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 79999999987665443 3469999999999999999999999999999999999999999999999999998754322
Q ss_pred CC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 309 SV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 309 ~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.. .....++|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.+...++..+....+.+..+.|......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 11 1233577999999998876555799999999999999999999999999888889999998888877666432111
Q ss_pred cCccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
....+....+ .........+.++..+.+||.+||+.||.+|||+.++|+||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 1100000000 01112223456788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=382.91 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=219.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---- 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---- 226 (714)
..++|++.+.||+|+||+||+|++..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3579999999999999999999999999999999998776666777788999999999999999999876643321
Q ss_pred --ceEEEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCc
Q 005111 227 --CSLYLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 227 --~~l~LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
..+++||||+.++.|..++. ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 23789999999877765442 235799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 301 ASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 301 a~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
++.+..... ......+||+.|+|||++.+.. |+.++|||||||+||||++|..||.+.+..+.+..+.....
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------ 262 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------ 262 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence 987643221 1223457899999999998765 89999999999999999999999998887666666532110
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
......+++.+.+||.+||+.||.+|||+.++|+|||+..
T Consensus 263 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 ----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 0112457889999999999999999999999999999875
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=354.80 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=209.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+|+.++|++|+.+++.+.... .+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~--~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD--ALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--EEEEE
Confidence 48899999999999999999999999999999875432 2333456778999999999999999999886654 49999
Q ss_pred EeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+.++.+..++. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999877765442 23468999999999999999999999999999999999999999999999999997654322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.........+........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 223457899999999998765 89999999999999999999999987543211111111000000
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQ 442 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~ 442 (714)
......+++++.+||.+||+.||.+||| +.++++||||...
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 222 -----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 0112357889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.31 Aligned_cols=286 Identities=36% Similarity=0.602 Sum_probs=230.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---- 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---- 226 (714)
..+.|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3578999999999999999999999999999999987543333445567899999999999999999998764322
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
..+|+||||+...+.... +..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 247999999986543322 23689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .....+++.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....|.+...++......
T Consensus 170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 170 E----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred C----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 2 234567899999999877555789999999999999999999999999988899999998888877766543221
Q ss_pred cCccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
....+....+ ....+...++.++..+.+||.+||+.||.+|||+.++|.||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 1111100000 11222334456788999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=362.92 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=206.3
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|++..+++.||+|+++... ......+.+.+|+.++.++ .||||+.+++++..... +||||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~--~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR--LFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE--EEEEEeCC
Confidence 36999999999999999999999999998652 2344567788999999988 69999999998876544 99999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.+..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceeccc
Confidence 998887666666689999999999999999999999999999999999999999999999999997532221 2233457
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh------HHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE------VEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~------~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
||+.|+|||++.+.. ++.++|||||||+||+|++|.+||..... .+.+..+... .
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~---------------- 218 (327)
T cd05617 158 GTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K---------------- 218 (327)
T ss_pred CCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C----------------
Confidence 899999999998765 79999999999999999999999964321 1112111110 0
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC------HHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT------ATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT------a~e~L~Hp~f~~~~ 443 (714)
.......++..+.+||.+||..||.+|++ ..+++.||||....
T Consensus 219 ----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 219 ----------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 00112357889999999999999999998 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.87 Aligned_cols=287 Identities=32% Similarity=0.557 Sum_probs=230.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---- 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---- 226 (714)
..++|++++.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999999999999999986544344455678899999999999999999998765432
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
..+++||||+++++. .+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~~l~-~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFMGTDLG-KLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecCCCCHH-HHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 246899999965443 3333 24789999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .....+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+....+..+++..+.++.+++......
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07880 171 E----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246 (343)
T ss_pred C----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence 2 233467899999999876555789999999999999999999999999988889999888888776665443211
Q ss_pred cCccccC-Cch-hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKP-VQP-YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~-~~p-~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
....+.. ... ....+....+.++..+.+||.+||+.||.+|||+.++|.||||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 1110000 000 01122334467888999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=359.71 Aligned_cols=289 Identities=36% Similarity=0.585 Sum_probs=237.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC---CceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT---SCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~---~~~l~ 230 (714)
+|++.+.||.|+||.||+|++..++..||||++..........+.+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 589999999999999999999889999999998765443556677899999999999999999999887653 23489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS- 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~- 309 (714)
+||||+.+++...+ .....+++..++.++.||+.||.|||++||+|+||||.|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVI-KSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999997655444 3445899999999999999999999999999999999999999999999999999988754431
Q ss_pred -CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 -VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 -~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......++++|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....|.+..+.|........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1234457799999999998874589999999999999999999999999999999999999999998877653221111
Q ss_pred ccccCC--chhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 389 TVFKPV--QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 389 ~~~~~~--~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..+... ......+...++.++..+.+||.+||+.||.+|||++++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 111000 0011122334566899999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=349.97 Aligned_cols=282 Identities=44% Similarity=0.767 Sum_probs=232.9
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|++.+.||.|++|.||+|.+..+++.+|+|.+............+.+|+.+|++++|+||+++++++..... +|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD--LYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCC--EEEEEe
Confidence 678899999999999999998899999999987665444556778899999999999999999998876644 999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccc
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 314 (714)
|+++++...+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99987777666655689999999999999999999999999999999999999999999999999998775443 12334
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc-CccccC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH-STVFKP 393 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~-~~~~~~ 393 (714)
..++..|+|||.+.+...++.++|+|||||++|+|++|++||++.+..+.+.++...++.+....|....... ...+..
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 5678999999999876458999999999999999999999999999999999999988888776665422100 000000
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
............+.++..+.+||.+||..||.+||++.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0001111233445678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=361.27 Aligned_cols=290 Identities=37% Similarity=0.611 Sum_probs=234.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.+++++ +||||+++++++.......+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 35689999999999999999999998999999998865433334456677899999999 99999999998876555568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||+.+++...+ ..+ .+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 85 ~lv~e~~~~~L~~~~-~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYMETDLHAVI-RAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccccCHHHHH-hcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 999999997554433 333 789999999999999999999999999999999999999999999999999987654332
Q ss_pred C----CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 310 V----PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 310 ~----~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
. .....++|..|+|||++.+...++.++|||||||++|+|++|++||.+....+.+.++....+.+....|.....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1 223456899999999987766678999999999999999999999999999999999999888887765544221
Q ss_pred ccCcccc--CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 386 RHSTVFK--PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 386 ~~~~~~~--~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....+. ........+...++.++.++.+||.+||+.||++|||+.++|+||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 1111000 00111122334456689999999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.54 Aligned_cols=288 Identities=34% Similarity=0.595 Sum_probs=234.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---- 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---- 226 (714)
..++|++.+.||+|+||.||+|++..++..||||++............+.+|+.+++.+.||||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999999999999999987554344455677889999999999999999987754432
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
..+|+|+||+++++...+. . ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~~L~~~~~-~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVK-C-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecCCCCHHHHHh-c-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 3489999999765544433 2 4699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+++..|.+....
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred c----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 2 234567899999999876555789999999999999999999999999999999999999998888776554322
Q ss_pred cCccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 387 HSTVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 387 ~~~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
....+....+ ....+...+..++..+.+||.+||..||.+|||+.++|.||||.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 1111110000 011223344567899999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=348.63 Aligned_cols=282 Identities=41% Similarity=0.753 Sum_probs=232.2
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++|+||+++++++.... .+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER--KLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC--ceEEEec
Confidence 67889999999999999999999999999999875433444566788999999999999999999987664 4999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccc
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 314 (714)
|+++++...+......+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 999865555444335799999999999999999999999999999999999999999999999999987654322 2333
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV 394 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~ 394 (714)
..++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++...++.+....|..............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 45688999999987764589999999999999999999999999999999999999999999888865322210000000
Q ss_pred chhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 395 ~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.-........++.++..+.++|.+||..||.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 001112234456678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=378.07 Aligned_cols=277 Identities=23% Similarity=0.315 Sum_probs=209.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|+|||++++++..... .+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~--~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGL--TCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE--EEE
Confidence 4579999999999999999999999999999996432 235689999999999999999998776544 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.......
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99999888777665555579999999999999999999999999999999999999999999999999998764332221
Q ss_pred -cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCC-CCCCC------hHHHHHHHHHhhCCCChhH----
Q 005111 312 -MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV-LPGKT------EVEQLHRIFKLCGSPSEDY---- 379 (714)
Q Consensus 312 -~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~p-F~g~~------~~e~l~~I~k~~G~p~~~~---- 379 (714)
....+||+.|+|||++.+.. ++.++||||||||||||++|..+ |.... ...++.+++...+....++
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 22357899999999998766 89999999999999999998754 43321 1244555555443322111
Q ss_pred ----HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 380 ----WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 380 ----w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.............+ .........+..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRP--AYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCC--ccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00000000000000 0000000112246778999999999999999999999999999975
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.18 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=213.6
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|+..+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+|+.++|+||+.+++++...+. +|+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~--~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA--LCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE--EEEE
Confidence 47889999999999999999999999999999875432 22334567789999999999999999988876554 9999
Q ss_pred EeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+.++.+..... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999877654442 23469999999999999999999999999999999999999999999999999997654222
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.........+.........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~------------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE------------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc-------------
Confidence 223457899999999998765 799999999999999999999999887665544444322111100
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~ 443 (714)
.....++..+.+||..||..||++||| +.+++.|+||...+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 223 ------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred ------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 112357889999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=348.55 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=214.1
Q ss_pred CCCCeeEE-eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc--cCC
Q 005111 151 RANTFEKL-DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS--QTS 226 (714)
Q Consensus 151 ~~~~Y~~~-~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~--~~~ 226 (714)
.+++|.+- ++||-|-.|.|..|.++.||+.+|+|++... ....+|++..-.. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 35677776 6799999999999999999999999998632 2345788776555 69999999999865 233
Q ss_pred ceEEEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCcc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLA 301 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla 301 (714)
.++.||||.|+||.|...+... ..|+|.++..|++||..|+.|||+.+|.||||||+|+|... +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 4589999999998877665544 45999999999999999999999999999999999999975 457999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChH----HHHHHHHHhhCCCCh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV----EQLHRIFKLCGSPSE 377 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~----e~l~~I~k~~G~p~~ 377 (714)
+.... ...+.+.|.||.|.|||++-... |+...|+||+|||+|.||||.|||...... ..-.+|......++.
T Consensus 212 K~t~~--~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 212 KETQE--PGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred cccCC--CccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 97653 33455668899999999775544 999999999999999999999999875532 334556555555666
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
+.| ..+|+.++++|+.||..+|.+|.|++++|.|||+...+
T Consensus 289 pEW-------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 289 PEW-------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hhH-------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 666 35899999999999999999999999999999998764
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.82 Aligned_cols=268 Identities=28% Similarity=0.362 Sum_probs=220.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD-PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ....+.+..|+.+|+.++|+||+++++++.... .+|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET--YLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC--EEEE
Confidence 4699999999999999999999999999999999865333 245667889999999999999999999886554 4899
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||+.++.+..++.. +..+++..++.++.||+.||.|||++||+|+||||+||||+.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999998777665543 35799999999999999999999999999999999999999999999999999876533211
Q ss_pred C----------------------------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh
Q 005111 310 V----------------------------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE 361 (714)
Q Consensus 310 ~----------------------------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~ 361 (714)
. .....+||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1 111346788999999998765 78999999999999999999999998887
Q ss_pred HHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC----HHHHHcCc
Q 005111 362 VEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT----ATLALNSE 437 (714)
Q Consensus 362 ~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT----a~e~L~Hp 437 (714)
...+..+...-.. + .....++..+.+||.+||+.||++||| ++++|.||
T Consensus 238 ~~~~~~~~~~~~~----------------~-----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVT----------------F-----------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCcc----------------C-----------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 7666555321000 0 001126889999999999999999999 99999999
Q ss_pred CCCCCCCCCCCCC
Q 005111 438 FFTTQPLACNPSN 450 (714)
Q Consensus 438 ~f~~~~~~~~~~~ 450 (714)
||+..+++....+
T Consensus 291 ~~~~~~~~~~~~~ 303 (316)
T cd05574 291 FFRGVNWALIRHT 303 (316)
T ss_pred hhhcCChhhcccC
Confidence 9998776654443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=361.56 Aligned_cols=283 Identities=22% Similarity=0.331 Sum_probs=215.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.++||.|+||.||+|.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++.... .+||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG--EISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--EEEE
Confidence 478999999999999999999999999999999987643 3445677899999999999999999999987654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||+.++.|..++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++..+....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 999999988877766666799999999999999999999975 79999999999999999999999999997653221
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHH--hhCCCChhHHhhhhccc-
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK--LCGSPSEDYWRKSKLRH- 387 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k--~~G~p~~~~w~~~~~~~- 387 (714)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||......+.. .++. ..+.+............
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred -cccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCcccCCcc
Confidence 23346899999999998765 799999999999999999999999876543322 2211 11111110000000000
Q ss_pred ------CccccCCchh---hhh-hhhh-----ccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 ------STVFKPVQPY---RRR-IAET-----FKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ------~~~~~~~~p~---~~~-i~~~-----~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....+.... ... +... ...++.++.+||.+||++||++|||+.++|.|+||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0000000000 000 0000 01357889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.18 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=212.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|++++.||.|++|.||++.+..+++.||+|.+..........+.+.+|+.++++++|+|++++++.+.... ..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED-GLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC-CEEEEEe
Confidence 489999999999999999999999999999999766555556677889999999999999999998765433 3489999
Q ss_pred eeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||++++.+..+... ...+++.+++.++.||+.||.+||++||+|+||||+|||++.++.++|+|||++..+..... .
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-M 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-c
Confidence 99998776655432 34689999999999999999999999999999999999999999999999999987643222 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~---------------- 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L---------------- 219 (257)
T ss_pred cccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C----------------
Confidence 33446789999999988765 7899999999999999999999998776555444432210 0
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
......++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 220 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ----------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01113578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=356.65 Aligned_cols=293 Identities=25% Similarity=0.421 Sum_probs=230.4
Q ss_pred hhhhhhcccccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC------C
Q 005111 139 VAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH------P 212 (714)
Q Consensus 139 ~~g~~~~~~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H------p 212 (714)
..|..+...-....++|++++.||+|+||.|..+.|..++..||||+++.-. ...+...-||.+|.++.+ -
T Consensus 75 ~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 75 KDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred CCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCce
Confidence 4444444444455789999999999999999999999999999999997532 334445679999999942 2
Q ss_pred CeeeeeccccccCCceEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC--
Q 005111 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-- 289 (714)
Q Consensus 213 nIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-- 289 (714)
-+|++.++|...+. ++||+|.++-.+.+.+... -.+|+..+++.+++||+.+++|||+.+++|.||||+|||+.+
T Consensus 152 rcv~m~~wFdyrgh--iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGH--ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred EEEeeehhhhccCc--eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccc
Confidence 36788888877665 8999999987777666543 357999999999999999999999999999999999999842
Q ss_pred ------------------CCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh
Q 005111 290 ------------------NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351 (714)
Q Consensus 290 ------------------~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt 351 (714)
+..|+|+|||.|++..+.. ...+.|..|+|||+++|-+ ++.++||||+||||+||.+
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeec
Confidence 2258999999999865443 4567799999999999988 8999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh---------hcccC---------ccccCCchhhhhhhhhccCCcHHHH
Q 005111 352 GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS---------KLRHS---------TVFKPVQPYRRRIAETFKDFPTSAL 413 (714)
Q Consensus 352 G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~---------~~~~~---------~~~~~~~p~~~~i~~~~~~~p~~l~ 413 (714)
|..+|++.++.|++..+...+|.+|..+..+. ++... ..+.+..|........ ..--..+.
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~-d~e~~~Lf 383 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD-DLEHVQLF 383 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC-cHHHhHHH
Confidence 99999999999999999999998888766543 11100 0111112221111100 01123589
Q ss_pred HHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 414 RLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 414 ~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+||++||.+||.+|+|+.|+|.||||+..
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 99999999999999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=395.23 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=217.0
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++++.||+|+||+||+|++..++..||+|++............+.+|+.+|..|+|||||+++++|.......+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 35679999999999999999999999999999999998766566667788999999999999999999998876655669
Q ss_pred EEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhc-------CeeeccCCCccEEEcC---------
Q 005111 230 YLVFEYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSH-------GVLHRDIKGSNLLLDH--------- 289 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~-------gIiHrDLKP~NILl~~--------- 289 (714)
||||||++++.|..++.. ...|++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999998777654432 35799999999999999999999984 4999999999999964
Q ss_pred --------CCcEEEeecCcccccCCCCCCCcccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCC
Q 005111 290 --------NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKT 360 (714)
Q Consensus 290 --------~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~ 360 (714)
.+.+||+|||++..+.... .....+||+.|+|||++.+. ..++.++||||||||||+|++|.+||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2358999999998764332 22345789999999998653 347899999999999999999999998776
Q ss_pred hHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 361 EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 361 ~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
....+..++... + . ..+..++..+.+||..||..+|.+|||+.++|.|+||.
T Consensus 248 ~~~qli~~lk~~--p------------------~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 248 NFSQLISELKRG--P------------------D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred cHHHHHHHHhcC--C------------------C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 655544432211 0 0 00134678999999999999999999999999999998
Q ss_pred CC
Q 005111 441 TQ 442 (714)
Q Consensus 441 ~~ 442 (714)
..
T Consensus 300 ~i 301 (1021)
T PTZ00266 300 NV 301 (1021)
T ss_pred hc
Confidence 64
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=377.19 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=215.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC-CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH-DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~-g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|..++|||||++++++..... +|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~--~~ 141 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK--LL 141 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE--EE
Confidence 45599999999999999999998877 788999987543 33445677889999999999999999999876554 99
Q ss_pred EEEeecccccccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 231 LVFEYMEHDLVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
|||||++++.|..++ ....++++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999988776433 2345799999999999999999999999999999999999999999999999999987653
Q ss_pred CCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 307 KDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 307 ~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----------- 289 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD----------- 289 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 322 1233457899999999988765 899999999999999999999999988877766666431100
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.....++..+.+||.+||..||++|||+.++|.|+|+..
T Consensus 290 -----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 -----------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 011246789999999999999999999999999999864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=357.85 Aligned_cols=288 Identities=35% Similarity=0.581 Sum_probs=223.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC-----
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----- 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----- 226 (714)
..+|++.+.||.|+||.||+|.+..+|..||+|++..... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4789999999999999999999999999999999876533 455678899999999999999999987665432
Q ss_pred -------ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeec
Q 005111 227 -------CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADF 298 (714)
Q Consensus 227 -------~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DF 298 (714)
..+|+||||+++++..... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 2479999999975544332 346899999999999999999999999999999999999974 567899999
Q ss_pred CcccccCCCCCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 299 GLASFFDPKDSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 299 Gla~~~~~~~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
|++..+...... ......++..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999865432111 112235788999999887655688999999999999999999999999988888888776655444
Q ss_pred hhHHhhhhcccCcccc-CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 377 EDYWRKSKLRHSTVFK-PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~-~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+............ .............+.++.++.+||.+||+.||.+|||+.++|.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 3322211000000000 111111223334567889999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.38 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=200.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+|..+ +|||||++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 468999999999999999999752 34678999998743 2334556788999999999 8999999999876543
Q ss_pred CceEEEEEeeccccccccccCC----------------------------------------------------------
Q 005111 226 SCSLYLVFEYMEHDLVGLASLP---------------------------------------------------------- 247 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~---------------------------------------------------------- 247 (714)
..+|+||||++++.|..++..
T Consensus 85 -~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 85 -GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred -CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 348999999998776544321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-CCccccccccccc
Q 005111 248 ----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-VPMTSRVVTLWYR 322 (714)
Q Consensus 248 ----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~ 322 (714)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..... .......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 13478899999999999999999999999999999999999999999999999986532221 1122234568899
Q ss_pred CcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhh
Q 005111 323 PPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRI 401 (714)
Q Consensus 323 APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i 401 (714)
|||++.+.. |+.++|||||||+||||++ |.+||.+....+.+...+.. +..
T Consensus 244 aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~-------------------------- 295 (338)
T cd05102 244 APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR-------------------------- 295 (338)
T ss_pred CcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC--------------------------
Confidence 999998765 7999999999999999997 99999886544433332221 000
Q ss_pred hhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 402 AETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 402 ~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0011356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.50 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=201.3
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQD-PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
||+|+||.||++++..+|+.||+|++...... ......+..|+.+|+.++||||+++++++.... .+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~--~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT--HLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC--eEEEEEecCCCC
Confidence 79999999999999999999999998653221 122344567999999999999999999887654 499999999987
Q ss_pred ccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccc
Q 005111 240 LVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317 (714)
Q Consensus 240 ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 317 (714)
.+..+.. ....+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....... ......|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccCC
Confidence 7754432 23458999999999999999999999999999999999999999999999999998764322 2234468
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchh
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPY 397 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~ 397 (714)
|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+.... ..
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~------------~~----------- 212 (277)
T cd05607 157 TNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRT------------LE----------- 212 (277)
T ss_pred CCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHh------------hc-----------
Confidence 99999999998776 8999999999999999999999997643321111111100 00
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH----HHHHcCcCCCCCCC
Q 005111 398 RRRIAETFKDFPTSALRLMETLMSIDPAHRGTA----TLALNSEFFTTQPL 444 (714)
Q Consensus 398 ~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa----~e~L~Hp~f~~~~~ 444 (714)
..+......++.++.+||.+||+.||.+|||+ ++++.|+||....+
T Consensus 213 -~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 213 -DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred -cccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 00000113578899999999999999999999 77889999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=373.33 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=220.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.|+++..||.|+||.||+|..+.++-..|.|+|.. ...+.++.+.-||.||..++||+||+|++.|..++. ++|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk--Lwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK--LWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc--eEEE
Confidence 346888999999999999999999999999999865 345677888899999999999999999998887766 9999
Q ss_pred Eeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
.|||+||-.+.++ .-+..|++.++..+++|+|.||.|||+++|||||||..|||++.+|.|+|+|||.+.... .....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 9999998877544 345679999999999999999999999999999999999999999999999999987543 22334
Q ss_pred cccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 312 MTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
..+++|||+|||||++.+ ..+|++++||||||++|.||..+.||...-+....+-+|.+. .+.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePP---------- 253 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPP---------- 253 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCC----------
Confidence 567899999999999854 345899999999999999999999999888887777777542 111
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.. .+ +...+..+.|||.+||.+||..||+++++|.||||+..+
T Consensus 254 -TL---lq---------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 254 -TL---LQ---------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred -cc---cC---------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 01 11 134577899999999999999999999999999999754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=338.31 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=215.1
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--KLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC--EEEEEE
Confidence 588999999999999999999999999999999876555667778899999999999999999999887654 499999
Q ss_pred eeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||+.++.+..++.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+..... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-F 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-h
Confidence 99998777655543 35789999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+.... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------- 218 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--F---------------- 218 (256)
T ss_pred hhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C----------------
Confidence 23346789999999988765 7899999999999999999999998887665555543211 0
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
. .....++..+.++|.+||+.+|++||++.++++|||+
T Consensus 219 ~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 P----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred C----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0 0112467899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=358.06 Aligned_cols=268 Identities=27% Similarity=0.396 Sum_probs=223.1
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.|...+.|...++||+|+||.||-+....||+.||+|.+.+... .........+|-.||.+++.++||.|-..|...+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 57788999999999999999999999999999999998854421 12233446689999999999999999877777666
Q ss_pred ceEEEEEeeccccccccccCCCC--CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGM--KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~--~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
++|||..|.||.|...+...+ .|++..++.|+.+|+.||++||+.+||+|||||+|||+|+.|+++|.|+|+|..+
T Consensus 260 --LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 260 --LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred --eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999998887766544 7999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.. ..+..+++||..|||||++.+.. |+...|+|||||+||||+.|+.||....+...-..+-+..-.-+
T Consensus 338 ~~--g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-------- 406 (591)
T KOG0986|consen 338 PE--GKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-------- 406 (591)
T ss_pred CC--CCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--------
Confidence 54 44567789999999999998877 99999999999999999999999986543322212211110011
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPLA 445 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~~ 445 (714)
.+....+++++++|.+.+|++||.+|. +++++.+||||++..|.
T Consensus 407 -----------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 407 -----------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred -----------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 112246899999999999999999996 47899999999987764
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=341.84 Aligned_cols=259 Identities=28% Similarity=0.468 Sum_probs=210.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ---DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468999999999999999999999999999999876532 23445678899999999999999999998766544568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
+++|||++++.+..++.....+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999887776666556799999999999999999999999999999999999999999999999999976542211
Q ss_pred --CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 --VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 --~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.......++..|+|||++.+.. ++.++|||||||++|+|++|.+||........+..+.. .+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~----------- 226 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT----------- 226 (266)
T ss_pred cCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC-----------
Confidence 1122345788999999998765 78999999999999999999999987655544443321 100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
.+ .....++..+.+|| .||..||++|||+.++|+||||.
T Consensus 227 ----~~---------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----NP---------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----CC---------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00 11124677888898 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=346.88 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=217.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|++++||||+++++++..... +|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN--LYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe--EEE
Confidence 47999999999999999999999999999999987542 233456778899999999999999999998876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++.+..++.....+++..+..++.||+.||.|||+.||+|+||+|.||||+.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999988777777666678999999999999999999999999999999999999999999999999999876433
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+.......+.. +.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~---------------- 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--GKV---------------- 215 (290)
T ss_pred CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCc----------------
Confidence 22346799999999987765 78999999999999999999999988776555555432 100
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
.....++..+.++|.+||..||.+|+ +++++++||||....+
T Consensus 216 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 262 (290)
T cd05580 216 -----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDW 262 (290)
T ss_pred -----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCH
Confidence 01134688999999999999999999 9999999999987653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=354.69 Aligned_cols=287 Identities=33% Similarity=0.542 Sum_probs=227.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC----C
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----S 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----~ 226 (714)
..++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 457899999999999999999999999999999998765444445567889999999999999999999875422 2
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
..+|++++++.+.+.. +... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~lv~~~~~~~L~~-~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLMGADLNN-IVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhcccCHHH-HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 3478999998665433 3332 3689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+....+......
T Consensus 173 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T cd07877 173 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248 (345)
T ss_pred c----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence 2 234567899999999877555789999999999999999999999998888888888888887776655332111
Q ss_pred cCccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
....+....+ ........+...++.+.+||..||..||.+|||+.++|+||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0000000000 00111222335688999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=350.06 Aligned_cols=282 Identities=23% Similarity=0.320 Sum_probs=214.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++||||+++++++..... +|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE--ISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE--EEEE
Confidence 46999999999999999999999999999999987542 34456678899999999999999999999876554 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||++++.|..++.....+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999998888777666789999999999999999999997 599999999999999999999999999987653221
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC-hhH-HhhhhcccCc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS-EDY-WRKSKLRHST 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~-~~~-w~~~~~~~~~ 389 (714)
....++++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.... ..++....... ... ..........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred cccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCC
Confidence 23457899999999987655 78999999999999999999999987664332 22221111000 000 0000000000
Q ss_pred cccCCc--h-hhhhhhh-----hccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQ--P-YRRRIAE-----TFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~--p-~~~~i~~-----~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
...... . ....... ....++.++.+||.+||..||++|||+.++|+||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000000 0 0000000 011367889999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=349.21 Aligned_cols=264 Identities=25% Similarity=0.330 Sum_probs=216.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+.... .+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR--HLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC--EEEE
Confidence 479999999999999999999999999999999875432 2334567889999999999999999999887654 4899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC-
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV- 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~- 310 (714)
||||++|+.+..++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999888877766678999999999999999999999999999999999999999999999999998642111000
Q ss_pred -------------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005111 311 -------------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377 (714)
Q Consensus 311 -------------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~ 377 (714)
......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Confidence 011235688999999988765 79999999999999999999999998876665555433110000
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC---HHHHHcCcCCCCCCCC
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT---ATLALNSEFFTTQPLA 445 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT---a~e~L~Hp~f~~~~~~ 445 (714)
.....+|..+.+||.+||+.||++||| +.++|+||||...++.
T Consensus 237 -------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~ 282 (305)
T cd05609 237 -------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN 282 (305)
T ss_pred -------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHH
Confidence 001247889999999999999999998 8999999999876543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.58 Aligned_cols=280 Identities=39% Similarity=0.681 Sum_probs=223.7
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeccccccCC---ce
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL---DHPNIIKLEGLITSQTS---CS 228 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIVkl~~~~~~~~~---~~ 228 (714)
|++.+.||.|+||.||+|.+..++..||+|+++...........+.+|+.+++++ +|+||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999988899999999986543333345566788887766 59999999998765432 24
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|++|||+.+.+...+... ...+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++..+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 8999999998655433322 236899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.. .....++..|+|||++.+.. ++.++|+|||||++|+|++|.+||.+.+..+.+.+++...+.+....|.......
T Consensus 161 ~~--~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 MA--LTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred cc--cccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 22 23345788999999998765 7999999999999999999999999999999999999888777665554322111
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
...+.... ........+.++..+.+||.+||+.||.+||++.++|.||||
T Consensus 238 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYT--PRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhccccc--ccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11111111 112234445678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=343.49 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=207.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+|.+++||||+++++++..... +++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR--ISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE--EEEE
Confidence 36899999999999999999999999999999987542 34456678899999999999999999999876554 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++.+..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+.... .
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---A 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---c
Confidence 999999887654 357899999999999999999999999999999999999999999999999998664322 2
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHH---HHHHHHhhCCCChhHHhhhhcccCc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ---LHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~---l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
...++|..|+|||++.+.. ++.++|+|||||++|+|++|..||......+. ...+........
T Consensus 151 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------------- 216 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------------- 216 (279)
T ss_pred cCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------------
Confidence 3457899999999998765 79999999999999999999999965321110 001111000000
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
. + ......++..+.+||.+||+.||++||++.++|+||||...
T Consensus 217 --~---~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 217 --P---P-----VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --C---C-----CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0 0 00112467889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=338.20 Aligned_cols=261 Identities=26% Similarity=0.426 Sum_probs=215.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||.|+||+||+|.+..++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.... .+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--ELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC--EEEEE
Confidence 47999999999999999999998899999999987654333 6678899999999999999999999876654 48999
Q ss_pred EeeccccccccccCC---CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 233 FEYMEHDLVGLASLP---GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||+.++.+..++.. ...+++..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++..+.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999998877666543 24689999999999999999999999999999999999999999999999999987654332
Q ss_pred C---CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 310 V---PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 310 ~---~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .....+++..|+|||++.....++.++|+|||||++|+|++|+.||...+....+.++.... ++
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---------- 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PP---------- 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC--CC----------
Confidence 2 12234678999999998776457999999999999999999999998776665555543310 00
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.+.. ...+..++..+.+||.+||..||++|||+.++|.||||
T Consensus 226 ---~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 226 ---SLET--------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ---CcCC--------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000 00124678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=354.70 Aligned_cols=282 Identities=21% Similarity=0.311 Sum_probs=208.2
Q ss_pred EEeEEecc--CceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 157 KLDKIGQG--TYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 157 ~~~~LG~G--~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
++++||+| +|++||++.+..+|+.||+|++............+.+|+.+++.++||||+++++++..... +|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~--~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE--LWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE--EEEEEe
Confidence 56789999 77899999999999999999998765555667788899999999999999999999876654 899999
Q ss_pred eccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-C-
Q 005111 235 YMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-V- 310 (714)
Q Consensus 235 y~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-~- 310 (714)
|++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||+.+........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9998877655532 34589999999999999999999999999999999999999999999999987544321110 0
Q ss_pred ----CcccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC---------
Q 005111 311 ----PMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--------- 376 (714)
Q Consensus 311 ----~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~--------- 376 (714)
......++..|+|||++.+. ..|+.++|||||||++|+|++|..||.............. +..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence 01122467889999998763 3488999999999999999999999987655443333221 1111
Q ss_pred -hhHHhhh-h------cccCccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 377 -EDYWRKS-K------LRHSTVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 377 -~~~w~~~-~------~~~~~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
++..... . ...........+ ...........+++.+.+||.+||+.||++|||++++|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0000000 0 000000000000 0000111223467889999999999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=339.24 Aligned_cols=254 Identities=30% Similarity=0.519 Sum_probs=210.7
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC-------HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD-------PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~-------~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
|.+...||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH- 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc-
Confidence 67788999999999999999889999999998754221 2234678899999999999999999998876544
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+++||||++++.+..++.....+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 81 -~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 -LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred -cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 8999999999888777766678999999999999999999999999999999999999999999999999999876522
Q ss_pred CCC-----CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 308 DSV-----PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 308 ~~~-----~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
... ......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 228 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA---------- 228 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC----------
Confidence 111 112235788999999987765 7899999999999999999999998876655444432210
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.......++..+.+||.+||+.||.+||++.++|+||||
T Consensus 229 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=350.42 Aligned_cols=287 Identities=35% Similarity=0.577 Sum_probs=231.2
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...+.|++++.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++..... .+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE-DI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC-cE
Confidence 45688999999999999999999999999999999987554444455678899999999999999999998765332 48
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||+++++.... . ...+++..+..++.||+.||.|||++||+|+||+|.|||++.++.++|+|||++......
T Consensus 86 ~lv~e~~~~~L~~~~-~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 86 YFVTELLGTDLHRLL-T-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred EEEeehhccCHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 999999977554333 2 346899999999999999999999999999999999999999999999999999865322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
.....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+.+.+|.++.+.+.........
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 233467889999998876555899999999999999999999999999988888888889999887765432211111
Q ss_pred cccCCc--hhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 390 VFKPVQ--PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 390 ~~~~~~--p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+.... .......+..+.++..+.++|.+||+.+|++|||+.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 000000 001112234456889999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=365.06 Aligned_cols=255 Identities=32% Similarity=0.509 Sum_probs=220.5
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|.-++.||.|+||-||-|++..+.+.||||++.+. ....+-+..+..|+.+|++|.|||+|.+.++|..+.. .|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T--aWLV 104 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT--AWLV 104 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch--HHHH
Confidence 367788899999999999999999999999999887 4466778899999999999999999999999887666 7999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||||-|.-.+++.....++-+-++..|..+.+.||+|||+++.||||||..|||+++.|.|||+|||.|....+.
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 999999666555555578999999999999999999999999999999999999999999999999999887544
Q ss_pred ccccccccccCccccc--CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 313 TSRVVTLWYRPPELLL--GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~--g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.+++|||+|||||+++ ..+.|+-++||||||+++.||...+||+...+....+.-|.+.- +|.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sPt-------------- 244 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPT-------------- 244 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CCC--------------
Confidence 5779999999999985 45669999999999999999999999988777766666554311 110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+ -.+.+..+..||..||.+=|..|||++++|.|+|....
T Consensus 245 ----Lq--------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 245 ----LQ--------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred ----CC--------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 00 12457789999999999999999999999999998864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=331.48 Aligned_cols=282 Identities=30% Similarity=0.573 Sum_probs=234.1
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~ 228 (714)
...++|++++++|+|.|+.||.|.+..+++.++||+++. -..+.+.||+.||..|. ||||++|++++.+.....
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 356899999999999999999999999999999999864 34677899999999996 999999999998887777
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-CcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~-g~vKL~DFGla~~~~~~ 307 (714)
..|||||+++..+..+. ..|+.-.++.++.||+.||.|||++||+|||+||.|++||.. ..++|+|+|+|.++.+.
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 88999999986654443 368899999999999999999999999999999999999965 47999999999999765
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCC-CCCCCCChHHHHHHHHHhhCCCCh-hHHhhhhc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK-PVLPGKTEVEQLHRIFKLCGSPSE-DYWRKSKL 385 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~-~pF~g~~~~e~l~~I~k~~G~p~~-~~w~~~~~ 385 (714)
.. ...++.+..|--||+|..-..|+..-|+|||||+|+.|+..+ |.|.|.+..+|+-+|.+++|+..- .|..+..+
T Consensus 187 ~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 KE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 43 456688999999999998888999999999999999999976 566799999999999999997653 35555544
Q ss_pred ccCccccC------Cchhhhhhhhhcc-CCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 386 RHSTVFKP------VQPYRRRIAETFK-DFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 386 ~~~~~~~~------~~p~~~~i~~~~~-~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.....+.. ..+....+...-. -+++++.+||.++|.+|..+|+||.|+|.||||..
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 33222221 1111111111112 24689999999999999999999999999999975
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.24 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=213.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.|+++++||.|+||.||+|++..++..||+|++... .....+.+.+|+.+++.++|+||+++++++.... .+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG--KLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC--eEEEE
Confidence 6799999999999999999999999999999998753 3456677889999999999999999999887654 49999
Q ss_pred Eeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||++++++..+. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccc
Confidence 9999998876544 33456899999999999999999999999999999999999999999999999998764322 122
Q ss_pred cccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 312 MTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+.++.... ++
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~----------- 233 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP----------- 233 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc-----------
Confidence 234567899999998853 2336889999999999999999999998776554444432210 00
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.......++..+.+||.+||..||++||++.++|+||||....
T Consensus 234 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 234 -------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred -------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0001235678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.40 Aligned_cols=256 Identities=28% Similarity=0.490 Sum_probs=215.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++++.||.|+||.||+|.+..++..||+|++..........+.+..|+.+++.++|+||+++++++.......+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999999987666666677889999999999999999999987665556689999
Q ss_pred eeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhh-----hcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 234 EYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCH-----SHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 234 Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH-----~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
||++++.+..++. ....+++..++.++.||+.||.||| +.+|+|+||+|+|||++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999877654443 2467999999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
..... ......+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+... .
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~---------- 226 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--K---------- 226 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--C----------
Confidence 54332 123456899999999987765 789999999999999999999999887744443333210 0
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.......++..+.+||.+||..+|.+|||+.++|+|||+
T Consensus 227 ----------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ----------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 001123567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.55 Aligned_cols=257 Identities=25% Similarity=0.371 Sum_probs=212.0
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|++++.||.|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.... ..|+|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~--~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN--NLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC--EEEEEEE
Confidence 68889999999999999999999999999998643 3455677889999999999999999999887654 4899999
Q ss_pred eccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 235 YMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 235 y~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
|+.++.+..+.. ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 999988765543 34579999999999999999999999999999999999999999999999999997653221 2223
Q ss_pred cccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 314 SRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
...+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 227 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-------------- 227 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------------
Confidence 4468999999998842 2336789999999999999999999998877666655553311000
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 228 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 ------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00113468899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.16 Aligned_cols=254 Identities=27% Similarity=0.473 Sum_probs=216.8
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|++++.||.|+||.||.+++..++..|++|.+............+.+|+.+|++++|+||+++++++.... .+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--TLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC--eEEEEE
Confidence 489999999999999999999999999999998876555666778889999999999999999999987654 499999
Q ss_pred eeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||+.++.+..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 99998777655543 35689999999999999999999999999999999999999999999999999987644332 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+.. +.+.
T Consensus 158 ~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~--------------- 219 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT--------------- 219 (256)
T ss_pred ccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC---------------
Confidence 33457899999999988765 78999999999999999999999998877766666632 1110
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.....++..+.++|.+||..||.+|||+.++|.|+|+
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=339.11 Aligned_cols=280 Identities=37% Similarity=0.662 Sum_probs=226.0
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEEEE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
|++.+.||.|+||.||+|.+..+++.||||.+....... ......+|+..++++. |+||+++++++..... .|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~--~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDE--LYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc--EEEEE
Confidence 688999999999999999998899999999987543222 2233457999999998 9999999999876444 89999
Q ss_pred eeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 234 EYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||+.+.++..+.... ..+++.++..++.||+.+|.|||++||+|+||+|.|||++.++.++|+|||++....... ..
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--PY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--Cc
Confidence 999776665554432 478999999999999999999999999999999999999999999999999998764332 22
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc-cc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST-VF 391 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~-~~ 391 (714)
....++..|+|||++.+...++.++|+|||||++|+|++|.+||++.+..+.+.++....+.+..+.|......... ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 34567899999999876655789999999999999999999999999999999999999999888777553211111 00
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.........+...++..+..+.+||.+||+.||.+|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000111233344557899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=343.50 Aligned_cols=260 Identities=22% Similarity=0.378 Sum_probs=211.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|.+..++..||+|.++... .......+.+|+.+|++++|+||+++++.+.... .+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG--AVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC--eEEEE
Confidence 46899999999999999999999999999999987542 3445577889999999999999999999887654 49999
Q ss_pred EeeccccccccccCC---CCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 233 FEYMEHDLVGLASLP---GMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
|||++++.+..++.. ...+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.++|+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999887766544 2378999999999999999999996 599999999999999999999999999997653221
Q ss_pred CCCcccccccccccCcccccCCC-----CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 309 SVPMTSRVVTLWYRPPELLLGAS-----HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~-----~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
.....+++.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 22346788999999885432 257899999999999999999999976654443333322111110
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......++.++.+||.+||..+|.+||++.++++||||....
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 228 ------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 012235788999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=340.93 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=207.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC----C
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT----S 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~----~ 226 (714)
.+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.++.++ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4678999999999999999999999999999999875432 234678899999998 7999999999876532 2
Q ss_pred ceEEEEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 227 CSLYLVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
..+|+||||+.++.+..+... ...+++..+..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 348999999998776655443 346899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCcccccccccccCcccccCC----CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~----~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
..... ......|++.|+|||++.+. ..|+.++|||||||++|+|++|..||...........+... +
T Consensus 162 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 162 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred ccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 43222 23345789999999998632 24788999999999999999999999765544333222110 0
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.. ......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 233 ----------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 ----------AP---------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------CC---------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00 00112467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=341.03 Aligned_cols=257 Identities=28% Similarity=0.457 Sum_probs=215.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++|+||+++++++.... .+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS--KLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC--eEEEE
Confidence 46899999999999999999999999999999987653 2344566889999999999999999999887654 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
+||+.++.+..+.... .+++..++.++.||+.||.|||+.+|+|+||+|+|||++.++.++|+|||++........ ..
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cc
Confidence 9999998777666554 899999999999999999999999999999999999999999999999999988754322 22
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....+++.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+.... .
T Consensus 156 ~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------------~ 215 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------------P 215 (274)
T ss_pred ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-------------------C
Confidence 3446788999999998766 8999999999999999999999998766554444332210 0
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+..+ ...++.++.++|.+||..||++|||++++|+|+||+..
T Consensus 216 ~~~~--------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 216 PSLE--------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CCCc--------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0000 01268899999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.29 Aligned_cols=288 Identities=35% Similarity=0.562 Sum_probs=229.4
Q ss_pred CeeEEeEEeccCceEEEEEEEccC--CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc--cCCce
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIH--DKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS--QTSCS 228 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~--g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~--~~~~~ 228 (714)
.|++.+.||+|+||.||+|.+..+ +..||||++..........+.+.+|+.+++++ +||||++++++... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 489999999999999999999888 89999999875433334456778899999999 59999999886432 22234
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|++|||+++++...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~~e~~~~~L~~~l-~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 8999999987665544 345679999999999999999999999999999999999999999999999999998764322
Q ss_pred CC---CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 309 SV---PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 309 ~~---~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.. .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..++..+|.++.+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 21 123457899999999887655589999999999999999999999999999999999999999988776554322
Q ss_pred ccCccc---cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 386 RHSTVF---KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 386 ~~~~~~---~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.....+ ....+ ...+....+.++..+.+||.+||+.||.+|||+.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 240 PKAQNYIRSLPNIP-KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhHHHHHHhccccC-CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 111000 00000 1122233455788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.68 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=211.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN---QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..|++.+.||+|+||.||+|.+..++..||||.+.... ......+.+.+|+.+++.+.||||+++++++.......+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999999999999999987542 223456788999999999999999999998766544568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||++++.+..++.....+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999887776665556789999999999999999999999999999999999999999999999999986542211
Q ss_pred --CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 --VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 --~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.......++..|+|||++.+.. ++.++|||||||++|+|++|.+||...+....+..+. ..+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCC----------
Confidence 1122346789999999988755 7999999999999999999999998765554443332 11100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
+ .....++..+.++|.+||. +|+.|||++++++|||+.
T Consensus 228 -----~---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 -----P---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -----C---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 1123467789999999994 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=338.85 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=204.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHH-HHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAI-LRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~i-L~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|.+..+|+.||||++......... ..+..|+.+ ++.++||||+++++++..... +|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~--~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGD--VWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCc--EEE
Confidence 4799999999999999999999999999999999765433333 345556665 666799999999998876544 999
Q ss_pred EEeeccccccccc---cCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 232 VFEYMEHDLVGLA---SLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 232 V~Ey~~g~ll~~~---~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
||||+++.+...+ ......+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999998654332 23445799999999999999999999997 9999999999999999999999999999875422
Q ss_pred CCCCcccccccccccCcccccCC---CCCCccccccchhHHHHHHhhCCCCCCCC-ChHHHHHHHHHhhCCCChhHHhhh
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGA---SHYGAAVDLWSTGCILGELFSGKPVLPGK-TEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~---~~y~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
. ..+...++..|+|||++.+. ..++.++|+|||||++|+|++|..||... ...+.+..+.... .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------- 225 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S-------- 225 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C--------
Confidence 1 12234678999999988652 23688999999999999999999999643 3333333332210 0
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+..+ ...+|.++.+||.+||..||.+|||+.+++.||||...
T Consensus 226 ---------~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 226 ---------PQLP--------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ---------CCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0000 12368899999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=365.60 Aligned_cols=261 Identities=29% Similarity=0.498 Sum_probs=231.2
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
....+-|.++++||+|.|+.|.+|++..++..||||++.....+....+.+.+|+++|..|+|||||+++.++..+..
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~-- 129 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT-- 129 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce--
Confidence 456688999999999999999999999999999999999887777777789999999999999999999999887666
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|+||||+.++.+..++..++.+.+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++.++....
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999999997543
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
...+.||++.|.|||++.|..+.++.+|+||+|++||-|++|..||.|.+-.+.-.+.+. |
T Consensus 210 --~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~--g--------------- 270 (596)
T KOG0586|consen 210 --MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR--G--------------- 270 (596)
T ss_pred --cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee--e---------------
Confidence 456779999999999999999889999999999999999999999998775443332211 0
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+ ..+.--++.++.+||+++|.++|.+|++.++++.|.|....
T Consensus 271 ---k---------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 271 ---K---------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ---e---------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 0 01112367899999999999999999999999999998653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=374.38 Aligned_cols=285 Identities=22% Similarity=0.315 Sum_probs=208.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCC-eEEEEEEe--------------ec-CCCCHHHHHHHHHHHHHHHhCCCCCee
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHD-KIVALKKV--------------RF-DNQDPESVKFMAREIAILRKLDHPNII 215 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-~~VAiK~i--------------~~-~~~~~~~~~~~~rEi~iL~~L~HpnIV 215 (714)
.+.|++++.||+|+||+||+|...... ..+++|.+ .. ..........+.+|+.+|+.++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998754322 22222211 10 012223456688999999999999999
Q ss_pred eeeccccccCCceEEEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 216 KLEGLITSQTSCSLYLVFEYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 216 kl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
++++++..... .|+|++++.++++..+... .......+++.|+.||+.||.|||++|||||||||+||||+.++
T Consensus 227 ~l~~~~~~~~~--~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEAN--TYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECCe--eEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999877654 8999999988776544322 22345678889999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCC-CCCC--CChHHHHHHH
Q 005111 292 ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKP-VLPG--KTEVEQLHRI 368 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~-pF~g--~~~~e~l~~I 368 (714)
.+||+|||++..+...........+||+.|+|||++.+.. |+.++|||||||+||||++|.. ||.+ .....++.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999999877544333344568999999999998766 8999999999999999999875 4432 3455667777
Q ss_pred HHhhCCCChhHHhh----hhcccCccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 369 FKLCGSPSEDYWRK----SKLRHSTVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 369 ~k~~G~p~~~~w~~----~~~~~~~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+..++....++... ..+.....+.... ..+...+ ..++.++.++|.+||.+||.+|||+.|+|.||||...
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG---HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCc---cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 66665443332110 0000000000000 0111111 2467889999999999999999999999999999864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=360.55 Aligned_cols=268 Identities=31% Similarity=0.485 Sum_probs=213.4
Q ss_pred ccccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccccc
Q 005111 146 GWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQ 224 (714)
Q Consensus 146 ~~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~ 224 (714)
..+......|+++++||+||.+.||++.. .....||+|.+.....+...+.-+.+||..|.+| .|.+||+|++|-..
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~- 431 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT- 431 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-
Confidence 34555667899999999999999999974 4557788898888878888999999999999999 59999999997554
Q ss_pred CCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
..++||||||-+.+|-..+.....-++.-.++.|.+|||.|+.++|.+||||.||||.|+|+- .|.+||+|||+|..+
T Consensus 432 -d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 -DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred -CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 345999999999998777666655566669999999999999999999999999999999985 589999999999987
Q ss_pred CCCCCC-CcccccccccccCcccccCCC----------CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhC
Q 005111 305 DPKDSV-PMTSRVVTLWYRPPELLLGAS----------HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG 373 (714)
Q Consensus 305 ~~~~~~-~~~~~~gT~~Y~APE~l~g~~----------~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G 373 (714)
.+.+.. ...+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..-. .++.++..+.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~- 586 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAIT- 586 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhc-
Confidence 655432 234679999999999985422 14678999999999999999999996422 1222222111
Q ss_pred CCChhHHhhhhcccCccccCCchhhhhhhhhccCCc--HHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFP--TSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 374 ~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p--~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.|.. .. .|+.+| .++.++++.||..||.+|||..++|+|||++..+.
T Consensus 587 ~P~~----------~I--------------efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 587 DPNH----------EI--------------EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred CCCc----------cc--------------cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 1100 00 122222 23999999999999999999999999999986554
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=340.38 Aligned_cols=258 Identities=26% Similarity=0.430 Sum_probs=208.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..+|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.... .+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--KLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--EEEE
Confidence 3679999999999999999999999999999999975432 33456789999999999999999999887654 4899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++.+..+......+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+..... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 999999988876665566899999999999999999999999999999999999999999999999999987643221 1
Q ss_pred cccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 312 MTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
.....+++.|+|||.+.+ ...++.++|+|||||++|+|++|.+||......+....+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------------ 224 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------------ 224 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------------
Confidence 233467899999998752 333678999999999999999999998655433322222110
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.+.+.. ......++..+.+||.+||..||++|||++++|+|+|
T Consensus 225 ~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 NFQPPK------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCCCC------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 0011246789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.58 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=214.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++++.||.|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++..... +|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK--LWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe--EEE
Confidence 35689999999999999999999889999999998753 34556778899999999999999999998876544 899
Q ss_pred EEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||++++.+..+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999887766543 45799999999999999999999999999999999999999999999999999876543222
Q ss_pred CcccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 311 PMTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
......+++.|+|||++.. ...++.++|+|||||++|+|++|.+||.+.+....+.++.... ++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---------- 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PP---------- 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CC----------
Confidence 2234568999999998752 2336789999999999999999999998877665555543210 00
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.......++..+.+||..||..||.+|||+.++|+|+||...
T Consensus 227 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 --------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000113467899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=340.90 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=219.9
Q ss_pred eeEE-eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEE
Q 005111 155 FEKL-DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 155 Y~~~-~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
|++. +.||+|+|+.|--|....+|..||||+|.+. ......++.||++++.++ .|+||++|+++|++++. +|||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~--FYLV 154 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR--FYLV 154 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce--EEEE
Confidence 4443 5799999999999999999999999999764 445678899999999999 59999999999988776 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---cEEEeecCcccccCCC--
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLASFFDPK-- 307 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g---~vKL~DFGla~~~~~~-- 307 (714)
||-|.|+.+-..+.....|+|.++..+++.|+.||.|||.+||.||||||+|||..... -||||||.+..-....
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999988777777778999999999999999999999999999999999999987654 4899999987644322
Q ss_pred ----CCCCcccccccccccCccccc----CCCCCCccccccchhHHHHHHhhCCCCCCCCC---------------hHHH
Q 005111 308 ----DSVPMTSRVVTLWYRPPELLL----GASHYGAAVDLWSTGCILGELFSGKPVLPGKT---------------EVEQ 364 (714)
Q Consensus 308 ----~~~~~~~~~gT~~Y~APE~l~----g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~---------------~~e~ 364 (714)
....+.+.+|+..|||||++. ....|+.+.|.||||+|||.||+|++||.|.- ...+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 222345668999999999862 34568999999999999999999999998753 2245
Q ss_pred HHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 365 LHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 365 l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
++.|......+++..| ..++.++++||..+|..|+..|.+|.++|+|||+...
T Consensus 315 FesIQEGkYeFPdkdW-------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDW-------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHhccCCcCChhhh-------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 6666666666666666 4689999999999999999999999999999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=336.00 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=210.6
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC----CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ----DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~----~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
+|.+.+.||+|+||.||+|.+ .+++.+|+|.+..... .......+.+|+.+|+.++|+||+++++++.... .+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN--TI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC--eE
Confidence 478889999999999999985 5889999999876432 2334567889999999999999999999987654 49
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC-
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD- 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~- 308 (714)
|+||||+.++.+..++.....+++..+..++.||+.||+|||+.||+|+||+|+|||++.++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999998888777666689999999999999999999999999999999999999999999999999997653211
Q ss_pred ----CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 309 ----SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 309 ----~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
........++..|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------- 226 (265)
T ss_pred cccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence 11122346789999999987765 789999999999999999999999876655444333221110
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.......++..+.+||.+||..+|.+|||+.++|.||||
T Consensus 227 ----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 ----------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011123578899999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=340.03 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=208.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++..... +|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~--~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK--LWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE--EEEE
Confidence 57889999999999999999999999999999987653 2334567889999999999999999998876544 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++.+..+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cccc
Confidence 999999888776666678999999999999999999999999999999999999999999999999999765432 2222
Q ss_pred ccccccccccCccccc--CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 313 TSRVVTLWYRPPELLL--GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~--g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
....|+..|+|||++. ....++.++|+|||||++|+|++|.+||........+..+... ..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~--------------- 226 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NF--------------- 226 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CC---------------
Confidence 3457899999999874 2233788999999999999999999998765544333222110 00
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.+ + .. .....++..+.+||.+||..||++|||+.++|+|||
T Consensus 227 -~~--~---~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 227 -QP--P---KL-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -CC--C---cc-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00 0 00 001246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=333.19 Aligned_cols=254 Identities=25% Similarity=0.475 Sum_probs=212.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++++.||+|+||.||++.+..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++.... .+|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG--NLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC--eEEEEE
Confidence 589999999999999999999999999999999765444455677899999999999999999999887654 489999
Q ss_pred eeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||+.++.+...... ...+++.++..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..+..... .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-L 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-h
Confidence 99998666544432 33689999999999999999999999999999999999999999999999999987643221 1
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||......+....+.. +..+
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~--------------- 219 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYP--------------- 219 (256)
T ss_pred hhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCCC---------------
Confidence 22345788999999987765 78999999999999999999999987776666555532 1110
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.....++.++.++|.+||..+|.+||++.++|.||||
T Consensus 220 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 220 -----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.14 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=211.7
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC--
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT-- 225 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~-- 225 (714)
+...++|++.+.||.|+||.||+|.+..+++.|++|++.... .....+.+|+.+++++ .|+||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 455689999999999999999999999899999999987543 2346688999999999 7999999999886533
Q ss_pred --CceEEEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecC
Q 005111 226 --SCSLYLVFEYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFG 299 (714)
Q Consensus 226 --~~~l~LV~Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFG 299 (714)
...+|+||||++++.+..+... +..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCc
Confidence 3458999999998776654432 4579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcccccccccccCcccccCC----CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCC
Q 005111 300 LASFFDPKDSVPMTSRVVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375 (714)
Q Consensus 300 la~~~~~~~~~~~~~~~gT~~Y~APE~l~g~----~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p 375 (714)
++........ ......++..|+|||++.+. ..++.++|||||||+||+|++|.+||........+..+.... +
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~ 235 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--P 235 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC--C
Confidence 9976543222 22345689999999987542 346789999999999999999999998766555554442210 0
Q ss_pred ChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 376 SEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 376 ~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
. . + .....++..+.+||.+||..||.+|||+.+++.|||+
T Consensus 236 -~---------------~-------~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 -P---------------T-------L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -C---------------C-------C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 0 0 0012367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=334.28 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=212.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++..... +|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~--~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDK--LWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCE--EEEE
Confidence 679999999999999999999999999999999986532 356788999999999999999999998876544 9999
Q ss_pred EeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||++++.+..+.... ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999998887766544 6899999999999999999999999999999999999999999999999999987643221 1
Q ss_pred cccccccccccCcccccCC--CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 312 MTSRVVTLWYRPPELLLGA--SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~--~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
.....++..|+|||++.+. ..++.++|+|||||++|+|++|.+||.+.+.......+....-.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 223 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP-------------- 223 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC--------------
Confidence 2334678899999998765 237889999999999999999999998877655544432210000
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.. ......++.++.+||.+||..||..|||+.++|.|+|
T Consensus 224 ----~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 224 ----PK------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ----cc------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00 0001235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=343.88 Aligned_cols=258 Identities=27% Similarity=0.490 Sum_probs=213.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..+|++++.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.+.|+||+++++.+.... .+|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC--EEEE
Confidence 4689999999999999999999999999999999876433 23466889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ .
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 9999999887766643 4689999999999999999999999999999999999999999999999999886543322 1
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|++||...+....+..+.. .+.+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~--------------- 235 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE--------------- 235 (296)
T ss_pred cCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC---------------
Confidence 23346889999999987755 78999999999999999999999987766544333221 00000
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..||++|||+.++|+|+||...
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 ----------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ----------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00123577889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=338.45 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=207.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccccc----CC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQ----TS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~----~~ 226 (714)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++.++ +|+||+++++++... ..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 468999999999999999999999999999999986532 3445678899999998 799999999987532 23
Q ss_pred ceEEEEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 227 CSLYLVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
..+|+||||+.++.+..+.. ....+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 45899999999876665443 2346889999999999999999999999999999999999999999999999998865
Q ss_pred CCCCCCCcccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
..... ......+++.|+|||++.. ...++.++|||||||++|+|++|.+||........+..+.....
T Consensus 172 ~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------- 243 (282)
T cd06636 172 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP------- 243 (282)
T ss_pred hcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC-------
Confidence 43222 2234578999999998863 23478899999999999999999999977655444433211000
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.......++..+.+||.+||..||.+|||+.++|.||||
T Consensus 244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000113578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.19 Aligned_cols=253 Identities=30% Similarity=0.428 Sum_probs=212.4
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|++.+.||.|+||.||+|.+..++..||+|++.... ......+.+.+|+.++++++||||+++++++.... .+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE--NMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--eEEEE
Confidence 4899999999999999999999999999999997653 23356778999999999999999999999886554 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+.++.+...+.....+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999998887777666789999999999999999999999999999999999999999999999999998765432 22
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh--HHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE--VEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~--~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
....++..|+|||++.+.. ++.++|+|||||++|+|++|..||...+. .+.+...... .
T Consensus 157 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A--------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c---------------
Confidence 3446788999999987765 79999999999999999999999987664 2222221110 0
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH--HHHHcCcCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA--TLALNSEFF 439 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa--~e~L~Hp~f 439 (714)
.......+|..+.++|.+||..||.+||++ .++++||||
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001123467899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.09 Aligned_cols=244 Identities=21% Similarity=0.222 Sum_probs=204.1
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccc--cCCceEEEEEee
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITS--QTSCSLYLVFEY 235 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~--~~~~~l~LV~Ey 235 (714)
..||+|++|.||+|.. +|+.||||+++.... .....+.+.+|+.+|.+++|||||++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5699999999999975 799999999976533 33345778899999999999999999998866 444458999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccc
Q 005111 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314 (714)
Q Consensus 236 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 314 (714)
+.++.|..++.....+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++..+.... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----cc
Confidence 9999888887777789999999999999999999998 499999999999999999999999999998754321 23
Q ss_pred ccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 315 RVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
.++|..|+|||++.+. ..|+.++|||||||++|||++|..||.+.+..+.+..+......++
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 4678999999998752 3489999999999999999999999998877666665543211110
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....|..+.+||.+||+.||.+|||+.++|+
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11246889999999999999999999999986
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=342.54 Aligned_cols=258 Identities=27% Similarity=0.489 Sum_probs=216.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
...|++++.||.|+||.||+|.+..+++.||||.+..... ...+.+.+|+.+++.++||||+++++++.... .+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGD--ELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCc--eEEE
Confidence 3579999999999999999999999999999999875432 23566889999999999999999999887654 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++++..+... ..+++.++..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 9999999888776654 3689999999999999999999999999999999999999999999999999887644322 1
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+....+..+... +.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------------- 234 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE--------------- 234 (296)
T ss_pred CCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc---------------
Confidence 23346789999999887655 789999999999999999999999988776655544221 1100
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 ----------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ----------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 01123578899999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.65 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=212.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|++++.||+|+||.||+|.+..++..||+|.+............+.+|+.+|+.++||||+++++.+.... .+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK--ALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC--EEEEEE
Confidence 489999999999999999999999999999999876555566788999999999999999999999876544 489999
Q ss_pred eeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-CcEEEeecCcccccCCCCCC
Q 005111 234 EYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 234 Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~-g~vKL~DFGla~~~~~~~~~ 310 (714)
||++++.+..++.. ...+++..+..++.||+.||.|||++||+|+||+|+|||++.+ +.++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 99998777665543 3458999999999999999999999999999999999999865 4689999999987653322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~----------------- 218 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----------------- 218 (256)
T ss_pred -ccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-----------------
Confidence 22346789999999987755 78999999999999999999999988776555544432100
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
......++..+.+||..||..||.+|||+.++|+||||
T Consensus 219 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 -----------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -----------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00112468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=335.73 Aligned_cols=261 Identities=31% Similarity=0.525 Sum_probs=210.4
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC--------CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--------DPESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--------~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
.|.+.+.||.|+||.||+|.+..+|+.||+|.++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 47888999999999999999988999999999865311 1123456888999999999999999999887654
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
. +++||||+.++.+..++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~--~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 Y--LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred c--eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 4 99999999998887777666789999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCC-CcccccccccccCcccccCCC-CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 306 PKDSV-PMTSRVVTLWYRPPELLLGAS-HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 306 ~~~~~-~~~~~~gT~~Y~APE~l~g~~-~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
..... ......++..|+|||++.+.. .++.++|+|||||++|+|++|..||......+.+..+......+
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 231 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-------- 231 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC--------
Confidence 22111 122345788999999987543 37899999999999999999999997665544443332110000
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.+ .......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 232 ------~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 ------PI---------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ------cC---------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00 011224578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.64 Aligned_cols=260 Identities=30% Similarity=0.513 Sum_probs=210.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC----CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ----DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~----~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
.|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+|+.++|+||+++++++..... +
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH--F 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe--E
Confidence 47888999999999999999999999999999975431 12346788999999999999999999999876544 8
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~~~~ 308 (714)
++||||+.++++..++....++++..+..++.||+.||.|||++||+|+||+|+||+++.++ .++|+|||++..+....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999988877766666899999999999999999999999999999999999998776 69999999998764321
Q ss_pred C---CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 309 S---VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 309 ~---~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
. .......++..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+....-.
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 226 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA----------- 226 (268)
T ss_pred ccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-----------
Confidence 1 1112346788999999987755 789999999999999999999999765433333322211000
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
.. .......+++.+.++|.+||..||.+|||+.++|.||||+
T Consensus 227 ----~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ----TT---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ----CC---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00 0011235788999999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=348.46 Aligned_cols=256 Identities=24% Similarity=0.432 Sum_probs=214.6
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
-|.++.+||+|+||.||+|.++.+|..||||.+..+. .++.+..||.||.+++.|++|++|+.|..... +||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD--LWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD--LWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCc--eEeeh
Confidence 4678899999999999999999999999999987653 56778899999999999999999998776555 99999
Q ss_pred eecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 234 EYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 234 Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+.+....++ ..+.+|++.++..+++..|.||+|||...-||||||..|||++-+|..||+|||.|..+.. .....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence 999977766554 4667899999999999999999999999999999999999999999999999999987642 33445
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
.+.+|||.|||||++..-. |+..+||||||++..||..|+|||..-.....+..| --.|+..
T Consensus 187 NTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPT-------------- 248 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPT-------------- 248 (502)
T ss_pred CccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCC--------------
Confidence 6679999999999997665 899999999999999999999999765443222111 1111100
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+...+.++.+||++||.+.|++|-||.++++|+|++..+
T Consensus 249 ---------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 249 ---------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ---------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 011124578899999999999999999999999999999865
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=330.74 Aligned_cols=259 Identities=31% Similarity=0.534 Sum_probs=212.8
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++|+||+++++++.... .+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE--KVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC--EEEEEE
Confidence 488999999999999999999889999999999876555567888999999999999999999999876544 499999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc-
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM- 312 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~- 312 (714)
||+.++++..+......+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999988888777766789999999999999999999999999999999999999999999999999987654332211
Q ss_pred --ccccccccccCcccccCCC--CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 313 --TSRVVTLWYRPPELLLGAS--HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 313 --~~~~gT~~Y~APE~l~g~~--~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
....++..|+|||++.+.. .++.++|||||||++|+|++|..||............... +..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~------------- 224 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK------------- 224 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC-------------
Confidence 1346788999999987643 2688999999999999999999999765432222211111 100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
+..+ ....++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 225 ----~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 ----PPIP-------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----CCCC-------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 112458889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=336.81 Aligned_cols=264 Identities=27% Similarity=0.428 Sum_probs=210.7
Q ss_pred ccccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc-
Q 005111 146 GWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS- 223 (714)
Q Consensus 146 ~~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~- 223 (714)
.+++...++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 456677899999999999999999999999999999999876432 1234577899999999 69999999998643
Q ss_pred --cCCceEEEEEeecccccccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEee
Q 005111 224 --QTSCSLYLVFEYMEHDLVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIAD 297 (714)
Q Consensus 224 --~~~~~l~LV~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~D 297 (714)
.....+|+||||++++.|..++ .....+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 2334589999999988776443 2345789999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCCCcccccccccccCcccccCC----CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhC
Q 005111 298 FGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG 373 (714)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~----~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G 373 (714)
||++..+..... ......|++.|+|||++.+. ..++.++|||||||++|+|++|.+||........+..+....
T Consensus 168 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~- 245 (286)
T cd06638 168 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP- 245 (286)
T ss_pred CCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-
Confidence 999987643322 22344689999999988532 337889999999999999999999998766544433321100
Q ss_pred CCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 374 ~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
+ +. ......++..+.+||.+||+.||++|||+.++|+|+||
T Consensus 246 -~-----------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 -P-----------------PT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -C-----------------Cc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0 00 00012357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.96 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=209.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC---C
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT---S 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~---~ 226 (714)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++...+ .
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4688999999999999999999999999999999986432 2235577899999999 8999999999876433 2
Q ss_pred ceEEEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccc
Q 005111 227 CSLYLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~ 302 (714)
..+|+||||++++.+..++. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 35899999999877765432 34578999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCC----CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLGAS----HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g~~----~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~ 378 (714)
........ .....++..|+|||++.... .++.++|||||||++|+|++|.+||...+....+..+.+.. + ..
T Consensus 177 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~--~-~~ 252 (291)
T cd06639 177 QLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP--P-PT 252 (291)
T ss_pred hccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC--C-CC
Confidence 76433221 12346789999999885432 25789999999999999999999998876655554442210 0 00
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
. .....++..+.+||.+||..||++||++.++|+||||+
T Consensus 253 ------------~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 ------------L-----------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ------------C-----------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 00124567899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=330.20 Aligned_cols=255 Identities=30% Similarity=0.492 Sum_probs=212.7
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN---QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
+|++.+.||+|+||.||+|.+..++..|++|.+.... ...+..+.+.+|+.+++.++|+||+++++++..... +|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~--~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN--LY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe--EE
Confidence 4678889999999999999998899999999987643 224456788999999999999999999998876544 89
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||++++.+..++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999998887777666679999999999999999999999999999999999999999999999999998764332
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
......++..|+|||.+.....++.++|+|||||++|+|++|.+||......+....+.....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE----------------- 219 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----------------
Confidence 223456789999999886554478999999999999999999999987665444444321000
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.......++..+.+||.+||..+|.+|||+.++|.||||
T Consensus 220 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 ----------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 001123568899999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=343.28 Aligned_cols=259 Identities=27% Similarity=0.480 Sum_probs=213.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..+|.+++.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.... .+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGD--ELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--EEEE
Confidence 4789999999999999999999999999999999876433 23456789999999999999999999887654 4899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence 9999999888776643 4689999999999999999999999999999999999999999999999999987643322 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+.+....+..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (297)
T ss_pred cCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------------
Confidence 23346789999999988755 78999999999999999999999987655433222211 01110
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||..||++|||+.++|.||||....
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 235 ----------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 001234678899999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=334.89 Aligned_cols=251 Identities=18% Similarity=0.254 Sum_probs=204.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+|.+++||||+++++++..... +
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT--M 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC--c
Confidence 57999999999999999999765 456789999987543 23445678899999999999999999999876544 8
Q ss_pred EEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||||++++++..++.. ...+++.+++.++.||+.||+|||++|++||||||+|||++.++.++|+|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999888766543 4578999999999999999999999999999999999999999999999999876543222
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------------- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-------------
Confidence 11111223467899999987755 8999999999999999775 99999988777666655321100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.+++..||+.+|.+|||+.++++
T Consensus 228 ---------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ---------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.35 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=210.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.... .+|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNG--DISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCC--EEEEE
Confidence 468889999999999999999999999999999876533 355677889999999999999999999887654 49999
Q ss_pred EeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+.+..+..++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999987776665543 689999999999999999999999 99999999999999999999999999998765432211
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC-----hHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT-----EVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~-----~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
...++..|+|||.+.+.. ++.++|||||||++|+|++|..||.... ..+.+..+... .
T Consensus 158 ---~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~---------- 220 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---P---------- 220 (265)
T ss_pred ---cccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---C----------
Confidence 256788999999987765 7999999999999999999999997642 22222222110 0
Q ss_pred ccCccccCCchhhhhhhhhcc-CCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFK-DFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~-~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+ .... .++..+.+||.+||..||.+|||+.++|.||||+..
T Consensus 221 ------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 221 ------PP---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ------CC---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 00 0011 178889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.39 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=212.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+..... +|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~--~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE--LWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe--EEEE
Confidence 34555677999999999999999999999999986532 3445678899999999999999999998876544 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++++..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... ...
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999999888766543 468999999999999999999999999999999999999999999999999997654322 222
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....++..|+|||++.+.. ++.++|||||||++|||++|..||.+.+....+..+.......
T Consensus 176 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 237 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR----------------- 237 (292)
T ss_pred ceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------------
Confidence 3457899999999987655 7899999999999999999999998877665554442211000
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
......++..+.+||.+||..||.+|||+.++|+||||...+.
T Consensus 238 ---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 238 ---------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ---------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 0001246788999999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.79 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=209.1
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
||.|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++..... +|+||||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY--IYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc--cEEEEecCCCC
Confidence 699999999999999899999999997643 233456779999999999999999999998876544 89999999988
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccc
Q 005111 240 LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL 319 (714)
Q Consensus 240 ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~ 319 (714)
.+..++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 887777666679999999999999999999999999999999999999999999999999998775432 223346789
Q ss_pred cccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC--hHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchh
Q 005111 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT--EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPY 397 (714)
Q Consensus 320 ~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~--~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~ 397 (714)
.|+|||.+.+.. ++.++|+|||||++|+|++|..||.... ..+.+..+......+
T Consensus 157 ~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 213 (262)
T cd05572 157 EYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL---------------------- 213 (262)
T ss_pred CccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC----------------------
Confidence 999999987655 7899999999999999999999998776 444444443100000
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCC
Q 005111 398 RRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQP 443 (714)
Q Consensus 398 ~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~ 443 (714)
......+..+.+||.+||+.||++||| +.|+++||||....
T Consensus 214 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 214 -----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred -----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 011234789999999999999999999 99999999998653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.99 Aligned_cols=253 Identities=29% Similarity=0.477 Sum_probs=209.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||.|+||.||+|.+..++..||+|.+.... ..+.+.+|+.+++.++|+||+++++++..... +|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~--~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTD--LWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCc--EEEE
Confidence 67999999999999999999998889999999986432 26778899999999999999999998876644 8999
Q ss_pred EeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
+||+.++.+..++. ....+++..+..++.||+.||.|||+.+|+|+||+|.||+++.++.++|+|||++........ .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 99999887776654 345789999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....++..|+|||++.+.. ++.++||||||||+|+|++|.+||...+.......+... ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~--------------- 216 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP--------------- 216 (256)
T ss_pred cccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC---------------
Confidence 22345788999999987765 799999999999999999999999876554433222110 00
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
+ .......++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 217 -~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 217 -P-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -C-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 000112467889999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=334.72 Aligned_cols=291 Identities=35% Similarity=0.546 Sum_probs=241.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC---ce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---CS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---~~ 228 (714)
.-+.+--+.||.|+||.||.+.|..+|+.||+|++..-.......+.+.+|+.+|..++|.|++..+++...... ..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred cccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 344555678999999999999999999999999987555555677888999999999999999998876543222 12
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|+|+|+|..++-..+..+ ..++...++-+++||+.||.|||+.+|+||||||.|+|++.+..+||||||+|+..+..+
T Consensus 132 iYV~TELmQSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 7899999988877666654 479999999999999999999999999999999999999999999999999999988888
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh---c
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK---L 385 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~---~ 385 (714)
...++..+.|..|+|||++.|..+|+.++||||+|||+.|||..+-+|......+++..|..++|+|+.+..+... .
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 8888888999999999999999999999999999999999999999999999999999999999999987654321 1
Q ss_pred ccCccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+...-.+..|....+..+- .+-..+..+++..||..||.+|.+.++++.|+|+....
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 11111222222222221111 13345789999999999999999999999999987654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.06 Aligned_cols=256 Identities=30% Similarity=0.498 Sum_probs=212.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..|++++.||+|+||.||+|.+..+++.||+|++.... ...+..+.+.+|+.+++.++||||+++++++..... .|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~--~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT--AWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe--EEE
Confidence 45899999999999999999999999999999987543 344556778899999999999999999999876554 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++++..+......+++..+..++.||+.||.|||+.||+|+||+|.||+++.++.++|+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999998877766555567999999999999999999999999999999999999999999999999999765432
Q ss_pred cccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 312 MTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+.......+... .+
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~-------------- 231 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS-------------- 231 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC--------------
Confidence 23467889999998852 344788999999999999999999999877665544433210 00
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+. .....++..+.+||.+||..||.+|||+.+++.||||...
T Consensus 232 ---~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 232 ---PT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ---CC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 00 0012357789999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=336.06 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=205.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHD-----KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g-----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|..++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~- 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP- 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc-
Confidence 57899999999999999999876555 789999987442 34556678999999999999999999998875544
Q ss_pred eEEEEEeeccccccccccCCC----------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPG----------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~----------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
.|++|||++++.+..++... ..+++..+..++.||+.||.|||++||+|+||||+|||+++++
T Consensus 83 -~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 83 -TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred -eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 89999999987765544322 4588999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 005111 292 ILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIF 369 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~ 369 (714)
.++|+|||++........ .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+.+..+....|.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999986543322 1223345688999999987765 7999999999999999998 999998877766555543
Q ss_pred HhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 370 KLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 370 k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
... .......+|.++.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~----------------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQ----------------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCC----------------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 210 001124678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.73 Aligned_cols=255 Identities=33% Similarity=0.507 Sum_probs=214.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~ 230 (714)
++|++.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++++. |+||+++++++..... +|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~--~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN--LY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce--EE
Confidence 47999999999999999999999999999999987642 23344567889999999998 9999999998876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS- 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~- 309 (714)
+||||+.++.+..++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999998877776666666899999999999999999999999999999999999999999999999999987654332
Q ss_pred ------------------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHh
Q 005111 310 ------------------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL 371 (714)
Q Consensus 310 ------------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~ 371 (714)
.......++..|+|||++.+.. ++.++|+|||||++++|++|..||...+....+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 1122345689999999887655 789999999999999999999999988766555554321
Q ss_pred hCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH----HHHHcCcCC
Q 005111 372 CGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA----TLALNSEFF 439 (714)
Q Consensus 372 ~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa----~e~L~Hp~f 439 (714)
.. .....+++.+.+||.+||..||.+|||+ .++|+||||
T Consensus 238 ~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EY-----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CC-----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 10 1113468899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.35 Aligned_cols=257 Identities=30% Similarity=0.443 Sum_probs=215.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||.|++|.||+|.+..+++.||+|++...... .....+.+|+.++..++|+||+++++++.... .+|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEG--EISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC--eEEEE
Confidence 4689999999999999999999999999999998765432 45677889999999999999999999887654 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||++++.+..++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999988888777666789999999999999999999999 99999999999999999999999999999877543322
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC---hHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT---EVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~---~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.... ..+....+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~------------- 219 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP------------- 219 (264)
T ss_pred ccceeecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC-------------
Confidence 22446789999999887764 7999999999999999999999998764 2222222211 00
Q ss_pred ccccCCchhhhhhhhhccC-CcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKD-FPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~-~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
....... ++..+.++|..||..+|++|||+.++|+||||+..
T Consensus 220 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 220 ------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 0011123 78899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=334.15 Aligned_cols=258 Identities=28% Similarity=0.495 Sum_probs=211.9
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeccccccCCceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD---HPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIVkl~~~~~~~~~~~l~ 230 (714)
.|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. |||++++++++.... .+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~--~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP--RLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC--EEE
Confidence 5888999999999999999999999999999987543 2344567889999999996 999999999886544 489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||+.++.+..+...+ .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 79 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS- 156 (277)
T ss_pred EEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc-
Confidence 999999998877666543 799999999999999999999999999999999999999999999999999987754432
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
......|+..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+.......+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------------- 217 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------------- 217 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------------
Confidence 2234468899999999876555789999999999999999999999876544332221100
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..+. + ....++.++.+||.+||..||.+|||+.+++.|+||....
T Consensus 218 ~~~~------~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 218 KPPR------L--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCC------C--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 0000 0 0012678999999999999999999999999999998643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=352.37 Aligned_cols=248 Identities=26% Similarity=0.421 Sum_probs=208.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
..+.+++.||+|-||.||+|.... ...||+|.++...+.. +.|.+|+.+|++|+|+|||++++++..+.. +|||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p--iyIV 279 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEP--IYIV 279 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCc--eEEE
Confidence 345678899999999999997542 3379999998765443 346799999999999999999999987665 9999
Q ss_pred EeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||..|.|..+++. +..+...+.+.++.||++|++||+++++|||||-..||||++++.+||+|||+|+........
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 999998877666654 678999999999999999999999999999999999999999999999999999965544443
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
...+.--..-|.|||.+.-.. ++.++|||||||+||||+| |+.||++.+..+.+..+.+...-|
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-------------- 424 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-------------- 424 (468)
T ss_pred ecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC--------------
Confidence 333333367799999998665 8999999999999999999 899999999999999885532211
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+..+|+++.+|+..||..+|++|||.+.+..
T Consensus 425 --------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 425 --------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred --------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 23578999999999999999999999986543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=352.48 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=219.6
Q ss_pred eeEE--eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 155 FEKL--DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 155 Y~~~--~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
|++. +.||+|-||+||-|++..+|+.||||+|.+-.........+.+|+.||..+.||.||.|.-.|+..+. +++|
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er--vFVV 641 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER--VFVV 641 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce--EEEE
Confidence 6665 78999999999999999999999999997765555555789999999999999999999888876655 9999
Q ss_pred EeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---cEEEeecCcccccCCCC
Q 005111 233 FEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLASFFDPKD 308 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g---~vKL~DFGla~~~~~~~ 308 (714)
||-+.|+.|..++. ..++|++...+.++.||+.||.|||.++|+|+||||+|||+.... ++||||||+|+.+.+..
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 99999999987654 567899999999999999999999999999999999999997643 79999999999997654
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh-HHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE-VEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
. ..+.+|||.|+|||+|.... |+..-|+||+|+|+|--|+|..||....+ .++++...
T Consensus 722 F--RrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------------ 780 (888)
T KOG4236|consen 722 F--RRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------------ 780 (888)
T ss_pred h--hhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhHHhhccc------------------
Confidence 3 45679999999999999877 89999999999999999999999976543 34444321
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+-|. .-|+.++..+++||..+|++.-.+|.|.+..|.|||++.+.
T Consensus 781 --FMyPp--------~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 781 --FMYPP--------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred --cccCC--------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 11111 22467899999999999999999999999999999999753
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=327.84 Aligned_cols=258 Identities=25% Similarity=0.435 Sum_probs=212.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN---QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..|++.+.||+|+||.||+|.+..++..||+|.+.... ........+.+|+.++++++|+||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999986532 223456788899999999999999999998866555568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
++||||+.++.+..+......+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999887776665556789999999999999999999999999999999999999999999999999986532111
Q ss_pred --CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 --VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 --~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.......++..|+|||++.+.. ++.++|+|||||++|+|++|.+||......+.+.++. ..+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~---------- 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTK---------- 227 (264)
T ss_pred cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCC----------
Confidence 1123346789999999998765 7899999999999999999999998776655554442 11110
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
......++..+.++|.+||. +|..|||+.++|.|||.
T Consensus 228 --------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 --------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01124578899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.51 Aligned_cols=263 Identities=27% Similarity=0.393 Sum_probs=209.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|+.++.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.....+.+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 468999999999999999999999999999999875433 2456678899999999999999999998876665669999
Q ss_pred Eeecccccccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 233 FEYMEHDLVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 233 ~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
|||++++.|..+. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 9999987665432 234568999999999999999999999999999999999999999999999999987654222
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh-----HHHHHHHHHhhCCCChhHHhhh
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE-----VEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~-----~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
. ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... .+....+... ...
T Consensus 160 ~---~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~------ 226 (287)
T cd06621 160 A---GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNP------ 226 (287)
T ss_pred c---ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cch------
Confidence 1 2335688999999887655 79999999999999999999999986521 2222221110 000
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.. ......-..+++.+.+||.+||..||.+|||+.|++.|+||...
T Consensus 227 ------~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 227 ------EL-------KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred ------hh-------ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 00 00000001356789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.36 Aligned_cols=254 Identities=27% Similarity=0.488 Sum_probs=209.7
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++.+.||.|+||.||++.+..+|..||+|.+..........+.+.+|+.+++.++|+||+++++.+.... .+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG--RLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC--eEEEEE
Confidence 489999999999999999999999999999999765444445567889999999999999999999886654 489999
Q ss_pred eeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcccccCCCCCC
Q 005111 234 EYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 234 Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~~~~~~ 310 (714)
||+.++.+..+... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .++|+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 99998776655433 23589999999999999999999999999999999999999886 469999999987653322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 218 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------ 218 (257)
T ss_pred cccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------------
Confidence 222346789999999887665 7899999999999999999999998776555544432210
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
+......++..+.++|.+||..+|++|||+.++|.||||
T Consensus 219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 001123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.04 Aligned_cols=259 Identities=23% Similarity=0.283 Sum_probs=200.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc----------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI----------------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~----------------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIV 215 (714)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 34579999987542 344566788999999999999999
Q ss_pred eeeccccccCCceEEEEEeeccccccccccCC-------------------CCCCCHHHHHHHHHHHHHHhhHhhhcCee
Q 005111 216 KLEGLITSQTSCSLYLVFEYMEHDLVGLASLP-------------------GMKFTESQVKCYMKQLLSGLEHCHSHGVL 276 (714)
Q Consensus 216 kl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~-------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIi 276 (714)
++++++..... +||||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVDEDP--LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEecCCc--eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999876554 8999999998766544321 12478889999999999999999999999
Q ss_pred eccCCCccEEEcCCCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh--CC
Q 005111 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GK 353 (714)
Q Consensus 277 HrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt--G~ 353 (714)
||||||+|||++.++.+||+|||++..+....... .....++..|+|||++.+.. ++.++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCC
Confidence 99999999999999999999999998764332211 12234578899999987765 8999999999999999987 56
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHH
Q 005111 354 PVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA 433 (714)
Q Consensus 354 ~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~ 433 (714)
.||.+.+..+.+..+......... ..+ ......+|..+.+||.+||+.||.+|||+.++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~----------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGR-----------QVY----------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccc-----------ccc----------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 788776665555443221100000 000 01123578899999999999999999999999
Q ss_pred Hc
Q 005111 434 LN 435 (714)
Q Consensus 434 L~ 435 (714)
.+
T Consensus 299 ~~ 300 (304)
T cd05096 299 HA 300 (304)
T ss_pred HH
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=339.45 Aligned_cols=259 Identities=25% Similarity=0.443 Sum_probs=212.9
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|+....||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++..... +|+||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~--~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE--LWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCe--EEEEE
Confidence 34556679999999999999999999999999875432 234568899999999999999999998876544 89999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 175 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-cccc
Confidence 99998887765543 468999999999999999999999999999999999999999999999999997654322 2223
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
..+++..|+|||++.+.. ++.++|||||||++|+|++|++||...+..+.+..+.. .+. ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~-~~-------------- 236 (297)
T cd06659 176 SLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPP-PK-------------- 236 (297)
T ss_pred ceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCC-CC--------------
Confidence 457899999999997765 79999999999999999999999988776665554421 000 00
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
......++..+.++|..||+.||.+|||+.++++|+||.....+
T Consensus 237 --------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 237 --------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred --------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCc
Confidence 01123567889999999999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.91 Aligned_cols=257 Identities=28% Similarity=0.472 Sum_probs=213.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
..|+.++.||.|+||.||+|.+..++..||||++.... .......+.+|+.+++.+.|+||+++++++.... .+|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--KLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC--EEEEE
Confidence 45788899999999999999999999999999987543 2345677889999999999999999999887654 49999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++.+..++.. .++++.++..++.||+.||+|||+.+++|+||+|+|||++.++.++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 999999887766654 4789999999999999999999999999999999999999999999999999977643322 22
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....++..|+|||++.+.. ++.++|+|||||++|+|++|.+||.+.+.......+.. +.+
T Consensus 159 ~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~----------------- 218 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNP----------------- 218 (277)
T ss_pred ccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCC-----------------
Confidence 3346788999999987765 78999999999999999999999987765544333211 000
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||..+|++|||+.++|.|+||....
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 219 ---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 011234678899999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.70 Aligned_cols=254 Identities=30% Similarity=0.493 Sum_probs=214.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++.+.||.|+||.||++.+..++..||+|++............+.+|+.+++.++|+|++++++.+... ..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 58999999999999999999998999999999987665566777889999999999999999999987765 3499999
Q ss_pred eeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 234 EYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 234 Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||++++.+...... +..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99998776655433 3679999999999999999999999999999999999999999999999999998765433
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------------- 219 (258)
T ss_pred ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----------------
Confidence 1223346789999999887765 7899999999999999999999998776554444432210
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
. ......++..+.++|..||..+|++|||+.++|+||||
T Consensus 220 -~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 -Y----------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -C----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0 01112578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.60 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=211.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.... .+||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN--NICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC--EEEE
Confidence 468999999999999999999999999999999987543 3445677889999999999999999999987664 4999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||++++++..+......+++..+..++.||+.||.|||+ .+|+|+||+|+|||++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999998887777666689999999999999999999997 699999999999999999999999999987543221
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHH----HHHHHHhhCCCChhHHhhhhcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ----LHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~----l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
....+++..|+|||++.+.. ++.++|||||||++|+|++|..||......+. ...+... +......
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 228 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------LQQIVQE 228 (284)
T ss_pred -cCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH--------HHHHhhc
Confidence 12346899999999987764 78999999999999999999999986554211 1111100 0000000
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..+. + ....++..+.+||.+||..||.+|||+.++++|+||...
T Consensus 229 ----~~~~------~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 229 ----PPPR------L--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred ----cCCC------C--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0000 0 001367889999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.28 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=198.9
Q ss_pred EEeccCceEEEEEEEccCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHH---hCCCCCeeeeeccccccCCceEEEEEee
Q 005111 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD-PESVKFMAREIAILR---KLDHPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~-~~~~~~~~rEi~iL~---~L~HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
.||+|+||.||+|.+..+++.||+|.+...... ........+|..+++ ..+||||+.+++++...+. +|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~--~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK--LCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe--EEEEEec
Confidence 389999999999999999999999998764322 122223344544444 3479999999998876544 8999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccc
Q 005111 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315 (714)
Q Consensus 236 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 315 (714)
+.++.+..++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 9998887777666789999999999999999999999999999999999999999999999999997654322 1234
Q ss_pred cccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChH--HHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV--EQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 316 ~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~--e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
.||+.|+|||++.+...++.++|||||||++|+|++|..||.+.... ..+..+.. .
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---------------~------- 213 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---------------T------- 213 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---------------c-------
Confidence 68999999998875444789999999999999999999999764321 11111100 0
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
........++..+.+||.+||..||.+|+ |+.++++||||....+
T Consensus 214 ------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 214 ------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred ------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 00012245788999999999999999999 6999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.74 Aligned_cols=262 Identities=21% Similarity=0.319 Sum_probs=206.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|+..+.||+|+||.||++.+..++..||+|.+...... .....+.+|+.++.++. |+||+++++++..... .++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~--~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD--CWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc--EEE
Confidence 4677788999999999999999999999999998765333 45567889999999996 9999999998766544 899
Q ss_pred EEeeccccccccc----cCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 232 VFEYMEHDLVGLA----SLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 232 V~Ey~~g~ll~~~----~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+|||+...+.... ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9999987543321 12345799999999999999999999975 999999999999999999999999999976543
Q ss_pred CCCCCcccccccccccCcccccCC--CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGA--SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~--~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.. ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+.+........
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~------ 230 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI------ 230 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc------
Confidence 22 12334678999999998766 3589999999999999999999999976542 222222211110000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
. .......++..+.+||.+||..||++|||+.+++.||||...
T Consensus 231 ----------~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 231 ----------L-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ----------C-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 0 001113478899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.76 Aligned_cols=254 Identities=26% Similarity=0.368 Sum_probs=204.1
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++..... +|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD--LCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe--EEEEEecCCCC
Confidence 6999999999999999999999999875422 22334556789999999999999999998876544 89999999987
Q ss_pred ccccccCCCC--CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccc
Q 005111 240 LVGLASLPGM--KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317 (714)
Q Consensus 240 ll~~~~~~~~--~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 317 (714)
.+..++.... .+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 7765554333 6999999999999999999999999999999999999999999999999999876432 22234467
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchh
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPY 397 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~ 397 (714)
+..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+....-
T Consensus 157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------ 211 (277)
T cd05577 157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL------------------------ 211 (277)
T ss_pred CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc------------------------
Confidence 88999999988766 78999999999999999999999977554211112211000
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 398 RRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 398 ~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
.........+++.+.+||.+||+.||.+|| ++.+++.||||....+
T Consensus 212 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 212 -EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred -cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 000112245788999999999999999999 9999999999987554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.26 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=204.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|.+.+.||+|+||.||+|.+..++..||+|++.... .....+.+|+.+|+.++|+||+++++++..... +++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--FYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC--cEEE
Confidence 56899999999999999999999999999999986432 335668899999999999999999998876554 8999
Q ss_pred EeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||++++.+..++.. ...+++..++.++.||+.||.|||++||+|+||||+|||+++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999998777655432 345899999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||++.+..+....+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------- 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY----------------- 222 (263)
T ss_pred ccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----------------
Confidence 222223356799999887765 7899999999999999998 999999877655544442210
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.. .....+|..+.+||.+||..||++|||+.++++
T Consensus 223 --~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 --RM---------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 112457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=332.30 Aligned_cols=257 Identities=26% Similarity=0.468 Sum_probs=213.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|...+.||+|++|.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..... .|+|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~--~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE--LWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe--EEEEE
Confidence 4666789999999999999999999999999986532 2345568899999999999999999998775544 89999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
||+.++.+..+... ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 99998888766655 5789999999999999999999999999999999999999999999999999876543221 223
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
...|++.|+|||++.+.. ++.++|||||||++|+|++|..||...+....+..+.... .+.
T Consensus 174 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~----------------- 234 (285)
T cd06648 174 SLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PPK----------------- 234 (285)
T ss_pred cccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CCC-----------------
Confidence 346899999999987765 7999999999999999999999998877766665553210 000
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||..||.+|||+.++|+|+||....
T Consensus 235 --------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 235 --------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred --------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 001123678999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=322.16 Aligned_cols=254 Identities=31% Similarity=0.504 Sum_probs=215.7
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++++.|+|++++++++.... .+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD--SLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC--EEEEEE
Confidence 488999999999999999999989999999999876554566788999999999999999999999887653 489999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
||++++.+..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 99999888777666678999999999999999999999999999999999999999999999999999877544332 23
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
...++..|+|||.+.+.. ++.++||||||+++|+|++|.+||...+....+.++... ..
T Consensus 158 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------~~-- 216 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD------------------DH-- 216 (254)
T ss_pred ccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc------------------CC--
Confidence 346789999999887765 789999999999999999999999876654444333210 00
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
......++..+.++|.+||..+|++|||+.++|.||||
T Consensus 217 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 217 --------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 01123568899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=324.80 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=206.5
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++.+.||.|+||.||++.+..++..||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.... .+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG--HLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC--EEEEEE
Confidence 58999999999999999999999999999999875432 345677889999999999999999999887654 499999
Q ss_pred eeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........ .
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 9999866544332 345689999999999999999999999999999999999999999999999999987643222 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|.+||...+.......+.... .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------- 217 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS--Y---------------- 217 (255)
T ss_pred cccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC--C----------------
Confidence 23456889999999987765 7999999999999999999999998877655544442210 0
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
. .....++..+.+||.+||+.||++|||+.++|.-
T Consensus 218 ~----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 K----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred C----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 0112467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=347.40 Aligned_cols=281 Identities=31% Similarity=0.519 Sum_probs=230.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC------CCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD------HPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~------HpnIVkl~~~~~~~~ 225 (714)
...|++....|+|-||+|..|.|..-|..||||+|+.. +...+.=++|++||++|+ --|++.|+..|....
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 36799999999999999999999999999999999854 234556678999999994 357889988887665
Q ss_pred CceEEEEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLAS 302 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~ 302 (714)
. +|||||-+..+|...+.. .+..|....++.|++||+.||..|-..||+|.||||+||||++.. .+||||||.|.
T Consensus 508 H--LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 508 H--LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred e--eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 5 999999999887665543 334588899999999999999999999999999999999999754 68999999999
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
...... .+.+..+..|+|||+++|.+ |+...|+||+||+||||.||+.+|+|.+....+...+.+-|.++..+..+
T Consensus 586 ~~~ene---itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASENE---ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccc---ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 876554 45677899999999999988 89999999999999999999999999999999999999999999988877
Q ss_pred hhcccCc-------------------------cccCCchhhhhhhhh--c----cCCcHHHHHHHHHhcccCcCCCCCHH
Q 005111 383 SKLRHST-------------------------VFKPVQPYRRRIAET--F----KDFPTSALRLMETLMSIDPAHRGTAT 431 (714)
Q Consensus 383 ~~~~~~~-------------------------~~~~~~p~~~~i~~~--~----~~~p~~l~~LI~~mL~~DP~kRpTa~ 431 (714)
..+.... ..+|...+...+... + ..+-..+.+||.+||..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 6543210 111211121111110 0 11224689999999999999999999
Q ss_pred HHHcCcCCCC
Q 005111 432 LALNSEFFTT 441 (714)
Q Consensus 432 e~L~Hp~f~~ 441 (714)
++|.||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.64 Aligned_cols=283 Identities=33% Similarity=0.563 Sum_probs=234.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
..+|.-+..+|.|.- .|..|-|..+++.||+|++..........++..+|..++..+.|+||++++.+|+.... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888899999998 89999999999999999986654445567778899999999999999999999876543 2
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+|||||..++-..+. ..++-..+..++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+..+..
T Consensus 95 e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 479999999998877666 46788999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
..++.+++|..|+|||++.+.. |...+||||+|||+.||++|..+|+|.+..++..+|...+|.|...+..+..-..
T Consensus 172 --~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred --cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 4577889999999999999988 8999999999999999999999999999999999999999999998876521100
Q ss_pred CccccCCchhh-hhhhhhccC------------CcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 388 STVFKPVQPYR-RRIAETFKD------------FPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 388 ~~~~~~~~p~~-~~i~~~~~~------------~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.........|. ..+.+.|++ -...+.+|+.+||..||++|.++.++|+||||+-
T Consensus 249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 00000000000 111122221 2345899999999999999999999999999983
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.55 Aligned_cols=252 Identities=31% Similarity=0.484 Sum_probs=207.9
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++.+.... .+|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK--NLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc--EEEEEEecCCCC
Confidence 6899999999999998999999999875432 2345677889999999999999999999876544 489999999987
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-------CCc
Q 005111 240 LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-------VPM 312 (714)
Q Consensus 240 ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-------~~~ 312 (714)
.+..++.....+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 7776665555899999999999999999999999999999999999999999999999999876543211 122
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+..+....+.. +... |
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---~------------ 220 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKIE---W------------ 220 (265)
T ss_pred cCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcC---C------------
Confidence 3346788999999987766 78999999999999999999999988876665555432 1000 0
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH---HHHHcCcCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA---TLALNSEFFTTQ 442 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa---~e~L~Hp~f~~~ 442 (714)
+ ....++..+.+||.+||+.+|.+|||+ .++|+||||+..
T Consensus 221 ---~-------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 221 ---P-------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ---C-------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 0 001258899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=335.28 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=212.7
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|..+++||+|+||.||+|++..++..||+|++.... ........+.+|+.+++.++|||++++++++..... .|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 99 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT--AWLV 99 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE--EEEE
Confidence 3777888999999999999999999999999997653 234455678899999999999999999999876544 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+.++++..+......+++.++..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..... .
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~ 174 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----A 174 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----C
Confidence 99999887776665566799999999999999999999999999999999999999999999999999865322 2
Q ss_pred ccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 313 TSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
....++..|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+..+.... .+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~~-------------- 239 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SPT-------------- 239 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCC--------------
Confidence 24467899999999852 2347889999999999999999999998877666655543210 000
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.....++..+.+||.+||+.+|.+|||+.++|.||||...+
T Consensus 240 ------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 240 ------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00124677899999999999999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=330.44 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=199.5
Q ss_pred EEeccCceEEEEEEEccCCeEEEEEEeecCCCC-HHHHHHHHHH---HHHHHhCCCCCeeeeeccccccCCceEEEEEee
Q 005111 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD-PESVKFMARE---IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~-~~~~~~~~rE---i~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
.||+|+||.||+|.+..+++.||+|++...... ......+..| +..++...||+|+.+++++..... +|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~--~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK--LSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE--EEEEEec
Confidence 389999999999999999999999998764322 1111223333 344555689999999998876554 8999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccc
Q 005111 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315 (714)
Q Consensus 236 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 315 (714)
+.|+.+..+......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..+.... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 9998887777666789999999999999999999999999999999999999999999999999997654322 2234
Q ss_pred cccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHH--HHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ--LHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 316 ~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~--l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
+|+..|+|||++.+...++.++|||||||++|+|++|..||.+...... ...... . .
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~-~------------------ 214 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--T-M------------------ 214 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--c-c------------------
Confidence 7899999999987655589999999999999999999999987632211 111100 0 0
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
.......++..+.+||.+||..||.+|| ++.++++||||....+
T Consensus 215 -------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 215 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred -------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCc
Confidence 0011234688999999999999999999 9999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.70 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=199.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHD-----KIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||.||+|++..+| ..||+|++..... ......+.+|+.+|+.+ +|+|||++++++....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 357999999999999999999865443 5799999975432 34466788999999999 8999999999887655
Q ss_pred CceEEEEEeeccccccccccCC----------------------------------------------------------
Q 005111 226 SCSLYLVFEYMEHDLVGLASLP---------------------------------------------------------- 247 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~---------------------------------------------------------- 247 (714)
. +|||||||.++.+..++..
T Consensus 116 ~--~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 116 P--VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred C--eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 4 8999999998766543311
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc-cc
Q 005111 248 ------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM-TS 314 (714)
Q Consensus 248 ------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~-~~ 314 (714)
..++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+........ ..
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 13578899999999999999999999999999999999999999999999999986543322111 12
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
..+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||........+..+..... ..
T Consensus 274 ~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~------------------~~ 334 (374)
T cd05106 274 ARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY------------------QM 334 (374)
T ss_pred CCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc------------------Cc
Confidence 23456799999987655 8999999999999999997 9999987654433333322100 00
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. ....+|.++.+||.+||+.||.+|||+.++++
T Consensus 335 ~---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 S---------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred c---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 01235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=326.56 Aligned_cols=252 Identities=29% Similarity=0.396 Sum_probs=203.1
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHH-HhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAIL-RKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL-~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||.|+||.||+|.+..+++.||+|+++.... .......+..|..++ ..++|+||+++++++.... .+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD--YLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC--eEEEEEecc
Confidence 569999999999999999999999999875432 122233445555544 4458999999999987654 499999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRV 316 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~ 316 (714)
.++.+..++.....+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.++|+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9988887776666899999999999999999999999999999999999999999999999999876432 12335
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||...+.......+...... +.
T Consensus 155 ~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------~~---- 213 (260)
T cd05611 155 GTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN----------------WP---- 213 (260)
T ss_pred CCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC----------------CC----
Confidence 788999999998766 799999999999999999999999887766555544221100 00
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC---HHHHHcCcCCCCCC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGT---ATLALNSEFFTTQP 443 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT---a~e~L~Hp~f~~~~ 443 (714)
......++..+.++|.+||+.||++||| ++|+|.||||....
T Consensus 214 -----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 214 -----EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred -----CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 0112357899999999999999999995 47999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=325.06 Aligned_cols=249 Identities=21% Similarity=0.365 Sum_probs=203.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|+++++||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++..... +|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP--IYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC--cEE
Confidence 46899999999999999999986 456779999876432 235678899999999999999999998765544 899
Q ss_pred EEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||+.++.+..++. ....+++..+..++.||+.||+|||+.+++|+||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999998876665543 345689999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM-------------- 223 (261)
T ss_pred eccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 2222334567899999987655 7899999999999999998 99999988776665555321100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|.++.+||.+||..||++|||++++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 --------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=337.92 Aligned_cols=285 Identities=26% Similarity=0.424 Sum_probs=224.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--------CCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD--------HPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--------HpnIVkl~~~~~~ 223 (714)
.++|.++++||.|-|++||+|.|..+.+.||+|+++-. ....+....||.+|+++. ..+||+|+++|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 37899999999999999999999999999999999743 234556678999999983 3579999999875
Q ss_pred cC--CceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCC---------
Q 005111 224 QT--SCSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHN--------- 290 (714)
Q Consensus 224 ~~--~~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~--------- 290 (714)
.+ ...++||||+++..||.++...+ ..++...++.|++|||.||.|||.. ||||.||||+|||+..+
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 43 34689999999999999887654 4589999999999999999999965 99999999999998000
Q ss_pred --------------------------------------------------------------------------------
Q 005111 291 -------------------------------------------------------------------------------- 290 (714)
Q Consensus 291 -------------------------------------------------------------------------------- 290 (714)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------CcE
Q 005111 291 -----------------------------------------------------------------------------GIL 293 (714)
Q Consensus 291 -----------------------------------------------------------------------------g~v 293 (714)
-.+
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 025
Q ss_pred EEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC------ChHHHHHH
Q 005111 294 KIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK------TEVEQLHR 367 (714)
Q Consensus 294 KL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~------~~~e~l~~ 367 (714)
||+|||.|.++. ...+.-+.|..|+|||+++|.. |++.+||||++|++|||+||..+|... -+.+.+..
T Consensus 394 KIaDlGNACW~~----khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhhh----hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 677777777653 2234556799999999999988 899999999999999999999999643 36789999
Q ss_pred HHHhhCCCChhHHhh-----------hhcccCccccCCchhhhhhhhhcc---CCcHHHHHHHHHhcccCcCCCCCHHHH
Q 005111 368 IFKLCGSPSEDYWRK-----------SKLRHSTVFKPVQPYRRRIAETFK---DFPTSALRLMETLMSIDPAHRGTATLA 433 (714)
Q Consensus 368 I~k~~G~p~~~~w~~-----------~~~~~~~~~~~~~p~~~~i~~~~~---~~p~~l~~LI~~mL~~DP~kRpTa~e~ 433 (714)
|+.++|..+...... ..+.+....++-. +...+.+.+. .-..++.+||.-||+.+|++||||.++
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~Wp-L~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWP-LYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCc-HHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 999999877643332 2333333333322 2222332221 223568899999999999999999999
Q ss_pred HcCcCCCCCCCC
Q 005111 434 LNSEFFTTQPLA 445 (714)
Q Consensus 434 L~Hp~f~~~~~~ 445 (714)
|+|||+...+.+
T Consensus 548 l~hPwLn~~~~~ 559 (590)
T KOG1290|consen 548 LKHPWLNPVAGP 559 (590)
T ss_pred hcCccccCCCCC
Confidence 999999976654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=334.83 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=210.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
..|+.++.||+|+||.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++++..... +|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK--LWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc--eEEE
Confidence 357778889999999999999999999999999875533 2355678899999999999999999998876544 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+..... ..
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-hh
Confidence 999998877766644 4789999999999999999999999999999999999999999999999999987643321 12
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....++..|+|||++.+.. ++.++|+|||||++|+|++|.+||...........+... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-------------------~~ 218 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN-------------------SP 218 (277)
T ss_pred hcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC-------------------CC
Confidence 2345788999999987765 789999999999999999999999765544333222110 00
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+ .....++..+.+||.+||..+|.+|||+.++|.||||...
T Consensus 219 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 219 P---------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred C---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 0 0112467889999999999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.09 Aligned_cols=261 Identities=27% Similarity=0.391 Sum_probs=225.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
+..+|..+.+||+|+||.|.+|..+.+.+.||||+++.+. ...+.++-...|-++|... .-|.+++|+..|..-+.
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR-- 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR-- 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh--
Confidence 4578999999999999999999999999999999998873 2233455556788888766 57899999998876655
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|+||||+.|+.|...++.-++|.|..+..|+.+|+.||-+||++|||+||||.+|||++.+|++||+|||+++.-- -.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc-cC
Confidence 99999999998888777777899999999999999999999999999999999999999999999999999997532 22
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+.||||.|+|||++.-.+ |+.++|+||+||+|||||.|++||.|+++.+.++.|....-+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvs-------------- 568 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVS-------------- 568 (683)
T ss_pred CcceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCc--------------
Confidence 33455679999999999988766 899999999999999999999999999999999999753222
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQPL 444 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~~ 444 (714)
.++.++.++.++...+|.+.|.+|.. -.++-.||||....|
T Consensus 569 ---------------yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 569 ---------------YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred ---------------CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 22468999999999999999999965 367889999997665
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.26 Aligned_cols=259 Identities=30% Similarity=0.518 Sum_probs=214.3
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|.+.+.||+|++|.||+|.+..+++.|++|++..........+.+.+|+.++++++|+||+++++.+.......+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47889999999999999999998999999999987654456678899999999999999999999988765334599999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC-Cc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV-PM 312 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~-~~ 312 (714)
||++++.+..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99988877776666568999999999999999999999999999999999999999999999999999887654321 12
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... ....+.....
T Consensus 161 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~------------------- 218 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS------------------- 218 (260)
T ss_pred cCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc-------------------
Confidence 3346789999999887765 79999999999999999999999987652 1111111110
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
..........++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 219 -----~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 -----SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -----cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000011223468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=369.13 Aligned_cols=149 Identities=28% Similarity=0.417 Sum_probs=133.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.+.|.++++||+|+||.||+|.+..+++.||||+++.. .........+.+|+.++..++||||+++++++.... .+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN--NVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC--EEE
Confidence 47899999999999999999999999999999999754 234455678899999999999999999998876554 499
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccc
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~ 302 (714)
|||||+.++.|..++.....+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999988777666655678999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.82 Aligned_cols=265 Identities=27% Similarity=0.408 Sum_probs=219.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
...|..++.||-|+||.|.+++...|...||+|.+++. ......+.++..|-.||..-+++.||+||..|.+.+. +|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn--LY 705 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN--LY 705 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc--eE
Confidence 35799999999999999999999999999999999764 4455677888999999999999999999888776655 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC--
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD-- 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~-- 308 (714)
+||||++||.+..++..-+.|.|..++.|+.++.+|+++.|..|+|||||||+|||||.+|+|||+||||++-+....
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999987766555556689999999999999999999999999999999999999999999999999996432110
Q ss_pred -------C--------------------------------CCcccccccccccCcccccCCCCCCccccccchhHHHHHH
Q 005111 309 -------S--------------------------------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGEL 349 (714)
Q Consensus 309 -------~--------------------------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeL 349 (714)
. ....+.+||+.|+|||+|...+ |+..+|+||+|||||||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHH
Confidence 0 0012468999999999998776 89999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC
Q 005111 350 FSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT 429 (714)
Q Consensus 350 ltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT 429 (714)
+.|++||-..+..+.-.+|.. |... ..+.. -.+++.++.+||.++. .+++.|..
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n---------w~~~-----l~~~~-----------~~~ls~e~~~li~kLc-~sad~RLG 918 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN---------WRNF-----LHIPY-----------QGNLSKEALDLIQKLC-CSADSRLG 918 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee---------hhhc-----ccccc-----------ccccCHHHHHHHHHHh-cChhhhhc
Confidence 999999998887776666543 3221 01110 1358999999999874 57888874
Q ss_pred ---HHHHHcCcCCCCCCCC
Q 005111 430 ---ATLALNSEFFTTQPLA 445 (714)
Q Consensus 430 ---a~e~L~Hp~f~~~~~~ 445 (714)
++++..||||+...+.
T Consensus 919 kng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred ccchhhhhcCccccccchH
Confidence 7889999999987654
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=325.34 Aligned_cols=254 Identities=30% Similarity=0.470 Sum_probs=205.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++.+.||+|+||.||+|++..+++.||||.+... ..+......+.+|+.+|+.++||||+++++++..... +|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE--LNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe--EEE
Confidence 5799999999999999999999999999999988753 3345566778899999999999999999998876544 899
Q ss_pred EEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 232 VFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
||||++++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999876654432 3446899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh-HHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE-VEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.. ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||..... ...+...+...+.++.
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd08228 160 TT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL--------- 228 (267)
T ss_pred hH-HHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC---------
Confidence 22 122346788999999987765 78999999999999999999999865432 1222222221111110
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
....++..+.+||.+||..+|++|||+.++|+.
T Consensus 229 -----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 -----------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -----------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=325.25 Aligned_cols=253 Identities=22% Similarity=0.290 Sum_probs=202.6
Q ss_pred eeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
|.+.+.||+|+||.||+|....+ +..||+|+++...........+.+|+.+|+.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57889999999999999987653 4789999998765555566788999999999999999999997654332 2
Q ss_pred eEEEEEeeccccccccccC------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 228 SLYLVFEYMEHDLVGLASL------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
..++||||+.++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 3799999999877654431 2246899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 302 SFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 302 ~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
+.+....... .....++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~---- 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--R---- 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C----
Confidence 8764332211 11123467899999887655 7999999999999999999 899998877665554442210 0
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......++..+.++|.+||..||.+|||+.+++.+
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ----------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.23 Aligned_cols=252 Identities=33% Similarity=0.535 Sum_probs=210.5
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++.+.||+|++|.||++.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++..... .++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE--LWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe--EEEEE
Confidence 58899999999999999999988999999999976433 456778899999999999999999998876544 89999
Q ss_pred eeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 234 EYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||+++..+..+.... ..+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999987777665543 5799999999999999999999999999999999999999999999999999987754432 2
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+....+..+.. ...+. .
T Consensus 155 ~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~--------------~- 217 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPG--------------L- 217 (253)
T ss_pred cceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCC--------------c-
Confidence 3456789999999987765 78999999999999999999999987765544444322 00000 0
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
+ ....++..+.++|..||..||.+|||+.++|.|||
T Consensus 218 ---~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 218 ---R-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---C-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 00124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=335.11 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=213.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..|...+.||+|+||.||+|++..++..||+|++.... ...+....+.+|+.+++.++|||++++++++..... .||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT--AWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe--EEE
Confidence 34889999999999999999999999999999987652 334556778899999999999999999998876554 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.+.++........++++.++..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++......
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 9999998777666555667999999999999999999999999999999999999999999999999998765322
Q ss_pred cccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 312 MTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+..+......+
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 243 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-------------- 243 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------------
Confidence 23467899999998742 2347899999999999999999999998776665555553311100
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....++..+.+||.+||..+|.+|||+.++++|+|+...
T Consensus 244 -------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 -------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0012467789999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=324.52 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=201.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|... .+..+|+|.+...... ...+.+|+.+|+.++||||+++++++..... +|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP--LYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCC--EEEE
Confidence 56899999999999999999864 4567999987644322 3457789999999999999999998876554 8999
Q ss_pred EeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||++++.+..++. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999877665553 33468999999999999999999999999999999999999999999999999998654332222
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |++||...+..+.+..+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------------- 220 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------------- 220 (256)
T ss_pred cCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------------
Confidence 22233466899999987665 7999999999999999999 89999988877766666431100
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+..+.+||.+||..||.+|||+.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=346.98 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=199.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEE-----ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARD-----VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d-----~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||.||+|.+ ..++..||||+++.... ....+.+.+|+.+|..+ +|||||++++++....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 35799999999999999999964 34677899999875432 23456788999999999 8999999999987665
Q ss_pred CceEEEEEeeccccccccccCC----------------------------------------------------------
Q 005111 226 SCSLYLVFEYMEHDLVGLASLP---------------------------------------------------------- 247 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~---------------------------------------------------------- 247 (714)
. .|+|||||+++.|..++..
T Consensus 113 ~--~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 113 P--TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred c--ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 4 8999999998765433321
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 248 -----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 248 -----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 125788999999999999999999999999999999999999999999999999876433221
Q ss_pred C-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 311 P-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 311 ~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
. .....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+......+.+++...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~---------------- 333 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG---------------- 333 (375)
T ss_pred cccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC----------------
Confidence 1 11223456799999998765 8999999999999999998 899998765443333332210
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
... ......+.++.+||..||+.||++|||+.++++.
T Consensus 334 --~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 --YRM---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --ccC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 000 0112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=353.11 Aligned_cols=252 Identities=29% Similarity=0.496 Sum_probs=206.8
Q ss_pred EEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccc
Q 005111 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
+||+|+||+||.|+|..|...+|||.+... +....+-+..||.+.+.|.|.|||+++|.+...+ ++-|.||-++||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG--f~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG--FFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC--eEEEEeecCCCC
Confidence 699999999999999999999999998643 3345667889999999999999999999876544 488999999999
Q ss_pred ccccccCCC-CCC--CHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc-CCCcEEEeecCcccccCCCCCCCcccc
Q 005111 240 LVGLASLPG-MKF--TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDSVPMTSR 315 (714)
Q Consensus 240 ll~~~~~~~-~~l--se~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~-~~g~vKL~DFGla~~~~~~~~~~~~~~ 315 (714)
.|..+++.. +++ .|..+-.|.+||++||.|||++.|||||||.+||||+ -.|.+||.|||.++++..-.. -+.++
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence 888776644 456 8999999999999999999999999999999999997 589999999999998753322 23456
Q ss_pred cccccccCccccc-CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCC
Q 005111 316 VVTLWYRPPELLL-GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV 394 (714)
Q Consensus 316 ~gT~~Y~APE~l~-g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~ 394 (714)
.||+.|||||++. |...|+.++|||||||++.||.||+|||... |.|...+++ ...|+..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El-------------gspqAAMFk------VGmyKvH 797 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL-------------GSPQAAMFK------VGMYKVH 797 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec-------------CChhHhhhh------hcceecC
Confidence 8999999999985 4555999999999999999999999999643 222222221 1112211
Q ss_pred chhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 395 ~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
. .++..++.+++.||.+|+.+||.+||+|.++|..||++..
T Consensus 798 P-------~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 798 P-------PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred C-------CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1 1224577889999999999999999999999999999864
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=328.15 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=212.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+-|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++..... +|+|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe--EEEE
Confidence 357889999999999999999988999999999865432 3455678899999999999999999998876554 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++++..++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..+..... ..
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 999999887766644 4689999999999999999999999999999999999999999999999999976643221 12
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
....++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||...........+... + +
T Consensus 159 ~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-~----------------- 218 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N-P----------------- 218 (277)
T ss_pred ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C-C-----------------
Confidence 2346788999999887654 688999999999999999999999876654444433110 0 0
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++.++.++|.+||..||.+||++.++++||||...
T Consensus 219 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 219 ---------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 01113568899999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.05 Aligned_cols=279 Identities=21% Similarity=0.289 Sum_probs=206.0
Q ss_pred eEEecc--CceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQG--TYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G--~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
..||.| +||+||+|++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++..... +|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~--~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW--LWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc--eEEEEecc
Confidence 346666 99999999999999999999998765556667889999999999999999999999987654 89999999
Q ss_pred cccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC---
Q 005111 237 EHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP--- 311 (714)
Q Consensus 237 ~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~--- 311 (714)
.++.+..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 98776655443 2358999999999999999999999999999999999999999999999998654332111100
Q ss_pred ---cccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 312 ---MTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 312 ---~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+..++...... .|.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 238 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYS---PLDITTFPC 238 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCC---Cccccccch
Confidence 0011345679999998764 337899999999999999999999998877655554443321111 110000000
Q ss_pred Cc-c-------c---------c----CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 ST-V-------F---------K----PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~~-~-------~---------~----~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.. . + . ...............++..+.+||.+||+.||++|||+.++|+|+||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00 0 0 0 00000000011123467889999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.16 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=204.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..+|.+++.||+|+||.||+|.+.. ++..||+|++.... ..+..+.+.+|+.+|+.+.|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 3578999999999999999998743 46889999987543 23456788999999999999999999999876644
Q ss_pred ceEEEEEeeccccccccccCC--------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc
Q 005111 227 CSLYLVFEYMEHDLVGLASLP--------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI 292 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~--------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~ 292 (714)
+|+||||+.++.+..++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 83 --PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred --eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999998877655432 235889999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHH
Q 005111 293 LKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370 (714)
Q Consensus 293 vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k 370 (714)
++|+|||++..+...... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999999765332211 112234578899999998765 8999999999999999998 9999988776665555432
Q ss_pred hhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 371 LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 371 ~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. .. ......++..+.+||.+||+.||++|||+.|+++
T Consensus 240 ~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 G--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred C--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 1 00 0111357889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=332.93 Aligned_cols=258 Identities=28% Similarity=0.492 Sum_probs=212.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..... +|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~--~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDE--LWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc--EEE
Confidence 4789999999999999999999988999999999865322 334668899999999999999999998876544 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++.+..+... ..+++.++..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+..... .
T Consensus 94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 9999999888776654 3689999999999999999999999999999999999999999999999999876654332 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....+++.|+|||++.+.. ++.++|+|||||++|+|++|.+||...+..+.+..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (293)
T ss_pred cccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------------
Confidence 23346789999999987655 78999999999999999999999987765544332211 00000
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..+|++||++.+++.|+||...
T Consensus 235 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 235 ----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 00123467889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.50 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=201.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.... .+|+|
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--FFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC--EEEEE
Confidence 33444568999999999999999999999999886542 345567889999999999999999999887654 48999
Q ss_pred EeeccccccccccCCC-CCC--CHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeecCcccccCCCC
Q 005111 233 FEYMEHDLVGLASLPG-MKF--TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKD 308 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~-~~l--se~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla~~~~~~~ 308 (714)
|||+.++.|..++... ..+ ++..+..++.||+.||+|||++||+|+||||+|||++. ++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999988777655432 345 88999999999999999999999999999999999986 6799999999997664322
Q ss_pred CCCcccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
. ......+++.|+|||++.+. ..++.++|+|||||++|+|++|.+||................
T Consensus 164 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 227 (268)
T cd06624 164 P-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--------------- 227 (268)
T ss_pred C-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------
Confidence 2 22234578999999998653 237889999999999999999999997543221111000000
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.........++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus 228 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 -----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00011123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.82 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=200.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTS 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~ 226 (714)
++|++.+.||.|+||.||+|.+.. +++.||+|+++... .....+.+.+|+.++.++ +|+||+++++++...+
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~- 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG- 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-
Confidence 579999999999999999997543 45889999987543 334456788999999999 8999999999876543
Q ss_pred ceEEEEEeeccccccccccCC-----------------------------------------------------------
Q 005111 227 CSLYLVFEYMEHDLVGLASLP----------------------------------------------------------- 247 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~----------------------------------------------------------- 247 (714)
..+|++|||+.++.+..++..
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 348999999998776544321
Q ss_pred --CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC-CcccccccccccCc
Q 005111 248 --GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPP 324 (714)
Q Consensus 248 --~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~AP 324 (714)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 126899999999999999999999999999999999999999999999999999876432221 12233456789999
Q ss_pred ccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhh
Q 005111 325 ELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAE 403 (714)
Q Consensus 325 E~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~ 403 (714)
|++.+.. ++.++|||||||+||+|++ |.+||.+....+.+...+... . .. .
T Consensus 245 E~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~-----------------~~---------~ 296 (337)
T cd05054 245 ESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-T-----------------RM---------R 296 (337)
T ss_pred HHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc-C-----------------CC---------C
Confidence 9998766 8999999999999999998 999998755443333322110 0 00 0
Q ss_pred hccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 404 TFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 404 ~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
....++.++.+++.+||+.+|++|||+.++++|
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=329.53 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=209.8
Q ss_pred CeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCc
Q 005111 154 TFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDN--QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~--~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~ 227 (714)
.|++.+.||.|+||.||+|.+. .+|..||+|+++... ......+.+.+|+.+|.++ +|+||+++++.+....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT-- 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC--
Confidence 4889999999999999999875 478999999987532 1223456678999999999 6999999998887654
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||++++.+..++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 48999999998877777666667999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.........++..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.+.+-.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------ 226 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK------------ 226 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc------------
Confidence 33333445689999999998653 23678999999999999999999999754322222222111000
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
... .....++..+.+||.+||..||.+|| ++.+++.||||....
T Consensus 227 ------~~~-------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 227 ------SEP-------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ------cCC-------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 000 01134788899999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.87 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=200.0
Q ss_pred eEEeEEeccCceEEEEEEEccCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc----CCceE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDK--IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ----TSCSL 229 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~--~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~----~~~~l 229 (714)
.+.+.||+|+||.||+|.+..++. .||+|.++.........+.+.+|+.+|+.++|+||+++++++... .....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999999877765 699999877655566678889999999999999999999875321 12247
Q ss_pred EEEEeecccccccccc------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 230 YLVFEYMEHDLVGLAS------LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~------~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
++||||+.++.+..+. .....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 8999999987665432 1234589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 304 FDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 304 ~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
+....... .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~------ 232 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN--R------ 232 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--C------
Confidence 64332211 11223467899999887765 7999999999999999999 899998876655444442200 0
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......++..+.++|.+||+.||++|||+.+++++
T Consensus 233 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 --------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00113567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.94 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=202.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeec-ccccc---C-
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEG-LITSQ---T- 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~-~~~~~---~- 225 (714)
...+++.+.|.+|||+.||+|.+...|..||+|++-.. ++...+.+.+||.+|++|. |+|||.+++ ..... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 46788999999999999999999888899999998654 6788999999999999996 999999999 33222 2
Q ss_pred CceEEEEEeeccc-cccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 226 SCSLYLVFEYMEH-DLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 226 ~~~l~LV~Ey~~g-~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
...++|.||||.| ++++.+.. -...|+|.+++.|+.|+++||++||... |||||||-|||||+.+|.+||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 2458899999995 66665542 2345999999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCC-CCCc-------ccccccccccCcccc---cCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHH
Q 005111 302 SFFDPKD-SVPM-------TSRVVTLWYRPPELL---LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370 (714)
Q Consensus 302 ~~~~~~~-~~~~-------~~~~gT~~Y~APE~l---~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k 370 (714)
...-... .... ....-|+.|+|||++ .|.+ ++.++|||+|||+||-|+....||.+......+..-+
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p-I~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y- 271 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP-IGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY- 271 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC-CcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc-
Confidence 7532211 1000 012349999999997 3444 7999999999999999999999998764432221110
Q ss_pred hhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 371 LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 371 ~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.+. .++.++..+.+||..||+.||.+||++.+++.+-+
T Consensus 272 -------------------~~P-----------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 272 -------------------SFP-----------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred -------------------cCC-----------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 111 12457889999999999999999999999998655
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.17 Aligned_cols=259 Identities=20% Similarity=0.293 Sum_probs=204.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4689999999999999999997652 356899998865432 2334457789999999999999999998876544
Q ss_pred ceEEEEEeeccccccccccCC----------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEe
Q 005111 227 CSLYLVFEYMEHDLVGLASLP----------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~----------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~ 296 (714)
.|+||||+.++.|..++.. ...++...+..++.||+.||.|||+++|+||||||+|||++.++.++|+
T Consensus 84 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 84 --TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred --cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 8999999998777655532 1335677899999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCC
Q 005111 297 DFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGS 374 (714)
Q Consensus 297 DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~ 374 (714)
|||+++......... .....++..|+|||.+.+.. ++.++|+|||||++|||++ |.+||.+.+..+.+..+... +.
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~ 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GY 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 999998654322211 11224467899999987655 7999999999999999998 78999887765554444220 00
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc------CcCCCCC
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN------SEFFTTQ 442 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~------Hp~f~~~ 442 (714)
......++..+.+||.+||+.||.+|||+.++++ ||||...
T Consensus 240 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 240 ---------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 0011246789999999999999999999999987 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.48 Aligned_cols=252 Identities=26% Similarity=0.446 Sum_probs=211.7
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+|++.+.||.|+||.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++++.... .+|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN--KLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC--EEEEEe
Confidence 489999999999999999999999999999999866545556677889999999999999999999887654 499999
Q ss_pred eeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 234 EYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 234 Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||+++..+..+... ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99998777655433 356899999999999999999999999999999999999999999999999999877544
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+..+....+....
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 217 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK----------------- 217 (256)
T ss_pred -CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Confidence 222346789999999987765 7899999999999999999999998877655444432100
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
+ ......++.++.++|.+||..+|.+|||+.++|+||++
T Consensus 218 -~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 -Y----------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -C----------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0 01112467889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=333.72 Aligned_cols=273 Identities=23% Similarity=0.277 Sum_probs=201.3
Q ss_pred CceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccccccccc
Q 005111 165 TYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLA 244 (714)
Q Consensus 165 ~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~ 244 (714)
++|.||.+++..+++.||||++..........+.+.+|+.+|+.++|+||+++++++..... +|++|||+.++++..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~--~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE--LYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe--EEEEEeccCCCCHHHH
Confidence 44566666667799999999998765556677889999999999999999999998876554 8999999998877665
Q ss_pred cCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC------CCccccc
Q 005111 245 SLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS------VPMTSRV 316 (714)
Q Consensus 245 ~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~------~~~~~~~ 316 (714)
+.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||.+..+..... .......
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 543 34689999999999999999999999999999999999999999999999999875532211 1112335
Q ss_pred ccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChh----HHhhhhcccCc--
Q 005111 317 VTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED----YWRKSKLRHST-- 389 (714)
Q Consensus 317 gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~----~w~~~~~~~~~-- 389 (714)
++..|+|||++.+. ..|+.++|||||||++|+|++|..||........+... ..|..... .+.........
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCccccccCchhhhcCCcCccc
Confidence 67889999998753 34789999999999999999999999876654433222 12221110 00000000000
Q ss_pred --cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 --VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 --~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..... ............++..+.+||..||..||++|||+.++|+||||+..
T Consensus 248 ~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 248 SSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00000 00000111122456789999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.21 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=196.7
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccc
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH 238 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g 238 (714)
+.||+|+||.||+|.+..+++.||+|.+... ...+....+.+|+.+|+.++||||+++++++..... +||||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP--IYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC--eEEEEeeccC
Confidence 3699999999999999999999999987643 234556778899999999999999999998876554 8999999998
Q ss_pred cccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc-ccc
Q 005111 239 DLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT-SRV 316 (714)
Q Consensus 239 ~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~-~~~ 316 (714)
+.+..++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++............ ...
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 77776654 3446899999999999999999999999999999999999999999999999999865432111111 112
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCc
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~ 395 (714)
.+..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+.......+..... .
T Consensus 158 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-------------------~-- 215 (252)
T cd05084 158 IPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-------------------L-- 215 (252)
T ss_pred CceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------------------C--
Confidence 245699999987765 7999999999999999998 8899977665544433322100 0
Q ss_pred hhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 396 p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.27 Aligned_cols=252 Identities=22% Similarity=0.376 Sum_probs=203.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEc----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.+|++.+.||+|+||.||+|... .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP-- 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc--
Confidence 67899999999999999999853 456789999987543 34455678899999999999999999998876554
Q ss_pred EEEEEeeccccccccccCC-----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 229 LYLVFEYMEHDLVGLASLP-----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
.|+||||+.++.+..++.. ...+++.++..++.||+.||.|||++||+|+||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 8999999998766544321 23478999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 005111 292 ILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIF 369 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~ 369 (714)
.+||+|||++..+..... .......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+.+..+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999987643321 1122334567899999987765 7999999999999999998 999998877655555442
Q ss_pred HhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 370 KLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 370 k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
... . ......++..+.+||..||+.||++||++.+++++
T Consensus 241 ~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQ-L---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCC-c---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 210 0 01123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.65 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=204.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.++|++.+.||+|+||.||+|.+..+ ...||||+++... .......+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP-- 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc--
Confidence 36799999999999999999987654 4689999987543 34455678899999999999999999998876544
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|+||||+.++.+..++.. ...+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 8999999998877766543 457899999999999999999999999999999999999999999999999999987522
Q ss_pred CCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 308 DSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 308 ~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... ......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL----------- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 211 111223467899999887665 7999999999999999998 99999877766555554321100
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......+..+.+||..||+.||++||++.+++++
T Consensus 228 -----------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 -----------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.22 Aligned_cols=253 Identities=17% Similarity=0.274 Sum_probs=201.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 467999999999999999999864 245789999986432 23345568899999999999999999998865544
Q ss_pred ceEEEEEeeccccccccccCC----------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEe
Q 005111 227 CSLYLVFEYMEHDLVGLASLP----------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~----------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~ 296 (714)
.++||||++++.+..++.. ...++...+..++.||+.||.|||+.|++|+||||+|||++.++.++|+
T Consensus 84 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 84 --TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred --eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 8999999998877655432 1236788899999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCC
Q 005111 297 DFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGS 374 (714)
Q Consensus 297 DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~ 374 (714)
|||++.......... .....+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+... +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GL 239 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 999997654322211 11234577899999987755 7999999999999999999 78999887765555443221 00
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......++..+.+||.+||+.||++|||+.+++++
T Consensus 240 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 ---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00113467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.53 Aligned_cols=244 Identities=24% Similarity=0.331 Sum_probs=200.1
Q ss_pred EEeccCceEEEEEEE--ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 160 KIGQGTYSSVYRARD--VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d--~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
.||+|+||.||+|.+ ..++..||+|++..........+.+.+|+.+|+.++||||+++++++... ..++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE---SWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC---CcEEEEecCC
Confidence 589999999999964 46789999999876655566677899999999999999999999987532 3789999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC--cccc
Q 005111 238 HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP--MTSR 315 (714)
Q Consensus 238 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~--~~~~ 315 (714)
++.+..++.....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++..+....... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 88777666666679999999999999999999999999999999999999999999999999998764332211 1122
Q ss_pred cccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCC
Q 005111 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV 394 (714)
Q Consensus 316 ~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~ 394 (714)
.++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+....+.+...
T Consensus 159 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--------------------- 216 (257)
T cd05116 159 KWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--------------------- 216 (257)
T ss_pred CCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC---------------------
Confidence 3357899999887654 7899999999999999998 9999988777666555532100
Q ss_pred chhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 395 ~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......++.++.+||.+||+.||+.||++.++..
T Consensus 217 -------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 -------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0112357889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.56 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=201.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeE----EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKI----VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~----VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..+|++++.||+|+||.||+|.+..++.. ||+|++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~-- 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC--
Confidence 46799999999999999999988766654 899998643 23445667889999999999999999999886532
Q ss_pred eEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.++|+||+.++.+..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 -~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 83 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred -ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 6899999998766555443 44689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
..... .....++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+. ..++.....+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--------- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL--------- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC---------
Confidence 32211 12223467899999988765 7999999999999999997 9999987665443 2332210000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....++..+.++|.+||..||.+|||+.+++.+
T Consensus 231 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.18 Aligned_cols=247 Identities=23% Similarity=0.355 Sum_probs=196.4
Q ss_pred CCeeEEeEE--eccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKI--GQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~L--G~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l 229 (714)
+.|++.+.+ |.|+||.||++.+..++..+|+|++....... .|+.+...+ +||||+++++.+..... +
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~--~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKG--H 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCe--e
Confidence 556776666 99999999999999999999999987542211 122222222 79999999999876654 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~~~~ 308 (714)
|+||||++++.|..++.....+++.+++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999999877776666556899999999999999999999999999999999999999998 9999999999876422
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHH-HHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ-LHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~-l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
....++..|+|||++.+.. ++.++|||||||++|+|++|..||......+. ...+.... .
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------- 224 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q------------- 224 (267)
T ss_pred ----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c-------------
Confidence 2236789999999998765 78999999999999999999999986543321 11111100 0
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-HHHHHcCcCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-ATLALNSEFFT 440 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-a~e~L~Hp~f~ 440 (714)
.....++.+++.+.+||.+||+.||.+|++ .+++|+||||.
T Consensus 225 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 225 ------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 000112357899999999999999999997 59999999996
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.22 Aligned_cols=256 Identities=31% Similarity=0.505 Sum_probs=211.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..|..++.||+|+||.||+|++..++..||+|.+... .........+.+|+.+++.++|+|++++++++..... .|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~l 92 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWL 92 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe--eEE
Confidence 4588889999999999999999999999999998754 2234456678899999999999999999998876544 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.+.+...+......+++.++..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 9999998776665555567899999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 312 MTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+.... .+
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~-------------- 232 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP-------------- 232 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CC--------------
Confidence 23467889999999853 2336889999999999999999999997766554444432210 00
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..+|.+|||+.+++.|+||...
T Consensus 233 ------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 ------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00012467889999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.32 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=201.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.+.||+|+||.||+|.+. .++.||+|.++.... ..+.+.+|+.++++++||||+++++++..... +|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP--IYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCC--eee
Confidence 357999999999999999999864 457899999875432 24557889999999999999999998876554 899
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||+.++.+..+... +..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999987766655433 24689999999999999999999999999999999999999999999999999987753222
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
........+..|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+....+..+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------------- 223 (261)
T ss_pred cccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1111222245799999887655 7999999999999999999 99999988776666555321100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.+||.+||..||.+||++.+++.
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 --------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.94 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=200.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|.+++.||+|+||.||+|.... +..||+|.+..... ....+.+|+.+++.++||||+++++++..... +|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP--IYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC--cEEE
Confidence 578999999999999999997643 45699998875432 23457899999999999999999999876554 8999
Q ss_pred EeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||+.++.+..++.. ...+++..++.++.||+.||.|||+.||+|+||||.|||++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999998766655433 3468999999999999999999999999999999999999999999999999998654332211
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------------- 220 (256)
T ss_pred cCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------------
Confidence 12223467899999987655 7999999999999999998 99999877766555555321100
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......+..+.++|.+||..||.+|||+.+++.+
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0012357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.40 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=200.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.++||+|+||.||+|.+..++ .||+|++..... ..+.+.+|+.+++.++||||+++++++.. . ..|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~--~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-C--CcEEE
Confidence 56999999999999999999876554 599999875432 23467899999999999999999987643 2 37999
Q ss_pred EeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+.++.+..++.. ...+++..+..++.||+.||+|||+.+|+|+||||+|||++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999998776655543 345899999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM--------------- 222 (262)
T ss_pred cccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC---------------
Confidence 222334567899999887655 7999999999999999999 88999887766655554221000
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 223 -------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011357889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=325.86 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=203.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH-----DKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~-----g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||.||++.+... ...||+|.+.... .......+.+|+.++.++ +|+||+++++++....
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 46899999999999999999987643 3789999987543 234456788999999999 8999999999887655
Q ss_pred CceEEEEEeecccccccccc----------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC
Q 005111 226 SCSLYLVFEYMEHDLVGLAS----------------LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH 289 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~----------------~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~ 289 (714)
. +|+||||+.++.+..++ .....+++..+..++.||+.||.|||++||+|+||||+|||++.
T Consensus 90 ~--~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 90 P--LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred C--eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 4 89999999987766544 23456899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHH
Q 005111 290 NGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHR 367 (714)
Q Consensus 290 ~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~ 367 (714)
++.+||+|||+++.+....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 9999999999998765332211 11223456799999887655 7999999999999999997 9999988766554444
Q ss_pred HHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 368 IFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 368 I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
+.... . ......++..+.+||.+||..||.+|||+.++|++
T Consensus 247 ~~~~~-------------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGY-------------------R---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCC-------------------c---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 32100 0 01113467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.07 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=203.9
Q ss_pred eEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEee
Q 005111 159 DKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
+.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.+++.++|+||+++++++.... .+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEE--PLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCC--ceEEEEEe
Confidence 3699999999999998866 8999999998664333 5678899999999999999999999887643 49999999
Q ss_pred ccccccccccCCC---------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 236 MEHDLVGLASLPG---------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 236 ~~g~ll~~~~~~~---------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+.++.+..++... ..+++..++.++.||+.||.|||++||+|+||+|+|||++.++.++|+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9887776665543 7899999999999999999999999999999999999999999999999999987754
Q ss_pred CCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.. +.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~---------- 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--GY---------- 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC----------
Confidence 321 1122345688999999987764 7999999999999999999 6999998876655555432 00
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.......+|..+.++|.+||..||.+|||+.+++.+
T Consensus 225 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ----------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.47 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=200.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|.+. .+..||+|.+...... .+.+.+|+.++++++|+||+++++++.. . ..|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~--~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-E--PIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-C--CcEE
Confidence 357899999999999999999765 5667999998765433 3457899999999999999999998743 2 3799
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||+.++.+..+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999998777655432 34589999999999999999999999999999999999999999999999999987644322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR--------------- 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 2222234466899999887655 7899999999999999999 8999988777666655532100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......++..+.+||.+||..||.+|||+.+++.
T Consensus 222 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 222 -------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112357889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.96 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=202.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
+.|.+.+.||+|+||.||++.+. .++..||+|.+... .......+.+|+.+|++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP- 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc-
Confidence 67999999999999999999853 34677999988643 33456678899999999999999999998876544
Q ss_pred eEEEEEeeccccccccccCCC-------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEE
Q 005111 228 SLYLVFEYMEHDLVGLASLPG-------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILK 294 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~-------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vK 294 (714)
+|+||||+.++.+..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++
T Consensus 82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 82 -LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred -cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 89999999987776554321 2489999999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhh
Q 005111 295 IADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLC 372 (714)
Q Consensus 295 L~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~ 372 (714)
|+|||++......... ......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+.+..+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999865432211 112234577899999987755 7999999999999999998 999998877666655553210
Q ss_pred CCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 373 GSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 373 G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. ......++.++.+||.+||+.||.+|||+.+++.
T Consensus 240 --~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 --V--------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred --c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0011246789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.78 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=202.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.+.|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3679999999999999999999877 78899999886543 23345568889999999999999999998766544
Q ss_pred ceEEEEEeeccccccccccCCC-------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---cEEEe
Q 005111 227 CSLYLVFEYMEHDLVGLASLPG-------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIA 296 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~-------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g---~vKL~ 296 (714)
.|+||||+.++.+..++... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+
T Consensus 84 --~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 84 --RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred --cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999987776554322 2589999999999999999999999999999999999998765 59999
Q ss_pred ecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCC
Q 005111 297 DFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGS 374 (714)
Q Consensus 297 DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~ 374 (714)
|||++..+....... ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+... +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc
Confidence 999998763222111 11223356799999997765 8999999999999999997 99999987766554443221 00
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
+ .....+|..+.+||.+||+.||++|||+.++|+|
T Consensus 240 ~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0123578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.82 Aligned_cols=259 Identities=30% Similarity=0.507 Sum_probs=214.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++++..... +|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~ 91 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDE--LW 91 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE--EE
Confidence 45678999999999999999999988899999999976433 45668899999999999999999998876644 99
Q ss_pred EEEeeccccccccccCCCC-CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGM-KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~-~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
+||||++++.|..++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 9999999877776665554 799999999999999999999999999999999999999999999999999876543221
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......++..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+... +.+.
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------- 235 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP------------- 235 (286)
T ss_pred -hhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC-------------
Confidence 122335688999999887765 799999999999999999999999877665544443220 0000
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||+.+|.+|||+.++|.|+||+..
T Consensus 236 ------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 236 ------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00112368899999999999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=319.17 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=215.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++.+.+..||.|+.|+|++++.+.+|...|||.++... ..+..++++..+.++... ++|+||+.+|+|..... ++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d--V~ 167 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD--VF 167 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch--HH
Confidence 356677888999999999999999999999999998654 345667788888887766 59999999999987666 88
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|.||.|..-.-.++.+-..+++|..+-.+...++.||.||.+ +||||||+||+|||+|+.|++||||||++.++-...
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 999999864434444445679999999999999999999985 599999999999999999999999999998874332
Q ss_pred CCcccccccccccCccccc--CCCCCCccccccchhHHHHHHhhCCCCCCC-CChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 310 VPMTSRVVTLWYRPPELLL--GASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~--g~~~y~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
..+...|.+.|||||.+. ....|+..+||||||++|+||+||+.||++ .++.+.+.+|+... |
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--P----------- 312 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--P----------- 312 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--C-----------
Confidence 233447889999999985 245589999999999999999999999997 57888888886521 1
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
|..++ ...|++.+.+|+..||.+|+.+||...++|+|||+..+
T Consensus 313 ------P~L~~-------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 313 ------PLLPG-------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ------CCCCc-------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 11111 12489999999999999999999999999999999865
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.44 Aligned_cols=251 Identities=26% Similarity=0.327 Sum_probs=198.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeE--EEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKI--VALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~--VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++.....
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~-- 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-- 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC--
Confidence 47899999999999999999998877764 466665432 2345567788999999999 89999999998876544
Q ss_pred EEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc
Q 005111 229 LYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI 292 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~ 292 (714)
+|+||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 9999999998766544321 235899999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHh
Q 005111 293 LKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKL 371 (714)
Q Consensus 293 vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~ 371 (714)
+||+|||++........ .....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhhh--cccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 99999999864321111 11123356799999887655 7899999999999999998 99999877665544433110
Q ss_pred hCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 372 CGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 372 ~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
+.. .....++..+.+||.+||+.+|++|||+.++|.+
T Consensus 240 -------------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 -------------------YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -------------------CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 0112467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.72 Aligned_cols=252 Identities=19% Similarity=0.282 Sum_probs=202.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH-----DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~-----g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|..++||||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 46899999999999999999987643 4889999986443 23445667899999999999999999999876544
Q ss_pred ceEEEEEeeccccccccccCC----------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEe
Q 005111 227 CSLYLVFEYMEHDLVGLASLP----------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~----------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~ 296 (714)
+|+||||+.++.|..++.. ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+
T Consensus 84 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 84 --TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred --cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 8999999998776654422 2347888999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCC
Q 005111 297 DFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGS 374 (714)
Q Consensus 297 DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~ 374 (714)
|||+++.+..... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.. +.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~ 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GG 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--CC
Confidence 9999986543322 1122335678899999987655 7999999999999999998 9999988776655444421 10
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. ......++..+.+||.+||+.+|.+|||+.+++.
T Consensus 239 ~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 H--------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0111245889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=319.43 Aligned_cols=248 Identities=23% Similarity=0.392 Sum_probs=201.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|+++++||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.+++.++|+||+++++++.. . .+|+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ-E--PIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc-C--CcEE
Confidence 46899999999999999999985 46788999998754432 3467889999999999999999998643 2 3899
Q ss_pred EEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||+.++.+..+.. .+..+++.++..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999998876654432 345789999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------
Confidence 2222334567899999887665 7899999999999999999 99999987766555544221100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.+||.+||..||++|||+++++.
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 --------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.74 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=204.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCC----------------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHD----------------KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g----------------~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIV 215 (714)
..+|++++.||+|+||.||+|.+..++ ..||+|++.... .....+.+.+|+.+|.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 467999999999999999999876544 568999987553 235567889999999999999999
Q ss_pred eeeccccccCCceEEEEEeeccccccccccCCCC-----------CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCcc
Q 005111 216 KLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGM-----------KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSN 284 (714)
Q Consensus 216 kl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~-----------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~N 284 (714)
++++++..... +++||||+.++.+..++.... .+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 83 ~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPP--LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCC--cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99998876544 899999999877765544333 68999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh--CCCCCCCCCh
Q 005111 285 LLLDHNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKPVLPGKTE 361 (714)
Q Consensus 285 ILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt--G~~pF~g~~~ 361 (714)
||++.++.++|+|||++......... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999865433221 122334578899999987755 7999999999999999998 6788877766
Q ss_pred HHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 362 VEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 362 ~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+.+..+......... . ........+|.++.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~--------------~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGR--------------Q-------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccc--------------c-------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6555554322111000 0 000112346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.31 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=199.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++..... +|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP--IFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc--eEEE
Confidence 46889999999999999999875 5678999998644322 2356789999999999999999998876544 8999
Q ss_pred EeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||++++.+..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999876665543 23478999999999999999999999999999999999999999999999999998654322211
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----------------- 219 (256)
T ss_pred cCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-----------------
Confidence 11222345799999988765 7999999999999999999 8999988776655554422110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
. .....+|..+.+|+.+||..+|++|||+.++++.
T Consensus 220 --~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 --L---------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --C---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0 1113468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.17 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=210.4
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|....+||+|+||.||++.+..++..||||++.... ......+.+|+.+++.++|+||+++++++..... .|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE--EEEEEe
Confidence 334467999999999999999999999999986432 3345678899999999999999999998876554 899999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccc
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~ 314 (714)
|++++.+..+... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 98 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 9999888776543 4689999999999999999999999999999999999999999999999999876543221 2233
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV 394 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~ 394 (714)
..+++.|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+....+.+..+......
T Consensus 176 ~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------------- 234 (292)
T cd06657 176 LVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-------------------- 234 (292)
T ss_pred cccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc--------------------
Confidence 46789999999887654 789999999999999999999999887766555444221100
Q ss_pred chhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 395 ~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
. ......++..+.++|.+||..||.+||++.++|.||||....
T Consensus 235 -----~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 -----K-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -----c-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 0 001134678899999999999999999999999999999765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=316.02 Aligned_cols=252 Identities=31% Similarity=0.498 Sum_probs=203.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
+.|++.+.||+|+||.||+|.+..+|+.||+|.++.. ..+....+.+.+|+.++++++|+||+++++++.... ..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~--~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN--ELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC--eEEE
Confidence 5799999999999999999999989999999998753 334455678899999999999999999999887654 4899
Q ss_pred EEeecccccccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 232 VFEYMEHDLVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 232 V~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
||||++++.+..++ .....+++.++..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999987665443 23456899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh--HHHHHHHHHhhCCCChhHHhhhhc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE--VEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~--~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.. ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||..... .+....+...
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 223 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC-------------- 223 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--------------
Confidence 22 223346789999999988765 78999999999999999999999965431 1111111110
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+.+. + ...++..+.++|.+||..+|++|||+.++++
T Consensus 224 ----~~~~~-~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 ----DYPPL-P--------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----CCCCC-C--------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00000 0 1246789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.63 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=206.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
...+|+++++||.|+||.||+|.+.. +..||+|++.... ......+.+|+.+|+.++|+||+++++++..... +|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP--VY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC--eE
Confidence 34679999999999999999999877 8999999987543 2345568899999999999999999998876554 89
Q ss_pred EEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||++++.+..++. .+..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999877765554 34568999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.. .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM------------- 223 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-------------
Confidence 21 22334567899999887655 7899999999999999998 89999888776666665321100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.++|.+||..||.+|||+.++++
T Consensus 224 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ---------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.35 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=203.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEccC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIH-----DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~-----g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.+|++++.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.++..++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~- 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP- 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc-
Confidence 4678889999999999999987543 5789999987543 23445678899999999999999999999876654
Q ss_pred eEEEEEeeccccccccccC----------------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 228 SLYLVFEYMEHDLVGLASL----------------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~----------------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
+++++||+.++.+..++. ....+++..+..++.||+.||.|||++||+||||||+|||+++++
T Consensus 83 -~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 83 -LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred -eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 899999999776554432 123588999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 005111 292 ILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIF 369 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~ 369 (714)
.+||+|||+++........ ......+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998865433221 122334578899999987665 7999999999999999998 889998877766655553
Q ss_pred HhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 370 KLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 370 k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.... .....++|..+.+||..||+.||.+||++.+++..
T Consensus 241 ~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQV----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCc----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 2110 01123678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=348.21 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=207.5
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
.....|++...||.|+||.|-.+.+..+++..++|++..... ...+|+.++... +||||+++++++.+...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~-- 390 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE-- 390 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCce--
Confidence 357889999999999999999999999999999999976522 123577666655 79999999999876554
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE-cCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL-DHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl-~~~g~vKL~DFGla~~~~~~ 307 (714)
+|+|||++.|+.+...+.....+. .++..|+.||+.|+.|||++|||||||||+|||+ +..|+++|+|||.+......
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999999987766655554444 7888999999999999999999999999999999 68999999999999877544
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
..+.+-|..|.|||++.... |+.++||||||++||+||+|+.||........ |...++.+...
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~~s--------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPKFS--------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCccc---------
Confidence 33446799999999998655 89999999999999999999999987665522 22222322211
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..+|..+++||..||++||.+|+++.+++.||||...+
T Consensus 533 ------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~ 570 (612)
T KOG0603|consen 533 ------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHP 570 (612)
T ss_pred ------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcchhcCC
Confidence 35899999999999999999999999999999995443
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=317.53 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=203.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.+.||+|+||.||+|.+. .+..||||.+..... ..+.+.+|+.+++.++|+||+++++++..... +++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP--IYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc--eEE
Confidence 478999999999999999999865 557799999875443 23567899999999999999999998765444 899
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||++++.+..++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999998777655543 24689999999999999999999999999999999999999999999999999987653222
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||.+.+....+..+......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------------- 223 (261)
T ss_pred hhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1112223456899999988765 7999999999999999998 99999988777666665331110
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.++|.+||..+|.+|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 --------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=325.85 Aligned_cols=250 Identities=24% Similarity=0.272 Sum_probs=199.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDK--IVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~--~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l 229 (714)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++..... +
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~--~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY--L 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc--c
Confidence 679999999999999999999877764 4788887632 2334556788999999999 79999999998866543 8
Q ss_pred EEEEeeccccccccccCCC----------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcE
Q 005111 230 YLVFEYMEHDLVGLASLPG----------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGIL 293 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~----------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~v 293 (714)
|+||||++++.+..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 9999999987665444321 358899999999999999999999999999999999999999999
Q ss_pred EEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhh
Q 005111 294 KIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLC 372 (714)
Q Consensus 294 KL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~ 372 (714)
||+|||++........ ......+..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999864321111 11112245799999887665 7999999999999999997 999998877665555442210
Q ss_pred CCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 373 GSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 373 G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
. ......++..+.+||.+||..||.+|||++++++.
T Consensus 236 ~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 R----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 01123578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=366.18 Aligned_cols=263 Identities=30% Similarity=0.477 Sum_probs=208.9
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC----
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT---- 225 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~---- 225 (714)
+-.++|+.+..||+||||.||+++++.+|+.||||+|.... .......+.+|+..|.+|+|||||+++..+.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34688999999999999999999999999999999998876 5667788999999999999999998875421000
Q ss_pred --------------------------------------------------------------------------------
Q 005111 226 -------------------------------------------------------------------------------- 225 (714)
Q Consensus 226 -------------------------------------------------------------------------------- 225 (714)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------ceEEEEEeeccccccccccCCCCCC-CHHHHHHHHHHHHHHhhHhh
Q 005111 226 -------------------------S--------CSLYLVFEYMEHDLVGLASLPGMKF-TESQVKCYMKQLLSGLEHCH 271 (714)
Q Consensus 226 -------------------------~--------~~l~LV~Ey~~g~ll~~~~~~~~~l-se~~i~~i~~QIl~aL~~LH 271 (714)
. ..+||-||||+..++..++..+... ....++.+++||++||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 2479999999999999888877554 47889999999999999999
Q ss_pred hcCeeeccCCCccEEEcCCCcEEEeecCcccccC-----------------CCCCCCcccccccccccCcccccCCC--C
Q 005111 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD-----------------PKDSVPMTSRVVTLWYRPPELLLGAS--H 332 (714)
Q Consensus 272 ~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~-----------------~~~~~~~~~~~gT~~Y~APE~l~g~~--~ 332 (714)
++|||||||||.|||++.++.|||+|||+|+... .......++.+||.-|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 11122467789999999999998766 6
Q ss_pred CCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHH
Q 005111 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSA 412 (714)
Q Consensus 333 y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l 412 (714)
|+.++||||||+||+||+. ||. |.+|....+..+- . ..++.. ...+..--+.-
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~--TsMERa~iL~~LR-~--------g~iP~~-------------~~f~~~~~~~e 847 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFG--TSMERASILTNLR-K--------GSIPEP-------------ADFFDPEHPEE 847 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCC--chHHHHHHHHhcc-c--------CCCCCC-------------cccccccchHH
Confidence 9999999999999999985 354 4444444332211 1 111111 01111112345
Q ss_pred HHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 413 LRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 413 ~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
..+|++||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 6799999999999999999999999987
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=365.08 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=202.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|+++++||+|+||.||+|.+..+|+.||||+++... ......+.+.+|+.+++.++||||+++++++...+ ..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~--~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD--PVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC--EEEE
Confidence 68999999999999999999999999999999997652 23445667899999999999999999999887654 4899
Q ss_pred EEeeccccccccccCC-----------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCc
Q 005111 232 VFEYMEHDLVGLASLP-----------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~-----------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
||||++|+.+..++.. ...++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999999877654321 13456778899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-----------------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH
Q 005111 301 ASFFDPKDS-----------------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE 363 (714)
Q Consensus 301 a~~~~~~~~-----------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e 363 (714)
+........ ......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||...+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 987621110 1112347899999999998766 7999999999999999999999998754432
Q ss_pred HHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 364 QLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 364 ~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..... ....+. ....+..+|+.+.+++.+||..||++|+++.+.|.+
T Consensus 239 i~~~~--~i~~P~------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYRD--VILSPI------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhh--hccChh------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22110 000000 001123678899999999999999999987776654
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.36 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=206.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.++..+ .|+||+++++++..... +
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~--~ 89 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD--V 89 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe--E
Confidence 457899999999999999999999988999999999754332 3345566788777666 59999999999876544 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
|+||||+.+.+..........+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++..+....
T Consensus 90 ~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9999999876555554444579999999999999999999997 599999999999999999999999999998764322
Q ss_pred CCCcccccccccccCcccccCC---CCCCccccccchhHHHHHHhhCCCCCCCCC-hHHHHHHHHHhhCCCChhHHhhhh
Q 005111 309 SVPMTSRVVTLWYRPPELLLGA---SHYGAAVDLWSTGCILGELFSGKPVLPGKT-EVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~---~~y~~~sDIWSLG~iLyeLltG~~pF~g~~-~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
. .....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.... ..+.+..+.....
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 236 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----------- 236 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-----------
Confidence 2 2233568899999998654 236889999999999999999999997532 2333333322100
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+.. .....++.++.+||.+||..||.+|||+.+++.|+||...
T Consensus 237 --------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 237 --------PSL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred --------CCC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 000 0011467899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=321.32 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=200.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~----~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.++|++++.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.++..++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 4689999999999999999999877776 48999987543 344566788999999999999999999987643
Q ss_pred eEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
..+++|||++++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.+..
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 27899999997766655543 45799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... ......+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||...........+.. ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC---------
Confidence 2221 111223467899999987765 7999999999999999998 8999987665443332211 1000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.++|.+||..||+.|||+.+++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 ------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011346788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=323.73 Aligned_cols=263 Identities=28% Similarity=0.406 Sum_probs=206.7
Q ss_pred CeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCc
Q 005111 154 TFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDN--QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~--~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~ 227 (714)
.|++.+.||+|+||.||+|.+. .+++.||||+++... ......+.+.+|+.++.++ +||||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~-- 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT-- 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC--
Confidence 4889999999999999999864 467899999987532 1233456688999999999 6999999998876554
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+.++.+..+......+++..++.++.||+.||.|||+.|++|+||+|.|||++.++.++|+|||++..+...
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 38999999998877766666667999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccccccCcccccCCC-CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGAS-HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~-~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.........++..|+|||.+.+.. .++.++|+|||||++|+|++|..||...........+.+..- .
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~------------~ 226 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL------------K 226 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH------------c
Confidence 322223346789999999986543 257899999999999999999999965432211111111000 0
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC---HHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT---ATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT---a~e~L~Hp~f~~~~ 443 (714)
........++..+.+||.+||+.||++||| +.++|+||||+..-
T Consensus 227 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 227 -------------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred -------------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 000112346788999999999999999998 56789999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.36 Aligned_cols=252 Identities=31% Similarity=0.493 Sum_probs=203.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++.+.||.|+||.||+|.+..+++.||||.+... .........+.+|+.+++.++|+||+++++++..... +++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~--~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE--LNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe--EEE
Confidence 5688999999999999999999999999999988653 2334456678899999999999999999998876544 899
Q ss_pred EEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 232 VFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
||||+.++.+..++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999877665432 3456899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChH--HHHHHHHHhhCCCChhHHhhhhc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV--EQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~--e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.. ......++..|+|||++.+.. ++.++|+|||||++|+|++|..||.+.... .....+.. ..
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------------ 224 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CD------------ 224 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc-CC------------
Confidence 22 223446889999999987765 789999999999999999999999765321 11111111 00
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.+. ....++..+.+||.+||..||.+|||+.++++
T Consensus 225 -----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 -----YPPL---------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----CCCC---------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0000 11247889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=324.14 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=201.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..+|.+.+.||+|+||.||+|.+. .++..|++|.+... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 357899999999999999999754 34567999987643 23445678899999999999999999998876544
Q ss_pred ceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN 290 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~ 290 (714)
+++||||++++.+..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 82 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 82 --LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred --eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 8999999998877665432 2348999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHH
Q 005111 291 GILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368 (714)
Q Consensus 291 g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I 368 (714)
+.++|+|||++......... ......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+.+..+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999765433221 112335678899999988765 7999999999999999998 99999887766554443
Q ss_pred HHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 369 FKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 369 ~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
... .. ......+|..+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQG--RV--------------------------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCC--CC--------------------------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 210 00 0011246889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=374.02 Aligned_cols=262 Identities=30% Similarity=0.498 Sum_probs=220.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
+-++....+||.|.||.||-|.+..+|+..|+|.++.........+.+.+|+.+|..|+|||+|++||+-.+... +||
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek--v~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK--VYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH--HHH
Confidence 345577788999999999999999999999999998876556777889999999999999999999998666555 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC--
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-- 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-- 309 (714)
.||||++++|......+...+|...+.|..|++.||+|||++|||||||||+||||+.+|.+|++|||.|..+.....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999999999988888889999999999999999999999999999999999999999999999999988765421
Q ss_pred -CCcccccccccccCcccccCCC--CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 310 -VPMTSRVVTLWYRPPELLLGAS--HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 310 -~~~~~~~gT~~Y~APE~l~g~~--~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
..+...+||+.|||||++.|.. ..+.+.||||||||+.||+||+.||..-+..-++.--+.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~---------------- 1455 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA---------------- 1455 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh----------------
Confidence 1234678999999999997643 236799999999999999999999976544333222111
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
...+|..| ..++++..+||+.||..||..|.++.|+|+|.|-+..
T Consensus 1456 --~gh~Pq~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1456 --AGHKPQIP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred --ccCCCCCc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 12233333 2488999999999999999999999999999997653
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=317.28 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=199.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ..+.+.+|+.+++.++|+|++++++++.. . ..|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-E--PIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C--CcEEE
Confidence 5689999999999999999987655 4599998865432 23557889999999999999999998743 2 37899
Q ss_pred EeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+.++.+..+... ...+++..+..++.||+.||.|||+.||+|+||||+|||+++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999998666555432 345899999999999999999999999999999999999999999999999999876433322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.... .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~--------------- 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R--------------- 221 (260)
T ss_pred ccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C---------------
Confidence 222334567899999887665 7999999999999999999 999999887766655543210 0
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. .....++..+.+||.+||..||.+||+++++++
T Consensus 222 ---~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 ---M---------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---C---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 012357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.24 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=197.7
Q ss_pred eEEeccCceEEEEEEEccCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEee
Q 005111 159 DKIGQGTYSSVYRARDVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g---~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++|+|||++++++... .+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGE---PLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC---ceEEEEEe
Confidence 46999999999999876655 78999998765433 4556788999999999999999999976532 37999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCccc-
Q 005111 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS- 314 (714)
Q Consensus 236 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~- 314 (714)
+.++.+..++.....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++..+..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9988777776666689999999999999999999999999999999999999999999999999998765433221111
Q ss_pred -ccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 315 -RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 315 -~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
..++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+.... +
T Consensus 157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~----------------- 216 (257)
T cd05060 157 AGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--R----------------- 216 (257)
T ss_pred CccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--c-----------------
Confidence 12246799999987665 7999999999999999998 999998877655444432110 0
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......++..+.+||.+||..||.+|||+.++++
T Consensus 217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=316.08 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=204.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~---~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.+.|+..+.||+|+||.||+|.+..++. .||+|.+.... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP-- 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC--
Confidence 3578999999999999999999876654 79999986543 23446678899999999999999999999876554
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|+||||++++.+..++.. ...+++.++..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 8999999999887766543 457899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCccc--ccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 308 DSVPMTS--RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 308 ~~~~~~~--~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
....... ...+..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--------- 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---------
Confidence 2221111 12245799999987755 7999999999999999997 999998877766665553211100
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
...+++..+.+||.+||..||.+||++.++++
T Consensus 231 -------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01246889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.36 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=202.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g---~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
.+|++.+.||+|+||.||+|.+..++ ..||+|.++... .....+.+.+|+.+|+.++||||+++++++..... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP--V 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc--c
Confidence 57899999999999999999876544 379999986543 23456778999999999999999999998876544 8
Q ss_pred EEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
|+||||++++.+..++.. ...+++.++..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999998777655543 3568999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCc--ccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 309 SVPM--TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 309 ~~~~--~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.... ....++..|+|||++.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+.+....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----------- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-----------
Confidence 2111 1122356899999998755 7999999999999999886 99999887766555554321100
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.+||.+||+.+|.+|||+.++++
T Consensus 229 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 -----------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.63 Aligned_cols=246 Identities=31% Similarity=0.480 Sum_probs=205.5
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
||.|+||.||++.+..+++.||+|+++... ........+..|+.+++.++|+||+++++.+..... +|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK--LYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCe--eEEEEecCCCC
Confidence 699999999999998889999999987653 233456778899999999999999999998865544 99999999877
Q ss_pred ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccc
Q 005111 240 LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL 319 (714)
Q Consensus 240 ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~ 319 (714)
.+..+......+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCcCCc
Confidence 7766665556799999999999999999999999999999999999999999999999999987644321 223446788
Q ss_pred cccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhh
Q 005111 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRR 399 (714)
Q Consensus 320 ~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~ 399 (714)
.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+.. +.+
T Consensus 158 ~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~------------------------ 210 (250)
T cd05123 158 EYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPL------------------------ 210 (250)
T ss_pred cccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCC------------------------
Confidence 999999987765 68899999999999999999999987776544444432 000
Q ss_pred hhhhhccCCcHHHHHHHHHhcccCcCCCCCH---HHHHcCcCC
Q 005111 400 RIAETFKDFPTSALRLMETLMSIDPAHRGTA---TLALNSEFF 439 (714)
Q Consensus 400 ~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa---~e~L~Hp~f 439 (714)
.....++..+.++|.+||..||+.|||+ ++++.||||
T Consensus 211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1112358899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.94 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=203.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~---~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
++|++.+.||+|+||.||+|.+..+++ .||||++... ........+..|+.+++.++||||+++++++..... +
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~--~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP--V 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc--e
Confidence 568999999999999999999877664 6999998654 234556789999999999999999999998865544 8
Q ss_pred EEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
++||||++++.+..+.. ....+++.+++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999887765554 34568999999999999999999999999999999999999999999999999997664322
Q ss_pred CCC-ccccc---ccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 309 SVP-MTSRV---VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 309 ~~~-~~~~~---gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
... ..... .+..|+|||.+.+.. ++.++|||||||++|||++ |..||......+....+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~--------- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL--------- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC---------
Confidence 211 11111 245799999987665 7999999999999999886 99999887766555554221100
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
....++|..+.++|..||..+|.+||++.+++.
T Consensus 231 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 -------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=320.61 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=201.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.+|.+.++||+|+||.||++... .++..||+|.+... .......+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP- 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc-
Confidence 57889999999999999999743 35678999987643 34456678999999999999999999998876544
Q ss_pred eEEEEEeeccccccccccCCC---------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc
Q 005111 228 SLYLVFEYMEHDLVGLASLPG---------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI 292 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~---------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~ 292 (714)
+|+||||+.++.+..++... ..+++..+..++.||+.||+|||++||+|+||||+|||+++++.
T Consensus 82 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 82 -LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred -eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 89999999987776554322 34899999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHH
Q 005111 293 LKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370 (714)
Q Consensus 293 vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k 370 (714)
+||+|||++.......... .....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+.+..+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 9999999997654322111 11223467899999988766 7999999999999999998 9999987776665555432
Q ss_pred hhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 371 LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 371 ~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
... ......+|+.+.+||.+||+.||.+||++.+++.
T Consensus 240 ~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred Ccc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 110 0111357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.91 Aligned_cols=249 Identities=29% Similarity=0.421 Sum_probs=203.1
Q ss_pred eeEEeEEeccCceEEEEEEEccCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHD----KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
|++.+.||.|+||.||+|.+...+ ..||+|++..... ....+.+..|+.+|..++|+||+++++++.... ..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE--PLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--eeE
Confidence 457789999999999999988766 8999999975533 235678889999999999999999999887654 499
Q ss_pred EEEeeccccccccccCCCCC--CCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMK--FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~--lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
++|||+.++.+..+...... +++.++..++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999998777666543333 8999999999999999999999999999999999999999999999999998765442
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+.+..+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------------- 222 (258)
T ss_pred ccccccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 22211223678999999886544 7999999999999999998 8899988776666555532100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......++..+.++|.+||..||.+|||+.++++
T Consensus 223 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 --------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0111236889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=338.60 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=198.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH-----DKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~-----g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~ 225 (714)
.+.|++.+.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|..+. |||||++++++....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 56899999999999999999986433 4579999997543 3344567899999999996 999999999987654
Q ss_pred CceEEEEEeeccccccccccCC----------------------------------------------------------
Q 005111 226 SCSLYLVFEYMEHDLVGLASLP---------------------------------------------------------- 247 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~---------------------------------------------------------- 247 (714)
. +|||||||.++.|..++..
T Consensus 115 ~--~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 115 P--IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred c--eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 4 9999999998766433211
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC
Q 005111 248 --------------------------------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH 289 (714)
Q Consensus 248 --------------------------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~ 289 (714)
...+++..+..++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124788899999999999999999999999999999999999
Q ss_pred CCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHH
Q 005111 290 NGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHR 367 (714)
Q Consensus 290 ~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~ 367 (714)
++.+||+|||++..+...... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |..||........+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999865432221 122335678899999987765 7999999999999999997 9999987654333322
Q ss_pred HHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 368 IFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 368 I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
..... ... .....++..+.+||.+||+.||++|||+.++.+
T Consensus 352 ~~~~~------------------~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSG------------------YRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcC------------------CCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22110 000 011357889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=324.99 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=199.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccccc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI-------HDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQ 224 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~-------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~ 224 (714)
++|.+.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 679999999999999999998643 23579999987542 234456788899999999 799999999988765
Q ss_pred CCceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD 288 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~ 288 (714)
.. +|+||||+.++.|..++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 97 ~~--~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 97 GP--LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred Cc--eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 54 8999999998766554432 13588999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHH
Q 005111 289 HNGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLH 366 (714)
Q Consensus 289 ~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~ 366 (714)
.++.+||+|||++.......... .....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 99999999999997654322111 11123356899999988765 7999999999999999998 889998766544333
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+... . ..+....++..+.+||.+||..+|.+|||+.+++.+
T Consensus 254 ~~~~~--~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 254 LLKEG--H--------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcC--C--------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33110 0 001123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.81 Aligned_cols=244 Identities=24% Similarity=0.380 Sum_probs=200.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++..... .|+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP--LYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC--eEE
Confidence 46889999999999999999975 488999999875432 56778899999999999999999998876443 899
Q ss_pred EEeeccccccccccCCCC--CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGM--KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~--~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||++++.+..+..... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999877766654433 689999999999999999999999999999999999999999999999999987632221
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
....+..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 158 ----~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------- 215 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------------- 215 (256)
T ss_pred ----cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-----------------
Confidence 223466799999987655 7899999999999999997 99999877655444333210
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.. .....+|+.+.+||.+||..+|++|||+.+++.
T Consensus 216 --~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 --YRM---------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --CCC---------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 112356889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=315.80 Aligned_cols=253 Identities=27% Similarity=0.454 Sum_probs=204.0
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC---CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD---NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~---~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
+|.+.+.||+|+||.||++.+..++..+++|+++.. .........+.+|+.+++.++||||+++++++..... ++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA--FC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc--eE
Confidence 488999999999999999999888777777776532 1222334456789999999999999999998876554 89
Q ss_pred EEEeecccccccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 231 LVFEYMEHDLVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+||||+.++.+..++ .....+++..++.++.||+.||.|||++|++|+||+|+||+++. +.++|+|||++..+..
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999987776543 23457999999999999999999999999999999999999975 6799999999987643
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.+.......+.. +.+
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~----------- 222 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPT----------- 222 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCC-----------
Confidence 322 122345788999999887655 78899999999999999999999987766655555432 100
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
......++.++.+||.+||..||++||++.++|+||||
T Consensus 223 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 ---------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00113567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=332.47 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=197.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEE-----ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARD-----VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d-----~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|.++ +||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 35799999999999999999984 3567899999997543 234456788999999999 6899999999876544
Q ss_pred CceEEEEEeeccccccccccCC----------------------------------------------------------
Q 005111 226 SCSLYLVFEYMEHDLVGLASLP---------------------------------------------------------- 247 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~---------------------------------------------------------- 247 (714)
..+++|||||+++.|..++..
T Consensus 85 -~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 85 -GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred -CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 348999999998776544321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-CCcccccc
Q 005111 248 ---------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-VPMTSRVV 317 (714)
Q Consensus 248 ---------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~g 317 (714)
...+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..... .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12468888999999999999999999999999999999999999999999999986532211 11122234
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+......+...+..... .
T Consensus 244 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------~--- 301 (343)
T cd05103 244 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------M--- 301 (343)
T ss_pred CcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC------------------C---
Confidence 67799999987765 7999999999999999997 99999875433322222110000 0
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....+++.+.+++..||+.||.+|||+.++++|
T Consensus 302 ------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.55 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=232.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...+++++..||-|+||.|-++........+|+|++++. ..+....+++..|-+||..++.|+||+||..|.+.. ++
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k--yv 495 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK--YV 495 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch--hh
Confidence 446778899999999999999976555556999999765 345667788999999999999999999999887654 49
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||+||-|-|+.+..+++..+.|.+..++.|+..+++|++|||++|||+|||||+|+|++.+|.+||.|||+|+.+.....
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999865543
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
+.++||||.|.|||++++..+ +.++|.||||+++||||+|.|||.+.++..++..|++.+. .|
T Consensus 576 --TwTFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid-----~i--------- 638 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID-----KI--------- 638 (732)
T ss_pred --eeeecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-----hh---------
Confidence 567799999999999999885 9999999999999999999999999999999999987542 11
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQPLA 445 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~~~ 445 (714)
+.+..++..+.+||+++...+|.+|.. ..++-.|.||....|.
T Consensus 639 -------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 639 -------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred -------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 223467889999999999999999976 8999999999876653
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.52 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=202.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||.||+|.+. .++..||+|+++... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 367999999999999999999752 346689999987543 234556788999999999 7999999999887655
Q ss_pred CceEEEEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
. +|+||||+.++.+..++.. ...+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 113 ~--~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 113 P--ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred c--eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 4 8999999998777655432 23489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 304 FDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 304 ~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
+...... ......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+.+.++....
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~--------- 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG--------- 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC---------
Confidence 5432211 111224577899999988766 7999999999999999998 999998776555444432210
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
... .....++..+.+||.+||..+|++|||+.+++.
T Consensus 261 ---------~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 ---------YRM---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ---------CcC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 011246789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.70 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=201.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEccC--------------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeee
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIH--------------DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLE 218 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~--------------g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~ 218 (714)
++|++.+.||+|+||.||+|.+..+ ...||+|+++... .......+.+|+.+|++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 6899999999999999999986543 2359999987542 344566788999999999999999999
Q ss_pred ccccccCCceEEEEEeeccccccccccCCC------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEE
Q 005111 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPG------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLL 286 (714)
Q Consensus 219 ~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NIL 286 (714)
+++..... +|+||||+.++.+..++... ..+++..+..++.||+.||.|||++|++|+||||+|||
T Consensus 84 ~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCVSDDP--LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEcCCCc--cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 99876544 89999999987766544221 24788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh--CCCCCCCCChHH
Q 005111 287 LDHNGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKPVLPGKTEVE 363 (714)
Q Consensus 287 l~~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt--G~~pF~g~~~~e 363 (714)
++.++.+||+|||++..+....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999997654322211 12234467899999987765 7999999999999999988 678888877666
Q ss_pred HHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 364 QLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 364 ~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+..+.+....... .. .....+.+|..+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~-----------~~----------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGR-----------QI----------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccc-----------cc----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 55554331110000 00 00112346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.76 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=198.4
Q ss_pred CeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+|+.++||||+++++.+.....
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP-- 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC--
Confidence 47889999999999999998653 23678999886543 33445678899999999999999999998876554
Q ss_pred EEEEEeeccccccccccCC------------------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCcc
Q 005111 229 LYLVFEYMEHDLVGLASLP------------------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSN 284 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~------------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~N 284 (714)
.|+||||+.++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 8999999998777654321 2358899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChH
Q 005111 285 LLLDHNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEV 362 (714)
Q Consensus 285 ILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~ 362 (714)
||+++++.+||+|||++......... ......++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999865332221 112224567899999887665 7999999999999999998 99999887655
Q ss_pred HHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 363 EQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 363 e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+....+.... .. .....++..+.+||..||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~-------------------~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGY-------------------RM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCC-------------------CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4443321100 00 011356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.29 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=201.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|++.+.||.|+||.||+|.+. .+..+|+|++...... ...+.+|+.++++++||||+++++++..... +|+|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSP--ICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCc--eEEE
Confidence 57899999999999999999875 4778999998754332 2457789999999999999999998876554 8999
Q ss_pred EeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||+.++.+..+... ...+++..++.++.||+.||.|||+.+++|+||||+|||++.++.++|+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 999999877766543 3568999999999999999999999999999999999999999999999999998654332211
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||......+.+..+.+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------------ 218 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF------------------ 218 (256)
T ss_pred cCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC------------------
Confidence 22223467899999987655 7899999999999999998 999998877665555542210
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.. ......+..+.+|+.+||+.+|++|||+.++|++
T Consensus 219 -~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 -RL---------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -CC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00 0012357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.62 Aligned_cols=269 Identities=22% Similarity=0.333 Sum_probs=202.0
Q ss_pred CCeeEEeEEeccCceEEEEEEE----ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARD----VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d----~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
..|++++.||+|+||.||+|+. ..++..||+|.++... .......+.+|+.+|+.+.||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 4589999999999999999974 4578899999987543 3445567899999999999999999999887654455
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|+||||++++.|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 8999999998887766543 346899999999999999999999999999999999999999999999999999876433
Q ss_pred CCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 308 DSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 308 ~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... ......++..|+|||++.+.. ++.++|||||||++|+|+++..|+..... ...+..+....+.......
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhcccccccccHHHHH
Confidence 221 112335577899999988765 78999999999999999998766433211 1111112111110000000
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
. .... .........++..+.+||.+||+.||.+|||+.+++.+
T Consensus 237 ~---~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 R---VLEE-----GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred H---HHHc-----CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 0000 00011224578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.61 Aligned_cols=253 Identities=20% Similarity=0.368 Sum_probs=203.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.+|+++..||.|+||.||+|+... +.+.||+|.+.... .......+.+|+.+|++++|+||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP- 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc-
Confidence 579999999999999999998654 35679999876432 23356778899999999999999999998876544
Q ss_pred eEEEEEeeccccccccccCCCC---------CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 228 SLYLVFEYMEHDLVGLASLPGM---------KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~---------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
.|+||||++++.|..++.... .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+||
T Consensus 83 -~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 83 -HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred -ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 899999999877776554333 6899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 005111 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSE 377 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~ 377 (714)
|++...............++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+..+... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~- 237 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLE- 237 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcC-
Confidence 998765433333333446678899999887665 6899999999999999998 78899776655444433210 000
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
| .....+|..+.++|.+||..||.+|||+.+++..
T Consensus 238 --~----------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 238 --L----------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --C----------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 0113578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.24 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=206.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.+.+...||+|.||+||+|++ .| .||||++..+...++..+.|++|+.+|++-+|.||+-+.|++.... +.|
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~w--hG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~---~AI 464 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRW--HG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP---LAI 464 (678)
T ss_pred HHHhhccceeccccccceeeccc--cc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc---eee
Confidence 35677889999999999999975 34 3999999998888889999999999999999999999999997654 689
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC-CCC
Q 005111 232 VFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-KDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~-~~~ 309 (714)
|+.+|+|..|..++ ....+|.....+.|++||+.|+.|||.++|||||||..||||.+++.|||+||||+..-.- ...
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 99999998776554 3456899999999999999999999999999999999999999999999999999975321 112
Q ss_pred CCcccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 VPMTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.......|...|||||++.. ...|++.+|||||||++|||++|..||........+..+-...+.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~------------- 611 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM------------- 611 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC-------------
Confidence 22333456889999999863 334899999999999999999999999854433222222111111
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
..+.....+.+.++++|+..||.+++++||+..++|.
T Consensus 612 -----------pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 612 -----------PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----------ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1222334568899999999999999999999999987
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.90 Aligned_cols=244 Identities=22% Similarity=0.361 Sum_probs=197.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..+|++.+.||+|+||.||++.. .|..||+|.++... ..+.+.+|+.++++++|+|++++++++.... ..+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC-CceEE
Confidence 35789999999999999999964 48889999986432 3456889999999999999999998764433 34899
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||++++.+..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999998766655432 2348999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+.+..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 216 (256)
T ss_pred ---CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 2223467899999887655 7899999999999999997 999998766555444442210
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. ......+|..+.+||.+||..||++|||+.++++
T Consensus 217 ---~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 ---K---------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---C---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 0112357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.23 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=201.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.++|++++.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4679999999999999999998743 67899999987542 34456678899999999999999999998876554
Q ss_pred ceEEEEEeeccccccccccCC----------------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCcc
Q 005111 227 CSLYLVFEYMEHDLVGLASLP----------------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSN 284 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~----------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~N 284 (714)
+|+||||+.++.+..++.. ...+++.++..++.||+.||.|||++|++||||||+|
T Consensus 83 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 83 --MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred --cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 8999999998766544421 1247889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChH
Q 005111 285 LLLDHNGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEV 362 (714)
Q Consensus 285 ILl~~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~ 362 (714)
||++.++.++|+|||++..+....... ......+..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999997654322111 11223466799999887765 8999999999999999997 88899877766
Q ss_pred HHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 363 EQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 363 e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.+..+.... .......++..+.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGN----------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 5555442200 00112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=318.10 Aligned_cols=248 Identities=29% Similarity=0.415 Sum_probs=197.0
Q ss_pred eEEeEEeccCceEEEEEEEc----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDV----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++.+.||.|.||.||+|... ..+..|+||.+... ...+..+.+.+|+.++++++||||+++++++..... +++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~--~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP--LFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS--EEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccc--ccc
Confidence 56789999999999999877 45688999999543 345567889999999999999999999999985444 899
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||+.++.|..++.. ...+++.++..|+.||+.||.|||+++|+|+||++.|||++.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999998777665544 36799999999999999999999999999999999999999999999999999987632211
Q ss_pred C-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 V-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 ~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
. ..........|+|||.+.+.. ++.++||||||+++|||++ |..||...+..+.+.++.+..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~--------------- 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ--------------- 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE---------------
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---------------
Confidence 1 112234578899999987766 7999999999999999999 789998887777666663210
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.......+|..+.+||..||..||.+|||+.++++
T Consensus 223 -------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 -------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01112357899999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.86 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=199.3
Q ss_pred CCe-eEEeEEeccCceEEEEEE----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTF-EKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y-~~~~~LG~G~fG~Vy~a~----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
++| ++++.||+|+||+||++. ...++..||+|+++... .......+.+|+.+|+.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 999999999999998864 34568899999987542 233456778999999999999999999987665555
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+.++.+..+... ..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 68999999999888766654 36999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCC--cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHh-hCCCChhHHhhhh
Q 005111 308 DSVP--MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL-CGSPSEDYWRKSK 384 (714)
Q Consensus 308 ~~~~--~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~-~G~p~~~~w~~~~ 384 (714)
.... .....++..|+|||++.+.. ++.++|||||||++|+|++|..||...... +..+... .+......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~- 236 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL- 236 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh-
Confidence 2111 11223466799999887655 799999999999999999999888654321 1111110 000000000000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.. . .. .......++..+.+|+..||+.||++|||+.++++
T Consensus 237 ~~-~-~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 LE-R-GM---------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hh-c-CC---------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0 00 00112457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.98 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=200.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-------cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-------IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-------~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~ 223 (714)
.++|.+.+.||+|+||.||+|.+. .....||+|.++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 367899999999999999999763 235679999987543 344566788999999999 69999999998876
Q ss_pred cCCceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
... +|+||||+.++.+..++.. ...+++.++..++.||+.||.|||++||+|+||||+|||+
T Consensus 90 ~~~--~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 EGP--LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred CCc--eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 544 8999999998777654432 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l 365 (714)
+.++.+||+|||+++......... .....++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999998764322211 11122346799999987755 7999999999999999999 89999887765555
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
..+.... .......++.++.+||.+||..||.+|||+.+++.
T Consensus 247 ~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5442100 00112356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.54 Aligned_cols=267 Identities=23% Similarity=0.341 Sum_probs=198.8
Q ss_pred CCeeEEeEEeccCceEEEEEE----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.+|++++.||+|+||.||+|. +..++..||+|.+... .....+.+.+|+.+|+.++||||+++++++...+...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 579999999999999999997 3457889999998643 3455677899999999999999999999875555455
Q ss_pred EEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+++||||++++.+..++. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 899999999877766553 3456899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCc--ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh-
Q 005111 308 DSVPM--TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK- 384 (714)
Q Consensus 308 ~~~~~--~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~- 384 (714)
..... ....++..|+|||++.+.. ++.++|||||||++|||++|..++..... .....+........ ..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~ 238 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQM-IVYHLIEL 238 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhccccccccc-chHHHHHH
Confidence 22111 1112345699999987765 79999999999999999998876644322 11111100000000 0000000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.... .......++..+.+||.+||..+|++|||+.+++.
T Consensus 239 ~~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNNG-----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcCC-----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000 00112457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.13 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=202.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-------cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-------IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-------~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~ 223 (714)
.++|.+.+.||+|+||.||+|++. ..+..||+|.+... ........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 467899999999999999999753 23568999988643 2334567788999999999 89999999998876
Q ss_pred cCCceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
... +|+||||+.++.+..++.. ...++..++..++.||+.||.|||++||+||||||+|||+
T Consensus 93 ~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred CCc--eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 554 8999999998766654432 2357888999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l 365 (714)
+.++.+||+|||++..+....... .....+++.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 999999999999998764332221 12234567899999987765 7999999999999999998 88999887766555
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+.... . ......++..+.+||.+||..+|.+|||+.++|+.
T Consensus 250 ~~~~~~~--~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGH--R--------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCC--c--------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 5442100 0 00113578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.35 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=202.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.++|.+.+.||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---P 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC---C
Confidence 35689999999999999999987544 3578999876442 245567889999999999999999999987643 2
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.|+||||+.++.+..++.. ...+++..+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 7899999998777665543 346899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
.....+...++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------------- 226 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------------- 226 (270)
T ss_pred cceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence 222222223356899999887655 7999999999999999996 9999998877666555422100
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......+|..+.+||.+||..+|.+|||+.+++..
T Consensus 227 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 227 ---------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.97 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=203.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEcc----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVI----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..++|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+.+|+.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~- 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG- 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-
Confidence 35789999999999999999999876 3688999987643 34556777899999999999999999999866532
Q ss_pred ceEEEEEeeccccccccccCCC--------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 227 CSLYLVFEYMEHDLVGLASLPG--------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~--------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
...++++||+.++.+..++... ..+++..++.++.||+.||+|||+++++|+||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 3489999999977766554321 46899999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 299 GLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 299 Gla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
|+++.+....... .....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----- 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG----- 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-----
Confidence 9998664332211 11224467899999987765 7999999999999999999 99999887665544333210
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.. .....+|+.+.++|.+||..||++|||+.++++
T Consensus 236 --------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 --------------YRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------CCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 001246789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.90 Aligned_cols=244 Identities=25% Similarity=0.357 Sum_probs=196.0
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccc
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH 238 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g 238 (714)
+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++.++||||+++++++..... .++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP--IYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc--cEEEEECCCC
Confidence 3689999999999985 468899999987543 33445568899999999999999999998876554 8999999998
Q ss_pred cccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccc
Q 005111 239 DLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317 (714)
Q Consensus 239 ~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 317 (714)
+.+..+.. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 77665543 34468999999999999999999999999999999999999999999999999997653322111112233
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+.....
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 212 (250)
T cd05085 157 PIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------- 212 (250)
T ss_pred cccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 56799999987655 7899999999999999998 9999988776655544422100
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......++..+.+||.+||..+|++|||+.++++
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 213 -----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0112347889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=310.70 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=196.6
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccc
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH 238 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g 238 (714)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+.++++++|+||+++++++..... .|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP--IYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC--eEEEEEcCCC
Confidence 369999999999999877 999999998765332 456778999999999999999999998876544 8999999998
Q ss_pred cccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc-cccc
Q 005111 239 DLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM-TSRV 316 (714)
Q Consensus 239 ~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~-~~~~ 316 (714)
+.+..++. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 77665543 345689999999999999999999999999999999999999999999999999986542211111 1122
Q ss_pred ccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCc
Q 005111 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395 (714)
Q Consensus 317 gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~ 395 (714)
.+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+....+ .
T Consensus 157 ~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~-------------------~-- 214 (251)
T cd05041 157 IPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR-------------------M-- 214 (251)
T ss_pred ceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-------------------C--
Confidence 356799999987665 7999999999999999999 8899988776544444321100 0
Q ss_pred hhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 396 p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.+||.+||..+|.+|||+.++|+
T Consensus 215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.30 Aligned_cols=251 Identities=21% Similarity=0.282 Sum_probs=198.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~----~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..+|++++.||+|+||.||+|.+..++. .|++|.+... ........+..|+.++..++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~-- 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A-- 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C--
Confidence 4689999999999999999999877776 4777776532 223445678889999999999999999998643 2
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+++++||+.++.+..++. ....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 3789999999776665553 345789999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
..... .....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.........+ .....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~--------- 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERL--------- 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC---------
Confidence 32211 22334577899999987765 8999999999999999998 99999887654432222 110000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+..+.+++..||..||++|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 ------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001235678899999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=312.54 Aligned_cols=243 Identities=23% Similarity=0.295 Sum_probs=195.1
Q ss_pred EEeccCceEEEEEEEc--cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 160 KIGQGTYSSVYRARDV--IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~--~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
.||+|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+|++++||||+++++++... .+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~---~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE---ALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC---CeEEEEEeCC
Confidence 3899999999999764 446679999987542 344556789999999999999999999987532 3899999999
Q ss_pred ccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc--cc
Q 005111 238 HDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM--TS 314 (714)
Q Consensus 238 g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~--~~ 314 (714)
++.+..++. ....+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+........ ..
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 887776554 345799999999999999999999999999999999999999999999999999986643322111 11
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
..+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+.+.. .
T Consensus 158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------------- 216 (257)
T cd05115 158 GKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R------------------- 216 (257)
T ss_pred CCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C-------------------
Confidence 22357899999987655 7999999999999999996 999998877666554442210 0
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.......+.++.+||..||..||++||++.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 --------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.13 Aligned_cols=248 Identities=22% Similarity=0.359 Sum_probs=199.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..+|++.+.||+|+||.||+|.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 467999999999999999999754 5567999988643 2345678899999999999999999998765 33899
Q ss_pred EEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
+|||++++.+..++. ....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999766655543 245688999999999999999999999999999999999999999999999999987643322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......++..|+|||++.+.. ++.++|+|||||++|+|++ |.+||.+.+..+....+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------------- 221 (260)
T ss_pred ccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---------------
Confidence 2222234567799999987654 7999999999999999998 9999998776655544422100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......++..+.++|.+||..||++||++.+++.
T Consensus 222 -------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 -------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112357889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.41 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=199.3
Q ss_pred eEEeccCceEEEEEEEcc-CC--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEee
Q 005111 159 DKIGQGTYSSVYRARDVI-HD--KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~-~g--~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
+.||+|+||.||+|.+.. .+ ..||||.+...... ...+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999998765 33 36999999876443 667789999999999999999999998775 448999999
Q ss_pred ccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC--C
Q 005111 236 MEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV--P 311 (714)
Q Consensus 236 ~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~--~ 311 (714)
++++.+..++... ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+...... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9987766554433 46899999999999999999999999999999999999999999999999999877542221 1
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+.+..+...... +
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----~---------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER-----L---------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----C----------
Confidence 11234678899999887655 7999999999999999998 99999888777766665431000 0
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.+||..||..+|++|||+.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011246789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=306.33 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=201.7
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc---CC
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ---TS 226 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~---~~ 226 (714)
-..++|.+.+.||+|||+.||+++...+++.||+|++.... .+..+...+||...++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34578999999999999999999999999999999998765 46677889999999999999999998875332 33
Q ss_pred ceEEEEEeecccccccc----ccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcCCCcEEEeecCc
Q 005111 227 CSLYLVFEYMEHDLVGL----ASLPGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~----~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
...||++.|...+++.. ....+..++|.++..|+.+|+.||.+||+.. +.||||||.|||+++++.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 45899999998775443 2335567999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCC--------CCcccccccccccCcccccCCC--CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHH
Q 005111 301 ASFFDPKDS--------VPMTSRVVTLWYRPPELLLGAS--HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370 (714)
Q Consensus 301 a~~~~~~~~--------~~~~~~~gT~~Y~APE~l~g~~--~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k 370 (714)
++...-.-. ........|..|+|||++.-.. ..+.++|||||||+||.|+.|..||.. ++.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~ 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQ 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hhh
Confidence 976431110 0111234589999999985332 258899999999999999999999953 222
Q ss_pred hhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 371 LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 371 ~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..|+..-. - +.-.-.+... .-+|+.+.+||+.||+.||.+||++.++|.+
T Consensus 247 ~GgSlaLA--------------v-~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGGSLALA--------------V-QNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCeEEEe--------------e-eccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11211000 0 0000000001 1278999999999999999999999999864
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.09 Aligned_cols=254 Identities=23% Similarity=0.361 Sum_probs=217.0
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecC--CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD--NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~--~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+....||+|+|-+||+|.|..+|..||.-.++.. ...+...++|..|+++|+.|+|||||++|+.+.+.....+.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4457799999999999999999999997766654 35667789999999999999999999999998887777799999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcC-CCcEEEeecCcccccCCCCCC
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~-~g~vKL~DFGla~~~~~~~~~ 310 (714)
|++..|+|..+......++...++.|++|||.||.|||++. |||||||.+||||+. .|.|||+|+|||+.....
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 99999999999998889999999999999999999999995 999999999999985 589999999999987543
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH-HHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
...+.+|||.|||||++. ..|+..+||||||++|+||+|+..||..-+... .+.++.. |..|..+
T Consensus 200 ~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl---------- 265 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAAL---------- 265 (632)
T ss_pred ccceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHh----------
Confidence 334579999999999886 349999999999999999999999998655544 4444432 2222211
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+--.+++++||.+||.. ...|+||.|+|.|+||...
T Consensus 266 ---------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 266 ---------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ---------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 112257899999999999 9999999999999999975
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=324.25 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=201.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccC-------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccccc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIH-------DKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQ 224 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~-------g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~ 224 (714)
.+|++.+.||+|+||.||+|.+... +..||+|++... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 5799999999999999999986432 347999988743 2344567888999999999 899999999988765
Q ss_pred CCceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD 288 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~ 288 (714)
.. +|+||||+.++.+..++.. ...++..++..++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 91 GP--LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred Cc--eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 54 8999999998776654432 23478889999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHH
Q 005111 289 HNGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLH 366 (714)
Q Consensus 289 ~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~ 366 (714)
.++.+||+|||+++......... .....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999998764322111 11223356799999997765 7899999999999999998 889998877665554
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+.... . ......++..+.+||.+||..+|.+|||+.++|.+
T Consensus 248 ~~~~~~-------------------~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGH-------------------R---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCC-------------------C---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 442100 0 01123567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=345.95 Aligned_cols=278 Identities=22% Similarity=0.284 Sum_probs=190.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccC----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccc----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIH----DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLIT---- 222 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~----g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~---- 222 (714)
..++|++.+.||+|+||.||+|.+..+ +..||||++..... .+....| .++...+.+++.+...+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 568999999999999999999999988 99999998754321 1111111 122222233332222111
Q ss_pred ccCCceEEEEEeeccccccccccCCCC--------------------CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCC
Q 005111 223 SQTSCSLYLVFEYMEHDLVGLASLPGM--------------------KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKG 282 (714)
Q Consensus 223 ~~~~~~l~LV~Ey~~g~ll~~~~~~~~--------------------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP 282 (714)
......++|||||++++.|..+..... ...+..+..++.||+.||.|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 123345899999999887654443211 122445778999999999999999999999999
Q ss_pred ccEEEcC-CCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCC---------------------CCCcccccc
Q 005111 283 SNLLLDH-NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS---------------------HYGAAVDLW 340 (714)
Q Consensus 283 ~NILl~~-~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~---------------------~y~~~sDIW 340 (714)
+||||+. ++.+||+|||+|+.+...........++|+.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 689999999999876544333345568899999999764322 134456999
Q ss_pred chhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhc
Q 005111 341 STGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLM 420 (714)
Q Consensus 341 SLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL 420 (714)
|||||||||+++. |+..+....+..++..++.. ...|....... ..+......+.+......+.+||.+||
T Consensus 364 SlGviL~el~~~~--~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPN--LRSDSNLIQFNRQLKRNDYD-LVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCc--CCCchHHHHHHHHHHhcCCc-HHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999854 55566666777776665543 23343221110 000001111222334556789999999
Q ss_pred ccCcCCCCCHHHHHcCcCCCCCC
Q 005111 421 SIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 421 ~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
++||.+|||+.++|+||||+...
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCC
Confidence 99999999999999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.52 Aligned_cols=275 Identities=23% Similarity=0.413 Sum_probs=225.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|.++++||+|+|++|.+++.+.|.+.||+|++++. ..+.+.+..+..|-.+..+. +||.+|-|+..|..+..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr-- 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR-- 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce--
Confidence 457899999999999999999999999999999999876 33455667777888888877 79999999998876655
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+++|.||++|+.|....+...+|++++++.|..+|+.||.|||++|||+||||.+|+||+..|++||+|+|+++.-- ..
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-~~ 404 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GP 404 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC-CC
Confidence 99999999999888888888899999999999999999999999999999999999999999999999999997532 23
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCC--CC-----ChHHHHHHHHHhhCCCChhHHh
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP--GK-----TEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~--g~-----~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
.....+.||||.|+|||+|.|.. |++.+|+|+||++++||+.|+.||. |. +..+.+.+++-.
T Consensus 405 gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile---------- 473 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE---------- 473 (593)
T ss_pred CcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh----------
Confidence 33456789999999999999987 8999999999999999999999996 21 122222222110
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC------HHHHHcCcCCCCCCCCC--CCCCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT------ATLALNSEFFTTQPLAC--NPSNLPK 453 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT------a~e~L~Hp~f~~~~~~~--~~~~~p~ 453 (714)
+ -..++..++-.+..+++..|.+||.+|.. ..++-.|+||....|.. ....+|.
T Consensus 474 -----------------k-qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 474 -----------------K-QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred -----------------h-cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 0 01122346667888999999999999964 78999999999765533 2345666
Q ss_pred CCCC
Q 005111 454 YPPS 457 (714)
Q Consensus 454 ~~p~ 457 (714)
|.|.
T Consensus 536 f~p~ 539 (593)
T KOG0695|consen 536 FQPQ 539 (593)
T ss_pred CCCc
Confidence 6553
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=317.02 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=198.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc----------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeee
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI----------------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~----------------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVk 216 (714)
++|++.+.||+|+||.||+|.+.. ++..||+|+++... .......+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 569999999999999999986432 34579999987542 3445677889999999999999999
Q ss_pred eeccccccCCceEEEEEeeccccccccccCCC-----------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccE
Q 005111 217 LEGLITSQTSCSLYLVFEYMEHDLVGLASLPG-----------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNL 285 (714)
Q Consensus 217 l~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~-----------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NI 285 (714)
+++++..... +|+||||+.++.+..++... ..+++.++..++.||+.||+|||++||+|+||||+||
T Consensus 84 ~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCITSDP--LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEecCCc--cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9998876554 89999999987665443321 2477889999999999999999999999999999999
Q ss_pred EEcCCCcEEEeecCcccccCCCCCCCc-ccccccccccCcccccCCCCCCccccccchhHHHHHHhh--CCCCCCCCChH
Q 005111 286 LLDHNGILKIADFGLASFFDPKDSVPM-TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKPVLPGKTEV 362 (714)
Q Consensus 286 Ll~~~g~vKL~DFGla~~~~~~~~~~~-~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt--G~~pF~g~~~~ 362 (714)
|++.++.++|+|||++..+........ ....+++.|++||++.+.. ++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999986543322111 1223467899999887665 8999999999999999998 77888776665
Q ss_pred HHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 363 EQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 363 e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.+...... +.... ...+. .....++..+.+||..||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~--------~~~~~---~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEF--------FRDQG---RQVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHH--------Hhhcc---ccccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 544433111 10000 00000 111346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.96 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=196.9
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
...++.|..-..||+|+||.||+|.- ..|..||||.+....... .+.|.+|+.+|.+++|||+|+|+|||.+... .
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~ 146 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-H 146 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-e
Confidence 34467888889999999999999984 455899999877654322 4459999999999999999999999987653 3
Q ss_pred EEEEEeeccccccccccCCCC--CCCHHHHHHHHHHHHHHhhHhhhcC---eeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 229 LYLVFEYMEHDLVGLASLPGM--KFTESQVKCYMKQLLSGLEHCHSHG---VLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~--~lse~~i~~i~~QIl~aL~~LH~~g---IiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
.+||+|||..|.|...+.... .++|.....|+.+++.||+|||... ||||||||+|||||.+.+.||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999999988877665443 8999999999999999999999854 99999999999999999999999999966
Q ss_pred cCCCCCCCcccc-cccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHH--HHHHHHhhCCCChhHH
Q 005111 304 FDPKDSVPMTSR-VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ--LHRIFKLCGSPSEDYW 380 (714)
Q Consensus 304 ~~~~~~~~~~~~-~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~--l~~I~k~~G~p~~~~w 380 (714)
.... ....... .||..|+|||++... ..+.++||||||++|+||++|+.+......... +.... ...|
T Consensus 227 ~~~~-~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~-------~~~~ 297 (361)
T KOG1187|consen 227 GPEG-DTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA-------KPLL 297 (361)
T ss_pred CCcc-ccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH-------HHHH
Confidence 5431 1112222 789999999998764 379999999999999999999987764321110 11110 0011
Q ss_pred hhhhcccCccccCCchhhhhhhhhcc--CCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFK--DFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~--~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
...++. ....+.... ..+. ..-..+..+...|+..+|..||++.+++.
T Consensus 298 ~~~~~~--eiiD~~l~~-----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 298 EEGKLR--EIVDPRLKE-----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HCcchh--heeCCCccC-----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111010 001110000 0000 01123677889999999999999999754
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=312.02 Aligned_cols=239 Identities=22% Similarity=0.273 Sum_probs=187.7
Q ss_pred eEEeccCceEEEEEEEcc------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 159 DKIGQGTYSSVYRARDVI------------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~------------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
+.||+|+||.||+|.... ....||+|++.... ......+..|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999997432 23368899875432 3345567889999999999999999998876544
Q ss_pred ceEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc-------EEEeec
Q 005111 227 CSLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI-------LKIADF 298 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~-------vKL~DF 298 (714)
.++||||++++.+..+... ...+++..++.++.||+.||+|||++||+||||||+||||+.++. ++|+||
T Consensus 79 --~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 79 --NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred --CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 7999999999887766543 457999999999999999999999999999999999999987664 899999
Q ss_pred CcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHh-hCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005111 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELF-SGKPVLPGKTEVEQLHRIFKLCGSPSE 377 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLl-tG~~pF~g~~~~e~l~~I~k~~G~p~~ 377 (714)
|++..+... ....++..|+|||++.+...++.++|||||||++|+|+ .|..||......+.. .+...
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~------ 224 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG------ 224 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc------
Confidence 998765322 23467889999998875555899999999999999998 588888765433221 11110
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+ ......+.++.+||.+||+.||.+||++.++|++
T Consensus 225 ------------~~-----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 ------------QC-----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ------------Cc-----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00 0011245689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.37 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=201.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~----~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..+|++++.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+|..++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 4679999999999999999999877665 68999876543 24556778899999999999999999998865 3
Q ss_pred eEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
..++||||+.++.+..++.. ...+++..+..++.||+.||+|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 48999999998766655443 45689999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
..... .....++..|+|||.+.... ++.++|+|||||++|||++ |..||.+....+....+.... .+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--------- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL--------- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC---------
Confidence 32211 11122356799999887655 7899999999999999998 999998876655444442210 00
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+..+.++|.+||..||..|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=312.01 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=190.6
Q ss_pred EEeccCceEEEEEEEccCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEEEeec
Q 005111 160 KIGQGTYSSVYRARDVIHDK--IVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~--~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
.||+|+||.||+|.+..++. .+|+|.+... ......+.+.+|+.++.++ +||||+++++++..... +|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC--ceEEEEeC
Confidence 58999999999999888775 4688877632 2345566788999999999 89999999998876544 89999999
Q ss_pred cccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCc
Q 005111 237 EHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 237 ~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
.++.+..++.. ...+++.+++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 98766544432 12478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 301 ASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 301 a~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
+........ ......+..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 159 ~~~~~~~~~--~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-------- 227 (270)
T cd05047 159 SRGQEVYVK--KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-------- 227 (270)
T ss_pred ccccchhhh--ccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC--------
Confidence 864321111 11112356799999887655 7999999999999999997 99999877655544443110
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.. .+....++..+.+||.+||..||.+|||+.+++.
T Consensus 228 -----------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 -----------YR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -----------CC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 0111246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=310.99 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=190.3
Q ss_pred EEeccCceEEEEEEEcc--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 160 KIGQGTYSSVYRARDVI--HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~--~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+..... +||||||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~--~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP--YLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc--eEEEEEeCC
Confidence 59999999999996432 45678888876432 34445678899999999999999999998876544 899999999
Q ss_pred ccccccccCCC-----CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC-C
Q 005111 238 HDLVGLASLPG-----MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV-P 311 (714)
Q Consensus 238 g~ll~~~~~~~-----~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~-~ 311 (714)
++.+..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 88776554322 23567889999999999999999999999999999999999999999999998754322111 1
Q ss_pred cccccccccccCcccccC------CCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 312 MTSRVVTLWYRPPELLLG------ASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g------~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.....+++.|+|||++.. ...++.++|||||||++|+|++ |.+||......+.+..+........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~-------- 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL-------- 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC--------
Confidence 122345678999998743 2336889999999999999999 7889988777666655543211100
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
..+ .....++..+.+++..|+ .||++|||++++++
T Consensus 231 ---------~~~------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 ---------PKP------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ---------CCC------cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 000 112357788899999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=313.41 Aligned_cols=239 Identities=20% Similarity=0.243 Sum_probs=188.8
Q ss_pred eEEeccCceEEEEEEEccCCe-------EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 159 DKIGQGTYSSVYRARDVIHDK-------IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~-------~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
+.||.|+||.||+|.+...+. .||+|.+... .....+.+..|+.+|+.++||||+++++++..... .++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~--~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE--SIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC--cEE
Confidence 369999999999998765544 4888887532 23445667889999999999999999998876544 899
Q ss_pred EEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc--------EEEeecCccc
Q 005111 232 VFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI--------LKIADFGLAS 302 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~--------vKL~DFGla~ 302 (714)
||||+.++.+..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999887766643 446899999999999999999999999999999999999987764 6999999987
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
..... ....+++.|+|||++.+...++.++|||||||++|+|++| .+||...+........ ...
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~--------- 221 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDR--------- 221 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hcc---------
Confidence 65422 2346788999999998755579999999999999999998 4666655443322211 100
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.......+.++.+||.+||+.||++|||+.++++.
T Consensus 222 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 --------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00112345789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=313.98 Aligned_cols=238 Identities=20% Similarity=0.271 Sum_probs=187.2
Q ss_pred EEeccCceEEEEEEEcc------------------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee
Q 005111 160 KIGQGTYSSVYRARDVI------------------------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~------------------------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIV 215 (714)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999997432 12468899876432 23445678899999999999999
Q ss_pred eeeccccccCCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---
Q 005111 216 KLEGLITSQTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG--- 291 (714)
Q Consensus 216 kl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g--- 291 (714)
++++++..... .||||||++++.+..++. ....+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~--~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVRGSE--NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEeCCc--eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999876554 899999999988876664 356789999999999999999999999999999999999998654
Q ss_pred ----cEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHh-hCCCCCCCCChHHHHH
Q 005111 292 ----ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELF-SGKPVLPGKTEVEQLH 366 (714)
Q Consensus 292 ----~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLl-tG~~pF~g~~~~e~l~ 366 (714)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|.+||.+.+..+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999998654221 22356788999999876555899999999999999984 7999998766543322
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+ .... ......+..+.+||.+||+.+|++|||+.++|++
T Consensus 233 ~~-~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY-EKKH-----------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-Hhcc-----------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 11 1000 0011245679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=332.71 Aligned_cols=237 Identities=27% Similarity=0.403 Sum_probs=199.8
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
++-||.|+.|-||+|+ ..++.||||+++.- -..+|.-|++|+||||+.+.|+|+... +++||||||.
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsP--cyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSP--CYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCc--eeEEeeeccc
Confidence 4569999999999995 56899999987521 125788899999999999999997543 3899999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccc
Q 005111 238 HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317 (714)
Q Consensus 238 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g 317 (714)
.+-|..++..+..++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.++..... ....+++|
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaG 273 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAG 273 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhh
Confidence 9999999988899999999999999999999999999999999999999999999999999999987543 44567899
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchh
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPY 397 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~ 397 (714)
|..|||||++.+.+ .+.++|||||||||||||||.-||..-+.... | =..|...-.
T Consensus 274 TVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---I-wGVGsNsL~------------------- 329 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---I-WGVGSNSLH------------------- 329 (904)
T ss_pred hHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchhee---E-EeccCCccc-------------------
Confidence 99999999999877 79999999999999999999999976543321 1 111211100
Q ss_pred hhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCc
Q 005111 398 RRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSE 437 (714)
Q Consensus 398 ~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp 437 (714)
...+...|..++-||+.||.-.|..||++.++|.|=
T Consensus 330 ----LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 330 ----LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred ----ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 011246788999999999999999999999999984
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.48 Aligned_cols=251 Identities=24% Similarity=0.457 Sum_probs=202.7
Q ss_pred CeeEEeEEeccCceEEEEEEEcc-CCeEEEEEEeecCC--------CCHHHHHHHHHHHHHHHh-CCCCCeeeeeccccc
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVI-HDKIVALKKVRFDN--------QDPESVKFMAREIAILRK-LDHPNIIKLEGLITS 223 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~-~g~~VAiK~i~~~~--------~~~~~~~~~~rEi~iL~~-L~HpnIVkl~~~~~~ 223 (714)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47889999999999999999887 68999999986431 223455667789998875 799999999998876
Q ss_pred cCCceEEEEEeecccccccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeec
Q 005111 224 QTSCSLYLVFEYMEHDLVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
.. .+|+||||++++.+..++ .....+++..++.++.||+.||.|||+ .||+|+||+|.|||++.++.++|+||
T Consensus 81 ~~--~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 ND--RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CC--eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 54 499999999987665433 334579999999999999999999996 78999999999999999999999999
Q ss_pred CcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005111 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~ 378 (714)
|++....... ......++..|+|||++.+.. ++.++|+|||||++|+|++|.+||...........+......+
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 232 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--- 232 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc---
Confidence 9998765433 234457889999999998765 7999999999999999999999998766555444443211100
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
. ....++..+.+||.+||+.||++|||+.++..+
T Consensus 233 ---------------~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 ---------------L---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ---------------C---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0 012467899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.33 Aligned_cols=247 Identities=24% Similarity=0.310 Sum_probs=191.5
Q ss_pred eEEeccCceEEEEEEEcc---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEee
Q 005111 159 DKIGQGTYSSVYRARDVI---HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~---~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
+.||+|+||.||+|.+.. .+..||||.+... ......+.+.+|+.+++.++||||+++++++...+ ...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE-GSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC-CCcEEEEec
Confidence 368999999999998654 3467999987532 23445677889999999999999999999765433 237899999
Q ss_pred ccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC---C
Q 005111 236 MEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV---P 311 (714)
Q Consensus 236 ~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~---~ 311 (714)
+.++.+..++.. ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..+...... .
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 998777666543 345678888999999999999999999999999999999999999999999999765332111 1
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+..+....+... .+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~--------------- 220 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR--------------- 220 (262)
T ss_pred cccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC---------------
Confidence 11234567899999887655 7999999999999999999 57788776655544433210 00
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
+ .....+|..+.+++..||..+|++||++.+++..
T Consensus 221 --~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 --L---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred --C---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0 0012467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=309.78 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=199.8
Q ss_pred eeEEeEEeccCceEEEEEEEcc---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 155 FEKLDKIGQGTYSSVYRARDVI---HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~---~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
|.+.+.||+|+||.||+|.+.. ++..||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6778899999999999998643 57899999998765555667788899999999999999999997754321 1
Q ss_pred eEEEEEeeccccccccccC------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 228 SLYLVFEYMEHDLVGLASL------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
..++++||+.++.+..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478999999776653321 1235789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 302 SFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 302 ~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
+........ ......+++.|++||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~----- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-R----- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-c-----
Confidence 876432211 112224467899999887665 7899999999999999999 899998877655544443210 0
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......++..+.+|+.+||..+|..|||+.+++.+
T Consensus 234 ----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 ----------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00013467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.29 Aligned_cols=264 Identities=22% Similarity=0.342 Sum_probs=200.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.+|++++.||+|+||.||+|.... ++..||+|++...... .....+.+|+.+++.++|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 568899999999999999998543 4889999999765433 45677899999999999999999999887655556
Q ss_pred EEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+++||||++++.+..++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 89999999987776655433 36899999999999999999999999999999999999999999999999999877532
Q ss_pred CCCC--cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC----hhHHh
Q 005111 308 DSVP--MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS----EDYWR 381 (714)
Q Consensus 308 ~~~~--~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~----~~~w~ 381 (714)
.... .....++..|+|||.+.+.. ++.++|||||||++|+|++|..||....... ....+... ...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQMIVTRLL 236 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchh-----ccccccccccccHHHHH
Confidence 2211 11223456799999887765 7999999999999999999998886543211 00000000 00000
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.. +..... ......++..+.+||.+||..+|.+|||+.++++
T Consensus 237 ~~-~~~~~~-----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 EL-LKEGER-----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HH-HHcCCc-----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 000000 0011346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.34 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=199.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTS 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~ 226 (714)
++|.+.++||+|+||.||+|++. .+++.||+|+++.... ....+.+.+|+.+|.++. |||||++++++.....
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 56888999999999999999853 4567899999975432 334556889999999997 9999999998876554
Q ss_pred ceEEEEEeeccccccccccCC-----------------------------------------------------------
Q 005111 227 CSLYLVFEYMEHDLVGLASLP----------------------------------------------------------- 247 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~----------------------------------------------------------- 247 (714)
+|||||||.++.|..++..
T Consensus 116 --~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 116 --IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred --cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 8999999998766543321
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc
Q 005111 248 ---------------------------------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD 288 (714)
Q Consensus 248 ---------------------------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~ 288 (714)
...+++..+..|+.||+.||.|||+.+|+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 12467888999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHH
Q 005111 289 HNGILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLH 366 (714)
Q Consensus 289 ~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~ 366 (714)
.++.+||+|||+++.+..... .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||......+.+.
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999986533221 1122335678899999987765 7999999999999999998 889998766555443
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+.. + ..+ .....++..+.+||.+||..||.+||++.++|+.
T Consensus 353 ~~~~~-~-----------------~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKR-G-----------------YRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHc-C-----------------CCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33221 0 000 0123568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=309.09 Aligned_cols=229 Identities=25% Similarity=0.312 Sum_probs=185.3
Q ss_pred cCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccccccc
Q 005111 164 GTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGL 243 (714)
Q Consensus 164 G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~ 243 (714)
|.||.||+|++..+++.||+|.++... ...+|...+....||||+++++++.... .+|+||||+.++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSED--SVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCC--eEEEEEecCCCCCHHH
Confidence 899999999999999999999987542 1234555556667999999999887654 4999999999887766
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccC
Q 005111 244 ASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323 (714)
Q Consensus 244 ~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~A 323 (714)
+......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 6555567999999999999999999999999999999999999999999999999988765432 123355788999
Q ss_pred cccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhh
Q 005111 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAE 403 (714)
Q Consensus 324 PE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~ 403 (714)
||.+.+.. ++.++|+||+||++|+|++|.+||...... + .. .. ...
T Consensus 151 PE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~-----~~-----------~~~ 196 (237)
T cd05576 151 PEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT-----HT-----------TLN 196 (237)
T ss_pred CcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc-----cc-----------ccC
Confidence 99886655 789999999999999999999877432110 0 00 00 001
Q ss_pred hccCCcHHHHHHHHHhcccCcCCCCCH-----HHHHcCcCC
Q 005111 404 TFKDFPTSALRLMETLMSIDPAHRGTA-----TLALNSEFF 439 (714)
Q Consensus 404 ~~~~~p~~l~~LI~~mL~~DP~kRpTa-----~e~L~Hp~f 439 (714)
....++..+.+||.+||+.||.+|+|+ ++++.||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 123478899999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=305.86 Aligned_cols=241 Identities=24% Similarity=0.392 Sum_probs=196.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|++.+.||+|+||.||++. .+++.||+|.++... ....+.+|+.+++.++||||+++++++... . +|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~--~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-G--LYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-C--cEEE
Confidence 578999999999999999985 578899999986432 335678999999999999999999987643 2 7999
Q ss_pred EeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 233 FEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||+.++.+..++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999998766655432 335899999999999999999999999999999999999999999999999999764322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||...+..+....+.+..
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------- 214 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----------------- 214 (254)
T ss_pred -CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-----------------
Confidence 11223457899999887655 7899999999999999997 999998877655444432110
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.. .....+|..+.+||.+||..+|..|||+.+++.
T Consensus 215 --~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 --RM---------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --CC---------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 011357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.87 Aligned_cols=250 Identities=21% Similarity=0.242 Sum_probs=189.1
Q ss_pred eEEeccCceEEEEEEEc--cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDV--IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~--~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++..... +|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP--YLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC--cEEEEECC
Confidence 35899999999999754 3567899999876533 2344568889999999999999999998876544 89999999
Q ss_pred cccccccccCC-----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC-
Q 005111 237 EHDLVGLASLP-----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV- 310 (714)
Q Consensus 237 ~g~ll~~~~~~-----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~- 310 (714)
+++.+..++.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 98777655432 234677888899999999999999999999999999999999999999999999754322211
Q ss_pred CcccccccccccCcccccCCC------CCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 311 PMTSRVVTLWYRPPELLLGAS------HYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~------~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
......++..|+|||++.+.. .++.++|||||||++|+|++ |.+||...+..+.+........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------- 227 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ---------- 227 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc----------
Confidence 112235678899999885421 25789999999999999996 9999987665544333211000
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+ .....++..+.++|..|+ .+|++|||+.+++.
T Consensus 228 -------~~~~~~------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 228 -------LKLPKP------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -------CCCCCC------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000000 011235778999999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=315.04 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=198.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~----~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.++|+.++.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-- 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT-- 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC--
Confidence 4678999999999999999999887776 57888876443 2344456889999999999999999999876432
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.++++||+.++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 83 -~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 83 -IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred -ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 679999999766655443 344689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.. .+......+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~--------- 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGERL--------- 230 (303)
T ss_pred cccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCCC---------
Confidence 3221 122234577899999987765 7999999999999999997 89999876543322 222211000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......+..+.++|..||..||++||++.+++..
T Consensus 231 ------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112356789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.75 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=194.1
Q ss_pred EEeccCceEEEEEEEccCC------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 160 KIGQGTYSSVYRARDVIHD------KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g------~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.||+|+||.||+|.+.... ..||||.+.... .......+.+|+.+|+.++||||+++++++..... .|+||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP--QYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC--eEEEE
Confidence 5899999999999876544 789999886432 22445678899999999999999999998876554 89999
Q ss_pred eeccccccccccC-------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-----cEEEeecCcc
Q 005111 234 EYMEHDLVGLASL-------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-----ILKIADFGLA 301 (714)
Q Consensus 234 Ey~~g~ll~~~~~-------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-----~vKL~DFGla 301 (714)
||++++.+..++. ....+++.++..++.||+.||.|||+.+++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999877665442 223578999999999999999999999999999999999999887 8999999999
Q ss_pred cccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 302 SFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 302 ~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
......... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG------- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-------
Confidence 765332211 112234568899999987765 7999999999999999998 999998877665554442100
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.......+|..+.+||.+||..+|.+||++.++++
T Consensus 231 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ---------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00112357889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.99 Aligned_cols=236 Identities=22% Similarity=0.289 Sum_probs=188.0
Q ss_pred eEEeccCceEEEEEEEccCC----------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 159 DKIGQGTYSSVYRARDVIHD----------KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g----------~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
+.||+|+||.||+|.+..++ ..|++|++..... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~-- 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DE-- 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CC--
Confidence 36999999999999988776 4588887764322 15678899999999999999999998766 33
Q ss_pred EEEEEeeccccccccccCCCC-CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-------cEEEeecCc
Q 005111 229 LYLVFEYMEHDLVGLASLPGM-KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-------ILKIADFGL 300 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~-~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-------~vKL~DFGl 300 (714)
.++||||+.++.+..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 799999999988887765444 789999999999999999999999999999999999999888 799999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCC-CCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChh
Q 005111 301 ASFFDPKDSVPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSED 378 (714)
Q Consensus 301 a~~~~~~~~~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~ 378 (714)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+.......
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-------- 221 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-------- 221 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc--------
Confidence 987643 1233567789999998776 347999999999999999999 5777766543222221110
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
....+ ......+.+||.+||..+|.+|||+.++|+
T Consensus 222 ----------~~~~~------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 ----------QHRLP------------MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----------CCCCC------------CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 011268999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=337.00 Aligned_cols=265 Identities=28% Similarity=0.456 Sum_probs=219.6
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC-
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT- 225 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~- 225 (714)
+|...+.|++.+.||.|.+|.||+++++.+++.+|+|++..+... -+.+.-|++||+.+ .|||++.++++|....
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 567788999999999999999999999999999999999876432 34466899999988 6999999999875432
Q ss_pred --CceEEEEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 226 --SCSLYLVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 226 --~~~l~LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
...+|||||||.||+..++.. .+..+.|+.+.+|++.+|.||.|||.+.++|||||..|||++.+|.|||+|||.+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 345999999999987765543 2668999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCC----CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGAS----HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~----~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~ 377 (714)
..++.... ...+.+|||.|||||++.... .|+..+|+||||++..||.-|.|||........+..|- ..|+.
T Consensus 171 aQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip---RNPPP 246 (953)
T KOG0587|consen 171 AQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP---RNPPP 246 (953)
T ss_pred eeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---CCCCc
Confidence 98865433 445669999999999996532 36789999999999999999999998776655444441 11111
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
. ...++..+.++.+||..||.+|-.+||+..++|.|||++..
T Consensus 247 k-----------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 247 K-----------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred c-----------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 0 01123457889999999999999999999999999999954
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=329.43 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=212.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCe---E-EEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDK---I-VALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~---~-VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
.+++-.+.++||+|+||.||+|..+..+. . ||+|..+.. ....+....+.+|+++|++++|||||++||+...+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 45566677999999999999998765422 3 899998863 366788899999999999999999999999988777
Q ss_pred CceEEEEEeeccccccccccCCCC-CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGM-KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~-~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
. +|||||+|.||.|..++.... .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++.-
T Consensus 235 P--l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 235 P--LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred c--cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 6 999999999999988887665 5999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
...... ....-....|+|||.+.... |++++|||||||++||+++ |..||++.+..+...+|.......
T Consensus 313 ~~~~~~-~~~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~-------- 382 (474)
T KOG0194|consen 313 SQYVMK-KFLKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM-------- 382 (474)
T ss_pred cceeec-cccccCcceecChhhhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC--------
Confidence 311111 11123467899999998764 8999999999999999999 888999999998888884421100
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......|..+..++..|+..||+.|||+.++.+
T Consensus 383 -------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 -------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 011256888999999999999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=321.75 Aligned_cols=266 Identities=25% Similarity=0.425 Sum_probs=216.6
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-----CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-----QDPESVKFMAREIAILRKLDHPNIIKLEGLITS 223 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-----~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~ 223 (714)
|...++|-++..||+|||+.||+|.|....+.||+|+-.... ......+...||..|.+.|+||.||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 344577889999999999999999999999999999865432 234456778899999999999999999999876
Q ss_pred cCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc--CeeeccCCCccEEEcC---CCcEEEeec
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH--GVLHRDIKGSNLLLDH---NGILKIADF 298 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--gIiHrDLKP~NILl~~---~g~vKL~DF 298 (714)
+.. .++-|+|||+|+.|+.++..+..+++.+++.|+.||+.||.||.+. -|||-||||.||||.. -|.+||+||
T Consensus 539 Dtd-sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTD-SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccc-cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 544 4899999999999999999999999999999999999999999977 4999999999999954 478999999
Q ss_pred CcccccCCCCCCC------cccccccccccCccccc-C--CCCCCccccccchhHHHHHHhhCCCCCCCCCh-HHHH--H
Q 005111 299 GLASFFDPKDSVP------MTSRVVTLWYRPPELLL-G--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTE-VEQL--H 366 (714)
Q Consensus 299 Gla~~~~~~~~~~------~~~~~gT~~Y~APE~l~-g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l--~ 366 (714)
|+++.++...... .....||.||++||.|. + .+..+.++||||+|||+|.++.|+.||..... .+.+ .
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 9999886543321 22347899999999985 3 34578899999999999999999999975432 2222 1
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.|++... ..| |. -+.+++++.+||++||++--+.|....++-.||||..
T Consensus 698 TIlkAtE---------------VqF-P~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 698 TILKATE---------------VQF-PP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred chhccee---------------ccC-CC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 2222100 000 00 1357899999999999999999999999999999974
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=309.62 Aligned_cols=261 Identities=20% Similarity=0.176 Sum_probs=189.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHH---------HHHHHHHHHHHHhCCCCCeeeeec
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPES---------VKFMAREIAILRKLDHPNIIKLEG 219 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~---------~~~~~rEi~iL~~L~HpnIVkl~~ 219 (714)
.+.|++.+.||+|+||.||+|.+..+ +..+|+|+.......... ......++..+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999998877 677888875544321110 011223444556678999999988
Q ss_pred cccccCC--ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEee
Q 005111 220 LITSQTS--CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIAD 297 (714)
Q Consensus 220 ~~~~~~~--~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~D 297 (714)
....... ...+++||++...+..... ....+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 6543322 1347788887665443332 223468899999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCC------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHh
Q 005111 298 FGLASFFDPKDS------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL 371 (714)
Q Consensus 298 FGla~~~~~~~~------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~ 371 (714)
||+|+.+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+......+....+
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~- 247 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK- 247 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH-
Confidence 999987643221 1122346899999999988766 89999999999999999999999987743222221111
Q ss_pred hCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 372 CGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 372 ~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+++..... -...++..+..+.+++..|+..+|++||+..++++
T Consensus 248 -----~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 -----CDFIKRLHE---------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -----HHHHHHhhh---------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 011100000 00012356889999999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=339.66 Aligned_cols=250 Identities=27% Similarity=0.438 Sum_probs=212.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.+-+..+.||+|+||.||+|+... ....||||.++.. .+.+..+.|.||+++|..|+|||||+|+|+|...+.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P- 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREGDP- 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe-
Confidence 456778899999999999997532 3467999998754 345578889999999999999999999999998777
Q ss_pred eEEEEEeeccccccccccC----------CCC----CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcE
Q 005111 228 SLYLVFEYMEHDLVGLASL----------PGM----KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGIL 293 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~----------~~~----~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~v 293 (714)
+|||||||.+|.|..++. .+. +|+..+.+.|+.||+.|+.||-++.+|||||-..|+||.++..|
T Consensus 564 -~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 564 -LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred -eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 999999999887765443 122 38999999999999999999999999999999999999999999
Q ss_pred EEeecCcccccCCCCCCCcc-cccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHh
Q 005111 294 KIADFGLASFFDPKDSVPMT-SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKL 371 (714)
Q Consensus 294 KL~DFGla~~~~~~~~~~~~-~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~ 371 (714)
||+|||+++..-..+..... ...-...|||||.++-.. |+.++||||+||+|||+++ |+.|+.|-+..+.+..|..
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~- 720 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA- 720 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-
Confidence 99999999876555544333 223468899999998766 8999999999999999998 8999999999999988854
Q ss_pred hCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHH
Q 005111 372 CGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLAL 434 (714)
Q Consensus 372 ~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L 434 (714)
+.+-+...+.|.++.+|+..||+..|.+||++.|+-
T Consensus 721 ---------------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 ---------------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred ---------------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 223344568999999999999999999999999864
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=334.35 Aligned_cols=203 Identities=33% Similarity=0.489 Sum_probs=174.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC----Cce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----SCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----~~~ 228 (714)
..+..-+.||+|+||.||+++++.+|+.||||.++... ....++...+|+++|++|+|+|||++.++-.... ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 44677888999999999999999999999999998653 3345677889999999999999999998755444 334
Q ss_pred EEEEEeeccccccccccCC---CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc--CCC--cEEEeecCcc
Q 005111 229 LYLVFEYMEHDLVGLASLP---GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD--HNG--ILKIADFGLA 301 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~--~~g--~vKL~DFGla 301 (714)
..+|||||.||.|...+.. ...|++.+++.++..+..||.|||++|||||||||.||++- .+| ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 6899999999888766653 34599999999999999999999999999999999999984 334 4799999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCC
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPG 358 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g 358 (714)
+.++... ..++.+||+.|++||++.....|+..+|.|||||++|+++||..||-.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 9986554 678899999999999988555699999999999999999999999854
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.66 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=188.4
Q ss_pred EEeccCceEEEEEEEccC--CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecc
Q 005111 160 KIGQGTYSSVYRARDVIH--DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~--g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
.||+|+||.||+|..... ...+++|.+.... .....+.+.+|+.+++.++||||+++++.+..... +|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~--~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP--YLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc--cEEEEecCC
Confidence 599999999999975433 3456677765432 23456778999999999999999999998876544 899999999
Q ss_pred ccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-CCc
Q 005111 238 HDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-VPM 312 (714)
Q Consensus 238 g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~ 312 (714)
++.|..++.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++........ ...
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 8777655432 23467788899999999999999999999999999999999999999999999864322111 112
Q ss_pred ccccccccccCcccccCC------CCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 313 TSRVVTLWYRPPELLLGA------SHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~------~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
...+++..|+|||++... ..++.++|||||||++|||++ |.+||...+..+.+..+.+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------- 228 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc----------
Confidence 234678899999987431 125779999999999999997 578888777776666654321100
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+.+ .....++..+.++|..|| .+|++|||+.++++
T Consensus 229 ----~~~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ----LFKP---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----cCCC---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000 111246788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=301.08 Aligned_cols=264 Identities=24% Similarity=0.363 Sum_probs=210.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++.+-+..||.|+||+|++..++.+|+..|||.|+..+. ....++++.|.....+- ++||||++||.+..++. .|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--cW 139 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--CW 139 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--ee
Confidence 3445667789999999999999999999999999998765 44566777888776555 79999999999887776 79
Q ss_pred EEEeeccccccccc----cCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 231 LVFEYMEHDLVGLA----SLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 231 LV~Ey~~g~ll~~~----~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
|.||+|+-.+-.++ ......++|.-+-.|....+.||.||-. ..||||||||+||||+..|.+||||||++..+.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99999986543222 2244578999999999999999999985 589999999999999999999999999998764
Q ss_pred CCCCCCcccccccccccCcccccCCCC-CCccccccchhHHHHHHhhCCCCCCCCCh-HHHHHHHHHhhCCCChhHHhhh
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASH-YGAAVDLWSTGCILGELFSGKPVLPGKTE-VEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~-y~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
. +...+...|...|||||.+..... |+.++|+||||++|||+.||..|+.+.+. .+++..+. .|.|+.-..
T Consensus 220 ~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~~--- 292 (361)
T KOG1006|consen 220 D--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILLF--- 292 (361)
T ss_pred H--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeecC---
Confidence 2 233345578899999999964433 89999999999999999999999887543 45555553 244332100
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
+ ..--+++..+..+|..||.+|-..||...+++.+||+....
T Consensus 293 ------------~------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 293 ------------D------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred ------------c------ccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 0 00124788999999999999999999999999999998653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=334.81 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=208.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHD-----KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
...-++.+.||+|.||.||.|...... ..||||.++.. .+.+....|.+|..+|+.++|||||+++|++.....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 355678899999999999999765432 34999988754 456677889999999999999999999999987544
Q ss_pred ceEEEEEeeccccccccccC-C------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecC
Q 005111 227 CSLYLVFEYMEHDLVGLASL-P------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFG 299 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~-~------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFG 299 (714)
.+|++|||+|+.|..+++ . ...++..+...++.||+.|+.||+++++|||||...|+||+....+||+|||
T Consensus 770 --~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 770 --PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred --cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 899999999866655444 3 3568999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcccc-cccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 005111 300 LASFFDPKDSVPMTSR-VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSE 377 (714)
Q Consensus 300 la~~~~~~~~~~~~~~-~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~ 377 (714)
+|+.+...+....... .-...|||||.|.... ++.++|||||||+|||+++ |..||++.+..+.+......- .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R--- 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R--- 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c---
Confidence 9995543433333332 2246899999998755 8999999999999999999 899999999988887654421 1
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+.+..+|..+.+||..||..+|++||+...+++
T Consensus 923 ------------------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 ------------------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------------------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1123468999999999999999999999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=283.98 Aligned_cols=244 Identities=39% Similarity=0.609 Sum_probs=198.1
Q ss_pred CceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccccccccc
Q 005111 165 TYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLA 244 (714)
Q Consensus 165 ~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~ 244 (714)
+||.||+|.+..+|+.||+|++........ .+.+.+|+..+++++|+||+++++++.... ..+++|||++++.+..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDED--KLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCC--EEEEEEeCCCCCCHHHH
Confidence 589999999988899999999876533221 678899999999999999999999887654 38999999999776666
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCc
Q 005111 245 SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPP 324 (714)
Q Consensus 245 ~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~AP 324 (714)
......+++..+..++.+|+.+|.+||+.+|+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 5544458999999999999999999999999999999999999999999999999998875432 23345678999999
Q ss_pred ccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhh
Q 005111 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAET 404 (714)
Q Consensus 325 E~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~ 404 (714)
|.+.+.. ++.++||||||+++|+|++|..||......+.+........... ...
T Consensus 156 E~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~ 209 (244)
T smart00220 156 EVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------------------------PPP 209 (244)
T ss_pred HHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------ccc
Confidence 9887655 78899999999999999999999987433333333222100000 000
Q ss_pred ccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 405 FKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 405 ~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
...++..+.+++.+||..||.+||++.++++||||
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 11277899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=316.08 Aligned_cols=275 Identities=25% Similarity=0.328 Sum_probs=189.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEc----------------cCCeEEEEEEeecCCCCH--H----------HHHHHHHH
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDV----------------IHDKIVALKKVRFDNQDP--E----------SVKFMARE 202 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~----------------~~g~~VAiK~i~~~~~~~--~----------~~~~~~rE 202 (714)
..++|++.++||+|+||+||+|.+. ..++.||||.+....... + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4679999999999999999999752 245679999987542210 0 11223457
Q ss_pred HHHHHhCCCCCe-----eeeecccccc------CCceEEEEEeeccccccccccCC------------------------
Q 005111 203 IAILRKLDHPNI-----IKLEGLITSQ------TSCSLYLVFEYMEHDLVGLASLP------------------------ 247 (714)
Q Consensus 203 i~iL~~L~HpnI-----Vkl~~~~~~~------~~~~l~LV~Ey~~g~ll~~~~~~------------------------ 247 (714)
+.++.++.|.++ ++++++|... .....||||||++++.|..++..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 5666666432 12348999999998776544321
Q ss_pred CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccc
Q 005111 248 GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327 (714)
Q Consensus 248 ~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l 327 (714)
...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++...............+|+.|+|||++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 12346778999999999999999999999999999999999999999999999976543322211222348999999988
Q ss_pred cCCCC-------------------CC--ccccccchhHHHHHHhhCCC-CCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 328 LGASH-------------------YG--AAVDLWSTGCILGELFSGKP-VLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 328 ~g~~~-------------------y~--~~sDIWSLG~iLyeLltG~~-pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
..... |+ ...||||+|||+|+|++|.. ||.+....... ++.+ ......|...+.
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~-~~~~~~~r~~~~ 458 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQY-DNDLNRWRMYKG 458 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhc-cchHHHHHhhcc
Confidence 54221 12 24799999999999999874 66543221111 1100 001112322111
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCc---CCCCCHHHHHcCcCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDP---AHRGTATLALNSEFFTT 441 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP---~kRpTa~e~L~Hp~f~~ 441 (714)
.. .-...+...++.+++||.+||..+| .+|+|+.|+|+||||..
T Consensus 459 ~~------------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QK------------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cC------------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0011245678999999999999876 68999999999999964
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.30 Aligned_cols=286 Identities=31% Similarity=0.510 Sum_probs=218.5
Q ss_pred cccCCCCCeeEEeEEeccCceEEEEEEEcc---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccc
Q 005111 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVI---HDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLIT 222 (714)
Q Consensus 147 ~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~---~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~ 222 (714)
.+|...+.|.++++||.|+|++||+|.+.. .++.||+|.+.... ....+.+|+++|..+ .+.||+++.+++.
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence 355567889999999999999999999887 78999999987653 344588999999999 6999999999988
Q ss_pred ccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeecCcc
Q 005111 223 SQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADFGLA 301 (714)
Q Consensus 223 ~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla 301 (714)
..+. ..+||||+++.....+.. .++..+++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|
T Consensus 106 nnd~--v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 106 NNDQ--VAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred cCCe--eEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 7766 999999999977666653 5789999999999999999999999999999999999985 567899999999
Q ss_pred cccCCCC------------C-------------------------------CCcccccccccccCcccccCCCCCCcccc
Q 005111 302 SFFDPKD------------S-------------------------------VPMTSRVVTLWYRPPELLLGASHYGAAVD 338 (714)
Q Consensus 302 ~~~~~~~------------~-------------------------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sD 338 (714)
..++... . .....+.||++|+|||++...+.-+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321100 0 00113578999999999998877789999
Q ss_pred ccchhHHHHHHhhCCCCC-CCCChHHHHHHHHHhhCCCCh--------h--HHhhhhcccCc----cccCC-----chhh
Q 005111 339 LWSTGCILGELFSGKPVL-PGKTEVEQLHRIFKLCGSPSE--------D--YWRKSKLRHST----VFKPV-----QPYR 398 (714)
Q Consensus 339 IWSLG~iLyeLltG~~pF-~g~~~~e~l~~I~k~~G~p~~--------~--~w~~~~~~~~~----~~~~~-----~p~~ 398 (714)
|||.|+|+..++++..|| ...++.+.+..|..+.|.-.- . +|.+..++... .|... .+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999998665 456666666666666654321 1 34322111100 01111 0000
Q ss_pred ---hhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 399 ---RRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 399 ---~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.........+|..+.+|+++||+.||.+|+||+++|.||||+.
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 0111222345679999999999999999999999999999994
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=303.65 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=205.3
Q ss_pred CCCCeeEE-------eEEeccCceEEEEEEEccC----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeec
Q 005111 151 RANTFEKL-------DKIGQGTYSSVYRARDVIH----DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEG 219 (714)
Q Consensus 151 ~~~~Y~~~-------~~LG~G~fG~Vy~a~d~~~----g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~ 219 (714)
...+|++- +.||.|-||.||.|..... .-.||||..+.+ .+.+..+.|..|..+|+.++|||||+|+|
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheee
Confidence 34456654 6799999999999975432 345889987764 44566888999999999999999999999
Q ss_pred cccccCCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 220 LITSQTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 220 ~~~~~~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
++.+.. .|||||++.-|.|..++. ....|+......|+.||+.||+|||+.++|||||-..||||...-.|||+||
T Consensus 459 v~~e~P---~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 459 VCVEQP---MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred eeeccc---eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeeccc
Confidence 998654 899999999777766554 4567999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 005111 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSE 377 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~ 377 (714)
|+++.++.......+...-..-|||||.+.-.. ++.++|||.|||++||+|. |..||.|-...+.+..|.+.-.
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR---- 610 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER---- 610 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC----
Confidence 999998765544333223367799999886544 8999999999999999887 8899999877666655533111
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
...++.+|+.+..|+.+||++||.+||+..++..
T Consensus 611 ------------------------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 611 ------------------------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred ------------------------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 1123578999999999999999999999887654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=311.12 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=218.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g---~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
+...+.++||.|.||.||+|+.+..| ..||||.++.. ..+.....|+.|+.||-+++||||++|.|+++.... +
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P--v 705 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP--V 705 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce--e
Confidence 45677899999999999999987766 57999999865 345677789999999999999999999999987665 8
Q ss_pred EEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
.||.|||+++.|+.+++ .++.|+.-++.-+++.|+.|+.||-++++|||||-..||||+.+-.+|++|||+++.+....
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999886665 45779999999999999999999999999999999999999999999999999999886554
Q ss_pred CCCcccccc--cccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 309 SVPMTSRVV--TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 309 ~~~~~~~~g--T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
....++.-| ...|.|||.+.-.. ++.++||||+|++|||.++ |..||...++.+.+..|.+...-|+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP-------- 856 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP-------- 856 (996)
T ss_pred CccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC--------
Confidence 333444333 57899999987665 7999999999999999776 99999999999999999876655432
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+.|..+..|+..||++|-..||+..+++.+
T Consensus 857 --------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 --------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred --------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 3789999999999999999999999998873
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=298.41 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=205.6
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
+..+-.+||.|-||.||.|.++...-.||||.++.+. ..++.|+.|+.+|+.+.|||+|+|+++|+.+.. +|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP--FYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP--FYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC--eEEEE
Confidence 4456688999999999999999999999999998554 457789999999999999999999999998877 99999
Q ss_pred eecccc-ccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHD-LVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~-ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||..+ ||+.+...+ ..++.-..+.++.||..|++||..+++|||||-..|+||.++..|||+||||++.+...+.+.
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 999865 444443333 346666788888999999999999999999999999999999999999999999987665544
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....-..-|.|||-|.-.. ++.++|||+|||+|||+.| |..||+|-+....+..+.+.
T Consensus 423 HAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg------------------- 482 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG------------------- 482 (1157)
T ss_pred ccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc-------------------
Confidence 44444467899999887655 7899999999999999998 88999998765544444221
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
...+....+|+....|+..||.+.|..||+..|+-+
T Consensus 483 ---------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 483 ---------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred ---------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 112334679999999999999999999999988644
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=306.74 Aligned_cols=261 Identities=27% Similarity=0.415 Sum_probs=219.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|+.+..+|.|+||.||+|+|+.+++..|+|+++.... ..+.-+.+||-+++.++|||||.+++-|...+. ++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dk--lwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK--LWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcC--cEE
Confidence 4789999999999999999999999999999999998643 345667899999999999999999998887666 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
+||||+|+.+..+..-.+++++.++....+..+.||+|||+.|-+|||||..|||+++.|.+||+|||.+..+.. ....
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TIAK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh-hhhh
Confidence 999999999998888888999999999999999999999999999999999999999999999999999977653 2334
Q ss_pred cccccccccccCccccc--CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 312 MTSRVVTLWYRPPELLL--GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~--g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
..+..||+.|||||+.. ....|...+|||++|+...||-.-++|....-....+..+.+....|+.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~------------ 236 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT------------ 236 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc------------
Confidence 45779999999999862 2334899999999999999999888887666555444444332211110
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
- +.-...++.+-+|++.+|.++|.+|||++.+|.|||.+.
T Consensus 237 ------l------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 ------L------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------c------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 0 001134677899999999999999999999999999764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=296.88 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=206.1
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
...+.++||+|-||.|.+|. ...+..||+|+++.+.. ....+.|.+||.+|.+|+|||||.|+++|..++. ++||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP--icmI~ 614 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP--LCMIT 614 (807)
T ss_pred heehhhhhcCcccceeEEEE-ecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc--hHHHH
Confidence 45678999999999999997 45579999999987643 3446789999999999999999999999987776 89999
Q ss_pred eeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 234 EYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||+.|.|..++..+ ..+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-+-..+...
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 999988777665544 223556677899999999999999999999999999999999999999999999765555444
Q ss_pred ccc-ccccccccCcccccCCCCCCccccccchhHHHHHHhh--CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 312 MTS-RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS--GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 312 ~~~-~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt--G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
... .+-...|||||.++... ++.++|+|+||++|||+++ ...||...++.+.......++...+.
T Consensus 695 vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~----------- 762 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR----------- 762 (807)
T ss_pred eecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc-----------
Confidence 333 34478999999998766 8999999999999999765 67889887776665554333222211
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+.-+|..+.+||..|+..|-.+|||.+++-.
T Consensus 763 ----------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 ----------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ----------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1112223568999999999999999999999999753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=263.15 Aligned_cols=217 Identities=24% Similarity=0.389 Sum_probs=182.1
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCc
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~ 227 (714)
.-..++...+..||+|+||.|-+.++..+|...|+|.++.... ....+++.+|+.+..+. .+|++|.+||.+..+..
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd- 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD- 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-
Confidence 3345666778889999999999999999999999999987643 34567788899887766 79999999998876666
Q ss_pred eEEEEEeecccccc---ccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 228 SLYLVFEYMEHDLV---GLASLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll---~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
++|.||.|+..+- ...+..+..++|..+-.|+.-++.||.|||++ .|||||+||+||||+.+|++|+||||++..
T Consensus 120 -vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 -VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred -EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999987543 34456778899999999999999999999976 899999999999999999999999999988
Q ss_pred cCCCCCCCcccccccccccCcccccC---CCCCCccccccchhHHHHHHhhCCCCCC-CCChHHHHHHHHH
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLG---ASHYGAAVDLWSTGCILGELFSGKPVLP-GKTEVEQLHRIFK 370 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g---~~~y~~~sDIWSLG~iLyeLltG~~pF~-g~~~~e~l~~I~k 370 (714)
+... ...+-..|...|||||.+.. ...|+.++||||||+++.||.+++.||+ +.++.+++.++.+
T Consensus 199 L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 199 LVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 7432 22233467789999999843 3358999999999999999999999986 5688889888865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=325.39 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=185.5
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|...+.||+|+||.||+|.+..++..||||++...... ...|+.++++++|||||++++++..... .|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~--~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKG--AYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCC--CEEEE
Confidence 355667899999999999999899999999998643211 1246889999999999999999876654 89999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhh---hcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH---SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH---~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||++++.+..++. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||.+......
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999988877764 4899999999999999999999 6699999999999999998888775 6665443211
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChH-HHHHHHHHhhCC-CChhHHhhhhcccC
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV-EQLHRIFKLCGS-PSEDYWRKSKLRHS 388 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~-e~l~~I~k~~G~-p~~~~w~~~~~~~~ 388 (714)
....+|+.|+|||++.+.. |+.++|||||||++|||++|+.||...... ..+....+..-. .....|
T Consensus 836 --~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 904 (968)
T PLN00113 836 --TKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMW-------- 904 (968)
T ss_pred --CCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhhe--------
Confidence 2336789999999988765 899999999999999999999998542211 011111110000 000001
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+... ............+.+++.+||+.||++|||+.++++.
T Consensus 905 --~~~~~~---~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 905 --IDPSIR---GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred --eCcccc---CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000 0000001123467889999999999999999999875
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=295.62 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=209.8
Q ss_pred CeeEEeEEeccCceEEEEEEEccC-C--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIH-D--KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~-g--~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
+..+.++||+|.||.|++|.+... | -.||||+++.+.... ....|.+|+.+|.+|+|+|+|+|||++.++. +.
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp---~m 186 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP---AM 186 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch---hh
Confidence 445678899999999999987643 3 469999999775544 6778999999999999999999999998643 78
Q ss_pred EEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||++++|.|-..+. ....|.......|+.||+.||.||..+++|||||-..||||-....|||+||||.+.+....
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999766554433 45678999999999999999999999999999999999999999999999999999987655
Q ss_pred CCCcc--cccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 309 SVPMT--SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 309 ~~~~~--~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
..... .......|+|||.|.... ++.++|+|++||++|||++ |+-||.|......+++|-+.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~-------------- 331 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG-------------- 331 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc--------------
Confidence 43211 123356799999998766 8999999999999999999 68999999999888887321
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
......+.+|+++.+++..||..+|++|||+..+...-++.
T Consensus 332 --------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 332 --------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred --------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 01122357899999999999999999999999887655443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=305.92 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=190.0
Q ss_pred eeEEeEEeccCceE-EEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEEE
Q 005111 155 FEKLDKIGQGTYSS-VYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 155 Y~~~~~LG~G~fG~-Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
|.--+.+|.|+-|+ ||+|. ..|+.||||.+- .+......|||..|+.- .|||||++++ .+.+...+||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEe--eCCceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEE
Confidence 33346689999885 79994 679999999874 24566788999999988 6999999966 45566679999
Q ss_pred EeeccccccccccCC--CCCC-CHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CC--cEEEeecCccccc
Q 005111 233 FEYMEHDLVGLASLP--GMKF-TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NG--ILKIADFGLASFF 304 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~--~~~l-se~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g--~vKL~DFGla~~~ 304 (714)
.|+|...|-+.+... .... ..-..+.++.|++.||+|||+.+||||||||.||||+. ++ .++|.|||+++.+
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999998776655442 1111 11456889999999999999999999999999999986 34 6899999999988
Q ss_pred CCCCCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 305 DPKDSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 305 ~~~~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
...... ...+..||-.|+|||++.... -..++||||||||+|..++| ..||...- +.-..|+... +
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~--~------ 730 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGN--Y------ 730 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCc--c------
Confidence 655432 244567899999999998776 47799999999999999997 78986532 2223332210 0
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
++...-+.....+.+||.+||.+||..||+|.++|.||||=.
T Consensus 731 ------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 731 ------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred ------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 000111111228999999999999999999999999999954
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=285.30 Aligned_cols=204 Identities=28% Similarity=0.421 Sum_probs=175.9
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHH------HHHHHHHHHHHHhCC---CCCeeeeec
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES------VKFMAREIAILRKLD---HPNIIKLEG 219 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~------~~~~~rEi~iL~~L~---HpnIVkl~~ 219 (714)
+....+|..++.||.|+||.|++|.++.+...|+||.|.+...-.+. .-.+-.||.||..|+ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 45567899999999999999999999999999999998764211111 122446999999996 999999999
Q ss_pred cccccCCceEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 220 LITSQTSCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 220 ~~~~~~~~~l~LV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
+|++++. +||+||-...+ .|..++.....++|.+++.|++||..|+++||+.||||||||-+|+.++.+|-+||+||
T Consensus 637 fFEddd~--yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 637 FFEDDDY--YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eeecCCe--eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9987665 99999987643 34556666678999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCC
Q 005111 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP 357 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~ 357 (714)
|.|.... ..+....+||..|.|||+|.|..+.+..-|||+||++||-++...-||.
T Consensus 715 gsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998763 3456778999999999999999988999999999999999999888874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=273.27 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=191.7
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh--CCCCCeeeeeccccccC--CceE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK--LDHPNIIKLEGLITSQT--SCSL 229 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIVkl~~~~~~~~--~~~l 229 (714)
..++++.||+|.||.||+|. .+++.||||++.. +..+.+..|-.|... +.|+||++++++-...+ ...+
T Consensus 211 pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 34677889999999999994 6789999999864 455667777777665 48999999988643322 2348
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc---------CeeeccCCCccEEEcCCCcEEEeecCc
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH---------GVLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~---------gIiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
+||++|.+.+.|..++..+ .+++....+++.-|+.||+|||+- .|+|||||..||||-.|++..|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999998888765 689999999999999999999952 499999999999999999999999999
Q ss_pred ccccCCCCCC-CcccccccccccCcccccCCCCCC-----ccccccchhHHHHHHhhCCCCCC-CCChHHHHHHHHHhhC
Q 005111 301 ASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYG-----AAVDLWSTGCILGELFSGKPVLP-GKTEVEQLHRIFKLCG 373 (714)
Q Consensus 301 a~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~-----~~sDIWSLG~iLyeLltG~~pF~-g~~~~e~l~~I~k~~G 373 (714)
|..+.+.... .....+||..|||||+|.|...+. .+.||||+|.|||||++....+. +..+.-++.--.++--
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 9988754332 344579999999999998876544 36999999999999999875553 2221111111111122
Q ss_pred CCChh-HHhhhhcccCccccCCchhhhhhhhhccC--CcHHHHHHHHHhcccCcCCCCCHHH
Q 005111 374 SPSED-YWRKSKLRHSTVFKPVQPYRRRIAETFKD--FPTSALRLMETLMSIDPAHRGTATL 432 (714)
Q Consensus 374 ~p~~~-~w~~~~~~~~~~~~~~~p~~~~i~~~~~~--~p~~l~~LI~~mL~~DP~kRpTa~e 432 (714)
.|..+ +|... . .+. .++.+.+.+.. ...-+.+.|+.||..||+.|.||.=
T Consensus 443 hPt~e~mq~~V-V-----~kK---~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 443 HPTLEEMQELV-V-----RKK---QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CCCHHHHHHHH-H-----hhc---cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 23322 22111 0 001 11222233322 2456889999999999999999753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=241.79 Aligned_cols=213 Identities=38% Similarity=0.617 Sum_probs=181.5
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDL 240 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~l 240 (714)
||+|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++.... ..+++|||+.+..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDEN--HLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCC--eEEEEEecCCCCc
Confidence 689999999999988889999999987653321 4567889999999999999999999887653 4899999999776
Q ss_pred cccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeecCcccccCCCCCCCccccccc
Q 005111 241 VGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKDSVPMTSRVVT 318 (714)
Q Consensus 241 l~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla~~~~~~~~~~~~~~~gT 318 (714)
+..+.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 66655433 46899999999999999999999999999999999999999 89999999999987654321 12334568
Q ss_pred ccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhh
Q 005111 319 LWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYR 398 (714)
Q Consensus 319 ~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~ 398 (714)
..|++||.+.....++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8999999887653478999999999999999
Q ss_pred hhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCc
Q 005111 399 RRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSE 437 (714)
Q Consensus 399 ~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp 437 (714)
..+.++|..||..||.+||++.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2577899999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=289.71 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=196.4
Q ss_pred eEEeEEeccCceEEEEEEEc----c---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCc
Q 005111 156 EKLDKIGQGTYSSVYRARDV----I---HDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~----~---~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~ 227 (714)
.+.+.||+|.||.|++|.-. . ....||||.++..... ...+.+..|+.+|+.+ .|+||+.++++++.. +
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~--~ 375 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD--G 375 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC--C
Confidence 55669999999999999633 1 1567999998866544 6778899999999999 699999999999874 4
Q ss_pred eEEEEEeeccccccccccCCCC----------------CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGM----------------KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~----------------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
.+++|+||+..+.+..+++... .++..+...++.||+.|++||++..+|||||-..||||..+.
T Consensus 376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence 4999999999766654443332 489999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCCCCcccccc--cccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCC-hHHHHHH
Q 005111 292 ILKIADFGLASFFDPKDSVPMTSRVV--TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKT-EVEQLHR 367 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~~~~~~~~g--T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~-~~e~l~~ 367 (714)
.+||+|||+|+..............+ ...|||||.+.... |+.++||||+|++||||++ |..||++-. ..+.+..
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999999654433322222222 34599999998844 8999999999999999999 789998854 3333332
Q ss_pred HHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 368 IFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 368 I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.. . ...+.+...+.++.+++..|+..+|++||+..++..
T Consensus 535 l~~-------------------G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKE-------------------G---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred Hhc-------------------C---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 211 0 111223457899999999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=243.74 Aligned_cols=211 Identities=37% Similarity=0.586 Sum_probs=175.5
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++..... .++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~--~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEP--LYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCc--eEEEEe
Confidence 67789999999999999999888999999999765332 356788899999999999999999998765544 899999
Q ss_pred eccccccccccCCCCC-CCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 235 YMEHDLVGLASLPGMK-FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~-lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
|++++.+..+...... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++..+.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999766666554444 899999999999999999999999999999999999999999999999999887544211223
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCC-CChH-HHHHHH
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEV-EQLHRI 368 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g-~~~~-e~l~~I 368 (714)
...++..|++||++.+...++.++|+|+|||++|+|++|+.||.. .... .....|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 456788999999884334478899999999999999999999987 4444 444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=300.23 Aligned_cols=204 Identities=18% Similarity=0.222 Sum_probs=144.9
Q ss_pred hCCC-CCeeeeecccccc-----CCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCC
Q 005111 208 KLDH-PNIIKLEGLITSQ-----TSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIK 281 (714)
Q Consensus 208 ~L~H-pnIVkl~~~~~~~-----~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLK 281 (714)
.+.| +||+.+++.|... ....++++|||+++++...+......+++.+++.|+.||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 5777777765211 112378899999887666554545679999999999999999999999999999999
Q ss_pred CccEEEcC-------------------CCcEEEeecCcccccCCCCC---------------CCcccccccccccCcccc
Q 005111 282 GSNLLLDH-------------------NGILKIADFGLASFFDPKDS---------------VPMTSRVVTLWYRPPELL 327 (714)
Q Consensus 282 P~NILl~~-------------------~g~vKL~DFGla~~~~~~~~---------------~~~~~~~gT~~Y~APE~l 327 (714)
|+||||+. ++.+||+|||+++....... ......+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999965 34566666666654211000 001124689999999999
Q ss_pred cCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccC
Q 005111 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKD 407 (714)
Q Consensus 328 ~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~ 407 (714)
.+.. |+.++||||||||||||++|.+||.... ..+..+.... .+ .. +..
T Consensus 188 ~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~-~~--------------------------~~~ 236 (793)
T PLN00181 188 NGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LP-PQ--------------------------ILL 236 (793)
T ss_pred ccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cC-hh--------------------------hhh
Confidence 8776 8999999999999999999988875322 1122221100 00 00 001
Q ss_pred CcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 408 FPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 408 ~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......+++..||.+||.+|||+.++|+||||...
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 12346788999999999999999999999999763
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=256.66 Aligned_cols=252 Identities=28% Similarity=0.351 Sum_probs=188.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh--CCCCCeeeeeccccccC--Cc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK--LDHPNIIKLEGLITSQT--SC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIVkl~~~~~~~~--~~ 227 (714)
+.+..+++.||+|.||.||+|+ .-|+.||||++... ++ +...||.+|.+. |+|+||+.+++.-.... -.
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~sr--dE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSR--DE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hheeEEEEEecCccccceeecc--ccCCceEEEEeccc--ch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4567899999999999999995 56999999998643 22 234566666654 59999999887533222 12
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc--------CeeeccCCCccEEEcCCCcEEEeecC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH--------GVLHRDIKGSNLLLDHNGILKIADFG 299 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--------gIiHrDLKP~NILl~~~g~vKL~DFG 299 (714)
.+|||.+|.+.|+|.+++.. ..++......++.-++.||+|||.. .|.|||||..||||..+|...|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 48999999999999988877 5799999999999999999999942 39999999999999999999999999
Q ss_pred cccccCCCCC---CCcccccccccccCcccccCCCCC-----CccccccchhHHHHHHhhC----------CCCCCCC--
Q 005111 300 LASFFDPKDS---VPMTSRVVTLWYRPPELLLGASHY-----GAAVDLWSTGCILGELFSG----------KPVLPGK-- 359 (714)
Q Consensus 300 la~~~~~~~~---~~~~~~~gT~~Y~APE~l~g~~~y-----~~~sDIWSLG~iLyeLltG----------~~pF~g~-- 359 (714)
||........ ...+.++||..|||||+|...... -..+||||||.|+||++.. ++||.+-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9988765532 234567999999999998643221 1358999999999999863 2566432
Q ss_pred --ChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCc--HHHHHHHHHhcccCcCCCCCHHHHH
Q 005111 360 --TEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFP--TSALRLMETLMSIDPAHRGTATLAL 434 (714)
Q Consensus 360 --~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p--~~l~~LI~~mL~~DP~kRpTa~e~L 434 (714)
...+.+.+++- .+.+++.+...+...| ..+..|++.||..+|.-|.||-.+-
T Consensus 442 ~DPs~eeMrkVVC-----------------------v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 SDPSFEEMRKVVC-----------------------VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCHHHHhccee-----------------------ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 23333333321 1222333333444333 3467899999999999999986654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=272.27 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=199.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~----~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..+..++||+|+||+||+|.....|+ +||||++... ...+....+..|+.+|.+|+|||+++|++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~---~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST---L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch---H
Confidence 45667899999999999998876654 6899988654 33455667889999999999999999999986543 7
Q ss_pred EEEEeeccccccccc-cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLA-SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
.||++||++|.|..+ ...+..+-....+.|..||++||.|||++++|||||-..||||..-..+||.|||+++.+.+..
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 899999997655544 4456678899999999999999999999999999999999999999999999999999876554
Q ss_pred CCCccc-ccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 309 SVPMTS-RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 309 ~~~~~~-~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
...... ....+-|||-|.+.... |+.++|||||||++|||+| |..|+.+....+ +.++++.--
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~ge------------- 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGE------------- 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccc-------------
Confidence 432221 12356788989887665 8999999999999999998 888888876543 333332110
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
....++..+-++..++.+||..|+..||+++++..
T Consensus 918 --------------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 918 --------------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --------------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 01223467889999999999999999999988654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=239.63 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=196.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l 229 (714)
..+.|.+.+.||+|-||.+.+|+++.++..+++|.+.... ...+.|.+|..---.| .|.||+.-|++.. +....+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceE
Confidence 3577999999999999999999999999999999987543 4566788898876666 5899999887643 333458
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc--CCCcEEEeecCcccccCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD--HNGILKIADFGLASFFDPK 307 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~--~~g~vKL~DFGla~~~~~~ 307 (714)
++++||++-+.|..-.... .+-|...+.++.|+++||.|||+.++||||||.+||||- +.-.|||||||+.+..+..
T Consensus 98 vF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 8999999977776655543 578999999999999999999999999999999999994 3348999999999865422
Q ss_pred CCCCcccccccccccCcccccCCC----CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGAS----HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~----~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
- .-.--+..|.+||++.... ...+.+|+|.||+|+|.+|+|.+||...... ...||+-.
T Consensus 177 V----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-------------d~~Y~~~~ 239 (378)
T KOG1345|consen 177 V----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-------------DKPYWEWE 239 (378)
T ss_pred e----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-------------CchHHHHH
Confidence 1 1122367799999874321 2367899999999999999999999733211 12233221
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCC---CCHHHHHcCcCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR---GTATLALNSEFF 439 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kR---pTa~e~L~Hp~f 439 (714)
... +.....+...|.-+++.+..+.++-|..+|.+| -++.......|.
T Consensus 240 ~w~--------~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 240 QWL--------KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHh--------cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 111 111123445667789999999999999999999 556666655664
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-25 Score=226.94 Aligned_cols=264 Identities=35% Similarity=0.548 Sum_probs=207.9
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH-HHHHHHHHHHHHHHhCCCC-CeeeeeccccccCCceEEEE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP-ESVKFMAREIAILRKLDHP-NIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~Hp-nIVkl~~~~~~~~~~~l~LV 232 (714)
|.+...||.|+||.||++.+. ..+++|.+....... .....+.+|+.++..+.|+ +|+++++++..... .+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~--~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS--LYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE--EEEE
Confidence 788999999999999999876 889999998764333 3677899999999999988 79999998854433 7999
Q ss_pred EeeccccccccccCCCC---CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcccccCCCC
Q 005111 233 FEYMEHDLVGLASLPGM---KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKD 308 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~---~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~~~~ 308 (714)
++|+.++.+..+..... .+++..+..++.|++.+|.|+|..+++||||||+|||++..+ .++++|||++..+....
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999887775554443 799999999999999999999999999999999999999988 79999999998665433
Q ss_pred CC-----CcccccccccccCcccccCC--CCCCccccccchhHHHHHHhhCCCCCCCCCh---HHHHHHHHHhhCCCChh
Q 005111 309 SV-----PMTSRVVTLWYRPPELLLGA--SHYGAAVDLWSTGCILGELFSGKPVLPGKTE---VEQLHRIFKLCGSPSED 378 (714)
Q Consensus 309 ~~-----~~~~~~gT~~Y~APE~l~g~--~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~~I~k~~G~p~~~ 378 (714)
.. .....+||.+|+|||.+.+. ..+....|+||+|++++++++|..||..... .......+...+.+.
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS-- 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc--
Confidence 22 24567899999999999874 4578999999999999999999999887764 334434333322220
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.......... ......+.+++..++..+|..|.++.+...++|+...
T Consensus 235 -----------~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 235 -----------LASPLSPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred -----------cccccCcccc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1223678999999999999999999999999776653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-27 Score=269.16 Aligned_cols=264 Identities=27% Similarity=0.332 Sum_probs=203.2
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeec----CCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRF----DNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~----~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.....+|.|++|.|+.+......+.++.|.++. ..........+..|+.+-..|.|+|++.....+..... .+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--ILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--chh
Confidence 445779999999999998887777777776652 22222333337778888899999999888777665554 455
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC--
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-- 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-- 309 (714)
+||||++ .|..++.....++..++.++++||+.||.|||+.||.||||||+|+|++.+|.+||+|||.+..+.-...
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 5999999 4444444446899999999999999999999999999999999999999999999999999987654333
Q ss_pred -CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHH-HHHHhhCCCChhHHhhhhccc
Q 005111 310 -VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH-RIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 -~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~-~I~k~~G~p~~~~w~~~~~~~ 387 (714)
......+|+..|+|||++.+..+....+||||.|++++.|++|+.||.-....+... .+. .
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-----------------~ 540 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-----------------Y 540 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-----------------c
Confidence 445677899999999999988855678999999999999999999887544332211 000 0
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+.... ....++..+|.....+|.+||++||.+|.|++++|+.+||+...
T Consensus 541 ~~~~~~~~----~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 541 SDQRNIFE----GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred cccccccc----ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 00000011 11233456888999999999999999999999999999999754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-26 Score=221.19 Aligned_cols=157 Identities=24% Similarity=0.324 Sum_probs=122.3
Q ss_pred CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccc
Q 005111 248 GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327 (714)
Q Consensus 248 ~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l 327 (714)
+..|++.+++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||++....... ..||+.|+|||++
T Consensus 11 ~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------~~g~~~y~aPE~~ 76 (176)
T smart00750 11 GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------SRVDPYFMAPEVI 76 (176)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------CCCcccccChHHh
Confidence 456999999999999999999999999 999999999999999 99998764322 2679999999999
Q ss_pred cCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH-HHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhcc
Q 005111 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFK 406 (714)
Q Consensus 328 ~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~ 406 (714)
.+.. |+.++|||||||++|||++|.+||....... .+..+....... .+... ....
T Consensus 77 ~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~---~~~~ 133 (176)
T smart00750 77 QGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD-------------------DPRDR---SNLE 133 (176)
T ss_pred cCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC-------------------Ccccc---ccHH
Confidence 8766 8999999999999999999999997654432 233332211000 00000 0011
Q ss_pred CCcH--HHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 407 DFPT--SALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 407 ~~p~--~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.++. .+.+||.+||..||.+|||+.+++.|+|+..
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 2333 6999999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=238.75 Aligned_cols=168 Identities=22% Similarity=0.286 Sum_probs=132.8
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEcc-CCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeee-eecccc
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVI-HDKIVALKKVRFDN---QDPESVKFMAREIAILRKLDHPNIIK-LEGLIT 222 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~-~g~~VAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIVk-l~~~~~ 222 (714)
++...+.|.+.+.||+|+||+||+|++.. ++..||||++.... ........+.+|+.+|+.++|+|++. ++++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 44567889999999999999999998876 68888999875331 12345667999999999999999985 5432
Q ss_pred ccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccC-CCccEEEcCCCcEEEeecCcc
Q 005111 223 SQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDI-KGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 223 ~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDL-KP~NILl~~~g~vKL~DFGla 301 (714)
. ..|||||||+|++|.... . .. ...++.||+.||.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 --~--~~~LVmE~~~G~~L~~~~-~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 --G--KDGLVRGWTEGVPLHLAR-P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred --C--CcEEEEEccCCCCHHHhC-c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 2 279999999998776321 1 11 2568899999999999999999999 999999999999999999999
Q ss_pred cccCCCCCC-------CcccccccccccCccccc
Q 005111 302 SFFDPKDSV-------PMTSRVVTLWYRPPELLL 328 (714)
Q Consensus 302 ~~~~~~~~~-------~~~~~~gT~~Y~APE~l~ 328 (714)
+.+...... ..+..++++.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 976543211 124557788899999884
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=230.75 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=201.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHD-----KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..+++....+-+|+||.||.|...+.+ +.|-+|.++.. ..+-.+..+..|-..|..+.|||+..+.++..+...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 356888888999999999999765432 34666766533 455677889999999999999999999988765433
Q ss_pred ceEEEEEeeccccccccccC--------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 227 CSLYLVFEYMEHDLVGLASL--------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
..++++.+++-+.|..++. ....++..+...++.||+.|++|||++||||.||-..|.+|++.-++||+|=
T Consensus 362 -~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 362 -TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred -cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 4678888888655544332 1234778889999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCCCcccc-cccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 299 GLASFFDPKDSVPMTSR-VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~-~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
.+++.+-+.+..-+... .-...||+||.+.... |+.++|+||||++||||+| |+.|+..-++.|..+.+.+.
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG----- 514 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG----- 514 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-----
Confidence 99998876655433221 1256799999998765 8999999999999999998 88999988888877776431
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.-.+| -++|+++..++..||..+|++||+.+++..
T Consensus 515 --------------yRlaQP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 --------------YRLAQP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred --------------ceecCC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 222222 368999999999999999999999999764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-25 Score=247.44 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=202.2
Q ss_pred EEeccCceEEEEEEE---ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEEEEee
Q 005111 160 KIGQGTYSSVYRARD---VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d---~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~LV~Ey 235 (714)
.+|+|+||.|++++. ...|..+|+|++++.............|..++..++ ||.+|+++..+..+.. +|++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k--l~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK--LYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc--hhHhhhh
Confidence 379999999998753 345788999998765322222225667888899886 9999999988877666 9999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccc
Q 005111 236 MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315 (714)
Q Consensus 236 ~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~ 315 (714)
..|+.+.........+.+...+.+...++.+++++|+.+|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----- 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence 999888877777778999999999999999999999999999999999999999999999999999876433322
Q ss_pred cccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCc
Q 005111 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395 (714)
Q Consensus 316 ~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~ 395 (714)
|||..|||||++.| ...++|+||||+++|+|++|..||.+ +.+..|.+..-..+
T Consensus 154 cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------------- 207 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------------- 207 (612)
T ss_pred ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc-------------------
Confidence 89999999999883 57899999999999999999999988 67777766322111
Q ss_pred hhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCCCC
Q 005111 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQPLA 445 (714)
Q Consensus 396 p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~~~ 445 (714)
..++..+.+++..|+..+|..|.- +.++++|+||....+.
T Consensus 208 ----------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 208 ----------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ----------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 246678999999999999999975 5899999999987654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=220.01 Aligned_cols=255 Identities=24% Similarity=0.230 Sum_probs=189.5
Q ss_pred CeeEEeEEeccCceEEEEEEEccCC-eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC----CCeeeeeccccccCCce
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHD-KIVALKKVRFDNQDPESVKFMAREIAILRKLDH----PNIIKLEGLITSQTSCS 228 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g-~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H----pnIVkl~~~~~~~~~~~ 228 (714)
.|.+.++||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.+|..+.. +++..+++... ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 8999999999999999999988775 6899998765422111 156788999988862 57888877663 22334
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-----CcEEEeecCccc
Q 005111 229 LYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN-----GILKIADFGLAS 302 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~-----g~vKL~DFGla~ 302 (714)
-||||+.++.++.++.... ...|+...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|+|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 7999999998888766433 4789999999999999999999999999999999999999865 469999999998
Q ss_pred --ccCCCCC----C--C-cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhC
Q 005111 303 --FFDPKDS----V--P-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG 373 (714)
Q Consensus 303 --~~~~~~~----~--~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G 373 (714)
.+-.... . . .....||..|.++.+..+.. .+...|+||++.++.+|+.|..||.+........++.+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 3221111 1 1 12345999999999988877 69999999999999999999999977654433333322110
Q ss_pred CCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 374 ~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.... .......+..+..++..+-..+...+|....+...
T Consensus 255 ~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLT------------------------DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhcc------------------------ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 0000 00112345677777777777788888887766554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-24 Score=244.62 Aligned_cols=227 Identities=27% Similarity=0.353 Sum_probs=173.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
...+|+.++.|-.|+||-||+.+|+.+.+.+|+|+ ...+. +.|- ||.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-------hhhc--cccccCCccee---------------
Confidence 45789999999999999999999999999999954 32211 1111 33333444433
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|+....+.. -++++.. ++.+++|||+.||+|||+||+|+||+.-|++|++|||+++........
T Consensus 136 -------gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -------GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -------chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 332222222 1234433 278999999999999999999999999999999999998753211110
Q ss_pred --------------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 311 --------------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 311 --------------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
.-...|||+.|+|||+++... |+..+|+|++|+|+||.+.|..||.|++..+++...+......+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 112358999999999998777 89999999999999999999999999999999888776444333
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC---CHHHHHcCcCCCCCCCC
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG---TATLALNSEFFTTQPLA 445 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp---Ta~e~L~Hp~f~~~~~~ 445 (714)
+.. ..+++++.++|..+|..+|..|. .+.++.+|+||+...|.
T Consensus 279 E~d--------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 279 EED--------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ccC--------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 322 25789999999999999999994 68889999999977665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=200.12 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=190.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC-CCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH-PNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIVkl~~~~~~~~~~~l 229 (714)
..+.|.++++||.|+||.+|+|....+|+.||||+-+..... ..+..|..+.+.|++ ..|..+..+..+... -
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y--n 86 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY--N 86 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccc--c
Confidence 357899999999999999999999999999999987654332 346788888888864 555556555555443 6
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC---CcEEEeecCcccccCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN---GILKIADFGLASFFDP 306 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~---g~vKL~DFGla~~~~~ 306 (714)
.|||++++..+-+++......|+...++.++-||+.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.+-.
T Consensus 87 vlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 87 VLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 8999999988888877777889999999999999999999999999999999999998643 4699999999987743
Q ss_pred CCCC------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 307 KDSV------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 307 ~~~~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
.... .-....||..|.+--...|.. -+...|+=|+|.+|..+.-|..||.|.......++..+...
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E------- 238 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE------- 238 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH-------
Confidence 3221 123457899999988777765 48899999999999999999999999766554444322110
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT 429 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT 429 (714)
.+. ...+..+-+.+|.++...|.-|-..-=++-|.
T Consensus 239 --kK~------------s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 239 --KKM------------STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred --hhc------------CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 000 01122334577888888777775444444444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=201.24 Aligned_cols=142 Identities=22% Similarity=0.235 Sum_probs=110.3
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHH------------------------HHHHHHHHHHHHhCCCCC
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES------------------------VKFMAREIAILRKLDHPN 213 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~------------------------~~~~~rEi~iL~~L~Hpn 213 (714)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 356999999999999986 8999999999865221111 123346999999998777
Q ss_pred eeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHh-hhcCeeeccCCCccEEEcCCCc
Q 005111 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC-HSHGVLHRDIKGSNLLLDHNGI 292 (714)
Q Consensus 214 IVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~L-H~~gIiHrDLKP~NILl~~~g~ 292 (714)
+.....+ .. .. .+|||||++|+.+.........+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~-~~-~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPI-LL-KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEE-Ee-cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 6433222 11 12 489999999876654333346799999999999999999999 799999999999999998 578
Q ss_pred EEEeecCcccccC
Q 005111 293 LKIADFGLASFFD 305 (714)
Q Consensus 293 vKL~DFGla~~~~ 305 (714)
++|+|||+|...+
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=202.25 Aligned_cols=174 Identities=16% Similarity=0.186 Sum_probs=133.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHH------HHHHHHHHHhCCCCCeeeeecccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKF------MAREIAILRKLDHPNIIKLEGLITSQ 224 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~------~~rEi~iL~~L~HpnIVkl~~~~~~~ 224 (714)
.++|++++.||.|+||.||++.+ ++..+|||+++.... .+..... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999754 467899999976532 2233233 67999999999999999988875533
Q ss_pred C------CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 225 T------SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 225 ~------~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
. ....+|||||++|..+..+. .+++ ..+.+|+.+|..||+.||+||||||+|||++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 12479999999998776552 2333 3466999999999999999999999999999999 999999
Q ss_pred CcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHh
Q 005111 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELF 350 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLl 350 (714)
|........... . .+++.. .|+.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~---d----------~~vler-~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK---D----------RIDLER-HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH---H----------HHHHHh-HhcccccccceeEeehHHH
Confidence 988765322111 0 023333 3778999999999987764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=199.20 Aligned_cols=209 Identities=22% Similarity=0.312 Sum_probs=171.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~L 231 (714)
-.|++.++||+|+||.+++|.+..++++||||.-..... ..++..|....+.| ..++|..+|.|=.+ ..+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhh
Confidence 479999999999999999999999999999997654332 34567788888888 57888877654322 223579
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-----cEEEeecCcccccCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-----ILKIADFGLASFFDP 306 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-----~vKL~DFGla~~~~~ 306 (714)
|+|+++..|-+++.-.+..|+...+..++.||+.-++|+|++.+|.|||||+|+||..-+ .|.|+|||+|+.+-.
T Consensus 102 VidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999999988888777888999999999999999999999999999999999999997543 589999999998743
Q ss_pred CCCCC------cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC---hHHHHHHH
Q 005111 307 KDSVP------MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT---EVEQLHRI 368 (714)
Q Consensus 307 ~~~~~------~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~---~~e~l~~I 368 (714)
..... ..+..||..||+--..+|.. -+...|+=|||-+++..|-|..||.|.. ..+.+++|
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 32211 23457899999999888877 4899999999999999999999998853 44444444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=194.04 Aligned_cols=142 Identities=20% Similarity=0.265 Sum_probs=112.4
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH------------------------HHHHHHHHHHHHHHhCCCCC
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP------------------------ESVKFMAREIAILRKLDHPN 213 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~------------------------~~~~~~~rEi~iL~~L~Hpn 213 (714)
.+.||+|+||+||+|.+. +|+.||||+++...... .....+.+|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999977 89999999998652110 01223468999999999988
Q ss_pred eeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCc
Q 005111 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGI 292 (714)
Q Consensus 214 IVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~ 292 (714)
+.....+... . .||||||++|+.+.........+++..+..++.|++.+|.+||+ .||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~--~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK--K--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec--C--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 7544333221 1 48999999987443222234568899999999999999999999 9999999999999999 899
Q ss_pred EEEeecCcccccC
Q 005111 293 LKIADFGLASFFD 305 (714)
Q Consensus 293 vKL~DFGla~~~~ 305 (714)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-22 Score=230.64 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=181.5
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC--CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD--NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~--~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.|...+.||.+.|=+|.+|++. .|. |+||++-.. ........+...|+. ...+++||++++.-+...... .||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA--Ayl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA--AYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH--HHH
Confidence 7888999999999999999853 455 899988654 233444455556666 566799999998776544433 789
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc--CCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF--DPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~--~~~~~ 309 (714)
|-+|+.++|.+.+... ..+...+.+.|+.||+.||..||..||+|+|||.+||||+.-..+.|+||..-+.. ...+.
T Consensus 99 vRqyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9999999988766543 46788899999999999999999999999999999999999999999999876432 12222
Q ss_pred CCcccccc----cccccCcccccCCC----------CCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCC
Q 005111 310 VPMTSRVV----TLWYRPPELLLGAS----------HYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGS 374 (714)
Q Consensus 310 ~~~~~~~g----T~~Y~APE~l~g~~----------~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~ 374 (714)
...+-+.. -.+|+|||.|.... ..+++.||||+||+++||++ |.|||.- .++-.... .+.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~-~~~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRS-GNA 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhc-cCc
Confidence 22222222 36799999985421 14678999999999999988 6899842 11111100 000
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.. ...+.+...+ ..++.||..|++.||.+|.+|++.|+-
T Consensus 253 ~~---------------------~e~~Le~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DD---------------------PEQLLEKIED--VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cC---------------------HHHHHHhCcC--ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 1111122222 378999999999999999999999986
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-22 Score=207.97 Aligned_cols=238 Identities=21% Similarity=0.305 Sum_probs=153.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCC----------CCeeeeeccc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDH----------PNIIKLEGLI 221 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~H----------pnIVkl~~~~ 221 (714)
..+...+.||.|+++.||.+.|..||+.+|+|++..... ....++.+.+|.-....+.+ -.++--++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 456778999999999999999999999999999877642 23457777777755554322 1111111111
Q ss_pred c---------ccC---Cc---eEEEEEeeccccccccccC----CCC--CCCHHHHHHHHHHHHHHhhHhhhcCeeeccC
Q 005111 222 T---------SQT---SC---SLYLVFEYMEHDLVGLASL----PGM--KFTESQVKCYMKQLLSGLEHCHSHGVLHRDI 280 (714)
Q Consensus 222 ~---------~~~---~~---~l~LV~Ey~~g~ll~~~~~----~~~--~lse~~i~~i~~QIl~aL~~LH~~gIiHrDL 280 (714)
. ... .. ..+++|+-+.+++...... ... .+.......+..|++..+++||..||+|+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 010 11 2477888888776543211 111 1223334555689999999999999999999
Q ss_pred CCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCC-------CCCCccccccchhHHHHHHhhCC
Q 005111 281 KGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA-------SHYGAAVDLWSTGCILGELFSGK 353 (714)
Q Consensus 281 KP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~-------~~y~~~sDIWSLG~iLyeLltG~ 353 (714)
+|+|+|++.+|.++|+||+.....+.... ....+..|.+||..... ..++.+.|.|+||+++|.|+||.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999999887643221 13446789999976432 23788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCC
Q 005111 354 PVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427 (714)
Q Consensus 354 ~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kR 427 (714)
.||...+.... ..| .+.... ++|+.+..||..||..||.+|
T Consensus 248 lPf~~~~~~~~-------------~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEAD-------------PEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGST-------------SGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCcccc-------------ccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99976543200 000 122223 789999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=189.28 Aligned_cols=190 Identities=17% Similarity=0.142 Sum_probs=142.0
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--DPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+...|++|+||+||++.. .+..++.+.+..... ..-....+.+|+.+|++|. |++|++++++ .. .|++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~--~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG--RHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC--EEEE
Confidence 4567899999999998864 677888777764432 1122336789999999995 5888888875 12 6999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccC-CCccEEEcCCCcEEEeecCcccccCCCCCC-
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDI-KGSNLLLDHNGILKIADFGLASFFDPKDSV- 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDL-KP~NILl~~~g~vKL~DFGla~~~~~~~~~- 310 (714)
|||+.|..|..... . ....++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 77 meyI~G~~L~~~~~------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRPP------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhhh------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99999987754321 1 12457889999999999999999999 799999999999999999999866543310
Q ss_pred ---C--------cccccccccccCcccccCCCCCC-ccccccchhHHHHHHhhCCCCCCCCC
Q 005111 311 ---P--------MTSRVVTLWYRPPELLLGASHYG-AAVDLWSTGCILGELFSGKPVLPGKT 360 (714)
Q Consensus 311 ---~--------~~~~~gT~~Y~APE~l~g~~~y~-~~sDIWSLG~iLyeLltG~~pF~g~~ 360 (714)
. ..-...++.|++|+.-.-....+ ...++++.|+-+|.++|+..++.++.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 00112478888888654332223 67899999999999999998876554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=185.55 Aligned_cols=148 Identities=20% Similarity=0.181 Sum_probs=117.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEE-EccCCeEEEEEEeecCCCCH----------------------HHHHHHHHHHHHHH
Q 005111 151 RANTFEKLDKIGQGTYSSVYRAR-DVIHDKIVALKKVRFDNQDP----------------------ESVKFMAREIAILR 207 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~-d~~~g~~VAiK~i~~~~~~~----------------------~~~~~~~rEi~iL~ 207 (714)
+...|.+.+.||+|+||.||+|. +..+|+.||||+++...... .....+.+|+.++.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34568999999999999999998 67899999999998542110 01234678999999
Q ss_pred hCCCCC--eeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC-eeeccCCCcc
Q 005111 208 KLDHPN--IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG-VLHRDIKGSN 284 (714)
Q Consensus 208 ~L~Hpn--IVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g-IiHrDLKP~N 284 (714)
++.+.. +.++++ .. . .||||||++|+.+.........+....+..++.||+.+|.+||++| |+||||||+|
T Consensus 106 ~L~~~~i~~p~~~~---~~-~--~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 106 RLYEAGVPVPKPIA---WR-R--NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred HHHhcCCCCCeeeE---ec-C--ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 997533 333333 22 2 5899999999877655444456777788999999999999999999 9999999999
Q ss_pred EEEcCCCcEEEeecCcccccC
Q 005111 285 LLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 285 ILl~~~g~vKL~DFGla~~~~ 305 (714)
||++ ++.++|+|||++....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.5e-19 Score=187.91 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=173.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCC-----------------------------------eEEEEEEeec-C--CCC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHD-----------------------------------KIVALKKVRF-D--NQD 192 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-----------------------------------~~VAiK~i~~-~--~~~ 192 (714)
..++|++...||+|.-..||.|.-...| -+.|||.+.. + ..+
T Consensus 155 tiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~ 234 (598)
T KOG4158|consen 155 TIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGD 234 (598)
T ss_pred chhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCch
Confidence 4577999999999999999998643211 1246665432 1 223
Q ss_pred HHHHHHHHHHHHH------H--------Hh--------CCCCCeeeeeccccccC-------------------------
Q 005111 193 PESVKFMAREIAI------L--------RK--------LDHPNIIKLEGLITSQT------------------------- 225 (714)
Q Consensus 193 ~~~~~~~~rEi~i------L--------~~--------L~HpnIVkl~~~~~~~~------------------------- 225 (714)
....+.+-+|+-- + +. -.|||||.+.++|.+.-
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 3344555555311 1 11 15999999998875421
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc--CCC--cEEEeecCcc
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD--HNG--ILKIADFGLA 301 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~--~~g--~vKL~DFGla 301 (714)
...+|+||--..+.+...+-.. ..+....+-++.|+++|+.|||.+||.|||||.+||||. +|+ .+.|+|||.+
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcchhhHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 1348899988887665544332 467888899999999999999999999999999999984 444 5899999988
Q ss_pred cccCCC-----CCCCcccccccccccCcccccCCCC-----CCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHh
Q 005111 302 SFFDPK-----DSVPMTSRVVTLWYRPPELLLGASH-----YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL 371 (714)
Q Consensus 302 ~~~~~~-----~~~~~~~~~gT~~Y~APE~l~g~~~-----y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~ 371 (714)
-.-+.. ........-|.-..||||+....+. .-.++|.|+.|.+.||++...-||.+..+...-..-++
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq- 471 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ- 471 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-
Confidence 543211 0111123345777899998754321 12479999999999999999999987443311111100
Q ss_pred hCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH---HHHHc
Q 005111 372 CGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA---TLALN 435 (714)
Q Consensus 372 ~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa---~e~L~ 435 (714)
. ..+......+|+.+.+||..+|..||.+|+++ +.+|+
T Consensus 472 ----------e----------------~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 472 ----------E----------------SQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred ----------h----------------hhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 0 11222334688999999999999999999984 45555
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=175.40 Aligned_cols=137 Identities=18% Similarity=0.209 Sum_probs=105.8
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-----CCCCeeeeeccccccCC-ceEE-
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-----DHPNIIKLEGLITSQTS-CSLY- 230 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-----~HpnIVkl~~~~~~~~~-~~l~- 230 (714)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ +||||+++++++..... ..++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 46799999999995 6767665 6999876432 2346789999999999 57999999999876542 2334
Q ss_pred EEEeecc--ccccccccCCCCCCCHHHHHHHHHHHHHHh-hHhhhcCeeeccCCCccEEEcCC----CcEEEeecCccc
Q 005111 231 LVFEYME--HDLVGLASLPGMKFTESQVKCYMKQLLSGL-EHCHSHGVLHRDIKGSNLLLDHN----GILKIADFGLAS 302 (714)
Q Consensus 231 LV~Ey~~--g~ll~~~~~~~~~lse~~i~~i~~QIl~aL-~~LH~~gIiHrDLKP~NILl~~~----g~vKL~DFGla~ 302 (714)
+||||++ +++|..++... .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 7899944 67777666543 56666 46688888888 99999999999999999999743 379999955443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-19 Score=209.28 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=209.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-HDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l 229 (714)
...|.+.+.||+|+|+.|-++.... +...+|.|.+............+..|+.+-..+. |.|++.+++....... .
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~--~ 96 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS--Y 96 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc--c
Confidence 4678899999999999999987643 3566788877665545556677778999888887 9999999998765554 8
Q ss_pred EEEEeecccccccccc-CCCC-CCCHHHHHHHHHHHHHHhhHhh-hcCeeeccCCCccEEEcCCC-cEEEeecCcccccC
Q 005111 230 YLVFEYMEHDLVGLAS-LPGM-KFTESQVKCYMKQLLSGLEHCH-SHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFD 305 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~-~~~~-~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~ 305 (714)
+++++|..|+.+...+ ..+. ..+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .++++|||+|..+.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999988777666 5555 6888999999999999999999 99999999999999999999 99999999999876
Q ss_pred C--CCCCCcccccc-cccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 306 P--KDSVPMTSRVV-TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 306 ~--~~~~~~~~~~g-T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
. .........+| ++.|.|||.+.+..+.....|+||+|+++.-|++|..|+......+.. ...|..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------~~~~~~ 245 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------YSSWKS 245 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------ceeecc
Confidence 5 22233445688 999999999988666789999999999999999999887644322100 001111
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.+ ...-...+..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 246 ~~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NK-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cc-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00 00011234578889999999999999999999999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-19 Score=195.21 Aligned_cols=211 Identities=27% Similarity=0.412 Sum_probs=150.7
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeec-------cccccC---CceEEEEEeeccccccccccCCC---CCCCHHHHHHHH
Q 005111 194 ESVKFMAREIAILRKLDHPNIIKLEG-------LITSQT---SCSLYLVFEYMEHDLVGLASLPG---MKFTESQVKCYM 260 (714)
Q Consensus 194 ~~~~~~~rEi~iL~~L~HpnIVkl~~-------~~~~~~---~~~l~LV~Ey~~g~ll~~~~~~~---~~lse~~i~~i~ 260 (714)
.......+++-.+....|.+..-+.+ .+.... ..++||.|++|..+.|.+|+... ...+....+.++
T Consensus 286 ~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~ 365 (516)
T KOG1033|consen 286 CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIF 365 (516)
T ss_pred hhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHH
Confidence 34455556666666665544443333 111111 12489999999998888887532 346778899999
Q ss_pred HHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC-----CCCcccccccccccCcccccCCCCCCc
Q 005111 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD-----SVPMTSRVVTLWYRPPELLLGASHYGA 335 (714)
Q Consensus 261 ~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~-----~~~~~~~~gT~~Y~APE~l~g~~~y~~ 335 (714)
.|+..|++| +|.+|+|+||.||++..+..+||.|||+........ ....+..+||.+||+||.+.|.. |+.
T Consensus 366 ~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~ 441 (516)
T KOG1033|consen 366 KQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSE 441 (516)
T ss_pred Hhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhh
Confidence 999999999 999999999999999999999999999998775444 23456678999999999999877 899
Q ss_pred cccccchhHHHHHHhhCCCCCCCCChHHHHHHHHH-hhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHH
Q 005111 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK-LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALR 414 (714)
Q Consensus 336 ~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k-~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~ 414 (714)
++||||||+|||||+.- | .+..+....... .-|..+..+| .+. +.-..
T Consensus 442 kvdIyaLGlil~EL~~~---f--~T~~er~~t~~d~r~g~ip~~~~-------------------------~d~-p~e~~ 490 (516)
T KOG1033|consen 442 KVDIYALGLILAELLIQ---F--STQFERIATLTDIRDGIIPPEFL-------------------------QDY-PEEYT 490 (516)
T ss_pred hcchhhHHHHHHHHHHH---h--ccHHHHHHhhhhhhcCCCChHHh-------------------------hcC-cHHHH
Confidence 99999999999999972 1 122222221110 0111111111 122 34567
Q ss_pred HHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 415 LMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 415 LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
|+.+||...|.+||++.+.--|.|.
T Consensus 491 ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 491 LLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHHHhcCCCcccCchHHHHhhhhhc
Confidence 9999999999999988887777775
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.6e-18 Score=201.97 Aligned_cols=194 Identities=25% Similarity=0.290 Sum_probs=152.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeccccccCCc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD---HPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIVkl~~~~~~~~~~ 227 (714)
....|.|-+.||+|+||+||+|.+.. |+.||||+-+....-+- .--.+++.+|+ -+.|+.+..++...+.
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf-----YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~- 768 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF-----YICLQVMERLKPQMLPSIMHISSAHVFQNA- 768 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee-----eehHHHHHhhchhhhcchHHHHHHHccCCc-
Confidence 45789999999999999999999766 99999998765432110 00122233333 2445556655555555
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-------CCcEEEeecCc
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-------NGILKIADFGL 300 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-------~g~vKL~DFGl 300 (714)
-+||+||.+.|+|-.+......+++..+..++.|||..|++||..+|||+||||+|+||.. ..-++|+|||.
T Consensus 769 -S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~ 847 (974)
T KOG1166|consen 769 -SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR 847 (974)
T ss_pred -ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence 5899999998777777777788999999999999999999999999999999999999942 33599999999
Q ss_pred ccccCC-CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCC
Q 005111 301 ASFFDP-KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK 353 (714)
Q Consensus 301 a~~~~~-~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~ 353 (714)
+..+.. .+.......++|-.+-++|+..|.+ +++.+|.|.|..+++.||.|+
T Consensus 848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence 965432 2223456677899999999999987 999999999999999999997
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=176.45 Aligned_cols=242 Identities=18% Similarity=0.235 Sum_probs=188.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+..++.+|.+.-.|..|+|+. .|..+++|++.........-+.|..|.-.|+-+.||||+.+++.|..... +.++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn--lv~i 265 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN--LVII 265 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC--ceEe
Confidence 4556778899999999999964 56678889887766555666778889999999999999999999987655 8999
Q ss_pred EeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcCCCcEEEe--ecCcccccCC
Q 005111 233 FEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDHNGILKIA--DFGLASFFDP 306 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~~g~vKL~--DFGla~~~~~ 306 (714)
..||+.+.|...+... ...+..++..++..|+.|++|||+.. |.---|....++||++-+.+|. |--++
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs----- 340 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS----- 340 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee-----
Confidence 9999987776555433 34678899999999999999999874 4444688899999998876653 32222
Q ss_pred CCCCCcccccccccccCcccccCCCCC--CccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHY--GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y--~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.+...+...|.|++||.+...+.. -.++|+|||.++||||.|...||...+..+.-.+|.- -|
T Consensus 341 ---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-eg----------- 405 (448)
T KOG0195|consen 341 ---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-EG----------- 405 (448)
T ss_pred ---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-cc-----------
Confidence 112234558999999999765432 3589999999999999999999999888877666631 11
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHH
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA 433 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~ 433 (714)
....+++.++..+..|+.-|+..||.+||....+
T Consensus 406 ---------------lrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 406 ---------------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ---------------ccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 0112346788899999999999999999987654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=166.45 Aligned_cols=141 Identities=23% Similarity=0.235 Sum_probs=109.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHH--------------------HHHHHHHHHHHHHhCCCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPE--------------------SVKFMAREIAILRKLDHP 212 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~--------------------~~~~~~rEi~iL~~L~Hp 212 (714)
..|.+.+.||+|+||.||+|.. .+|+.||||+++....... ......+|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 93 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE 93 (198)
T ss_pred chhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence 3478889999999999999986 4799999999875421100 112366899999999877
Q ss_pred C--eeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC
Q 005111 213 N--IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN 290 (714)
Q Consensus 213 n--IVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~ 290 (714)
+ ++.+++ . +..++||||++|..+..... ......++.+|+.++.++|+.||+|+||||+||||+.+
T Consensus 94 ~i~v~~~~~---~---~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 94 GFPVPKPID---W---NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCCceee---c---CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence 4 333332 1 22689999999987654432 14567889999999999999999999999999999999
Q ss_pred CcEEEeecCcccccCC
Q 005111 291 GILKIADFGLASFFDP 306 (714)
Q Consensus 291 g~vKL~DFGla~~~~~ 306 (714)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999976643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.8e-17 Score=165.71 Aligned_cols=136 Identities=20% Similarity=0.255 Sum_probs=108.7
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCCC-H-----HHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD-P-----ESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~-~-----~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.||+|++|.||+|.+ .|..|++|+....... . .....+.+|+.++..+.|++|.....++..... .++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN--FIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC--CEEE
Confidence 5799999999999975 7788999986543221 1 123457789999999999888665555443333 7899
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
|||++|..+..+.... .. ....++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998777665432 22 7889999999999999999999999999999999 78999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=158.55 Aligned_cols=139 Identities=25% Similarity=0.290 Sum_probs=99.3
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHH----------------------HHHHHHHHHhCCCCC--
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKF----------------------MAREIAILRKLDHPN-- 213 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~----------------------~~rEi~iL~~L~Hpn-- 213 (714)
.+.||+|+||+||+|.+. +|+.||||+++........... ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 457999999999999876 8999999998764322111111 135666666664432
Q ss_pred eeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCc
Q 005111 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGI 292 (714)
Q Consensus 214 IVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~ 292 (714)
+.+.+++. ..+|||||++++.+........... .++..++.+++.++.++|. .||+|+||||+|||++ ++.
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 33333321 2589999999843321111111111 6789999999999999999 9999999999999999 899
Q ss_pred EEEeecCcccccC
Q 005111 293 LKIADFGLASFFD 305 (714)
Q Consensus 293 vKL~DFGla~~~~ 305 (714)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=159.76 Aligned_cols=133 Identities=17% Similarity=0.222 Sum_probs=102.1
Q ss_pred EEeccCceEEEEEEEccCCeEEEEEEeecCCC-C-----HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-D-----PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~-----~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.||+|+||.||+|. .++..|++|+...... . ......+.+|+.++..+.|+++.....++..... .+|||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~--~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN--KTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC--CEEEE
Confidence 38999999999997 5678899998654321 1 1123667899999999988765433333333333 68999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
||++|..+........ ..++.||+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++...
T Consensus 77 e~~~g~~l~~~~~~~~-------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN-------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcH-------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999987765543221 18899999999999999999999999999999 889999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.1e-16 Score=179.10 Aligned_cols=139 Identities=14% Similarity=0.173 Sum_probs=107.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-C-----CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-Q-----DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~-----~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..|...+.||+|+||.||++... +..+++|+..... . .....+.+.+|+.++..+.|++++..+.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34456789999999999999754 4445555432211 1 11234568899999999999998876655444333
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
.++||||++|+.+..+.. ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++..
T Consensus 411 --~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 411 --KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred --CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 789999999987765542 467899999999999999999999999999999 6789999999999764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.6e-16 Score=171.70 Aligned_cols=206 Identities=26% Similarity=0.370 Sum_probs=153.8
Q ss_pred HHhCCCCCeeeeeccccccCCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCe-eeccCCCc
Q 005111 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGV-LHRDIKGS 283 (714)
Q Consensus 206 L~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gI-iHrDLKP~ 283 (714)
|+.+.|.|+.++++.+..... +++|.+||..+++.+.+. ....++.-....++++|+.||.|||.--| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~--~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPE--MIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCc--eEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 457899999999999887744 899999999776665554 46788999999999999999999998765 99999999
Q ss_pred cEEEcCCCcEEEeecCcccccCCC-CCCCcccccccccccCcccccCCCC------CCccccccchhHHHHHHhhCCCCC
Q 005111 284 NLLLDHNGILKIADFGLASFFDPK-DSVPMTSRVVTLWYRPPELLLGASH------YGAAVDLWSTGCILGELFSGKPVL 356 (714)
Q Consensus 284 NILl~~~g~vKL~DFGla~~~~~~-~~~~~~~~~gT~~Y~APE~l~g~~~------y~~~sDIWSLG~iLyeLltG~~pF 356 (714)
|.+++....+||+|||+....... .........-..-|.|||++.+... .+.+.||||||+|++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999876420 0011111123566899999876421 356799999999999999999999
Q ss_pred CCCChH----HHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHH
Q 005111 357 PGKTEV----EQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATL 432 (714)
Q Consensus 357 ~g~~~~----e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e 432 (714)
...... +.+..+.+ .|. .+.++.+.... .+++.+..++..|+..+|..||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~--------------------~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGS--------------------NPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCC--------------------CCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHH
Confidence 864322 23333322 111 11111121111 46668999999999999999999988
Q ss_pred HHc
Q 005111 433 ALN 435 (714)
Q Consensus 433 ~L~ 435 (714)
+-.
T Consensus 217 i~~ 219 (484)
T KOG1023|consen 217 IRS 219 (484)
T ss_pred HHh
Confidence 754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.6e-15 Score=137.87 Aligned_cols=133 Identities=25% Similarity=0.265 Sum_probs=109.9
Q ss_pred EEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeccccccCCceEEEEEe
Q 005111 157 KLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH--PNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIVkl~~~~~~~~~~~l~LV~E 234 (714)
+++.||.|.++.||++... +..+++|.+..... ...+.+|+.+++.+.| .++++++.++...+ ..|++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~--~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDG--WSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC--ccEEEEE
Confidence 4578999999999999863 47899998865432 4567889999999976 58888888766543 4899999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc---CeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH---GVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~---gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
|+.+..+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++|+|||++...
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 9998766533 5677788899999999999985 7999999999999999899999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=6e-15 Score=152.93 Aligned_cols=139 Identities=16% Similarity=0.163 Sum_probs=103.1
Q ss_pred eEEe-ccCceEEEEEEEccCCeEEEEEEeecCCC-----------CHHHHHHHHHHHHHHHhCCCCCe--eeeecccccc
Q 005111 159 DKIG-QGTYSSVYRARDVIHDKIVALKKVRFDNQ-----------DPESVKFMAREIAILRKLDHPNI--IKLEGLITSQ 224 (714)
Q Consensus 159 ~~LG-~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-----------~~~~~~~~~rEi~iL~~L~HpnI--Vkl~~~~~~~ 224 (714)
..|| .|+.|+||.+.. .+..++||.+..... +......+.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 888999999864 478899998853210 11234567899999999988775 5566553332
Q ss_pred CCc--eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 225 TSC--SLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 225 ~~~--~l~LV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
... ..+|||||++| .++..++.. ..+++.. +.||+.+|.+||++||+|+||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 221 13599999997 455544433 3556543 578999999999999999999999999999999999999998
Q ss_pred ccc
Q 005111 302 SFF 304 (714)
Q Consensus 302 ~~~ 304 (714)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.8e-15 Score=165.50 Aligned_cols=256 Identities=22% Similarity=0.256 Sum_probs=198.9
Q ss_pred CCCeeEEeEEec--cCceEEEEEEE--ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQ--GTYSSVYRARD--VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~--G~fG~Vy~a~d--~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~ 226 (714)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+.....+..-..=.+|+...+.+ .|+|.|+.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345677788999 99999999988 88899999998544433223333334677777777 59999998777765554
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHH----HhhHhhhcCeeeccCCCccEEEcCC-CcEEEeecCcc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLS----GLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLA 301 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~----aL~~LH~~gIiHrDLKP~NILl~~~-g~vKL~DFGla 301 (714)
+|+-+|+|...+..........+++..++.++.+... ||.++|..+|+|-|+||.||++..+ ...+++|||+.
T Consensus 193 --lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 193 --LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred --ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 8999999998887777777777999999999999999 9999999999999999999999999 78999999999
Q ss_pred cccCCCCCCCccc----ccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC--ChHHHHHHHHHhhCCC
Q 005111 302 SFFDPKDSVPMTS----RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK--TEVEQLHRIFKLCGSP 375 (714)
Q Consensus 302 ~~~~~~~~~~~~~----~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~--~~~e~l~~I~k~~G~p 375 (714)
..+.......... ..|..-|++||++.+. ++...|||+||.++.+..+|..++... +.+.++..++ .
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-----i 343 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-----I 343 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----C
Confidence 8876554322111 1456789999988764 689999999999999999987666543 3332222221 0
Q ss_pred ChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 376 SEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 376 ~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+. +.....+.++..++..|+..+|..|+++..++.|.+...
T Consensus 344 p~-------------------------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 344 PL-------------------------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ch-------------------------hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11 122345666777999999999999999999999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.2e-15 Score=174.15 Aligned_cols=267 Identities=22% Similarity=0.265 Sum_probs=200.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..+.|.+.+-+-+|.++.++.+.-..+|...++|+...... ....++.+.++-.++-...+|.++....-+..... +
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP--~ 879 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP--L 879 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC--c
Confidence 45678899999999999999998777887778777654321 11223344445455444556777655433333333 8
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC--
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK-- 307 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~-- 307 (714)
+||++|..++.+.-.+...+..+.+-++.++..+..++++||...++|+|++|.|+|+..+|..++.|||........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 999999988766665555557888889999999999999999999999999999999999999999999844322100
Q ss_pred -------------------C---------CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC
Q 005111 308 -------------------D---------SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK 359 (714)
Q Consensus 308 -------------------~---------~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~ 359 (714)
. ...-...++|+.|.+||.+++..+ +..+|+|++|++++|.++|.+||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 001123467999999999999874 89999999999999999999999998
Q ss_pred ChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHH---HHHcC
Q 005111 360 TEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT---LALNS 436 (714)
Q Consensus 360 ~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~---e~L~H 436 (714)
+....+..|....- -| .......+..+.+++..+|..+|.+|..+. ++-.|
T Consensus 1039 tpq~~f~ni~~~~~-----~~---------------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDI-----PW---------------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred chhhhhhccccCCC-----CC---------------------CCCccccChhhhhhhhhhhccCchhccCcccccccccC
Confidence 88776666543110 11 112234678999999999999999999988 99999
Q ss_pred cCCCCCCCCC
Q 005111 437 EFFTTQPLAC 446 (714)
Q Consensus 437 p~f~~~~~~~ 446 (714)
+||+...+..
T Consensus 1093 ~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1093 PFFQDVDWEN 1102 (1205)
T ss_pred CccCCCCccc
Confidence 9999876543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.3e-15 Score=167.41 Aligned_cols=204 Identities=16% Similarity=0.179 Sum_probs=135.4
Q ss_pred hHHHHHHHHhhccccccCCCCcCCCCCCCchh------hhhcCCCchhhhhhhhhhcccc----cCCCCCeeEEeEEecc
Q 005111 95 KKKVDEQIEKCEVNVINHHPAIGRLPKGVEGE------QVAAGWPTWLATVAGEAIKGWI----PRRANTFEKLDKIGQG 164 (714)
Q Consensus 95 ~~~~~e~~~~~~~~~i~~~~~i~~~p~~~~~~------~~~~~~p~~~~~~~g~~~~~~i----~~~~~~Y~~~~~LG~G 164 (714)
-..+...+++++..+++-++.++..++-++.+ .+...-|+.....+...+...+ ......|+. +.||+|
T Consensus 52 ~~rlr~aLe~LGp~fIKlGQ~LStR~DllP~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~Plasa 130 (537)
T PRK04750 52 GERLRLALEELGPIFVKFGQMLSTRRDLFPPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASA 130 (537)
T ss_pred HHHHHHHHHHcCcHHHHHHHHHHcCcccCCHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCC
Confidence 34567788899999999999888888776655 4555556555554444443322 122355776 789999
Q ss_pred CceEEEEEEEccCCeEEEEEEeecCCCC----------------------------H----HHHHHHH------HHHHHH
Q 005111 165 TYSSVYRARDVIHDKIVALKKVRFDNQD----------------------------P----ESVKFMA------REIAIL 206 (714)
Q Consensus 165 ~fG~Vy~a~d~~~g~~VAiK~i~~~~~~----------------------------~----~~~~~~~------rEi~iL 206 (714)
++|+||+|+...+|+.||||+++..... . +..+.+. +|+..+
T Consensus 131 SiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~ 210 (537)
T PRK04750 131 SIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANA 210 (537)
T ss_pred CccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHH
Confidence 9999999998888999999999754210 0 1122233 344444
Q ss_pred HhCC----CCCeeeeeccccccCCceEEEEEeecccccccccc--CCCC----CCCHHHHHHHHHHHHHHhhHhhhcCee
Q 005111 207 RKLD----HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLAS--LPGM----KFTESQVKCYMKQLLSGLEHCHSHGVL 276 (714)
Q Consensus 207 ~~L~----HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~--~~~~----~lse~~i~~i~~QIl~aL~~LH~~gIi 276 (714)
.++. +.+.+.+-.+|.+-. ...+|||||++|..+..+. ...+ .+.+..+..++.||+ ..|++
T Consensus 211 ~~~~~~f~~~~~v~VP~v~~d~s-t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~Gff 282 (537)
T PRK04750 211 SQLRRNFEDSDMLYVPEVYWDYC-SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFF 282 (537)
T ss_pred HHHHHHccCCCCeecceeecccC-CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCee
Confidence 4442 333344434333221 2268999999997765421 1111 355555666666665 58999
Q ss_pred eccCCCccEEEcCCC----cEEEeecCcccccCCC
Q 005111 277 HRDIKGSNLLLDHNG----ILKIADFGLASFFDPK 307 (714)
Q Consensus 277 HrDLKP~NILl~~~g----~vKL~DFGla~~~~~~ 307 (714)
|+|+||.|||++.+| .++++|||++..++..
T Consensus 283 HaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 283 HADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred eCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 999999999999988 9999999999887543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.3e-14 Score=157.45 Aligned_cols=207 Identities=18% Similarity=0.208 Sum_probs=134.5
Q ss_pred HhHHHHHHHHhhccccccCCCCcCCCCCCCchh------hhhcCCCchhhhhhhhhhcccccC----CCCCeeEEeEEec
Q 005111 94 RKKKVDEQIEKCEVNVINHHPAIGRLPKGVEGE------QVAAGWPTWLATVAGEAIKGWIPR----RANTFEKLDKIGQ 163 (714)
Q Consensus 94 r~~~~~e~~~~~~~~~i~~~~~i~~~p~~~~~~------~~~~~~p~~~~~~~g~~~~~~i~~----~~~~Y~~~~~LG~ 163 (714)
+-..+...+++++..+++-++.++..++-++.+ .+...-|+..-......+...+.. ....|+ .+.||.
T Consensus 49 ~~~~l~~~l~~lGp~fiKlGQ~lS~r~dllp~~~~~~L~~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plas 127 (437)
T TIGR01982 49 RGERLRLALEELGPTFIKFGQTLSTRADLLPADIAEELSLLQDRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAA 127 (437)
T ss_pred HHHHHHHHHHHcCchhHHHhHHHHhCcccCCHHHHHHHHHHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-Ccceee
Confidence 345677788899999999999988877766655 345555554444444444432221 112233 257999
Q ss_pred cCceEEEEEEEccCCeEEEEEEeecCCCCHH----------------------------H----HH------HHHHHHHH
Q 005111 164 GTYSSVYRARDVIHDKIVALKKVRFDNQDPE----------------------------S----VK------FMAREIAI 205 (714)
Q Consensus 164 G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~----------------------------~----~~------~~~rEi~i 205 (714)
|++|+||+|+. .+|+.||||+.+......- . .. .+.+|+..
T Consensus 128 aSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n 206 (437)
T TIGR01982 128 ASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAAN 206 (437)
T ss_pred eehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHH
Confidence 99999999985 5799999999875421100 0 00 13345555
Q ss_pred HHhC----CCCCeeeeeccccccCCceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHH-HhhHhhhcCeeecc
Q 005111 206 LRKL----DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLS-GLEHCHSHGVLHRD 279 (714)
Q Consensus 206 L~~L----~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~-aL~~LH~~gIiHrD 279 (714)
+.++ .+.+-|.+-.++..... ..+|||||++|..+..+.... ..+ ....++.+++. .+..+|..|++|+|
T Consensus 207 ~~~~~~~~~~~~~v~vP~v~~~~~~-~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D 282 (437)
T TIGR01982 207 ASELGENFKNDPGVYVPEVYWDRTS-ERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGFFHAD 282 (437)
T ss_pred HHHHHHhcCCCCCEEeCCEehhhcC-CceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCceeCC
Confidence 5555 23333444344432222 268999999998776543211 112 23445555555 46789999999999
Q ss_pred CCCccEEEcCCCcEEEeecCcccccCC
Q 005111 280 IKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 280 LKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
++|.|||++.+|.++|+|||++..+.+
T Consensus 283 ~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 283 LHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.6e-12 Score=128.79 Aligned_cols=140 Identities=20% Similarity=0.231 Sum_probs=100.9
Q ss_pred eEEeccCceEEEEEEEcc------CCeEEEEEEeecCCC-----------C---------HHHHHHHH----HHHHHHHh
Q 005111 159 DKIGQGTYSSVYRARDVI------HDKIVALKKVRFDNQ-----------D---------PESVKFMA----REIAILRK 208 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~------~g~~VAiK~i~~~~~-----------~---------~~~~~~~~----rEi~iL~~ 208 (714)
..||.|--+.||.|.... .+..+|||+.+.... + ....+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 357999999864210 0 01122233 79999999
Q ss_pred CCC--CCeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHh-hhcCeeeccCCCccE
Q 005111 209 LDH--PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC-HSHGVLHRDIKGSNL 285 (714)
Q Consensus 209 L~H--pnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~L-H~~gIiHrDLKP~NI 285 (714)
+.. -++..++++ . . -+|||||++++.+.........+++.++..+..+++.+|..| |+.||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~---~-~--~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL---K-K--HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe---c-C--CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 842 344455543 1 2 579999999754322222233566777888899999999998 899999999999999
Q ss_pred EEcCCCcEEEeecCcccccC
Q 005111 286 LLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 286 Ll~~~g~vKL~DFGla~~~~ 305 (714)
|+. ++.+.|+|||.+...+
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 5789999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.1e-13 Score=149.38 Aligned_cols=258 Identities=21% Similarity=0.224 Sum_probs=189.2
Q ss_pred ccccCCCCCeeEEeEEeccCceEEEEEEEc-cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc
Q 005111 146 GWIPRRANTFEKLDKIGQGTYSSVYRARDV-IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS 223 (714)
Q Consensus 146 ~~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~-~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~ 223 (714)
.|......+|..+..||.|.|+.|+.+... .++..|++|.+............-..|+.+...+ .|.+++.++..+..
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 345556789999999999999999998644 6788999998765533333333334566666666 58888887766655
Q ss_pred cCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-CcEEEeecCccc
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLAS 302 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~-g~vKL~DFGla~ 302 (714)
... .||-.|||+++...+.......+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+.
T Consensus 338 ~r~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 LRQ--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccc--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 444 67999999988777666545568899999999999999999999999999999999999886 788999999987
Q ss_pred ccCCCCCCCccccccccccc-CcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 303 FFDPKDSVPMTSRVVTLWYR-PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~-APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
.+.-.. .....+-++. ..|++.....+..+.|++|||.-+++.++|.++-...... ..|
T Consensus 416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i------------- 475 (524)
T KOG0601|consen 416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI------------- 475 (524)
T ss_pred ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee-------------
Confidence 532211 1223344555 3666666666899999999999999999998653322211 001
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+.......+.+...+..+.+.++..|+..|+.+.++..|.=|..
T Consensus 476 ----------------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 476 ----------------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred ----------------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 01111122344567888999999999999999999998876653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.2e-12 Score=123.98 Aligned_cols=128 Identities=19% Similarity=0.178 Sum_probs=95.0
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCee-eeeccccccCCceEEEEEeec
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII-KLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIV-kl~~~~~~~~~~~l~LV~Ey~ 236 (714)
++.|+.|.++.||++.. .+..|++|+...... ....+.+|+.+++.+.+.+++ +++.+.. .. -++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC--CeEEEEec
Confidence 46789999999999975 478899998754321 122356899999988654443 4444322 22 47999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCe-----eeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV-----LHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gI-----iHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
+|..+.... .....++.+++.+|+.||..++ +|+|++|.|||++ ++.++|+|||.+..
T Consensus 74 ~G~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCcccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 997664321 1124567899999999999885 9999999999999 67899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-11 Score=136.56 Aligned_cols=169 Identities=21% Similarity=0.330 Sum_probs=127.6
Q ss_pred EEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccccccccccCCCCC
Q 005111 171 RARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK 250 (714)
Q Consensus 171 ~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~ 250 (714)
.|..+.++.+|.|.+...... +....+.+-+..|+.|+||||+++++.+...+. +|||+|-+..-.. +. ..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~--~ylvTErV~Pl~~--~l---k~ 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGT--LYLVTERVRPLET--VL---KE 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCc--eEEEeeccccHHH--HH---HH
Confidence 455677888999998876543 445667788999999999999999998876664 9999999864211 11 12
Q ss_pred CCHHHHHHHHHHHHHHhhHhh-hcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccC
Q 005111 251 FTESQVKCYMKQLLSGLEHCH-SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329 (714)
Q Consensus 251 lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g 329 (714)
+....+..-+.||+.||.||| +.+++|++|.-..|+|+..|..||++|.++........ +.....---.|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 347778888999999999998 56899999999999999999999999999876543321 1111122334677764432
Q ss_pred CCCCCccccccchhHHHHHHhhC
Q 005111 330 ASHYGAAVDLWSTGCILGELFSG 352 (714)
Q Consensus 330 ~~~y~~~sDIWSLG~iLyeLltG 352 (714)
. +...|.|.|||++++++.|
T Consensus 180 s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 S---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c---ccchhhhhHHHHHHHHhCc
Confidence 1 2568999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.4e-12 Score=134.08 Aligned_cols=239 Identities=19% Similarity=0.205 Sum_probs=157.1
Q ss_pred EEEEEEEccCCeEEEEEEeecCCC-C-HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC---ceEEEEEeeccccccc
Q 005111 168 SVYRARDVIHDKIVALKKVRFDNQ-D-PESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---CSLYLVFEYMEHDLVG 242 (714)
Q Consensus 168 ~Vy~a~d~~~g~~VAiK~i~~~~~-~-~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---~~l~LV~Ey~~g~ll~ 242 (714)
.||++.+...|..|+--.+.+... + .+.-..+..-...|-++.|.|||+++.|+++... ....++.|||..+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 478887777777776555543211 1 1112222333455666789999999998876432 3478899999987665
Q ss_pred cccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcCCCcEEEeecCcccccCCCC----CCCc
Q 005111 243 LASL----PGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD----SVPM 312 (714)
Q Consensus 243 ~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~----~~~~ 312 (714)
.+++ ....+.....++|+.||+.||.|||+.. |+|+++...-|++..+|-+||.---.. ...+.- ....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhh
Confidence 4443 4456889999999999999999999885 999999999999999998887421111 110000 0001
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCC-CCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV-LPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~p-F~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+-+.|.+||.-.... .+.++|||+||....+|..|..- -.+.+..+.-..|..
T Consensus 240 ~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~--------------------- 297 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN--------------------- 297 (458)
T ss_pred hccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh---------------------
Confidence 1123468899999654433 57899999999999999988732 222221111111110
Q ss_pred cCCchhhhhhhhhccCCc-HHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 392 KPVQPYRRRIAETFKDFP-TSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p-~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
..-.+. .--.++|.+||+-.|..||+|.++|.||.+-.
T Consensus 298 ------------~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 298 ------------VIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ------------heeeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 000111 12346799999999999999999999998654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.8e-10 Score=112.50 Aligned_cols=144 Identities=19% Similarity=0.253 Sum_probs=107.2
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC--CeeeeeccccccC-CceEEEEEe
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP--NIIKLEGLITSQT-SCSLYLVFE 234 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp--nIVkl~~~~~~~~-~~~l~LV~E 234 (714)
++.|+.|.++.||++... +|+.+++|+....... .....+.+|+.++..+.+. ++.+++.+..... ....++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 356899999999999753 3688999987654221 2345678999999999653 3455666544322 123689999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh------------------------------------------
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS------------------------------------------ 272 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~------------------------------------------ 272 (714)
|++|..+...... ..+++.+...++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999877654432 357888888888899888888883
Q ss_pred --------------cCeeeccCCCccEEEcC--CCcEEEeecCccccc
Q 005111 273 --------------HGVLHRDIKGSNLLLDH--NGILKIADFGLASFF 304 (714)
Q Consensus 273 --------------~gIiHrDLKP~NILl~~--~g~vKL~DFGla~~~ 304 (714)
..++|+|+.|.|||++. ++.+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 677899999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=132.68 Aligned_cols=153 Identities=23% Similarity=0.356 Sum_probs=115.4
Q ss_pred HHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc--------cccccccccCcccccCCCCCCc
Q 005111 265 SGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT--------SRVVTLWYRPPELLLGASHYGA 335 (714)
Q Consensus 265 ~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~--------~~~gT~~Y~APE~l~g~~~y~~ 335 (714)
.||.|+|.. ++||+.|.|++|.++..|..||+.|+++.........+.. ...-...|.|||++.+.. .+.
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-~~~ 188 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-NTP 188 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-ccc
Confidence 899999965 8999999999999999999999999998765442221111 112367799999998854 689
Q ss_pred cccccchhHHHHHHh-hCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHH
Q 005111 336 AVDLWSTGCILGELF-SGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALR 414 (714)
Q Consensus 336 ~sDIWSLG~iLyeLl-tG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~ 414 (714)
++|+|||||++|.+. .|++.|.+.........-....+.. ....-..+|+++++
T Consensus 189 ~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~el~~ 243 (700)
T KOG2137|consen 189 ASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPSELRE 243 (700)
T ss_pred cccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcHHHHH
Confidence 999999999999999 6788776654333222221111110 00011478999999
Q ss_pred HHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 415 LMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 415 LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
=|.++|..|+..||++.+++..+||+...
T Consensus 244 ~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 244 SLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred HHHHHhcCCcccCcchhhhhcccccCCch
Confidence 99999999999999999999999998754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.2e-09 Score=113.86 Aligned_cols=238 Identities=21% Similarity=0.290 Sum_probs=163.0
Q ss_pred ccCCCCCeeEEeEEec--cCc-eEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc-
Q 005111 148 IPRRANTFEKLDKIGQ--GTY-SSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS- 223 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~--G~f-G~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~- 223 (714)
+|.....|.-+-.|-- |-| .+.|+|....+|..|++|.+.-+.. ........-+++++++.|+|||++.++|..
T Consensus 268 ~p~lv~~~~~L~pl~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~ 345 (655)
T KOG3741|consen 268 IPSLVESFVNLYPLELLNDLFSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTY 345 (655)
T ss_pred CCcchhhhhceeecccccccccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhh
Confidence 4444555554433321 224 5789999999999999999943311 111112245788999999999999998763
Q ss_pred -cCCceEEEEEeeccc--ccccccc--------------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEE
Q 005111 224 -QTSCSLYLVFEYMEH--DLVGLAS--------------LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLL 286 (714)
Q Consensus 224 -~~~~~l~LV~Ey~~g--~ll~~~~--------------~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NIL 286 (714)
-+...+++|++|.++ .|++.+. ..+...+|..+|.|+.||..||.++|+.|+..+-|.|.+||
T Consensus 346 tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIl 425 (655)
T KOG3741|consen 346 TFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKIL 425 (655)
T ss_pred ccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeE
Confidence 233468999999986 3333222 12345789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHH
Q 005111 287 LDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366 (714)
Q Consensus 287 l~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 366 (714)
++.+.+++|...|+...+.+... |.+.+ -.+-|.=.||.+++.|.||..--...+.....
T Consensus 426 v~G~~RIriS~C~i~Dvl~~d~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s- 485 (655)
T KOG3741|consen 426 VTGKMRIRISGCGIMDVLQEDPT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS- 485 (655)
T ss_pred eeCcceEEEecccceeeecCCCC---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH-
Confidence 99998999988887766644331 11221 24568889999999999996321111111000
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC---cCCCC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS---EFFTT 441 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H---p~f~~ 441 (714)
.+..+...++.++.++|.-+....+.. -+..++|.+ -||+.
T Consensus 486 ---------------------------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~v 529 (655)
T KOG3741|consen 486 ---------------------------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTV 529 (655)
T ss_pred ---------------------------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHH
Confidence 011122356788999999998888886 677887765 45654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-09 Score=106.31 Aligned_cols=130 Identities=23% Similarity=0.285 Sum_probs=92.0
Q ss_pred EEeccCceEEEEEEEccCCeEEEEEEee-cCCCCHH-----HHHHHHHHHHHHHhCCCC--CeeeeeccccccCCceEEE
Q 005111 160 KIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPE-----SVKFMAREIAILRKLDHP--NIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~~VAiK~i~-~~~~~~~-----~~~~~~rEi~iL~~L~Hp--nIVkl~~~~~~~~~~~l~L 231 (714)
.+++|+-+.+|.+.. .|..+++|.=. +....++ ...+..+|+.+|.++.-- +...++++.. .. ..|
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~--~~--~~I 76 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP--DN--GLI 76 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC--CC--CEE
Confidence 578999999999943 46566666422 1122222 245577899999887422 2233444332 22 579
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
+|||++|.++...+... ...++..|-.-+.-||..||||+||.++||++..++ +.++|||++.+
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999887665443 255666777777889999999999999999998765 99999999975
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.4e-09 Score=103.45 Aligned_cols=141 Identities=20% Similarity=0.254 Sum_probs=97.0
Q ss_pred EEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCC-----HHHHHHHHHHHHHHHhCCCCCee--eeeccccccCCce
Q 005111 157 KLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQD-----PESVKFMAREIAILRKLDHPNII--KLEGLITSQTSCS 228 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~-----~~~~~~~~rEi~iL~~L~HpnIV--kl~~~~~~~~~~~ 228 (714)
.+..|-+|+-+.|+++. ..|+.+.||.-... ... .-..++..+|+.+|.++.--.|. .++ ++....
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-~~D~~~--- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-FIDTYG--- 84 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-EEecCC---
Confidence 67789999999999995 67998888853211 111 22456788999999988422221 121 122222
Q ss_pred EEEEEeeccc--cccccccCCCCC-CCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---cEEEeecCccc
Q 005111 229 LYLVFEYMEH--DLVGLASLPGMK-FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLAS 302 (714)
Q Consensus 229 l~LV~Ey~~g--~ll~~~~~~~~~-lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g---~vKL~DFGla~ 302 (714)
-.|+|||++| ...+.+...... ....-...++++|-..|.-||.++|||+||..+||||..+| .+.|+|||++.
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 3699999998 333333222222 23333378899999999999999999999999999998765 35899999986
Q ss_pred c
Q 005111 303 F 303 (714)
Q Consensus 303 ~ 303 (714)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=5e-09 Score=104.64 Aligned_cols=127 Identities=23% Similarity=0.264 Sum_probs=83.8
Q ss_pred EEEEEEEccCCeEEEEEEeecCCC------------------------CHHHHHHHHHHHHHHHhCCCC--Ceeeeeccc
Q 005111 168 SVYRARDVIHDKIVALKKVRFDNQ------------------------DPESVKFMAREIAILRKLDHP--NIIKLEGLI 221 (714)
Q Consensus 168 ~Vy~a~d~~~g~~VAiK~i~~~~~------------------------~~~~~~~~~rEi~iL~~L~Hp--nIVkl~~~~ 221 (714)
.||.|.. ..|..+|||+.+.... .........+|..+|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899975 5788999999864210 011234567899999999755 445555432
Q ss_pred cccCCceEEEEEeecc--ccccccccCCCCCCCHHHHHHHHHHHHHHhhH-hhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 222 TSQTSCSLYLVFEYME--HDLVGLASLPGMKFTESQVKCYMKQLLSGLEH-CHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 222 ~~~~~~~l~LV~Ey~~--g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~-LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
. -+|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+||
T Consensus 80 ---~---~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ---R---NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ---T---TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ---C---CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2 379999999 6555443322 22245677888888885555 579999999999999999887 9999999
Q ss_pred Cccccc
Q 005111 299 GLASFF 304 (714)
Q Consensus 299 Gla~~~ 304 (714)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.6e-08 Score=115.07 Aligned_cols=207 Identities=19% Similarity=0.247 Sum_probs=131.3
Q ss_pred HHHHHHHHhhccccccCCCCcCCCCCCCchh------hhhcCCCchhhhhhhhhhcccccCC-CCCeeEE--eEEeccCc
Q 005111 96 KKVDEQIEKCEVNVINHHPAIGRLPKGVEGE------QVAAGWPTWLATVAGEAIKGWIPRR-ANTFEKL--DKIGQGTY 166 (714)
Q Consensus 96 ~~~~e~~~~~~~~~i~~~~~i~~~p~~~~~~------~~~~~~p~~~~~~~g~~~~~~i~~~-~~~Y~~~--~~LG~G~f 166 (714)
+....++++++..+|+-++.++..|+.++.+ .+...-|+.....+.+.+.+.+-.. .+-|... ..|+.++-
T Consensus 59 ~rL~~~L~~LGPtfIK~GQ~LStR~Dl~p~e~~~eL~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~~~PiAsASI 138 (517)
T COG0661 59 ERLRLALEELGPTFIKLGQILSTRPDLVPPEYAEELAKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFEPEPIASASI 138 (517)
T ss_pred HHHHHHHHHhCCchhhhhhHHhcCccccCHHHHHHHHHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcCCCchhhhhH
Confidence 5667789999999999999999999988776 4556667666666555554433211 1112222 57999999
Q ss_pred eEEEEEEEccCCeEEEEEEeecCCCCH-----HH---------------------------HHH------HHHHHHHHHh
Q 005111 167 SSVYRARDVIHDKIVALKKVRFDNQDP-----ES---------------------------VKF------MAREIAILRK 208 (714)
Q Consensus 167 G~Vy~a~d~~~g~~VAiK~i~~~~~~~-----~~---------------------------~~~------~~rEi~iL~~ 208 (714)
|+||+|+. .+|+.||||+.+..-... .. .+. +.+|...+.+
T Consensus 139 aQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~ 217 (517)
T COG0661 139 AQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAER 217 (517)
T ss_pred hhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHH
Confidence 99999984 569999999987542110 00 011 2245555544
Q ss_pred CC-----CCCeeeeeccccccCCceEEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCC
Q 005111 209 LD-----HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKG 282 (714)
Q Consensus 209 L~-----HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP 282 (714)
+. .++ +.+-.+|.+-. ..-+|+|||++|--+.... .....++...+...+.++ .+..+-..|++|.|.+|
T Consensus 218 ~~~nf~~~~~-v~VP~V~we~t-~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHp 293 (517)
T COG0661 218 FRENFKDDPD-VYVPKVYWEYT-TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFHADPHP 293 (517)
T ss_pred HHHHcCCCCC-eEeceeehhcc-CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccccCCCc
Confidence 41 233 33333333211 1258999999995554432 111234433332222222 12333458999999999
Q ss_pred ccEEEcCCCcEEEeecCcccccCCC
Q 005111 283 SNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 283 ~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.||+++.+|.+.+.|||+...+++.
T Consensus 294 GNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 294 GNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999877654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=6e-08 Score=102.26 Aligned_cols=133 Identities=17% Similarity=0.129 Sum_probs=89.2
Q ss_pred EEEEEEEccCCeEEEEEEeecCCCCHHHHH----------HHHHHHHHHHhCCCCCe--eeeeccccccC---CceEEEE
Q 005111 168 SVYRARDVIHDKIVALKKVRFDNQDPESVK----------FMAREIAILRKLDHPNI--IKLEGLITSQT---SCSLYLV 232 (714)
Q Consensus 168 ~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~----------~~~rEi~iL~~L~HpnI--Vkl~~~~~~~~---~~~l~LV 232 (714)
.|++.. ..|+.|.||........ +..+ .+.+|...+.+|..-+| ..++.+..... ...-+||
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 466653 46788999966332211 1111 36688888877732222 22222222111 2236899
Q ss_pred Eeecccc-ccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-------CCcEEEeecCccc
Q 005111 233 FEYMEHD-LVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-------NGILKIADFGLAS 302 (714)
Q Consensus 233 ~Ey~~g~-ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-------~g~vKL~DFGla~ 302 (714)
||++++. .+..+... ....+......++.+|+..+.-||..||+|+||++.||||+. ++.+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999985 44444321 234567788899999999999999999999999999999975 4689999999886
Q ss_pred c
Q 005111 303 F 303 (714)
Q Consensus 303 ~ 303 (714)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.5e-08 Score=99.65 Aligned_cols=138 Identities=23% Similarity=0.241 Sum_probs=102.3
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC--------------------HHHHHHHHHHHHHHHhCCCC-
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD--------------------PESVKFMAREIAILRKLDHP- 212 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~--------------------~~~~~~~~rEi~iL~~L~Hp- 212 (714)
-+.+..+||-|--|.||.|.+. .|..+|||.=+....+ -.......+|..+|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 3566789999999999999864 7899999975422100 11234466899999999644
Q ss_pred -CeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 213 -NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 213 -nIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
.+.+.+++ +.-.+||||++|-.|.... ++......++..|+.-+..+-..||||+|+.+-|||++++|
T Consensus 171 ~~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 171 VKVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC
Confidence 44444442 2257999999996665432 24556667777777777777799999999999999999999
Q ss_pred cEEEeecCcccc
Q 005111 292 ILKIADFGLASF 303 (714)
Q Consensus 292 ~vKL~DFGla~~ 303 (714)
.+.++||=-+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.6e-07 Score=94.81 Aligned_cols=141 Identities=18% Similarity=0.241 Sum_probs=99.3
Q ss_pred EEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHH----------------------HHHHHHHHHHHHhCC--CC
Q 005111 157 KLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES----------------------VKFMAREIAILRKLD--HP 212 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~----------------------~~~~~rEi~iL~~L~--Hp 212 (714)
+...|..|--+.||+|.. ..+..||+|+++.....-.. .....+|+..|.++. +=
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 345788888899999973 67899999998754221111 112336777787773 33
Q ss_pred CeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCC
Q 005111 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 213 nIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g 291 (714)
.+.+-+.+. . -.|||||++......-......+...++..+..+++..+.-|-. .++||+||+.-|||+. ++
T Consensus 131 rvP~Pi~~~---~---nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 131 RVPEPIAFR---N---NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCCCceeec---C---CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence 333334432 1 37999999876222112223344555788899999999999877 8999999999999999 88
Q ss_pred cEEEeecCcccccC
Q 005111 292 ILKIADFGLASFFD 305 (714)
Q Consensus 292 ~vKL~DFGla~~~~ 305 (714)
.+.|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999997654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.7e-07 Score=98.01 Aligned_cols=254 Identities=15% Similarity=0.149 Sum_probs=151.0
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeee-e----eccccccCCceEEEE
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIK-L----EGLITSQTSCSLYLV 232 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVk-l----~~~~~~~~~~~l~LV 232 (714)
+.||+|+-+.+|-.-. -+ -.+.|++....-.... +-+..|... .||-+-. + -..+.......+-+.
T Consensus 17 r~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~~a-----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 17 RPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAAQA-----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred ccccCCccceeeecch--hh-chhheeecCCCchHHH-----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 5699999999997632 22 2455877654221111 122333333 4554322 0 011112222236678
Q ss_pred Eeecccc--cccccc-----CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 233 FEYMEHD--LVGLAS-----LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 233 ~Ey~~g~--ll~~~~-----~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
|..+.|. ...++. +....+.+..+.+.++.|+.+.+.||..|.+-+|+.++|+||++++.+.|+|=..-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc
Confidence 8888763 111111 122346788999999999999999999999999999999999999999999754433221
Q ss_pred CCCCCCcccccccccccCccccc-----CCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLL-----GASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~-----g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
........+|...|.+||.-. +.. -+...|.|.||+++|+||.| +.||.|-.... -.+.|-+..
T Consensus 169 --ng~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap~p~E~~ 238 (637)
T COG4248 169 --NGTLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAPNPLETD 238 (637)
T ss_pred --CCceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCCCcchhh
Confidence 222234458899999999643 222 36689999999999999997 89998742110 000000111
Q ss_pred HhhhhcccCccccCCchhhhh-hhhhccCCcHHHHHHHHHhccc--CcCCCCCHHH
Q 005111 380 WRKSKLRHSTVFKPVQPYRRR-IAETFKDFPTSALRLMETLMSI--DPAHRGTATL 432 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~-i~~~~~~~p~~l~~LI~~mL~~--DP~kRpTa~e 432 (714)
+....+-... +...+++.. ..--+.-+|+++..|..+|+.. .+.-|||++.
T Consensus 239 Ia~g~f~ya~--~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 239 IAHGRFAYAS--DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhcceeeech--hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1111111000 011111111 1122345788999999999865 3568999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=3e-07 Score=93.21 Aligned_cols=108 Identities=19% Similarity=0.209 Sum_probs=78.9
Q ss_pred HHHHHHHHHHHhCCCCCe--eeeeccccccC--CceEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHhhHhh
Q 005111 197 KFMAREIAILRKLDHPNI--IKLEGLITSQT--SCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271 (714)
Q Consensus 197 ~~~~rEi~iL~~L~HpnI--Vkl~~~~~~~~--~~~l~LV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH 271 (714)
....+|...+..|..-.| .+.+.+..... ....+||+|++++. .+..+......++......++.+|+..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 356678887777732222 22333322211 12358999999983 45555544333678888999999999999999
Q ss_pred hcCeeeccCCCccEEEcCCC---cEEEeecCccccc
Q 005111 272 SHGVLHRDIKGSNLLLDHNG---ILKIADFGLASFF 304 (714)
Q Consensus 272 ~~gIiHrDLKP~NILl~~~g---~vKL~DFGla~~~ 304 (714)
+.||+|+|+++.|||++.++ .+.|+||+.+...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.8e-06 Score=87.68 Aligned_cols=141 Identities=22% Similarity=0.280 Sum_probs=91.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHH-HHHH------HHHHHHHHHhCC---CCCeeeeeccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPE-SVKF------MAREIAILRKLD---HPNIIKLEGLI 221 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~-~~~~------~~rEi~iL~~L~---HpnIVkl~~~~ 221 (714)
.+.|.+++.+-......|.+.. ..|+.+++|..+......+ .... ..+++..+..+. .-.+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4689999999998888888874 5678999998875432111 1111 224444444442 22222222221
Q ss_pred cccC---CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 222 TSQT---SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 222 ~~~~---~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
.-.. ....+|||||++|-.+.... .+++ .+...|..+|.-||+.|++|+|+.|.|+++++++ ++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEEC
Confidence 1111 12256899999997665443 1333 2446677889999999999999999999998655 999999
Q ss_pred Ccccc
Q 005111 299 GLASF 303 (714)
Q Consensus 299 Gla~~ 303 (714)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.4e-08 Score=109.21 Aligned_cols=248 Identities=15% Similarity=0.115 Sum_probs=169.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN-IIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-IVkl~~~~~~~~~~~l~L 231 (714)
.-|+...-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-+. .....++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i 311 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWI 311 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCC--cccccch
Confidence 34666677899999999999877776665 6666432 23446889999999999 444444333 3345899
Q ss_pred EEeecccc--ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHD--LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~--ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
+|+|+.++ ...........|.+-+...+.+.-+.+|++||+.-=+|+| |||..+ +..++.||+....+....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999976 3333333334466667777778888999999998778998 887765 678999999998776443
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+|+.++|||+..+.. +....|.|++|.--.+|.-|.+|-..... . ....|..+..
T Consensus 386 -~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~----~~~~g~~p~s----------- 446 (829)
T KOG0576|consen 386 -KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA--V----LPMIGNGPNS----------- 446 (829)
T ss_pred -ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc--c----cCCCCCCCCc-----------
Confidence 234557899999999887766 78999999999987788888776543110 0 0011111100
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
..+......-+..-.++...||...|..|+++..++-|.+|..-|.
T Consensus 447 ---------~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 447 ---------PMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ---------cccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 0000000000111115678899999999999999999999987654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.5e-06 Score=99.10 Aligned_cols=208 Identities=15% Similarity=0.150 Sum_probs=129.7
Q ss_pred HHHHHHHHhhccccccCCCCcCCCCCCCchh------hhhcCCCchhhhhhhhhhcccccCCCC-CeeEE--eEEeccCc
Q 005111 96 KKVDEQIEKCEVNVINHHPAIGRLPKGVEGE------QVAAGWPTWLATVAGEAIKGWIPRRAN-TFEKL--DKIGQGTY 166 (714)
Q Consensus 96 ~~~~e~~~~~~~~~i~~~~~i~~~p~~~~~~------~~~~~~p~~~~~~~g~~~~~~i~~~~~-~Y~~~--~~LG~G~f 166 (714)
+...+....++..+|+-++-++..|..++.+ .+...-|+..-..+-..+.+.+....+ -|... +.||..+.
T Consensus 95 ~~L~e~~~~nGg~yIKlGQ~lst~~dllP~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASl 174 (538)
T KOG1235|consen 95 ERLLELFLRNGGTYIKLGQHLSTRPDLLPKEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASL 174 (538)
T ss_pred HHHHHHHHHcCCeEEEechhhccccccCcHHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcch
Confidence 6677888999999999999999999888776 355566665555555555544433222 23333 57999999
Q ss_pred eEEEEEEEccCCeEEEEEEeecCCCCH-----------------------------HHHHHHH------HHHHHHHhC--
Q 005111 167 SSVYRARDVIHDKIVALKKVRFDNQDP-----------------------------ESVKFMA------REIAILRKL-- 209 (714)
Q Consensus 167 G~Vy~a~d~~~g~~VAiK~i~~~~~~~-----------------------------~~~~~~~------rEi~iL~~L-- 209 (714)
|+||+|+.+ .|+.||||+-+..-... +..+.+. +|.+...++
T Consensus 175 aQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~ 253 (538)
T KOG1235|consen 175 AQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRE 253 (538)
T ss_pred hheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHH
Confidence 999999955 59999999987542111 0111122 333333222
Q ss_pred --CCCC---eeeeeccccccCCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCc
Q 005111 210 --DHPN---IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGS 283 (714)
Q Consensus 210 --~Hpn---IVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~ 283 (714)
.|-+ -|.+-.+|.+-.. .-+|+||||+|.-+.+... ....++...+...+.++.. ..+-..|++|+|-+|.
T Consensus 254 ~f~~~~~~~~V~VP~Vy~~~st-~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPG 330 (538)
T KOG1235|consen 254 NFKDFSLLTYVLVPKVYWDLST-KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPG 330 (538)
T ss_pred HHHhcccccceeCCeehhhcCc-ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCC
Confidence 3444 1222233322211 2689999999954432211 1223455544444433322 2234578999999999
Q ss_pred cEEEcC----CCcEEEeecCcccccCCC
Q 005111 284 NLLLDH----NGILKIADFGLASFFDPK 307 (714)
Q Consensus 284 NILl~~----~g~vKL~DFGla~~~~~~ 307 (714)
|||++. ++.+.|.|||+...+...
T Consensus 331 Nilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 331 NILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred cEEEecCCCCCccEEEEcccccccccHH
Confidence 999984 668999999999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.1e-06 Score=85.63 Aligned_cols=140 Identities=14% Similarity=0.136 Sum_probs=97.4
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecC---CCC-HHHHHHHHHHHHHHHhCCCCC--eeeeecccc---ccCCceEEE
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFD---NQD-PESVKFMAREIAILRKLDHPN--IIKLEGLIT---SQTSCSLYL 231 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~---~~~-~~~~~~~~rEi~iL~~L~Hpn--IVkl~~~~~---~~~~~~l~L 231 (714)
-|.||-|-|+... ..|..+-+|..... ..- +--...|.+|+..|.+|..-+ +.++. ++. ......-+|
T Consensus 26 ~~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3668889999874 34556888876411 110 234567889999999884322 33332 221 122233689
Q ss_pred EEeeccc-cccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc--EEEeecCcccc
Q 005111 232 VFEYMEH-DLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI--LKIADFGLASF 303 (714)
Q Consensus 232 V~Ey~~g-~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~--vKL~DFGla~~ 303 (714)
|+|-+++ ..|..+... -.+.++.+...++.+|+..|.-||+.|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998885 334333322 234678888999999999999999999999999999999987777 99999987764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.6e-06 Score=82.30 Aligned_cols=140 Identities=24% Similarity=0.337 Sum_probs=80.2
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC--Ceeeeeccccc-cCCceEEEEEe
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP--NIIKLEGLITS-QTSCSLYLVFE 234 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp--nIVkl~~~~~~-~~~~~l~LV~E 234 (714)
++.|+.|..+.||+..... ..+++|+.... .....+.+|+.+++.|... .+.+++.+... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 5789999999999997543 58999986532 4566788899998888432 23445443222 22233799999
Q ss_pred ecccccccc----------------c-----cC--CCCCCCHHH------HHHH---------------HHHHHH-HhhH
Q 005111 235 YMEHDLVGL----------------A-----SL--PGMKFTESQ------VKCY---------------MKQLLS-GLEH 269 (714)
Q Consensus 235 y~~g~ll~~----------------~-----~~--~~~~lse~~------i~~i---------------~~QIl~-aL~~ 269 (714)
+++|..+.. . .. ....+.... ...+ ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999865544 0 00 011111000 0000 011111 2333
Q ss_pred hh-------hcCeeeccCCCccEEEc-CCCcEEEeecCcccc
Q 005111 270 CH-------SHGVLHRDIKGSNLLLD-HNGILKIADFGLASF 303 (714)
Q Consensus 270 LH-------~~gIiHrDLKP~NILl~-~~g~vKL~DFGla~~ 303 (714)
++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 33 24699999999999999 667778999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=83.25 Aligned_cols=134 Identities=18% Similarity=0.113 Sum_probs=78.2
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe--eeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI--IKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI--Vkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
..||+|..+.||+. .+..+++|..+... ....+.+|..+++.+..-.+ .+.+.+..... .+.+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~--~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG--RLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC--eeeeeeeec
Confidence 56899999999984 25567889876432 22346789999988853322 34444443333 368899999
Q ss_pred cccc-cccccC--------------------CC---CCCCHHH-HHHHHHH----------HHHH-hhHhh----hcCee
Q 005111 237 EHDL-VGLASL--------------------PG---MKFTESQ-VKCYMKQ----------LLSG-LEHCH----SHGVL 276 (714)
Q Consensus 237 ~g~l-l~~~~~--------------------~~---~~lse~~-i~~i~~Q----------Il~a-L~~LH----~~gIi 276 (714)
+|.. +..... .. ....... ...+..+ +... ..+|. ...++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9952 110000 00 0011111 0011000 0011 11111 12478
Q ss_pred eccCCCccEEEcCCCcEEEeecCcccc
Q 005111 277 HRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 277 HrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999988 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.2e-05 Score=80.00 Aligned_cols=135 Identities=18% Similarity=0.188 Sum_probs=78.3
Q ss_pred EEeccCc-eEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEEEEeecc
Q 005111 160 KIGQGTY-SSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 160 ~LG~G~f-G~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
.|-.|.+ +.||+... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+ ..++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~--~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDG--RAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCC--ccEEEEEeeC
Confidence 3444555 78999963 34678888865322 234668999988883 333445565544332 3689999999
Q ss_pred ccccccccC---------------------C--CCCCCHH------HHHHH-------------------HHHHHHHhhH
Q 005111 238 HDLVGLASL---------------------P--GMKFTES------QVKCY-------------------MKQLLSGLEH 269 (714)
Q Consensus 238 g~ll~~~~~---------------------~--~~~lse~------~i~~i-------------------~~QIl~aL~~ 269 (714)
|..+..... . ..++... ..... ..+++.-|..
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 865442210 0 0011100 00000 0111111111
Q ss_pred h----hhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 270 C----HSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 270 L----H~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
. ....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 0 123489999999999999988889999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00011 Score=73.96 Aligned_cols=130 Identities=23% Similarity=0.333 Sum_probs=90.3
Q ss_pred CCCeeEEeEEeccCc-eEEEEEEEccCCeEEEEEEeec---CCC-------C--H-------HHHHHHHHHHHHHHhC--
Q 005111 152 ANTFEKLDKIGQGTY-SSVYRARDVIHDKIVALKKVRF---DNQ-------D--P-------ESVKFMAREIAILRKL-- 209 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~f-G~Vy~a~d~~~g~~VAiK~i~~---~~~-------~--~-------~~~~~~~rEi~iL~~L-- 209 (714)
..+++.++.||.|.- |.||+++ ..|+.||||+++. ... . . ....-|..|.+...+|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 9999995 5788999999432 110 0 0 1123356677666665
Q ss_pred -CCCCe--eeeecccccc----------------CCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHh
Q 005111 210 -DHPNI--IKLEGLITSQ----------------TSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270 (714)
Q Consensus 210 -~HpnI--Vkl~~~~~~~----------------~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~L 270 (714)
.+.++ |+++|++.=. ......||.||+.... .++. .-+.+|++-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHH
Confidence 45566 8888875211 1112468888877644 2233 3355677788899
Q ss_pred hhcCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 271 H~~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
|..||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999985 2378999865
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00013 Score=88.89 Aligned_cols=148 Identities=22% Similarity=0.347 Sum_probs=90.1
Q ss_pred EEeEEeccCceEEEEEEEccCC--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCe--eeeeccccccC-CceEE
Q 005111 157 KLDKIGQGTYSSVYRARDVIHD--KIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNI--IKLEGLITSQT-SCSLY 230 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~g--~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnI--Vkl~~~~~~~~-~~~l~ 230 (714)
.+..|+.|.+..+|+......+ ..+++|+...... ......+.+|+.+|+.|. |.+| .+++.++.+.. .+..|
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 4677899999999998654332 4677887543321 112346789999999995 6664 56666654421 13478
Q ss_pred EEEeecccccccccc------------------------C-C--C-------CC--CCHHHHHHHHHH------------
Q 005111 231 LVFEYMEHDLVGLAS------------------------L-P--G-------MK--FTESQVKCYMKQ------------ 262 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~------------------------~-~--~-------~~--lse~~i~~i~~Q------------ 262 (714)
+||||++|..+.... . . . .+ +...++..|..+
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 999999986432100 0 0 0 00 111233332222
Q ss_pred ---HHHHhhHhhh-----------cCeeeccCCCccEEEcCC-C-cEEEeecCcccccC
Q 005111 263 ---LLSGLEHCHS-----------HGVLHRDIKGSNLLLDHN-G-ILKIADFGLASFFD 305 (714)
Q Consensus 263 ---Il~aL~~LH~-----------~gIiHrDLKP~NILl~~~-g-~vKL~DFGla~~~~ 305 (714)
+...+.+|.. ..+||+|+++.|||++.+ + .+-|+||+++..-+
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2223455521 359999999999999853 3 35799999998644
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.89 E-value=2.1e-05 Score=94.70 Aligned_cols=206 Identities=17% Similarity=0.149 Sum_probs=141.4
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeeeccccccCC-c-eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh
Q 005111 195 SVKFMAREIAILRKLDHPNIIKLEGLITSQTS-C-SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272 (714)
Q Consensus 195 ~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~-~-~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~ 272 (714)
......-|+..+....|+|++.++.+-..... + .+.+.-+||....+......-...+...++.+..++++||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34455567888888899999998776433222 1 133455778776666666666788999999999999999999999
Q ss_pred cCeeeccCCCc---cEEEcCCCcEEEe--ecCcccccCCCCCCCcccccccccccCcccccCCCCCCc--cccccchhHH
Q 005111 273 HGVLHRDIKGS---NLLLDHNGILKIA--DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA--AVDLWSTGCI 345 (714)
Q Consensus 273 ~gIiHrDLKP~---NILl~~~g~vKL~--DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~--~sDIWSLG~i 345 (714)
....|.-|... +..++..+.+.+. ||+.+..+..... ..+...+..|.++|.+.... +.. ..|+|++|..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLL 381 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCcccccccccccccc-chhhhhhHHHHHHHH
Confidence 96655554444 3334555666666 8988877654332 22334466778888775443 333 4699999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhcc-CCcHHHHHHHHHhcccCc
Q 005111 346 LGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFK-DFPTSALRLMETLMSIDP 424 (714)
Q Consensus 346 LyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~-~~p~~l~~LI~~mL~~DP 424 (714)
+..+..|..+-.-. ..+ ..... .......+++.+|+.-|+
T Consensus 382 ~~~~~~~~~i~~~~------~~~---------------------------------~~~l~~~~~~~~~d~~~~~~~~~~ 422 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKS------AVP---------------------------------VSLLDVLSTSELLDALPKCLDEDS 422 (1351)
T ss_pred HhhhhhcCcccccc------cch---------------------------------hhhhccccchhhhhhhhhhcchhh
Confidence 99999887432110 000 00111 122268889999999999
Q ss_pred CCCCCHHHHHcCcCCCCC
Q 005111 425 AHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 425 ~kRpTa~e~L~Hp~f~~~ 442 (714)
++|+++.++|.|+|....
T Consensus 423 ~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 423 EERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhccchhhhhhchhcccc
Confidence 999999999999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.88 E-value=4e-05 Score=75.10 Aligned_cols=130 Identities=22% Similarity=0.263 Sum_probs=90.0
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeee-eeccccccCCceEEEEEe
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK-LEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVk-l~~~~~~~~~~~l~LV~E 234 (714)
++.+.||+|++|.||++. ..|..+|+|+-+.+. ....+..|+++|..+.--++-+ +|. |. . .++.||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~-yg-~----~~i~me 92 (201)
T COG2112 25 RVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYF-YG-E----DFIRME 92 (201)
T ss_pred hhhhhhhcccccEEEEee--ccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEE-ec-h----hhhhhh
Confidence 456779999999999996 457799999876543 3566889999999997655543 332 21 1 356799
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCC-CccEEEcCCCcEEEeecCccccc
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIK-GSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLK-P~NILl~~~g~vKL~DFGla~~~ 304 (714)
|+.|-.|..+.... + +.-+..+++.---|-..||-|..|. |..++|..++.+.|+||..|++-
T Consensus 93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 99996554433211 2 3334445555455677899999986 45555556669999999999853
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0001 Score=76.02 Aligned_cols=31 Identities=26% Similarity=0.419 Sum_probs=26.4
Q ss_pred cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
.+++|+|+.|.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998776667999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00016 Score=78.06 Aligned_cols=143 Identities=22% Similarity=0.275 Sum_probs=100.9
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-----------------------CCHHHHH-HHHHHHHHHHhCCC
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-----------------------QDPESVK-FMAREIAILRKLDH 211 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-----------------------~~~~~~~-~~~rEi~iL~~L~H 211 (714)
++-..|..|--+.||.|. ..+|..+|||+++... .....++ ....|+..|.+|..
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 444678889999999997 4678889999875321 0011111 23468888988865
Q ss_pred CCeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhh-hcCeeeccCCCccEEEcCC
Q 005111 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH-SHGVLHRDIKGSNLLLDHN 290 (714)
Q Consensus 212 pnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKP~NILl~~~ 290 (714)
-.|.--.-+.. .. -+|||+|++.+-+..-...+..++...+..+-.|++.-+.-|- ..++||.||.--|+|+ .+
T Consensus 226 aGIP~PePIlL-k~---hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 226 AGIPCPEPILL-KN---HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HD 300 (520)
T ss_pred cCCCCCCceee-ec---ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-EC
Confidence 44321111111 11 4799999997655544445667888899999999988888875 5699999999999998 56
Q ss_pred CcEEEeecCccccc
Q 005111 291 GILKIADFGLASFF 304 (714)
Q Consensus 291 g~vKL~DFGla~~~ 304 (714)
|.+.|+|-+-+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 78999999887654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00054 Score=70.27 Aligned_cols=75 Identities=15% Similarity=0.229 Sum_probs=46.9
Q ss_pred EeEEeccCceEEEEEEEcc-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCceEEEEEee
Q 005111 158 LDKIGQGTYSSVYRARDVI-HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCSLYLVFEY 235 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~-~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~l~LV~Ey 235 (714)
++.|..|-...||++.... .++.|++|+...... ..-...+|+.++..+....+ .+++... . . .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~-~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF--Q-N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe--C-C---cEEEEe
Confidence 4678888889999986432 357899997653311 11123478888888853333 3444322 1 1 379999
Q ss_pred cccccc
Q 005111 236 MEHDLV 241 (714)
Q Consensus 236 ~~g~ll 241 (714)
++|..+
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998544
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00058 Score=68.97 Aligned_cols=132 Identities=21% Similarity=0.256 Sum_probs=90.3
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCC--------------CCHHHHHHHHHHHHHHHhCC------CCCeeeee
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--------------QDPESVKFMAREIAILRKLD------HPNIIKLE 218 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~--------------~~~~~~~~~~rEi~iL~~L~------HpnIVkl~ 218 (714)
..||+|+.=.||.- ..+....||+++... ......+...+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999975 455668899987654 11122455666776666655 88899999
Q ss_pred ccccccCCceEEEEEeecccc------ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-
Q 005111 219 GLITSQTSCSLYLVFEYMEHD------LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG- 291 (714)
Q Consensus 219 ~~~~~~~~~~l~LV~Ey~~g~------ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g- 291 (714)
|++..... +-+|+|.+... +|..+... ..+++ .+...+-.-..||-+++|+.+||+|.||++....
T Consensus 84 G~veT~~G--~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLG--LGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCc--eEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 98876555 88999988642 33344432 23554 3333444556788899999999999999996432
Q ss_pred ---cEEEee-cCc
Q 005111 292 ---ILKIAD-FGL 300 (714)
Q Consensus 292 ---~vKL~D-FGl 300 (714)
.+.|+| ||-
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 578887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00052 Score=68.71 Aligned_cols=99 Identities=22% Similarity=0.126 Sum_probs=78.7
Q ss_pred HHHHHHHhCCC-CCeeeeeccccccCCceEEEEEeecccccccc---ccCCCCCCCHHHHHHHHHHHHHHhhHhhh---c
Q 005111 201 REIAILRKLDH-PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGL---ASLPGMKFTESQVKCYMKQLLSGLEHCHS---H 273 (714)
Q Consensus 201 rEi~iL~~L~H-pnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~---~~~~~~~lse~~i~~i~~QIl~aL~~LH~---~ 273 (714)
.|.-+|+.+.+ +++.+++|+|. -++|.||...+.+.. .+..-...++.....|+.+++..+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58888898865 69999999873 367899999653321 01111245899999999999999999987 4
Q ss_pred CeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 274 gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
.+.-.|++|+|+-|+++|.+|++|...+...+
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 58889999999999999999999999886553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00088 Score=69.94 Aligned_cols=132 Identities=22% Similarity=0.263 Sum_probs=75.7
Q ss_pred EeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCceEEEEEeecccc
Q 005111 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCSLYLVFEYMEHD 239 (714)
Q Consensus 161 LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~l~LV~Ey~~g~ 239 (714)
+..|-.+.+|+.. .++..+++|+........ .. ...+|..+|+.+....+ .+++.+. . -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GV-DRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cC-cHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCc
Confidence 5567788999886 457788888754321110 01 24678899988854333 2233322 1 26899999986
Q ss_pred cccccc------------------C---CCCCCCH-HHHHHHHHHH---------HHHhhHhhh--------cCeeeccC
Q 005111 240 LVGLAS------------------L---PGMKFTE-SQVKCYMKQL---------LSGLEHCHS--------HGVLHRDI 280 (714)
Q Consensus 240 ll~~~~------------------~---~~~~lse-~~i~~i~~QI---------l~aL~~LH~--------~gIiHrDL 280 (714)
.+.... . ...+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 543210 0 0111221 1122222122 111111211 25899999
Q ss_pred CCccEEEcCCCcEEEeecCcccc
Q 005111 281 KGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 281 KP~NILl~~~g~vKL~DFGla~~ 303 (714)
.|.|||++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999887 78999998865
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.32 E-value=8.7e-06 Score=99.36 Aligned_cols=263 Identities=14% Similarity=-0.000 Sum_probs=165.8
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEee---cCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR---FDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ 224 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~---~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~ 224 (714)
++.+...|++.=-+|-|.++.--.-+.+..+ +.+|+.+ +....+...+.+..|..-++...|++++..+.-....
T Consensus 1224 M~s~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps 1301 (2724)
T KOG1826|consen 1224 MFSAMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPS 1301 (2724)
T ss_pred HHHHhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCC
Confidence 3455677777766666655432211111111 2334332 2223333344455566666777899988776655554
Q ss_pred CCceEEEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhcC-----eeeccCCCccEEEcCCCcEEE
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSHG-----VLHRDIKGSNLLLDHNGILKI 295 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~g-----IiHrDLKP~NILl~~~g~vKL 295 (714)
.....|++++|+.++.+..++.. ..++.+.-+....++.+.+..-+|... .+|++||+-|.+|..+..+|+
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~ 1381 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKL 1381 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccc
Confidence 44557899999998766654432 234556666666676677888877542 799999999999999999999
Q ss_pred eecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCC
Q 005111 296 ADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375 (714)
Q Consensus 296 ~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p 375 (714)
+++|+.+...+ ........++++.|+.|++...-. ++.++|+|..||.+|++..|.++|- ..+..+.+.. .
T Consensus 1382 gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~rs~~n~~fi-----~flq~~Lkgi--i 1452 (2724)
T KOG1826|consen 1382 GKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLRSDGNAYFI-----FFLQPALKGI--I 1452 (2724)
T ss_pred cccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHHhcccHHHH-----HHHHHHHcCc--c
Confidence 99999984322 222234456788899999765444 6778999999999999999987762 2233332211 0
Q ss_pred ChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 376 SEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 376 ~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+ ... .+...-.|.++......+|-..-..||.-...+.-+.|...
T Consensus 1453 dn----------~tf-----------~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1453 DN----------HTF-----------FSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred cc----------ccc-----------ccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence 00 000 01111234455555556666667789999999988887643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0034 Score=67.37 Aligned_cols=79 Identities=14% Similarity=0.129 Sum_probs=52.1
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC---CCeeeeecccccc-CCceEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH---PNIIKLEGLITSQ-TSCSLYL 231 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H---pnIVkl~~~~~~~-~~~~l~L 231 (714)
.-.+.||.|..+.||.... .++ .+.+|..+.. . ....+.+|...|+.|.- -.+.++++++... ..+..+|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~-~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 17 SRVECISEQPYAALWALYD-SQG-NPMPLMARSF-S---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred heeeecCCccceeEEEEEc-CCC-CEEEEEeccc-c---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3456799999999999853 223 4677774321 1 12467889999998842 3466677655432 1233799
Q ss_pred EEeeccccc
Q 005111 232 VFEYMEHDL 240 (714)
Q Consensus 232 V~Ey~~g~l 240 (714)
|||+++|..
T Consensus 91 VmE~i~G~~ 99 (297)
T PRK10593 91 LLERLRGVS 99 (297)
T ss_pred EEeccCCEe
Confidence 999999854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0016 Score=69.95 Aligned_cols=143 Identities=19% Similarity=0.152 Sum_probs=80.4
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeecccc----ccCCce
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN--IIKLEGLIT----SQTSCS 228 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IVkl~~~~~----~~~~~~ 228 (714)
...+..|+.|....+|++.. .+| .+++|+..... . ...+..|+.++..|.... +.+++.... ....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 34567788888889999863 334 57889875421 1 223456777777763222 333322110 011234
Q ss_pred EEEEEeecccccccc---------------ccC--CCCC------CCHHH-----HH----------HHHHHHHHHhhHh
Q 005111 229 LYLVFEYMEHDLVGL---------------ASL--PGMK------FTESQ-----VK----------CYMKQLLSGLEHC 270 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~---------------~~~--~~~~------lse~~-----i~----------~i~~QIl~aL~~L 270 (714)
.+++|+|++|..... +.. .+.. ..... .. .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 789999999843211 000 0000 00000 00 0011223344444
Q ss_pred h-------hcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 271 H-------SHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 271 H-------~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
. ..++||+|+.+.||+++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 3 36899999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0031 Score=67.07 Aligned_cols=140 Identities=16% Similarity=0.162 Sum_probs=80.9
Q ss_pred EEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeccccc----cCCceEE
Q 005111 157 KLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN--IIKLEGLITS----QTSCSLY 230 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IVkl~~~~~~----~~~~~l~ 230 (714)
-++.|..|....+|+... .+..+++|+... . ....+..|+.++..|.+.. +.+++..... ...+..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 356788888889999853 345788998753 1 2234667888887774322 3333321100 1112368
Q ss_pred EEEeeccccccccc---------------cC--CCCCC------CHHHHH------------HHHHHHHHHhhHhhh---
Q 005111 231 LVFEYMEHDLVGLA---------------SL--PGMKF------TESQVK------------CYMKQLLSGLEHCHS--- 272 (714)
Q Consensus 231 LV~Ey~~g~ll~~~---------------~~--~~~~l------se~~i~------------~i~~QIl~aL~~LH~--- 272 (714)
+||+|++|..+... .. ..... ...... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 99999998654320 00 00000 000000 011112233344332
Q ss_pred ----cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 ----HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 ----~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999988789999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0043 Score=69.20 Aligned_cols=77 Identities=19% Similarity=0.154 Sum_probs=52.4
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCC----CC-HHHHHHHHHHHHHHHhCC---CCCeeeeeccccccCCceE
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN----QD-PESVKFMAREIAILRKLD---HPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~----~~-~~~~~~~~rEi~iL~~L~---HpnIVkl~~~~~~~~~~~l 229 (714)
.+.||.|.+..||++.+...++.|+||.-.... .. +-..++...|.+.|..+. -.++.+++.+-. .. .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~--~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--EL--A 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CC--C
Confidence 467999999999999875444689999853211 10 224566778888888863 245666666522 22 5
Q ss_pred EEEEeeccc
Q 005111 230 YLVFEYMEH 238 (714)
Q Consensus 230 ~LV~Ey~~g 238 (714)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999986
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0004 Score=74.01 Aligned_cols=139 Identities=18% Similarity=0.219 Sum_probs=94.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC---------------HHH-----HHHHHHHHHHHHhCC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD---------------PES-----VKFMAREIAILRKLD 210 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~---------------~~~-----~~~~~rEi~iL~~L~ 210 (714)
+..-|.+.++||-|.-+.||.+-+ ..|.+.++|+-+..... ... .-...+|...|+.|.
T Consensus 90 R~~v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~ 168 (465)
T KOG2268|consen 90 RGSVESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALY 168 (465)
T ss_pred cchhhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHH
Confidence 445678899999999999999975 56888999964432110 000 112346888888873
Q ss_pred -CCC-eeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc
Q 005111 211 -HPN-IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD 288 (714)
Q Consensus 211 -Hpn-IVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~ 288 (714)
|-. +.+.+++ +..++|||++.|-.+..... ...+..+...|+.-+--|-.+|+||+|..-=||+|.
T Consensus 169 e~gfpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 169 ERGFPVPKPIDH------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred HcCCCCCCcccc------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 322 2223332 23689999999865543331 112334455556666678899999999999999999
Q ss_pred CCCcEEEeecCccc
Q 005111 289 HNGILKIADFGLAS 302 (714)
Q Consensus 289 ~~g~vKL~DFGla~ 302 (714)
+++.++++||--..
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999996543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0019 Score=68.96 Aligned_cols=75 Identities=21% Similarity=0.269 Sum_probs=46.7
Q ss_pred EeEEeccCceEEEEEEEcc------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCceEE
Q 005111 158 LDKIGQGTYSSVYRARDVI------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCSLY 230 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~l~ 230 (714)
++.|..|-...||++.... +++.|++|+..... .......+|+.++..+....+ .+++.++. + .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP--N----G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC--C----C
Confidence 4567777778999987432 25789999865432 122345678888888853333 34444432 2 2
Q ss_pred EEEeecccccc
Q 005111 231 LVFEYMEHDLV 241 (714)
Q Consensus 231 LV~Ey~~g~ll 241 (714)
+|+||++|..+
T Consensus 74 ~v~e~i~G~~l 84 (302)
T cd05156 74 RIEEFIPSRTL 84 (302)
T ss_pred chhheeCCCcC
Confidence 68999988543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0054 Score=66.09 Aligned_cols=31 Identities=29% Similarity=0.490 Sum_probs=26.8
Q ss_pred cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999999766668999998853
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0087 Score=64.68 Aligned_cols=148 Identities=20% Similarity=0.229 Sum_probs=85.0
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeccccccCCceEEEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH--PNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.+++.+-.|....+|...+ +++.+++. ...............+|+.+++.+.- --+...++++........|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 4455554444445566543 37888888 33223445567778899999998842 1223345555444323479999
Q ss_pred eeccccccccccCCC--------------------------------CCCCHHHHHHHHHHH--------------HHHh
Q 005111 234 EYMEHDLVGLASLPG--------------------------------MKFTESQVKCYMKQL--------------LSGL 267 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~--------------------------------~~lse~~i~~i~~QI--------------l~aL 267 (714)
+|++|.......... ..+...++..+..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999994322111100 001111122222221 1122
Q ss_pred hHhhh--------cCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 268 EHCHS--------HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 268 ~~LH~--------~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+|+. ..++|+|+.+.||+|+..+-+-|+||+++..-++
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 23322 2489999999999999998899999999986543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0061 Score=64.78 Aligned_cols=31 Identities=19% Similarity=0.322 Sum_probs=26.1
Q ss_pred CeeeccCCCccEEEcCCCc-EEEeecCccccc
Q 005111 274 GVLHRDIKGSNLLLDHNGI-LKIADFGLASFF 304 (714)
Q Consensus 274 gIiHrDLKP~NILl~~~g~-vKL~DFGla~~~ 304 (714)
.++|+|+.|.|||++.++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 569999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0024 Score=71.71 Aligned_cols=173 Identities=24% Similarity=0.294 Sum_probs=113.1
Q ss_pred HHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeee
Q 005111 198 FMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277 (714)
Q Consensus 198 ~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiH 277 (714)
.+.--..+++.+.|+|+..++++-.... ....+|||+++..+.+...... +-... + + .+|+.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~~~Sled~~~~~~--l~~~s-------~---~----~~~~~~ 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHYTMSLEDILKTGN--LKDES-------L---L----AHGVLH 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhhccchHHHHHhcc--cchhh-------h---c----ccccce
Confidence 3556678899999999999988765443 3488999999877665443322 11111 0 0 222222
Q ss_pred ccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCC
Q 005111 278 RDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP 357 (714)
Q Consensus 278 rDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~ 357 (714)
- | .++++| -++.. | | ...++++||||+|.|+.++.-|...++
T Consensus 91 ~-----~-------~~~~td-~~~t~-----------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 L-----N-------IIYITD-HFLTK-----------------Y--P------SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred e-----h-------hhhccc-ccccc-----------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 1 1 233333 00000 0 1 112359999999999999999999999
Q ss_pred CCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCc
Q 005111 358 GKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSE 437 (714)
Q Consensus 358 g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp 437 (714)
..+..+++..|.+..-.+..-..- .+.-......+....+++.+|+-..|..||...+++.++
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~-----------------a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLST-----------------AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHH-----------------HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 999988888887765443321100 000012235677899999999999999999999999999
Q ss_pred CCCCC
Q 005111 438 FFTTQ 442 (714)
Q Consensus 438 ~f~~~ 442 (714)
-|+..
T Consensus 196 i~~ev 200 (725)
T KOG1093|consen 196 SFTEV 200 (725)
T ss_pred cHHHH
Confidence 99753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.023 Score=61.97 Aligned_cols=142 Identities=15% Similarity=0.232 Sum_probs=79.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~ 228 (714)
+..++ +.|..|-...+|++..... +..|++|+...... ..+. -.+|+.+++.+..-++ .++++++. ..
T Consensus 15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~Id-R~~E~~il~~l~~~gl~P~~l~~~~--~G-- 86 (330)
T PLN02421 15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVID-RERELQAIKYLSAAGFGAKLLGVFG--NG-- 86 (330)
T ss_pred CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEec-hHHHHHHHHHHHhcCCCCceeEEeC--Cc--
Confidence 34444 4455588888999864332 34788998754321 1111 2478888888854444 34554442 22
Q ss_pred EEEEEeeccccccccc------------------cCCC----CCC-CHHHHHHHHHHHH---------------------
Q 005111 229 LYLVFEYMEHDLVGLA------------------SLPG----MKF-TESQVKCYMKQLL--------------------- 264 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~------------------~~~~----~~l-se~~i~~i~~QIl--------------------- 264 (714)
+|.+|++|..+... .... ..+ ....+..+..++.
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 58999987654210 0000 001 1223333332221
Q ss_pred -HHhhH----hhhc----CeeeccCCCccEEEcC-CCcEEEeecCccccc
Q 005111 265 -SGLEH----CHSH----GVLHRDIKGSNLLLDH-NGILKIADFGLASFF 304 (714)
Q Consensus 265 -~aL~~----LH~~----gIiHrDLKP~NILl~~-~g~vKL~DFGla~~~ 304 (714)
.-+.. +... -++|.||.+.|||+++ ++.++|+||..|..-
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11111 1111 2799999999999975 578999999998653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.013 Score=64.22 Aligned_cols=75 Identities=17% Similarity=0.210 Sum_probs=48.0
Q ss_pred EEeccCceEEEEEEEccCCeEEEEEEeecC-----CCCHHHHHHHHHHHHHHHhCC--CC-CeeeeeccccccCCceEEE
Q 005111 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFD-----NQDPESVKFMAREIAILRKLD--HP-NIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-----~~~~~~~~~~~rEi~iL~~L~--Hp-nIVkl~~~~~~~~~~~l~L 231 (714)
.||.|....||++.+...++.|+||.-... ..-+-...+..-|...|+... .| .+.++|.+ .. .. ..+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~-e~--~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DT-EM--AVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-cc-cc--cee
Confidence 479999999999997543468999964211 111334556667888887763 34 34445543 22 22 569
Q ss_pred EEeeccc
Q 005111 232 VFEYMEH 238 (714)
Q Consensus 232 V~Ey~~g 238 (714)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.031 Score=61.30 Aligned_cols=141 Identities=15% Similarity=0.177 Sum_probs=81.7
Q ss_pred eeEEeEEeccCceEEEEEEEcc----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCceE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVI----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCSL 229 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~l 229 (714)
..-+..|-.|-...+|++.... .++.|++|+..... ...+.+ .+|+.+++.+..-++ .++++.+. .
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~--~---- 108 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDR-DDEIRTFECMSRHGQGPRLLGRFP--N---- 108 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeech-HHHHHHHHHHHHcCCCCceEEEEC--C----
Confidence 3445566668888999986432 24689999875432 122222 578888888854333 24445432 2
Q ss_pred EEEEeeccccccccc------------------cC---CCC--CCCHHHHHHHHHHHH-----------------HHhhH
Q 005111 230 YLVFEYMEHDLVGLA------------------SL---PGM--KFTESQVKCYMKQLL-----------------SGLEH 269 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~------------------~~---~~~--~lse~~i~~i~~QIl-----------------~aL~~ 269 (714)
..|.+|+++..+... .. ... ......+..++.++. ..+..
T Consensus 109 g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 109 GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 157999987554311 00 000 111233334432221 11111
Q ss_pred --------hhhcCeeeccCCCccEEEcC-CCcEEEeecCccccc
Q 005111 270 --------CHSHGVLHRDIKGSNLLLDH-NGILKIADFGLASFF 304 (714)
Q Consensus 270 --------LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla~~~ 304 (714)
.+...++|+|+++.|||+++ ++.+.|+||..|..-
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 12336899999999999986 478999999988753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.018 Score=64.05 Aligned_cols=77 Identities=22% Similarity=0.242 Sum_probs=50.3
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEe----ecCCCCHHHHHHHHHHHHHHHhCC--CC-CeeeeeccccccCCceEE
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKV----RFDNQDPESVKFMAREIAILRKLD--HP-NIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i----~~~~~~~~~~~~~~rEi~iL~~L~--Hp-nIVkl~~~~~~~~~~~l~ 230 (714)
++.||.|.-..||++.+...++.|+||.- +....-+-...+..-|..+|+.+. .| .+.+++.+ ... . ..
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e-~--~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSV-M--NC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcH-H--hh
Confidence 67799999999999987433567999863 221111334566777888888763 34 34455543 222 2 56
Q ss_pred EEEeeccc
Q 005111 231 LVFEYMEH 238 (714)
Q Consensus 231 LV~Ey~~g 238 (714)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.078 Score=59.28 Aligned_cols=76 Identities=16% Similarity=0.197 Sum_probs=50.3
Q ss_pred EEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC--C---HHHHHHHHHHHHHHHhCC---CCCeeeeeccccccCCce
Q 005111 157 KLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--D---PESVKFMAREIAILRKLD---HPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--~---~~~~~~~~rEi~iL~~L~---HpnIVkl~~~~~~~~~~~ 228 (714)
..+.||.|....||+..+ .+..|+||.-..... . +-...+...|+..|+.+. ..++.+++.+..+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~-- 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--M-- 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--C--
Confidence 467799999999999876 345689997542211 1 113445556777777663 2466777776542 2
Q ss_pred EEEEEeeccc
Q 005111 229 LYLVFEYMEH 238 (714)
Q Consensus 229 l~LV~Ey~~g 238 (714)
-+++|||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5789999977
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.032 Score=56.48 Aligned_cols=31 Identities=29% Similarity=0.591 Sum_probs=22.1
Q ss_pred cCeeeccCCCccEEE-cCCCcEEEeecCcccc
Q 005111 273 HGVLHRDIKGSNLLL-DHNGILKIADFGLASF 303 (714)
Q Consensus 273 ~gIiHrDLKP~NILl-~~~g~vKL~DFGla~~ 303 (714)
.-++|.||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.074 Score=59.23 Aligned_cols=78 Identities=22% Similarity=0.261 Sum_probs=44.6
Q ss_pred eEEeEEeccCceEEEEEEEccC-CeE-----EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCce
Q 005111 156 EKLDKIGQGTYSSVYRARDVIH-DKI-----VALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCS 228 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~-g~~-----VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~ 228 (714)
..++.|..|-...+|++..... +.. |.+++... .....+ .-.+|+.+++.|...++ .++++.+.
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~------ 123 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--YNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFG------ 123 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC--CCceEe-ccHHHHHHHHHHHhCCCCCeEEEecC------
Confidence 3445666688889999964332 122 34333211 111111 12468999999965444 44555542
Q ss_pred EEEEEeeccccccc
Q 005111 229 LYLVFEYMEHDLVG 242 (714)
Q Consensus 229 l~LV~Ey~~g~ll~ 242 (714)
-++|.||++|..+.
T Consensus 124 ~g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 DFTIQEWVEGNTMG 137 (383)
T ss_pred CEEEEEEeccccCC
Confidence 25999999986553
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.18 Score=57.23 Aligned_cols=94 Identities=13% Similarity=0.149 Sum_probs=55.4
Q ss_pred hhhhhhhcccccCCCCCeeEEeEEeccCceEEEEEEEcc--------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC
Q 005111 138 TVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI--------HDKIVALKKVRFDNQDPESVKFMAREIAILRKL 209 (714)
Q Consensus 138 ~~~g~~~~~~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~--------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L 209 (714)
..+.+.+.+|.....++. -++.|..|-.-.+|++.... .++.|.+++.-.... ... .-.+|..+++.+
T Consensus 91 ~i~~~~vp~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~lI-dR~~E~~v~~~l 166 (442)
T PTZ00296 91 KICLEKVPEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--ELY-NPISEFEVYKTM 166 (442)
T ss_pred HHHHHHCCccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--cee-CHHHHHHHHHHH
Confidence 444444556653333455 67778778888999987442 256788888754321 111 234677887777
Q ss_pred CCCCee-eeeccccccCCceEEEEEeecccccc
Q 005111 210 DHPNII-KLEGLITSQTSCSLYLVFEYMEHDLV 241 (714)
Q Consensus 210 ~HpnIV-kl~~~~~~~~~~~l~LV~Ey~~g~ll 241 (714)
..-+|- ++++.+. + +.|.||++|..+
T Consensus 167 s~~gi~P~l~~~f~--g----g~I~efi~g~~l 193 (442)
T PTZ00296 167 SKYRIAPQLLNTFS--G----GRIEEWLYGDPL 193 (442)
T ss_pred HHCCCCCceEEEeC--C----CEEEEeeCCccC
Confidence 543443 3455432 1 467899998633
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.084 Score=57.60 Aligned_cols=72 Identities=21% Similarity=0.289 Sum_probs=56.8
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
..++|++|++-.+.+.- +. .-..+++..|+.+.+..++-+... ..-|||+.-.||||+ .|+|-|+||-+++.
T Consensus 298 ~~y~yl~~kdhgt~is~-ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPISI-IK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceeee-ee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 44578888887665432 22 235678889999888877777654 689999999999999 99999999999984
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.17 Score=54.36 Aligned_cols=30 Identities=27% Similarity=0.284 Sum_probs=28.1
Q ss_pred CeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 274 GVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 274 gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
++||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.17 Score=54.11 Aligned_cols=75 Identities=15% Similarity=0.204 Sum_probs=44.7
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeccccccCCceEEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD---HPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+..+.|+.|....+|+.. .+++.+.||+-.. .....+..|..-|+.|. --.+.+++.+....+. -|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLl 90 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLL 90 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEE
Confidence 456789999999999986 7788899998652 22345678888888883 3334556665444443 4899
Q ss_pred Eeecccc
Q 005111 233 FEYMEHD 239 (714)
Q Consensus 233 ~Ey~~g~ 239 (714)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999865
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.6 Score=50.96 Aligned_cols=136 Identities=21% Similarity=0.262 Sum_probs=75.5
Q ss_pred EEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeee---eeccccccCC--ceEEE
Q 005111 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD---HPNIIK---LEGLITSQTS--CSLYL 231 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIVk---l~~~~~~~~~--~~l~L 231 (714)
.|.+ .-..||+... ..|+ +++|+.+.. .. ...+.-|+..|..|. .+-.++ +-|-....-. ...+-
T Consensus 33 ~l~s-~eN~~f~~~~-~~g~-~iLki~~~~-~~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDGR-YILKIYRPG-WT---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred cccc-ccCceEEEEe-cCCC-eEEEEecCC-CC---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 3444 5567999863 3444 499988765 22 334556777777662 222222 2221111111 35788
Q ss_pred EEeecccccccc-ccC-----------------CCCC---------CCHH----H---------HHHHHHHHHHHhhHhh
Q 005111 232 VFEYMEHDLVGL-ASL-----------------PGMK---------FTES----Q---------VKCYMKQLLSGLEHCH 271 (714)
Q Consensus 232 V~Ey~~g~ll~~-~~~-----------------~~~~---------lse~----~---------i~~i~~QIl~aL~~LH 271 (714)
|++|++|..+.. ... .+.+ ..+. . -.....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999976652 100 0000 1111 0 0012223333444443
Q ss_pred h--------cC--eeeccCCCccEEEcCCCc-EEEeecCccc
Q 005111 272 S--------HG--VLHRDIKGSNLLLDHNGI-LKIADFGLAS 302 (714)
Q Consensus 272 ~--------~g--IiHrDLKP~NILl~~~g~-vKL~DFGla~ 302 (714)
+ .+ +||+|+.|.|||++.+.. +.++|||-+.
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 2 23 999999999999998874 8999999875
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.48 Score=59.41 Aligned_cols=31 Identities=32% Similarity=0.542 Sum_probs=26.5
Q ss_pred cCeeeccCCCccEEEcCCC--cEE-EeecCcccc
Q 005111 273 HGVLHRDIKGSNLLLDHNG--ILK-IADFGLASF 303 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g--~vK-L~DFGla~~ 303 (714)
.++||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 554 999998864
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.057 Score=57.93 Aligned_cols=134 Identities=20% Similarity=0.261 Sum_probs=92.6
Q ss_pred eEEeccCceEEEEEEE-------cc---CCeEEEEEEeecC-----C-----------------CCHHHHHH--HHHHHH
Q 005111 159 DKIGQGTYSSVYRARD-------VI---HDKIVALKKVRFD-----N-----------------QDPESVKF--MAREIA 204 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d-------~~---~g~~VAiK~i~~~-----~-----------------~~~~~~~~--~~rEi~ 204 (714)
..|..|.-+.|+.|.- .. .-..+|||+++.. + ..+..+-. ..+|+.
T Consensus 258 GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkEmh 337 (531)
T KOG2269|consen 258 GIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKEMH 337 (531)
T ss_pred hhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHHHH
Confidence 4578888888888832 11 2345899987521 0 01111111 235677
Q ss_pred HHHhC-----CCCCeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHh-hhcCeeec
Q 005111 205 ILRKL-----DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC-HSHGVLHR 278 (714)
Q Consensus 205 iL~~L-----~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~L-H~~gIiHr 278 (714)
.|.++ .+|-+|.+.. -+|||-|++..-+..-......|+..+.+..-.|++.++.-| |+.-+||.
T Consensus 338 NL~RMq~~GlpcP~vV~lkk---------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHA 408 (531)
T KOG2269|consen 338 NLSRMQKHGLPCPQVVKLKK---------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHA 408 (531)
T ss_pred HHHHHHhcCCCCCceeeeec---------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeec
Confidence 77766 3677776633 469999998765554444556799999999999999998887 56789999
Q ss_pred cCCCccEEEcCCCcEEEeecCccc
Q 005111 279 DIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 279 DLKP~NILl~~~g~vKL~DFGla~ 302 (714)
||.--|||...+ .+-++|..-+.
T Consensus 409 DlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 409 DLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred chhhhhheecCC-ceEEEechhcc
Confidence 999999999876 78888876553
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.2 Score=51.28 Aligned_cols=116 Identities=18% Similarity=0.208 Sum_probs=71.7
Q ss_pred cCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeecccccccc
Q 005111 164 GTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGL 243 (714)
Q Consensus 164 G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~ 243 (714)
|+-++.-.+.... | ...+|+++.-.... ....+..+..++.++. .|++|.. .....+-+++|+|-.--.
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i-- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI-- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc--
Confidence 3444444443222 3 34556655322211 2344578899998875 6788763 233447899999864111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHhhHhhh--cCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 244 ASLPGMKFTESQVKCYMKQLLSGLEHCHS--HGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 244 ~~~~~~~lse~~i~~i~~QIl~aL~~LH~--~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
.+ ..++..=+.+|.-+|+ .+.+|+|..|+|||-|..|.+||.|-+..
T Consensus 142 -------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 142 -------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred -------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 11 1122222456777883 47999999999999999999999997654
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.91 Score=49.37 Aligned_cols=28 Identities=25% Similarity=0.185 Sum_probs=24.0
Q ss_pred cCeeeccCCCccEEEcCCCcEEEeecCccc
Q 005111 273 HGVLHRDIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g~vKL~DFGla~ 302 (714)
.++||+|+.+.|||++ + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4799999999999995 4 57899999875
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.48 E-value=0.21 Score=53.27 Aligned_cols=30 Identities=27% Similarity=0.475 Sum_probs=26.3
Q ss_pred cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
.+++|+|+.+.|||++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57999999999999987 6789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 714 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-58 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-58 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-58 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-58 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-57 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-57 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-56 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-56 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-56 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-56 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-56 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-56 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-56 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-56 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-56 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-56 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-56 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-56 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-56 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-56 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-56 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-56 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-56 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-56 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-56 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-56 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-56 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-56 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-56 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-56 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-56 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-56 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-56 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-56 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-56 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-56 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-56 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-56 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-56 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-56 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-56 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-56 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-52 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-52 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-51 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-51 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-51 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-51 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-46 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-46 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-45 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-45 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-45 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-44 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-44 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-44 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-44 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-42 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-42 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-41 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-41 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-40 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-40 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-40 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-39 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-39 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-39 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-39 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-39 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-39 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-39 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-39 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-39 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-39 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-39 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-39 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-39 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-39 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-39 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-39 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-39 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-39 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-39 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-38 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-38 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-38 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-38 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-38 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-38 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-38 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-38 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-38 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-38 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-38 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-38 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-38 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-38 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-38 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-38 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-38 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-38 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-38 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-38 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-38 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-38 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-38 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-38 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-38 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-38 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-38 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-38 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-38 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-38 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-38 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-38 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-38 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-38 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-38 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-38 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-38 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-38 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-38 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-38 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-38 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-38 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-38 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-38 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-38 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-38 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-38 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-38 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-38 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-38 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-38 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-38 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-38 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-38 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-38 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-38 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-38 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-38 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-38 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-38 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-38 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-38 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-38 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-38 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-38 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-38 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-38 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-38 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-37 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-37 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-37 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-37 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-37 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-37 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-37 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-37 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-37 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-37 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-37 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-37 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-37 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-36 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-36 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-36 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-36 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-36 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-36 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-36 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-36 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-36 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-36 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-36 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-36 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-36 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-36 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-36 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-36 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-36 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-35 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-35 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-35 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-35 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-35 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-35 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-34 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-34 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-34 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-34 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-34 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-34 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-34 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-34 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-34 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-33 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-33 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-33 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-33 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-33 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-33 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-33 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-31 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-31 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-29 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-27 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-27 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-26 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-26 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-26 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-26 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-26 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-26 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-25 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-25 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-25 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-25 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-25 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-25 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-25 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-25 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-25 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-25 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-25 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-24 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-24 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-24 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-24 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-24 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-24 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 9e-24 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-24 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-23 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-22 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-22 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-22 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-22 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-22 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-22 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-21 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-21 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-21 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-21 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-21 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-21 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-21 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-21 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-21 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-21 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-21 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-21 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-21 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-21 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-21 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-21 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-21 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-21 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-21 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-21 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-21 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-20 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-20 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-19 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-19 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-18 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-18 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-18 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-18 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-18 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-18 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-18 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-18 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-18 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-18 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-18 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-17 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-17 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-17 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-17 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-17 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-17 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 9e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-17 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-16 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-16 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-16 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-16 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-16 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-16 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-15 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-15 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-15 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-12 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-12 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 9e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-11 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-11 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-11 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-11 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-06 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 506 bits (1306), Expect = e-176
Identities = 126/344 (36%), Positives = 192/344 (55%), Gaps = 14/344 (4%)
Query: 142 EAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA- 200
++++ + +EKL KIGQGT+ V++AR + VALKKV +N + E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 201 REIAILRKLDHPNIIKLEGLITSQTS------CSLYLVFEYMEHDLVGLASLPGMKFTES 254
REI IL+ L H N++ L + ++ S S+YLVF++ EHDL GL S +KFT S
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 255 QVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP---KDSVP 311
++K M+ LL+GL + H + +LHRD+K +N+L+ +G+LK+ADFGLA F
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL 371
T+RVVTLWYRPPELLLG YG +DLW GCI+ E+++ P++ G TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 372 CGSPSEDYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTS--ALRLMETLMSIDPAHRG 428
CGS + + W + V+ +R++ + K + AL L++ L+ +DPA R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 429 TATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRH 472
+ ALN +FF + P+ + + + + H
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHHH 348
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 460 bits (1185), Expect = e-158
Identities = 129/344 (37%), Positives = 189/344 (54%), Gaps = 11/344 (3%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD--PESVKFMA-REIA 204
+ RA +EKLD +G+G +++VY+ARD ++IVA+KK++ ++ + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLL 264
+L++L HPNII L +++ + LVF++ME DL + + T S +K YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVVTLWYRP 323
GLE+ H H +LHRD+K +NLLLD NG+LK+ADFGLA SF P T +VVT WYR
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRA 180
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK- 382
PELL GA YG VD+W+ GCIL EL P LPG ++++QL RIF+ G+P+E+ W
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442
L FK + F L L++ L +P R TAT AL ++F+ +
Sbjct: 241 CSLPDYVTFKSFPG--IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298
Query: 443 PLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHR 486
P LP+ E + + ++G L +
Sbjct: 299 PGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPK 342
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-134
Identities = 114/327 (34%), Positives = 177/327 (54%), Gaps = 16/327 (4%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDH 211
T+ KLDK+G+GTY++VY+ + + D +VALK++R +++ E A RE+++L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKH 59
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
NI+ L +I ++ S L LVFEY++ DL G VK ++ QLL GL +CH
Sbjct: 60 ANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVVTLWYRPPELLL 328
VLHRD+K NLL++ G LK+ADFGLA S+P + VVTLWYRPP++LL
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAK----SIPTKTYDNEVVTLWYRPPDILL 173
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRH 387
G++ Y +D+W GCI E+ +G+P+ PG T EQLH IF++ G+P+E+ W
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 233
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACN 447
+ + + + L+ L+ + +R +A A+ FF + +
Sbjct: 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293
Query: 448 PSNLPKYPPSKEID-AKLRDEESRRHG 473
LP + +L+ E S R
Sbjct: 294 K--LPDTTSIFALKEIQLQKEASLRSA 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 391 bits (1008), Expect = e-132
Identities = 102/305 (33%), Positives = 155/305 (50%), Gaps = 17/305 (5%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKF---MAREIAIL 206
+ +E + +IG G Y +VY+ARD VALK VR N RE+A+L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 207 RKL---DHPNIIKLEGLITSQTS---CSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCY 259
R+L +HPN+++L + + + + LVFE+++ DL L P +K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 260 MKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL 319
M+Q L GL+ H++ ++HRD+K N+L+ G +K+ADFGLA + + +T VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALTPVVVTL 183
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY 379
WYR PE+LL S Y VD+WS GCI E+F KP+ G +E +QL +IF L G P ED
Sbjct: 184 WYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 380 WRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
W + L R + + S +L+ +++ +P R +A AL +
Sbjct: 243 WPRDVSLPR---GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 439 FTTQP 443
Sbjct: 300 LHKDE 304
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 390 bits (1005), Expect = e-131
Identities = 107/323 (33%), Positives = 172/323 (53%), Gaps = 22/323 (6%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKL 209
++ F++L+K+G GTY++VY+ + VALK+V+ D++ E A REI+++++L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL 60
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGL-----ASLPGMKFTESQVKCYMKQLL 264
H NI++L +I ++ L LVFE+M++DL + VK + QLL
Sbjct: 61 KHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVVTLWY 321
GL CH + +LHRD+K NLL++ G LK+ DFGLA F +P +S VVTLWY
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF----GIPVNTFSSEVVTLWY 174
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
R P++L+G+ Y ++D+WS GCIL E+ +GKP+ PG + EQL IF + G+P+E W
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 382 K-SKLRHSTVFKPVQPYR----RRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436
+KL +P R T + + + + L+ ++P R +A AL+
Sbjct: 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294
Query: 437 EFFTTQPLACNPSNLPKYPPSKE 459
+F + +
Sbjct: 295 PWFAEYYHHASMGGSRSHHHHHH 317
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 390 bits (1004), Expect = e-131
Identities = 116/302 (38%), Positives = 176/302 (58%), Gaps = 13/302 (4%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAI 205
+ ++KL+K+G+GTY VY+A+D +IVALK++R D +D E + A REI++
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAED-EGIPSTAIREISL 72
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLS 265
L++L HPNI+ L +I S+ L LVFE+ME DL + +SQ+K Y+ QLL
Sbjct: 73 LKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVVTLWYR 322
G+ HCH H +LHRD+K NLL++ +G LK+ADFGLA F +P T VVTLWYR
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF----GIPVRSYTHEVVTLWYR 186
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382
P++L+G+ Y +VD+WS GCI E+ +GKP+ PG T+ +QL +IF + G+P+ W +
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246
Query: 383 -SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
+L ++ + F + L+ ++ DP R +A A+N +F
Sbjct: 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
Query: 442 QP 443
Sbjct: 307 LD 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-131
Identities = 117/296 (39%), Positives = 172/296 (58%), Gaps = 14/296 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
+EKL+KIG+GTY +V++A++ +IVALK+VR D+ D E V A REI +L++L H N
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKN 62
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I++L ++ S L LVFE+ + DL VK ++ QLL GL CHS
Sbjct: 63 IVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVVTLWYRPPELLLGA 330
VLHRD+K NLL++ NG LK+A+FGLA F +P ++ VVTLWYRPP++L GA
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAF----GIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 331 SHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHS 388
Y ++D+WS GCI EL + G+P+ PG +QL RIF+L G+P+E+ W +KL
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444
+ P+ P + + L++ L+ +P R +A AL +F+
Sbjct: 237 KPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 388 bits (999), Expect = e-129
Identities = 114/396 (28%), Positives = 182/396 (45%), Gaps = 45/396 (11%)
Query: 146 GWIPRRANTFEKLD-KIGQGTYSSVYRAR--DVIHDKIVALKKVRFDNQDPESVKFMARE 202
R + FE K+G+GTY VY+A+ D DK ALK++ + RE
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----RE 68
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGL--------ASLPGMKFTES 254
IA+LR+L HPN+I L+ + S ++L+F+Y EHDL + A+ ++
Sbjct: 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 255 QVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASFF-DPKDS 309
VK + Q+L G+ + H++ VLHRD+K +N+L+ G +KIAD G A F P
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 310 VP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV------ 362
+ + VVT WYR PELLLGA HY A+D+W+ GCI EL + +P+ + E
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 363 ---EQLHRIFKLCGSPSEDYWRK-SKLRHSTVFKPV---QPY-----RRRIAETFKDFPT 410
+QL RIF + G P++ W K+ + Y + + + +
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 411 SALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLP---KYPPSKEIDAKLRDE 467
A L++ L+++DP R T+ A+ +F PL + YP + + + D+
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDD 368
Query: 468 ES---RRHGVAGGRDQKGDLHRSWRKEYLPIPAPNR 500
+ + G G H + P +
Sbjct: 369 KGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLK 404
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-129
Identities = 114/330 (34%), Positives = 174/330 (52%), Gaps = 19/330 (5%)
Query: 145 KGWIPRRANTFEKLDKIGQGTYSSVYRARDVIH-DKIVALKKVRFDNQDPESVKFMA-RE 202
K + R +E + +IG+G Y V++ARD+ + + VALK+VR + E + RE
Sbjct: 3 KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIRE 61
Query: 203 IAILRKL---DHPNIIKLEGLITSQTS---CSLYLVFEYMEHDLVG-LASLPGMKFTESQ 255
+A+LR L +HPN+++L + T + L LVFE+++ DL L +P
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315
+K M QLL GL+ HSH V+HRD+K N+L+ +G +K+ADFGLA + + +TS
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSV 179
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375
VVTLWYR PE+LL S Y VDLWS GCI E+F KP+ G ++V+QL +I + G P
Sbjct: 180 VVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 376 SEDYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLAL 434
E+ W + L + I + D L+ ++ +PA R +A AL
Sbjct: 239 GEEDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 435 NSEFFTTQPLACN--PSNLPKYPPSKEIDA 462
+ +F S+LP + E++
Sbjct: 296 SHPYFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-129
Identities = 96/312 (30%), Positives = 151/312 (48%), Gaps = 11/312 (3%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDH 211
+EK+ KIG+G+Y V++ R+ +IVA+KK D +K +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKH 61
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
PN++ L + + L+LVFEY +H ++ E VK Q L + CH
Sbjct: 62 PNLVNLLEVFRRKRR--LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
H +HRD+K N+L+ + ++K+ DFG A P D V T WYR PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGD 177
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW---RKSKLRH 387
+ YG VD+W+ GC+ EL SG P+ PGK++V+QL+ I K G + ++
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACN 447
+ + F + AL L++ + +DP R T L+ +F +
Sbjct: 238 GVKIPDPED-MEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296
Query: 448 PSNLPKYPPSKE 459
+ P
Sbjct: 297 LAKEHDKPAENL 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-128
Identities = 109/291 (37%), Positives = 164/291 (56%), Gaps = 14/291 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
+ L+KIG+GTY VY+A++ + ALKK+R + +D E + REI+IL++L H N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKED-EGIPSTTIREISILKELKHSN 61
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I+KL +I ++ L LVFE+++ DL L + K ++ QLL+G+ +CH
Sbjct: 62 IVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---MTSRVVTLWYRPPELLLGA 330
VLHRD+K NLL++ G LKIADFGLA F +P T +VTLWYR P++L+G+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF----GIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK-SKLRHST 389
Y +D+WS GCI E+ +G P+ PG +E +QL RIF++ G+P+ W ++L
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
V K S + L+ ++ +DP R TA AL +F
Sbjct: 236 PNFTVYE-PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-128
Identities = 94/315 (29%), Positives = 162/315 (51%), Gaps = 11/315 (3%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRK 208
+ +E L +G+G+Y V + R+ +IVA+KK + D + VK +A REI +L++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQ 80
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
L H N++ L + + YLVFE+++H ++ L V+ Y+ Q+++G+
Sbjct: 81 LRHENLVNLLEVCKKKKR--WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVVTLWYRPPELL 327
CHSH ++HRDIK N+L+ +G++K+ DFG A + P + V T WYR PELL
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELL 196
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW---RKSK 384
+G YG AVD+W+ GC++ E+F G+P+ PG ++++QL+ I G+ + K+
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444
+ ++ R + + + L + + IDP R L+ +FF
Sbjct: 257 VFAGVRLPEIKE-REPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGF 315
Query: 445 ACNPSNLPKYPPSKE 459
A S + K+
Sbjct: 316 AERFSQELQLKVQKD 330
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 378 bits (974), Expect = e-127
Identities = 103/308 (33%), Positives = 165/308 (53%), Gaps = 18/308 (5%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAI 205
+ + ++ K+G+GTY VY+A D + ++ VA+K++R ++++ E V A RE+++
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSL 86
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLS 265
L++L H NII+L+ +I L+L+FEY E+DL + +K ++ QL++
Sbjct: 87 LKELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLIN 143
Query: 266 GLEHCHSHGVLHRDIKGSNLLLD-----HNGILKIADFGLASFFDPKDSVP---MTSRVV 317
G+ CHS LHRD+K NLLL +LKI DFGLA F +P T ++
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF----GIPIRQFTHEII 199
Query: 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377
TLWYRPPE+LLG+ HY +VD+WS CI E+ P+ PG +E++QL +IF++ G P +
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259
Query: 378 DYWRK-SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436
W + L P + L L+ ++ +DP R +A AL
Sbjct: 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 437 EFFTTQPL 444
+F+
Sbjct: 320 PYFSHNDF 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-103
Identities = 113/394 (28%), Positives = 171/394 (43%), Gaps = 35/394 (8%)
Query: 118 RLPKGVEGEQVAAGWP-TWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVI 176
+ P +V+ + + TV +G + ++ IG G++ VY+A+
Sbjct: 18 QQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD 77
Query: 177 HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----CSLYLV 232
++VA+KKV D +F RE+ I+RKLDH NI++L S L LV
Sbjct: 78 SGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 233 FEYMEHDLVGLA---SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH 289
+Y+ + +A S VK YM QL L + HS G+ HRDIK NLLLD
Sbjct: 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP 191
Query: 290 N-GILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGE 348
+ +LK+ DFG A + P S + + +YR PEL+ GA+ Y +++D+WS GC+L E
Sbjct: 192 DTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 349 LFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETF-KD 407
L G+P+ PG + V+QL I K+ G+P+ + R+ + T FK Q + F
Sbjct: 250 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFKFPQIKAHPWTKVFRPR 308
Query: 408 FPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL---ACNPSNLPKYPP-------- 456
P A+ L L+ P R T A FF L N P
Sbjct: 309 TPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRDPNVKLPNGRDTPALFNFTTQE 366
Query: 457 ---SKEIDAKLRDEESRRHGVAGGRDQKGDLHRS 487
+ + L +R A +
Sbjct: 367 LSSNPPLATILIPPHARIQAAASTPTNATAASDA 400
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = 4e-97
Identities = 104/354 (29%), Positives = 168/354 (47%), Gaps = 35/354 (9%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL 209
+R + IG G++ V++A+ V VA+KKV D +F RE+ I+R +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLV-ESDEVAIKKVLQDK------RFKNRELQIMRIV 89
Query: 210 DHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLA---SLPGMKFTESQVKCYMKQ 262
HPN++ L+ S L LV EY+ + + + +K YM Q
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDSVPMTSRVVTLWY 321
LL L + HS G+ HRDIK NLLLD +G+LK+ DFG A + P S + + +Y
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRYY 207
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
R PEL+ GA++Y +D+WSTGC++ EL G+P+ PG++ ++QL I K+ G+PS + +
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267
Query: 382 KSKLRHSTVFKPVQPYRRRIAETF-KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
+ + K Q ++ F P A+ L+ L+ P+ R TA AL FF
Sbjct: 268 -TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF- 325
Query: 441 TQPLACNPSNLPKYPP--------------SKEIDAKLRDEESRRHGVAGGRDQ 480
L + +P ++ ++L + + ++ G D
Sbjct: 326 -DELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRGIDV 378
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 4e-91
Identities = 92/320 (28%), Positives = 141/320 (44%), Gaps = 25/320 (7%)
Query: 137 ATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESV 196
+ A A + + F+ GQGT+ +V ++ VA+KKV QDP
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDP--- 60
Query: 197 KFMAREIAILRKL---DHPNIIKLEGLITSQTSCS-----LYLVFEYMEHDLVGLA---S 245
+F RE+ I++ L HPNI++L+ + L +V EY+ L
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYY 120
Query: 246 LPGMKFTESQVKCYMKQLLSGLE--HCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLAS 302
+ +K ++ QL+ + H S V HRDIK N+L++ +G LK+ DFG A
Sbjct: 121 RRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 303 FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV 362
P + P + + + +YR PEL+ G HY AVD+WS GCI E+ G+P+ G
Sbjct: 181 KLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 363 EQLHRIFKLCGSPSEDYWRK---SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETL 419
QLH I ++ G PS + RK S P+ ++ A L+ L
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 420 MSIDPAHRGTATLALNSEFF 439
+ P R AL +F
Sbjct: 299 LQYLPEERMKPYEALCHPYF 318
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 4e-89
Identities = 89/297 (29%), Positives = 147/297 (49%), Gaps = 23/297 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPN 213
++ + K+G+G YS V+ A ++ +++ V +K ++ P K + REI IL L PN
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPN 92
Query: 214 IIKLEGLITSQTSCSLYLVFEY-MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
II L ++ S + LVFE+ D L T+ ++ YM ++L L++CHS
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS 148
Query: 273 HGVLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
G++HRD+K N+++DH + L++ D+GLA F+ P RV + +++ PELL+
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQ 206
Query: 332 HYGAAVDLWSTGCILGELFSGK-PVLPGKTEVEQLHRIFKLCGSPS-EDYWRKSKLRHST 389
Y ++D+WS GC+L + K P G +QL RI K+ G+ DY K +
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 390 VFKPVQPYRRRI-------AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
F + R +E AL ++ L+ D R TA A+ +F
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 280 bits (717), Expect = 6e-88
Identities = 93/361 (25%), Positives = 153/361 (42%), Gaps = 57/361 (15%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
+ + +G G++ V D+ K ALKKV QDP ++ RE+ I++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL---QDP---RYKNRELDIMKV 56
Query: 209 LDHPNIIKLEGLITSQTSCS------------------------------------LYLV 232
LDH NIIKL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 233 FEYMEHDL---VGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD- 288
EY+ L + G + + Y+ QL + HS G+ HRDIK NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 289 HNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGE 348
+ LK+ DFG A P + P + + + +YR PEL+LGA+ Y ++DLWS GC+ GE
Sbjct: 177 KDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 349 LFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK---SKLRHSTVFKPVQPYRRRIAETF 405
L GKP+ G+T ++QL RI ++ G+P+++ + + +R+ +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP--- 291
Query: 406 KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLR 465
+ P+ A+ L+E ++ +P R A+ FF L N S +
Sbjct: 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF--DHLR-NSYESEVKNNSNFPHGVNQ 348
Query: 466 D 466
+
Sbjct: 349 N 349
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 7e-84
Identities = 101/309 (32%), Positives = 157/309 (50%), Gaps = 25/309 (8%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+ R + L +G G V+ A D DK VA+KK+ + P+SVK REI I+R
Sbjct: 9 LGSR---YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIR 63
Query: 208 KLDHPNIIKLEGLITSQTSCS------------LYLVFEYMEHDLVGLASLPGMKFTESQ 255
+LDH NI+K+ ++ S +Y+V EYME DL + L E
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV--LEQGPLLEEH 121
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDS--VPM 312
+ +M QLL GL++ HS VLHRD+K +NL ++ + +LKI DFGLA DP S +
Sbjct: 122 ARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLC 372
+ +VT WYR P LLL ++Y A+D+W+ GCI E+ +GK + G E+EQ+ I +
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 373 GSPSEDYWRK--SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
E+ ++ S + +P + + + A+ +E +++ P R TA
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 431 TLALNSEFF 439
AL+ +
Sbjct: 301 EEALSHPYM 309
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 9e-84
Identities = 102/298 (34%), Positives = 156/298 (52%), Gaps = 16/298 (5%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+P+ + +G G Y SV A D + VA+KK+ Q K RE+ +L+
Sbjct: 22 LPKT---YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLK 78
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H N+I L + T +S YLV +M+ DL + G+KF+E +++ + Q+
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDL---QKIMGLKFSEEKIQYLVYQM 135
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L GL++ HS GV+HRD+K NL ++ + LKI DFGLA D + MT VVT WYR
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRA 191
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
PE++L HY VD+WS GCI+ E+ +GK + GK ++QL +I K+ G P ++ +K
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251
Query: 384 KLRHSTVFKPVQPYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ + + P R + F A L+E ++ +D R TA AL FF
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 5e-82
Identities = 98/298 (32%), Positives = 149/298 (50%), Gaps = 15/298 (5%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+P R ++ L +G G Y SV A D VA+KK+ Q K RE+ +L+
Sbjct: 27 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H N+I L + T S +YLV M DL + + K T+ V+ + Q+
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQI 141
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L GL++ HS ++HRD+K SNL ++ + LKI DFGLA + MT V T WYR
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRA 197
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
PE++L HY VD+WS GCI+ EL +G+ + PG ++QL I +L G+P + +K
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257
Query: 384 KLRHSTVFKPVQPYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ + ++ A F A+ L+E ++ +D R TA AL +F
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 1e-81
Identities = 99/356 (27%), Positives = 159/356 (44%), Gaps = 70/356 (19%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
IP R +E IG G+Y V A D + ++VA+KK+ +D K + REIAIL
Sbjct: 51 IPDR---YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 208 KLDHPNIIKLEGLITSQTSCS---LYLVFEYMEHDL--VGLASLPGMKFTESQVKCYMKQ 262
+L+H +++K+ ++ + LY+V E + D + + + TE +K +
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL-FRT--PVYLTELHIKTLLYN 164
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP----------- 311
LL G+++ HS G+LHRD+K +N L++ + +K+ DFGLA D ++
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 312 ---------------MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS----- 351
+T VVT WYR PEL+L +Y A+D+WS GCI EL +
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 352 ------GKPVLPGK--------------------TEVEQLHRIFKLCGSPSEDYWRKSKL 385
P+ PG +QL+ IF + G+PSE+ +
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 386 RHSTVFKPVQPYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ + + P R AE F A+ L++ ++ +P R T L FF
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 2e-81
Identities = 94/315 (29%), Positives = 153/315 (48%), Gaps = 18/315 (5%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+ + L +G G Y +V A D VA+KK+ Q K RE+ +L+
Sbjct: 23 VRAV---YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 79
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H N+I L + T + YLV +M DL L + K E +++ + Q+
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL--MKHEKLGEDRIQFLVYQM 137
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L GL + H+ G++HRD+K NL ++ + LKI DFGLA D + MT VVT WYR
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRA 193
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
PE++L Y VD+WS GCI+ E+ +GK + G ++QL I K+ G+P ++ ++
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253
Query: 384 KLRHSTVFKPVQPYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
+ + + P + A + A+ L+E ++ +D R TA AL +F
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-- 311
Query: 442 QPLACNPSNLPKYPP 456
+ L + + P+
Sbjct: 312 ESLH-DTEDEPQVQK 325
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 3e-81
Identities = 98/300 (32%), Positives = 157/300 (52%), Gaps = 15/300 (5%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAIL 206
+ R + L IG+G Y V A D ++ VA+KK+ F++ + REI IL
Sbjct: 25 VGPR---YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKIL 79
Query: 207 RKLDHPNIIKLEGLITSQTSCS---LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H NII + +I + T +Y+V + ME DL L L + + ++ Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKL--LKTQHLSNDHICYFLYQI 137
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA--SFFDPKDSVPMTSRVVTLWY 321
L GL++ HS VLHRD+K SNLLL+ LKI DFGLA + D + +T V T WY
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
R PE++L + Y ++D+WS GCIL E+ S +P+ PGK ++QL+ I + GSPS++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 382 KSKLRHSTVFKPVQPYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ + P++ ++ F + + AL L++ +++ +P R AL +
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 8e-81
Identities = 93/309 (30%), Positives = 145/309 (46%), Gaps = 25/309 (8%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-FDNQDPESVKFMAREIAIL 206
I F+ +G+G Y V A +IVA+KK+ FD P REI IL
Sbjct: 9 ISSD---FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKIL 63
Query: 207 RKLDHPNIIKLEGLITSQTSCS---LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H NII + + + + +Y++ E M+ DL + S ++ ++ ++ Q
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQT 121
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP---------MTS 314
L ++ H V+HRD+K SNLL++ N LK+ DFGLA D + M
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGS 374
V T WYR PE++L ++ Y A+D+WS GCIL ELF +P+ PG+ QL IF + G+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 375 PSEDYWRKSKLRHSTVFKPVQ--PYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTA 430
P D + + ++ P + F + L++ ++ DPA R TA
Sbjct: 242 PHSDND-LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300
Query: 431 TLALNSEFF 439
AL +
Sbjct: 301 KEALEHPYL 309
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 1e-80
Identities = 84/337 (24%), Positives = 136/337 (40%), Gaps = 25/337 (7%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN---------QDPESVKF 198
+ + I G+Y +V D VA+K+V D K
Sbjct: 20 MQSP---YTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 199 MAREIAILRKLDHPNIIKLEGLITSQTSCS---LYLVFEYMEHDLVGLASLPGMKFTESQ 255
+ REI +L HPNI+ L + + LYLV E M DL + + +
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR 315
++ +M +L GL H GV+HRD+ N+LL N + I DF LA T
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHY 193
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375
V WYR PEL++ + VD+WS GC++ E+F+ K + G T QL++I ++ G+P
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 376 SEDYWRKSKLRHSTVF-KPVQPYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATL 432
+ + + + AL L+ ++ +P R +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313
Query: 433 ALNSEFFTTQPLACNPSNLPKYPPSK-EIDAKLRDEE 468
AL +F + L +P +L + + D + D
Sbjct: 314 ALRHPYF--ESLF-DPLDLTEGLSERFHFDESVTDVY 347
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 5e-78
Identities = 101/348 (29%), Positives = 164/348 (47%), Gaps = 47/348 (13%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+ R+ +E + K+G+G Y V+++ D ++VA+KK+ Q+ + REI IL
Sbjct: 7 VLRK---YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 208 KL-DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSG 266
+L H NI+ L ++ + +YLVF+YME DL + + + + QL+
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAV--IRANILEPVHKQYVVYQLIKV 121
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA--------------------SFFDP 306
+++ HS G+LHRD+K SN+LL+ +K+ADFGL+ +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366
D +T V T WYR PE+LLG++ Y +D+WS GCILGE+ GKP+ PG + + QL
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 367 RIFKLCGSPSED------------YWR----KSKLRHSTVFKPVQPYRRRIAETFKDFPT 410
RI + PS + K ++R S ++ + +
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 411 S--ALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPP 456
+ AL L++ L+ +P R +A AL F NP+ P
Sbjct: 302 NEEALDLLDKLLQFNPNKRISANDALKHPFV--SIFH-NPNEEPNCDH 346
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-77
Identities = 94/331 (28%), Positives = 159/331 (48%), Gaps = 29/331 (8%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+ +R ++ L IG G V A D I ++ VA+KK+ Q+ K RE+ +++
Sbjct: 23 VLKR---YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 79
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
++H NII L + T Q S +Y+V E M+ +L + M+ ++ + Q+
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHERMSYLLYQM 136
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L G++H HS G++HRD+K SN+++ + LKI DFGLA MT VVT +YR
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRA 194
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK- 382
PE++LG Y VD+WS GCI+GE+ G + PG ++Q +++ + G+P ++ +K
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 383 -SKLR---HSTVFKPVQPYRRR--------IAETFKDFPTSALRLMETLMSIDPAHRGTA 430
+R + + + +E K + A L+ ++ ID + R +
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313
Query: 431 TLALNSEFFTTQPLACNPSNLPKYPPSKEID 461
AL + +PS PP
Sbjct: 314 DEALQHPYI--NVWY-DPSEAEAPPPKIPDK 341
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 2e-76
Identities = 95/328 (28%), Positives = 162/328 (49%), Gaps = 29/328 (8%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+ +R ++ L IG G V A D + D+ VA+KK+ Q+ K RE+ +++
Sbjct: 60 VLKR---YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
++H NII L + T Q + +YLV E M+ +L + M+ ++ + Q+
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHERMSYLLYQM 173
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L G++H HS G++HRD+K SN+++ + LKI DFGLA MT VVT +YR
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRA 231
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK- 382
PE++LG Y VD+WS GCI+GE+ K + PG+ ++Q +++ + G+P ++ +K
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 383 -SKLR---HSTVFKPVQPYRRR--------IAETFKDFPTSALRLMETLMSIDPAHRGTA 430
+R + + + +E K + A L+ ++ IDPA R +
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 431 TLALNSEFFTTQPLACNPSNLPKYPPSK 458
AL + +P+ + PP
Sbjct: 351 DDALQHPYI--NVWY-DPAEVEAPPPQI 375
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 2e-73
Identities = 101/346 (29%), Positives = 155/346 (44%), Gaps = 58/346 (16%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+P + IG+G+Y VY A D +K VA+KKV +D K + REI IL
Sbjct: 24 VPDN---YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80
Query: 208 KLDHPNIIKLEGLITSQTSCS---LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLL 264
+L II+L LI LY+V E + DL L P + TE +K + LL
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLL 139
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP------------- 311
G H G++HRD+K +N LL+ + +K+ DFGLA + +
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGP 199
Query: 312 --------MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG----------- 352
+TS VVT WYR PEL+L +Y ++D+WSTGCI EL +
Sbjct: 200 HNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 353 KPVLPG-----------------KTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395
P+ PG K+ +QL+ IF + G+P+ED + + +
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
Query: 396 PYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
P+R+ I + + + L+E+++ +P R T AL+ +
Sbjct: 320 PHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-64
Identities = 76/321 (23%), Positives = 126/321 (39%), Gaps = 49/321 (15%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ L +IG G S V++ + +I A+K V + D +++ EIA L KL
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 213 N--IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+ II+L T +Y+V E DL + K Y K +L +
Sbjct: 87 SDKIIRLYDYE--ITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 143
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-KDSVPMTSRVVTLWYRPPELLLG 329
H HG++H D+K +N L+ +G+LK+ DFG+A+ P SV S+V T+ Y PPE +
Sbjct: 144 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 330 ASH----------YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE-D 378
S D+WS GCIL + GK P + + Q+ ++ + E +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE 260
Query: 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
+ +++ + DP R + L +
Sbjct: 261 FP-------------------------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 295
Query: 439 FTTQPLACNPSNLPKYPPSKE 459
Q +P N ++E
Sbjct: 296 VQIQT---HPVNQMAKGTTEE 313
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-63
Identities = 70/315 (22%), Positives = 126/315 (40%), Gaps = 55/315 (17%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL 209
R A+ FE++ +GQG + V +AR+ + + A+KK+R + ++ E+ +L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 210 DHPNIIKL-----------EGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVK 257
+H +++ + + + +L++ EY E L L + +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 258 CYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP------ 311
+Q+L L + HS G++HRD+K N+ +D + +KI DFGLA +
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 312 -------MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ 364
+TS + T Y E+L G HY +D++S G I E+ P G V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 365 LHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDP 424
L ++ + D+ + +++ L+ DP
Sbjct: 238 LKKLRSVSIEFPPDFD-------------------------DNKMKVEKKIIRLLIDHDP 272
Query: 425 AHRGTATLALNSEFF 439
R A LNS +
Sbjct: 273 NKRPGARTLLNSGWL 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-63
Identities = 77/332 (23%), Positives = 126/332 (37%), Gaps = 44/332 (13%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ L +IG G S V++ + +I A+K V + D +++ EIA L KL
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 213 N--IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+ II+L T +Y+V E DL + K Y K +L +
Sbjct: 68 SDKIIRLYDYE--ITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 124
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-KDSVPMTSRVVTLWYRPPELLLG 329
H HG++H D+K +N L+ +G+LK+ DFG+A+ P SV S+V T+ Y PPE +
Sbjct: 125 HQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 330 ASH----------YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY 379
S D+WS GCIL + GK P + + Q+ ++ +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDP----- 236
Query: 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ + +D ++ + DP R + L +
Sbjct: 237 ------------NHEIEFPDIPEKDLQDV-------LKCCLKRDPKQRISIPELLAHPYV 277
Query: 440 TTQPLACNPSNLPKYPPSKEIDAKLRDEESRR 471
Q N K + +L S
Sbjct: 278 QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 309
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-61
Identities = 78/337 (23%), Positives = 125/337 (37%), Gaps = 44/337 (13%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
I + + L +IG G S V++ + +I A+K V + D +++ EIA L
Sbjct: 51 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 208 KLDHPN--IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLS 265
KL + II+L T +Y+V E DL + K Y K +L
Sbjct: 110 KLQQHSDKIIRLYDYE--ITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLE 166
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-KDSVPMTSRVVTLWYRPP 324
+ H HG++H D+K +N L+ +G+LK+ DFG+A+ P SV S+V + Y PP
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
Query: 325 ELLLGASH----------YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGS 374
E + S D+WS GCIL + GK P + + Q+ ++
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA---- 279
Query: 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLAL 434
H F +++ + DP R + L
Sbjct: 280 -------IIDPNHEIEFPD-------------IPEKDLQDVLKCCLKRDPKQRISIPELL 319
Query: 435 NSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRR 471
+ Q N K + +L S
Sbjct: 320 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPN 356
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 5e-60
Identities = 65/299 (21%), Positives = 114/299 (38%), Gaps = 25/299 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ D +GQG ++V+R R + A+K + V RE +L+KL+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFN-NISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCH 271
+KL + T+ L+ E+ L + P ES+ ++ ++ G+ H
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 272 SHGVLHRDIKGSNLLL----DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
+G++HR+IK N++ D + K+ DFG A + D S T Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDMY 187
Query: 328 LGAS-------HYGAAVDLWSTGCILGELFSGKP----VLPGKTEVEQLHRIFKLCGSPS 376
A YGA VDLWS G +G + E +++I S +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
+K++ + P ++ + T L + + D
Sbjct: 248 ISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVLLTPVLANI---LEADQEKCWGFDQFFA 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-58
Identities = 65/294 (22%), Positives = 114/294 (38%), Gaps = 25/294 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ D +GQG ++V+R R + A+K + V RE +L+KL+H NI
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNI 69
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCH 271
+KL + T+ L+ E+ L + P ES+ ++ ++ G+ H
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 272 SHGVLHRDIKGSNLLL----DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
+G++HR+IK N++ D + K+ DFG A + D S T Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEYLHPDMY 187
Query: 328 LGAS-------HYGAAVDLWSTGCILGELFSGKP----VLPGKTEVEQLHRIFKLCGSPS 376
A YGA VDLWS G +G + E +++I S +
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
+K++ + P ++ + T L + + D
Sbjct: 248 ISGVQKAE-NGPIDWSGDMPVSCSLSRGLQVLLTPVLANI---LEADQEKCWGF 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 72/231 (31%), Positives = 111/231 (48%), Gaps = 11/231 (4%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
P RA +E L IG G+Y + R KI+ K++ + + + + E+ +LR+
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLL 264
L HPNI++ I +T+ +LY+V EY E ++ + E V M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 265 SGLEHCHS-----HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL 319
L+ CH H VLHRD+K +N+ LD +K+ DFGLA + S + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTP 180
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
+Y PE + S Y D+WS GC+L EL + P ++ E +I +
Sbjct: 181 YYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-56
Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 37/286 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPN 213
F++L ++G G+Y V++ R ++ A+K+ + P+ E+ K+ HP
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
++LE + LYL E L G E+QV Y++ L L H HS
Sbjct: 119 CVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
G++H D+K +N+ L G K+ DFGL + + Y PELL G+ Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQEGDPRYMAPELLQGS--Y 232
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
G A D++S G + E+ LP E ++ + P
Sbjct: 233 GTAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQG------------------YLPP 271
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
++ + L +M + DP R TA L
Sbjct: 272 EFT--AGLSSELRSV----LVMM---LEPDPKLRATAEALLALPVL 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-56
Identities = 68/307 (22%), Positives = 115/307 (37%), Gaps = 58/307 (18%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
R F++++ IG G + V++A+ I K +K+V+++N+ RE+ L K
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAK 60
Query: 209 LDHPNIIKL--------------EGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFT 252
LDH NI+ + + L++ E+ + L + G K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312
+ +Q+ G+++ HS +++RD+K SN+ L +KI DFGL +
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--R 178
Query: 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLC 372
T TL Y PE + YG VDL++ G IL EL
Sbjct: 179 TRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCD------------------ 219
Query: 373 GSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATL 432
+ E + LR + K L++ L+S P R +
Sbjct: 220 -TAFETSKFFTDLRD-------GIISDIFDKKEKT-------LLQKLLSKKPEDRPNTSE 264
Query: 433 ALNSEFF 439
L +
Sbjct: 265 ILRTLTV 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-55
Identities = 70/336 (20%), Positives = 130/336 (38%), Gaps = 41/336 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ +L KIG+G++ + + +K++ + + RE+A+L + HPNI
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
++ + + SLY+V +Y E DL + + G+ F E Q+ + Q+ L+H H
Sbjct: 86 VQYRESF--EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
+LHRDIK N+ L +G +++ DFG+A + + + + T +Y PE+
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGTPYYLSPEICENKP- 201
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392
Y D+W+ GC+L EL + K + + +I
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS---------------------G 240
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF-------FTTQPLA 445
P + + L+ L +P R + L F F + L
Sbjct: 241 SFPPVSLHYSYDLRS-------LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLI 293
Query: 446 CNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQK 481
L + + S ++ ++ QK
Sbjct: 294 AEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQK 329
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
F KIG+G +S VYRA ++ VALKKV+ + + +EI +L++L+HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 214 IIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
+IK + L +V E + ++ E V Y QL S LEH
Sbjct: 94 VIKYYA--SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
HS V+HRDIK +N+ + G++K+ D GL FF K + S V T +Y PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLVGTPYYMSPERIHE 210
Query: 330 ASHYGAAVDLWSTGCILGELFSGKP 354
+ Y D+WS GC+L E+ + +
Sbjct: 211 -NGYNFKSDIWSLGCLLYEMAALQS 234
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 1e-54
Identities = 74/303 (24%), Positives = 117/303 (38%), Gaps = 19/303 (6%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
+ +E +++G G + V R + VA+K+ R + P++ + EI I++K
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKK 68
Query: 209 LDHPNIIKL----EGLITSQTSCSLYLVFEYMEH-DLVGLASLPG--MKFTESQVKCYMK 261
L+HPN++ +GL + L EY E DL + E ++ +
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLASFFDPKDSVPMTSRVVT 318
+ S L + H + ++HRD+K N++L I KI D G A D + T V T
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGT 186
Query: 319 LWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378
L Y PELL Y VD WS G + E +G + Q H + +E
Sbjct: 187 LQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR--EKSNEH 243
Query: 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
L + F V P ++ L+ M + RGT N
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM---LMWHQRQRGTDPQNPNVGC 300
Query: 439 FTT 441
F
Sbjct: 301 FQA 303
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 3e-54
Identities = 84/333 (25%), Positives = 136/333 (40%), Gaps = 51/333 (15%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILR 207
PR + + +G+G ++ + D ++ A K V + P + M+ EI+I R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSG 266
L H +++ G +++V E L+ L TE + + Y++Q++ G
Sbjct: 97 SLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 153
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
++ H + V+HRD+K NL L+ + +KI DFGLA+ + T Y PE+
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEV 212
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
L H VD+WS GCI+ L GKP P E
Sbjct: 213 LSKKGH-SFEVDVWSIGCIMYTLLVGKP--------------------PFET-------- 243
Query: 387 HSTVFKPVQPYRRRIAE---TF-KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442
++ RI + + K A L++ ++ DP R T LN EFFT+
Sbjct: 244 -----SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298
Query: 443 PLACNPSNLPKY----PPSKEIDAKLRDEESRR 471
+ P+ LP PP I D +R+
Sbjct: 299 YI---PARLPITCLTIPPRFSIAPSSLDPSNRK 328
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 9e-54
Identities = 79/310 (25%), Positives = 128/310 (41%), Gaps = 47/310 (15%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILR 207
PR + + +G+G ++ + D ++ A K V + P + M+ EI+I R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSG 266
L H +++ G +++V E L+ L TE + + Y++Q++ G
Sbjct: 71 SLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLG 127
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
++ H + V+HRD+K NL L+ + +KI DFGLA+ + T Y PE+
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEV 186
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
L H VD+WS GCI+ L GKP P E
Sbjct: 187 LSKKGH-SFEVDVWSIGCIMYTLLVGKP--------------------PFET-------- 217
Query: 387 HSTVFKPVQPYRRRIAE---TF-KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442
++ RI + + K A L++ ++ DP R T LN EFFT+
Sbjct: 218 -----SCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS- 271
Query: 443 PLACNPSNLP 452
P+ LP
Sbjct: 272 --GYIPARLP 279
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-53
Identities = 85/321 (26%), Positives = 141/321 (43%), Gaps = 46/321 (14%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
++++ K+G G Y V RD + A+K +R + S + E+A+L+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
NI+KL + + YLV E + +++ KF E +KQ+LSG+
Sbjct: 97 NIMKLYDFF--EDKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGV 149
Query: 268 EHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPP 324
+ H H ++HRD+K NLLL + + ++KI DFGL++ F+ + M R+ T +Y P
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYYIAP 207
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
E+L Y D+WS G IL L +G P G+T+ E L ++ K + W+
Sbjct: 208 EVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN-- 263
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444
++E KD ++ M + D R +A AL +
Sbjct: 264 ----------------VSEGAKDL----IKQM---LQFDSQRRISAQQALEHPWIKEM-- 298
Query: 445 ACNPSNLPKYPPSKEIDAKLR 465
+ + P +R
Sbjct: 299 CSKKESGIELPSLANAIENMR 319
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-53
Identities = 71/319 (22%), Positives = 122/319 (38%), Gaps = 56/319 (17%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL 209
R FE + +G+G + V+ A++ + D A+K++R N++ K M RE+ L KL
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 210 DHPNIIK----------LEGLITSQTSCSLYLVFEYMEH-DLVGL--ASLPGMKFTESQV 256
+HP I++ E L S LY+ + +L + S
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 257 KCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD----------- 305
Q+ +E HS G++HRD+K SN+ + ++K+ DFGL + D
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQL 365
T +V T Y PE + G + Y VD++S G IL EL P T++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY-----PFSTQMERV 234
Query: 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPA 425
+ + + F +++ ++S P
Sbjct: 235 RTLTDVR-------------------------NLKFPPLFTQKYPCEYVMVQDMLSPSPM 269
Query: 426 HRGTATLALNSEFFTTQPL 444
R A + + F
Sbjct: 270 ERPEAINIIENAVFEDLDF 288
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 6e-53
Identities = 85/319 (26%), Positives = 143/319 (44%), Gaps = 46/319 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + +G+G++ V + +D I + A+K + + + + RE+ +L+KLDHPNI
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 215 IKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
+KL ++ + S S Y+V E +++ +F+E +KQ+ SG+ +
Sbjct: 84 MKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITY 136
Query: 270 CHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
H H ++HRD+K N+LL + + +KI DFGL++ F M R+ T +Y PE+
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEV 194
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
L G Y D+WS G IL L SG P GK E + L R+ + WR
Sbjct: 195 LRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT---- 248
Query: 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLAC 446
I++ KD +R M ++ P+ R TAT L + +
Sbjct: 249 --------------ISDDAKDL----IRKM---LTFHPSLRITATQCLEHPWIQKY--SS 285
Query: 447 NPSNLPKYPPSKEIDAKLR 465
+ P + +R
Sbjct: 286 ETPTISDLPSLESAMTNIR 304
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 18/217 (8%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
+ + K+G+G +S V + ALK++ + + + RE + R +HPN
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPN 87
Query: 214 IIKLEG--LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
I++L L +L+ + + + + G TE Q+ + + GL
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV--------TL 319
E H+ G HRD+K +N+LL G + D G + + + T+
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 320 WYRPPELLLGASH--YGAAVDLWSTGCILGELFSGKP 354
YR PEL SH D+WS GC+L + G+
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-52
Identities = 67/211 (31%), Positives = 109/211 (51%), Gaps = 10/211 (4%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIA 204
I + F+ + +G+G+++ VYRA + VA+K K V+ + E+
Sbjct: 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM--YKAGMVQRVQNEVK 63
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQL 263
I +L HP+I++L + S +YLV E + ++ F+E++ + +M Q+
Sbjct: 64 IHCQLKHPSILELYNYF--EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
++G+ + HSHG+LHRD+ SNLLL N +KIADFGLA+ T T Y
Sbjct: 122 ITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYIS 180
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKP 354
PE+ ++H G D+WS GC+ L G+P
Sbjct: 181 PEIATRSAH-GLESDVWSLGCMFYTLLIGRP 210
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-52
Identities = 83/322 (25%), Positives = 143/322 (44%), Gaps = 52/322 (16%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
++ +G+G++ V +D I + A+K + + + + RE+ +L++LDHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 214 IIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
I+KL + YLV E +++ +F+E ++Q+LSG+
Sbjct: 88 IMKLYEFF--EDKGYFYLVGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGIT 140
Query: 269 HCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
+ H + ++HRD+K NLLL + ++I DFGL++ F+ M ++ T +Y PE
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPE 198
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--EDYWRKS 383
+L G Y D+WSTG IL L SG P G E + L ++ K G + W+K
Sbjct: 199 VLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQWKK- 253
Query: 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
++E+ KD +R M ++ P+ R +A AL+ E+ T
Sbjct: 254 -----------------VSESAKDL----IRKM---LTYVPSMRISARDALDHEWIQT-- 287
Query: 444 LACNPSNLPKYPPSKEIDAKLR 465
P +R
Sbjct: 288 -YTKEQISVDVPSLDNAILNIR 308
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-51
Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 54/290 (18%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILRKLDHPNII 215
+G+G++ V + +D I + A+K K N+D ++ RE+ +L+KLDHPNI+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIM 84
Query: 216 KLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
KL ++ + S S Y+V E +++ +F+E +KQ+ SG+ +
Sbjct: 85 KLFEIL--EDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYM 137
Query: 271 HSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
H H ++HRD+K N+LL + + +KI DFGL++ F M R+ T +Y PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVL 195
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--EDYWRKSKL 385
G Y D+WS G IL L SG P GK E + L R+ G + WR
Sbjct: 196 RG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRT--- 248
Query: 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
I++ KD L+ +++ P+ R TAT L
Sbjct: 249 ---------------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-51
Identities = 85/319 (26%), Positives = 138/319 (43%), Gaps = 55/319 (17%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR-----------FDNQDPESVKFMAR 201
++ K+ K+G G Y V ++ A+K ++ + + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 202 EIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQV 256
EI++L+ LDHPNIIKL + + YLV E+ E ++ KF E
Sbjct: 96 EISLLKSLDHPNIIKLFDVF--EDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDA 148
Query: 257 KCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMT 313
MKQ+LSG+ + H H ++HRDIK N+LL + +KI DFGL+SFF +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLR 206
Query: 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG 373
R+ T +Y PE+L Y D+WS G I+ L G P G+ + + + ++ K
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264
Query: 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA 433
+ W+ I++ K+ ++LM ++ D R TA A
Sbjct: 265 YFDFNDWKN------------------ISDEAKEL----IKLM---LTYDYNKRCTAEEA 299
Query: 434 LNSEFFTTQPLACNPSNLP 452
LNS + N S+
Sbjct: 300 LNSRWIKKYANNINKSDQK 318
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 3e-51
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 46/287 (16%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKV--RFDNQDPESVKFMAREIAILRKLDHPNIIK 216
K+G G + V+ + +K + E ++ EI +L+ LDHPNIIK
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE---AEIEVLKSLDHPNIIK 84
Query: 217 LEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
+ + + ++Y+V E E +V + +E V MKQ+++ L + H
Sbjct: 85 IFEVF--EDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFH 141
Query: 272 SHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
S V+H+D+K N+L + +KI DFGLA F + T+ T Y PE+
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK 199
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
D+WS G ++ L +G G + E + + ++
Sbjct: 200 R--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA------------TYKEPNYA 245
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
+P+ P A+ L++ +++ DP R +A L+
Sbjct: 246 VECRPLTP--------------QAVDLLKQMLTKDPERRPSAAQVLH 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 53/308 (17%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILRKLDHPNII 215
+++G+G +S V R A K + +D + ++ RE I RKL HPNI+
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIV 68
Query: 216 KLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+L I Q YLVF+ + D+V ++E+ ++Q+L + +C
Sbjct: 69 RLHDSI--QEESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYC 121
Query: 271 HSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
HS+G++HR++K NLLL +K+ADFGLA + + T Y PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLSPEVL 179
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--EDYWRKSKL 385
Y VD+W+ G IL L G P + + +I G+ W
Sbjct: 180 KK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDT--- 233
Query: 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445
+ K L++++++++P R TA AL + +
Sbjct: 234 ---------------VTPEAKS-------LIDSMLTVNPKKRITADQALKVPWICNRERV 271
Query: 446 CNPSNLPK 453
+ +
Sbjct: 272 ASAIHRQD 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-50
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 47/300 (15%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HP 212
+F D +G G ++ R + ++ VA+K++ PE F RE+ +LR+ D HP
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHP 78
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
N+I+ T + Y+ E L + ++Q SGL H HS
Sbjct: 79 NVIRYFC--TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 273 HGVLHRDIKGSNLLLDHNG-----ILKIADFGLASFFDPKDS--VPMTSRVVTLWYRPPE 325
++HRD+K N+L+ I+DFGL + T + PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 326 LLLGASH--YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP--SEDYWR 381
+L VD++S GC+ + S GS + R
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISE--------------------GSHPFGKSLQR 236
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
++ + + ++ L+E ++++DP R +A L FF +
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARE-------LIEKMIAMDPQKRPSAKHVLKHPFFWS 289
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 85/304 (27%), Positives = 130/304 (42%), Gaps = 53/304 (17%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKL 217
+ IG+G++ V A A KK+ +D + K +EI I++ LDHPNII+L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRL 71
Query: 218 EGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
+ + +YLV E +V F ES MK +LS + +CH
Sbjct: 72 YETF--EDNTDIYLVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHK 124
Query: 273 HGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
V HRD+K N L + LK+ DFGLA+ F P M ++V T +Y P++L G
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG 182
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--EDYWRKSKLRH 387
YG D WS G ++ L G P T+ E + +I G+ + E W
Sbjct: 183 --LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLN----- 233
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACN 447
++ + +R + ++ P R T+ AL E+F Q + +
Sbjct: 234 -------------VSPQAESL----IRRL---LTKSPKQRITSLQALEHEWFEKQLSS-S 272
Query: 448 PSNL 451
P NL
Sbjct: 273 PRNL 276
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-50
Identities = 62/299 (20%), Positives = 107/299 (35%), Gaps = 49/299 (16%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++G+G++ V+R +D A+KKVR + E E+ L P I
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRI 112
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+ L G + + + E +E L+ E + Y+ Q L GLE+
Sbjct: 113 VPLYG--AVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYL 166
Query: 271 HSHGVLHRDIKGSNLLLDHNGIL-KIADFGLASFFDPKDSVPMTSRVVTL----WYRPPE 325
H+ +LH D+K N+LL +G + DFG A P + + PE
Sbjct: 167 HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385
+++G A VD+WS+ C++ + +G + + K+ P
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWT---QYFRGPLCLKIASEP---------- 272
Query: 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444
P++ A + E L +P HR +A Q +
Sbjct: 273 ------PPIREIPPSCAPLTAQA------IQEGLR-KEPVHRASAMELRRKVGKALQEV 318
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-50
Identities = 86/328 (26%), Positives = 140/328 (42%), Gaps = 56/328 (17%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILRKLDHPNII 215
+ IG+G +S V R + + A+K +F + S + + RE +I L HP+I+
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 216 KLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+L + LY+VFE+M+ ++V A G ++E+ YM+Q+L L +C
Sbjct: 90 ELLETY--SSDGMLYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYC 146
Query: 271 HSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
H + ++HRD+K +LL +++ +K+ FG+A + + RV T + PE++
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVV 205
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK--LCGSPS--EDYWRKS 383
YG VD+W G IL L SG G E R+F+ + G W
Sbjct: 206 KR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWSH- 258
Query: 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
I+E+ KD +R M + +DPA R T ALN +
Sbjct: 259 -----------------ISESAKDL----VRRM---LMLDPAERITVYEALNHPWL---- 290
Query: 444 LACNPSNLPKYPPSKEIDAKLRDEESRR 471
E +LR +RR
Sbjct: 291 --KERDRYAYKIHLPETVEQLRKFNARR 316
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-49
Identities = 73/337 (21%), Positives = 126/337 (37%), Gaps = 76/337 (22%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILRKL 209
+ IGQG+Y V A + I A+K K + +P+ V+ + E+ +++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYME-------------------------------- 237
HPNI +L + + + LV E
Sbjct: 86 HHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 238 --------HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL-- 287
+ G E + M+Q+ S L + H+ G+ HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 288 DHNGILKIADFGLASFF---DPKDSVPMTSRVVTLWYRPPELLLGASH-YGAAVDLWSTG 343
+ + +K+ DFGL+ F + + MT++ T ++ PE+L + YG D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 344 CILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAE 403
+L L G PG + + + ++ KL F+ P ++
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQV------------LNKKLC----FEN--PNYNVLSP 305
Query: 404 TFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
+D L+ L++ + R A AL + +
Sbjct: 306 LARD-------LLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 82/319 (25%), Positives = 129/319 (40%), Gaps = 68/319 (21%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALK---------KVRFDNQDPESVKFMAREIAILRKLD 210
+G G V A + K VA+K + +V+ EI IL+KL+
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE---TEIEILKKLN 73
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLS 265
HP IIK++ ++ Y+V E ME +VG + E+ K Y Q+L
Sbjct: 74 HPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLL 125
Query: 266 GLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
+++ H +G++HRD+K N+LL + + ++KI DFG + M + T Y
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYL 183
Query: 323 PPELLLGASH--YGAAVDLWSTGCILGELFSGKPVLP---GKTEVEQLHRIFKLCGS--- 374
PE+L+ Y AVD WS G IL SG P P +T+V +I G
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGKYNF 239
Query: 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLAL 434
E W + ++E D L++ L+ +DP R T AL
Sbjct: 240 IPE-VWAE------------------VSEKALD-------LVKKLLVVDPKARFTTEEAL 273
Query: 435 NSEFFTTQPLACNPSNLPK 453
+ + + +L
Sbjct: 274 RHPWLQDEDMKRKFQDLLS 292
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-49
Identities = 80/379 (21%), Positives = 150/379 (39%), Gaps = 60/379 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
++ L+++G G + V+R + ++ K + D +VK EI+I+ +L HP
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPK 109
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
+I L + + L+ E++ +L + K +E++V YM+Q GL+H H
Sbjct: 110 LINLHDAF--EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 273 HGVLHRDIKGSNLLLDH--NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
H ++H DIK N++ + +KI DFGLA+ +P + + T + PE++
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDR- 224
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390
G D+W+ G + L SG G+ ++E L + + ED +
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS-------- 276
Query: 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSN 450
++ KDF ++ L+ +P R T AL +
Sbjct: 277 ----------VSPEAKDF-------IKNLLQKEPRKRLTVHDALEHPWLKGDHSN----- 314
Query: 451 LPKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLPIPAPNRDAELSIMQKR 510
+ I + ++ ++ + + P PA R A S ++K
Sbjct: 315 -----LTSRIPSSRYNKIRQK------------IKEKYADWPAPQPAIGRIANFSSLRKH 357
Query: 511 HHTNSRSKNEMFISQKEAA 529
+ + F +KEA
Sbjct: 358 RPQEYQIYDSYF-DRKEAV 375
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-49
Identities = 78/313 (24%), Positives = 127/313 (40%), Gaps = 59/313 (18%)
Query: 136 LATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQD 192
+AT+ ++ +++G+G +S V R V+ + A + +D
Sbjct: 1 MATITCTRFT-------EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD 53
Query: 193 PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLP 247
+ ++ RE I R L HPNI++L I YL+F+ + D+V
Sbjct: 54 HQKLE---REARICRLLKHPNIVRLHDSI--SEEGHHYLIFDLVTGGELFEDIVARE--- 105
Query: 248 GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFF 304
++E+ ++Q+L + HCH GV+HR++K NLLL +K+ADFGLA
Sbjct: 106 --YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163
Query: 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ 364
+ + T Y PE+L YG VDLW+ G IL L G P + +
Sbjct: 164 EGEQQA-WFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221
Query: 365 LHRIFKLCGSPS--EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSI 422
+I G+ W + KD L+ +++I
Sbjct: 222 YQQI--KAGAYDFPSPEWDT------------------VTPEAKD-------LINKMLTI 254
Query: 423 DPAHRGTATLALN 435
+P+ R TA AL
Sbjct: 255 NPSKRITAAEALK 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 78/303 (25%), Positives = 124/303 (40%), Gaps = 56/303 (18%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVK----FMAREIAILRKLD-H 211
+G+G S V R K A+K + E V+ +E+ ILRK+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSG 266
PNII+L+ +T+ +LVF+ M+ L +E + + M+ LL
Sbjct: 84 PNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEV 136
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
+ H ++HRD+K N+LLD + +K+ DFG + DP + + T Y PE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLAPEI 194
Query: 327 LLGAS-----HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--EDY 379
+ + YG VD+WSTG I+ L +G P + ++ L I + G+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGNYQFGSPE 252
Query: 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
W ++T KD L+ + + P R TA AL FF
Sbjct: 253 WDD------------------YSDTVKD-------LVSRFLVVQPQKRYTAEEALAHPFF 287
Query: 440 TTQ 442
Sbjct: 288 QQY 290
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 79/330 (23%), Positives = 135/330 (40%), Gaps = 59/330 (17%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILRKLDH 211
++ +++G+G +S V R A K + +D + ++ RE I RKL H
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQH 87
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSG 266
PNI++L I Q YLVF+ + D+V ++E+ ++Q+L
Sbjct: 88 PNIVRLHDSI--QEESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILES 140
Query: 267 LEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
+ +CHS+G++HR++K NLLL +K+ADFGLA + + T Y
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTPGYLS 198
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--EDYWR 381
PE+L Y VD+W+ G IL L G P + + +I G+ W
Sbjct: 199 PEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWD 255
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
+ K L++++++++P R TA AL +
Sbjct: 256 T------------------VTPEAKS-------LIDSMLTVNPKKRITADQALKVPWI-- 288
Query: 442 QPLACNPSNLPKYPPSKEIDAKLRDEESRR 471
CN + ++ L+ +RR
Sbjct: 289 ----CNRERVASAIHRQDTVDCLKKFNARR 314
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 65/314 (20%), Positives = 115/314 (36%), Gaps = 43/314 (13%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKV---------------RFDNQDPESVK 197
N + + + QG ++ + +K ALKK
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 198 FMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME--------HDLVGLASLPGM 249
E+ I+ + + + EG+I +Y+++EYME L
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGII--TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 250 KFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308
+KC +K +L+ + H+ + HRD+K SN+L+D NG +K++DFG + + D
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VD 204
Query: 309 SVPMTSRVVTLWYRPPELLLGASHY-GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH- 366
S T + PPE S Y GA VD+WS G L +F K + +L
Sbjct: 205 KKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH 426
I ++ + ++ + + ++ + +PA
Sbjct: 264 NIRT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 427 RGTATLALNSEFFT 440
R T+ AL E+
Sbjct: 314 RITSEDALKHEWLA 327
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-49
Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 38/239 (15%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALK------------------------ 184
+ N + D+IG+G+Y V A + + A+K
Sbjct: 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 185 KVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH----DL 240
Q ++ + +EIAIL+KLDHPN++KL ++ LY+VFE + ++
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 241 VGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGL 300
L +E Q + Y + L+ G+E+ H ++HRDIK SNLL+ +G +KIADFG+
Sbjct: 129 PTLK-----PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 301 ASFFDPKDSVPMTSRVVTLWYRPPELLLGASH-Y-GAAVDLWSTGCILGELFSGKPVLP 357
++ F D++ + V T + PE L + G A+D+W+ G L G+ P
Sbjct: 184 SNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ--CP 239
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-49
Identities = 75/218 (34%), Positives = 103/218 (47%), Gaps = 9/218 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
FE +G+G + +VY AR+ I+ALK + + + RE+ I L HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I++L G + +YL+ EY + KF E + Y+ +L + L +CHS
Sbjct: 71 ILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 127
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
V+HRDIK NLLL G LKIADFG + S TL Y PPE++ G
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDL-CGTLDYLPPEMIEGRM- 183
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
+ VDLWS G + E GKP T E RI +
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 175 bits (444), Expect = 6e-49
Identities = 47/323 (14%), Positives = 89/323 (27%), Gaps = 56/323 (17%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRK 208
+ + ++ + G S V+ RDV + ALK ++ + +
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 209 LDHPN------------------------IIKLEGLITSQTSCSLYLVFEYMEHDLVGLA 244
L + +L + L+ DL L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 245 SL------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298
S + QL+ + S G++H NL + +G L + D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH-YGAAVDLWSTGCILGELFSGKPVLP 357
K + V + Y P E L ++ + A++ W G + ++ P
Sbjct: 239 SALW----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P 292
Query: 358 GKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLME 417
F L + W++ LR + P L+
Sbjct: 293 -----------FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL-------PDFVKTLIG 334
Query: 418 TLMSIDPAHRGTATLALNSEFFT 440
++ D R A+ + F
Sbjct: 335 RFLNFDRRRRLLPLEAMETPEFL 357
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-49
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK-----KVRFDNQDPESVKFMAREIAILRKLDHPNII 215
+G+G+Y V D A+K K+R +VK +EI +LR+L H N+I
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVI 69
Query: 216 KLEGLITSQTSCSLYLVFEYMEHDLVGL-ASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
+L ++ ++ +Y+V EY + + S+P +F Q Y QL+ GLE+ HS G
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDP--KDSVPMTSRVVTLWYRPPELLLGASH 332
++H+DIK NLLL G LKI+ G+A P D TS+ + ++PPE+ G
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIANGLDT 188
Query: 333 Y-GAAVDLWSTGCILGELFSGKPVLP 357
+ G VD+WS G L + +G P
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGL--YP 212
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 9e-49
Identities = 63/305 (20%), Positives = 117/305 (38%), Gaps = 42/305 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + +G+G + V+R + K K V+ D VK +EI+IL H NI
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNI 63
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+ L ++ L ++FE++ + + S + E ++ Y+ Q+ L+
Sbjct: 64 LHLHESF--ESMEELVMIFEFISGLDIFERI-NTS--AFELNEREIVSYVHQVCEALQFL 118
Query: 271 HSHGVLHRDIKGSNLLLDH--NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
HSH + H DI+ N++ + +KI +FG A P D Y PE+
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQ 176
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
A D+WS G ++ L SG +T + + I + E+ +++
Sbjct: 177 H-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE------ 229
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNP 448
I+ DF ++ L+ + R TA+ AL + + +
Sbjct: 230 ------------ISIEAMDF-------VDRLLVKERKSRMTASEALQHPWLKQKIERVST 270
Query: 449 SNLPK 453
+
Sbjct: 271 KVIRT 275
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-48
Identities = 59/308 (19%), Positives = 109/308 (35%), Gaps = 62/308 (20%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPN 213
F +L+KIG G + SV++ + I A+K+ + + RE+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 214 IIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
+++ + + EY D + F E+++K + Q+ GL +
Sbjct: 73 VVRYFS--AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 270 CHSHGVLHRDIKGSNLLLDHNGIL-------------------KIADFGLASFFDPKDSV 310
HS ++H DIK SN+ + I KI D G +
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
SR + E+L + D+++ + +P LP +Q H I
Sbjct: 191 EGDSR-----FLANEVLQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQWHEI-- 240
Query: 371 LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
R+ +L P P + +++ F + L++M + DP R +A
Sbjct: 241 ----------RQGRL-------PRIP--QVLSQEFTEL----LKVM---IHPDPERRPSA 274
Query: 431 TLALNSEF 438
+
Sbjct: 275 MALVKHSV 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-48
Identities = 77/369 (20%), Positives = 132/369 (35%), Gaps = 66/369 (17%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-H 211
N +G G+ +V + + VA+K++ + EI +L + D H
Sbjct: 15 NLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRM-----LIDFCDIALMEIKLLTESDDH 68
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYME---HDLV---GLASLPGMKFTESQVKCYMKQLLS 265
PN+I+ T LY+ E DLV ++ E ++Q+ S
Sbjct: 69 PNVIRYYCSE--TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDH-------------NGILKIADFGLASFFDPKDS--- 309
G+ H HS ++HRD+K N+L+ N + I+DFGL D S
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 310 VPMTSRVVTLWYRPPELLLGASH------YGAAVDLWSTGCILGELFS-GKPVLPGKTEV 362
+ + T +R PELL +++ ++D++S GC+ + S GK P +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--PFGDKY 244
Query: 363 EQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSI 422
+ I + G S D + + R + D L+ ++
Sbjct: 245 SRESNIIR--GIFSLD-------------EMKCLHDRSLIAEATD-------LISQMIDH 282
Query: 423 DPAHRGTATLALNSEFFTT--QPLA--CNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGR 478
DP R TA L F + L S+ + A L ++ V
Sbjct: 283 DPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSG 342
Query: 479 DQKGDLHRS 487
D ++
Sbjct: 343 DWTVKFDKT 351
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-48
Identities = 79/313 (25%), Positives = 131/313 (41%), Gaps = 60/313 (19%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKV------RFDNQDPESVKFMAREIAILRKLDHPN 213
+G G V A + K VA++ + ++ + + EI IL+KL+HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 214 IIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
IIK++ ++ Y+V E ME +VG + E+ K Y Q+L ++
Sbjct: 202 IIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQ 253
Query: 269 HCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
+ H +G++HRD+K N+LL + + ++KI DFG + M + T Y PE
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPE 311
Query: 326 LLLGASH--YGAAVDLWSTGCILGELFSGKPVLP---GKTEVEQLHRIFKLCGSPS--ED 378
+L+ Y AVD WS G IL SG P P +T+V +I G + +
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGKYNFIPE 367
Query: 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
W + ++E D L++ L+ +DP R T AL +
Sbjct: 368 VWAE------------------VSEKALD-------LVKKLLVVDPKARFTTEEALRHPW 402
Query: 439 FTTQPLACNPSNL 451
+ + +L
Sbjct: 403 LQDEDMKRKFQDL 415
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-47
Identities = 79/401 (19%), Positives = 142/401 (35%), Gaps = 78/401 (19%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK-------KVRFDNQDPESVKFMAREIAILR 207
++ +++G G ++ V + R+ A K + E ++ RE++ILR
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE---REVSILR 70
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQ 262
++ HPNII L + + + L+ E + L S +E + ++KQ
Sbjct: 71 QVLHPNIITLHDVY--ENRTDVVLILELVSGGELFDFLAQKES-----LSEEEATSFIKQ 123
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASFFDPKDSVPMTSRVVT 318
+L G+ + H+ + H D+K N++L +K+ DFGLA + + T
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGT 181
Query: 319 LWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378
+ PE++ G D+WS G I L SG G T+ E L I + E+
Sbjct: 182 PEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE 240
Query: 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
++ + +E KDF + L+ + R T AL +
Sbjct: 241 FFSQ------------------TSELAKDF-------IRKLLVKETRKRLTIQEALRHPW 275
Query: 439 FTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLPIPAP 498
T S + + RR W+ + +
Sbjct: 276 ITPVD----TQQAMVRRESVVNLENFKKQYVRRR---------------WKLSFSIVSLC 316
Query: 499 NRDAELSIMQKRHHT-----NSRSKNEMFISQKEAAHAINP 534
N + + T N S E I++++A H
Sbjct: 317 NHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRRR 357
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 52/287 (18%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKV-RFDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
+G G +S V+ + + K+ ALK + + S++ EIA+L+K+ H NI+ LE
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 219 GLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ +++ YLV + + ++ +TE ++Q+LS +++ H +
Sbjct: 73 DIY--ESTTHYYLVMQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN 125
Query: 274 GVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
G++HRD+K NLL + N + I DFGL+ M++ T Y PE+L
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQK 182
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--EDYWRKSKLRHS 388
Y AVD WS G I L G P +TE + +I + G +W
Sbjct: 183 P-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFESPFWDD------ 233
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
I+E+ KDF + L+ DP R T AL+
Sbjct: 234 ------------ISESAKDF-------ICHLLEKDPNERYTCEKALS 261
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-47
Identities = 58/293 (19%), Positives = 112/293 (38%), Gaps = 44/293 (15%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
+IG+G++ +VY+ D VA +++ + E +L+ L HPNI++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 219 G--LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
T + + LV E M + ++ + +Q+L GL+ H+
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT 147
Query: 273 HG--VLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
++HRD+K N+ + G +KI D GLA+ + + T + PE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPE--MY 202
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389
Y +VD+++ G + E+ + + E + +I++ S
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYS---ECQNAAQIYRRVTSGV------------- 246
Query: 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442
KP + I E K+ + + + R + LN FF +
Sbjct: 247 --KPASFDKVAIPE-VKEI------IEGCI-RQNKDERYSIKDLLNHAFFQEE 289
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-47
Identities = 66/206 (32%), Positives = 109/206 (52%), Gaps = 16/206 (7%)
Query: 157 KLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK 216
+G+GTY VY RD+ + +A+K++ +D + + EIA+ + L H NI++
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 217 LEGLITSQTSCSLYLVFEYME----HDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCH 271
G + + + + E + L L S G +K E + Y KQ+L GL++ H
Sbjct: 84 YLG--SFSENGFIKIFMEQVPGGSLSAL--LRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 272 SHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLG 329
+ ++HRDIKG N+L++ ++G+LKI+DFG + + T TL Y PE++
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDK 197
Query: 330 ASH-YGAAVDLWSTGCILGELFSGKP 354
YG A D+WS GC + E+ +GKP
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-47
Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 9/218 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
F+ +G+G + +VY AR+ + I+ALK + + + REI I L HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I+++ +YL+ E+ +L G +F E + +M++L L +CH
Sbjct: 76 ILRMYNYF--HDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE 132
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
V+HRDIK NLL+ + G LKIADFG + S+ + TL Y PPE++ G
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRTMCGTLDYLPPEMIEG-KT 188
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
+ VDLW G + E G P + E RI
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-47
Identities = 71/345 (20%), Positives = 124/345 (35%), Gaps = 60/345 (17%)
Query: 146 GWIPRRANTFEKL----DKIGQGTYSSVYRARDVIHDKIVALK-------KVRFDNQDPE 194
G P + E +++G G ++ V + R+ A K + E
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSRE 60
Query: 195 SVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMK 250
++ RE++ILR++ H N+I L + + + L+ E + D +
Sbjct: 61 EIE---REVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFL----AQKES 111
Query: 251 FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASFFDP 306
+E + ++KQ+L G+ + H+ + H D+K N++L +K+ DFGLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366
+ T + PE++ G D+WS G I L SG G T+ E L
Sbjct: 172 GV--EFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH 426
I + E+++ +E KDF + L+ +
Sbjct: 229 NITSVSYDFDEEFFSH------------------TSELAKDF-------IRKLLVKETRK 263
Query: 427 RGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRR 471
R T AL + T S R + RR
Sbjct: 264 RLTIQEALRHPWITPVD----NQQAMVRRESVVNLENFRKQYVRR 304
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 80/302 (26%), Positives = 123/302 (40%), Gaps = 59/302 (19%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALK-----KVRFDNQDPESVKFM-AREIAILRKL-DHP 212
IG+G S V R A+K R + E V+ RE ILR++ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME-----HDLV--GLASLPGMKFTESQVKCYMKQLLS 265
+II L ++S ++LVF+ M L +E + + M+ LL
Sbjct: 161 HIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKV-------ALSEKETRSIMRSLLE 211
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
+ H++ ++HRD+K N+LLD N ++++DFG + +P + + T Y PE
Sbjct: 212 AVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPE 269
Query: 326 LLLGAS-----HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--ED 378
+L + YG VDLW+ G IL L +G P + ++ L I + G
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQYQFSSP 327
Query: 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
W + T KD L+ L+ +DP R TA AL F
Sbjct: 328 EWDD------------------RSSTVKD-------LISRLLQVDPEARLTAEQALQHPF 362
Query: 439 FT 440
F
Sbjct: 363 FE 364
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 74/372 (19%), Positives = 129/372 (34%), Gaps = 51/372 (13%)
Query: 152 ANTFEKLDKIGQG--TYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL 209
+E L IG+G +V AR + V ++++ + E V F+ E+ + +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLS 265
+HPNI+ + L++V +M DL+ + GM E + ++ +L
Sbjct: 84 NHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLK 139
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS------VPMTSRVVTL 319
L++ H G +HR +K S++L+ +G + ++ V L
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 320 WYRPPELLLGASH-YGAAVDLWSTGCILGELFSGKP---------VL------------- 356
+ PE+L Y A D++S G EL +G +L
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 357 --PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALR 414
E + + S D S R S P PY R + F F L+
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 415 LMETLMSIDPAHRGTATLALNSEFFTT---QPLACNPSNLPKYPPSKEIDAKLRDEESRR 471
+P R +A+ LN FF + P L P + + S
Sbjct: 320 R-------NPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGI 372
Query: 472 HGVAGGRDQKGD 483
G+ ++
Sbjct: 373 FGLVTNLEELEV 384
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-46
Identities = 72/304 (23%), Positives = 127/304 (41%), Gaps = 43/304 (14%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHP 212
T K + +G G + V++ + +A K ++ +D E VK EI+++ +LDH
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHA 146
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
N+I+L ++ + LV EY++ D + + TE +MKQ+ G+
Sbjct: 147 NLIQLYDAF--ESKNDIVLVMEYVDGGELFDRI-IDE--SYNLTELDTILFMKQICEGIR 201
Query: 269 HCHSHGVLHRDIKGSNLLLDH--NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
H H +LH D+K N+L + +KI DFGLA + P++ + T + PE+
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEV 259
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
+ D+WS G I L SG G + E L+ I ++ ++
Sbjct: 260 VNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD---- 314
Query: 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLAC 446
I+E K+F + L+ + + R +A+ AL + + L
Sbjct: 315 --------------ISEEAKEF-------ISKLLIKEKSWRISASEALKHPWLSDHKLHS 353
Query: 447 NPSN 450
S
Sbjct: 354 RLSA 357
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 66/293 (22%), Positives = 121/293 (41%), Gaps = 46/293 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRKLD 210
++ +++G G ++ V + R+ A K ++ ++ S + + RE++IL+++
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSG 266
HPN+I L + + + L+ E + D + TE + ++KQ+L+G
Sbjct: 73 HPNVITLHEVY--ENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNG 126
Query: 267 LEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
+ + HS + H D+K N++L +KI DFGLA D + + T +
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFV 184
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382
PE++ G D+WS G I L SG G T+ E L + + ++Y+
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
+ KDF + L+ DP R T +L
Sbjct: 244 ------------------TSALAKDF-------IRRLLVKDPKKRMTIQDSLQ 271
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 72/294 (24%), Positives = 122/294 (41%), Gaps = 48/294 (16%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRKLD 210
+E +++G G ++ V + R K A K ++ ++ S + + RE+ ILR++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLS 265
HPNII L + + + L+ E + L S TE + ++KQ+L
Sbjct: 67 HPNIITLHDIF--ENKTDVVLILELVSGGELFDFLAEKES-----LTEDEATQFLKQILD 119
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDH----NGILKIADFGLASFFDPKDSVPMTSRVVTLWY 321
G+ + HS + H D+K N++L N +K+ DFG+A + + + T +
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEF 177
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
PE++ G D+WS G I L SG G+T+ E L I + E+Y+
Sbjct: 178 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
+E KDF + L+ DP R T +L
Sbjct: 237 N------------------TSELAKDF-------IRRLLVKDPKRRMTIAQSLE 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 63/307 (20%), Positives = 119/307 (38%), Gaps = 40/307 (13%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH-PNIIKLE 218
++G+G ++ V + + A K ++ + + + EIA+L P +I L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 219 GLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
+ + + + L+ EY L L L M +E+ V +KQ+L G+ + H +
Sbjct: 96 EVY--ENTSEIILILEYAAGGEIFSLC-LPELAEM-VSENDVIRLIKQILEGVYYLHQNN 151
Query: 275 VLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
++H D+K N+LL G +KI DFG++ + + T Y PE+L
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNY-D 208
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
A D+W+ G I L + G+ E I ++ SE+ +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS--------- 259
Query: 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNL 451
+++ DF +++L+ +P R TA + L+ +
Sbjct: 260 ---------VSQLATDF-------IQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPE 303
Query: 452 PKYPPSK 458
S+
Sbjct: 304 ETSSSSQ 310
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-45
Identities = 75/388 (19%), Positives = 137/388 (35%), Gaps = 56/388 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++ +++G G + V+R + A K V + + + +EI + L HP +
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTL 216
Query: 215 IKLEGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ L + + +++E+M +L + K +E + YM+Q+ GL H H +
Sbjct: 217 VNLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 274 GVLHRDIKGSNLLLDHNG--ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
+H D+K N++ LK+ DFGL + DPK + T + PE+ G
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEG-K 331
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
G D+WS G + L SG G+ + E L + + + +
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG--------- 382
Query: 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNL 451
I+E KDF + L+ DP R T AL + T +
Sbjct: 383 ---------ISEDGKDF-------IRKLLLADPNTRMTIHQALEHPWLTP-----GNAPG 421
Query: 452 PKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLPIPAPNRDAELSIMQKRH 511
K+RD + + P+P R + S ++K
Sbjct: 422 RDSQIPSSRYTKIRDSIKTK----------------YDAWPEPLPPLGRISNYSSLRKHR 465
Query: 512 HTNSRSKNEMFISQKEAAHAINPTKQRQ 539
++ + + I +
Sbjct: 466 PQEYSIRDAFWDRSEAQPRFIVKPYGTE 493
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-45
Identities = 88/356 (24%), Positives = 147/356 (41%), Gaps = 50/356 (14%)
Query: 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-------- 209
+ K+G G +S+V+ A+D++++ VA+K VR D E+ + EI +L+++
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKE 80
Query: 210 ---DHPNIIKLEG--LITSQTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQL 263
+I+KL + +VFE + +L+ L VK KQL
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 264 LSGLEHCHSH-GVLHRDIKGSNLLLDH------NGILKIADFGLASFFDPKDSVPMTSRV 316
L GL++ H G++H DIK N+L++ +KIAD G A ++D T+ +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSI 196
Query: 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT------EVEQLHRIFK 370
T YR PE+LLGA +G D+WST C++ EL +G + + + + +I +
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 371 LCGSPSEDYWRKSKL-----------RHSTVFKPVQPYRRRIAETFKDFPTSALR---LM 416
L G R K R+ + K P + E +K A +
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF-WPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 417 ETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRRH 472
++ +DP R A +N + + D EE R H
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEEVRDH 370
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-45
Identities = 72/298 (24%), Positives = 123/298 (41%), Gaps = 55/298 (18%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKL 217
+G+G++S + ++ A+K + + + + +EI L+ + HPNI+KL
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQ---KEITALKLCEGHPNIVKL 71
Query: 218 EGLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
+ +LV E + + F+E++ M++L+S + H H
Sbjct: 72 HEVF--HDQLHTFLVMELLNGGELFERIKKKKH-----FSETEASYIMRKLVSAVSHMHD 124
Query: 273 HGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
GV+HRD+K NLL + N +KI DFG A P + P+ + TL Y PE LL
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPCFTLHYAAPE-LLN 182
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---VEQLHRIFK--LCGSPS--EDYWRK 382
+ Y + DLWS G IL + SG+ I K G S + W+
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN 242
Query: 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
+++ KD L++ L+++DP R + +E+
Sbjct: 243 ------------------VSQEAKD-------LIQGLLTVDPNKRLKMSGLRYNEWLQ 275
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-45
Identities = 91/344 (26%), Positives = 146/344 (42%), Gaps = 75/344 (21%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAR----EIAILR 207
A +E L IG+G++ V +A D + VALK VR + K R EI IL
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILE 148
Query: 208 KL------DHPNIIKLEGLITSQTSCSLYLVFEYME---HDLVGLASLPGMKFTESQVKC 258
L + N+I + T + + + FE + ++L+ G F+ V+
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNH--ICMTFELLSMNLYELIKKNKFQG--FSLPLVRK 204
Query: 259 YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG--ILKIADFGLASFFDPKDSVPMTSRV 316
+ +L L+ H + ++H D+K N+LL G +K+ DFG + + + + + +
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYI 260
Query: 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376
+ +YR PE++LGA YG +D+WS GCIL EL +G P+LPG+ E +QL + +L G PS
Sbjct: 261 QSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 377 EDYWRKSKLRH--------------------STVFKPVQPYRRRIAET------------ 404
+ SK S V + R ++
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 405 -----FKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
F DF L+ + DPA R T AL + +
Sbjct: 380 CDDPLFLDF----LKQC---LEWDPAVRMTPGQALRHPWLRRRL 416
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-45
Identities = 72/315 (22%), Positives = 124/315 (39%), Gaps = 37/315 (11%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
+ +E + IG G + V A + VA+K++ + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGM----KFTESQVKCYM 260
HPNI+ + L+LV + + D++ G ES + +
Sbjct: 70 CHHPNIVSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGL-ASFFDPKDSVPMTSR---V 316
+++L GLE+ H +G +HRD+K N+LL +G ++IADFG+ A D R V
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 317 VTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376
T + PE++ Y D+WS G EL +G ++ L + P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-NDPP- 245
Query: 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436
L + ++ ++F+ + L+ DP R TA L
Sbjct: 246 -------SLETGV---QDKEMLKKYGKSFRKMISLCLQ-------KDPEKRPTAAELLRH 288
Query: 437 EFFTTQPLACNPSNL 451
+FF A N L
Sbjct: 289 KFFQK---AKNKEFL 300
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 63/293 (21%), Positives = 104/293 (35%), Gaps = 56/293 (19%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKL 217
+G G V + ALK + D+ +E+ + P+I+ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKAR------QEVDHHWQASGGPHIVCI 87
Query: 218 EGLI--TSQTSCSLYLVFEYMEHDLVG------LASLPGMKFTESQVKCYMKQLLSGLEH 269
+ L ++ E ME G + FTE + M+ + + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 270 CHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
HSH + HRD+K NLL + + +LK+ DFG A + + T +Y PE
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPE- 199
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK--LCGSPS--EDYWRK 382
+LG Y + D+WS G I+ L G P T + + G W +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
++E K L+ L+ DP R T T +N
Sbjct: 260 ------------------VSEDAKQ-------LIRLLLKTDPTERLTITQFMN 287
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 52/302 (17%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
+G+G Y V A + + ++ VA+K R + PE++K +EI I + L+H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK---KEICINKMLNHENVVKF 70
Query: 218 EGLITSQTSCSLYLVFEYMEH----DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
G YL EY D + P + E + + QL++G+ + H
Sbjct: 71 YGHRREGNI--QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLGASH 332
G+ HRDIK NLLLD LKI+DFGLA+ F + + +++ TL Y PELL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392
+ VD+WS G +L + +G+ LP + ++Y + +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE---KKTYL 228
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLP 452
P+++ ++ L L+ ++ +P+ R T ++ L
Sbjct: 229 N--PWKK--------IDSAPLALLHKILVENPSARITIPDIKKDRWYNK--------PLK 270
Query: 453 KY 454
K
Sbjct: 271 KG 272
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 53/294 (18%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLE 218
IG G+YS R + A+K + ++ EI IL + HPNII L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPT---EEIEILLRYGQHPNIITLK 82
Query: 219 GLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ +Y+V E M+ ++ F+E + + + +E+ H+
Sbjct: 83 DVY--DDGKYVYVVTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQ 135
Query: 274 GVLHRDIKGSNLLL----DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
GV+HRD+K SN+L + ++I DFG A ++ + + T + PE+L
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLER 194
Query: 330 ASHYGAAVDLWSTGCILGELFSGKP---VLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
Y AA D+WS G +L + +G P T E L RI S S YW
Sbjct: 195 -QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS---- 249
Query: 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
+++T KD L+ ++ +DP R TA L L +
Sbjct: 250 --------------VSDTAKD-------LVSKMLHVDPHQRLTAALVLRHPWIV 282
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 81/351 (23%), Positives = 140/351 (39%), Gaps = 56/351 (15%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
+G+G Y V A + + ++ VA+K R + PE++K +EI I + L+H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-CPENIK---KEICINKMLNHENVVKF 70
Query: 218 EGLITSQTSCSLYLVFEYMEH----DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
G YL EY D + P + E + + QL++G+ + H
Sbjct: 71 YGHRREGNI--QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLGASH 332
G+ HRDIK NLLLD LKI+DFGLA+ F + + +++ TL Y PELL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392
+ VD+WS G +L + +G+ LP + ++Y + +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE---KKTYL 228
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLP 452
P+++ ++ L L+ ++ +P+ R T ++ L
Sbjct: 229 N--PWKK--------IDSAPLALLHKILVENPSARITIPDIKKDRWYNK--------PLK 270
Query: 453 KYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLPIPAPNRDAE 503
K + + E + + +L S P E
Sbjct: 271 KGAKRPRVTSGGVSESP----SGFSKHIQSNLDFSPVNSASRTPGSGWSKE 317
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 81/289 (28%), Positives = 121/289 (41%), Gaps = 54/289 (18%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLE 218
++G+G S VYR + K ALK ++ D + V+ EI +L +L HPNIIKL+
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSHPNIIKLK 114
Query: 219 GLITSQTSCSLYLVFEYME-----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ +T + LV E + +V ++E +KQ+L + + H +
Sbjct: 115 EIF--ETPTEISLVLELVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHEN 167
Query: 274 GVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
G++HRD+K NLL + LKIADFGL+ + V M + T Y PE+L G
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEILRG- 224
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK--LCGSPS--EDYWRKSKLR 386
YG VD+WS G I L G P E +F+ L +W +
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRRILNCEYYFISPWWDE---- 277
Query: 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
++ KD L+ +DP R T AL
Sbjct: 278 --------------VSLNAKDLVRK-------LIVLDPKKRLTTFQALQ 305
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-43
Identities = 64/293 (21%), Positives = 107/293 (36%), Gaps = 55/293 (18%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKL 217
+G G V + + + ALK ++ D RE+ + + P+I+++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKAR------REVELHWRASQCPHIVRI 120
Query: 218 EGLI--TSQTSCSLYLVFEYMEHDLVG------LASLPGMKFTESQVKCYMKQLLSGLEH 269
+ L +V E ++ G + FTE + MK + +++
Sbjct: 121 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 270 CHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
HS + HRD+K NLL N ILK+ DFG A + +T+ T +Y PE
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPE- 233
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK--LCGSPS--EDYWRK 382
+LG Y + D+WS G I+ L G P + + G W +
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
++E K L+ L+ +P R T T +N
Sbjct: 294 ------------------VSEEVKM-------LIRNLLKTEPTQRMTITEFMN 321
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 26/207 (12%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGL 220
IG+G ++ V AR ++ + VA+K + +P S++ + RE+ I++ L+HPNI+KL +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 221 ITSQTSCSLYLVFEY----------MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I ++ + LYL+ EY + H + E + + +Q++S +++C
Sbjct: 83 IETEKT--LYLIMEYASGGEVFDYLVAHG----------RMKEKEARSKFRQIVSAVQYC 130
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
H ++HRD+K NLLLD + +KIADFG ++ F + + Y PEL G
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGK 188
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLP 357
+ G VD+WS G IL L SG LP
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGS--LP 213
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 68/309 (22%), Positives = 113/309 (36%), Gaps = 64/309 (20%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKL 217
D +G+G ++ V ++I + A+K + + Q + RE+ +L + H N+++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 218 EGLITSQTSCSLYLVFEYMEHDLVGLASLPG----------MKFTESQVKCYMKQLLSGL 267
+ YLVFE M G F E + ++ + S L
Sbjct: 77 IEFF--EEEDRFYLVFEKMR----------GGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 268 EHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSV------PMTSRVVT 318
+ H+ G+ HRD+K N+L + +KI DF L S + + +
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 319 LWYRPPELLLGASH----YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGS 374
Y PE++ S Y DLWS G IL L SG P G+ + + C +
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 375 PSEDYWRKSKLRHSTVFKPVQ--------PYRRRIAETFKDFPTSALRLMETLMSIDPAH 426
+F+ +Q I+ KD L+ L+ D
Sbjct: 245 CQNM-----------LFESIQEGKYEFPDKDWAHISCAAKD-------LISKLLVRDAKQ 286
Query: 427 RGTATLALN 435
R +A L
Sbjct: 287 RLSAAQVLQ 295
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 68/348 (19%), Positives = 125/348 (35%), Gaps = 80/348 (22%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDV-IHDKIVALKKVRFDNQDPESVKFMAR----EIAIL 206
+ +E +D +G+G + V D + VA+K V+ +V EI +L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVL 65
Query: 207 RKL------DHPNIIKLEG---------LITSQTSCSLYLVFEYM-EHDLVGLASLPGMK 250
L +++ ++ S Y +++ E+ +
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY---DFIKENGFLP-------- 114
Query: 251 FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI------------------ 292
F ++ Q+ + HS+ + H D+K N+L +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 293 -LKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
+K+ DFG A++ D ++ V T YR PE++L + D+WS GCIL E +
Sbjct: 175 DIKVVDFGSATY----DDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYL 229
Query: 352 GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH----------------STVFKPVQ 395
G V P E L + ++ G + +K++ R V + +
Sbjct: 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289
Query: 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
P + + + L++ ++ DPA R T AL FF
Sbjct: 290 PLKEFMLSQDVEHE-RLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 72/360 (20%), Positives = 127/360 (35%), Gaps = 80/360 (22%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDK-IVALKKVRFDNQDPESVKFMAR----EIAIL 206
+E + +G+GT+ V D K VALK +R +V EI +L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 207 RKL------DHPNIIKLEG---------LITSQTSCSLYLVFEYM-EHDLVGLASLPGMK 250
+K+ + + + + + + E++ E++
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF---EFLKENNFQP-------- 119
Query: 251 FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI------------------ 292
+ V+ QL L H + + H D+K N+L ++
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 293 -LKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
+++ADFG A+F D T+ V T YRPPE++L + D+WS GCIL E +
Sbjct: 180 SIRVADFGSATF----DHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYR 234
Query: 352 GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH----------------STVFKPVQ 395
G + E L + K+ G +++ + V + +
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294
Query: 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYP 455
P + + + + LM ++ DPA R T AL FF + + P
Sbjct: 295 PLKSYMLQDSLEHV-QLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNP 353
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 48/347 (13%), Positives = 98/347 (28%), Gaps = 81/347 (23%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP-ESVKFMAREIAILRK 208
R T + +GQ + A D + + F + P ++K M E+ LR
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 209 L-------------------------DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGL 243
L +I++ S + ++ M+ +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 244 ASL------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIAD 297
+ Q++ L H +G++H ++ +++LD G + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 298 FGLASFFDPKDSVPMTSRVVTLWYRPPELL----------LGASHYGAAVDLWSTGCILG 347
F + V+ + PPEL + + D W+ G ++
Sbjct: 250 FEHLVRDGAR-----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 348 ELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKD 407
++ + + IF+ C K+
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSC---------------------------------KN 331
Query: 408 FPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKY 454
P L+E + R A+ + + Q + LP Y
Sbjct: 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTELSAALPLY 377
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 74/340 (21%), Positives = 139/340 (40%), Gaps = 66/340 (19%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA---REIAILRK 208
+ +E IG+G++ V +A D + + VA+K ++ N+ F+ E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK--NKK----AFLNQAQIEVRLLEL 106
Query: 209 L------DHPNIIKLEGLITSQTSCSLYLVFEYME---HDLVGLASLPGMKFTESQVKCY 259
+ I+ L+ + L LVFE + +DL+ + G + + + +
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNH--LCLVFEMLSYNLYDLLRNTNFRG--VSLNLTRKF 162
Query: 260 MKQLLSGLEHCHSH--GVLHRDIKGSNLLLDHNG--ILKIADFGLASFFDPKDSVPMTSR 315
+Q+ + L + ++H D+K N+LL + +KI DFG + + +
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQY 218
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSP 375
+ + +YR PE+LLG Y A+D+WS GCIL E+ +G+P+ G EV+Q+++I ++ G P
Sbjct: 219 IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277
Query: 376 SEDYWRKSKLRH---------STVFKPVQPYRRRIAETFKDFPTSALR------------ 414
++ + K + +R + L
Sbjct: 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337
Query: 415 --------------LMETLMSIDPAHRGTATLALNSEFFT 440
L+ ++ DP R AL FF
Sbjct: 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFK 377
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK-----KVRFDNQDPESVKFMAREIAILRKL 209
+ +G+G + +V+ + VA+K +V + +SV E+A+L K+
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKV 91
Query: 210 D----HPNIIKLEGLITSQTSCSLYLVFEYMEH--DLVGLASLPGMKFTESQVKCYMKQL 263
HP +I+L +Q LV E DL + G E +C+ Q+
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG--FMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQV 148
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
++ ++HCHS GV+HRDIK N+L+D G K+ DFG + D T Y
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDF-DGTRVYS 205
Query: 323 PPELLLGASHYGAAVDLWSTGCIL 346
PPE + ++ +WS G +L
Sbjct: 206 PPEWISRHQYHALPATVWSLGILL 229
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-42
Identities = 68/203 (33%), Positives = 105/203 (51%), Gaps = 10/203 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP-ESVKFMAREIAILRKLDHPN 213
F L +IG G++ +VY ARDV + ++VA+KK+ + + E + + +E+ L+KL HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I+ G + + +LV EY L + E ++ L GL + HSH
Sbjct: 116 TIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA--S 331
++HRD+K N+LL G++K+ DFG AS P +S V T ++ PE++L
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-----VGTPYWMAPEVILAMDEG 228
Query: 332 HYGAAVDLWSTGCILGELFSGKP 354
Y VD+WS G EL KP
Sbjct: 229 QYDGKVDVWSLGITCIELAERKP 251
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 69/337 (20%), Positives = 123/337 (36%), Gaps = 51/337 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK-----KVRFDNQ-DPESVKFMAREIAILRK 208
+ + +G G + V+ A D +K V +K KV D + + + EIAIL +
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEH--DLVGLASLPGMKFTESQVKCYMKQLLSG 266
++H NIIK+ + +Q LV E DL + E +QL+S
Sbjct: 86 VEHANIIKVLDIFENQGF--FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSA 142
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
+ + ++HRDIK N+++ + +K+ DFG A++ + + T+ Y PE+
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--LFYTFCGTIEYCAPEV 200
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGS-PSEDYWRKSKL 385
L+G + G +++WS G L L + P + +
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTL---------------------VFEENPFCEL----EE 235
Query: 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445
P PY + L+ L+ P R T + + TQP+
Sbjct: 236 TVEAAIHP--PYL---------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV-TQPVN 283
Query: 446 CNPSNLPKYPPSKEIDAKLRDEESRRHGVAGGRDQKG 482
+ + ++ + S G D
Sbjct: 284 LADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQ 320
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 26/225 (11%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHP 212
+ +G ++ VY A+DV + ALK++ + + E + + +E+ ++KL HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 213 NIIKLEGLITSQTSCS------LYLVFEYMEHDLVGL--ASLPGMKFTESQVKCYMKQLL 264
NI++ + S L+ E + LV + V Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 265 SGLEHCHSHG--VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS-------- 314
++H H ++HRD+K NLLL + G +K+ DFG A+ ++
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 315 ---RVVTLWYRPPELLLGASH--YGAAVDLWSTGCILGELFSGKP 354
R T YR PE++ S+ G D+W+ GCIL L +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-42
Identities = 75/349 (21%), Positives = 129/349 (36%), Gaps = 84/349 (24%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAR----EIAILR 207
N F + K+G GT+ V + + + K A+K VR ++K R E IL+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILK 86
Query: 208 KL-----DHPNIIKLEG---------LITSQTSCSLYLVFEYM-EHDLVGLASLPGMKFT 252
K+ ++ NI+K G LI SLY E + ++ G F
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIITRNNYNG--------FH 135
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI-------------------- 292
+K Y ++L L + + H D+K N+LLD
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 293 -----LKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILG 347
+K+ DFG A+F S S + T YR PE++L + + D+WS GC+L
Sbjct: 196 TKSTGIKLIDFGCATF----KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLA 250
Query: 348 ELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF------KPVQPYRRRI 401
EL++G + +E L + + ++ ++ + + + K P
Sbjct: 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASS 310
Query: 402 AETFKDFPTSA-----------LRLMETLMSIDPAHRGTATLALNSEFF 439
+ K + +++ IDP R + L +F
Sbjct: 311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 23/256 (8%)
Query: 111 NHHPAIGRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVY 170
+HH + G +P+G T LA + + ++ +G G + SVY
Sbjct: 7 HHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKE------PLESQYQVGPLLGSGGFGSVY 60
Query: 171 RARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRKLDH--PNIIKLEGLITSQ 224
V + VA+K V D + + + E+ +L+K+ +I+L
Sbjct: 61 SGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120
Query: 225 TSCSLYLVFEYMEH--DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKG 282
S L+ E E DL + G E + + Q+L + HCH+ GVLHRDIK
Sbjct: 121 DS--FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 177
Query: 283 SNLLLDHN-GILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWS 341
N+L+D N G LK+ DFG + KD+V T Y PPE + ++G + +WS
Sbjct: 178 ENILIDLNRGELKLIDFGSGALL--KDTVYTDF-DGTRVYSPPEWIRYHRYHGRSAAVWS 234
Query: 342 TGCILGELFSGKPVLP 357
G +L ++ G +P
Sbjct: 235 LGILLYDMVCGD--IP 248
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-41
Identities = 52/392 (13%), Positives = 103/392 (26%), Gaps = 76/392 (19%)
Query: 110 INHHPAIGRLPKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSV 169
N + + + W T + R T + +GQ +
Sbjct: 39 ANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGE----RPRTLVRGTVLGQEDPYAY 94
Query: 170 YRARDVIHDKIVALKKVRFDNQDPES-VKFMAREIAILRKL------------------- 209
A D + + F + P + +K M E+ LR L
Sbjct: 95 LEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154
Query: 210 ------DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL------PGMKFTESQVK 257
+I++ S + ++ M+ +L +
Sbjct: 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL 214
Query: 258 CYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV 317
Q++ L H +G++H ++ +++LD G + + F P+
Sbjct: 215 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFA 274
Query: 318 TLWYRPPELLLGASH----YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG 373
+L H A D W+ G + ++ + IF+ C
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC- 333
Query: 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA 433
K+ P L+E + R A
Sbjct: 334 --------------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQA 361
Query: 434 LNSEFFT---TQPLACNPSNLPKYPPSKEIDA 462
+ + + T+ A P P++E A
Sbjct: 362 METPEYEQLRTELSAALPLYQTDGEPTREGGA 393
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 67/202 (33%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK---KVRFDNQD-PESVKFMAREIAILRKLDHPNIIK 216
+G GT+ V + VA+K + + + D +K REI L+ HP+IIK
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK---REIQNLKLFRHPHIIK 75
Query: 217 LEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
L +I++ T ++V EY+ +L G + E + + +Q+LS +++CH H V
Sbjct: 76 LYQVISTPTD--FFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
+HRD+K N+LLD + KIADFGL++ TS + Y PE++ G + G
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS-CGSPNYAAPEVISGRLYAGP 190
Query: 336 AVDLWSTGCILGELFSGKPVLP 357
VD+WS G IL L G LP
Sbjct: 191 EVDIWSCGVILYALLCGT--LP 210
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 157 KLDK-IGQGTYSSVYRARDVIHDKIVALK---KVRFDNQD-PESVKFMAREIAILRKLDH 211
+ + +G+G++ V A + VALK + D V+ REI+ L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
P+IIKL +IT+ T + +V EY +L + TE + + + +Q++ +E+CH
Sbjct: 69 PHIIKLYDVITTPTD--IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH 125
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
H ++HRD+K NLLLD N +KIADFGL++ + TS + Y PE++ G
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS-CGSPNYAAPEVINGKL 183
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLP 357
+ G VD+WS G +L + G+ LP
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR--LP 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 13/200 (6%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGL 220
IG G + RD + ++VA+K + E+V+ REI R L HPNI++ + +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEV 84
Query: 221 ITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRD 279
I + T L ++ EY +L G +F+E + + + +QLLSG+ +CHS + HRD
Sbjct: 85 ILTPTH--LAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRD 141
Query: 280 IKGSNLLLDHNGI--LKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAV 337
+K N LLD + LKI DFG + S P ++ V T Y PE+LL + G
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKST-VGTPAYIAPEVLLRQEYDGKIA 199
Query: 338 DLWSTGCILGELFSGKPVLP 357
D+WS G L + G P
Sbjct: 200 DVWSCGVTLYVMLVGA--YP 217
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 84/324 (25%), Positives = 139/324 (42%), Gaps = 45/324 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F+ L+K+G+G+Y SVY+A +IVA+K+V + D + + +EI+I+++ D P++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-SDLQEII---KEISIMQQCDSPHV 86
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+K G T L++V EY D++ L + TE ++ ++ L GLE+
Sbjct: 87 VKYYGSYFKNTD--LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYL 141
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
H +HRDIK N+LL+ G K+ADFG+A + + + T ++ PE++
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEI 200
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390
Y D+WS G E+ GKP + + I P R +
Sbjct: 201 G-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPP--------TFRKPEL 250
Query: 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSN 450
+ F DF L P R TAT L F + A S
Sbjct: 251 WSDN----------FTDFVKQCLV-------KSPEQRATATQLLQHPFVRS---AKGVSI 290
Query: 451 L-PKYPPSKEIDAKLRDEESRRHG 473
L + ++ K ++ + R G
Sbjct: 291 LRDLINEAMDVKLKRQESQQREEG 314
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 65/204 (31%), Positives = 112/204 (54%), Gaps = 14/204 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F KL+KIG+G++ V++ D K+VA+K + + + E ++ + +EI +L + D P +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 82
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
K G T L+++ EY+ DL+ PG E+Q+ ++++L GL++
Sbjct: 83 TKYYGSYLKDTK--LWIIMEYLGGGSALDLL----EPG-PLDETQIATILREILKGLDYL 135
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
HS +HRDIK +N+LL +G +K+ADFG+A T V T ++ PE++ +
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQS 194
Query: 331 SHYGAAVDLWSTGCILGELFSGKP 354
+ Y + D+WS G EL G+P
Sbjct: 195 A-YDSKADIWSLGITAIELARGEP 217
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 81/303 (26%), Positives = 137/303 (45%), Gaps = 48/303 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + +KIGQG +VY A DV + VA++++ Q + + EI ++R+ +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--NEILVMRENKNPNI 79
Query: 215 IKLEG--LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+ L+ + L++V EY+ D+V E Q+ ++ L LE
Sbjct: 80 VNYLDSYLVGDE----LWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALE 130
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
HS+ V+HRDIK N+LL +G +K+ DFG + P+ S ++ V T ++ PE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT 189
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
YG VD+WS G + E+ G+P + + L+ I G+P +L++
Sbjct: 190 R-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP--------ELQNP 239
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNP 448
+ F+DF L + D RG+A L +F A
Sbjct: 240 EKLSAI----------FRDFLNRCLEM-------DVEKRGSAKELLQHQFLKI---AKPL 279
Query: 449 SNL 451
S+L
Sbjct: 280 SSL 282
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 15/207 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK-----KVRFDNQDPESVKFMAREIAILRKL 209
F+ +G+G++S+V AR++ + A+K + +N+ V ++ RE ++ +L
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----VPYVTRERDVMSRL 87
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
DHP +KL T Q LY Y ++ +L+ G F E+ + Y +++S LE
Sbjct: 88 DHPFFVKLYF--TFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALE 144
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELL 327
+ H G++HRD+K N+LL+ + ++I DFG A P+ + V T Y PELL
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKP 354
S + DLW+ GCI+ +L +G P
Sbjct: 205 TEKSA-CKSSDLWALGCIIYQLVAGLP 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-40
Identities = 67/297 (22%), Positives = 124/297 (41%), Gaps = 42/297 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E + ++G G + VY+A++ + A K + + + E ++ EI IL DHP I
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDHPYI 78
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
+KL G L+++ E+ ++ TE Q++ +Q+L L
Sbjct: 79 VKLLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFL 133
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
HS ++HRD+K N+L+ G +++ADFG+++ S + T ++ PE+++
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-KRDSFIGTPYWMAPEVVMCE 192
Query: 331 ----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
+ Y D+WS G L E+ +P E+ + + K+ S L
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSDP------PTLL 243
Query: 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
+ + F+DF AL +P R +A L F ++
Sbjct: 244 TPSKWSVE----------FRDFLKIALD-------KNPETRPSAAQLLEHPFVSSIT 283
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 76/292 (26%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLE 218
+G G V + + + ALK ++ D + RE+ + + P+I+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRASQCPHIVRIV 77
Query: 219 GLI--TSQTSCSLYLVFEYMEHDLVG------LASLPGMKFTESQVKCYMKQLLSGLEHC 270
+ L +V E ++ G + FTE + MK + +++
Sbjct: 78 DVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 271 HSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
HS + HRD+K NLL N ILK+ DFG A E
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KETT 171
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK--LCGSPS--EDYWRKS 383
Y + D+WS G I+ L G P + + G W +
Sbjct: 172 --GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE- 228
Query: 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
++E K L+ L+ +P R T T +N
Sbjct: 229 -----------------VSEEVKM-------LIRNLLKTEPTQRMTITEFMN 256
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEG 219
+G+G + + +++ +K+ D E+ + +E+ ++R L+HPN++K G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 220 LITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHR 278
++ L + EY++ L G+ ++ SQ + K + SG+ + HS ++HR
Sbjct: 75 VLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 279 DIKGSNLLLDHNGILKIADFGLA-------------SFFDPKDSVPMTSRVVTLWYRPPE 325
D+ N L+ N + +ADFGLA D + V ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPG 358
++ G Y VD++S G +L E+ P
Sbjct: 193 MING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 13/228 (5%)
Query: 142 EAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA 200
+A W IP +IG G++ +VY+ + VA+K + P+ ++
Sbjct: 14 DAADDWEIPD--GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFK 68
Query: 201 REIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCY 259
E+ +LRK H NI+ G T+ L +V ++ E L KF ++
Sbjct: 69 NEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDI 125
Query: 260 MKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-KDSVPMTSRVVT 318
+Q G+++ H+ ++HRD+K +N+ L + +KI DFGLA+ S +
Sbjct: 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 319 LWYRPPELLLGASH--YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ 364
+ + PE++ Y D+++ G +L EL +G+ +Q
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 76/303 (25%), Positives = 131/303 (43%), Gaps = 48/303 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ KIG+G+ V AR+ + VA+K + Q + F E+ I+R H N+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHFNV 104
Query: 215 IKLEG--LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+++ L+ + L+++ E+++ D+V ++ E Q+ + +L L
Sbjct: 105 VEMYKSYLVGEE----LWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALA 155
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
+ H+ GV+HRDIK ++LL +G +K++DFG + S V T ++ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVIS 214
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
S Y VD+WS G ++ E+ G+P + V+ + R+ P KL++S
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-SPPP--------KLKNS 264
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNP 448
PV +DF L DP R TA L+ F P
Sbjct: 265 HKVSPV----------LRDFLERMLVR-------DPQERATAQELLDHPFLLQ---TGLP 304
Query: 449 SNL 451
L
Sbjct: 305 ECL 307
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-D 210
A FE ++ +G GTY VY+ R V ++ A+K + + E +K +EI +L+K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 79
Query: 211 HPNIIKLEG----LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQ 262
H NI G L+LV E+ DL+ + G E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICRE 137
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
+L GL H H H V+HRDIKG N+LL N +K+ DFG+++ D + + T ++
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWM 196
Query: 323 PPELLLGA----SHYGAAVDLWSTGCILGELFSGKP 354
PE++ + Y DLWS G E+ G P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 70/307 (22%), Positives = 112/307 (36%), Gaps = 39/307 (12%)
Query: 144 IKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMARE 202
I G N E L ++G GT V++ R ++A+K++R + E K + +
Sbjct: 15 IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMD 73
Query: 203 IAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMK 261
+ ++ K D P I++ G + T +++ E M L E +
Sbjct: 74 LDVVLKSHDCPYIVQCFGTFITNTD--VFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 262 QLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW 320
++ L + HGV+HRD+K SN+LLD G +K+ DFG++ D
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRSAGCAA 189
Query: 321 YRPPE----LLLGASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQLHRIFKLCGSP 375
Y PE Y D+WS G L EL +G+ KT+ E L ++ + P
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP 247
Query: 376 SEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
P+ P + F+ F L D R L
Sbjct: 248 -----------------PLLPGHMGFSGDFQSFVKDCLT-------KDHRKRPKYNKLLE 283
Query: 436 SEFFTTQ 442
F
Sbjct: 284 HSFIKRY 290
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 155 FEKLD---KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
+ L+ KIG G++ +V+RA H VA+K + + E V RE+AI+++L H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
PNI+ G +T + L +V EY+ + L+ S + E + + G+
Sbjct: 94 PNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGM 150
Query: 268 EHCHSHG--VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
+ H+ ++HR++K NLL+D +K+ DFGL+ + S T + PE
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPE 209
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGK 353
+L D++S G IL EL + +
Sbjct: 210 VLRD-EPSNEKSDVYSFGVILWELATLQ 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 64/309 (20%), Positives = 116/309 (37%), Gaps = 37/309 (11%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
FEK+ ++G G V++ ++A K + + P + RE+ +L + + P I
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYI 93
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-H 273
+ G S + E+M+ + + E + ++ GL + H
Sbjct: 94 VGFYGAFYSDGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
++HRD+K SN+L++ G +K+ DFG++ DS+ + V T Y PE L G +HY
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANS-FVGTRSYMSPERLQG-THY 207
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
D+WS G L E+ G+ +P E + + + + + K
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 394 VQPYRRRIA----------------------ETFKDFPTSALRLMETLMSIDPAHRGTAT 431
R +A F+DF + + +PA R
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF-------VNKCLIKNPAERADLK 320
Query: 432 LALNSEFFT 440
+ F
Sbjct: 321 QLMVHAFIK 329
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 40/253 (15%), Positives = 82/253 (32%), Gaps = 30/253 (11%)
Query: 153 NTFEKLDKIGQGTYSSVYRAR-----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+G+G ++ VY A D + + LK +P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ--KPANPWEFYIGTQLMERLK 122
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHD-----LVGLASLPGMKFTESQVKCYMKQ 262
+K Q LV E + + + P + V + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLL-----------DHNGILKIADFGLASFFDP-KDSV 310
+L +E H ++H DIK N +L D + L + D G +
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV-LPGKTEVEQLHRIF 369
T++ T ++ E+L + +D + + + G + + + + +F
Sbjct: 241 IFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 370 KLCGSPSEDYWRK 382
+ P D W +
Sbjct: 300 R--RLPHLDMWNE 310
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-38
Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 161 IGQGTYSSVYRARDVIHDKIVALK---KVRFDNQD-PESVKFMAREIAILRKLDHPNIIK 216
+G GT+ V + + VA+K + + + D ++ REI L+ HP+IIK
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---REIQNLKLFRHPHIIK 80
Query: 217 LEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
L +I++ + +++V EY+ +L G + E + + +Q+LSG+++CH H V
Sbjct: 81 LYQVISTPSD--IFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
+HRD+K N+LLD + KIADFGL++ TS + Y PE++ G + G
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS-CGSPNYAAPEVISGRLYAGP 195
Query: 336 AVDLWSTGCILGELFSGKPVLP 357
VD+WS+G IL L G LP
Sbjct: 196 EVDIWSSGVILYALLCGT--LP 215
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 33/210 (15%), Positives = 78/210 (37%), Gaps = 21/210 (10%)
Query: 155 FEKLD---KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
F++L+ K+ + +++ R + +K ++ + + E LR H
Sbjct: 9 FKQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
PN++ + G S + L+ +M +++ L +SQ + + G+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGM 124
Query: 268 EHCHSHG--VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
H+ + + ++++D + +I+ + F R+ + PE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE 178
Query: 326 LLLG--ASHYGAAVDLWSTGCILGELFSGK 353
L + D+WS +L EL + +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 65/304 (21%), Positives = 116/304 (38%), Gaps = 47/304 (15%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAI-LRKL 209
+A+ E + ++G+G Y V + R V +I+A+K++R + + K + ++ I +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTV 63
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYME---HDLVGLASLPGMKFTESQVKCYMKQLLSG 266
D P + G + + ++ E M+ G E + ++
Sbjct: 64 DCPFTVTFYGALFREGDV--WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 267 LEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
LEH HS V+HRD+K SN+L++ G +K+ DFG++ + D V Y PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKDIDAGCKPYMAPE 179
Query: 326 LLLG---ASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQLHRIFKLCGSP---SED 378
+ Y D+WS G + EL + T +QL ++ + D
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPAD 237
Query: 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
+ F DF + L+ + R T + F
Sbjct: 238 KFSAE---------------------FVDFTSQCLK-------KNSKERPTYPELMQHPF 269
Query: 439 FTTQ 442
FT
Sbjct: 270 FTLH 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL- 209
A + L +IG+G Y SV + +I+A+K++R D + K + ++ ++ +
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSS 78
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYM----EHDLVGLASLPGMKFTESQVKCYMKQLLS 265
D P I++ G + + ++ E M + + S+ E + +
Sbjct: 79 DCPYIVQFYGALFREGD--CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 266 GLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPP 324
L H ++HRDIK SN+LLD +G +K+ DFG++ DS+ T Y P
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAP 194
Query: 325 ELLLGASH---YGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQLHRI 368
E + ++ Y D+WS G L EL +G+ P + +QL ++
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-36
Identities = 47/215 (21%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 155 FEKLD---KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
FE+L+ IG+G + VY R VA++ + + + + +K RE+ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
N++ G S L ++ + L + + ++ + ++++ G+ +
Sbjct: 89 ENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASF----FDPKDSVPMTSRVVTLWYRPPEL 326
H+ G+LH+D+K N+ D NG + I DFGL S + + + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 327 LLGAS--------HYGAAVDLWSTGCILGELFSGK 353
+ S + D+++ G I EL + +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 12/209 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDHP 212
FE L IG+G +S V + ++ A+K + + + E F E +L D
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE-ERDVLVNGDRR 121
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
I +L Q LYLV EY DL+ L S G + + Y+ +++ ++ H
Sbjct: 122 WITQLHF--AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG-- 329
G +HRDIK N+LLD G +++ADFG +V V T Y PE+L
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 330 ----ASHYGAAVDLWSTGCILGELFSGKP 354
YG D W+ G E+F G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES-----VKFMAREIAILRKL 209
E +IG+G + V++ R V +VA+K + + + E+ + RE+ I+ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+HPNI+KL GL+ + +V E++ DL S M + G+E
Sbjct: 81 NHPNIVKLYGLMHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 269 HCHSHG--VLHRDIKGSNLLLDHNG-----ILKIADFGLASFFDPKDSVPMTSRVVTLWY 321
+ + ++HRD++ N+ L K+ADFGL+ ++ + +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQW 192
Query: 322 RPPELLLGAS-HYGAAVDLWSTGCILGELFSGK 353
PE + Y D +S IL + +G+
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
E + +G+G + V +A+ K VA+K++ + E F+ E+ L +++HPNI
Sbjct: 10 IEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIE---SESERKAFI-VELRQLSRVNHPNI 63
Query: 215 IKLEGLITSQTSCSLYLVFEYME----HDLVGLASL-PGMKFTESQVKCYMKQLLSGLEH 269
+KL G + + LV EY E +++ L P +T + + Q G+ +
Sbjct: 64 VKLYGACLN----PVCLVMEYAEGGSLYNV--LHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 270 CHSH---GVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
HS ++HRD+K NLLL G +LKI DFG A MT+ + + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPE 173
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGK 353
+ G S+Y D++S G IL E+ + +
Sbjct: 174 VFEG-SNYSEKCDVFSWGIILWEVITRR 200
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 155 FEKLD---KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP--ESVKFMAREIAILRKL 209
F +L IG G + VYRA VA+K R D + ++++ + +E + L
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
HPNII L G+ + +L LV E+ L + L G + + + Q+ G+
Sbjct: 64 KHPNIIALRGVCLKEP--NLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQIARGMN 119
Query: 269 HCHSHG---VLHRDIKGSNLLLD--------HNGILKIADFGLASFFDPKDSVPMTSRVV 317
+ H ++HRD+K SN+L+ N ILKI DFGLA S
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAAG 176
Query: 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK 353
+ PE++ S + D+WS G +L EL +G+
Sbjct: 177 AYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGE 211
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDHP 212
FE L IG+G + V + DK+ A+K + + E+ F E +L D
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE-ERDVLVNGDSK 134
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
I L Q +LYLV +Y DL+ L S + E + Y+ +++ ++ H
Sbjct: 135 WITTLHY--AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL--- 328
+HRDIK N+L+D NG +++ADFG +V + V T Y PE+L
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 329 -GASHYGAAVDLWSTGCILGELFSGKP 354
G YG D WS G + E+ G+
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 11/206 (5%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDHP 212
+E + IG+G + V R K+ A+K + + +S F E I+ + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE-ERDIMAFANSP 129
Query: 213 NIIKLEGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
+++L Q LY+V EYM DLV L + E + Y +++ L+ H
Sbjct: 130 WVVQLFY--AFQDDRYLYMVMEYMPGGDLVNL--MSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL--- 328
S G +HRD+K N+LLD +G LK+ADFG + + V + V T Y PE+L
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 329 GASHYGAAVDLWSTGCILGELFSGKP 354
G +YG D WS G L E+ G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 60/361 (16%), Positives = 108/361 (29%), Gaps = 103/361 (28%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDV----------------------IHDKIVALKKVR 187
R FE + +G+G + V+ A++ + ++ AL K+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 188 FDNQ----------------------------------DPESVKFMAREIAILRKLDHPN 213
P + + +I + N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH-DLVGL--ASLPGMKFTESQVKCYMKQLLSGLEHC 270
+ L S LY+ + +L Q+ +E
Sbjct: 123 TVG--QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLA-----------SFFDPKDSVPMTSRVVTL 319
HS G++HRD+K SN+ + ++K+ DFGL T +V T
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY 379
Y PE + G ++Y VD++S G IL EL T++E++ I +
Sbjct: 241 LYMSPEQIHG-NNYSHKVDIFSLGLILFELLY-----SFSTQMERVRIITDVR------- 287
Query: 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ F +++ ++S P R AT + + F
Sbjct: 288 ------------------NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
Query: 440 T 440
Sbjct: 330 E 330
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 65/305 (21%), Positives = 125/305 (40%), Gaps = 45/305 (14%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
++ + L+ +G + V++A+ + ++ VA+K F QD +S + E+ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 211 HPNIIKLEG--LITSQTSCSLYLVFEYMEH----DLVGLASLPGMKFTESQVKCYMKQLL 264
H NI++ G + L+L+ + E D L + +++ + +
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF-----LKANVVSWNELCHIAETMA 131
Query: 265 SGLEHCHSH----------GVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-KDSVPMT 313
GL + H + HRDIK N+LL +N IADFGLA F+ K +
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 314 SRVVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIF 369
+V T Y PE+L GA +D+++ G +L EL S G + L
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 370 KLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSI----DPA 425
++ PS + ++ + + R + + ++ + + ++ + D
Sbjct: 252 EIGQHPSLEDMQEVVVH--------KKKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAE 301
Query: 426 HRGTA 430
R +A
Sbjct: 302 ARLSA 306
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 75/301 (24%), Positives = 114/301 (37%), Gaps = 45/301 (14%)
Query: 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
+ + +IG+G Y V+ + + VA+K F + S F EI + H NI+
Sbjct: 40 QMVKQIGKGRYGEVWMGK--WRGEKVAVKV--FFTTEEAS-WFRETEIYQTVLMRHENIL 94
Query: 216 KLEG--LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
+ + + LYL+ +Y E +D L + +SGL H
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDY-----LKSTTLDAKSMLKLAYSSVSGLCH 149
Query: 270 CHSH--------GVLHRDIKGSNLLLDHNGILKIADFGLASFFDP---KDSVPMTSRVVT 318
H+ + HRD+K N+L+ NG IAD GLA F + +P +RV T
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 319 LWYRPPELLLGASH-----YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG 373
Y PPE+L + + D++S G IL E+ E + +
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 374 SPSEDYWR---KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
ED KLR P P R E + +LM + +PA R TA
Sbjct: 270 PSYEDMREIVCIKKLR------PSFPNRWSSDECLRQM----GKLMTECWAHNPASRLTA 319
Query: 431 T 431
Sbjct: 320 L 320
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 40/283 (14%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDH 211
+ F +G+G + V+ + K+ A KK+ + + + E IL K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYME------HDLVGLASLPGMKFTESQVKCYMKQLLS 265
I+ L +T L LV M H + + F E + Y Q++S
Sbjct: 245 RFIVSLAY--AFETKTDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTAQIVS 300
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
GLEH H +++RD+K N+LLD +G ++I+D GLA T + PE
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAPE 359
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385
LLLG Y +VD ++ G L E+ + + + E + + +
Sbjct: 360 LLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ--------------- 403
Query: 386 RHSTVFKPVQ-PYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
+ + V P F ++ E L+ DP R
Sbjct: 404 --RVLEQAVTYP---------DKFSPASKDFCEALLQKDPEKR 435
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 73/372 (19%), Positives = 132/372 (35%), Gaps = 92/372 (24%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-- 209
+ + K+G G +S+V+ + D+ K VA+K V+ E+ EI +L+ +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRN 92
Query: 210 ---DHPN---IIKLEG--LITSQTSCSLYLVFEYMEHDLVGL-ASLPGMKFTESQVKCYM 260
+ PN +++L I+ + +VFE + H L+ VK +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 261 KQLLSGLEHCHSH-GVLHRDIKGSNLLL-------------------------------- 287
+Q+L GL++ H+ ++H DIK N+LL
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 288 -----------------DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
+KIAD G A + + + +R YR E+L+G+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEVLIGS 268
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKT------EVEQLHRIFKLCGSPSEDYWRKSK 384
Y D+WST C+ EL +G + + + + + I +L G K
Sbjct: 269 -GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327
Query: 385 -----------LRHSTVFKPVQPYRRRIAETFKDFP----TSALRLMETLMSIDPAHRGT 429
L+H T KP + ++ + ++ + P R T
Sbjct: 328 YSKEFFTKKGDLKHITKLKP--WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385
Query: 430 ATLALNSEFFTT 441
A L + +
Sbjct: 386 AAECLRHPWLNS 397
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 59/235 (25%), Positives = 90/235 (38%), Gaps = 32/235 (13%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
A L+ +G+G Y V+R + VA+K F ++D +S F E+ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGS--WQGENVAVKI--FSSRDEKSW-FRETELYNTVMLRH 61
Query: 212 PNIIKLEG--LITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLS 265
NI+ + + +S L+L+ Y E +D L + + S
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY-----LQLTTLDTVSCLRIVLSIAS 116
Query: 266 GLEHCHS--------HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP---KDSVPMTS 314
GL H H + HRD+K N+L+ NG IAD GLA + V
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 315 RVVTLWYRPPELLLGA-----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ 364
RV T Y PE+L VD+W+ G +L E+ + +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 41/282 (14%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDH 211
NTF + +G+G + V + K+ A KK+ + + E IL K++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYME------HDLVGLASLPGMKFTESQVKCYMKQLLS 265
++ L +T +L LV M H + + F E++ Y ++
Sbjct: 244 RFVVSLAY--AYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYAAEICC 297
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
GLE H +++RD+K N+LLD +G ++I+D GLA ++ RV T+ Y PE
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI--KGRVGTVGYMAPE 355
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385
++ Y + D W+ GC+L E+ +G+ + + + + +
Sbjct: 356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE------------RLVK 402
Query: 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
+ F A L L+ DPA R
Sbjct: 403 EVPEEYSE-------------RFSPQARSLCSQLLCKDPAER 431
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
FE L IG+G++ V + K+ A+K + + V+ + +E+ I++ L+HP
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
++ L + Q +++V + + DL F E VK ++ +L+ L++ +
Sbjct: 77 LVNLWY--SFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQN 133
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL--GA 330
++HRD+K N+LLD +G + I DF +A+ + +T+ T Y PE+
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKG 191
Query: 331 SHYGAAVDLWSTGCILGELFSGKP 354
+ Y AVD WS G EL G+
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 56/225 (24%), Positives = 84/225 (37%), Gaps = 26/225 (11%)
Query: 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNII 215
+ IG+G + V+R + + VA+K F +++ S F EI L H NI+
Sbjct: 45 VLQESIGKGRFGEVWRGK--WRGEEVAVKI--FSSREERSW-FREAEIYQTVMLRHENIL 99
Query: 216 KLEGLITSQTSCS--LYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
L+LV +Y EH L L T + SGL H H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDY--LNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 273 H--------GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS---VPMTSRVVTLWY 321
+ HRD+K N+L+ NG IAD GLA D + RV T Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 322 RPPELLLGAS-----HYGAAVDLWSTGCILGELFSGKPVLPGKTE 361
PE+L + D+++ G + E+ + +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 67/310 (21%), Positives = 125/310 (40%), Gaps = 52/310 (16%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMA-REIAILRKLDHPN 213
+ L+ IG+G Y +VY+ + ++ VA+K F + ++ F+ + I + ++H N
Sbjct: 15 LKLLELIGRGRYGAVYKGS--LDERPVAVKV--FSFANRQN--FINEKNIYRVPLMEHDN 68
Query: 214 IIKLEG---LITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYM-KQLLSGLE 268
I + +T+ LV EY + G L + ++ C + + GL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPN---GSLXKYLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 269 HCHS---------HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-------KDSVPM 312
+ H+ + HRD+ N+L+ ++G I+DFGL+ ++
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 313 TSRVVTLWYRPPELLLGA------SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366
S V T+ Y PE+L GA VD+++ G I E+F L V +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 367 RIF--KLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSI-- 422
F ++ P+ + + R + R + E +K+ A+R ++ +
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSR--------EKQRPKFPEAWKENSL-AVRSLKETIEDCW 296
Query: 423 --DPAHRGTA 430
D R TA
Sbjct: 297 DQDAEARLTA 306
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 8/203 (3%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPN 213
++ +DK+G G S+VY A D I + VA+K + + E++K RE+ +L H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 214 IIKLEGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
I+ + + + YLV EY+E L G + + Q+L G++H H
Sbjct: 73 IVSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHD 129
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLGAS 331
++HRDIK N+L+D N LKI DFG+A + S+ T+ V+ T+ Y PE G
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG-E 187
Query: 332 HYGAAVDLWSTGCILGELFSGKP 354
D++S G +L E+ G+P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEP 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIK 216
+G+G VY A D + ++IVALK + + DP M RE +L P+++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 217 L--EGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ G I Q LY+ + DL + G + ++Q+ S L+ H+
Sbjct: 99 IHDFGEIDGQ----LYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAA 153
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RVV-TLWYRPPELLLGA 330
G HRD+K N+L+ + + DFG+AS +T V TL+Y PE +
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKT 360
H D+++ C+L E +G P G
Sbjct: 211 -HATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 44/219 (20%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK-----KVRFDNQDPESVKFMAREIAILRKL 209
F+ L +G G++ V+ R + + A+K V Q V+ E +L +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ----VEHTNDERLMLSIV 63
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG----------MKFTESQVKCY 259
HP II++ G T Q + ++++ +Y+ G +F K Y
Sbjct: 64 THPFIIRMWG--TFQDAQQIFMIMDYI----------EGGELFSLLRKSQRFPNPVAKFY 111
Query: 260 MKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL 319
++ LE+ HS +++RD+K N+LLD NG +KI DFG A K +T TL
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-----KYVPDVTY---TL 163
Query: 320 W----YRPPELLLGASHYGAAVDLWSTGCILGELFSGKP 354
Y PE++ Y ++D WS G ++ E+ +G
Sbjct: 164 CGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYT 201
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 8/206 (3%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPN 213
+E + +G G S V+ ARD+ + VA+K +R D +DP RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 214 IIKL--EGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I+ + G + Y+V EY++ L + G T + + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS 132
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKDSVPMTSRVV-TLWYRPPELLL 328
H +G++HRD+K +N+++ +K+ DFG+A + D +SV T+ V+ T Y PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 329 GASHYGAAVDLWSTGCILGELFSGKP 354
G A D++S GC+L E+ +G+P
Sbjct: 193 G-DSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVA---LKKVRFDNQDPESVKFMAREI-AILRK 208
N F IG+G + VY R K+ A L K R + E++ R + +++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGL 267
D P I+ + T L + + M DL S G F+E+ ++ Y +++ GL
Sbjct: 249 GDCPFIVCMSY--AFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGL 305
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
EH H+ V++RD+K +N+LLD +G ++I+D GLA F K + V T Y PE+L
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVL 362
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKP 354
Y ++ D +S GC+L +L G
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 65/235 (27%), Positives = 108/235 (45%), Gaps = 37/235 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDN--QDPESVKFMAREIAILRKL 209
FE L +G+G Y V++ R V KI A+K ++ ++ + E IL ++
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG----------MKFTESQVKCY 259
HP I+ L QT LYL+ EY+ G F E Y
Sbjct: 79 KHPFIVDLIY--AFQTGGKLYLILEYL----------SGGELFMQLEREGIFMEDTACFY 126
Query: 260 MKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL 319
+ ++ L H H G+++RD+K N++L+H G +K+ DFGL K+S+ + T
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-----KESIHDGTVTHTF 181
Query: 320 W----YRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
Y PE+L+ + + AVD WS G ++ ++ +G P G+ + + +I K
Sbjct: 182 CGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK-----KVRFDNQDPESVKFMAREIAILRKL 209
F+++ +G G++ V + A+K KV Q ++ E IL+ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ----IEHTLNEKRILQAV 98
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+ P ++KLE + + + +LY+V EY+ ++ G +F+E + Y Q++ E
Sbjct: 99 NFPFLVKLEF--SFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFE 155
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELL 327
+ HS +++RD+K NLL+D G +++ DFG A K T + T PE++
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAPEII 210
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKP 354
L + AVD W+ G ++ E+ +G P
Sbjct: 211 LSKGY-NKAVDWWALGVLIYEMAAGYP 236
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 15/213 (7%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRAR-DVIHDK---IVALKKVRFDNQDPESVKFMAREI 203
+R + +G+G + V R D D VA+K ++ ++ +EI
Sbjct: 18 FEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEI 74
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
ILR L H NI+K +G+ T + L+ E++ L K Q Y Q
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ 134
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL--- 319
+ G+++ S +HRD+ N+L++ +KI DFGL D T +
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPV 193
Query: 320 -WYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
WY PE L+ S + A D+WS G L EL +
Sbjct: 194 FWY-APECLM-QSKFYIASDVWSFGVTLHELLT 224
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDHP 212
F+ L +G+GT+ V R+ + A+K +R + E V E +L+ HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHP 65
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
+ L+ QT L V EY +L S FTE + + Y +++S LE+ H
Sbjct: 66 FLTALKY--AFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH 122
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL----WYRPPELL 327
S V++RDIK NL+LD +G +KI DFGL K+ + + + T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLC-----KEGISDGATMKTFCGTPEYLAPEVL 177
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
YG AVD W G ++ E+ G+ + I
Sbjct: 178 EDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 62/232 (26%), Positives = 111/232 (47%), Gaps = 21/232 (9%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIA 204
+ + +K +G G + V R + K VA+K ++ + + F+ E +
Sbjct: 42 LDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEAS 98
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQL 263
I+ + DHPNII+LEG++T S + +V EYME+ L +FT Q+ ++ +
Sbjct: 99 IMGQFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL---W 320
SG+++ G +HRD+ N+L++ N + K++DFGL + T+R + W
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 321 YRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
PE A Y +A D+WS G +L E+ S G+ + + + +
Sbjct: 217 T-SPE----AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 20/231 (8%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI--VALKKVRFDNQDPESVKFMAREIAI 205
+ R + ++G G + SV + + K VA+K ++ + ++ + M RE I
Sbjct: 6 LKRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQI 63
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLL 264
+ +LD+P I++L G+ ++ L LV E L + S V + Q+
Sbjct: 64 MHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL---WY 321
G+++ +HRD+ N+LL + KI+DFGL+ DS WY
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180
Query: 322 RPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
PE ++ + D+WS G + E S G+ E + I
Sbjct: 181 -APE----CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRAR-DVIHDK---IVALKKVRFDNQDPESVKFMAREI 203
R F + ++G+G + SV R D + D +VA+KK++ + + F REI
Sbjct: 7 FEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REI 62
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
IL+ L H NI+K +G+ S +L L+ EY+ + L + ++ Y Q
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 122
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL--- 319
+ G+E+ + +HRD+ N+L+++ +KI DFGL P+D +
Sbjct: 123 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFKVKEPGESPI 181
Query: 320 -WYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
WY PE L S + A D+WS G +L ELF+
Sbjct: 182 FWY-APESLT-ESKFSVASDVWSFGVVLYELFT 212
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-29
Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 25/218 (11%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARD-VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
A +E I G +Y A D ++ + V LK + D E+ E L ++
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVV 137
Query: 211 HPNIIKL-----EGLITSQTSCSLYLVFEYMEHDLVG--LASLPGMKFTESQVKCYMKQL 263
HP+I+++ Y+V EY+ G L G K ++ Y+ ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPV--GYIVMEYVG----GQSLKRSKGQKLPVAEAIAYLLEI 191
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYR 322
L L + HS G+++ D+K N++L + K+ D G S + + T ++
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVS------RINSFGYLYGTPGFQ 244
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT 360
PE++ A D+++ G L L P G+
Sbjct: 245 APEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 21/232 (9%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIA 204
I EK IG G V R + + VA+K ++ + + F+ E +
Sbjct: 46 IEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEAS 102
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQL 263
I+ + DHPNII+LEG++T +V EYME+ L +FT Q+ ++ +
Sbjct: 103 IMGQFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL---W 320
+G+ + G +HRD+ N+L+D N + K++DFGL+ + T+ + W
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 321 YRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
PE A + +A D+WS G ++ E+ + G+ T + + +
Sbjct: 221 T-APE----AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 55/239 (23%), Positives = 104/239 (43%), Gaps = 21/239 (8%)
Query: 140 AGEAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI---VALKKVRFDNQDPES 195
G + + + I R + IG+G + V++ + + VA+K + D
Sbjct: 3 MGSSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 60
Query: 196 VKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTES 254
KF+ +E +R+ DHP+I+KL G+IT ++++ E +L + +
Sbjct: 61 EKFL-QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLA 116
Query: 255 QVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT- 313
+ Y QL + L + S +HRDI N+L+ N +K+ DFGL+ + + +
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 314 SRVVTLWYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
++ W PE + ++ +A D+W G + E+ G G + + RI
Sbjct: 177 GKLPIKWM-APE----SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 16/213 (7%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRAR-DVIHDK---IVALKKVRFDNQDPESVKFMAREI 203
R F + ++G+G + SV R D + D +VA+KK++ + + F REI
Sbjct: 38 FEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REI 93
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
IL+ L H NI+K +G+ S +L L+ EY+ + L + ++ Y Q
Sbjct: 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQ 153
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL--- 319
+ G+E+ + +HRD+ N+L+++ +KI DFGL P+D +
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYKVKEPGESPI 212
Query: 320 -WYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
WY PE L S + A D+WS G +L ELF+
Sbjct: 213 FWY-APESLT-ESKFSVASDVWSFGVVLYELFT 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVKFMAREI 203
+R + +G+G + V + +VA+K ++ D + +EI
Sbjct: 28 FHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEI 84
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
ILR L H +IIK +G + SL LV EY+ L LP +Q+ + +Q
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQ 142
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA-SFFDPKD--SVPMTSRVVTL 319
+ G+ + H+ +HRD+ N+LLD++ ++KI DFGLA + + + V
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
WY PE L + A D+WS G L EL +
Sbjct: 203 WY-APECLK-EYKFYYASDVWSFGVTLYELLT 232
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 53/234 (22%), Positives = 103/234 (44%), Gaps = 14/234 (5%)
Query: 140 AGEAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKF 198
W + R T + K+G G Y VY + VA+K ++ D + E +F
Sbjct: 208 VSPNYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EF 263
Query: 199 MAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQV 256
+ E A+++++ HPN+++L G+ T Y++ E+M + +L+ L + + +
Sbjct: 264 LK-EAAVMKEIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 320
Query: 257 KCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-DPKDSVPMTSR 315
Q+ S +E+ +HR++ N L+ N ++K+ADFGL+ + ++
Sbjct: 321 LYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 316 VVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W P L + D+W+ G +L E+ + G PG + +
Sbjct: 381 FPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 19/234 (8%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI---VALKKVRFDNQDPESVKFMAREI 203
I + + IG+G + VY + +D A+K + E +F+ E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 77
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
I++ HPN++ L G+ ++ S +V YM+H DL T + + Q
Sbjct: 78 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL--- 319
+ G+++ S +HRD+ N +LD +K+ADFGLA K+ + ++
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 320 -WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W E + D+WS G +L EL + G P P + +
Sbjct: 197 KWM-ALE----SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 37/234 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDN-QDPESVKFMAREIAILRKLD 210
FE L +GQG++ V+ + + ++ A+K ++ + + V+ E IL +++
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG----------MKFTESQVKCYM 260
HP I+KL QT LYL+ +++ G + FTE VK Y+
Sbjct: 85 HPFIVKLH--YAFQTEGKLYLILDFL----------RGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL- 319
+L L+H HS G+++RD+K N+LLD G +K+ DFGL+ K+S+ + +
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-----KESIDHEKKAYSFC 187
Query: 320 ---WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
Y PE++ + + D WS G ++ E+ +G GK E + I K
Sbjct: 188 GTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 22/233 (9%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREI 203
I T +K IG G + VY+ + VA+K ++ + + V F+ E
Sbjct: 41 IHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEA 97
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
I+ + H NII+LEG+I+ + ++ EYME+ L +F+ Q+ ++
Sbjct: 98 GIMGQFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL--- 319
+ +G+++ + +HRD+ N+L++ N + K++DFGL+ + T+ +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 320 WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W PE A Y +A D+WS G ++ E+ + G+ + E + I
Sbjct: 216 WT-APE----AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 45/238 (18%), Positives = 93/238 (39%), Gaps = 22/238 (9%)
Query: 142 EAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVK 197
+A+ + K +G G + +VY+ + + VA+K++R + +
Sbjct: 6 QALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 198 FMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQV 256
+ E ++ +D+P++ +L G+ + T + L+ + M L+ +
Sbjct: 64 IL-DEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 257 KCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS-- 314
+ Q+ G+ + ++HRD+ N+L+ +KI DFGLA ++
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 315 RVVTLWYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
+V W E + + D+WS G + EL + G G E +
Sbjct: 180 KVPIKWM-ALE----SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 75/283 (26%), Positives = 121/283 (42%), Gaps = 51/283 (18%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAIL-RKL 209
F +G+G++ V+ A ++ A+K ++ + D E E +L
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM---VEKRVLSLAW 75
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+HP + + T QT +L+ V EY+ DL+ KF S+ Y +++ GL+
Sbjct: 76 EHPFLTHMFC--TFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQ 132
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL----WYRPP 324
HS G+++RD+K N+LLD +G +KIADFG+ K+++ ++ T Y P
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-----KENMLGDAKTNTFCGTPDYIAP 187
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
E+LLG Y +VD WS G +L E+ G+ G+ E E H I
Sbjct: 188 EILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---------------- 230
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
R F P + A L+ L +P R
Sbjct: 231 -RMDNPFYP------------RWLEKEAKDLLVKLFVREPEKR 260
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 14/212 (6%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRAR-DVIHDKI---VALKKVRFDNQDPESVKFMAREI 203
R + ++G+G + SV R D + D VA+K+++ + P+ + REI
Sbjct: 20 FEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQQRDFQREI 75
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
IL+ L I+K G+ SL LV EY+ L + S++ Y Q
Sbjct: 76 QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL--- 319
+ G+E+ S +HRD+ N+L++ +KIADFGLA +
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFS 351
WY PE L + + D+WS G +L ELF+
Sbjct: 196 WY-APESLS-DNIFSRQSDVWSFGVVLYELFT 225
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 15/225 (6%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
IPR + E K+GQG + V+ + VA+K ++ PE F+ +E +++
Sbjct: 181 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMK 234
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQLLS 265
KL H +++L +++ + +Y+V EYM L+ L G Q+ Q+ S
Sbjct: 235 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-DPKDSVPMTSRVVTLWYRPP 324
G+ + +HRD++ +N+L+ N + K+ADFGLA D + + ++ W P
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
L G + D+WS G +L EL + G+ PG E L ++
Sbjct: 352 AALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 24/234 (10%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRA--RDVIHDKI-VALKKVRFDNQDPESV--KFMARE 202
I + + K+G G++ V R + VA+K ++ D F+ RE
Sbjct: 15 IGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-RE 71
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMK 261
+ + LDH N+I+L G++ + + +V E L+ F + Y
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL-- 319
Q+ G+ + S +HRD+ NLLL ++KI DFGL D + +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 320 -WYRPPELLLGASHYGA---AVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W PE + A D W G L E+F+ G+ G + LH+I
Sbjct: 189 AWC-APE----SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 15/227 (6%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+ ++IG+G + V+ R + +VA+K R KF+ +E IL+
Sbjct: 111 LNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILK 167
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSG 266
+ HPNI++L G+ T + +Y+V E ++ D + G + + + +G
Sbjct: 168 QYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL----WYR 322
+E+ S +HRD+ N L+ +LKI+DFG++ + D V S + W
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWT- 282
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
PE L Y + D+WS G +L E FS G P + + +
Sbjct: 283 APEALN-YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 63/232 (27%), Positives = 100/232 (43%), Gaps = 26/232 (11%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAI 205
W I TF + +IG G + V+ + DK VA+K +R E F+ E +
Sbjct: 3 WVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEE--DFI-EEAEV 56
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLL 264
+ KL HP +++L G+ Q + LV E+MEH L F + +
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 114
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL----W 320
G+ + V+HRD+ N L+ N ++K++DFG+ F D TS T W
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQ-YTSSTGTKFPVKW 171
Query: 321 YRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
PE + + D+WS G ++ E+FS GK ++ E + I
Sbjct: 172 A-SPE----VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 56/230 (24%), Positives = 106/230 (46%), Gaps = 20/230 (8%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAI 205
W + R T + K+G G Y VY + VA+K ++ D + E +F+ +E A+
Sbjct: 8 WEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFL-KEAAV 62
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQL 263
++++ HPN+++L G+ T + Y++ E+M + +L+ L + + + Q+
Sbjct: 63 MKEIKHPNLVQLLGVCTREPP--FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL---- 319
S +E+ +HRD+ N L+ N ++K+ADFGL+ T+
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDT-YTAHAGAKFPIK 177
Query: 320 WYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W PE L + + D+W+ G +L E+ + G PG + +
Sbjct: 178 WT-APESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 54/235 (22%), Positives = 94/235 (40%), Gaps = 27/235 (11%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI---VALKKVRFDNQDPESVKFMARE 202
+ I R + +G+G + VY H VA+K + D KFM E
Sbjct: 7 YGIAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SE 63
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMK 261
I++ LDHP+I+KL G+I + +++ E + +L + Y
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL-- 319
Q+ + + S +HRDI N+L+ +K+ DFGL+ + + +D VT
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLP 177
Query: 320 --WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W PE + ++ A D+W + E+ S GK + + +
Sbjct: 178 IKWM-SPE----SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 16/223 (7%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
FE L +G+GT+ V ++ + A+K ++ + + V E +L+ HP
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
+ L+ + QT L V EY +L S F+E + + Y +++S L++ HS
Sbjct: 210 LTALKY--SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS 266
Query: 273 -HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW----YRPPELL 327
V++RD+K NL+LD +G +KI DFGL K+ + + + T Y PE+L
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLC-----KEGIKDGATMKTFCGTPEYLAPEVL 321
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
+ YG AVD W G ++ E+ G+ + + I
Sbjct: 322 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 29/233 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDN--QDPESVKFMAREIAILRKL 209
FE L +G G Y V+ R + K+ A+K ++ Q ++ + E +L +
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 210 DH-PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG----------MKFTESQVKC 258
P ++ L QT L+L+ +Y+ G +FTE +V+
Sbjct: 116 RQSPFLVTLHY--AFQTETKLHLILDYI----------NGGELFTHLSQRERFTEHEVQI 163
Query: 259 YMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVT 318
Y+ +++ LEH H G+++RDIK N+LLD NG + + DFGL+ F ++ T
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 319 LWYRPPELLLGASH-YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
+ Y P+++ G + AVD WS G ++ EL +G E I +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 28/233 (12%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAI 205
W +PR + ++G G + V+ H K VA+K ++ + P+ F+A E +
Sbjct: 8 WEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPD--AFLA-EANL 61
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQL 263
+++L H +++L ++T + +Y++ EYME+ LV L + G+K T +++ Q+
Sbjct: 62 MKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL---- 319
G+ +HRD++ +N+L+ KIADFGLA + + T+R
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIK 175
Query: 320 WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W PE A +YG D+WS G +L E+ + G+ PG T E + +
Sbjct: 176 WT-APE----AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRKLD 210
F L +G+G++ V + D++ A+K ++ + D E E +L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPG 78
Query: 211 -HPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
P + +L QT LY V EY+ DL+ G +F E Y ++ GL
Sbjct: 79 KPPFLTQLHS--CFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLF 135
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW----YRPP 324
S G+++RD+K N++LD G +KIADFG+ K+++ T Y P
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGTPDYIAP 190
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
E++ YG +VD W+ G +L E+ +G+ G+ E E I +
Sbjct: 191 EIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 19/234 (8%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI---VALKKVRFDNQDPESVKFMAREI 203
I + + IG+G + VY + +D A+K + E +F+ E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEG 141
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
I++ HPN++ L G+ ++ S +V YM+H DL T + + Q
Sbjct: 142 IIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 200
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL--- 319
+ G++ S +HRD+ N +LD +K+ADFGLA K+ + ++
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 320 -WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W E + D+WS G +L EL + G P P + +
Sbjct: 261 KWM-ALE----SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 71/285 (24%), Positives = 125/285 (43%), Gaps = 46/285 (16%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRK-L 209
F+ L IG+G+Y+ V R D+I A+K V+ D++D + V+ E + +
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQAS 67
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+HP ++ L QT L+ V EY+ DL+ K E + Y ++ L
Sbjct: 68 NHPFLVGLHS--CFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALN 124
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL----WYRPP 324
+ H G+++RD+K N+LLD G +K+ D+G+ K+ + T Y P
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTPNYIAP 179
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR-KS 383
E+L G YG +VD W+ G ++ E+ +G+ P F + GS +
Sbjct: 180 EILRGED-YGFSVDWWALGVLMFEMMAGRS--P-----------FDIVGSSDNPDQNTED 225
Query: 384 KLRHSTVFKPVQ-PYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
L + K ++ P + A ++++ ++ DP R
Sbjct: 226 YLFQVILEKQIRIP---------RSLSVKAASVLKSFLNKDPKER 261
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-27
Identities = 67/241 (27%), Positives = 113/241 (46%), Gaps = 16/241 (6%)
Query: 133 PTWLATVAGEAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ 191
PT G A W IPR + E K+GQG + V+ + VA+K ++
Sbjct: 248 PTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM 304
Query: 192 DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGM 249
PE F+ +E +++KL H +++L +++ + +Y+V EYM L+ L G
Sbjct: 305 SPE--AFL-QEAQVMKKLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGK 358
Query: 250 KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF-DPKD 308
Q+ Q+ SG+ + +HRD++ +N+L+ N + K+ADFGLA D +
Sbjct: 359 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418
Query: 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHR 367
+ ++ W P L G + D+WS G +L EL + G+ PG E L +
Sbjct: 419 TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 476
Query: 368 I 368
+
Sbjct: 477 V 477
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 47/340 (13%), Positives = 99/340 (29%), Gaps = 77/340 (22%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD------PESVKFMAREIAIL 206
++ +KIG+G + V++ VA+K + + D ++ + + EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 207 RKL---------DHPNIIKLEGLITSQTSCS----------------------------L 229
++L I L + Q S L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH-SHGVLHRDIKGSNLLLD 288
++V E E + L + + + K + QL + L S HRD+ N+LL
Sbjct: 138 FIVLE-FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 289 HNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGE 348
+ K+ +P V++ Y + + +
Sbjct: 197 KTSLKKLHYTLNGKSST----IPSCGLQVSII-----------DYTLSRLERDGIVVFCD 241
Query: 349 LFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV---------FKPVQPYRR 399
+ + + G + + I++L + + W + + + K + +
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299
Query: 400 RIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
K T+++ A L F
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFSSA----TDLLCQHSLF 335
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 57/244 (23%), Positives = 104/244 (42%), Gaps = 25/244 (10%)
Query: 139 VAGEAI--KGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI--VALKKVRFDNQDP 193
+A E I K + R+ T E ++G G + +V + + + VA+K ++ + DP
Sbjct: 1 MALEEIRPKEVYLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 59
Query: 194 ESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASL-PGMKF 251
+ E ++++LD+P I+++ G+ ++ S LV E E L L
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPL--NKYLQQNRHV 114
Query: 252 TESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311
+ + + Q+ G+++ +HRD+ N+LL KI+DFGL+ ++
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 312 MTSRVVTL---WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQ 364
WY PE +Y + D+WS G ++ E FS G+ G E
Sbjct: 175 KAQTHGKWPVKWY-APE----CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229
Query: 365 LHRI 368
+
Sbjct: 230 TAML 233
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 14/227 (6%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI---VALKKVRFDNQDPESVKFMAREIA 204
I R + IG+G + V++ + + VA+K + D KF+ +E
Sbjct: 387 IQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEAL 443
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQL 263
+R+ DHP+I+KL G+IT ++++ E +L + + + Y QL
Sbjct: 444 TMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL-WYR 322
+ L + S +HRDI N+L+ N +K+ DFGL+ + + + + + W
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
P + + +A D+W G + E+ G G + + RI
Sbjct: 561 PESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 22/226 (9%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRK-L 209
FE + +G+G++ V AR + A+K ++ + D E E IL
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLAR 81
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+HP + +L QT L+ V E++ DL+ +F E++ + Y +++S L
Sbjct: 82 NHPFLTQLFC--CFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALM 138
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL----WYRPP 324
H G+++RD+K N+LLDH G K+ADFG+ K+ + T Y P
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-----KEGICNGVTTATFCGTPDYIAP 193
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370
E+L YG AVD W+ G +L E+ G + E + I
Sbjct: 194 EILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 38/232 (16%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALK----KVRFDNQDPESVKFMAREIAILRKLD 210
F L IG+G++ V AR + A+K K ++ + + R + +L+ +
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNV-LLKNVK 97
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPG----------MKFTESQVKCYM 260
HP ++ L + QT+ LY V +Y+ G F E + + Y
Sbjct: 98 HPFLVGLHF--SFQTADKLYFVLDYI----------NGGELFYHLQRERCFLEPRARFYA 145
Query: 261 KQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL- 319
++ S L + HS +++RD+K N+LLD G + + DFGL K+++ S T
Sbjct: 146 AEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-----KENIEHNSTTSTFC 200
Query: 320 ---WYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
Y PE+L Y VD W G +L E+ G P + E I
Sbjct: 201 GTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 47/229 (20%), Positives = 87/229 (37%), Gaps = 16/229 (6%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVKFMAREI 203
K +G G + +V++ + + V +K + + +
Sbjct: 10 FKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHM 66
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
+ LDH +I++L GL + L LV +Y+ L+ + + Q
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS--RVVTLW 320
+ G+ + HG++HR++ N+LL +++ADFG+A P D + S + W
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 321 YRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
E + Y D+WS G + EL + G G E +
Sbjct: 184 M-ALESIH-FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 19/234 (8%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREI 203
IP IG+G + VY + + A+K + + + F+ RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REG 73
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQ 262
++R L+HPN++ L G++ +++ YM H DL+ P T + + Q
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL--- 319
+ G+E+ +HRD+ N +LD + +K+ADFGLA ++ +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 320 -WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W E + D+WS G +L EL + G P + H +
Sbjct: 193 KWT-ALE----SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMAREIAIL-RKLDH 211
F L +G+G++ V + D++ A+K ++ D QD + V+ E +L
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD-VECTMVEKRVLALPGKP 401
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
P + +L QT LY V EY+ DL+ G +F E Y ++ GL
Sbjct: 402 PFLTQLHS--CFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL 458
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLW----YRPPEL 326
S G+++RD+K N++LD G +KIADFG+ K+++ T Y PE+
Sbjct: 459 QSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGTPDYIAPEI 513
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368
+ YG +VD W+ G +L E+ +G+ G+ E E I
Sbjct: 514 IAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 46/238 (19%), Positives = 96/238 (40%), Gaps = 22/238 (9%)
Query: 142 EAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVK 197
+A+ + F+K+ +G G + +VY+ + + VA+K++R + +
Sbjct: 6 QALLRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 198 FMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQV 256
+ E ++ +D+P++ +L G+ + T + L+ + M L+ +
Sbjct: 64 IL-DEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 257 KCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS-- 314
+ Q+ G+ + ++HRD+ N+L+ +KI DFGLA ++
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 315 RVVTLWYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
+V W E + + D+WS G + EL + G G E +
Sbjct: 180 KVPIKWM-ALE----SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 28/233 (12%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI-VALKKVRFDNQDPESVKFMAREIA 204
+ R T K ++G G + V + VA+K ++ + + +F +E
Sbjct: 3 MELKREEITLLK--ELGSGQFGVVKLG--KWKGQYDVAVKMIKEGSMSED--EFF-QEAQ 55
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQL 263
+ KL HP ++K G+ + + +Y+V EY+ + L+ G SQ+ +
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL---- 319
G+ SH +HRD+ N L+D + +K++DFG+ + S V T
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVK 170
Query: 320 WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W PE HY + D+W+ G ++ E+FS GK T E + ++
Sbjct: 171 WS-APE----VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 60/242 (24%), Positives = 109/242 (45%), Gaps = 28/242 (11%)
Query: 138 TVAGEAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI-VALKKVRFDNQDPES 195
+ AG W I + TF K ++G G + V + + VA+K ++ + +
Sbjct: 10 STAGLGYGSWEIDPKDLTFLK--ELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSED- 64
Query: 196 VKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTES 254
+F+ E ++ L H +++L G+ T Q ++++ EYM + L+ +F
Sbjct: 65 -EFI-EEAKVMMNLSHEKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQ 120
Query: 255 QVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314
Q+ K + +E+ S LHRD+ N L++ G++K++DFGL+ + + TS
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTS 177
Query: 315 RVVTL----WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLH 366
V + W PPE Y + D+W+ G ++ E++S GK T E
Sbjct: 178 SVGSKFPVRWS-PPE----VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232
Query: 367 RI 368
I
Sbjct: 233 HI 234
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 18/237 (7%)
Query: 136 LATVAGEAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPE 194
+A GW + + + IG+G + V VA+K ++ D
Sbjct: 5 VAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA 60
Query: 195 SVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFT 252
F+ E +++ +L H N+++L G+I + LY+V EYM LV L S
Sbjct: 61 ---FL-AEASVMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312
+ + + +E+ + +HRD+ N+L+ + + K++DFGL
Sbjct: 116 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--- 172
Query: 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
T ++ W PE L + D+WS G +L E++S G+ P + + R+
Sbjct: 173 TGKLPVKWT-APEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 70/285 (24%), Positives = 125/285 (43%), Gaps = 46/285 (16%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRK-L 209
F+ L IG+G+Y+ V R D+I A++ V+ D++D + V+ E + +
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEKHVFEQAS 110
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+HP ++ L QT L+ V EY+ DL+ K E + Y ++ L
Sbjct: 111 NHPFLVGLHS--CFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALN 167
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL----WYRPP 324
+ H G+++RD+K N+LLD G +K+ D+G+ K+ + T Y P
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTPNYIAP 222
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR-KS 383
E+L G YG +VD W+ G ++ E+ +G+ P F + GS +
Sbjct: 223 EILRGED-YGFSVDWWALGVLMFEMMAGRS--P-----------FDIVGSSDNPDQNTED 268
Query: 384 KLRHSTVFKPVQ-PYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
L + K ++ P + A ++++ ++ DP R
Sbjct: 269 YLFQVILEKQIRIP---------RSLSVKAASVLKSFLNKDPKER 304
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-26
Identities = 56/249 (22%), Positives = 101/249 (40%), Gaps = 19/249 (7%)
Query: 130 AGWPTWLATVAGEAIKGWIPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI--VALKKVR 187
+ + + + K +R N ++G G + SV + + K VA+K ++
Sbjct: 313 SVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK 372
Query: 188 FDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASL 246
+ ++ + M RE I+ +LD+P I++L G+ ++ L LV E L
Sbjct: 373 QGTEKADTEEMM-REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVG 428
Query: 247 PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306
+ S V + Q+ G+++ +HR++ N+LL + KI+DFGL+
Sbjct: 429 KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488
Query: 307 KDSVPMTSRVVTL---WYRPPELLLGASHYG---AAVDLWSTGCILGELFS-GKPVLPGK 359
DS WY PE ++ + D+WS G + E S G+
Sbjct: 489 DDSYYTARSAGKWPLKWY-APE----CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
Query: 360 TEVEQLHRI 368
E + I
Sbjct: 544 KGPEVMAFI 552
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 40/278 (14%), Positives = 76/278 (27%), Gaps = 58/278 (20%)
Query: 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIK 216
L G ++A D D+ VAL V + ++ L ++D P + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 217 LEGLITSQTSCSLYLVFEYME-HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGV 275
+ ++ ++ +V E++ L +A M+ L + + H GV
Sbjct: 96 VLDVVHTRAGG--LVVAEWIRGGSLQEVADTSPS---PVGAIRAMQSLAAAADAAHRAGV 150
Query: 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA 335
S + + +G + +A P
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA---------------------TMPDA--------NP 181
Query: 336 AVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQ 395
D+ G L L + LP L + P++
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ-----------------PIE 224
Query: 396 PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA 433
P +D P + + D R +TL
Sbjct: 225 PADID-----RDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 22/232 (9%)
Query: 145 KGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREI 203
W IPR + EK K+G G + V+ A H K VA+K ++ + E F+ E
Sbjct: 181 DAWEIPRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE--AFL-AEA 234
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMK 261
+++ L H ++KL ++T + +Y++ E+M L+ L S G K ++ +
Sbjct: 235 NVMKTLQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTL-- 319
Q+ G+ +HRD++ +N+L+ + + KIADFGLA + + T+R
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFP 348
Query: 320 --WYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
W P + G + D+WS G +L E+ + G+ PG + E + +
Sbjct: 349 IKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-25
Identities = 55/236 (23%), Positives = 99/236 (41%), Gaps = 18/236 (7%)
Query: 137 ATVAGEAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPES 195
A GW + + + IG+G + V VA+K ++ D
Sbjct: 178 AAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA- 232
Query: 196 VKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG-LASLPGMKFTE 253
F+ E +++ +L H N+++L G+I + LY+V EYM LV L S
Sbjct: 233 --FL-AEASVMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG 288
Query: 254 SQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313
+ + + +E+ + +HRD+ N+L+ + + K++DFGL T
Sbjct: 289 DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---T 345
Query: 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
++ W PE L + D+WS G +L E++S G+ P + + R+
Sbjct: 346 GKLPVKWT-APEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 47/240 (19%), Positives = 89/240 (37%), Gaps = 32/240 (13%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRAR-------DVIHDKIVALKKVRFDNQDPESVKFMA 200
I F + +GQGT++ +++ +H+ V LK + +++ F
Sbjct: 5 IRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF- 60
Query: 201 REIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCY 259
+++ KL H +++ G+ LV E+++ L
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 260 MKQLLSGLEHCHSHGVLHRDIKGSNLLLD--------HNGILKIADFGLASFFDPKDS-- 309
KQL + + + ++H ++ N+LL + +K++D G++ PKD
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRI 368
+ W PPE + + A D WS G L E+ S G L +L
Sbjct: 179 ERIP------WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 53/256 (20%), Positives = 93/256 (36%), Gaps = 46/256 (17%)
Query: 142 EAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI---VALKKVRFDNQDPESVK 197
++ I R K +G+G + SV D VA+K ++ DN ++
Sbjct: 24 NKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE 81
Query: 198 FMAREIAILRKLDHPNIIKLEGLIT---SQTSCSLYLVFEYMEH-DL-----VGLASLPG 248
E A ++ HPN+I+L G+ SQ ++ +M++ DL
Sbjct: 82 EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 249 MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308
+ +M + G+E+ + LHRD+ N +L + + +ADFGL+ D
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
Query: 309 SVPMTSRVVTLWYR------------PPELLLGASHYG---AAVDLWSTGCILGELFS-G 352
+YR E L + D+W+ G + E+ + G
Sbjct: 202 -----------YYRQGRIAKMPVKWIAIESL----ADRVYTSKSDVWAFGVTMWEIATRG 246
Query: 353 KPVLPGKTEVEQLHRI 368
PG E +
Sbjct: 247 MTPYPGVQNHEMYDYL 262
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 56/259 (21%), Positives = 102/259 (39%), Gaps = 51/259 (19%)
Query: 142 EAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVK 197
E ++ IP + T + +G+G + SV A+ D VA+K ++ D ++
Sbjct: 13 EKLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 198 FMAREIAILRKLDHPNIIKLEGLIT----SQTSCSLYLVFEYMEH-DLVGLASLPGMKFT 252
RE A +++ DHP++ KL G+ ++ +M+H DL A L +
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL--HAFLLASRIG 128
Query: 253 ESQVKCYMKQLL-------SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305
E+ ++ L+ G+E+ S +HRD+ N +L + + +ADFGL+
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 306 PKDSVPMTSRVVTLWYR------------PPELLLGASHYG---AAVDLWSTGCILGELF 350
D +YR E L D+W+ G + E+
Sbjct: 189 SGD-----------YYRQGCASKLPVKWLALESL----ADNLYTVHSDVWAFGVTMWEIM 233
Query: 351 S-GKPVLPGKTEVEQLHRI 368
+ G+ G E + +
Sbjct: 234 TRGQTPYAGIENAEIYNYL 252
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 35/169 (20%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDK---IVALKKVRFDNQDPESVKFMARE 202
+ R T + ++GQG++ VY A+ V+ D+ VA+K V E ++F+ E
Sbjct: 22 VAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NE 78
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVG--LASLPGMKFTESQVKCY 259
+++++ + ++++L G+++ ++ E M DL + P M
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 260 MKQLL-------SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
+ +++ G+ + +++ +HRD+ N ++ + +KI DFG+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/228 (28%), Positives = 99/228 (43%), Gaps = 42/228 (18%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVK----FMAREIAI 205
+K+G+G + VY+ +++ VA+KK+ D + + F EI +
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKG--YVNNTTVAVKKLA-AMVDITTEELKQQFDQ-EIKV 83
Query: 206 LRKLDHPNIIKLEGLITSQTSCS----LYLVFEYME--------HDLVGLASLP-GMKFT 252
+ K H N+++L G S L LV+ YM L G L M+
Sbjct: 84 MAKCQHENLVELLGF------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR-- 135
Query: 253 ESQVKCYMKQLL---SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309
K +G+ H + +HRDIK +N+LLD KI+DFGLA +
Sbjct: 136 -------CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 310 VPMTSRVV-TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL 356
MTSR+V T Y PE L G D++S G +L E+ +G P +
Sbjct: 189 TVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV 234
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 26/175 (14%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRAR-----DVIHDKIVALKKVRFDNQDPESVKFMARE 202
I A F + ++G+ + VY+ + VA+K ++ + P +F E
Sbjct: 6 ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HE 62
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL---------------VGLASL 246
+ +L HPN++ L G++T L ++F Y H DL
Sbjct: 63 AMLRARLQHPNVVCLLGVVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 247 PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
+ Q+ +G+E+ SH V+H+D+ N+L+ +KI+D GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 24/173 (13%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK--IVALKKVRFDNQDPESVKFMAREIAI 205
+ F+ IG+G + V +AR A+K+++ + F E+ +
Sbjct: 22 LDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEV 78
Query: 206 LRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL---------------VGLASLPG 248
L KL HPNII L G + LYL EY H +L +A+
Sbjct: 79 LCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 249 MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
+ Q+ + + G+++ +HRD+ N+L+ N + KIADFGL+
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 46/178 (25%), Positives = 71/178 (39%), Gaps = 27/178 (15%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRA--RDVIHDK---IVALKKVRFDNQDPESVKFMA 200
W PR K +G+G + V A + VA+K ++ E M
Sbjct: 22 WEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM- 78
Query: 201 REIAILRKLD-HPNIIKLEGLITSQTSCSLYLVFEYMEH-DL---------------VGL 243
E+ IL + H N++ L G T + L ++ E+ + +L V
Sbjct: 79 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 244 ASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
L T + CY Q+ G+E S +HRD+ N+LL ++KI DFGLA
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 40/185 (21%), Positives = 76/185 (41%), Gaps = 35/185 (18%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRAR--DVIHDK---IVALKKVRFDNQDPESVKFMA 200
W PR+ K +G+G + V +A + VA+K ++ + E +
Sbjct: 18 WEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL- 74
Query: 201 REIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL------------------- 240
E +L++++HP++IKL G + L L+ EY ++ L
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 241 ----VGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
L T + + Q+ G+++ ++HRD+ N+L+ +KI+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 297 DFGLA 301
DFGL+
Sbjct: 193 DFGLS 197
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 45/183 (24%), Positives = 84/183 (45%), Gaps = 34/183 (18%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDK---IVALKKVRFDNQDPESVKFMARE 202
PR + + IG+G + V++ A ++ + +VA+K ++ + F RE
Sbjct: 44 YPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 100
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL--------------------- 240
A++ + D+PNI+KL G+ + L+FEYM + DL
Sbjct: 101 AALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 241 --VGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298
++S + ++ C +Q+ +G+ + +HRD+ N L+ N ++KIADF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 299 GLA 301
GL+
Sbjct: 219 GLS 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 41/174 (23%), Positives = 77/174 (44%), Gaps = 26/174 (14%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDK---IVALKKVRFDNQDPESVKFMARE 202
I RR + ++G+G + V+ +++ ++ +VA+K ++ + + F RE
Sbjct: 38 IKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-RE 93
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL--------------VGLASLP 247
+L L H +I++ G+ T L +VFEYM H DL G +
Sbjct: 94 AELLTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 248 GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
Q+ Q+ +G+ + +HRD+ N L+ ++KI DFG++
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 61/264 (23%), Positives = 105/264 (39%), Gaps = 40/264 (15%)
Query: 63 GSNRYYDHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKCEVNVINHHPAIGRLPKG 122
GS+ + HH + H++ K++ + R+ V + + RL
Sbjct: 2 GSSHH--HHHHSQDPPAVHKLTKRIP---LRRQVTVSAESSSSMNSNTPLVRITTRLSST 56
Query: 123 VEGEQVAAGWPTWLATVAGEAIKGW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK-- 179
+ +A ++ W PR T K +G+G + V A V DK
Sbjct: 57 ADTPMLAG-----VSEYELPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDK 109
Query: 180 -----IVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVF 233
VA+K ++ D + + + E+ +++ + H NII L G T LY++
Sbjct: 110 PKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIV 166
Query: 234 EYMEH-DL---------------VGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLH 277
EY +L + +P + T + QL G+E+ S +H
Sbjct: 167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 226
Query: 278 RDIKGSNLLLDHNGILKIADFGLA 301
RD+ N+L+ N ++KIADFGLA
Sbjct: 227 RDLAARNVLVTENNVMKIADFGLA 250
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 59/227 (25%), Positives = 107/227 (47%), Gaps = 27/227 (11%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHD-KIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
+ F + +G+G + VY+ R + D +VA+K+++ + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR--LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVH 86
Query: 212 PNIIKLEGL-ITSQTSCSLYLVFEYMEHDLVGLAS-LPGMKFTESQVKCY--MKQLL--- 264
N+++L G +T LV+ YM + +AS L ++ + + L
Sbjct: 87 RNLLRLRGFCMTPTE---RLLVYPYMANG--SVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 265 SGL----EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TL 319
GL +HC ++HRD+K +N+LLD + DFGLA D KD+ +T+ V T+
Sbjct: 142 RGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTI 199
Query: 320 WYRPPE-LLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQ 364
+ PE L G S D++ G +L EL +G + + +
Sbjct: 200 GHIAPEYLSTGKSSEKT--DVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 50/180 (27%), Positives = 79/180 (43%), Gaps = 30/180 (16%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK-------IVALKKVRFDNQDPESVKF 198
W PR T K +G+G + V A V DK VA+K ++ D + +
Sbjct: 30 WEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 199 MAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL---------------V 241
+ E+ +++ + H NII L G T LY++ EY +L
Sbjct: 88 V-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 242 GLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
+ +P + T + QL G+E+ S +HRD+ N+L+ N ++KIADFGLA
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 54/236 (22%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDK---IVALKKVRFDNQDPESVKFMARE 202
+PR+ T + +G G + VY + +D VA+K + + + + F+ E
Sbjct: 27 VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 83
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL------VGLASLPGMKFTESQ 255
I+ K +H NI++ G+ +++ E M DL
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLASFFDPKDSVPM 312
+ + + G ++ + +HRDI N LL G + KI DFG+A
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----------- 190
Query: 313 TSRVV--TLWYR------------PPELLLGASHYG---AAVDLWSTGCILGELFS 351
R + +YR PPE + G + D WS G +L E+FS
Sbjct: 191 --RDIYRASYYRKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFS 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 27/175 (15%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDK---IVALKKVRFDNQDPESVKFMARE 202
I RR ++ ++G+G + V+ ++ K +VA+K ++ D F RE
Sbjct: 12 IKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-RE 67
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL--------VGLASLPGMKFTE 253
+L L H +I+K G+ L +VFEYM+H DL L + +
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 254 SQVKCYMKQLL-------SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
++ + + Q+L SG+ + S +HRD+ N L+ N ++KI DFG++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 65/261 (24%), Positives = 95/261 (36%), Gaps = 59/261 (22%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRA--RDVIHDK---IVALKKVRFDNQDPESVKFMA 200
W PR +F K +G G + V A +I VA+K ++ E M
Sbjct: 18 WEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM- 74
Query: 201 REIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL----------VGLASLPG 248
E+ +L L +H NI+ L G T ++ EY + DL +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 249 MKFTESQVKCYMKQLLS-------GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
+ ++ ++ LLS G+ S +HRD+ N+LL H I KI DFGLA
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 302 SFFDPKDSVPMTSRVV--TLWYR------------PPELLLGASHYGAAVDLWSTGCILG 347
R + Y PE + Y D+WS G L
Sbjct: 193 -------------RDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLW 238
Query: 348 ELFS-GKPVLPGKTEVEQLHR 367
ELFS G PG + ++
Sbjct: 239 ELFSLGSSPYPGMPVDSKFYK 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 30/180 (16%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDK-----IVALKKVRFDNQDPESVKF 198
W +PR K +G+G + V A + DK VA+K ++ D + +
Sbjct: 64 WELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 199 MAREIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL---------------V 241
+ E+ +++ + H NII L G T LY++ EY +L
Sbjct: 122 I-SEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 242 GLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
+ P + + + Q+ G+E+ S +HRD+ N+L+ + ++KIADFGLA
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 20/169 (11%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYR--ARDVIHDK---IVALKKVRFDNQDPESVKFMARE 202
+PR+ T + +G G + VY + +D VA+K + + + + F+ E
Sbjct: 68 VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-ME 124
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL------VGLASLPGMKFTESQ 255
I+ K +H NI++ G+ +++ E M DL
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 256 VKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLA 301
+ + + G ++ + +HRDI N LL G + KI DFG+A
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 43/176 (24%), Positives = 69/176 (39%), Gaps = 26/176 (14%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRA--RDVIHDK---IVALKKVRFDNQDPESVKFMA 200
W PR F K +G G + V A + + VA+K ++ E M
Sbjct: 41 WEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM- 97
Query: 201 REIAILRKLD-HPNIIKLEGLITSQTSCSLYLVFEYMEH-DL-------------VGLAS 245
E+ I+ L H NI+ L G T + ++ EY + DL +
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 246 LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301
+ + + + Q+ G+ S +HRD+ N+LL + + KI DFGLA
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 47/185 (25%), Positives = 73/185 (39%), Gaps = 35/185 (18%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRA--RDVIHDK---IVALKKVRFDNQDPESVKFMA 200
W PR F K +G G + V A + VA+K ++ E M
Sbjct: 40 WEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM- 96
Query: 201 REIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DL---------------VGL 243
E+ ++ +L H NI+ L G T +YL+FEY + DL +
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 244 ASLPGMKFTESQVKCYMKQLLS-------GLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296
+ ++ E + LL G+E +HRD+ N+L+ H ++KI
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 297 DFGLA 301
DFGLA
Sbjct: 215 DFGLA 219
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 49/238 (20%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHD-KIVALKKVRFDNQDPESVK----FMAREIAILR 207
N F+ IG G + VY+ V+ D VALK+ PES + F EI L
Sbjct: 39 NNFDHKFLIGHGVFGKVYKG--VLRDGAKVALKRR-----TPESSQGIEEFET-EIETLS 90
Query: 208 KLDHPNIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYM--K 261
HP+++ L G C + L+++YME+ +L + M +
Sbjct: 91 FCRHPHLVSLIGF------CDERNEMILIYKYMENG-----NLKRHLYGSDLPTMSMSWE 139
Query: 262 QLLS-------GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTS 314
Q L GL + H+ ++HRD+K N+LLD N + KI DFG++ D +++
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199
Query: 315 RVV-TLWYRPPE-----LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366
V TL Y PE L S D++S G +L E+ + + E ++
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKS------DVYSFGVVLFEVLCARSAIVQSLPREMVN 251
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 44/229 (19%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL---------- 209
KIG G + +Y A + A V+ + Q+ + E+ +++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SELKFYQRVAKKDCIKKWI 100
Query: 210 -----DHPNIIKLEGLITSQTSCSLY--LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQ 262
D+ I G ++ Y +V E + DL ++ G F +S V +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLD--HNGILKIADFGLAS-FFDPKDSVPMTSRVVTL 319
+L LE+ H + +H DIK +NLLL + + +AD+GL+ + +
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ------ 213
Query: 320 WYRPPELLLG----AS---HYGAAV----DLWSTGCILGELFSGKPVLP 357
P + G S H G A+ D+ G + GK LP
Sbjct: 214 -ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK--LP 259
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 63/260 (24%), Positives = 101/260 (38%), Gaps = 52/260 (20%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
N + KIG G++ +Y D+ + VA+K + P+ + E I + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQG 63
Query: 212 -PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I + +V E + L L + KF+ V Q++S +E+
Sbjct: 64 GVGIPTIRWC--GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 271 HSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFF-DPKDS--VPMTSRVVTLWYRPP 324
HS +HRD+K N L+ ++ I DFGLA + D + +P YR
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP---------YREN 172
Query: 325 ELLLGASHYGAAV------------DLWSTGCILGELFSGKPVLP-----GKTEVEQLHR 367
+ L G + Y A++ DL S G +L G LP T+ ++ R
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS--LPWQGLKAATKRQKYER 229
Query: 368 IFK---------LC-GSPSE 377
I + LC G PSE
Sbjct: 230 ISEKKMSTPIEVLCKGYPSE 249
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 56/266 (21%), Positives = 103/266 (38%), Gaps = 52/266 (19%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
++ +IG+G++ ++ ++++++ VA+K + P+ + E + L
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 64
Query: 212 -PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I + Q LV + + L L L G KF+ V KQ+L+ ++
Sbjct: 65 CTGIPNVYYF--GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 271 HSHGVLHRDIKGSNLLL-----DHNGILKIADFGLASFF-DPKDSVPMTSRVVTLWYRPP 324
H +++RDIK N L+ + ++ + DFG+ F+ DP + YR
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-------YREK 175
Query: 325 ELLLGASHYGAAV------------DLWSTGCILGELFSGKPVLP-----GKTEVEQLHR 367
+ L G + Y ++ DL + G + G LP T ++ R
Sbjct: 176 KNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS--LPWQGLKAATNKQKYER 232
Query: 368 IFK---------LC-GSPSE--DYWR 381
I + LC G P E Y
Sbjct: 233 IGEKKQSTPLRELCAGFPEEFYKYMH 258
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 9e-16
Identities = 47/229 (20%), Positives = 76/229 (33%), Gaps = 41/229 (17%)
Query: 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLE- 218
IGQG + +Y A + V +P + E+ ++ P I+
Sbjct: 42 PIGQGGFGCIYLADMNS-SESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 219 ----------------GLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQ 262
GL +++ + DL + +F+ V +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLD--HNGILKIADFGLAS-FFDPKDSVPMTSRVVTL 319
+L LE+ H H +H DIK SNLLL+ + + + D+GLA +
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA------ 214
Query: 320 WYRPPELLLG----AS---HYGAAV----DLWSTGCILGELFSGKPVLP 357
P G S H G A DL G + + +G LP
Sbjct: 215 -ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH--LP 260
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 53/246 (21%), Positives = 93/246 (37%), Gaps = 44/246 (17%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
F KIG G + + +++ ++ VA+K ++ P+ + E ++L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ----LHLEYRFYKQLGS 63
Query: 212 -PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I ++ +V E + L L L F+ V QL+S +E+
Sbjct: 64 GDGIPQVYYF--GPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 271 HSHGVLHRDIKGSNLLLDHNG-----ILKIADFGLASFF-DPKDS--VPMTSRVVTLWYR 322
HS +++RD+K N L+ G ++ I DF LA + DP+ +P YR
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP---------YR 172
Query: 323 PPELLLGASHYGAAV------------DLWSTGCILGELFSGKPVLP-----GKTEVEQL 365
+ L G + Y ++ DL + G + G LP T E+
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS--LPWQGLKADTLKERY 229
Query: 366 HRIFKL 371
+I
Sbjct: 230 QKIGDT 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 8e-15
Identities = 65/261 (24%), Positives = 99/261 (37%), Gaps = 48/261 (18%)
Query: 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK 208
PR N F KIG G++ +Y ++ ++ VA+K + P+ + E I R
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRI 58
Query: 209 L-DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
L I + LV + + L L + K + V Q+++ +
Sbjct: 59 LQGGTGIPNVRWFGVEGDYN--VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLASFF-DPKDSVPMTSRVVTLWYRP 323
E HS LHRDIK N L+ + I DFGLA + D + YR
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP-------YRE 169
Query: 324 PELLLGASHYGAAV------------DLWSTGCILGELFSGKPVLP-----GKTEVEQLH 366
+ L G + Y A+V DL S G +L G LP T+ ++
Sbjct: 170 NKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS--LPWQGLKAGTKKQKYE 226
Query: 367 RIFK---------LC-GSPSE 377
+I + LC G P+E
Sbjct: 227 KISEKKVATSIEALCRGYPTE 247
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 39/229 (17%), Positives = 61/229 (26%), Gaps = 41/229 (17%)
Query: 160 KIGQGTYSSVYRARDVI--------HDKIVALKKVRFDNQDPESVKFMAREI-------- 203
+ +Y A + +LK D + F R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 204 AILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGL-ASLPGMKFTESQVKCYMKQ 262
L I G Q +LV + L P +E V +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYR-FLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLL--DHNGILKIADFGLASFF-DPKDSVPMTSRVVTL 319
LL LE H + +H ++ N+ + + + +A +G A + V
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV------ 221
Query: 320 WYRPPELLLG----AS---HYGAAV----DLWSTGCILGELFSGKPVLP 357
G S H G DL S G + + G LP
Sbjct: 222 -EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF--LP 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 5e-11
Identities = 58/496 (11%), Positives = 144/496 (29%), Gaps = 137/496 (27%)
Query: 1 MGGKCAKPT-AVEDSRERLNRKEESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLL--- 56
+ G K A++ + + ++ + ++ T +++L
Sbjct: 158 VLG-SGKTWVALDVCLS--YKVQCKMDFKIFWLNLKNCNS--------PETVLEMLQKLL 206
Query: 57 --IDK----RVNGSNRYYDHHKIEKIAIDDHQVEKK-----MIYDQIERKKKVDEQIEKC 105
ID R + S+ + + K ++ ++ K + C
Sbjct: 207 YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC 266
Query: 106 EV-------NVIN-------HHPAIGRLPKGVEGEQVAAGWPTWLATVAG----EAIKGW 147
++ V + H ++ + ++V + +L E +
Sbjct: 267 KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT- 325
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
PRR + + + G T+ + V DK+ + + + +P + M +++
Sbjct: 326 NPRRLSIIAESIRDGLATWD---NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 208 KLDHPNIIKLEGLITSQTSCSL--YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLS 265
I + + ++ + + L S V+ K+
Sbjct: 383 P-SAH--------IPTILLSLIWFDVIKSDVMVVVNKLHKY-------SLVEKQPKESTI 426
Query: 266 GLEHCHSHGVLHRDIKG--SNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
+ ++ ++K N H I + + + FD D +P +
Sbjct: 427 SI-----PS-IYLELKVKLENEYALHRSI--VDHYNIPKTFDSDDLIPPYLDQYFYSH-- 476
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY-WRK 382
+G H+ ++ E + +F L D+ + +
Sbjct: 477 ----IG--HHLKNIE-------HPERMTLFR------------MVF-L------DFRFLE 504
Query: 383 SKLRHST-----------VFKPVQPYRRRIAE----------TFKDFPTSALRLMETLMS 421
K+RH + + ++ Y+ I + DF L +E +
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF----LPKIEENLI 560
Query: 422 IDPAHRGTATLALNSE 437
+ +AL +E
Sbjct: 561 CSK-YTDLLRIALMAE 575
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 1e-09
Identities = 83/622 (13%), Positives = 174/622 (27%), Gaps = 197/622 (31%)
Query: 11 VEDSRERLNRK--EESLNKHVARVSSSRREEVVRPKGKGDNTDVKVLLIDKRVNGSNRYY 68
+ +E + +K EE L + + S + E + T + I++R +R Y
Sbjct: 71 LLSKQEEMVQKFVEEVLRINYKFLMSPIKTE---QRQPSMMTR---MYIEQR----DRLY 120
Query: 69 DHHKIEKIAIDDHQVEKKMIYDQIERKKKVDEQIEKC------EVNVINHHPAIGRLPKG 122
+ D+QV K + R + ++ + NV+ G
Sbjct: 121 N----------DNQVFAKY---NVSRLQPY-LKLRQALLELRPAKNVLID---------G 157
Query: 123 VEGEQVAAGWPTWLA--TVAGEAIKG-------WI-------PRR-----ANTFEKLDKI 161
V G +G TW+A ++ W+ P ++D
Sbjct: 158 VLG----SG-KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN 212
Query: 162 GQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIK----- 216
+ IH L+++ + +L + +
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC-------LLVLLNVQNAKAWNAFNLS 265
Query: 217 ---LEGLITSQTSCSLYLVFEY-----MEHDLVG---------LASLPGMKFTE--SQVK 257
L L T + +L ++H + L + + +V
Sbjct: 266 CKIL--LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323
Query: 258 CYMKQLLSGL------EHCHSHGVLHRD-------IKGSNLLLDHNGILKIADF-----G 299
+ LS + H + I+ S L+ L+ A++
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS---LNV---LEPAEYRKMFDR 377
Query: 300 LASFFDPKDSVPMTSRV-VTLW----YRPPELLLGASHYGAAVDLWSTGCILGELFSGKP 354
L+ F P + + + +W +++ H + V+
Sbjct: 378 LSVF--PPS-AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP------------- 421
Query: 355 VLPGKTEVEQLHRI-FKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSAL 413
K + I +L +Y L H ++ V Y D L
Sbjct: 422 ----KESTISIPSIYLELKVKLENEY----AL-HRSI---VDHYNIPKTFDSDDLIPPYL 469
Query: 414 R------LMETLMSIDPAHRGTA--TLALNSEFFTTQPLACNPSNLPKYPPSKEIDAKLR 465
+ L +I+ R T + L+ F ++ K+R
Sbjct: 470 DQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF---------------------LEQKIR 508
Query: 466 DEESRRHGVAGGRDQKGDLHRSWRKEYLPIPAPNRDAEL-SIMQ--KRHHTNS-RSKN-- 519
+ + + + L + ++ Y+ P + + +I+ + N SK
Sbjct: 509 HDSTAWNASGSILNTLQQL-KFYKP-YICDNDPKYERLVNAILDFLPKIEENLICSKYTD 566
Query: 520 --EMFISQKEAAHAINPTKQRQ 539
+ + ++ A KQ Q
Sbjct: 567 LLRIALMAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 5e-07
Identities = 49/319 (15%), Positives = 82/319 (25%), Gaps = 103/319 (32%)
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H H H H D + + IL + + FD KD M +++
Sbjct: 1 HHHHH---HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILS---------- 47
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIF-KLCGSPSEDYWRKSKLRH 387
+D I+ K V R+F L E
Sbjct: 48 -----KEEIDH-----IIMS----------KDAVSGTLRLFWTLLSKQEEMV-------- 79
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALR-----LMETLM--SIDPAHRGTATLALNSEFFT 440
+ F LR LM + P ++ + +
Sbjct: 80 ------------------QKFVEEVLRINYKFLMSPIKTEQRQP--------SMMTRMYI 113
Query: 441 TQ--PLACNPSNLPKYP-PSKEIDAKLRD--EESRR------HGVAG-G---------RD 479
Q L + KY + KLR E R GV G G
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 480 QKGDLHRSWRKEYLPIPAPNRDAE-LSIMQKRHHTNSRSKNEMFISQKEAAHAINPTKQR 538
K ++ +L + N L ++QK + + + H+ N +
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS------RSDHSSNIKLRI 227
Query: 539 QSGKEASKDFLDHQRRKVS 557
S + + L + +
Sbjct: 228 HSIQAELRRLLKSKPYENC 246
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 28/129 (21%), Positives = 43/129 (33%), Gaps = 3/129 (2%)
Query: 173 RDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232
+ K + K I + K +I + +S L
Sbjct: 115 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL- 173
Query: 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI 292
+ L T + CY Q+ G+E S +HRD+ N+LL +
Sbjct: 174 --SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 231
Query: 293 LKIADFGLA 301
+KI DFGLA
Sbjct: 232 VKICDFGLA 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 23/99 (23%), Positives = 41/99 (41%), Gaps = 11/99 (11%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK-----IVALKKVRFDNQDPESVKFMA 200
W PR K +G+G + V A DK VA+K ++ + + +
Sbjct: 17 WEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALM 73
Query: 201 REIAILRKLD-HPNIIKLEGLITSQTSCSLYLVFEYMEH 238
E+ IL + H N++ L G T + L ++ E+ +
Sbjct: 74 SELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF 111
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.68 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.45 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.07 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.65 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.38 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.85 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.41 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-59 Score=513.22 Aligned_cols=291 Identities=33% Similarity=0.536 Sum_probs=244.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc----CCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ----TSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~----~~~ 227 (714)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++... ...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4689999999999999999999999999999999987666667778899999999999999999999987543 234
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|||||||+|+++..+. ....|++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 599999999987665554 4568999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 308 ---DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 308 ---~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
......+.+||++|||||++.+..+|+.++||||||||+|||++|++||.+.+..+++..|+...|.|+...|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 22335567999999999999988778999999999999999999999999999999999999999999988775422
Q ss_pred cccCc----cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 385 LRHST----VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 385 ~~~~~----~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
..... .+.+. ....+...++.+++++++||.+||.+||.+||||.|+|+||||+....+
T Consensus 292 ~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 292 AERVRAYIQSLPPR--QPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp --CHHHHHHSSCCC--CCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhhhhhhhcCCCc--CCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 11110 01111 1122345567889999999999999999999999999999999986543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-59 Score=499.17 Aligned_cols=263 Identities=28% Similarity=0.425 Sum_probs=229.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
+.++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+|++|+|||||+++++|.+... +
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--~ 107 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--L 107 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--E
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE--E
Confidence 34689999999999999999999999999999999975421 22345778999999999999999999999976554 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC-
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD- 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~- 308 (714)
|||||||+|+.|..++...+.|++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999998888777767789999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+.+||+.|||||++.+.. |+.++||||||||||+|++|.+||.+.+..+.+.+|.+.--.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-------------- 252 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD-------------- 252 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------
T ss_pred cccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 23455679999999999998876 899999999999999999999999999999988888652110
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHH------HHcCcCCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATL------ALNSEFFTTQPLA 445 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e------~L~Hp~f~~~~~~ 445 (714)
....+++++.+||.+||++||.+|||++| +++||||+...|.
T Consensus 253 ---------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 253 ---------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp ---------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ---------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 11357899999999999999999999987 5899999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-59 Score=504.20 Aligned_cols=259 Identities=24% Similarity=0.430 Sum_probs=222.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++|+|||||++++++.+... +|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~--~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS--LY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--EE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE--EE
Confidence 3478999999999999999999999999999999998877777778899999999999999999999999976554 99
Q ss_pred EEEeecccccccccc--CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLAS--LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~--~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||||+|+.|..++ .....+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999987776655 344568999999999999999999999999999999999999999999999999998764321
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
....+.+||+.|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+.+|....-.
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-------------- 243 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-------------- 243 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------------
T ss_pred -ccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------------
Confidence 1234568999999999998876 899999999999999999999999999999988888652110
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.....+|+++.+||.+||++||++|||++|+|+||||+.
T Consensus 244 --------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 244 --------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 112357999999999999999999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=500.24 Aligned_cols=258 Identities=27% Similarity=0.447 Sum_probs=224.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
..|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|...+. +|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~--~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE--EEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--EEEE
Confidence 4699999999999999999999999999999999765332 23457899999999999999999999987654 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||||+|+.|..++.. ..|++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ...
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 999999888776654 479999999999999999999999999999999999999999999999999999875432 334
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
.+.+||++|||||++.+.. |+.++||||||||||||++|.+||.+.+..+.+..|..... +..
T Consensus 228 ~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~--------------- 290 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRL--------------- 290 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCC---------------
T ss_pred cccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCC---------------
Confidence 5679999999999988766 89999999999999999999999999999888888754211 000
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..+..+|+++.+||.+||++||++|||++|+|+||||+...
T Consensus 291 ----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 291 ----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp ----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 11245889999999999999999999999999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=482.50 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=208.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|+.++|||||++++++..... +|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~--~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE--II 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--EE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE--EE
Confidence 4689999999999999999999999999999999986532 33446678999999999999999999999876554 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||||+|+++..+. ....+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+......
T Consensus 90 ivmEy~~g~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIV-QRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp EEEECCCEEHHHHHH-HSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 999999877766554 44689999999999999999999999999999999999999999999999999998765332
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
...+.+||+.|||||++.+..+++.++|||||||+||+|++|++||.+.+..+.+..|.... +
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~--------------- 229 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--Y--------------- 229 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C---------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--C---------------
Confidence 34567899999999999988766789999999999999999999999998888777775421 1
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.....+|+++.+||.+||++||++|||++|+|+||||+.
T Consensus 230 ------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 ------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 011357899999999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=502.10 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=225.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
..|+++++||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|...+. +|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~--~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE--EEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCE--EEEE
Confidence 5699999999999999999999999999999999865432 34568899999999999999999999987654 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||||+|+.|..++.. ..|++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... ...
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 304 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CCB
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-ccc
Confidence 999999888777654 479999999999999999999999999999999999999999999999999999875432 335
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
.+.+||++|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+..|..... +.
T Consensus 305 ~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~---------------- 366 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR---------------- 366 (423)
T ss_dssp CCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC----------------
T ss_pred cccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC----------------
Confidence 5679999999999998766 89999999999999999999999999999888888754211 00
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
...+..+++++.+||.+||++||++|||+.|+|+||||+..
T Consensus 367 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 367 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 01124689999999999999999999999999999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=475.03 Aligned_cols=257 Identities=21% Similarity=0.289 Sum_probs=218.3
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc--CCceEEEE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ--TSCSLYLV 232 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~--~~~~l~LV 232 (714)
|++.++||+|+||+||+|.+..++..||+|++..........+.+.+|+.+|++|+|||||++++++... ....+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4777889999999999999999999999999987766677788899999999999999999999988642 23458999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcC-CCcEEEeecCcccccCCCCC
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~-~g~vKL~DFGla~~~~~~~~ 309 (714)
||||+|+.|..++.....+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+....
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--- 184 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---
Confidence 999999988887777778999999999999999999999998 999999999999984 79999999999986432
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+.+||+.|||||++.+ . |+.++||||||||||||+||++||.+.+....+...+.. +..+.
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~------------ 249 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA------------ 249 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG------------
T ss_pred CccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCC------------
Confidence 33456799999999998865 3 899999999999999999999999887665555443321 11110
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 250 -------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 250 -------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 1123578899999999999999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-58 Score=487.72 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=216.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
++|++++.||+|+||+||+|++. .+++.||||+++...........+.+|+.+|++|+|||||++++++.+... +
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK--L 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE--E
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE--E
Confidence 67999999999999999999984 468899999997653322333457889999999999999999999987654 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||||||+|+.|..++.....|++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 180 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 180 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-
Confidence 9999999998888777777789999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+.+||+.|||||++.+.. |+.++|||||||+||||++|.+||.+.+..+.+.+|.+..-
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~---------------- 243 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL---------------- 243 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred ccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC----------------
Confidence 2345678999999999998876 89999999999999999999999999999998888865211
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQP 443 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~ 443 (714)
..+..+|+++.+||.+||++||++||| ++|+|+||||+...
T Consensus 244 -------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 244 -------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 012357899999999999999999998 58999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=479.34 Aligned_cols=257 Identities=24% Similarity=0.329 Sum_probs=218.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|++.++||+|+||.||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++.+... +|
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~--~~ 126 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPW--VN 126 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTE--EE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCE--EE
Confidence 34679999999999999999999999999999999986532 2479999999999999999999876554 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~~~~~ 309 (714)
||||||+|+.|..++...+.|++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999988887777667899999999999999999999999999999999999999998 699999999998754322
Q ss_pred C----CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 310 V----PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 310 ~----~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
. .....+||+.|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+.+|... .+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~---------- 273 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PP---------- 273 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CC----------
T ss_pred ccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CC----------
Confidence 1 123458999999999998876 899999999999999999999999988877777666541 11
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHH-------------HcCcCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA-------------LNSEFFTTQP 443 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~-------------L~Hp~f~~~~ 443 (714)
.+.+.++.+|+.+.+||.+||++||.+|||+.|+ |+|||+....
T Consensus 274 --------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 274 --------------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp --------------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred --------------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 1122345789999999999999999999999997 6799998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=481.23 Aligned_cols=288 Identities=27% Similarity=0.392 Sum_probs=227.7
Q ss_pred cccCCCCCeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccc
Q 005111 147 WIPRRANTFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLIT 222 (714)
Q Consensus 147 ~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~ 222 (714)
.+|...+.|+++++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.+ +|||||+++++|.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 35666788999999999999999999875 468899999986542 234578999999998 6999999999987
Q ss_pred ccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-CcEEEeecCcc
Q 005111 223 SQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLA 301 (714)
Q Consensus 223 ~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~-g~vKL~DFGla 301 (714)
..+. +|||||||+|+.+..++. .+++.+++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||+|
T Consensus 91 ~~~~--~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 91 KNDH--VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp ETTE--EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ECCE--EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 6554 999999999877766663 59999999999999999999999999999999999999876 89999999999
Q ss_pred cccCCCC---------------------------CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCC
Q 005111 302 SFFDPKD---------------------------SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKP 354 (714)
Q Consensus 302 ~~~~~~~---------------------------~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~ 354 (714)
+...... ....++.+||++|+|||++.+...|+.++||||+|||+|||++|++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 8654321 1123456899999999999987779999999999999999999998
Q ss_pred CC-CCCChHHHHHHHHHhhCCCChhHHhhhhcccCc--cccCCch-----------------------hhhhhhhhccCC
Q 005111 355 VL-PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST--VFKPVQP-----------------------YRRRIAETFKDF 408 (714)
Q Consensus 355 pF-~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~--~~~~~~p-----------------------~~~~i~~~~~~~ 408 (714)
|| .+.++.+++..|+..+|++....|......... ...+... ......+.+..+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 87 577889999999999998765444321110000 0000000 000112345678
Q ss_pred cHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 409 PTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 409 p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
|+++++||.+||++||++|+||+|+|+||||+..+
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999999998753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-54 Score=455.72 Aligned_cols=260 Identities=24% Similarity=0.393 Sum_probs=200.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC------
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS------ 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~------ 226 (714)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+|||||++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46999999999999999999999999999999998654 34556788999999999999999999998865432
Q ss_pred ----ceEEEEEeeccccccccccCCCCC---CCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecC
Q 005111 227 ----CSLYLVFEYMEHDLVGLASLPGMK---FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFG 299 (714)
Q Consensus 227 ----~~l~LV~Ey~~g~ll~~~~~~~~~---lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFG 299 (714)
..+|||||||+++.|..++..... .++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 247999999999888776655444 3556789999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-----------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHH
Q 005111 300 LASFFDPKDSV-----------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRI 368 (714)
Q Consensus 300 la~~~~~~~~~-----------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I 368 (714)
+|+.+...... ..++.+||+.|||||++.+.. |+.++||||||||||||++ ||.+. .+....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 99877543221 234568999999999998866 8999999999999999996 66543 3333333
Q ss_pred HHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 369 FKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 369 ~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
......... ..+...++.+.+||.+||+.||.+|||+.|+|+||||+...+
T Consensus 238 ~~~~~~~~p-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 238 TDVRNLKFP-------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHTTCCC-------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHhcCCCC-------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 222111100 111234567889999999999999999999999999987654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=487.24 Aligned_cols=268 Identities=23% Similarity=0.380 Sum_probs=232.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+|+++|.+... +||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE--EEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE--EEE
Confidence 468999999999999999999999999999999997643 4456778999999999999999999999976544 999
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC--CcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN--GILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~--g~vKL~DFGla~~~~~~~ 308 (714)
|||||+|+.|..++ .....|++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999987665544 455689999999999999999999999999999999999999854 899999999999876443
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+||++|||||++.+.. |+.++||||||||||||++|.+||.+.+..+++..|......++...
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 379 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA--------- 379 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG---------
T ss_pred --ceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc---------
Confidence 345678999999999998876 89999999999999999999999999999999998876443333222
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNL 451 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~ 451 (714)
+..+++++.+||.+||++||.+|||+.|+|+||||+...++.....+
T Consensus 380 ----------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~~ 426 (573)
T 3uto_A 380 ----------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426 (573)
T ss_dssp ----------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCEE
T ss_pred ----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhhC
Confidence 34689999999999999999999999999999999987665444333
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=443.84 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=209.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.++||+|+||+||+|+.. ..||||+++......+..+.|.+|+.+|++++|||||++++++.. +. +||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~--~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN--LAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS--CEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce--EEE
Confidence 478999999999999999999743 359999998776677788899999999999999999999998754 33 899
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC-C
Q 005111 232 VFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD-S 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~-~ 309 (714)
|||||+++.|..++ .....+++.++..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+...... .
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999988877655 445689999999999999999999999999999999999999999999999999998765332 2
Q ss_pred CCcccccccccccCcccccCC--CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 VPMTSRVVTLWYRPPELLLGA--SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~--~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
......+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+....+..+......++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p----------- 257 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP----------- 257 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-----------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----------
Confidence 234556899999999999753 3489999999999999999999999998877766665543211110
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+.....++|+.+.+||.+||+.||++|||+.+++++
T Consensus 258 ------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 258 ------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp ------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122345789999999999999999999999987654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=483.42 Aligned_cols=262 Identities=26% Similarity=0.355 Sum_probs=219.1
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC----CCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD----NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ 224 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~----~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~ 224 (714)
+...++|++++.||+|+||.||+|+++.+|+.||||++... ...........+++.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 55678999999999999999999999999999999999753 12223333344556777788999999999999766
Q ss_pred CCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
.. +|||||||.||.|..++...+.|++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus 265 ~~--lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 265 DK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp SE--EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CE--EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 54 9999999999888877777778999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh---HHHHHHHHHhhCCCChhHHh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---VEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~~I~k~~G~p~~~~w~ 381 (714)
.... ..+.+||+.|||||++.+...|+.++||||||||||||++|.+||.+.+. .+....+...-
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--------- 410 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------- 410 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC---------
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC---------
Confidence 5432 34569999999999997655589999999999999999999999986532 22233332200
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQPL 444 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~~ 444 (714)
...+..+|+++.+||.+||++||.+|++ ++++++||||+...|
T Consensus 411 --------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 411 --------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred --------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 0112468999999999999999999998 899999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=427.82 Aligned_cols=287 Identities=38% Similarity=0.692 Sum_probs=245.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|++++||||+++++++..... +|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK--LTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE--EEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE--EEEE
Confidence 57999999999999999999999999999999998776666667788899999999999999999999876554 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 9999999888877767789999999999999999999999999999999999999999999999999998765332 233
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCC-CCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK-PVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~-~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
...+||+.|+|||++.+...++.++|||||||++|+|++|. |+|.+.+..+.+..++...+.+....|...........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 45578999999999988776899999999999999999775 55788889999999999999999888865332211111
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+..+....+....+.++..+.+||.+||+.||++|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 222222333445556789999999999999999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=440.57 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=213.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
++|.+.++||+|+||+||+|++. .++..||||+++. ......+.|.+|+.+|++|+|||||++++++.+...
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~- 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP- 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE-
Confidence 68999999999999999999865 3688999999974 345667889999999999999999999999987655
Q ss_pred eEEEEEeeccccccccccCC-------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEE
Q 005111 228 SLYLVFEYMEHDLVGLASLP-------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILK 294 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~-------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vK 294 (714)
+|||||||+++.|..++.. ...|++.++..|+.||+.||.|||+++||||||||+||||+.++.+|
T Consensus 90 -~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 90 -LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp -EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred -EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 9999999999888766532 34699999999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhh
Q 005111 295 IADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLC 372 (714)
Q Consensus 295 L~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~ 372 (714)
|+|||+|+......... ....+||+.|||||++.+.. |+.++|||||||+||||+| |++||.+.+..+.+..|....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999998765433222 22346899999999998766 8999999999999999998 899999999888887775421
Q ss_pred CCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 373 GSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 373 G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
. ...+..+|+++.+||.+||+.||++|||+.+++ +|+..
T Consensus 248 --~--------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 248 --V--------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp --C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred --C--------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 0 011246899999999999999999999999994 56653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=440.05 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=206.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..+|.+.++||+|+||+||+|++. .++..||||+++. ......+.|.+|+.+|++|+|||||++++++.+...
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 367899999999999999999864 4689999999974 345667889999999999999999999999987655
Q ss_pred ceEEEEEeeccccccccccCC---------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLP---------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~---------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
+|||||||+++.|..++.. ..+|++.++..|+.||+.||.|||+++||||||||+||||+.++
T Consensus 118 --~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 118 --LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp --EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred --EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999888765432 24699999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 005111 292 ILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIF 369 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~ 369 (714)
.+||+|||+|+.+...... ..+..+||+.|||||++.+.. |+.++|||||||+||||+| |++||.+.+..+.+..|.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876543332 233467899999999998766 8999999999999999999 899999999888877775
Q ss_pred HhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 370 KLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 370 k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.... + ..+..+|+++.+||.+||+.||++|||+.|++++
T Consensus 275 ~g~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGRE-L---------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCC-C---------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCC-C---------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4210 0 1124688999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=436.79 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=211.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.+++++++||+|+||+||+|... .+++.||||+++... .....+.|.+|+.+|++|+|||||++++++.....
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~- 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP- 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE-
Confidence 56899999999999999999853 467899999997543 33456779999999999999999999999987655
Q ss_pred eEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
+|||||||+++.|..++.. ...|++.++..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 104 -~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 104 -LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp -CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred -EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 8999999999887765522 24589999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHH
Q 005111 292 ILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIF 369 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~ 369 (714)
.+||+|||+|+.+..... ...+..+||+.|||||++.+.. |+.++|||||||+||||+| |.+||.+.+..+.+..|.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999987644332 2344568999999999998766 8999999999999999998 899999999888777764
Q ss_pred HhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 370 KLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 370 k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.... ...+.++|..+.+||.+||+.||++|||+.+++++
T Consensus 262 ~~~~----------------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 262 NRQV----------------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp TTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3110 01124689999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=427.96 Aligned_cols=289 Identities=39% Similarity=0.707 Sum_probs=238.3
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++++.||+|+||+||+|++. +|+.||+|++............+.+|+.+|+.++||||+++++++..... +
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~ 94 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC--L 94 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC--E
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE--E
Confidence 34688999999999999999999984 58999999998765555556778899999999999999999999876554 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||||++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 9999999998888777777779999999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..++..+|.+....|.........
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 22344578999999999987666899999999999999999999999999999999999999999987776542211000
Q ss_pred -cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 -VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 -~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
................+.+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 00000001122334556789999999999999999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=449.98 Aligned_cols=293 Identities=33% Similarity=0.573 Sum_probs=228.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC---Cce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT---SCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~---~~~ 228 (714)
.++|++++.||+|+||+||+|++..+++.||||++..........+.+.+|+.+|+.++|||||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999999999999999999766666677888999999999999999999999885432 245
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||+++++...+. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+....
T Consensus 132 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 89999999887666554 44579999999999999999999999999999999999999999999999999998764322
Q ss_pred C--------------------------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-----------
Q 005111 309 S--------------------------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS----------- 351 (714)
Q Consensus 309 ~--------------------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt----------- 351 (714)
. ...+..+||++|+|||++.+...|+.++||||||||||||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 134566889999999987666669999999999999999998
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHhhCCCChhHHhhhhcccCccccCC--chhhhhhhhhccCCc
Q 005111 352 GKPVLPGKT--------------------EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV--QPYRRRIAETFKDFP 409 (714)
Q Consensus 352 G~~pF~g~~--------------------~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~--~p~~~~i~~~~~~~p 409 (714)
|.++|++.+ ..+++..|+..+|.++.+.|..........+... ......+.+.++.++
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 889998865 3688999999999999887755322111111000 011123445667889
Q ss_pred HHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 410 TSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 410 ~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
..+.+||.+||.+||.+|||++|+|+||||+...++
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 999999999999999999999999999999987544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=440.62 Aligned_cols=290 Identities=33% Similarity=0.576 Sum_probs=229.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.+. ||||+++++++...+...+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999999999999999999766556677788899999999997 99999999998766555699
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC---
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK--- 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~--- 307 (714)
||||||++++...+.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999876555443 47999999999999999999999999999999999999999999999999999876431
Q ss_pred -----------------CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHH
Q 005111 308 -----------------DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFK 370 (714)
Q Consensus 308 -----------------~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k 370 (714)
.....+..+||++|+|||++.+...|+.++||||||||+|||++|.+||.+.+..+++..|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112234568999999999998866689999999999999999999999999999999999999
Q ss_pred hhCCCChhHHhhhhcccCccc---------------cCCch-hhhhh--hhhccCCcHHHHHHHHHhcccCcCCCCCHHH
Q 005111 371 LCGSPSEDYWRKSKLRHSTVF---------------KPVQP-YRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATL 432 (714)
Q Consensus 371 ~~G~p~~~~w~~~~~~~~~~~---------------~~~~p-~~~~i--~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e 432 (714)
.+|.|..+.+.....+....+ ....+ ....+ ......+++.+.+||.+||+.||.+|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 999999877654221110000 00000 00000 0111267899999999999999999999999
Q ss_pred HHcCcCCCCCC
Q 005111 433 ALNSEFFTTQP 443 (714)
Q Consensus 433 ~L~Hp~f~~~~ 443 (714)
+|+||||+...
T Consensus 326 ~l~Hp~~~~~~ 336 (388)
T 3oz6_A 326 ALKHPFVSIFH 336 (388)
T ss_dssp HTTSTTTTTTC
T ss_pred HhCCHHHHHhc
Confidence 99999998653
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=419.48 Aligned_cols=283 Identities=37% Similarity=0.689 Sum_probs=233.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|++ .+|+.||+|++............+.+|+.+|+.++||||+++++++..... +|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR--LVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC--EEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe--EEEE
Confidence 5799999999999999999998 679999999997654433445678899999999999999999999876554 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 9999997777666656789999999999999999999999999999999999999999999999999998765332 223
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc--c
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST--V 390 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~--~ 390 (714)
...++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|......... .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 44578999999999987666899999999999999999999999999999999999999999887777542211000 0
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+.... ..........++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYE--PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCC--CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccc--CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00000 01123344678999999999999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=440.61 Aligned_cols=294 Identities=32% Similarity=0.544 Sum_probs=239.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC---c
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---C 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---~ 227 (714)
..++|++++.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999999999999999998766666778889999999999999999999998865432 3
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+||||||+++++...+ .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 104 ~~~lv~e~~~~~L~~~~-~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCSEEHHHHH-HSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCCcCHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 48999999998665544 44567999999999999999999999999999999999999999999999999999876543
Q ss_pred CC---------------------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-----------CCCC
Q 005111 308 DS---------------------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-----------GKPV 355 (714)
Q Consensus 308 ~~---------------------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-----------G~~p 355 (714)
.. ...+..+||++|+|||++.+...|+.++||||||||+|||++ |.++
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~ 262 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence 22 124667899999999997666669999999999999999998 6778
Q ss_pred CCCCC-----------------hHHHHHHHHHhhCCCChhHHhhhhcccCccccCC--chhhhhhhhhccCCcHHHHHHH
Q 005111 356 LPGKT-----------------EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV--QPYRRRIAETFKDFPTSALRLM 416 (714)
Q Consensus 356 F~g~~-----------------~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~--~p~~~~i~~~~~~~p~~l~~LI 416 (714)
|++.+ ..+++..|+..+|.|+.+.|..........+... ......+...++.+++.+.+||
T Consensus 263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl 342 (432)
T 3n9x_A 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL 342 (432)
T ss_dssp CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence 87765 4789999999999999887755322111100000 0011223445678999999999
Q ss_pred HHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 417 ETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 417 ~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
.+||..||.+|||++|+|+||||+....+
T Consensus 343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 343 ESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 99999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=447.36 Aligned_cols=284 Identities=31% Similarity=0.551 Sum_probs=230.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
.++|++++.||+|+||+||+|.+..+|+.||||++..........+.+.+|+.+|+.++|||||++++++..... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999999999999999998665566677889999999999999999999999865432 3
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|||||||+++++..+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 5899999999988776643 4899999999999999999999999999999999999999999999999999877543
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
...+..+||++|+|||++.+.. |+.++||||||||||+|++|++||.+.+..+++.+|++.+|.|..++|.......
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 2345678999999999998875 8999999999999999999999999999999999999999999988775431100
Q ss_pred ------CccccCCchhhhhhhh--------hccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 ------STVFKPVQPYRRRIAE--------TFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ------~~~~~~~~p~~~~i~~--------~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
...+. ...+...+.. .....++.+.+||.+||.+||.+|||++|+|+||||+..
T Consensus 295 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYA-GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCC-CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccC-CCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00000 0000000000 001126789999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=421.65 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=228.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... +|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT--LY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--EE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE--EE
Confidence 3578999999999999999999999999999999998776667778889999999999999999999999876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||++++.+..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 999999988777666556689999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------- 232 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR---------------- 232 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 3456689999999999998775568999999999999999999999999888777777542110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
....+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 233 -------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 233 -------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp -------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred -------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence 112468899999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=429.96 Aligned_cols=288 Identities=32% Similarity=0.541 Sum_probs=234.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---- 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---- 226 (714)
..+.|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4578999999999999999999999999999999997665566677889999999999999999999998875432
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
..+||||||+++++ ..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~~L-~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFMGTDL-GKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECCSEEH-HHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecCCCCH-HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 34799999995544 433332 4699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .+..++|++|+|||++.+...|+.++||||||||+|+|++|++||.+.+..+++..|++.+|.++.+.+......
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 2 345688999999999988556899999999999999999999999999999999999999999998877543211
Q ss_pred cCccccC--CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 387 HSTVFKP--VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 387 ~~~~~~~--~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
....+.. .......+...+..+++.+.+||.+||..||.+|||+.++|+||||+....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 1000000 000012234556778999999999999999999999999999999997643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=432.34 Aligned_cols=255 Identities=23% Similarity=0.326 Sum_probs=210.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC-CCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH-----DKIVALKKVRFDNQDPESVKFMAREIAILRKLDH-PNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~-----g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||+||+|.+..+ ++.||||++.... .....+.+.+|+.+|.++.| ||||+++++|....
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 36899999999999999999987654 4789999997543 34556789999999999965 89999999886543
Q ss_pred CceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH 289 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~ 289 (714)
..+|||||||+++.|..++.. ...|++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 142 -~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 142 -GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp -SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred -CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 238999999999887765532 245899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHH
Q 005111 290 NGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHR 367 (714)
Q Consensus 290 ~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~ 367 (714)
++.+||+|||+|+.+...... .....+||+.|||||++.+.. |+.++|||||||+||||+| |.+||.+.+..+.+.+
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876543322 234567899999999998766 8999999999999999998 9999998765555444
Q ss_pred HHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 368 IFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 368 I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
++.....+ ..+..+|+++.+||.+||+.||++|||+.++++|
T Consensus 300 ~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 43311111 1123578999999999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=424.12 Aligned_cols=296 Identities=41% Similarity=0.703 Sum_probs=242.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC-----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----- 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----- 225 (714)
..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 457899999999999999999999999999999999766544444556789999999999999999999887643
Q ss_pred -CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 226 -SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 226 -~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
...+||||||++++++..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 3358999999999888877777678999999999999999999999999999999999999999999999999999876
Q ss_pred CCCC---CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 305 DPKD---SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 305 ~~~~---~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
.... .......+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..+...++.++.+.|.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 254 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence 5322 2233456789999999999876668999999999999999999999999999999999999999999888775
Q ss_pred hhhcccC-ccccCCchhhhhhhhhcc--CCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCC
Q 005111 382 KSKLRHS-TVFKPVQPYRRRIAETFK--DFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLAC 446 (714)
Q Consensus 382 ~~~~~~~-~~~~~~~p~~~~i~~~~~--~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~ 446 (714)
....... ............+...+. ..++.+.+||.+||+.||.+|||+.|+|+||||+..+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred ccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 4321110 000000000111111111 2477899999999999999999999999999999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=421.66 Aligned_cols=288 Identities=35% Similarity=0.681 Sum_probs=222.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|+.++||||+++++++..... +||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENK--LTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE--EEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe--EEE
Confidence 4689999999999999999999999999999999986532 2234567899999999999999999999876544 999
Q ss_pred EEeeccccccccccC-----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 232 VFEYMEHDLVGLASL-----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~-----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999999866554322 224589999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
... .....+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..|+..+|.+....|......
T Consensus 161 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred Ccc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 322 2345578999999999987666899999999999999999999999999999999999999999998887653211
Q ss_pred cCcc--c--cCCchhhhhh-hhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTV--F--KPVQPYRRRI-AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~--~--~~~~p~~~~i-~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.... + .+.......+ ......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 1100 0 0011111111 122346889999999999999999999999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=424.74 Aligned_cols=261 Identities=24% Similarity=0.351 Sum_probs=228.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP----ESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.+.|++++.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~- 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD- 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE-
Confidence 467999999999999999999999999999999998653221 235678899999999999999999999876544
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC----cEEEeecCcccc
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG----ILKIADFGLASF 303 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g----~vKL~DFGla~~ 303 (714)
+||||||++|+.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 -~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 90 -VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp -EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred -EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999888887777777899999999999999999999999999999999999998877 799999999988
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
+.... .....+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..|......++.++|
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--- 242 (361)
T 2yab_A 169 IEDGV--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF--- 242 (361)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH---
T ss_pred cCCCC--ccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc---
Confidence 75432 344568999999999998765 899999999999999999999999999999888888765444444433
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 243 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 243 ----------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ----------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 4678999999999999999999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=413.90 Aligned_cols=286 Identities=35% Similarity=0.646 Sum_probs=231.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhC---CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ---DPESVKFMAREIAILRKL---DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~---~~~~~~~~~rEi~iL~~L---~HpnIVkl~~~~~~~~ 225 (714)
.++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.+ .||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 5789999999999999999999999999999999975431 111223456777777766 4999999999886543
Q ss_pred C---ceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 226 S---CSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 226 ~---~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
. ..+++||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 2479999999986666554432 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
..+... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+.+++..++.++...|.
T Consensus 168 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQ--MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTC--CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCC--cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 876533 2345568899999999998766 8999999999999999999999999999999999999999999988875
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.........+.+. ....+....+.++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 245 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPPR--GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCCC--CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCCC--CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 4322111111111 1123345567899999999999999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=421.31 Aligned_cols=294 Identities=41% Similarity=0.711 Sum_probs=237.5
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD---PESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
...++|++++.||+|+||.||+|.+..+|+.||||++...... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3568899999999999999999999999999999999754221 1223467899999999999999999999876554
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 87 --~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (346)
T 1ua2_A 87 --ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164 (346)
T ss_dssp --CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred --eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence 899999999987776666666799999999999999999999999999999999999999999999999999987754
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh-c
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK-L 385 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~-~ 385 (714)
... .....+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..|+..+|.+..+.|.... +
T Consensus 165 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 PNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp CCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred Ccc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 332 23456789999999999876668999999999999999999999999999999999999999999888775421 1
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNP 448 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~~~ 448 (714)
+....+.... ...+...+..++..+.+||.+||..||.+|||+.|+|+||||+..+.+...
T Consensus 244 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~ 304 (346)
T 1ua2_A 244 PDYVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 304 (346)
T ss_dssp TTCCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred cccccccccC--CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCc
Confidence 1111111111 011234556789999999999999999999999999999999987665433
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=422.40 Aligned_cols=287 Identities=36% Similarity=0.673 Sum_probs=231.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++..... +|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS--LTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC--EEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE--EEEE
Confidence 6799999999999999999999999999999999754321 122234579999999999999999999876554 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 9999998877776666679999999999999999999999999999999999999999999999999998654332 223
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC-ccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS-TVF 391 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~-~~~ 391 (714)
...+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+++..+...+|.+....|........ ..+
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 4457899999999998866689999999999999999999999999999999999999999999887754321100 000
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.........+....+.+++.+.+||.+||+.||.+|||++|+|+||||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 0000011122344567899999999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=407.69 Aligned_cols=289 Identities=33% Similarity=0.572 Sum_probs=236.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|++++||||+++++++..... +|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR--LHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--EEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe--EEE
Confidence 368999999999999999999999999999999998776666677888999999999999999999999876544 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 999999998887777677899999999999999999999999999999999999999999999999999987653322 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc--
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST-- 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~-- 389 (714)
....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++......+.........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 345578999999999987666899999999999999999999999999999999999998888776543322111100
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+.......+...++.++..+.+||.+||+.||.+|||++++|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 000111111122334567899999999999999999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=419.84 Aligned_cols=290 Identities=33% Similarity=0.648 Sum_probs=227.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||+||+|++..+++.||||+++.........+.+.+|+.+|+.++||||+++++++..... +|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR--LH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE--EE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE--EE
Confidence 4578999999999999999999999999999999998765555556678899999999999999999999876554 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc-----CCCcEEEeecCcccccC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD-----HNGILKIADFGLASFFD 305 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~-----~~g~vKL~DFGla~~~~ 305 (714)
|||||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+.
T Consensus 110 lv~e~~~~~L~~~~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMD-KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHH-HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999999986555443 445799999999999999999999999999999999999994 55569999999998775
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... ......++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|.....
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Ccc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 332 2234557899999999998866689999999999999999999999999999999999999999998877754321
Q ss_pred ccCccccCCchhhhhhh-hhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIA-ETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~-~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
...............+. .....++..+.+||.+||+.||.+|||+.++|+||||+...+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11100000000000111 112347899999999999999999999999999999997643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=425.19 Aligned_cols=288 Identities=33% Similarity=0.541 Sum_probs=224.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC----Cc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----SC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----~~ 227 (714)
.++|++++.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999999999999999999766556667788999999999999999999999886531 23
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+++++...+ .. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 108 ~~~lv~e~~~~~L~~~~-~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIV-KC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHH-hc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 48999999966554443 33 57999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
....+||++|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|++.+|.|+.+.|.......
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 3456889999999999886668999999999999999999999999999999999999999999988775432110
Q ss_pred CccccC--CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 388 STVFKP--VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 388 ~~~~~~--~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
...+.. .......+...+..+++.+.+||.+||..||.+|||+.++|+||||.....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 000000 0000122345566789999999999999999999999999999999976543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=420.62 Aligned_cols=283 Identities=31% Similarity=0.532 Sum_probs=230.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc------
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ------ 224 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~------ 224 (714)
..++|++++.||+|+||.||+|.+..+|+.||||++..+... ..+|+.+|+.++|||||++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 457899999999999999999999999999999998754321 23799999999999999999987442
Q ss_pred ------------------------------CCceEEEEEeeccccccc---cccCCCCCCCHHHHHHHHHHHHHHhhHhh
Q 005111 225 ------------------------------TSCSLYLVFEYMEHDLVG---LASLPGMKFTESQVKCYMKQLLSGLEHCH 271 (714)
Q Consensus 225 ------------------------------~~~~l~LV~Ey~~g~ll~---~~~~~~~~lse~~i~~i~~QIl~aL~~LH 271 (714)
....++|||||+++++.. .+...+..+++..++.++.||+.||.|||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp -------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 233488999999986443 33345678999999999999999999999
Q ss_pred hcCeeeccCCCccEEEc-CCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHh
Q 005111 272 SHGVLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELF 350 (714)
Q Consensus 272 ~~gIiHrDLKP~NILl~-~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLl 350 (714)
++||+||||||+||||+ .++.+||+|||+|..+.... .....++|+.|+|||++.+...|+.++|||||||++|+|+
T Consensus 159 ~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 99999999999999997 68999999999998765433 2345578999999999988777899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH
Q 005111 351 SGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430 (714)
Q Consensus 351 tG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa 430 (714)
+|.+||.+.+..+++..|++.+|.|..+.|............+..............+|..+.+||.+||.+||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 99999999999999999999999999887765332211111111110111112234589999999999999999999999
Q ss_pred HHHHcCcCCCC
Q 005111 431 TLALNSEFFTT 441 (714)
Q Consensus 431 ~e~L~Hp~f~~ 441 (714)
.|+|+||||+.
T Consensus 317 ~e~l~hp~f~~ 327 (383)
T 3eb0_A 317 YEAMAHPFFDH 327 (383)
T ss_dssp HHHHTSGGGHH
T ss_pred HHHhcCHHHHH
Confidence 99999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=425.38 Aligned_cols=283 Identities=35% Similarity=0.573 Sum_probs=230.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc----cCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS----QTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~----~~~~ 227 (714)
...|++++.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.++|||||++++++.. ....
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 3579999999999999999999999999999999875422 23479999999999999999998743 2233
Q ss_pred eEEEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-CcEEEeecCcccc
Q 005111 228 SLYLVFEYMEHDLVGLAS---LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLASF 303 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~-g~vKL~DFGla~~ 303 (714)
+++|||||++++++..+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 478999999987655432 345679999999999999999999999999999999999999965 6789999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
+.... .....+||++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++..|++.+|.|..+.|...
T Consensus 207 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 64332 2345688999999999987766899999999999999999999999999999999999999999999888653
Q ss_pred hcccCccccCCchhhhhhhh-hccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAE-TFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~-~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.-... .+.........+.. ....++..+.+||.+||++||.+|||+.++|+||||....
T Consensus 285 ~~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 285 NPNYT-EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CSCCC-CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred Chhhh-hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 22111 11100000011111 2246789999999999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=410.97 Aligned_cols=260 Identities=23% Similarity=0.354 Sum_probs=225.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++..... +|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~ 77 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEE--LV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE--EE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE--EE
Confidence 357899999999999999999999999999999998743 2445678899999999999999999999876554 99
Q ss_pred EEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC--CCcEEEeecCcccccCCC
Q 005111 231 LVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH--NGILKIADFGLASFFDPK 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~--~g~vKL~DFGla~~~~~~ 307 (714)
||||||+++.+..++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999998766655543 457999999999999999999999999999999999999987 789999999999887543
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------- 226 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------- 226 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH--------
T ss_pred C--ccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh--------
Confidence 2 344567899999999998765 79999999999999999999999999999888888876544443333
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
+..+|.++.+||.+||..||.+|||+.++|+||||+...
T Consensus 227 -----------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 227 -----------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp -----------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred -----------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 346899999999999999999999999999999998753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=416.60 Aligned_cols=260 Identities=26% Similarity=0.423 Sum_probs=227.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+|+.++|||||++++++..... +||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF--HYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--EEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE--EEE
Confidence 357999999999999999999999999999999998776667777889999999999999999999999876544 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC---CcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN---GILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~---g~vKL~DFGla~~~~~~~ 308 (714)
||||+.++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++.......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 99999998877666666789999999999999999999999999999999999999865 459999999998775332
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..|......++...
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 253 (362)
T 2bdw_A 186 --AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE--------- 253 (362)
T ss_dssp --SCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG---------
T ss_pred --ccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc---------
Confidence 334568999999999998765 89999999999999999999999999988888877765433222222
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+..+++.+.+||.+||..||.+|||+.++|+||||..
T Consensus 254 ----------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 254 ----------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ----------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ----------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 2357899999999999999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=418.58 Aligned_cols=286 Identities=31% Similarity=0.545 Sum_probs=225.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
.++|++++.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999999999999999998765566777889999999999999999999998865442 2
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+||||||+++++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 589999999998776654 35899999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc-
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR- 386 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~- 386 (714)
......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+++..+++.+|.+..++|......
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2234568899999999998865 899999999999999999999999999999999999999999988776442100
Q ss_pred -----cCccccCCchhhhhhh--------hhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 387 -----HSTVFKPVQPYRRRIA--------ETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 387 -----~~~~~~~~~p~~~~i~--------~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
....+.. ......+. +.....+..+.+||.+||+.||.+|||++++|+||||+....
T Consensus 258 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 258 RTYVENRPKYAG-YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHSSCCCCC-CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred HHHHhhCccccc-cchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 0000000 00000000 001113678999999999999999999999999999986543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=429.30 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=226.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+|+.++|||||++++++..... +||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~--~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH--HYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE--EEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE--EEE
Confidence 467999999999999999999999999999999998776666677889999999999999999999999876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc---CCCcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD---HNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~---~~g~vKL~DFGla~~~~~~~ 308 (714)
|||||.|+.+...+.....+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999987766665667899999999999999999999999999999999999998 46789999999998765432
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
......+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..+......++...
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 236 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE--------- 236 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT---------
T ss_pred -ceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc---------
Confidence 2334568999999999998765 89999999999999999999999999998888888866433332222
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 237 ----------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 ----------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp ----------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred ----------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 2467899999999999999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=406.98 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=225.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC----HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD----PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
+.|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-- 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD-- 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE--
Confidence 5699999999999999999999999999999999765322 1235678899999999999999999999876544
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC----cEEEeecCccccc
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG----ILKIADFGLASFF 304 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g----~vKL~DFGla~~~ 304 (714)
+|+||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999988887777777899999999999999999999999999999999999999887 8999999999887
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 169 ~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 240 (326)
T 2y0a_A 169 DFGN--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY----- 240 (326)
T ss_dssp CTTS--CCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHH-----
T ss_pred CCCC--ccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccc-----
Confidence 5432 234557999999999987765 89999999999999999999999999998888887765433333222
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 241 --------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 241 --------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp --------------------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred --------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 24678999999999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=421.77 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=220.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|++++.||+|+||.||+|++..+|+.||||+++... ......+.+.+|+.+|..+ +||||+++++++.....
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~-- 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR-- 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE--
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE--
Confidence 3578999999999999999999999999999999997542 1223456788999999998 79999999999876554
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|||||||.|+.|..++.....+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~- 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN- 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-
Confidence 9999999999888777666678999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|......
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 242 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV-------------- 242 (353)
T ss_dssp --------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred CccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 22345568999999999998765 899999999999999999999999999998888888652111
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH------HHHHcCcCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA------TLALNSEFFTTQPL 444 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa------~e~L~Hp~f~~~~~ 444 (714)
....++..+.+||.+||+.||.+||++ .++++||||....+
T Consensus 243 ---------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 243 ---------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred ---------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 112478899999999999999999999 99999999997643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=400.66 Aligned_cols=260 Identities=28% Similarity=0.398 Sum_probs=214.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC------------------------HHHHHHHHHHHHHHH
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD------------------------PESVKFMAREIAILR 207 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~------------------------~~~~~~~~rEi~iL~ 207 (714)
.++|++.+.||+|+||.||+|++..+++.||||++...... ....+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 47899999999999999999999999999999999764321 122456889999999
Q ss_pred hCCCCCeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 208 ~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
.++||||+++++++.......+||||||++++.+..+.. ...+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999999987655556999999999888776654 3579999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCC--CCccccccchhHHHHHHhhCCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH--YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~--y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l 365 (714)
+.++.+||+|||++..+..... .....+||+.|+|||++.+... ++.++|||||||++|+|++|.+||.+.......
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 9999999999999987654322 2344578999999999976542 478899999999999999999999988776655
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
..+....... .....++..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 250 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEF---------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCC---------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCC---------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 5553311000 01136889999999999999999999999999999996
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=414.34 Aligned_cols=259 Identities=27% Similarity=0.388 Sum_probs=222.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++..... +|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~--~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR--LC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE--EE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE--EE
Confidence 4789999999999999999999999999999999975311 12245678899999999999999999999876554 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||||++|+.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CC
Confidence 99999999888766666668999999999999999999999999999999999999999999999999999864322 22
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+....|....-
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------- 222 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred cccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 345568999999999998765 89999999999999999999999999888777777653110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
.....+++++.+||.+||+.||.+|| ++.++++||||....
T Consensus 223 ------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 01135789999999999999999999 999999999998754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=418.08 Aligned_cols=283 Identities=35% Similarity=0.592 Sum_probs=230.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC----Cc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----SC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----~~ 227 (714)
..+|++++.||+|+||.||+|++..++. ||+|++..... ...+|+.+|+.++|||||++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999999877766 88888764422 1237999999999999999999885432 23
Q ss_pred eEEEEEeecccccccccc---CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc-CCCcEEEeecCcccc
Q 005111 228 SLYLVFEYMEHDLVGLAS---LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLASF 303 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~---~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~-~~g~vKL~DFGla~~ 303 (714)
.+||||||++++++.... .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 478999999998765432 2345799999999999999999999999999999999999999 799999999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
+.... .....++|++|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..|++.+|.|+.+.|...
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 64433 2345688999999999988777899999999999999999999999999999999999999999998877653
Q ss_pred hcccCccccCCchhhhhhhhhc-cCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETF-KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~-~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.........+... ...+...+ ..+++++.+||.+||++||.+|||+.++|+||||+....
T Consensus 270 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 270 NPNYMEHKFPQIR-PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp CGGGSSSCCCCCC-CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred Chhhhhhcccccc-CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 2211111001000 11112222 358999999999999999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=412.15 Aligned_cols=292 Identities=33% Similarity=0.541 Sum_probs=240.5
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC--
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT-- 225 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~-- 225 (714)
+....++|++++.||+|+||.||+|.+..++..||||++... ......+.+.+|+.+|++++||||+++++++....
T Consensus 22 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 22 VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp BCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred eccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 344567899999999999999999999999999999999753 34456678899999999999999999999886532
Q ss_pred -CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 226 -SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 226 -~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
...+|+||||+++++...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 234899999999876655433 36999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 305 DPKDS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 305 ~~~~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
..... ......+||++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..|...+|.++.+.|..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 53322 1234558899999999987766689999999999999999999999999999999999999999999887654
Q ss_pred hhcccCccc--cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 383 SKLRHSTVF--KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 383 ~~~~~~~~~--~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
........+ .............++.++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 211000000 000011112344556789999999999999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=413.58 Aligned_cols=287 Identities=35% Similarity=0.581 Sum_probs=236.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc---
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC--- 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~--- 227 (714)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 34789999999999999999999999999999999987666667778899999999999999999999998765441
Q ss_pred -eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 -SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 -~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+|+||||+.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 249999999987655442 3599999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. ....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+++..|.++.+++......
T Consensus 197 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 197 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred C----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 2 345578999999999988556899999999999999999999999999999999999999999988876542211
Q ss_pred cCccc--cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 387 HSTVF--KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 387 ~~~~~--~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
....+ .........+...+..+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 00000 00011112234455678999999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=408.94 Aligned_cols=290 Identities=31% Similarity=0.589 Sum_probs=237.9
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... +
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~ 99 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR--W 99 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--E
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE--E
Confidence 34578999999999999999999999999999999998776666677788899999999999999999999876544 8
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999999999887766667899999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc--
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH-- 387 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~-- 387 (714)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|......+.......
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 23445789999999999887568999999999999999999999999999999999999988887765433211110
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....+...........++.++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0000011111122334456789999999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=431.16 Aligned_cols=281 Identities=23% Similarity=0.319 Sum_probs=230.3
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
...++|+++++||+|+||+||+|++..+++.||||++..... .......+.+|+.+|..++||||+++++++.....
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~-- 148 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN-- 148 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE--
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE--
Confidence 446789999999999999999999999999999999974211 11122347789999999999999999999876554
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|||||||.|+.|..++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999988777666544 568999999999999999999999999999999999999999999999999999877554
Q ss_pred CCCCcccccccccccCccccc----CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 308 DSVPMTSRVVTLWYRPPELLL----GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~----g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
........+||+.|+|||++. +...|+.++|||||||++|||++|++||.+.+..+.+.+|+.....+
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------- 300 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF-------- 300 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--------
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc--------
Confidence 443444568999999999987 23458999999999999999999999999999998888886421100
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC--CCCHHHHHcCcCCCCCCCCCCCCCCCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH--RGTATLALNSEFFTTQPLACNPSNLPKYPP 456 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k--RpTa~e~L~Hp~f~~~~~~~~~~~~p~~~p 456 (714)
.+...+..+++.+.+||.+||+.+|.+ |++++++++||||+...|.......|.+.|
T Consensus 301 ----------------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~P 359 (437)
T 4aw2_A 301 ----------------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIP 359 (437)
T ss_dssp ----------------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCCC
T ss_pred ----------------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCCC
Confidence 001112458999999999999999988 999999999999998766543333333333
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=400.94 Aligned_cols=259 Identities=27% Similarity=0.470 Sum_probs=221.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++..... +|
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~~ 93 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE--LW 93 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--EE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE--EE
Confidence 346899999999999999999999999999999999765332 24568899999999999999999999876554 89
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||++++.|..++... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 999999988887666543 699999999999999999999999999999999999999999999999999987754433
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+....+..+..... +.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~-------------- 235 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE-------------- 235 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC--------------
T ss_pred ccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CC--------------
Confidence 334568999999999998766 89999999999999999999999999888777666543211 10
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 236 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 -----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp -----------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -----------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 00123578899999999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=408.20 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=222.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++..... +|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~--~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE--EE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE--EE
Confidence 4789999999999999999999999999999999975311 11235668899999999999999999999876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||||++|+.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999888777766678999999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+.+|....-.
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------- 221 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---------------- 221 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----------------
T ss_pred -cccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 23458999999999998765 899999999999999999999999999888888877642110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
....++.++.+||.+||..||.+|| +++++++||||+...
T Consensus 222 -------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 222 -------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred -------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 1135788999999999999999999 999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=409.37 Aligned_cols=261 Identities=24% Similarity=0.397 Sum_probs=218.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+|.++ +|||||++++++.....
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~-- 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-- 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE--
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE--
Confidence 4578999999999999999999999999999999998653 3456677889999999998 89999999999876544
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999998877666655689999999999999999999999999999999999999999999999999998643222
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC---------hHHHHHHHHHhhCCCChhH
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT---------EVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~---------~~e~l~~I~k~~G~p~~~~ 379 (714)
......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.... .......|....
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred -CcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 2345568999999999998765 8999999999999999999999997521 112222222100
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH------HHHHcCcCCCCCCC
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA------TLALNSEFFTTQPL 444 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa------~e~L~Hp~f~~~~~ 444 (714)
......++..+.+||.+||..||.+||++ .++++||||....|
T Consensus 236 ----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 236 ----------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 01123578999999999999999999995 89999999987653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=417.42 Aligned_cols=290 Identities=36% Similarity=0.644 Sum_probs=217.1
Q ss_pred CCeeEE-eEEeccCceEEEEEEEc--cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKL-DKIGQGTYSSVYRARDV--IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~-~~LG~G~fG~Vy~a~d~--~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
+.|++. ++||+|+||.||+|++. .+++.||||++...... ..+.+|+.+|+.++|||||++++++.......+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 456764 47999999999999966 56899999999754332 346789999999999999999999866555669
Q ss_pred EEEEeeccccccccccC--------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE----cCCCcEEEee
Q 005111 230 YLVFEYMEHDLVGLASL--------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIAD 297 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl----~~~g~vKL~D 297 (714)
||||||++++++..+.. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999999987665431 22359999999999999999999999999999999999999 6778999999
Q ss_pred cCcccccCCCCC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh---------HHHHH
Q 005111 298 FGLASFFDPKDS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---------VEQLH 366 (714)
Q Consensus 298 FGla~~~~~~~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---------~e~l~ 366 (714)
||++..+..... ......+||++|+|||++.+...|+.++||||||||||+|++|.+||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653221 2234568899999999998866689999999999999999999999987665 48899
Q ss_pred HHHHhhCCCChhHHhhhhcc-cCcc----c----cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCc
Q 005111 367 RIFKLCGSPSEDYWRKSKLR-HSTV----F----KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSE 437 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~-~~~~----~----~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp 437 (714)
.|+..+|.|....|...... .... + .........+.......+..+.+||.+||++||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 99999999998888653211 0000 0 0000001111112223478899999999999999999999999999
Q ss_pred CCCCCCCCC
Q 005111 438 FFTTQPLAC 446 (714)
Q Consensus 438 ~f~~~~~~~ 446 (714)
||+..+.+.
T Consensus 336 ~f~~~~~~~ 344 (405)
T 3rgf_A 336 YFLEDPLPT 344 (405)
T ss_dssp GGTSSSCCC
T ss_pred hhccCCCCc
Confidence 999877654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=426.33 Aligned_cols=269 Identities=25% Similarity=0.355 Sum_probs=224.8
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
....++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|..++|||||++++++.....
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~- 143 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY- 143 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE-
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-
Confidence 3456889999999999999999999999999999999975210 01122347789999999999999999999876544
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|||||||+|+.|..++.. ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..+...
T Consensus 144 -~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 -LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp -EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred -EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999998877766543 46999999999999999999999999999999999999999999999999999877544
Q ss_pred CCCCcccccccccccCcccccCCCC---CCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASH---YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~---y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
........+||+.|+|||++.+... |+.++|||||||+||||++|.+||.+.+..+.+.+|........
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------- 293 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-------- 293 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC--------
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc--------
Confidence 3333446689999999999976542 78999999999999999999999999999988888865211000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCC--CCCHHHHHcCcCCCCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAH--RGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~k--RpTa~e~L~Hp~f~~~~~~ 445 (714)
......++..+.+||.+||..+|.+ |++++++++||||+...|.
T Consensus 294 -----------------~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 294 -----------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp -----------------CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred -----------------CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 0011358999999999999999988 9999999999999986553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=402.42 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=216.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++..... +|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~ 81 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI--QY 81 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSE--EE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe--EE
Confidence 45789999999999999999999999999999999975432 2334568899999999999999999999876544 89
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC-C
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD-S 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~-~ 309 (714)
||||||+++.+..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999998888887777789999999999999999999999999999999999999999999999999998654222 1
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+||+.|+|||++.+...++.++|||||||++|+|++|..||.+................
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~--------------- 226 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------------- 226 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---------------
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---------------
Confidence 22345688999999999988775588999999999999999999999876543222221111000
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
....+..++..+.+||.+||..||.+|||+.|+|+||||...
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 001124578999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=424.60 Aligned_cols=280 Identities=24% Similarity=0.361 Sum_probs=229.5
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
...++|++++.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|..++||||+++++++.....
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~-- 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY-- 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE--
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE--
Confidence 34688999999999999999999999999999999997531 112234457899999999999999999999876544
Q ss_pred EEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|||||||.|+.|..++.. +..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 9999999988777665543 347999999999999999999999999999999999999999999999999999887554
Q ss_pred CCCCcccccccccccCcccccC------CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 308 DSVPMTSRVVTLWYRPPELLLG------ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g------~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
........+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+.+.+|.......
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------ 289 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL------ 289 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC------
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc------
Confidence 3333345689999999999873 2348999999999999999999999999999988888886421000
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCC---CCHHHHHcCcCCCCCCCCCCCCCCCCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR---GTATLALNSEFFTTQPLACNPSNLPKYPP 456 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kR---pTa~e~L~Hp~f~~~~~~~~~~~~p~~~p 456 (714)
.+......+|.++.+||.+||+ +|.+| ++++++++||||+...|.......|.+.|
T Consensus 290 ------------------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p 348 (412)
T 2vd5_A 290 ------------------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP 348 (412)
T ss_dssp ------------------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred ------------------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 0001123689999999999999 99998 59999999999998877655555555555
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=417.80 Aligned_cols=261 Identities=23% Similarity=0.393 Sum_probs=215.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|++++.||+|+||.||+|++..+++.||||+++... ......+.+.+|+.+|.++ +|||||++++++.....
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~-- 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-- 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE--
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE--
Confidence 3478999999999999999999999999999999998652 2334456688999999887 89999999999876554
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|||||||+|+.|..++.....+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 9999999999888777666678999999999999999999999999999999999999999999999999999863322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh---------HHHHHHHHHhhCCCChhH
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---------VEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---------~e~l~~I~k~~G~p~~~~ 379 (714)
.......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+... ......|...
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------- 277 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------- 277 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--------
T ss_pred CCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--------
Confidence 22345668999999999998866 89999999999999999999999975321 1122222210
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH------HHHHcCcCCCCCCC
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA------TLALNSEFFTTQPL 444 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa------~e~L~Hp~f~~~~~ 444 (714)
.......++..+.+||.+||+.||.+||++ +++++||||+...|
T Consensus 278 ---------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 278 ---------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp ---------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred ---------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 001123578999999999999999999995 89999999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=405.17 Aligned_cols=279 Identities=24% Similarity=0.378 Sum_probs=226.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-----CCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-----HPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----HpnIVkl~~~~~~~~~ 226 (714)
.+.|+++++||+|+||.||+|++..+++.||||++.. .......+.+|+.+|+.+. |||||++++++.....
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 5789999999999999999999999999999999863 3455667788999999996 9999999999876554
Q ss_pred ceEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC----------------
Q 005111 227 CSLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---------------- 289 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---------------- 289 (714)
+||||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 111 --~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 111 --MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp --EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred --eEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 9999999965555544432 235999999999999999999999999999999999999975
Q ss_pred ---------CCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC
Q 005111 290 ---------NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT 360 (714)
Q Consensus 290 ---------~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~ 360 (714)
++.+||+|||++...... ....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999875432 23557899999999998876 8999999999999999999999999999
Q ss_pred hHHHHHHHHHhhCCCChhHHhhhhcccCccccCC------ch-----------hhhhhhhhccCCcHHHHHHHHHhcccC
Q 005111 361 EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV------QP-----------YRRRIAETFKDFPTSALRLMETLMSID 423 (714)
Q Consensus 361 ~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~------~p-----------~~~~i~~~~~~~p~~l~~LI~~mL~~D 423 (714)
..+.+..+....+.++...+..........+... .+ ....+.......++.+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 9999999999999888776654321111100000 00 000011111233578889999999999
Q ss_pred cCCCCCHHHHHcCcCCC
Q 005111 424 PAHRGTATLALNSEFFT 440 (714)
Q Consensus 424 P~kRpTa~e~L~Hp~f~ 440 (714)
|.+|||+.++|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=407.17 Aligned_cols=255 Identities=25% Similarity=0.287 Sum_probs=192.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC--ceEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS--CSLY 230 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~--~~l~ 230 (714)
.+|.+.++||+|+||+||+|++ +|+.||||++.... ........|+..+.+++|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4689999999999999999975 69999999986432 222233456777778999999999999876542 2489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc--------CeeeccCCCccEEEcCCCcEEEeecCccc
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH--------GVLHRDIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--------gIiHrDLKP~NILl~~~g~vKL~DFGla~ 302 (714)
||||||+++.|..++.. ..+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999888877654 4689999999999999999999987 99999999999999999999999999998
Q ss_pred ccCCCCCC---CcccccccccccCcccccCCC-----CCCccccccchhHHHHHHhhCCCCCCCCCh-------------
Q 005111 303 FFDPKDSV---PMTSRVVTLWYRPPELLLGAS-----HYGAAVDLWSTGCILGELFSGKPVLPGKTE------------- 361 (714)
Q Consensus 303 ~~~~~~~~---~~~~~~gT~~Y~APE~l~g~~-----~y~~~sDIWSLG~iLyeLltG~~pF~g~~~------------- 361 (714)
........ .....+||+.|||||++.+.. .|+.++||||||||||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 77544321 223468999999999997642 267899999999999999999887754321
Q ss_pred -HHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 362 -VEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 362 -~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+.+.+... .....+..| ..+ ...+..+.+||.+||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~-----------------~~~~rp~~p------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SVEEMRKVVC-----------------EQKLRPNIP------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CHHHHHHHHT-----------------TSCCCCCCC------GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHh-----------------cccCCCCCC------ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111111110 000111111 111 1234578899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=417.83 Aligned_cols=282 Identities=30% Similarity=0.492 Sum_probs=230.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC------CCCCeeeeecccccc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL------DHPNIIKLEGLITSQ 224 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L------~HpnIVkl~~~~~~~ 224 (714)
...+|++++.||+|+||.||+|.+..+++.||||+++. .......+.+|+.+|+.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 35679999999999999999999999999999999974 334556778899998887 577999999998765
Q ss_pred CCceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc--EEEeecCcc
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI--LKIADFGLA 301 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~--vKL~DFGla 301 (714)
.. +||||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 172 ~~--~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 172 NH--ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TE--EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred Ce--EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 44 99999999987776555433 45999999999999999999999999999999999999999987 999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
...... ....+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+++..++..+|.++...|.
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eecCCc----ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 865432 33558899999999998876 8999999999999999999999999999999999999999999988765
Q ss_pred hhhcccC----ccccC-------------------------Cchhhhhhhh-hccCCcHHHHHHHHHhcccCcCCCCCHH
Q 005111 382 KSKLRHS----TVFKP-------------------------VQPYRRRIAE-TFKDFPTSALRLMETLMSIDPAHRGTAT 431 (714)
Q Consensus 382 ~~~~~~~----~~~~~-------------------------~~p~~~~i~~-~~~~~p~~l~~LI~~mL~~DP~kRpTa~ 431 (714)
....... ..+.. ..+....+.. .....++.+.+||.+||++||.+|||+.
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 4321100 00000 0000011111 1224578899999999999999999999
Q ss_pred HHHcCcCCCCC
Q 005111 432 LALNSEFFTTQ 442 (714)
Q Consensus 432 e~L~Hp~f~~~ 442 (714)
|+|+||||+..
T Consensus 405 e~L~Hpw~~~~ 415 (429)
T 3kvw_A 405 QALRHPWLRRR 415 (429)
T ss_dssp HHHTSTTTC--
T ss_pred HHhCChhhccC
Confidence 99999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=403.56 Aligned_cols=285 Identities=35% Similarity=0.596 Sum_probs=234.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----C 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----~ 227 (714)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999998765666677889999999999999999999998876543 1
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 359999999976554432 35999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.+|.++.+++.......
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 3345789999999999875568999999999999999999999999999999999999999999887765422110
Q ss_pred Cccc-c-CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVF-K-PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~-~-~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+ . ........+...+..++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0000 0 000001123344567899999999999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=390.89 Aligned_cols=263 Identities=26% Similarity=0.417 Sum_probs=226.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++..... .|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF--HY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--EE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE--EE
Confidence 4588999999999999999999999999999999998776667778889999999999999999999999875544 89
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc---EEEeecCcccccCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI---LKIADFGLASFFDPK 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~---vKL~DFGla~~~~~~ 307 (714)
+||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999998777655555567999999999999999999999999999999999999987655 999999999876533
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
. ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+.......+..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 229 (284)
T 3kk8_A 162 E--AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP--------- 229 (284)
T ss_dssp C--BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---------
T ss_pred c--cccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch---------
Confidence 2 234567899999999998765 7999999999999999999999999988887777765432222111
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 230 ----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 230 ----------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp ----------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred ----------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 1246789999999999999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=412.71 Aligned_cols=262 Identities=26% Similarity=0.378 Sum_probs=222.6
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCc
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~ 227 (714)
...++|++++.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+|..+ +||||+++++++.....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~- 92 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN- 92 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE-
Confidence 356899999999999999999999999999999999975411 112355678899999877 99999999999876554
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+||||||++|+.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 93 -~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 -LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp -EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred -EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999888777666568999999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
. ......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|.... +
T Consensus 172 ~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~------------ 235 (345)
T 1xjd_A 172 D-AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--P------------ 235 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------------
T ss_pred C-CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--C------------
Confidence 2 2345568999999999998766 8999999999999999999999999999888877775411 0
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHH-HHHcCcCCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT-LALNSEFFTTQPL 444 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~-e~L~Hp~f~~~~~ 444 (714)
.....++..+.+||.+||..||.+||++. ++++||||+...+
T Consensus 236 ---------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 236 ---------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ---------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 01124789999999999999999999998 9999999987643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=410.64 Aligned_cols=258 Identities=23% Similarity=0.372 Sum_probs=223.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++..... +
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--L 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--E
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE--E
Confidence 34789999999999999999999999999999999975321 12345678899999999999999999999876544 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||||++|+.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999998877766665567999999999999999999999999999999999999999999999999999876533
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+.+|....-
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------------- 255 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------------- 255 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred --cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC----------------
Confidence 23558999999999998765 89999999999999999999999999988888877754210
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQPL 444 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~~ 444 (714)
.....++..+.+||.+||+.||.+||+ ++++++||||....+
T Consensus 256 -------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 256 -------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 011357899999999999999999998 999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=403.97 Aligned_cols=290 Identities=30% Similarity=0.477 Sum_probs=227.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC-----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT----- 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~----- 225 (714)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+|+..+..++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 34789999999999999999999999999999999865432 2234567888889999999999999885422
Q ss_pred CceEEEEEeeccccccccc---cCCCCCCCHHHHHHHHHHHHHHhhHhh--hcCeeeccCCCccEEEcC-CCcEEEeecC
Q 005111 226 SCSLYLVFEYMEHDLVGLA---SLPGMKFTESQVKCYMKQLLSGLEHCH--SHGVLHRDIKGSNLLLDH-NGILKIADFG 299 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~---~~~~~~lse~~i~~i~~QIl~aL~~LH--~~gIiHrDLKP~NILl~~-~g~vKL~DFG 299 (714)
...++|||||++++++..+ ......+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 2347899999999865433 345668999999999999999999999 999999999999999997 8999999999
Q ss_pred cccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 300 LASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 300 la~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
++..+.... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.++.+.
T Consensus 178 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 178 SAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 998775433 234557899999999998777689999999999999999999999999999999999999999999988
Q ss_pred HhhhhcccCcc---ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 380 WRKSKLRHSTV---FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 380 w~~~~~~~~~~---~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
|.......... .....+....+.......+..+.+||.+||+.||.+|||+.++|+||||+....+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 86643221110 0111122222233334478899999999999999999999999999999976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=404.50 Aligned_cols=261 Identities=29% Similarity=0.451 Sum_probs=215.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN---QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.+.|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-- 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM-- 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE--
Confidence 357999999999999999999999999999999986431 111235678899999999999999999999876544
Q ss_pred EEEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc---EEEeecCcc
Q 005111 229 LYLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI---LKIADFGLA 301 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~---vKL~DFGla 301 (714)
+|||||||+++.|...+. .+..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999876643322 3346899999999999999999999999999999999999987654 999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
..+.... ......+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.. .+.+..+..........
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~--- 254 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR--- 254 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH---
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc---
Confidence 8875432 2234568999999999998765 8999999999999999999999998853 34455554422222222
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 255 ----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 ----------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ----------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 234688999999999999999999999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=409.71 Aligned_cols=294 Identities=20% Similarity=0.280 Sum_probs=221.1
Q ss_pred ccCCCCCeeEEeEEecc--CceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 148 IPRRANTFEKLDKIGQG--TYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G--~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
+....++|++++.||+| +||.||+|++..+|+.||||++..........+.+.+|+.+|+.++|||||++++++....
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 34556889999999999 9999999999999999999999887666777888999999999999999999999987655
Q ss_pred CceEEEEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
. +|||||||+++.+..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 100 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 100 E--LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp E--EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred E--EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 4 9999999998877765543 25699999999999999999999999999999999999999999999999999865
Q ss_pred cCCCC------CCCcccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhC---
Q 005111 304 FDPKD------SVPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG--- 373 (714)
Q Consensus 304 ~~~~~------~~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G--- 373 (714)
..... .......+||+.|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+..+.+..+....-
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 42111 1112234789999999999873 3489999999999999999999999998776655544332110
Q ss_pred -----CCChhHHhhh-------hcccCccccCCch--hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 374 -----SPSEDYWRKS-------KLRHSTVFKPVQP--YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 374 -----~p~~~~w~~~-------~~~~~~~~~~~~p--~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.+....+... .+..........+ ...........+++.+.+||.+||+.||.+|||+.++|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 0000000000 0000000000000 0000112345688999999999999999999999999999999
Q ss_pred CCCC
Q 005111 440 TTQP 443 (714)
Q Consensus 440 ~~~~ 443 (714)
+...
T Consensus 338 ~~~~ 341 (389)
T 3gni_B 338 KQIK 341 (389)
T ss_dssp GGC-
T ss_pred HHHh
Confidence 8754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=410.19 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=222.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|++++.||+|+||.||+|++..+|+.||||+++.... .....+.+.+|+.+|..+ .||||+++++++.... .
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--R 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS--E
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC--E
Confidence 45789999999999999999999999999999999975421 122356678999999988 8999999999987654 4
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||++|+.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD- 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-
Confidence 9999999999887766665567999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|....-.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 239 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-------------- 239 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred CcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 22344568999999999998766 899999999999999999999999999988888887642100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
....++..+.+||.+||..||.+|| ++.++++||||+...|
T Consensus 240 ---------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w 285 (353)
T 2i0e_A 240 ---------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 285 (353)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCH
T ss_pred ---------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCH
Confidence 1135789999999999999999999 4799999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=404.38 Aligned_cols=292 Identities=27% Similarity=0.423 Sum_probs=231.2
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC---------CHHHHHHHHHHHHHHHhCCCCCeeeeec
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ---------DPESVKFMAREIAILRKLDHPNIIKLEG 219 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~---------~~~~~~~~~rEi~iL~~L~HpnIVkl~~ 219 (714)
....+.|++++.||+|+||.||+|.+.. |..||||++..... .....+.+.+|+.+|++++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 3456889999999999999999999754 99999999865422 2334578999999999999999999999
Q ss_pred cccc---cCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEe
Q 005111 220 LITS---QTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296 (714)
Q Consensus 220 ~~~~---~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~ 296 (714)
++.. .....+||||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 8744 2234589999999998888887777789999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 297 DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
|||++....... .....++|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|.+.
T Consensus 177 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 177 DFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999998654332 234457899999999998756689999999999999999999999999999999999999999998
Q ss_pred hhHHhhhhcccCcc---ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 377 EDYWRKSKLRHSTV---FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 377 ~~~w~~~~~~~~~~---~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+.+.......... ...............+.+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 76553321110000 00000011122344567889999999999999999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=407.57 Aligned_cols=260 Identities=24% Similarity=0.428 Sum_probs=221.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|+.++||||+++++++..... +||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE--EEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE--EEE
Confidence 467999999999999999999999999999999997542 3445678899999999999999999999876544 999
Q ss_pred EEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC--CCcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH--NGILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~--~g~vKL~DFGla~~~~~~~ 308 (714)
|||||.++.|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 999999877765554 3457999999999999999999999999999999999999974 5789999999998875432
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+||+.|+|||++.+.. ++.++||||||||+|+|++|.+||.+.+..+.+..+......++.
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 271 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 271 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred --ceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 234457899999999998765 899999999999999999999999999988888777542211111
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..+..++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 272 --------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 272 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp --------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred --------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 12346899999999999999999999999999999998753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=394.71 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=225.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP----ESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.+.|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.+|+.+.||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD- 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE-
Confidence 357999999999999999999999999999999998653221 235678899999999999999999999876544
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC----cEEEeecCcccc
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG----ILKIADFGLASF 303 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g----~vKL~DFGla~~ 303 (714)
+|+||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 90 -VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp -EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred -EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999888877776677899999999999999999999999999999999999999888 799999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+......++..
T Consensus 169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 240 (321)
T 2a2a_A 169 IEDGV--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE----- 240 (321)
T ss_dssp CCTTC--CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH-----
T ss_pred cCccc--cccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh-----
Confidence 75432 234557899999999998765 7999999999999999999999999998888887775533322222
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 241 --------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 241 --------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp --------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred --------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 234688999999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=396.01 Aligned_cols=293 Identities=31% Similarity=0.511 Sum_probs=232.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC---Cc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT---SC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~---~~ 227 (714)
..++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 457899999999999999999999999999999999643 34455677889999999999999999999875431 24
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+|+||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 88 ~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred eEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 5899999999866554433 46999999999999999999999999999999999999999999999999999876532
Q ss_pred CCC---------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005111 308 DSV---------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378 (714)
Q Consensus 308 ~~~---------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~ 378 (714)
... .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCST
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchh
Confidence 211 12235789999999998765568999999999999999999999999999999999999999887633
Q ss_pred HHhhh-hcccCcc-ccCCc-hhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCC
Q 005111 379 YWRKS-KLRHSTV-FKPVQ-PYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLAC 446 (714)
Q Consensus 379 ~w~~~-~~~~~~~-~~~~~-p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~ 446 (714)
..... ....... ..... .....+...++.++..+.+||.+||..||.+|||+.++|+||||+....+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 21100 0000000 00000 001122344567899999999999999999999999999999999865443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=410.51 Aligned_cols=261 Identities=23% Similarity=0.382 Sum_probs=219.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+|+.++|||||++++++..... +
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~--~ 90 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED--M 90 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE--E
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE--E
Confidence 3478999999999999999999999999999999997532 112345678899999999999999999999876554 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||+.|+.|..++.....+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 168 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-- 168 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--
Confidence 999999999888877777778999999999999999999999999999999999999999999999999999876533
Q ss_pred CCcccccccccccCcccccCC--CCCCccccccchhHHHHHHhhCCCCCCCCCh---HHHHHHHHHhhCCCChhHHhhhh
Q 005111 310 VPMTSRVVTLWYRPPELLLGA--SHYGAAVDLWSTGCILGELFSGKPVLPGKTE---VEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~--~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
......+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+... .+.+..+....
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------ 236 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------------ 236 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC------------
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc------------
Confidence 334567899999999998642 3479999999999999999999999985432 22222221100
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-HHHHHcCcCCCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-ATLALNSEFFTTQPL 444 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-a~e~L~Hp~f~~~~~ 444 (714)
......++..+.+||.+||+.||.+||+ ++++++||||....+
T Consensus 237 -----------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 237 -----------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred -----------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 0112357899999999999999999998 999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=399.83 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=211.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDNQ--DPESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~~--~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
..++|++++.||+|+||.||+|++. .+|+.||||+++.... .......+.+|+.+|+.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 3578999999999999999999985 6899999999976522 2334566789999999999999999999987655
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
. +||||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++....
T Consensus 95 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 95 K--LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp C--EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred E--EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 4 99999999988777666656679999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..|.....
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~------------ 238 (327)
T 3a62_A 173 HDG-TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL------------ 238 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC------------
T ss_pred cCC-ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 222 2234557899999999998765 79999999999999999999999999988888877754211
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
.....++..+.+||.+||..||.+|| ++.++|+||||+...
T Consensus 239 -----------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 239 -----------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred -----------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 01135788999999999999999999 899999999998653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=394.46 Aligned_cols=290 Identities=37% Similarity=0.638 Sum_probs=233.2
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEc-cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeccccc-
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDV-IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL---DHPNIIKLEGLITS- 223 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~-~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIVkl~~~~~~- 223 (714)
....++|++++.||+|+||.||+|++. .+|+.||||++............+.+|+.+++.+ .||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 344578999999999999999999985 6789999999976533222233455777777666 89999999998762
Q ss_pred --cCCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCc
Q 005111 224 --QTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 224 --~~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
.....+|+||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 13345899999999866554433 234599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 301 ASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 301 a~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
+....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..++..++.+....|
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred cccccCCC--CccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 98764322 234457899999999998765 899999999999999999999999999999999999999999988877
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..........+.. .....+......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 244 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 244 PRDVALPRQAFHS--KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CTTCSSCGGGSCC--CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccchhhhcc--cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 5422111111110 011123345567899999999999999999999999999999998764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=391.65 Aligned_cols=290 Identities=34% Similarity=0.576 Sum_probs=227.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc-------
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ------- 224 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~------- 224 (714)
.++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 47899999999999999999999999999999998753 456678899999999999999999999886432
Q ss_pred -----CCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc-CCCcEEEeec
Q 005111 225 -----TSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADF 298 (714)
Q Consensus 225 -----~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~-~~g~vKL~DF 298 (714)
....+|+||||+++++...+ . ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~-~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVL-E-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHH-T-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHh-h-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 22458999999997655444 3 35799999999999999999999999999999999999997 5679999999
Q ss_pred CcccccCCCCC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 299 GLASFFDPKDS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 299 Gla~~~~~~~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
|++........ .......+|++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99987643221 1233456799999999987755689999999999999999999999999999999999998887777
Q ss_pred hhHHhhhhcccCcccc-CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 377 EDYWRKSKLRHSTVFK-PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~-~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
.+.+............ ........+....+.++..+.+||.+||+.||.+|||+.++|+||||+...+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 6655432111000000 00000111234456789999999999999999999999999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=419.28 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=224.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|.+.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++..... +
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~--~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD--I 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--E
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--E
Confidence 35789999999999999999999999999999999975321 11235678899999999999999999999876554 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 9999999988888777777789999999999999999999999999999999999999999999999999998875432
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
.....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+.+|.....
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------- 233 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF---------------- 233 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC----------------
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc----------------
Confidence 344568999999999998877558899999999999999999999999888777777643211
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 234 -------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 -------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0113478899999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=400.53 Aligned_cols=259 Identities=30% Similarity=0.420 Sum_probs=203.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+|++++||||+++++++..... +|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE--IS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSE--EE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe--EE
Confidence 3567999999999999999999999999999999997542 34567899999999999999999999876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCcccccCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLASFFDPK 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla~~~~~~ 307 (714)
|||||++++.+..++.....+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999998888777766778999999999999999999999999999999999999975 889999999999876433
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH-HHHHHHHhhCCCChhHHhhhhcc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+ .+..+......+.
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~---------- 271 (349)
T 2w4o_A 205 V--LMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI---------- 271 (349)
T ss_dssp ----------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC----------
T ss_pred c--ccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC----------
Confidence 2 234567899999999998765 8999999999999999999999998766554 4444433211111
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
...+..++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 272 ---------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 272 ---------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp ---------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred ---------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 112346889999999999999999999999999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=405.51 Aligned_cols=282 Identities=24% Similarity=0.404 Sum_probs=228.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--------CCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD--------HPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--------HpnIVkl~~~~~~ 223 (714)
.++|++++.||+|+||+||+|++..+++.||||++.. .....+.+.+|+.+|+.+. |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4789999999999999999999999999999999963 3455677889999999985 7889999998763
Q ss_pred c--CCceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCC--------
Q 005111 224 Q--TSCSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNG-------- 291 (714)
Q Consensus 224 ~--~~~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g-------- 291 (714)
. ....+||||||++++++..+.... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 2 234589999999998888766543 5699999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------cEEEeecCcccccCCCCCCCcccccccccccCcccccCC
Q 005111 292 -----------------------------------------ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330 (714)
Q Consensus 292 -----------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~ 330 (714)
.+||+|||++...... ....+||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876432 3445789999999999887
Q ss_pred CCCCccccccchhHHHHHHhhCCCCCCCCC------hHHHHHHHHHhhCCCChhHHhhhhcccCcccc-----C---Cch
Q 005111 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKT------EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK-----P---VQP 396 (714)
Q Consensus 331 ~~y~~~sDIWSLG~iLyeLltG~~pF~g~~------~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~-----~---~~p 396 (714)
. |+.++||||||||||+|++|.+||.+.+ ..+.+..+...+|.++...|............ . ..+
T Consensus 269 ~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 G-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp C-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred C-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 6 8999999999999999999999998765 67788899999999988876554332111000 0 000
Q ss_pred --hhhhhh---hhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 397 --YRRRIA---ETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 397 --~~~~i~---~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
....+. ......+..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000011 111234567899999999999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=423.33 Aligned_cols=259 Identities=32% Similarity=0.526 Sum_probs=218.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++++.||+|+||+||+|++..++..||||++............+.+|+.+|+.++|||||++++++..... +||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN--YYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--EEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE--EEE
Confidence 356999999999999999999999999999999998764434445678899999999999999999999876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla~~~~~~~ 308 (714)
|||||.++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999998877655555567999999999999999999999999999999999999976 4569999999998775432
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 194 --~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 260 (494)
T 3lij_A 194 --KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE--------- 260 (494)
T ss_dssp --CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG---------
T ss_pred --cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh---------
Confidence 3445689999999998864 389999999999999999999999999999888888866443333222
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 261 ----------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 261 ----------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp ----------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred ----------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 2468899999999999999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=412.79 Aligned_cols=259 Identities=27% Similarity=0.430 Sum_probs=213.7
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
...+.|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-- 83 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD-- 83 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE--
Confidence 345889999999999999999999999999999999874311 11223568899999999999999999999876554
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||++|+++..+.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999999997776665543 4579999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------------------- 220 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------------------- 220 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------------------
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------------
Confidence 2345689999999999988775578999999999999999999999765422111000
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
. .........+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 221 ------~---~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 ------N---SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ------C---SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ------H---cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 0 00111224578999999999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=406.23 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=204.1
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++++.||+|+||.||+|++..+++.||||++...... .+.+.+|+.+++.++||||+++++++..... +
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTH--L 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--E
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE--E
Confidence 4568899999999999999999999999999999999765332 2457799999999999999999999876554 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc--EEEeecCcccccCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI--LKIADFGLASFFDPK 307 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~--vKL~DFGla~~~~~~ 307 (714)
||||||+.++.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998877766655567999999999999999999999999999999999999987765 999999999754322
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+......+..++.......
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----------- 238 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK----------- 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC-----------
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC-----------
Confidence 2234557999999999998877445569999999999999999999987654333322222110000
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..+ .....+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 239 -~~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 239 -YSI-----------PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -CCC-----------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -CCC-----------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 000 0012478999999999999999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=421.78 Aligned_cols=260 Identities=30% Similarity=0.506 Sum_probs=221.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|++++|||||++++++..... +|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS--FYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--EEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE--EEE
Confidence 367999999999999999999999999999999997542222345678899999999999999999999876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc---CCCcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD---HNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~---~~g~vKL~DFGla~~~~~~~ 308 (714)
|||||.++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+....
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999877765555556899999999999999999999999999999999999995 45689999999998775432
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+||+.|+|||++.+. |+.++||||||||+|+|++|.+||.+.+..+.+..+......+....
T Consensus 179 --~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--------- 245 (486)
T 3mwu_A 179 --KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ--------- 245 (486)
T ss_dssp -----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG---------
T ss_pred --ccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc---------
Confidence 34456899999999998763 89999999999999999999999999999888888765433222222
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 246 ----------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 246 ----------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ----------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ----------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 24578999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=394.39 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=208.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~L 231 (714)
+.|+++++||+|+||+||+|++..+|+.||||++...............|+..+..+ .||||+++++++..... +||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~--~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI--LYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--EEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE--EEE
Confidence 579999999999999999999999999999999876655555555666677666655 99999999999876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+++++...+...+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--A 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC--C
Confidence 99999888777666656679999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....||+.|+|||++.+ .++.++|||||||++|||++|..+|.+..... .+.. +..+
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~--------------- 270 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLP--------------- 270 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCC---------------
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCC---------------
Confidence 344578999999999886 38999999999999999999987776543322 1111 0011
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
......++..+.+||.+||+.||.+|||+.++|+||||++
T Consensus 271 ----------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 ----------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ----------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1123468999999999999999999999999999999985
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=420.67 Aligned_cols=260 Identities=30% Similarity=0.479 Sum_probs=225.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.+.|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|++++|||||++++++.... .+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG--YFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--EEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--EEE
Confidence 4679999999999999999999999999999999976532 2345677899999999999999999999987654 499
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE---cCCCcEEEeecCcccccCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl---~~~g~vKL~DFGla~~~~~~ 307 (714)
+|||||.++.+...+.....+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999988777666666789999999999999999999999999999999999999 56789999999999887543
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......+....
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------- 250 (484)
T 3nyv_A 183 --KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQ-------- 250 (484)
T ss_dssp --CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG--------
T ss_pred --cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcc--------
Confidence 23456689999999999876 389999999999999999999999999999988888865433322222
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+..+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 251 -----------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 251 -----------------WKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp -----------------GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred -----------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 24578999999999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=419.17 Aligned_cols=260 Identities=26% Similarity=0.368 Sum_probs=213.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++..... +
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~--~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR--L 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE--E
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE--E
Confidence 3478999999999999999999999999999999997542 223445667899999999999999999999876554 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
|||||||+++.|..++.....+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+|......
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD- 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-
Confidence 9999999998887776666789999999999999999999998 99999999999999999999999999999864322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......+||+.|+|||++.+.. |+.++||||||||||+|++|.+||.+.+..+.+..+......
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------- 367 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-------------- 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------------
T ss_pred CcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 22345568999999999998766 899999999999999999999999998888777776542110
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
....+++.+.+||.+||+.||.+|| |+.++|+||||+...
T Consensus 368 ---------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 368 ---------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp ---------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 1135789999999999999999999 999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=408.71 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=215.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHH-HHhCCCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAI-LRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~i-L~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|..+ ++.++|||||++++++.... .
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~--~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD--K 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS--E
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC--E
Confidence 4578999999999999999999999999999999998653 223345566778777 46789999999999987655 4
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||++|+.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++......
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999998887766666689999999999999999999999999999999999999999999999999998643322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..|....-
T Consensus 194 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------------- 256 (373)
T 2r5t_A 194 -STTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL--------------- 256 (373)
T ss_dssp -CCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC---------------
T ss_pred -CccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc---------------
Confidence 2345568999999999998766 89999999999999999999999999998888888754210
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH----HHHHcCcCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA----TLALNSEFFTTQPL 444 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa----~e~L~Hp~f~~~~~ 444 (714)
.....++..+.+||.+||+.||.+||++ .++++||||+...|
T Consensus 257 --------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w 302 (373)
T 2r5t_A 257 --------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINW 302 (373)
T ss_dssp --------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCH
Confidence 1123578999999999999999999996 69999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=393.12 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=221.3
Q ss_pred CCCeeEE-eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceE
Q 005111 152 ANTFEKL-DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 152 ~~~Y~~~-~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l 229 (714)
.+.|.+. +.||+|+||.||+|.+..+++.||||++............+.+|+.+|..+ .||||+++++++..... +
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~--~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE--I 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE--E
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe--E
Confidence 4568888 899999999999999999999999999987644445567788999999999 56999999999876544 9
Q ss_pred EEEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCccccc
Q 005111 230 YLVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLASFF 304 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla~~~ 304 (714)
|+||||+.++.+..+... ...+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 999999999877766543 367999999999999999999999999999999999999997 789999999999877
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+......++..
T Consensus 185 ~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------ 255 (327)
T 3lm5_A 185 GHAC--ELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE------ 255 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------
T ss_pred CCcc--ccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch------
Confidence 5332 234557899999999998765 8999999999999999999999999999888887776543332221
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.+..++..+.+||.+||+.||.+|||++++|+||||+...+
T Consensus 256 -------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 256 -------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp -------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred -------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 23467899999999999999999999999999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=382.45 Aligned_cols=257 Identities=32% Similarity=0.466 Sum_probs=222.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+|+.++||||+++++++..... +|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD--IYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE--EEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe--EEE
Confidence 3579999999999999999999999999999999976432 235678899999999999999999999876544 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE---cCCCcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl---~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999988776666556679999999999999999999999999999999999999 788999999999998775433
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++...|
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 231 (277)
T 3f3z_A 164 --MMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW-------- 231 (277)
T ss_dssp --CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH--------
T ss_pred --chhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh--------
Confidence 23455789999999988764 799999999999999999999999999988888887664443333322
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 232 -----------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 -----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -----------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 357899999999999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=403.11 Aligned_cols=256 Identities=28% Similarity=0.403 Sum_probs=212.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.+.|++++.||+|+||.||+|.+..+|+.||||++...... ..+|+.+|.++ +||||+++++++.... .+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~--~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGK--YVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSS--EEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCC--EEE
Confidence 46799999999999999999999999999999999765332 34688888888 7999999999987654 499
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC----CcEEEeecCcccccCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN----GILKIADFGLASFFDP 306 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~----g~vKL~DFGla~~~~~ 306 (714)
||||||.|+.+...+.....+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++..+..
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999987776666666789999999999999999999999999999999999998543 3599999999987654
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC---ChHHHHHHHHHhhCCCChhHHhhh
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK---TEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~---~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
... .....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+. +..+.+..|....-.++.
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~------ 244 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG------ 244 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS------
T ss_pred CCC-ceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc------
Confidence 332 234568899999999998755 799999999999999999999999863 444555555332111111
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..+..++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 245 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 245 -------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp -------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred -------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 1234689999999999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=419.02 Aligned_cols=261 Identities=32% Similarity=0.497 Sum_probs=221.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH-----------HHHHHHHHHHHHHHhCCCCCeeeeec
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP-----------ESVKFMAREIAILRKLDHPNIIKLEG 219 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~-----------~~~~~~~rEi~iL~~L~HpnIVkl~~ 219 (714)
..+.|+++++||+|+||+||+|.+..+++.||||++....... ...+.+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999999999999999997643221 33567889999999999999999999
Q ss_pred cccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---cEEEe
Q 005111 220 LITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIA 296 (714)
Q Consensus 220 ~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g---~vKL~ 296 (714)
++.... .+|||||||+++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 114 ~~~~~~--~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEECSS--EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEcCC--EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 987654 4999999999877766555556799999999999999999999999999999999999999876 69999
Q ss_pred ecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 297 DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
|||++..+.... .....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+......++
T Consensus 192 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 192 DFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ECCCCEEcCCCC--ccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 999998875432 3455689999999998874 389999999999999999999999999999888888866433333
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
...| ..+|+.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 268 ~~~~-------------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 268 FNDW-------------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp HHHH-------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred cccc-------------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 3332 4689999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=397.16 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=216.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC---CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD---NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~---~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+.+|+.+|+.++||||+++++++.... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ--Y 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC--e
Confidence 46799999999999999999999999999999998753 223456678999999999999999999999987654 4
Q ss_pred EEEEEeeccccccccccCC----------------------------------------CCCCCHHHHHHHHHHHHHHhh
Q 005111 229 LYLVFEYMEHDLVGLASLP----------------------------------------GMKFTESQVKCYMKQLLSGLE 268 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~----------------------------------------~~~lse~~i~~i~~QIl~aL~ 268 (714)
+|||||||+++.|..++.. ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999998776554420 223478889999999999999
Q ss_pred HhhhcCeeeccCCCccEEEcCCC--cEEEeecCcccccCCCCC---CCcccccccccccCcccccCC-CCCCccccccch
Q 005111 269 HCHSHGVLHRDIKGSNLLLDHNG--ILKIADFGLASFFDPKDS---VPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWST 342 (714)
Q Consensus 269 ~LH~~gIiHrDLKP~NILl~~~g--~vKL~DFGla~~~~~~~~---~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSL 342 (714)
|||++||+||||||+||||+.++ .+||+|||++..+..... .......||+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 899999999986543221 223456789999999998752 448999999999
Q ss_pred hHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhccc
Q 005111 343 GCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSI 422 (714)
Q Consensus 343 G~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~ 422 (714)
||++|+|++|..||.+.+..+.+..+......+... .+..+++.+.+||.+||+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHHHHHHHHHcCC
Confidence 999999999999999999888887776532222111 1235788999999999999
Q ss_pred CcCCCCCHHHHHcCcCCCCCC
Q 005111 423 DPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 423 DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
||.+|||+.++|+||||+...
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTS
T ss_pred ChhHCCCHHHHhcChhhccCh
Confidence 999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=404.09 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=213.6
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEe
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~E 234 (714)
|...+.||+|+||.||+|.+..+|+.||+|+++... ....+.+.+|+.+|++++|||||++++++..... +|||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~lv~E 166 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVME 166 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--EEEEEE
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE--EEEEEe
Confidence 344678999999999999999999999999998643 3456778999999999999999999999876544 999999
Q ss_pred eccccccccc-cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE--cCCCcEEEeecCcccccCCCCCCC
Q 005111 235 YMEHDLVGLA-SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL--DHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 235 y~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl--~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|++++.|..+ ......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.....
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9998666443 3344579999999999999999999999999999999999999 5678999999999998754432
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+||+.|+|||++.+.. ++.++||||||||+|+|++|.+||.+.+..+.+..|......++.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~-------------- 309 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED-------------- 309 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS--------------
T ss_pred cccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh--------------
Confidence 34457999999999987655 899999999999999999999999999999888888764322221
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 310 -----------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 310 -----------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -----------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1234689999999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=398.40 Aligned_cols=256 Identities=30% Similarity=0.503 Sum_probs=219.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
..|++++.||+|+||.||+|++..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++..... +||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--EEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe--EEE
Confidence 45999999999999999999999999999999998653 334556788999999999999999999999876554 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.|+++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 9999998877766555568999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 312 MTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
...+||+.|+|||++.+ ...++.++||||||||+|||++|.+||.+.+..+.+..+..... +.
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~~------------- 272 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA------------- 272 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC-------------
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-CC-------------
Confidence 34578999999999853 34489999999999999999999999999887777666643110 00
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 273 -------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 -------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0013578899999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=389.90 Aligned_cols=282 Identities=30% Similarity=0.524 Sum_probs=225.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+|+.+. ||||+++++++.......+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 357899999999999999999999999999999998642 2456889999999997 9999999999887555568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~~~~ 308 (714)
++||||+.++.+..+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+....
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999888776663 489999999999999999999999999999999999999777 89999999998765433
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCC-CCCChHHHHHHHHHhhCCCChhH-Hhhhhcc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVL-PGKTEVEQLHRIFKLCGSPSEDY-WRKSKLR 386 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF-~g~~~~e~l~~I~k~~G~p~~~~-w~~~~~~ 386 (714)
. ....++|+.|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+...++.+.... +......
T Consensus 186 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 186 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 2 345578999999999987666899999999999999999999887 56677788888888777543322 1211111
Q ss_pred cCccc------cCCchhhhh-hhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 387 HSTVF------KPVQPYRRR-IAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 387 ~~~~~------~~~~p~~~~-i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
....+ ......... .......++..+.+||.+||+.||.+|||++++|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 00000 000000000 011123478999999999999999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=399.32 Aligned_cols=282 Identities=26% Similarity=0.441 Sum_probs=224.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CC-----Ceeeeecccccc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HP-----NIIKLEGLITSQ 224 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-Hp-----nIVkl~~~~~~~ 224 (714)
..++|++++.||+|+||+||+|.+..+++.||||+++. .......+.+|+.++..+. |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 35789999999999999999999999999999999974 3345667788999998885 55 489999988765
Q ss_pred CCceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhh--hcCeeeccCCCccEEEc--CCCcEEEeecC
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCH--SHGVLHRDIKGSNLLLD--HNGILKIADFG 299 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH--~~gIiHrDLKP~NILl~--~~g~vKL~DFG 299 (714)
.. +||||||+++++...+.... ..+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||
T Consensus 129 ~~--~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 129 NH--LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp TE--EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred Cc--eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 44 99999999987766554432 46999999999999999999999 57999999999999995 47789999999
Q ss_pred cccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 300 LASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 300 la~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
++...... ....+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+++..|...+|.++...
T Consensus 207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred Cceecccc----cccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99877432 33568899999999998876 89999999999999999999999999999999999999999998877
Q ss_pred Hhhhhc--------ccCc---------cccCCchhhhhhhhhcc------------------CCcHHHHHHHHHhcccCc
Q 005111 380 WRKSKL--------RHST---------VFKPVQPYRRRIAETFK------------------DFPTSALRLMETLMSIDP 424 (714)
Q Consensus 380 w~~~~~--------~~~~---------~~~~~~p~~~~i~~~~~------------------~~p~~l~~LI~~mL~~DP 424 (714)
|..... +... ......+....+...+. .....+.+||.+||+.||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 643210 0000 00000000001111100 011478999999999999
Q ss_pred CCCCCHHHHHcCcCCCCC
Q 005111 425 AHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 425 ~kRpTa~e~L~Hp~f~~~ 442 (714)
++|||+.|+|+||||+..
T Consensus 362 ~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTSCCHHHHTTSGGGCC-
T ss_pred hhCCCHHHHhcCcccccC
Confidence 999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=394.48 Aligned_cols=265 Identities=23% Similarity=0.351 Sum_probs=218.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc--
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC-- 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~-- 227 (714)
..++|++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999999999999999998763 3456677899999999999999999999987654432
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+||||||++++.|..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 35999999998888777666668999999999999999999999999999999999999999999999999999876543
Q ss_pred CC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 308 DS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 308 ~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+......++
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 239 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--------- 239 (311)
T ss_dssp ------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH---------
T ss_pred ccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc---------
Confidence 22 2233457899999999998765 89999999999999999999999999888777666654222111
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
......++..+.+||.+||+.||.+||++.++|.|+|+..
T Consensus 240 ----------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 ----------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ----------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ----------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1123468999999999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=396.34 Aligned_cols=260 Identities=29% Similarity=0.452 Sum_probs=221.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC--C----HHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--D----PESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--~----~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
++|++.+.||+|+||.||+|.+..+|+.||||+++.... . ....+.+.+|+.+|+++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 569999999999999999999999999999999986532 1 22356688999999999 8999999999887654
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
.+||||||++++.+..+......+++..++.++.||+.||.|||+.||+|+||||+||||+.+|.+||+|||++..+.
T Consensus 174 --~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 --FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp --EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred --EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 499999999998877766656679999999999999999999999999999999999999999999999999998875
Q ss_pred CCCCCCcccccccccccCcccccCC-----CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGA-----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~-----~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+....+..+......+....
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~- 328 (365)
T 2y7j_A 252 PGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE- 328 (365)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH-
T ss_pred CCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc-
Confidence 433 23456899999999998632 2478999999999999999999999999888877777755332222222
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
+..++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 329 ------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 ------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp ------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 2467889999999999999999999999999999973
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=389.51 Aligned_cols=257 Identities=24% Similarity=0.422 Sum_probs=218.9
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~ 233 (714)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++..... +||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE--LWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE--EEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE--EEEEE
Confidence 47888999999999999999999999999999976532 235668899999999999999999999876554 99999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcc
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~ 313 (714)
||++++.+..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ...
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccc
Confidence 99999888777654 4799999999999999999999999999999999999999999999999999987654322 234
Q ss_pred cccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 314 ~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
..+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+..... +.
T Consensus 200 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~----------------- 260 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PK----------------- 260 (321)
T ss_dssp CCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC-----------------
T ss_pred cccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CC-----------------
Confidence 568999999999998765 89999999999999999999999999888777666543110 00
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......+++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus 261 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 261 --------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp --------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred --------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 001124788999999999999999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=390.19 Aligned_cols=265 Identities=24% Similarity=0.343 Sum_probs=208.3
Q ss_pred cCCCCCeeEE-eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCC
Q 005111 149 PRRANTFEKL-DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTS 226 (714)
Q Consensus 149 ~~~~~~Y~~~-~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~ 226 (714)
.+..+.|++. +.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|.++ +||||+++++++.....
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3456789996 789999999999999999999999999976532 3456788999999995 79999999999876554
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc---EEEeecCcccc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI---LKIADFGLASF 303 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~---vKL~DFGla~~ 303 (714)
+||||||++++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 86 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 --FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp --EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred --EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999998777766655567999999999999999999999999999999999999998775 99999999976
Q ss_pred cCCCCC------CCcccccccccccCcccccCC----CCCCccccccchhHHHHHHhhCCCCCCCCChH-----------
Q 005111 304 FDPKDS------VPMTSRVVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEV----------- 362 (714)
Q Consensus 304 ~~~~~~------~~~~~~~gT~~Y~APE~l~g~----~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~----------- 362 (714)
...... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 542211 112345689999999998641 23789999999999999999999999876421
Q ss_pred ----HHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 363 ----EQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 363 ----e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
..+..+......++. ..+..++..+.+||.+||+.||.+|||+.++|+|||
T Consensus 244 ~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPD-------------------------KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred hHHHHHHHHHhccCcccCc-------------------------hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 122222221111111 122467899999999999999999999999999999
Q ss_pred CCCC
Q 005111 439 FTTQ 442 (714)
Q Consensus 439 f~~~ 442 (714)
|+..
T Consensus 299 ~~~~ 302 (316)
T 2ac3_A 299 VQGC 302 (316)
T ss_dssp CC--
T ss_pred hcCC
Confidence 9864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=395.15 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=194.7
Q ss_pred CCeeEE---eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCce
Q 005111 153 NTFEKL---DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~---~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~ 228 (714)
+.|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+|+.+. ||||+++++++.....
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~-- 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH-- 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE--
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE--
Confidence 346665 7899999999999999999999999998642 3456779999999997 9999999999876544
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---cEEEeecCcccccC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLASFFD 305 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g---~vKL~DFGla~~~~ 305 (714)
+||||||++++.+..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 899999999988777766667899999999999999999999999999999999999998766 89999999998765
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh-------HHHHHHHHHhhCCCChh
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE-------VEQLHRIFKLCGSPSED 378 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~-------~e~l~~I~k~~G~p~~~ 378 (714)
... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+. .+.+..+......+..+
T Consensus 161 ~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 161 PDN-QPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp C-----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred CCC-CcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence 432 2344567899999999988765 89999999999999999999999987543 33444443222111111
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+..+++.+.+||.+||..||.+|||+.++|+||||+...
T Consensus 239 -------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 239 -------------------------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp -------------------------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred -------------------------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 2346899999999999999999999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=385.16 Aligned_cols=258 Identities=33% Similarity=0.457 Sum_probs=217.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++..... +
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR--V 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--E
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE--E
Confidence 45789999999999999999999999999999999865321 12234668899999999999999999999876544 8
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||++++.+...+.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 999999998877766655567999999999999999999999999999999999999999999999999998665332
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 225 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------------- 225 (279)
T ss_dssp ------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC---------------
T ss_pred -cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC---------------
Confidence 224457899999999998765 799999999999999999999999998887777766442111
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
....++..+.+||.+||+.||.+|||+.++|+||||+..+
T Consensus 226 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 226 --------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp --------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred --------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 1134788999999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=383.31 Aligned_cols=260 Identities=23% Similarity=0.368 Sum_probs=201.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||.||+|++..+|+.||||+++.........+.+..+...++.++||||+++++++..... +|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~--~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD--VW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS--EE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC--EE
Confidence 4578999999999999999999999999999999997664444445555566666888899999999999876554 89
Q ss_pred EEEeeccccccccc---cCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 231 LVFEYMEHDLVGLA---SLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 231 LV~Ey~~g~ll~~~---~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+||||+++++...+ ......+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99999998664433 23556899999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCCcccccccccccCcccc---cCCCCCCccccccchhHHHHHHhhCCCCCCC-CChHHHHHHHHHhhCCCChhHHhh
Q 005111 307 KDSVPMTSRVVTLWYRPPELL---LGASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l---~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
... .....||+.|+|||++ .....++.++|||||||++|+|++|..||.. ......+..+.......
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 233 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------- 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-------
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-------
Confidence 322 2334789999999997 3344589999999999999999999999986 34444444443211000
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.....++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 234 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 --------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp --------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred --------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 001357889999999999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=405.43 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=206.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC------CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ------DPESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~------~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|++++|||||++++++...
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 4789999999999999999999999999999999975421 122234578999999999999999999987532
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---cEEEeecCccc
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIADFGLAS 302 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g---~vKL~DFGla~ 302 (714)
.+|||||||+++.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++.
T Consensus 213 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp --EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred --ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 3899999999988877777777899999999999999999999999999999999999997544 59999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHH-HHHhhCCCChhH
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHR-IFKLCGSPSEDY 379 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~-I~k~~G~p~~~~ 379 (714)
..... ......+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+......+.. +......+
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~---- 364 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 364 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC----
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC----
Confidence 76533 22345689999999999864 34478999999999999999999999987544322222 22111111
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
....+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 365 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 365 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred ---------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 112335689999999999999999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=376.68 Aligned_cols=260 Identities=26% Similarity=0.413 Sum_probs=217.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++..... +|+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI--QYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE--EEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE--EEEE
Confidence 579999999999999999999999999999999976532 2345778899999999999999999998876544 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-CC
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-VP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~ 311 (714)
|||++++.+..++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999988877777777899999999999999999999999999999999999999999999999999986543221 12
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH-HHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....||+.|+|||++.+...++.++|||||||++|+|++|..||.+..... .+..+.... .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------------~ 226 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-----------------T 226 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-----------------T
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-----------------c
Confidence 3445789999999999876655889999999999999999999998765432 222221100 0
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
....+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 001123578999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=381.45 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=218.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC----HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD----PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
++|++++.||+|+||.||+|++..+|+.||+|++...... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-- 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD-- 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe--
Confidence 5699999999999999999999999999999999765322 1236778999999999999999999999876544
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC----cEEEeecCccccc
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG----ILKIADFGLASFF 304 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g----~vKL~DFGla~~~ 304 (714)
+|+||||++++.+..++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 899999999887777666566799999999999999999999999999999999999999877 8999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......+.
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 232 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE------- 232 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred cCCC--cccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-------
Confidence 5332 234457899999999987765 799999999999999999999999998888777776543222221
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
..+..++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 233 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 233 ------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 223467899999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=386.29 Aligned_cols=263 Identities=27% Similarity=0.406 Sum_probs=216.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||.||+|++..++..||+|++... .......+.+.+|+.++++++||||+++++++.... .+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD--CYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS--EEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC--eEE
Confidence 46899999999999999999999999999999998765 345567788999999999999999999999987554 499
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999888777666668999999999999999999999999999999999999999999999999999877654444
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+...++.... .+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~-------------- 230 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS--VP-------------- 230 (294)
T ss_dssp -------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC--CC--------------
T ss_pred ccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc--CC--------------
Confidence 445567999999999998866 7999999999999999999999999988776655543211 00
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.........+|+.+.++|.+||+.||.+||+..+.|.+.|..-
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 231 --------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0012233578999999999999999999997777777777543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=382.07 Aligned_cols=263 Identities=27% Similarity=0.396 Sum_probs=225.3
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.+.||||+++++++.... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 89 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND--F 89 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--E
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC--E
Confidence 45678999999999999999999999999999999997653 34566778999999999999999999999987654 4
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|+||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 89999999988777666655689999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 232 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--------------- 232 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------------
T ss_pred c-ccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC---------------
Confidence 2 234457899999999988765 79999999999999999999999998887766655532100
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
.....++..+.+||.+||+.||.+|||+.++|+||||+....+
T Consensus 233 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 233 --------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred --------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 1123578899999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=378.64 Aligned_cols=261 Identities=21% Similarity=0.283 Sum_probs=218.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc--CCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ--TSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~--~~~~ 228 (714)
....|++.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.+|+.++||||+++++++... ....
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 34568999999999999999999999999999999987766677788899999999999999999999987542 2345
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEc-CCCcEEEeecCcccccC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLD-HNGILKIADFGLASFFD 305 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~-~~g~vKL~DFGla~~~~ 305 (714)
+|+||||++++.|..++.....+++..++.++.||+.||.|||++| |+|+||||+||||+ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999888777766667999999999999999999999999 99999999999998 78999999999997654
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.. ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......+.........+
T Consensus 184 ~~---~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 248 (290)
T 1t4h_A 184 AS---FAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred cc---ccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----------
Confidence 32 23455789999999988753 7999999999999999999999998866554443332211000
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.......++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 249 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ----------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 01123567899999999999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=383.07 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=209.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+.+|+.+|+.++||||+++++++..... +|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN--MYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE--EEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe--EEE
Confidence 3579999999999999999999999999999999976532 2335678899999999999999999999876544 899
Q ss_pred EEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE---cCCCcEEEeecCccccc
Q 005111 232 VFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFF 304 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl---~~~g~vKL~DFGla~~~ 304 (714)
||||++++.+...+. .+..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999866654432 23579999999999999999999999999999999999999 45678999999999876
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------- 244 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY--------- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred CCcc--cCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc---------
Confidence 5332 2345578999999998864 37899999999999999999999999988766655543211100
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
......+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 245 -----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 -----------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -----------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 0111347889999999999999999999999999999985
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=378.74 Aligned_cols=254 Identities=19% Similarity=0.277 Sum_probs=209.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++..... +
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~--~ 86 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH--M 86 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE--E
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe--E
Confidence 34679999999999999999999999999999999987655556677888999999999 99999999999876554 9
Q ss_pred EEEEeeccccccccccCCC----CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC---------------
Q 005111 230 YLVFEYMEHDLVGLASLPG----MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN--------------- 290 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~----~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~--------------- 290 (714)
||||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999987776555432 569999999999999999999999999999999999999844
Q ss_pred ----CcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHH
Q 005111 291 ----GILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366 (714)
Q Consensus 291 ----g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 366 (714)
..+||+|||++....... ...||+.|+|||++.+...++.++|||||||++|+|++|.+++...... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---H 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---H
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---H
Confidence 479999999998775432 2368999999999987756788999999999999999999887654322 2
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+.. + ........++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 239 ~~~~--~--------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 239 EIRQ--G--------------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHHT--T--------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHHc--C--------------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2211 0 0011224678999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=386.23 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=204.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC-----
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS----- 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~----- 226 (714)
.++|++++.||+|+||.||+|++..+|+.||||+++... .....+.+.+|+.+|++++|||||++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 357999999999999999999999999999999998654 33456778999999999999999999998754321
Q ss_pred --------------------------------------------------ceEEEEEeeccccccccccCCCC---CCCH
Q 005111 227 --------------------------------------------------CSLYLVFEYMEHDLVGLASLPGM---KFTE 253 (714)
Q Consensus 227 --------------------------------------------------~~l~LV~Ey~~g~ll~~~~~~~~---~lse 253 (714)
..+|+|||||+++.+..+..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 23899999999987776655433 3566
Q ss_pred HHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-----------CCccccccccccc
Q 005111 254 SQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-----------VPMTSRVVTLWYR 322 (714)
Q Consensus 254 ~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-----------~~~~~~~gT~~Y~ 322 (714)
..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ......+||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 77999999999999999999999999999999999999999999999988764421 1233457899999
Q ss_pred CcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhh
Q 005111 323 PPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIA 402 (714)
Q Consensus 323 APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~ 402 (714)
|||++.+.. ++.++|||||||++|+|++|..++.. ....+..+.. +.. .
T Consensus 244 aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~--------------------------~ 292 (332)
T 3qd2_B 244 SPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKF--------------------------P 292 (332)
T ss_dssp CHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCC--------------------------C
T ss_pred ChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCC--------------------------C
Confidence 999998765 89999999999999999998765421 1111111111 000 0
Q ss_pred hhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 403 ETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 403 ~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
..+...++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 111234678899999999999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=381.33 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=222.1
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
+|...++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++......
T Consensus 1 ~p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp --CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred CCCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 35567899999999999999999999999999999999988766677788899999999999999999999987655555
Q ss_pred eEEEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcC-----eeeccCCCccEEEcCCCcEEEeec
Q 005111 228 SLYLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHG-----VLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~g-----IiHrDLKP~NILl~~~g~vKL~DF 298 (714)
.+|+||||++++.|..++. ....+++..++.++.||+.||.|||++| |+|+||||+|||++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 6999999999876665543 2345999999999999999999999999 999999999999999999999999
Q ss_pred CcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005111 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~ 378 (714)
|++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+.... .
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~--- 233 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--F--- 233 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C---
T ss_pred chheeeccccc-cccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc--c---
Confidence 99987643221 123457899999999998765 7999999999999999999999999988776666654311 0
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..||.+|||+.++|+|+|++..
T Consensus 234 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 -----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -----------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 01123578999999999999999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=385.08 Aligned_cols=257 Identities=30% Similarity=0.425 Sum_probs=217.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+|+.++||||+++++++..... +|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv 84 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH--YYLV 84 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSE--EEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE--EEEE
Confidence 579999999999999999999999999999999985432 234568899999999999999999999876544 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE---cCCCcEEEeecCcccccCCCCC
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl---~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||++++.+..++.....+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9999987776655555679999999999999999999999999999999999999 77889999999999765322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 228 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES------------ 228 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT------------
T ss_pred -ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc------------
Confidence 234457899999999998765 899999999999999999999999998888777777543221111
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 229 -------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1224678999999999999999999999999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=378.08 Aligned_cols=263 Identities=28% Similarity=0.424 Sum_probs=222.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC---C----HHHHHHHHHHHHHHHhCC-CCCeeeeecccc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ---D----PESVKFMAREIAILRKLD-HPNIIKLEGLIT 222 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~---~----~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~ 222 (714)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... . ....+.+.+|+.+|+++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 46899999999999999999999999999999999976531 1 233567889999999995 999999999987
Q ss_pred ccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccc
Q 005111 223 SQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 223 ~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~ 302 (714)
... .+|+||||++++.+..++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 95 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 95 TNT--FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp CSS--EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cCC--eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 554 499999999987777766666689999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccccccCccccc-----CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLL-----GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~-----g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~ 377 (714)
.+.... ......+|+.|+|||++. ....++.++|||||||++|+|++|..||.+.+..+....+......++.
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 1phk_A 173 QLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250 (298)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred hcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence 775432 234457899999999985 2344789999999999999999999999998887777766543221111
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 -------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp -------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 1123578999999999999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=390.16 Aligned_cols=263 Identities=28% Similarity=0.405 Sum_probs=225.8
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++... .......+.+.+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 114 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND-- 114 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 34567899999999999999999999999999999999765 345566788999999999999999999999987654
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+||||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 49999999998877766665568999999999999999999999999999999999999999999999999999876533
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------- 258 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------- 258 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------
T ss_pred cc-cccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--------------
Confidence 22 234457899999999998765 79999999999999999999999998887766665533110
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.....++..+.+||.+||+.||.+|||+.++|+|+||+....
T Consensus 259 ---------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 259 ---------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred ---------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 011357889999999999999999999999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=380.85 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=218.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK--RI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC--EE
Confidence 35789999999999999999999999999999999865321 1123456889999999999999999999987654 48
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||++++.+..++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 9999999987776666555679999999999999999999999999999999999999999999999999997654322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+.....
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------- 229 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL---------------- 229 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------------
T ss_pred --cccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc----------------
Confidence 23457899999999998765 79999999999999999999999998887776666543110
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 230 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 230 -------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 0113578899999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=381.76 Aligned_cols=281 Identities=24% Similarity=0.394 Sum_probs=225.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEE-ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC------Ceeeeecccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARD-VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP------NIIKLEGLITSQ 224 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d-~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp------nIVkl~~~~~~~ 224 (714)
.++|++++.||+|+||.||+|.+ ..+++.||||++.. .....+.+.+|+.+++.+.|+ +|+++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46899999999999999999998 56899999999864 235567788999999998665 499999988765
Q ss_pred CCceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC--------------
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-------------- 289 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-------------- 289 (714)
. .+||||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 90 ~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 G--HICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp T--EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred C--cEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 5 499999999777666554332 46899999999999999999999999999999999999987
Q ss_pred -----CCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHH
Q 005111 290 -----NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ 364 (714)
Q Consensus 290 -----~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~ 364 (714)
++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999875432 23457899999999998765 89999999999999999999999999999999
Q ss_pred HHHHHHhhCCCChhHHhhhhcccCc-----cccCCchhhhhh----------hhhccCCcHHHHHHHHHhcccCcCCCCC
Q 005111 365 LHRIFKLCGSPSEDYWRKSKLRHST-----VFKPVQPYRRRI----------AETFKDFPTSALRLMETLMSIDPAHRGT 429 (714)
Q Consensus 365 l~~I~k~~G~p~~~~w~~~~~~~~~-----~~~~~~p~~~~i----------~~~~~~~p~~l~~LI~~mL~~DP~kRpT 429 (714)
+..+....+.++...|......... .+.........+ .......+..+.+||.+||..||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 9999999999888776543211100 000000000000 0011123678999999999999999999
Q ss_pred HHHHHcCcCCCCC
Q 005111 430 ATLALNSEFFTTQ 442 (714)
Q Consensus 430 a~e~L~Hp~f~~~ 442 (714)
+.|+|+||||+..
T Consensus 323 ~~ell~hp~f~~~ 335 (339)
T 1z57_A 323 LREALKHPFFDLL 335 (339)
T ss_dssp HHHHTTSGGGGGG
T ss_pred HHHHhcCHHHHHH
Confidence 9999999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=400.83 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=201.5
Q ss_pred CCCCeeEE-eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHH-hCCCCCeeeeeccccc--cCC
Q 005111 151 RANTFEKL-DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR-KLDHPNIIKLEGLITS--QTS 226 (714)
Q Consensus 151 ~~~~Y~~~-~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~-~L~HpnIVkl~~~~~~--~~~ 226 (714)
..++|.++ +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++. .++||||+++++++.. .+.
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 34678887 7899999999999999999999999998632 34668888874 4589999999998754 223
Q ss_pred ceEEEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCcc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLA 301 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla 301 (714)
..+|||||||+|+.|..++... ..+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 4589999999987776555432 36999999999999999999999999999999999999997 789999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH----HHHHHHHhhCCCCh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE----QLHRIFKLCGSPSE 377 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e----~l~~I~k~~G~p~~ 377 (714)
...... ......+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+..... ....+......++
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~- 287 (400)
T 1nxk_A 212 KETTSH--NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP- 287 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC-
T ss_pred cccCCC--CccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC-
Confidence 876432 2234568899999999987765 8999999999999999999999998765322 2222221100000
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
...+..++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 288 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 ------------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ------------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 01234689999999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=429.98 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=224.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|++++.||+|+||.||+|++..+++.||||+++... ......+.+.+|+.+|..+ +||+|+++++++.....
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~-- 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-- 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE--
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE--
Confidence 4578999999999999999999999999999999997531 1122345678899999988 79999999998876544
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||||++|+.|..++.....|++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence 99999999998887777666789999999999999999999999999999999999999999999999999998643322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
......+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+.+..|......
T Consensus 497 -~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-------------- 560 (674)
T 3pfq_A 497 -VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA-------------- 560 (674)
T ss_dssp -CCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC--------------
T ss_pred -cccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 2345668999999999998766 899999999999999999999999999998888888642111
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCH-----HHHHcCcCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA-----TLALNSEFFTTQPL 444 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa-----~e~L~Hp~f~~~~~ 444 (714)
....++.++.+||.+||+.||.+|+++ +++++||||....|
T Consensus 561 ---------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 561 ---------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp ---------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred ---------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 113578999999999999999999997 99999999997644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=380.88 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=193.3
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
....++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 84 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN-- 84 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS--
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC--
Confidence 3455789999999999999999999999999999999964321 1123467889999999999999999999987654
Q ss_pred eEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+|+||||++++.+..++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 48999999998777655543 36799999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+.+..+..
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 226 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------- 226 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----------------
T ss_pred CCC-cceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----------------
Confidence 322 223457899999999988765 79999999999999999999999987654333222210
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.. ......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 227 ----~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 ----AD---------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ----SC---------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ----cc---------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00 01123578899999999999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=384.42 Aligned_cols=281 Identities=25% Similarity=0.387 Sum_probs=227.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCC-eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC------eeeeecccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHD-KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN------IIKLEGLITSQ 224 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn------IVkl~~~~~~~ 224 (714)
.++|++++.||+|+||.||+|.+..++ ..||||+++. .....+.+.+|+.+|+.+.|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 478999999999999999999998777 7999999864 2355677889999999997655 88888887765
Q ss_pred CCceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE----------------
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---------------- 287 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl---------------- 287 (714)
.. +||||||++++++..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 95 ~~--~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 95 GH--MCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TE--EEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred Ce--EEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 44 99999999888887665443 469999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHH
Q 005111 288 ---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ 364 (714)
Q Consensus 288 ---~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~ 364 (714)
+.++.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999875432 23457899999999998765 89999999999999999999999999999999
Q ss_pred HHHHHHhhCCCChhHHhhhhcccCc-----cccCCchhhhhhhh----------hccCCcHHHHHHHHHhcccCcCCCCC
Q 005111 365 LHRIFKLCGSPSEDYWRKSKLRHST-----VFKPVQPYRRRIAE----------TFKDFPTSALRLMETLMSIDPAHRGT 429 (714)
Q Consensus 365 l~~I~k~~G~p~~~~w~~~~~~~~~-----~~~~~~p~~~~i~~----------~~~~~p~~l~~LI~~mL~~DP~kRpT 429 (714)
+..+.+.+|.++..++......... .+.........+.. .....+..+.+||.+||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 9999999999988776543221100 00000000000000 01123568999999999999999999
Q ss_pred HHHHHcCcCCCCC
Q 005111 430 ATLALNSEFFTTQ 442 (714)
Q Consensus 430 a~e~L~Hp~f~~~ 442 (714)
+.++|+||||+..
T Consensus 328 ~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 328 LAEALLHPFFAGL 340 (355)
T ss_dssp HHHHTTSGGGGGC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=394.92 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=212.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH------HHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP------ESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~------~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
.++|++++.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|+.++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 467999999999999999999999999999999998653211 13345678999999999999999999987654
Q ss_pred CceEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 226 SCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
. +|+||||+.++ .+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 103 ~--~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 F--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp E--EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred E--EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 4 89999999765 66666666678999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... .....+||+.|+|||++.+...++.++|||||||++|+|++|..||...... ..
T Consensus 181 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------------- 238 (335)
T 3dls_A 181 ERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------------- 238 (335)
T ss_dssp CTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT--------------
T ss_pred CCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh--------------
Confidence 5432 2345679999999999988775589999999999999999999999652210 00
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
........++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 239 ---------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 239 ---------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ---------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ---------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 000112347899999999999999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=423.08 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=216.5
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
...++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|..++|||||++++++.... .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~--~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD--A 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--E
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC--E
Confidence 456789999999999999999999999999999999975311 1123456789999999999999999999887654 4
Q ss_pred EEEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 229 LYLVFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+||||||++|+.|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999988776554432 3499999999999999999999999999999999999999999999999999987753
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh----HHHHHHHHHhhCCCChhHHhh
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE----VEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~----~e~l~~I~k~~G~p~~~~w~~ 382 (714)
.. .....+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+... .+....+... +
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~------ 405 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----P------ 405 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----C------
T ss_pred Cc--cccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc----c------
Confidence 32 334568999999999998765 89999999999999999999999987643 2222222110 0
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQPL 444 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~~ 444 (714)
......++..+.+||.+||+.||.+|| +++++++||||+...+
T Consensus 406 -------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 406 -------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred -------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 011235789999999999999999999 8999999999997543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=390.49 Aligned_cols=263 Identities=27% Similarity=0.421 Sum_probs=208.3
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC--CCeeeeeccccccCC
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH--PNIIKLEGLITSQTS 226 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIVkl~~~~~~~~~ 226 (714)
....+.|++++.||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+|..+.| |||+++++++....
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~- 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ- 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC-
Confidence 34567899999999999999999987 568999999998877777778889999999999976 99999999987654
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+||||||..+++... +.....+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+..
T Consensus 83 -~~~lv~e~~~~~L~~~-l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 83 -YIYMVMECGNIDLNSW-LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp -EEEEEECCCSEEHHHH-HHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred -EEEEEEeCCCCCHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 4999999766555444 44456799999999999999999999999999999999999997 68899999999987654
Q ss_pred CCCC-CcccccccccccCcccccC----------CCCCCccccccchhHHHHHHhhCCCCCCCCCh-HHHHHHHHHhhCC
Q 005111 307 KDSV-PMTSRVVTLWYRPPELLLG----------ASHYGAAVDLWSTGCILGELFSGKPVLPGKTE-VEQLHRIFKLCGS 374 (714)
Q Consensus 307 ~~~~-~~~~~~gT~~Y~APE~l~g----------~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~~I~k~~G~ 374 (714)
.... .....+||+.|+|||++.+ ...|+.++|||||||++|+|++|.+||.+... ...+..+......
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 3322 2335679999999999864 23478999999999999999999999987533 2333333210000
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.......+..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 240 ---------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 240 ---------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp ---------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ---------------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 011124567899999999999999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=377.36 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=211.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++..... +|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD--FF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE--EE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe--EE
Confidence 4789999999999999999999999999999999875321 12235678899999999999999999999876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+||||++++.+..++.....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 999999987777666555679999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------- 228 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF----------------- 228 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------------
Confidence 233457899999999998776457899999999999999999999998877666655533110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 229 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 ------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 0113468899999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=384.16 Aligned_cols=259 Identities=29% Similarity=0.429 Sum_probs=209.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC------CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ------DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~------~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 579999999999999999999999999999999875421 1223445789999999999999999999886432
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc---EEEeecCcccc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI---LKIADFGLASF 303 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~---vKL~DFGla~~ 303 (714)
+|+||||++++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 89 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 --YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp --EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred --eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999998777776666778999999999999999999999999999999999999987664 99999999987
Q ss_pred cCCCCCCCcccccccccccCccccc--CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHH-HHHHHhhCCCChhHH
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLL--GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQL-HRIFKLCGSPSEDYW 380 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~--g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l-~~I~k~~G~p~~~~w 380 (714)
.... .......||+.|+|||++. +...++.++|||||||++|+|++|.+||.+......+ ..+......+
T Consensus 167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 239 (322)
T 2ycf_A 167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF----- 239 (322)
T ss_dssp CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-----
T ss_pred cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-----
Confidence 6432 1223457899999999974 3444789999999999999999999999865433222 2222111000
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
....+..++..+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 --------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 --------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp --------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred --------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 11233568999999999999999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=414.09 Aligned_cols=262 Identities=24% Similarity=0.353 Sum_probs=217.9
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
...++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-- 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD-- 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE--
Confidence 456889999999999999999999999999999999975421 11235678899999999999999999998876544
Q ss_pred EEEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 229 LYLVFEYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
+||||||++|+.|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999998877655432 346999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC----hHHHHHHHHHhhCCCChhHH
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT----EVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~----~~e~l~~I~k~~G~p~~~~w 380 (714)
..... .....+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.. ..+....+....
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~-------- 409 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-------- 409 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC--------
T ss_pred cCCCc-ccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc--------
Confidence 54332 234458999999999998865 8999999999999999999999998764 233334443210
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQPL 444 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~~ 444 (714)
......++..+.+||.+||+.||.+||+ ++++++||||+...+
T Consensus 410 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 410 ---------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred ---------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 0112357899999999999999999995 589999999997643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=398.04 Aligned_cols=261 Identities=27% Similarity=0.415 Sum_probs=208.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--CCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD--HPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--HpnIVkl~~~~~~~~~~~ 228 (714)
....|++++.||+|+||.||+|.+.. ++.||||++..........+.+.+|+.+|..+. |||||++++++.....
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~-- 130 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-- 130 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE--
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE--
Confidence 34579999999999999999999754 899999999887667777888999999999996 5999999998876554
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|||||+..+++ ..++.....+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+....
T Consensus 131 ~~lv~E~~~~~L-~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 131 IYMVMECGNIDL-NSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEECCSEEH-HHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEecCCCCH-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999999655544 44444445899999999999999999999999999999999999995 5899999999998775433
Q ss_pred CC-CcccccccccccCcccccCC----------CCCCccccccchhHHHHHHhhCCCCCCCCCh-HHHHHHHHHhhCCCC
Q 005111 309 SV-PMTSRVVTLWYRPPELLLGA----------SHYGAAVDLWSTGCILGELFSGKPVLPGKTE-VEQLHRIFKLCGSPS 376 (714)
Q Consensus 309 ~~-~~~~~~gT~~Y~APE~l~g~----------~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~~I~k~~G~p~ 376 (714)
.. .....+||+.|+|||++.+. ..|+.++||||||||||+|++|.+||.+... ...+..++.....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~-- 286 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-- 286 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC--
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc--
Confidence 21 23456899999999998752 3488999999999999999999999987543 3344433221000
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.......+..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 287 -------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 287 -------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp -------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred -------------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 001123477899999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=381.73 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=209.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||+||+|++ +|..||||++..........+.+.+|+.+|++++||||+++++++..... +|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~~ 110 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN--LS 110 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC--CE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc--eE
Confidence 357899999999999999999975 68999999998776677778889999999999999999999999876554 89
Q ss_pred EEEeeccccccccccCCCCC---CCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 231 LVFEYMEHDLVGLASLPGMK---FTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~---lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
+||||++++.+..++..... +++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++....
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999877766654433 999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------- 258 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL---------- 258 (309)
T ss_dssp ------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred ccc-cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC----------
Confidence 322 2234567899999999998766 7999999999999999999999999888776665553211110
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc--CcCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN--SEFFTTQ 442 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~--Hp~f~~~ 442 (714)
.....+++.+.+||.+||+.||.+|||+.++++ .+++...
T Consensus 259 -----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 -----------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 122467899999999999999999999999998 6777653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=379.91 Aligned_cols=264 Identities=27% Similarity=0.401 Sum_probs=217.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++||||+++++++.......+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 5789999999999999999999999999999999975321 12345778999999999999999999998855554559
Q ss_pred EEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||||+++++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999986554432 34579999999999999999999999999999999999999999999999999998765322
Q ss_pred C-CCcccccccccccCcccccCCC-CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 309 S-VPMTSRVVTLWYRPPELLLGAS-HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 309 ~-~~~~~~~gT~~Y~APE~l~g~~-~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+.+..+.... +
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~--~----------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS--Y----------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--C-----------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC--C-----------
Confidence 2 2223456899999999987643 24789999999999999999999999988777666654311 0
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.....++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 231 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 231 ----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 112357889999999999999999999999999999987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=388.35 Aligned_cols=284 Identities=28% Similarity=0.472 Sum_probs=223.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-----------CCCeeeeec
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-----------HPNIIKLEG 219 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIVkl~~ 219 (714)
..++|++++.||+|+||.||+|++..+++.||||++.. .......+.+|+.+++++. ||||+++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 35789999999999999999999999999999999874 3345667889999999886 899999999
Q ss_pred cccccC--CceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEc------C
Q 005111 220 LITSQT--SCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLD------H 289 (714)
Q Consensus 220 ~~~~~~--~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~------~ 289 (714)
++.... ...+++||||+.+++...+.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+ .
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred HhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 887543 235899999996666554443 334699999999999999999999998 999999999999995 3
Q ss_pred CCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC------hHH
Q 005111 290 NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT------EVE 363 (714)
Q Consensus 290 ~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~------~~e 363 (714)
.+.+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+ ..+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 448999999999876532 23457899999999998876 8999999999999999999999998765 567
Q ss_pred HHHHHHHhhCCCChhHHhhhhcccC-----ccccC-----Cchhhhhhh---hhccCCcHHHHHHHHHhcccCcCCCCCH
Q 005111 364 QLHRIFKLCGSPSEDYWRKSKLRHS-----TVFKP-----VQPYRRRIA---ETFKDFPTSALRLMETLMSIDPAHRGTA 430 (714)
Q Consensus 364 ~l~~I~k~~G~p~~~~w~~~~~~~~-----~~~~~-----~~p~~~~i~---~~~~~~p~~l~~LI~~mL~~DP~kRpTa 430 (714)
.+..++..+|.++...|...+.... ..... ..+....+. .....++..+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 8889999999998877654332100 00000 001111111 1122456789999999999999999999
Q ss_pred HHHHcCcCCCCC
Q 005111 431 TLALNSEFFTTQ 442 (714)
Q Consensus 431 ~e~L~Hp~f~~~ 442 (714)
.++|+||||+..
T Consensus 329 ~ell~hp~f~~~ 340 (373)
T 1q8y_A 329 GGLVNHPWLKDT 340 (373)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhhChhhhcc
Confidence 999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=375.29 Aligned_cols=259 Identities=30% Similarity=0.505 Sum_probs=218.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++.... .+|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv 99 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS--SFYIV 99 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--EEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC--eEEEE
Confidence 5799999999999999999999999999999999765444445677889999999999999999999987654 48999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC---CcEEEeecCcccccCCCCC
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN---GILKIADFGLASFFDPKDS 309 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~---g~vKL~DFGla~~~~~~~~ 309 (714)
|||+.++.+.........+++..++.++.||+.||.|||++||+|+||||+||||+.+ +.+||+|||++.......
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~- 178 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence 9999987765555445579999999999999999999999999999999999999764 479999999998765432
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+|+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..+.+..+......++.
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 243 (287)
T 2wei_A 179 -KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------------ 243 (287)
T ss_dssp -SCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS------------
T ss_pred -ccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc------------
Confidence 23445789999999988764 799999999999999999999999998887777666542211111
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..+..++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 244 -------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1224678999999999999999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=390.54 Aligned_cols=284 Identities=21% Similarity=0.300 Sum_probs=216.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|.+..++..||+|++... ......+.+.+|+.+|+.++||||+++++++..... +||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--ISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE--EEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE--EEE
Confidence 46899999999999999999999999999999999865 345667789999999999999999999999876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||++++.|..++.....+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999988877766666799999999999999999999996 9999999999999999999999999999765322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHh-hCCCChhHHhhhhccc--
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKL-CGSPSEDYWRKSKLRH-- 387 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~-~G~p~~~~w~~~~~~~-- 387 (714)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... .+......+.......
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 123457899999999998765 899999999999999999999999987765543332111 1111111100000000
Q ss_pred -Cccc--cCCc---hhhhhh------hhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 -STVF--KPVQ---PYRRRI------AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 -~~~~--~~~~---p~~~~i------~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.... .+.. .....+ ......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 0000 0000 000000 00112468899999999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=386.47 Aligned_cols=279 Identities=20% Similarity=0.286 Sum_probs=213.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++.......+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 35789999999999999999999999999999999975421 22356678999999999999999999988776655689
Q ss_pred EEEeeccccccccccCCC---CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE----cCCCcEEEeecCcccc
Q 005111 231 LVFEYMEHDLVGLASLPG---MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASF 303 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~---~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl----~~~g~vKL~DFGla~~ 303 (714)
|||||++++.|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999987776555432 239999999999999999999999999999999999999 7788899999999988
Q ss_pred cCCCCCCCcccccccccccCcccccC-------CCCCCccccccchhHHHHHHhhCCCCCCCCC----hHHHHHHHHHhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLG-------ASHYGAAVDLWSTGCILGELFSGKPVLPGKT----EVEQLHRIFKLC 372 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g-------~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~----~~e~l~~I~k~~ 372 (714)
+.... .....+||+.|+|||++.. ...++.++|||||||++|+|++|..||.... ..+.+.++...
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 242 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG- 242 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH-
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC-
Confidence 75433 2345678999999999862 2448999999999999999999999997433 34445554432
Q ss_pred CCCChhHHhhhhcccCc--cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 373 GSPSEDYWRKSKLRHST--VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 373 G~p~~~~w~~~~~~~~~--~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.+...|......... .+....+. .......++..+.+||.+||+.||++|||++|+|+||=
T Consensus 243 --~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 --KPSGAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp --CCTTCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred --CCcccchhhhcccCCccccCccCCc---ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 222222111000000 00000000 01122345778999999999999999999999999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=396.01 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=211.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDNQ--DPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~~--~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++++.||+|+||.||+|++. .+++.||||+++.... .....+.+.+|+.+|..+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 478999999999999999999985 5899999999864321 112334566899999999 7999999999887654
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
. +||||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 133 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 133 K--LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp E--EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred e--EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 4 89999999998877766656689999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCcccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChH----HHHHHHHHhhCCCChhHH
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEV----EQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~----e~l~~I~k~~G~p~~~~w 380 (714)
..........+||+.|+|||++.+. ..++.++||||||||||+|++|..||...... .....+....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 282 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------- 282 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--------
Confidence 4333334456899999999999863 34789999999999999999999999754322 2222221100
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||..||.+|| |+.++|+|+||+...
T Consensus 283 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 283 ---------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 011235788999999999999999999 999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=380.76 Aligned_cols=270 Identities=24% Similarity=0.360 Sum_probs=195.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++..... +|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~ 89 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE--LW 89 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC--EE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC--cE
Confidence 35789999999999999999999988999999999865432 2345678899999999999999999999876654 89
Q ss_pred EEEeeccccccccccC--------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccc
Q 005111 231 LVFEYMEHDLVGLASL--------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~--------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~ 302 (714)
+||||++++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999999877665543 34569999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC----CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005111 303 FFDPKDS----VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378 (714)
Q Consensus 303 ~~~~~~~----~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~ 378 (714)
.+..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+......+...........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 247 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL-- 247 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT--
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc--
Confidence 7643321 1123457899999999987644479999999999999999999999988776655444322110000
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
............++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 248 -----------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 248 -----------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred -----------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00001122345688999999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=378.72 Aligned_cols=265 Identities=27% Similarity=0.441 Sum_probs=212.4
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC-
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT- 225 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~- 225 (714)
+....+.|++++.||+|+||.||+|++..+|+.||||++..... ....+.+|+.+|+++ .||||+++++++....
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 45567899999999999999999999999999999999976532 235678999999999 8999999999987632
Q ss_pred ---CceEEEEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCc
Q 005111 226 ---SCSLYLVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 226 ---~~~l~LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
...+||||||++++.|..++.. ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 3458999999998776655432 35799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 301 ASFFDPKDSVPMTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 301 a~~~~~~~~~~~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
+..+..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+......+..+..... +
T Consensus 176 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~- 252 (326)
T 2x7f_A 176 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P- 252 (326)
T ss_dssp TC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-
T ss_pred ceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c-
Confidence 987653321 2334578999999999863 23478999999999999999999999998887766555432110 0
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||..||.+|||+.++|+||||...+
T Consensus 253 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 253 -------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp -------------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred -------------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 001235789999999999999999999999999999998753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=382.09 Aligned_cols=275 Identities=24% Similarity=0.393 Sum_probs=217.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH---------------HHHHHHHHHHHHHHhCCCCCeee
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP---------------ESVKFMAREIAILRKLDHPNIIK 216 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~---------------~~~~~~~rEi~iL~~L~HpnIVk 216 (714)
.++|++++.||+|+||.||+|.+ +|+.||||++....... ...+.+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 57899999999999999999998 99999999997542110 11267889999999999999999
Q ss_pred eeccccccCCceEEEEEeeccccccccc------cCC--CCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEE
Q 005111 217 LEGLITSQTSCSLYLVFEYMEHDLVGLA------SLP--GMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLL 287 (714)
Q Consensus 217 l~~~~~~~~~~~l~LV~Ey~~g~ll~~~------~~~--~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl 287 (714)
+++++.... .+|+||||++++.|..+ +.. ...+++..++.++.||+.||.|||+ +||+|+||||+|||+
T Consensus 108 ~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEESSS--EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEeeCC--eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 999987654 49999999999777665 444 5789999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCc-cccccchhHHHHHHhhCCCCCCCCCh-HHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGA-AVDLWSTGCILGELFSGKPVLPGKTE-VEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~-~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l 365 (714)
+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||.+.+. .+.+
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876433 2345578999999999987744666 99999999999999999999998776 5555
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..+.......+... .....+..+ .........++..+.+||.+||+.||.+|||+.++|+||||+..+
T Consensus 263 ~~i~~~~~~~~~~~--------~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 263 NNIRTKNIEYPLDR--------NHFLYPLTN--KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHTSCCCCCCCSS--------SSSTTTTCC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccCcCCccch--------hhhhccccc--cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 55533211111100 000000000 011122356899999999999999999999999999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=394.59 Aligned_cols=268 Identities=17% Similarity=0.204 Sum_probs=193.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhC--CCCCeeeeec-------c
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKL--DHPNIIKLEG-------L 220 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L--~HpnIVkl~~-------~ 220 (714)
....|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.++..| +||||++++. +
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 34569999999999999999999999999999999987644 345667788885555544 6999888542 2
Q ss_pred ccccCC---------------ceEEEEEeeccccccccccCCCCCCCHHHH------HHHHHHHHHHhhHhhhcCeeecc
Q 005111 221 ITSQTS---------------CSLYLVFEYMEHDLVGLASLPGMKFTESQV------KCYMKQLLSGLEHCHSHGVLHRD 279 (714)
Q Consensus 221 ~~~~~~---------------~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i------~~i~~QIl~aL~~LH~~gIiHrD 279 (714)
+..... ..+|||||||++++...+...+..+++... ..++.||+.||+|||++||+|||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 222111 348999999997665554433334455555 67779999999999999999999
Q ss_pred CCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccC-CCCCCccccccchhHHHHHHhhCCCCCCC
Q 005111 280 IKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG-ASHYGAAVDLWSTGCILGELFSGKPVLPG 358 (714)
Q Consensus 280 LKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g-~~~y~~~sDIWSLG~iLyeLltG~~pF~g 358 (714)
|||+||||+.+|.+||+|||+|...... .....+|+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876422 224467899999999976 13489999999999999999999999987
Q ss_pred CChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 359 KTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 359 ~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.+... ...|.......... ..........+|..+.+||.+||+.||++|||+.++|+|||
T Consensus 296 ~~~~~-------------~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 355 (371)
T 3q60_A 296 VTPGI-------------KGSWKRPSLRVPGT-------DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355 (371)
T ss_dssp CCTTC-------------TTCCCBCCTTSCCC-------CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred cCccc-------------ccchhhhhhhhccc-------cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence 64220 00010000000000 00011123478999999999999999999999999999999
Q ss_pred CCCC
Q 005111 439 FTTQ 442 (714)
Q Consensus 439 f~~~ 442 (714)
|+..
T Consensus 356 f~~~ 359 (371)
T 3q60_A 356 FLQL 359 (371)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=372.42 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=219.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+|+.++||||+++++++..... +|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--EEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe--EEE
Confidence 3569999999999999999999999999999999986533 2346778999999999999999999999876544 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+..... .
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 175 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence 9999999887776654 4799999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...........+.... +
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------- 236 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P---------------- 236 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C----------------
T ss_pred cCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C----------------
Confidence 34457899999999998765 7999999999999999999999999887766555543210 0
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 237 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 ----------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ----------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01123578899999999999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=375.21 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=212.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+|..++||||+++++++..... +|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK--LWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C--EEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe--EEE
Confidence 468999999999999999999999999999999987542 2345678899999999999999999999876554 999
Q ss_pred EEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||++++++..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 999999987765543 24579999999999999999999999999999999999999999999999999986432111 1
Q ss_pred CcccccccccccCccccc----CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 311 PMTSRVVTLWYRPPELLL----GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~----g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
......||+.|+|||++. ....++.++|||||||++|+|++|.+||...+....+..+.......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----------- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----------
Confidence 122347899999999984 33447899999999999999999999999888777666654321100
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 242 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 ---------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ---------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ---------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 001134688999999999999999999999999999998743
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=372.75 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=203.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc-------
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ------- 224 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~------- 224 (714)
.++|++++.||+|+||.||+|++..+++.||||++.. .....+.+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3579999999999999999999999999999999964 345667889999999999999999999987542
Q ss_pred ----CCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecC
Q 005111 225 ----TSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFG 299 (714)
Q Consensus 225 ----~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFG 299 (714)
....+|+||||++++.|..++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 2345899999999876665553 44568899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-------------CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCC-CChHHHH
Q 005111 300 LASFFDPKD-------------SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQL 365 (714)
Q Consensus 300 la~~~~~~~-------------~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l 365 (714)
++....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||.. .+..+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 998764221 1123445789999999999876568999999999999999998 4443 2233333
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..+.......+ .......+..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 239 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 239 KKLRSVSIEFP-------------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHSTTCCCC-------------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HhccccccccC-------------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 33322111000 01123567889999999999999999999999999999853
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=373.58 Aligned_cols=259 Identities=28% Similarity=0.455 Sum_probs=211.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|++++.||+|+||.||+|.+..+|+.||||++.... ..+.+.+|+.+|+.++||||+++++++..... +|
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD--LW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTE--EE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE--EE
Confidence 3578999999999999999999999999999999997643 23567899999999999999999998876544 89
Q ss_pred EEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
+||||++++.+..++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999877766553 456799999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......+..+..... +
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-------------- 243 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P-------------- 243 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C--------------
T ss_pred -ccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c--------------
Confidence 233457899999999998765 89999999999999999999999998776655544422110 0
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.+ .....++..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 244 ~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 TF-----------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp CC-----------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred cc-----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 00 01134688999999999999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=400.15 Aligned_cols=254 Identities=17% Similarity=0.242 Sum_probs=198.3
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHH---HHHhCCCCCeeeee------
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIA---ILRKLDHPNIIKLE------ 218 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~---iL~~L~HpnIVkl~------ 218 (714)
....++|++.+.||+|+||.||+|++..+|+.||||++... .......+.+.+|+. +|+.++|||||+++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 33457899999999999999999999899999999999865 234456778899994 55555899999998
Q ss_pred -ccccccCC------------c---eEEEEEeeccccccccccCCCCCCC-------HHHHHHHHHHHHHHhhHhhhcCe
Q 005111 219 -GLITSQTS------------C---SLYLVFEYMEHDLVGLASLPGMKFT-------ESQVKCYMKQLLSGLEHCHSHGV 275 (714)
Q Consensus 219 -~~~~~~~~------------~---~l~LV~Ey~~g~ll~~~~~~~~~ls-------e~~i~~i~~QIl~aL~~LH~~gI 275 (714)
+++..... . ..||||||++|++...+. ....++ +..++.|+.||+.||+|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~-~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE-VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHH-HHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHH-hccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44332211 0 278999999765544333 222344 48888999999999999999999
Q ss_pred eeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCcccccCC----------CCCCccccccchhHH
Q 005111 276 LHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA----------SHYGAAVDLWSTGCI 345 (714)
Q Consensus 276 iHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~----------~~y~~~sDIWSLG~i 345 (714)
+||||||+||||+.++.+||+|||++..... .....+| +.|+|||++.+. ..|+.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2345577 999999999876 248999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcC
Q 005111 346 LGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPA 425 (714)
Q Consensus 346 LyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~ 425 (714)
||||++|.+||.+.+....+.. +......+|+.+.+||.+||+.||.
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HHHHHHSSCCC------CCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHCCCCCcccccccchhh---------------------------------hhhhccCCCHHHHHHHHHHcCCCch
Confidence 9999999999976543221111 1112246899999999999999999
Q ss_pred CCCCHHHHHcCcCCCC
Q 005111 426 HRGTATLALNSEFFTT 441 (714)
Q Consensus 426 kRpTa~e~L~Hp~f~~ 441 (714)
+|||+.++|+||||+.
T Consensus 350 ~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 350 DRLLPLQAMETPEYEQ 365 (377)
T ss_dssp GCCCHHHHHTSHHHHH
T ss_pred hCCCHHHHhhChHHHH
Confidence 9999999999999975
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=364.17 Aligned_cols=250 Identities=23% Similarity=0.345 Sum_probs=211.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+|++++||||+++++++..... +|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--EEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc--eEE
Confidence 468999999999999999999976 5778999999865433 3458899999999999999999999876554 899
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||++++.+..++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999987776555 44557999999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------------
Confidence 333446688999999998765 8999999999999999999 99999998887777766432110
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....++..+.+||.+||+.||.+|||+.++++|
T Consensus 227 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 -------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0113468899999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=370.65 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=206.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||+||+|.+..+++.||+|++.. .+....+.+.+|+.+|++++||||+++++++..... +|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~--~~ 83 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR--LN 83 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE--EE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe--eE
Confidence 35789999999999999999999999999999998854 356677889999999999999999999999876544 89
Q ss_pred EEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
+||||++++.+..++.. ...+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999998777665543 56799999999999999999999999999999999999999999999999999987644332
Q ss_pred CC-------------cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 310 VP-------------MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 310 ~~-------------~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
.. ....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~------------ 230 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM------------ 230 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCT------------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHH------------
Confidence 21 11457899999999998765 89999999999999999999999875321100
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
... ..............+|+.+.+||.+||+.||++|||+.++++
T Consensus 231 -------------~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 231 -------------DFG-LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -------------TSS-BCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------HHh-hhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 000000001123568889999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=377.81 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=195.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~---~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..++|++.+.||+|+||.||+|.+..++. .||||++..........+.+.+|+.+|++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 35789999999999999999999877765 899999987655556678899999999999999999999988654431
Q ss_pred ----eEEEEEeeccccccccccC------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEee
Q 005111 228 ----SLYLVFEYMEHDLVGLASL------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIAD 297 (714)
Q Consensus 228 ----~l~LV~Ey~~g~ll~~~~~------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~D 297 (714)
..|+||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 2489999999977765542 223699999999999999999999999999999999999999999999999
Q ss_pred cCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCC
Q 005111 298 FGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSP 375 (714)
Q Consensus 298 FGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p 375 (714)
||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-- 257 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-- 257 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred ccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC--
Confidence 9999876443321 122345678999999998765 8999999999999999999 9999998887766666543110
Q ss_pred ChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-------HHHHHcCcCCCCC
Q 005111 376 SEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-------ATLALNSEFFTTQ 442 (714)
Q Consensus 376 ~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-------a~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||+.||.+||| +++++.|+|+...
T Consensus 258 --------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 --------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred --------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0112357899999999999999999999 8889999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=382.75 Aligned_cols=253 Identities=24% Similarity=0.361 Sum_probs=209.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-------cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-------IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-------~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~ 223 (714)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ......+.+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 478999999999999999999875 35678999999754 3455677899999999999 89999999999876
Q ss_pred cCCceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
... +||||||++++.|..++.. ...+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 159 ~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSS--CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCC--EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 554 8999999998777655432 2358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l 365 (714)
+.++.+||+|||++..+..... .......+|+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999987654332 2223346688999999998765 8999999999999999999 99999987766555
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+.... . ......++..+.+||.+||+.||.+|||+.+++++
T Consensus 316 ~~~~~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGH-------------------R---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTC-------------------C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCC-------------------C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4442210 0 01123578899999999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=361.18 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=210.2
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++++.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+|++++||||+++++++..... +
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~ 78 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP--I 78 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--E
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc--e
Confidence 34578999999999999999999765 6778999999765433 3458899999999999999999999876554 8
Q ss_pred EEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
|+||||++++.+..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999998766655443 3459999999999999999999999999999999999999999999999999998765443
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 224 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL------------- 224 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------------
T ss_pred hhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-------------
Confidence 33333445678899999998765 7999999999999999999 99999988887776665431110
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....+++.+.+||..||+.||.+|||+.++|++
T Consensus 225 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ---------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ---------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112468899999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=372.59 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=210.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g---~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..++|++.+.||+|+||.||+|.+..++ ..||||++... ......+.+.+|+.+|+.++||||+++++++.....
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL- 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC-
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc-
Confidence 3578999999999999999999988655 45999999754 345567789999999999999999999999876554
Q ss_pred eEEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+||||||++++.|..++ .....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 125 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 125 -AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp -CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred -cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 89999999987776655 3446799999999999999999999999999999999999999999999999999987754
Q ss_pred CCCCC--cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 307 KDSVP--MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 307 ~~~~~--~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
..... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+......+
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 274 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-------- 274 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--------
T ss_pred CccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC--------
Confidence 33221 22234578899999998765 8999999999999999999 999999988887777664321110
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
....++..+.+||..||..||.+|||+.++++
T Consensus 275 --------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 --------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12357899999999999999999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=378.39 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=209.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEE-----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccccc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRAR-----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQ 224 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~-----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~ 224 (714)
..++|++.+.||+|+||.||+|+ +..+++.||||+++.. ......+.+.+|+.+|.++ +|||||++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 35789999999999999999998 5567799999999754 3445567889999999999 799999999988764
Q ss_pred CCceEEEEEeeccccccccccCCCC-------------------------------------------------------
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPGM------------------------------------------------------- 249 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~~------------------------------------------------------- 249 (714)
.. .+|+|||||.++.|..++....
T Consensus 99 ~~-~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 99 GG-PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TS-CCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CC-ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 43 4899999999877765543322
Q ss_pred -----------CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-CCcccccc
Q 005111 250 -----------KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS-VPMTSRVV 317 (714)
Q Consensus 250 -----------~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~g 317 (714)
.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... .......|
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 289999999999999999999999999999999999999999999999999987643322 22334577
Q ss_pred cccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCch
Q 005111 318 TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQP 396 (714)
Q Consensus 318 T~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p 396 (714)
|+.|+|||++.+.. |+.++||||||||+|+|++ |.+||.+....+.+.........+
T Consensus 258 t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 315 (359)
T 3vhe_A 258 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------------------- 315 (359)
T ss_dssp CGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------
T ss_pred CceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC---------------------
Confidence 99999999998765 8999999999999999998 999999877555544443321111
Q ss_pred hhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 397 YRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 397 ~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....+++.+.+||..||+.||.+|||+.++++|
T Consensus 316 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123578899999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=369.80 Aligned_cols=263 Identities=23% Similarity=0.340 Sum_probs=198.0
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++++.||+|+||.||+|.+..+|+.||||++..........+.+..+..+++.++||||+++++++..... +
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~--~ 99 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD--V 99 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE--E
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc--E
Confidence 34578999999999999999999999999999999998765444445555566667888899999999999876544 9
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||||+++.+..........+++..++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++..+....
T Consensus 100 ~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 100 FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp EEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 99999995444333333356799999999999999999999995 99999999999999999999999999998764332
Q ss_pred CCCcccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCC-CChHHHHHHHHHhhCCCChhHHhhh
Q 005111 309 SVPMTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.. .+..+.+..+......
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 248 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP--------- 248 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC---------
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC---------
Confidence 2234578999999999852 33478999999999999999999999987 4455555555431100
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
. ......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 249 ----------~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 249 ----------L-------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ----------C-------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ----------C-------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 0 00113578999999999999999999999999999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=364.04 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=208.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+|+.++||||+++++++..... +|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--IF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--EE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC--eE
Confidence 4578999999999999999999865 6788999999865433 3457899999999999999999999876554 89
Q ss_pred EEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
+||||++++.+..++.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 99999988776655543 45799999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------------- 241 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY------------- 241 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC-------------
T ss_pred ccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC-------------
Confidence 2233445688899999998765 7999999999999999998 999999988877777764421111
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
....+++.+.+||..||+.||.+|||+.++|+|
T Consensus 242 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 ---------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ---------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 113468899999999999999999999999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=382.67 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=211.7
Q ss_pred CCCeeEEeEEeccCceEEEEEE-----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRAR-----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~-----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.++|++++.||+|+||.||+|. +..++..||||+++.. ........+.+|+.+|++++|||||++++++.....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4789999999999999999999 4567889999998643 344556678899999999999999999999876554
Q ss_pred ceEEEEEeeccccccccccCC-------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC---cEEEe
Q 005111 227 CSLYLVFEYMEHDLVGLASLP-------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG---ILKIA 296 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~-------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g---~vKL~ 296 (714)
+|||||||+++.|..++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.+| .+||+
T Consensus 149 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 149 --RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp --CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred --CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 8999999988766654432 24589999999999999999999999999999999999999655 59999
Q ss_pred ecCcccccCCCC-CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCC
Q 005111 297 DFGLASFFDPKD-SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGS 374 (714)
Q Consensus 297 DFGla~~~~~~~-~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~ 374 (714)
|||+++.+.... ........+|+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 999998653221 12233457799999999998765 8999999999999999998 99999998887777666432110
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.....++..+.+||.+||+.||.+|||+.++|++.++..
T Consensus 306 ----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 306 ----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 112357889999999999999999999999999988653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=363.67 Aligned_cols=253 Identities=22% Similarity=0.309 Sum_probs=198.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..++|++.+.||+|+||.||+|.+..+ +..||+|++... ......+.+.+|+.+|++++||||+++++++.. .
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-- 88 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N-- 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S--
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-C--
Confidence 457899999999999999999998654 567999998654 345567789999999999999999999998753 2
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+|+||||++++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 3799999999877665544 344799999999999999999999999999999999999999999999999999988754
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
..........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------------ 235 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------ 235 (281)
T ss_dssp ----------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------------
T ss_pred ccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC------------
Confidence 4433334446688999999997665 7999999999999999996 9999998877766665532110
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......+|+.+.+||.+||..||.+|||+.+++++
T Consensus 236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 ----------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01124678999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.93 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=211.3
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ 224 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~ 224 (714)
...++|++++.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 34578999999999999999999987 456899999997543 455677899999999999999999999998765
Q ss_pred CCceEEEEEeeccccccccccCC------------------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccC
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLP------------------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDI 280 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~------------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDL 280 (714)
.. +||||||++++.|..++.. ...+++.+++.++.||+.||.|||++||+||||
T Consensus 123 ~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 123 KP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SS--CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred Cc--eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 54 8999999998777655432 157999999999999999999999999999999
Q ss_pred CCccEEEcCCCcEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCC
Q 005111 281 KGSNLLLDHNGILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPG 358 (714)
Q Consensus 281 KP~NILl~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g 358 (714)
||+||||+.++.+||+|||++..+..... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999987643321 1223446789999999998765 8999999999999999999 9999998
Q ss_pred CChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 359 KTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 359 ~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+..+....+.... . ......+|..+.+||.+||+.||.+|||+.+++++
T Consensus 280 ~~~~~~~~~~~~~~--~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 280 MAHEEVIYYVRDGN--I--------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp SCHHHHHHHHHTTC--C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CChHHHHHHHhCCC--c--------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88777666553310 0 01123578999999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=355.64 Aligned_cols=250 Identities=16% Similarity=0.231 Sum_probs=211.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||.||+|.+ ++..||||++..........+.+.+|+.+|++++||||+++++++.......++
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 346899999999999999999986 489999999988776777788899999999999999999999998776445689
Q ss_pred EEEeeccccccccccCCCC--CCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 231 LVFEYMEHDLVGLASLPGM--KFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~--~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+||||++++.|..++.... .+++.+++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999877766654433 5899999999999999999999999 99999999999999999999999998765322
Q ss_pred CCCCCcccccccccccCcccccCCCC--CCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASH--YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~--y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
....||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 230 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--------- 230 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---------
Confidence 23478999999999987542 2337999999999999999999999988777666654321111
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112457899999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=369.62 Aligned_cols=252 Identities=20% Similarity=0.232 Sum_probs=203.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+|+.+ +||||+++++++.... .+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK--YNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--EEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--ccE
Confidence 4789999999999999999999999999999999876532 23477899999999 9999999999887654 489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc-----EEEeecCcccccC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI-----LKIADFGLASFFD 305 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~-----vKL~DFGla~~~~ 305 (714)
|||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+.
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999954444444434568999999999999999999999999999999999999998887 9999999998764
Q ss_pred CCCCC------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC---hHHHHHHHHHhhCCCC
Q 005111 306 PKDSV------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT---EVEQLHRIFKLCGSPS 376 (714)
Q Consensus 306 ~~~~~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~---~~e~l~~I~k~~G~p~ 376 (714)
..... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+ ..+.+..+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 43321 124568999999999998866 7999999999999999999999998843 3344444422110000
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.......+| .+.+||..||..||.+||++.++++
T Consensus 241 ------------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 ------------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111223466 9999999999999999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.14 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=205.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.|.....||+|+||.||+|.+..++..||||++.... ....+.+.+|+.+++.++||||+++++++..... +++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF--IKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE--EEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc--EEEE
Confidence 44555568999999999999999999999999997643 3445678899999999999999999999876544 8999
Q ss_pred EeeccccccccccCC---CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeecCcccccCCCC
Q 005111 233 FEYMEHDLVGLASLP---GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKD 308 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~---~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla~~~~~~~ 308 (714)
|||++++.+..++.. ...+++..++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999998777655432 235679999999999999999999999999999999999987 8999999999998765332
Q ss_pred CCCcccccccccccCcccccCC-CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~-~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||..................
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 243 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence 2 22345789999999998654 23789999999999999999999999764433221111100000
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.......++..+.+||.+||+.||++|||+.++|+||||+..
T Consensus 244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 001224678999999999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=366.76 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=201.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.++..++||||+++++++..... +
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~--~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ--L 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE--E
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe--E
Confidence 4578999999999999999999999999999999997652 344556789999999999999999999999876544 8
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|+||||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 99999999977777666556799999999999999999999999999999999999999999999999999987765444
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+ .....
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~--------------- 252 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIP--------------- 252 (309)
T ss_dssp -------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCC---------------
T ss_pred ccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCC---------------
Confidence 4445567899999999988765 799999999999999999999999887654322222 11100
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-CHHHHHc
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-TATLALN 435 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-Ta~e~L~ 435 (714)
........+|..+.+||.+||..||.+|| |++++++
T Consensus 253 ----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 ----------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01122356899999999999999999999 7777665
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=357.55 Aligned_cols=253 Identities=19% Similarity=0.248 Sum_probs=205.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.++..+ +|+|++++++++.... .+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~--~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL--HNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--EEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--eeE
Confidence 4789999999999999999999999999999999875432 23467899999999 7999999999886554 489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc-----EEEeecCcccccC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI-----LKIADFGLASFFD 305 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~-----vKL~DFGla~~~~ 305 (714)
+||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+.
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999954444444444557999999999999999999999999999999999999987776 9999999998775
Q ss_pred CCCCC------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC---hHHHHHHHHHhhCCCC
Q 005111 306 PKDSV------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT---EVEQLHRIFKLCGSPS 376 (714)
Q Consensus 306 ~~~~~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~---~~e~l~~I~k~~G~p~ 376 (714)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ ..+.+..+......
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 239 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-- 239 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH--
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC--
Confidence 43321 234557899999999998766 7999999999999999999999998743 33444444321110
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.........+|..+.+||..||+.||.+|||+.++++
T Consensus 240 ----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 240 ----------------------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ----------------------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1112333578999999999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=366.35 Aligned_cols=254 Identities=21% Similarity=0.318 Sum_probs=209.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
..++|++.+.||+|+||.||+|.+. .++..||||++... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 3478999999999999999999884 45689999999754 34566788999999999999999999999987655
Q ss_pred CceEEEEEeeccccccccccCCC------------------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPG------------------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIK 281 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~------------------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLK 281 (714)
. +|+||||++++.|..++... ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 100 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 100 P--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp S--CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred c--eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 4 89999999987776554322 238999999999999999999999999999999
Q ss_pred CccEEEcCCCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCC
Q 005111 282 GSNLLLDHNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGK 359 (714)
Q Consensus 282 P~NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~ 359 (714)
|+||||+.++.+||+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999876443221 123345688999999998765 7999999999999999999 99999987
Q ss_pred ChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 360 TEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 360 ~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
+.......+.... .......++..+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 257 PPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7655554442210 001123678999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=366.05 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=206.6
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC--CCCeeeeeccccccC
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD--HPNIIKLEGLITSQT 225 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--HpnIVkl~~~~~~~~ 225 (714)
+....++|++++.||+|+||.||+|.+. +++.||||++..........+.+.+|+.+|.++. ||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 3445678999999999999999999874 5899999999877667777888999999999997 599999999887654
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
. +|||||+..+++.. ++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+.
T Consensus 102 ~--~~lv~e~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 102 Y--IYMVMECGNIDLNS-WLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp E--EEEEECCCSEEHHH-HHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred E--EEEEEecCCCcHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 4 99999966555444 443445799999999999999999999999999999999999996 4899999999998765
Q ss_pred CCCCC-CcccccccccccCcccccCC----------CCCCccccccchhHHHHHHhhCCCCCCCCCh-HHHHHHHHHhhC
Q 005111 306 PKDSV-PMTSRVVTLWYRPPELLLGA----------SHYGAAVDLWSTGCILGELFSGKPVLPGKTE-VEQLHRIFKLCG 373 (714)
Q Consensus 306 ~~~~~-~~~~~~gT~~Y~APE~l~g~----------~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~-~e~l~~I~k~~G 373 (714)
..... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|..||..... ...+..+.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 43221 22345789999999998752 3478899999999999999999999986543 333333321000
Q ss_pred CCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 374 ~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
. .......+..+.+||.+||..||.+|||+.++|+||||+...
T Consensus 258 ~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 258 E---------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp C---------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred c---------------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 0 011124578899999999999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=374.47 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=210.4
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCC--CCCeeeeeccccc
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP----ESVKFMAREIAILRKLD--HPNIIKLEGLITS 223 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HpnIVkl~~~~~~ 223 (714)
...++|++.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.+. |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34678999999999999999999999999999999997653221 12244668999999996 5999999999876
Q ss_pred cCCceEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc-CCCcEEEeecCcc
Q 005111 224 QTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADFGLA 301 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~-~~g~vKL~DFGla 301 (714)
... +++||||+.+ +.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 120 ~~~--~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SSE--EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCc--EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 544 8999999985 55555555556899999999999999999999999999999999999999 7899999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||..... +.. +.
T Consensus 198 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~------- 259 (320)
T 3a99_A 198 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQ------- 259 (320)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CC-------
T ss_pred cccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cc-------
Confidence 876533 234457899999999998776558899999999999999999999975321 111 00
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 260 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 --------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp --------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred --------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 001135789999999999999999999999999999999753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=361.05 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=212.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+|++++||||+++++++..... +|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--FY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--EE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC--EE
Confidence 4578999999999999999999999999999999997543 346678899999999999999999999876554 89
Q ss_pred EEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||++++.+..++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999876665543 34569999999999999999999999999999999999999999999999999998876544
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------------- 230 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------- 230 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------
T ss_pred cccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC--------------
Confidence 33344456788999999998765 7999999999999999999 9999998776555444432100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+|+.+.+||..||..||.+|||+.++++
T Consensus 231 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 --------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0112457899999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=373.61 Aligned_cols=272 Identities=22% Similarity=0.258 Sum_probs=206.0
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC--Cc
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT--SC 227 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~--~~ 227 (714)
...++|++++.||+|+||.||+|++. ++.||||++.... .......+|+.+|++++|||||++++++.... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 34578999999999999999999764 8999999996532 33445667999999999999999999987644 23
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc----------CeeeccCCCccEEEcCCCcEEEee
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH----------GVLHRDIKGSNLLLDHNGILKIAD 297 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~----------gIiHrDLKP~NILl~~~g~vKL~D 297 (714)
.+||||||++++.|..++.. ..+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 47999999999777766644 3599999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCCC-CcccccccccccCcccccCC----CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhh
Q 005111 298 FGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGA----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLC 372 (714)
Q Consensus 298 FGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~----~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~ 372 (714)
||++..+...... .....+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+..............
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999876543322 23346789999999999863 235678999999999999999999998765432222222222
Q ss_pred CCCChhHHhhhhcccCccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 373 GSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 373 G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.+....+........ ..+ .+...+ ...+..+.+||.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKK--KRP------VLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp SSCCHHHHHHHHTTSC--CCC------CCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCchhhhhhhhhccc--CCC------CccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2333322221111000 000 001111 123456999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=370.16 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=203.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhC----CCCCeeeeecccc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP----ESVKFMAREIAILRKL----DHPNIIKLEGLIT 222 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~----~~~~~~~rEi~iL~~L----~HpnIVkl~~~~~ 222 (714)
..++|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4578999999999999999999999999999999997653221 2234466799999999 8999999999987
Q ss_pred ccCCceEEEEEee-ccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc-CCCcEEEeecCc
Q 005111 223 SQTSCSLYLVFEY-MEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD-HNGILKIADFGL 300 (714)
Q Consensus 223 ~~~~~~l~LV~Ey-~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~-~~g~vKL~DFGl 300 (714)
.... +++|||| +.++.+..++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 109 ~~~~--~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 109 TQEG--FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp ------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred cCCe--EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 6554 8999999 67777776665566799999999999999999999999999999999999999 889999999999
Q ss_pred ccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 301 ASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 301 a~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
+...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+... +....
T Consensus 187 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~-------- 249 (312)
T 2iwi_A 187 GALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEAE-------- 249 (312)
T ss_dssp CEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHTC--------
T ss_pred hhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhhc--------
Confidence 9877543 234557899999999998766556799999999999999999999975321 11100
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 250 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 250 ---------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred ---------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 01123578899999999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=363.83 Aligned_cols=269 Identities=22% Similarity=0.330 Sum_probs=202.7
Q ss_pred CCCeeEEeEEeccCceEEEEEE----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4789999999999999999998 5678999999998743 456677899999999999999999999988655444
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+||||||++++.|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 5899999998877665553 334599999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...... . ....+......+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTCCTHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCccccchhHHH
Confidence 3221 122335678899999998766 899999999999999999999988653221 1 1111211111000000
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
..... . ..........+|..+.+||..||+.||.+|||+.++++
T Consensus 241 ~~~~~--~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELL--K-----NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHH--H-----TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHH--h-----ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00000 0 00001123468899999999999999999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=374.73 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=211.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-------HDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~ 223 (714)
.++|++.+.||+|+||.||+|.+.. .+..||||++... ........+.+|+.+|+.+ +|||||++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4789999999999999999999754 3468999999765 3456677899999999999 99999999999876
Q ss_pred cCCceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
... +||||||++++.|..++.. ...+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 147 ~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 DGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp SSS--CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCc--eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 655 8999999998777655432 2359999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l 365 (714)
+.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987654332 2233446789999999998765 8999999999999999999 99999988877666
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+..... ......++..+.+||.+||+.||.+|||+.+++++
T Consensus 304 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55532110 01123578999999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=354.31 Aligned_cols=250 Identities=27% Similarity=0.390 Sum_probs=198.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
..++|++.+.||+|+||.||+|.+ ++..||||+++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN-- 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC----
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc--
Confidence 457899999999999999999986 489999999876532 23345778899999999999999999999876554
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC---eeeccCCCccEEEcC--------CCcEEEee
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG---VLHRDIKGSNLLLDH--------NGILKIAD 297 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g---IiHrDLKP~NILl~~--------~g~vKL~D 297 (714)
+|+||||++++++..+.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 899999999988877765 347999999999999999999999999 999999999999986 77899999
Q ss_pred cCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 005111 298 FGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE 377 (714)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~ 377 (714)
||++..+..... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 232 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--- 232 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC---
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC---
Confidence 999987653322 3457899999999998765 799999999999999999999999988876665554321100
Q ss_pred hHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 378 DYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 378 ~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......++..+.+||.+||..||.+|||+.+++++
T Consensus 233 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 ------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01123578899999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=359.13 Aligned_cols=256 Identities=22% Similarity=0.343 Sum_probs=199.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.++||+|+||.||+|++. ..||+|+++.........+.+.+|+.+|++++||||++++++... . .++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~--~~~ 95 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P--QLA 95 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S--SCE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-C--ccE
Confidence 3578999999999999999999743 359999998877677788889999999999999999999996543 2 379
Q ss_pred EEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC-
Q 005111 231 LVFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD- 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~- 308 (714)
+||||++++.+..++ .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999987766554 455679999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 309 SVPMTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
........||+.|+|||++.. ...++.++|||||||++|+|++|..||.+....+.+..+.......+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP---------- 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC----------
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc----------
Confidence 222344578999999999862 33478899999999999999999999998777666655543211110
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+......+|..+.+||.+||..||.+|||+.++|+
T Consensus 246 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 -------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011223467899999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=372.21 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=181.4
Q ss_pred CCCCeeEEe-EEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc--CCc
Q 005111 151 RANTFEKLD-KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ--TSC 227 (714)
Q Consensus 151 ~~~~Y~~~~-~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~--~~~ 227 (714)
..++|++++ .||+|+||.||+|.+..+|+.||||++... ... .......++.+.||||+++++++... ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 457899976 599999999999999999999999998642 222 22233345677999999999988652 233
Q ss_pred eEEEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCccc
Q 005111 228 SLYLVFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLAS 302 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla~ 302 (714)
.+||||||++++.|..++... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 489999999987766555433 46999999999999999999999999999999999999986 4569999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
..... .....++|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 247 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-------- 247 (336)
T ss_dssp EC-------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred ecccc---ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc--------
Confidence 76432 233457899999999987655 799999999999999999999999876544332211110000
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
... ......+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 248 ------~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 248 ------GQY-------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ------ccc-------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000 00011234689999999999999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=369.54 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=189.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHH-HHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIA-ILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~-iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+. +++.++||||+++++++..... +
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~--~ 96 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD--C 96 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE--E
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc--e
Confidence 45889999999999999999999999999999999986543 344455556666 6777899999999999876544 8
Q ss_pred EEEEeecccccccccc----CCCCCCCHHHHHHHHHHHHHHhhHhhhc-CeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 230 YLVFEYMEHDLVGLAS----LPGMKFTESQVKCYMKQLLSGLEHCHSH-GVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~----~~~~~lse~~i~~i~~QIl~aL~~LH~~-gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
||||||+++++...+. .....+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++..+
T Consensus 97 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9999999986654433 1346799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCCcccccccccccCccccc---CCCCCCccccccchhHHHHHHhhCCCCCCCCChH-HHHHHHHHhhCCCChhHH
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLL---GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV-EQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~---g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~-e~l~~I~k~~G~p~~~~w 380 (714)
.... ......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.... +.+..+.. +
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~------- 245 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--G------- 245 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--S-------
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--C-------
Confidence 4332 223347899999999983 2233789999999999999999999999865422 11111100 0
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
..+.. .......++..+.+||.+||..||.+|||+.++|+||||..
T Consensus 246 ----------~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 246 ----------DPPQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp ----------CCCCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ----------CCCCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 00000 01112468899999999999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.80 Aligned_cols=257 Identities=20% Similarity=0.275 Sum_probs=203.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEcc---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVI---HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~---~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++..........+.+.+|+.+|++++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 44789999999999999999998765 567899999987766677788899999999999999999999988764432
Q ss_pred ---eEEEEEeecccccccccc------CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 228 ---SLYLVFEYMEHDLVGLAS------LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 228 ---~l~LV~Ey~~g~ll~~~~------~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
..|+||||++++.+..++ .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 369999999987776554 34467999999999999999999999999999999999999999999999999
Q ss_pred CcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 299 GLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 299 Gla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
|++..+...... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--- 267 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--- 267 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC---
Confidence 999876443221 122345688999999998765 8999999999999999999 8999998877666555533110
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......++..+.+||.+||..||.+|||+.+++++
T Consensus 268 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 -------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01124678999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=368.53 Aligned_cols=257 Identities=23% Similarity=0.297 Sum_probs=206.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccccc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQ 224 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~ 224 (714)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|.++ +||||+++++++...
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3478999999999999999999973 467789999997542 234456788999999999 899999999998765
Q ss_pred CCceEEEEEeeccccccccccCCC-----------------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCC
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPG-----------------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIK 281 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~-----------------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLK 281 (714)
.. +||||||++++.|..++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 122 ~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 122 GP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SS--CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred Cc--cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 54 89999999987666554332 237999999999999999999999999999999
Q ss_pred CccEEEcCCCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCC
Q 005111 282 GSNLLLDHNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGK 359 (714)
Q Consensus 282 P~NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~ 359 (714)
|+||||+.++.+||+|||++..+...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999876543322 123346688999999988765 8999999999999999998 99999887
Q ss_pred ChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 360 TEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 360 ~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.....+..++.....+ .....++..+.+||.+||..||.+|||+.++++|-.
T Consensus 279 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 7555554443311000 112357899999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=361.24 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=209.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEE-----ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARD-----VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d-----~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+|.++ +||||+++++++....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 47899999999999999999985 4578899999997543 345567899999999999 9999999999987665
Q ss_pred CceEEEEEeeccccccccccCCC------------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPG------------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~------------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
. +|+||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 101 P--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp S--CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C--cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 4 89999999987666544322 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l 365 (714)
+.++.+||+|||++.......... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+......+
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999998775443221 22345688999999988765 8999999999999999999 99999887655555
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+......+ .....+|..+.+||.+||..||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4443321100 0113578899999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=377.30 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=209.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+.+|+.+|+.++|||||++++++..... +|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP--IY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS--CE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC--cE
Confidence 347899999999999999999999999999999998754 344556678899999999999999999999876554 89
Q ss_pred EEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||||++++.+..++. .+..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999776655543 334699999999999999999999999999999999999999999999999999986543211
Q ss_pred CC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 VP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 ~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.. .....+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+..... +
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~------------ 334 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-L------------ 334 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-C------------
T ss_pred eecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C------------
Confidence 11 11223578899999998665 8999999999999999998 9999998887665555432110 0
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.+||.+||+.||.+|||+.++++
T Consensus 335 ---------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 ---------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 012357889999999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=352.98 Aligned_cols=250 Identities=22% Similarity=0.332 Sum_probs=208.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++..... +|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--CEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC--eEE
Confidence 468999999999999999999975 6788999999865433 3568899999999999999999999876554 899
Q ss_pred EEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||++++.+..+.. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999876665543 3457899999999999999999999999999999999999999999999999999876433222
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~---------------- 223 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------------- 223 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------------
T ss_pred ccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc----------------
Confidence 223445688999999998665 7999999999999999999 8999999887776666643110
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
. .....++..+.+||.+||..||.+|||+.+++++
T Consensus 224 ---~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 ---L---------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---C---------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0112468899999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=359.02 Aligned_cols=268 Identities=22% Similarity=0.340 Sum_probs=203.8
Q ss_pred CCeeEEeEEeccCceEEEEEE----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
..|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++.......
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 569999999999999999998 56789999999997553 2334567889999999999999999999988765556
Q ss_pred EEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|+||||++++.|..++ .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 89999999987776655 44457999999999999999999999999999999999999999999999999999877544
Q ss_pred CC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 308 DS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 308 ~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
.. .......+|..|+|||++.+.. ++.++|||||||++|+|++|..|+... . ..+....+.......... .
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~--~---~~~~~~~~~~~~~~~~~~-~ 252 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSP--M---ALFLKMIGPTHGQMTVTR-L 252 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH--H---HHHHHHHCSCCGGGHHHH-H
T ss_pred CcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcch--h---hHHhhccCCcccccCHHH-H
Confidence 32 1223456788999999998765 789999999999999999999876432 1 112222222221110000 0
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
..... ..........+|+.+.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 253 VNTLK-------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHH-------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHh-------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000 00001122468899999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=353.64 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=203.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH--HH---HHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP--ES---VKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~--~~---~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
..++|++.+.||+|+||.||+|++..+++.||||++....... .. .+.+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 3578999999999999999999999999999999997653321 11 16788999999999999999999988643
Q ss_pred CceEEEEEeecccccc-ccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcCCCc-----EEEee
Q 005111 226 SCSLYLVFEYMEHDLV-GLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDHNGI-----LKIAD 297 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll-~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~~g~-----vKL~D 297 (714)
.++||||+.++.+ ..+......+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+|
T Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 3699999996555 455555668999999999999999999999999 999999999999988776 99999
Q ss_pred cCcccccCCCCCCCcccccccccccCcccccC-CCCCCccccccchhHHHHHHhhCCCCCCCCChHHH--HHHHHHhhCC
Q 005111 298 FGLASFFDPKDSVPMTSRVVTLWYRPPELLLG-ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQ--LHRIFKLCGS 374 (714)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g-~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~--l~~I~k~~G~ 374 (714)
||++..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.... ...+.. .+.
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGL 247 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCC
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCC
Confidence 999985432 2345678999999999843 33378899999999999999999999987553322 222211 110
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. ......+|+.+.+||.+||+.||.+|||+.++++
T Consensus 248 ~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 R--------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp C--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C--------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 0112467899999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=361.61 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=208.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEE-----ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeecccccc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARD-----VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQ 224 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d-----~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~ 224 (714)
..++|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.+|..+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 357899999999999999999985 3567999999997543 345567789999999999 799999999987654
Q ss_pred CCceEEEEEeeccccccccccCCCCC----------------CCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLPGMK----------------FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD 288 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~~~~----------------lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~ 288 (714)
. ..+|+||||++++.|..++..... +++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 104 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 104 G-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 182 (316)
T ss_dssp T-SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred C-CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence 3 348999999998777665543322 89999999999999999999999999999999999999
Q ss_pred CCCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHH
Q 005111 289 HNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLH 366 (714)
Q Consensus 289 ~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~ 366 (714)
.++.+||+|||++..+...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+.+.
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 9999999999999876443221 223456789999999998765 7999999999999999998 999998876544443
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+.....+ .....+++.+.+||..||+.||.+|||+.++++|
T Consensus 262 ~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 332211100 1113478899999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=358.63 Aligned_cols=247 Identities=18% Similarity=0.219 Sum_probs=202.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCC-------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHD-------KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS 223 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-------~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~ 223 (714)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 3578999999999999999999998877 579999986532 3456778999999999999999999999876
Q ss_pred cCCceEEEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc--------EE
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI--------LK 294 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~--------vK 294 (714)
... .||||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +|
T Consensus 84 ~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 84 GDE--NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TTC--CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCC--CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 554 89999999987776555433 34999999999999999999999999999999999999998887 99
Q ss_pred EeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHHHHhhC
Q 005111 295 IADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFKLCG 373 (714)
Q Consensus 295 L~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I~k~~G 373 (714)
|+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||............ ...
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~- 234 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDR- 234 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT-
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hcc-
Confidence 999999976532 23456799999999998755589999999999999999995 5555555443333222 110
Q ss_pred CCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 374 ~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.......+..+.+||.+||+.||.+|||+.++++|
T Consensus 235 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 ----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01112457789999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.52 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=207.2
Q ss_pred CCCeeEEe-EEeccCceEEEEEEE--ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLD-KIGQGTYSSVYRARD--VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~-~LG~G~fG~Vy~a~d--~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
..+|++.+ .||+|+||.||+|.+ ..+++.||||++..........+.+.+|+.+++.++||||+++++++. .. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~--~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE--S 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SS--S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-CC--C
Confidence 46899998 999999999999954 567899999999876555566788999999999999999999999883 23 3
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|+||||++++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999988887777666779999999999999999999999999999999999999999999999999998765433
Q ss_pred CCC--cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 309 SVP--MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 309 ~~~--~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.... .
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~---------- 238 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--R---------- 238 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--C----------
T ss_pred CcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C----------
Confidence 211 12234578899999997765 7999999999999999999 999999888766555543210 0
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+|..+.+||.+||+.||.+|||+.++++
T Consensus 239 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 ----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112367899999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=353.83 Aligned_cols=255 Identities=22% Similarity=0.234 Sum_probs=204.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+.|++++..+.++.... ..+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEET-TEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCC-CceE
Confidence 357899999999999999999999999999999998765332 34779999999999988777766654433 3489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE---cCCCcEEEeecCcccccCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl---~~~g~vKL~DFGla~~~~~~ 307 (714)
+||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 999999555554444355679999999999999999999999999999999999999 48889999999999877544
Q ss_pred CCC------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh---HHHHHHHHHhhCCCChh
Q 005111 308 DSV------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---VEQLHRIFKLCGSPSED 378 (714)
Q Consensus 308 ~~~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~~I~k~~G~p~~~ 378 (714)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+... .+.+..+....-.
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 236 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---- 236 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH----
T ss_pred ccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC----
Confidence 321 124557899999999998766 89999999999999999999999987432 2233333221000
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.........+|+.+.+||..||+.||.+|||+.++++
T Consensus 237 --------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 --------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0111223568999999999999999999999999886
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=356.31 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=205.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEcc---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVI---HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~---~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-- 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS--
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--
Confidence 45789999999999999999998654 34579999987642 4556778999999999999999999999876432
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.|+||||++++.+..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 87 -TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp -CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred -CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 689999999877765553 345699999999999999999999999999999999999999999999999999987755
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
..........+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~----------- 233 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL----------- 233 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-----------
T ss_pred ccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-----------
Confidence 4433334446688999999997665 7999999999999999998 99999877666555544331100
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 -----------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0113578899999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=367.07 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=199.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEE----EEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIV----ALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~V----AiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..++|++++.||+|+||+||+|++..+++.| |+|.++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 3478999999999999999999998887654 777765432 2345677889999999999999999999987543
Q ss_pred ceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 227 CSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
.++||||+.++.+..++. ....+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 91 --~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 91 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp --EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred --eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 789999999876655443 35679999999999999999999999999999999999999999999999999998875
Q ss_pred CCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 306 PKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 306 ~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
..... ......+|+.|+|||++.+.. |+.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--------- 238 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 238 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------
T ss_pred CCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC---------
Confidence 44332 223345688999999998765 8999999999999999999 99999987765544444221100
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 239 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 -------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0123468899999999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=351.20 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=210.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++... .+|+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE---PIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---SCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcCC---CcEE
Confidence 478999999999999999999864 677899999976543 245688999999999999999999987643 2799
Q ss_pred EEeeccccccccccCCCC--CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGM--KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~--~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||++++.|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999887776665432 699999999999999999999999999999999999999999999999999988754433
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--------------- 228 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------------- 228 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------------
T ss_pred ccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC---------------
Confidence 3333445688999999997655 7999999999999999999 9999999887776666532110
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc--CcCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN--SEFFT 440 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~--Hp~f~ 440 (714)
. .....++..+.+||..||..||.+|||+.++++ ..+|+
T Consensus 229 ----~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 ----M---------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp ----C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----C---------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 0 012357899999999999999999999999987 34444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=362.82 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=208.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-------cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-------IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-------~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~ 223 (714)
.++|++.+.||+|+||.||+|.+. .++..||||++... ......+.+.+|+.+|+.+ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 478999999999999999999976 46788999998754 3455677899999999999 89999999999876
Q ss_pred cCCceEEEEEeeccccccccccCCC----------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLPG----------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~~----------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
... +||||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 113 ~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 DGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp SSC--CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCc--eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 554 89999999987776555432 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l 365 (714)
+.++.+||+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999876543221 122335688999999998765 7999999999999999999 99999988877666
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+..... ......++..+.+||.+||..||.+|||+.+++++
T Consensus 270 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55533110 01123578899999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=363.88 Aligned_cols=262 Identities=17% Similarity=0.255 Sum_probs=214.2
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ 224 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~ 224 (714)
...++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 34578999999999999999999876 46789999998754 3345566788999999999999999999998765
Q ss_pred CCceEEEEEeeccccccccccCC----------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEE
Q 005111 225 TSCSLYLVFEYMEHDLVGLASLP----------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILK 294 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~~----------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vK 294 (714)
.. +|+||||++++.|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus 101 ~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 101 QP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SS--CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred Cc--cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 54 8999999998766655432 14579999999999999999999999999999999999999999999
Q ss_pred EeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhh
Q 005111 295 IADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLC 372 (714)
Q Consensus 295 L~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~ 372 (714)
|+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 9999999866433221 122345689999999988765 7999999999999999999 899999888776665553210
Q ss_pred CCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC------cCCCCCC
Q 005111 373 GSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS------EFFTTQP 443 (714)
Q Consensus 373 G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H------p~f~~~~ 443 (714)
.......++..+.+||.+||+.||.+|||+.++++| +||+...
T Consensus 258 ----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~ 306 (322)
T 1p4o_A 258 ----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306 (322)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred ----------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence 001123678999999999999999999999999987 6665443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.52 Aligned_cols=255 Identities=21% Similarity=0.238 Sum_probs=200.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+..+.... ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEET-TEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCC-CceE
Confidence 357899999999999999999999999999999987654322 34678999999999888887776664433 3489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE---cCCCcEEEeecCcccccCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl---~~~g~vKL~DFGla~~~~~~ 307 (714)
|||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++......
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 82 MVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 999999555555544445679999999999999999999999999999999999999 78899999999999877544
Q ss_pred CCC------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChH---HHHHHHHHhhCCCChh
Q 005111 308 DSV------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV---EQLHRIFKLCGSPSED 378 (714)
Q Consensus 308 ~~~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~---e~l~~I~k~~G~p~~~ 378 (714)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.. ..+..+....
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 234 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK------ 234 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH------
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc------
Confidence 321 223457899999999998766 899999999999999999999999875432 2222221110
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
...........+|+.+.+||..||+.||++|||+.++++
T Consensus 235 ------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 ------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ------------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ------------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 001112223568999999999999999999999999886
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=352.77 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=210.9
Q ss_pred CCCCeeEEe-EEeccCceEEEEEEEc--cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 151 RANTFEKLD-KIGQGTYSSVYRARDV--IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~-~LG~G~fG~Vy~a~d~--~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..++|.+++ .||+|+||.||+|.+. .++..||||+++.. ......+.+.+|+.+|+.++||||+++++++.. .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-- 82 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-- 82 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S--
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C--
Confidence 346788887 9999999999999854 46889999999765 345667889999999999999999999998843 2
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+|+||||++++.|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 3899999999877766553 445799999999999999999999999999999999999999999999999999987754
Q ss_pred CCCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 307 KDSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 307 ~~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.... .
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--~-------- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--R-------- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--C--------
T ss_pred CcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC--c--------
Confidence 3221 122335689999999997655 7999999999999999998 999999888776665553210 0
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
......+|+.+.+||..||..||.+|||+.+++++.+
T Consensus 232 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 232 ------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 0112467899999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=365.55 Aligned_cols=272 Identities=22% Similarity=0.286 Sum_probs=208.7
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
+....++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 109 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE- 109 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC-
T ss_pred HHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe-
Confidence 445678999999999999999999985 478999999887543 3456778999999999999999999999876554
Q ss_pred eEEEEEeeccccccccccCCC----CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 228 SLYLVFEYMEHDLVGLASLPG----MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~----~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
+|+||||++++.+..++... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 110 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 110 -MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp -CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred -EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 89999999987777665433 3589999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 304 FDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 304 ~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+ .|..
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~----------~~~~ 257 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA----------EWAV 257 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH----------HHTH
T ss_pred cccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH----------HHhh
Confidence 543322 2233456899999999998765 899999999999999999999999865432211111 0100
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCc
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSE 437 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp 437 (714)
.............+ ..........+..+.+||.+||+.||++|||+.++|++-
T Consensus 258 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 258 ESHNNGQLEQIVDP--NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHTTTCCCSSSSS--SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hccccccHHHhcCh--hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00000000000000 000011124567899999999999999999999999764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=355.56 Aligned_cols=255 Identities=31% Similarity=0.487 Sum_probs=196.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFD-NQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
..++|++.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++||||+++++++..... +
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE--L 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE--E
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc--E
Confidence 346899999999999999999999999999999999864 3456677889999999999999999999999876554 9
Q ss_pred EEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 230 YLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
|+||||++++.+..++. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999877665543 35679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh--HHHHHHHHHhhCCCChhHHhhh
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE--VEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~--~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+... ......+.. ...+
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~-------- 256 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-CDYP-------- 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-TCSC--------
T ss_pred CCCc-cccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-ccCC--------
Confidence 3322 233457899999999988765 79999999999999999999999976432 222222211 1100
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
+. ....++..+.+||.+||..||.+|||+.+++++
T Consensus 257 ---------~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 257 ---------PL---------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ---------CC---------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CC---------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00 013578899999999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.02 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=207.4
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ 224 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~---~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~ 224 (714)
++.....|.+.+.||+|+||.||+|.+..++. .||+|++... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 16 i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 45556678889999999999999999765544 7999998643 3455678899999999999999999999998765
Q ss_pred CCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 225 TSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
.. ..++||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 95 ~~-~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 95 EG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp SS-CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CC-CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 43 3589999998766655443 456799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCC---CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 304 FDPKD---SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 304 ~~~~~---~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
+.... ........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~----- 247 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL----- 247 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-----
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-----
Confidence 54321 12223446789999999998765 7999999999999999999 56667666655555444321110
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 248 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 -----------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012357889999999999999999999999886
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=366.02 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=202.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeE----EEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKI----VALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~----VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.++|++++.||+|+||.||+|.+..++.. ||+|++.... .......+.+|+.++..++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-- 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-S-- 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-S--
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C--
Confidence 47899999999999999999999888876 7777765332 12233456789999999999999999998853 2
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+++||||+.++.+..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 3899999999766655443 345799999999999999999999999999999999999999999999999999998754
Q ss_pred CCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------- 235 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----------- 235 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-----------
T ss_pred ccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------
Confidence 4332 234456788999999998765 8999999999999999999 9999998776555544432100
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
......++..+.+||.+||..||.+|||+.+++++
T Consensus 236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 -----------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -----------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -----------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112357789999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=381.00 Aligned_cols=277 Identities=22% Similarity=0.316 Sum_probs=211.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++.......+|
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 35689999999999999999999999999999999975421 22356678999999999999999999998776655689
Q ss_pred EEEeeccccccccccCCCC---CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE----cCCCcEEEeecCcccc
Q 005111 231 LVFEYMEHDLVGLASLPGM---KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL----DHNGILKIADFGLASF 303 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~---~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl----~~~g~vKL~DFGla~~ 303 (714)
||||||+++.+..++.... .+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999877776655432 39999999999999999999999999999999999999 7788899999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCC-------CCCCccccccchhHHHHHHhhCCCCCCCC----ChHHHHHHHHHhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGA-------SHYGAAVDLWSTGCILGELFSGKPVLPGK----TEVEQLHRIFKLC 372 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~-------~~y~~~sDIWSLG~iLyeLltG~~pF~g~----~~~e~l~~I~k~~ 372 (714)
..... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|..||.+. ...+.+.++..
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~-- 241 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT-- 241 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--
Confidence 65432 23455789999999998641 33788999999999999999999999743 33445555543
Q ss_pred CCCChhHHhhhhcccCc--cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 373 GSPSEDYWRKSKLRHST--VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 373 G~p~~~~w~~~~~~~~~--~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
+.| ...|......... .+....+. .......++..+.+||.+||..||++|||+.+++++
T Consensus 242 ~~p-~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 242 GKP-SGAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCC-TTCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCC-cccchhheeccCCCcccCccCCc---ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 222 2222111000000 00000000 011123456789999999999999999999998653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=362.91 Aligned_cols=252 Identities=26% Similarity=0.320 Sum_probs=204.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEE--EEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIV--ALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~V--AiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~ 227 (714)
..++|++.+.||+|+||.||+|++..++..+ |+|.+... ......+.+.+|+.+|+++ +||||+++++++.....
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~- 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY- 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE-
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc-
Confidence 3478999999999999999999999999865 99988743 2334556788999999999 89999999999876544
Q ss_pred eEEEEEeeccccccccccCCC----------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPG----------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG 291 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~----------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g 291 (714)
+||||||++++.|..++... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 101 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 101 -LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp -EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred -eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 99999999987766555433 3799999999999999999999999999999999999999999
Q ss_pred cEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHH
Q 005111 292 ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFK 370 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k 370 (714)
.+||+|||++....... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp CEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred eEEEcccCcCccccccc--cccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 99999999997543221 123345688999999987765 7999999999999999998 9999998887666555422
Q ss_pred hhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 371 LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 371 ~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.. . ......++..+.+||.+||..||.+|||+.++|++
T Consensus 257 ~~-------------------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 GY-------------------R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TC-------------------C---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-------------------C---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 10 0 01123578899999999999999999999999985
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.76 Aligned_cols=267 Identities=22% Similarity=0.301 Sum_probs=208.0
Q ss_pred CCCeeEEeEEeccCceEEEEEE----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4689999999999999999998 5678999999998753 455667899999999999999999999988765666
Q ss_pred eEEEEEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+||||||++++.|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 69999999988777655543 34699999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCCh--hHHhh
Q 005111 307 KDSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSE--DYWRK 382 (714)
Q Consensus 307 ~~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~--~~w~~ 382 (714)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||......... .......... .....
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR--MMGCERDVPALSRLLEL 256 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HCC----CCHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhh--hcccccccccHHHHHHH
Confidence 3321 223346788899999998765 799999999999999999999998764332111 0000000000 00000
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
... .........+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEE-------------GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHT-------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhc-------------ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 00011224688999999999999999999999999654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=361.98 Aligned_cols=259 Identities=21% Similarity=0.295 Sum_probs=207.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEE-----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRAR-----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~-----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~ 225 (714)
..++|++++.||+|+||.||+|+ +..++..||||++... ........+.+|+.+|++++||||+++++++....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 45789999999999999999998 5567889999998643 34456677889999999999999999999987655
Q ss_pred CceEEEEEeeccccccccccCCC-------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEE
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPG-------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKI 295 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~-------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL 295 (714)
. +||||||++++.|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+. +..+||
T Consensus 107 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 107 P--RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp S--CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred C--cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 4 89999999887666554322 35899999999999999999999999999999999999994 446999
Q ss_pred eecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhC
Q 005111 296 ADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCG 373 (714)
Q Consensus 296 ~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G 373 (714)
+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+.....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99999986543322 2223456789999999997765 8999999999999999998 9999998887766655533110
Q ss_pred CCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 374 ~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
......++..+.+||.+||..||.+|||+.++++|.|+..
T Consensus 264 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 ----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 0112357889999999999999999999999999988653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=369.25 Aligned_cols=264 Identities=20% Similarity=0.194 Sum_probs=198.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccC-----CeEEEEEEeecCCCCHH-H--------HHHHHHHHHHHHhCCCCCeee
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIH-----DKIVALKKVRFDNQDPE-S--------VKFMAREIAILRKLDHPNIIK 216 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~-----g~~VAiK~i~~~~~~~~-~--------~~~~~rEi~iL~~L~HpnIVk 216 (714)
..++|++++.||+|+||.||+|.+..+ ++.||||++........ . ...+.+|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 457899999999999999999998764 58899999875431100 0 112335666777788999999
Q ss_pred eeccccccC--CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc--CCCc
Q 005111 217 LEGLITSQT--SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD--HNGI 292 (714)
Q Consensus 217 l~~~~~~~~--~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~--~~g~ 292 (714)
+++++.... ...+||||||+.+++...+......+++..++.|+.||+.||.|||++||+||||||+||||+ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 999876542 245899999994444444444446899999999999999999999999999999999999999 8899
Q ss_pred EEEeecCcccccCCCCCC------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHH
Q 005111 293 LKIADFGLASFFDPKDSV------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366 (714)
Q Consensus 293 vKL~DFGla~~~~~~~~~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 366 (714)
+||+|||+++.+...... .....+||+.|+|||++.+.. ++.++|||||||+||+|++|..||.+......+.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999876433211 123446999999999998776 8999999999999999999999998643332222
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
........+.. ...+...+ ..+|..+.+||..||..||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENI--------------------ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCH--------------------HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhH--------------------HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 22111000000 00011111 468999999999999999999999999886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=371.82 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=198.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|.+++||||+++++++.....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP-- 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS--
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc--
Confidence 468999999999999999999876 467789999997643 45567789999999999999999999999876554
Q ss_pred EEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+||||||++++.|..++. ....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 899999998877766554 3457999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCc--ccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 308 DSVPM--TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 308 ~~~~~--~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
..... ....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~---------- 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL---------- 269 (373)
T ss_dssp -------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC----------
T ss_pred CccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 22211 1224477899999998765 8999999999999999998 99999988877666655321100
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.+||..||+.||.+|||+.++++
T Consensus 270 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 ------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 011357899999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=353.09 Aligned_cols=257 Identities=22% Similarity=0.260 Sum_probs=206.3
Q ss_pred ccCCCCCeeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc
Q 005111 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ 224 (714)
Q Consensus 148 i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~ 224 (714)
++.....|++.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.+|++++||||+++++++...
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 455667899999999999999999987544 346899988653 3456677899999999999999999999985543
Q ss_pred CCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 225 TSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
. ...|+||||++++.|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 99 E-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp S-SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred C-CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccc
Confidence 3 34899999999977665553 456789999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCC---CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhH
Q 005111 304 FDPKDS---VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDY 379 (714)
Q Consensus 304 ~~~~~~---~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~ 379 (714)
+..... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~----- 251 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL----- 251 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-----
T ss_pred ccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-----
Confidence 643321 1223446688999999998765 7999999999999999999 67888877766555554331110
Q ss_pred HhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 380 w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.+||.+||+.||.+|||+.++++
T Consensus 252 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 -----------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011347889999999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=384.04 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=210.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
...+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|++++|||||++++++..... +|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--FY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--CE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCc--EE
Confidence 35679999999999999999999999999999999976543 35678899999999999999999999876654 89
Q ss_pred EEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||||.++.|..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999877665553 33568999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........+++.|+|||++.+.. |+.++|||||||+||||++ |.+||.+.+..+....+.....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------- 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------------- 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--------------
T ss_pred eeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 32333445678999999998765 8999999999999999999 9999998876655544422100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+|..+.+||.+||+.||.+|||+.++++
T Consensus 438 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 --------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0112467899999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=360.61 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=208.7
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCe-----EEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDK-----IVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS 223 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~-----~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~ 223 (714)
...++|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+|+.+ +||||+++++++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 345889999999999999999999877664 79999987543 345667899999999999 89999999999876
Q ss_pred cCCceEEEEEeeccccccccccCC--------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLP--------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH 289 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~--------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~ 289 (714)
... +||||||++++.|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 122 ~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 122 GGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSS--CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred CCc--eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 554 8999999998766554421 346899999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHH
Q 005111 290 NGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHR 367 (714)
Q Consensus 290 ~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~ 367 (714)
++.+||+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+......+..
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 999999999999866433221 122345688999999988765 8999999999999999998 9999988765555544
Q ss_pred HHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 368 IFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 368 I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+......+ .....+|..+.+||..||+.||.+|||+.++++
T Consensus 279 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 43321100 011346889999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=360.58 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=188.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccc------
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITS------ 223 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~------ 223 (714)
...+|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+|.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 446899999999999999999999999999999998654 3456677899999999995 9999999998732
Q ss_pred cCCceEEEEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEcCCCcEEEeecC
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLDHNGILKIADFG 299 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~~~g~vKL~DFG 299 (714)
.....+|+||||+.|++...+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||
T Consensus 104 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 104 TGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp TSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred cCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 23345899999999877665432 4457999999999999999999999999 9999999999999999999999999
Q ss_pred cccccCCCCCCC-----------cccccccccccCccccc--CCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHH
Q 005111 300 LASFFDPKDSVP-----------MTSRVVTLWYRPPELLL--GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLH 366 (714)
Q Consensus 300 la~~~~~~~~~~-----------~~~~~gT~~Y~APE~l~--g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~ 366 (714)
++..+....... .....||+.|+|||++. ....++.++|||||||++|+|++|..||.+......+.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 998765432211 12446899999999983 23347899999999999999999999997654432221
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.... .......+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 264 ~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 264 GKYS-------------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp --CC-------------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred Cccc-------------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1100 0011345678999999999999999999999999854
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=358.39 Aligned_cols=254 Identities=21% Similarity=0.337 Sum_probs=203.2
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHD----KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
....|.+.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+|+.++||||+++++++.....
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 3578999999999999999999877553 469999997543 44566778999999999999999999999876544
Q ss_pred ceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 227 CSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
+||||||++++.|..++. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 121 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 121 --MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp --EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred --cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 999999999877765553 34679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCC--cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 306 PKDSVP--MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 306 ~~~~~~--~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+.+..+......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-------- 269 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-------- 269 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred cccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC--------
Confidence 432211 12234578899999998765 8999999999999999999 99999988877666665331100
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 270 --------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 --------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp --------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113578999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=363.31 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=199.4
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEE----EEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIV----ALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~V----AiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..++|++++.||+|+||.||+|.+..+++.| |+|.+.... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 3578999999999999999999998888765 666664332 2345667889999999999999999999887543
Q ss_pred ceEEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 227 CSLYLVFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
.++||||+.++.+..++ .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 91 --~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 91 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp --EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred --ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 78999999987665544 345679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 306 PKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 306 ~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
..... ......+|+.|+|||++.+.. |+.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~--------- 238 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 238 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------
T ss_pred CccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 33221 223345688999999998766 8999999999999999999 99999988766555544321100
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.+||.+||..||.+|||+.++|+
T Consensus 239 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 -------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112357889999999999999999999999997
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=363.56 Aligned_cols=262 Identities=18% Similarity=0.137 Sum_probs=199.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEcc---CCeEEEEEEeecCCCCHH---------HHHHHHHHHHHHHhCCCCCeeeee
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVI---HDKIVALKKVRFDNQDPE---------SVKFMAREIAILRKLDHPNIIKLE 218 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~---~g~~VAiK~i~~~~~~~~---------~~~~~~rEi~iL~~L~HpnIVkl~ 218 (714)
..++|++.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.++..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 35789999999999999999999987 789999999876532111 112356788999999999999999
Q ss_pred cccccc--CCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC--cEE
Q 005111 219 GLITSQ--TSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG--ILK 294 (714)
Q Consensus 219 ~~~~~~--~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g--~vK 294 (714)
+++... ....+||||||+ ++.|..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 987662 234599999999 666666665555899999999999999999999999999999999999999887 999
Q ss_pred EeecCcccccCCCCC------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC--ChHHHHH
Q 005111 295 IADFGLASFFDPKDS------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK--TEVEQLH 366 (714)
Q Consensus 295 L~DFGla~~~~~~~~------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~--~~~e~l~ 366 (714)
|+|||+++.+..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+. .......
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 272 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT 272 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence 999999987643221 1124557899999999998765 899999999999999999999999653 2222222
Q ss_pred HHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhcc--CCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 367 RIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFK--DFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 367 ~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~--~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.........+. .+..... .+|..+.+||..||..||.+|||+.++++.
T Consensus 273 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 273 AKTNLLDELPQ----------------------SVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHTTTH----------------------HHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHhhcccccH----------------------HHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 22111111111 1111112 689999999999999999999999999873
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=377.58 Aligned_cols=254 Identities=22% Similarity=0.381 Sum_probs=210.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||.||+|.+. .+..||||+++.... ..+.+.+|+.+|+.++|||||++++++.. . .+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~--~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK-E--PIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS-S--SCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C--ccE
Confidence 4578999999999999999999874 578899999976432 35678899999999999999999998863 2 389
Q ss_pred EEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||||.++.|..++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999987776665432 368999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........+|+.|+|||++.+.. ++.++|||||||+||||++ |.+||.+.+..+.+..+......+
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------ 405 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------------ 405 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------------
T ss_pred eeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 22223335678899999998665 8999999999999999999 999999998887777664421100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc--CcCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN--SEFFT 440 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~--Hp~f~ 440 (714)
....+|..+.+||.+||..||.+|||+.+++. ..|++
T Consensus 406 ----------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 406 ----------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ----------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 12357899999999999999999999999876 34554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=352.32 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=203.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc---------
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS--------- 223 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~--------- 223 (714)
.+|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999999999999999997543 245689999999999999999998753
Q ss_pred -----cCCceEEEEEeeccccccccccC--CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEe
Q 005111 224 -----QTSCSLYLVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296 (714)
Q Consensus 224 -----~~~~~l~LV~Ey~~g~ll~~~~~--~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~ 296 (714)
.....+|+||||++++.|..++. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 12334899999999977766553 23579999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 297 DFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 297 DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
|||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .....+..
T Consensus 165 Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~------ 233 (284)
T 2a19_B 165 DFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD------ 233 (284)
T ss_dssp CCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT------
T ss_pred cchhheecccccc--ccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc------
Confidence 9999987754322 33457899999999998765 7999999999999999999998774211 11111100
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
......++..+.+||.+||..||.+|||+.++++|.|+-.
T Consensus 234 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0011347889999999999999999999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.15 Aligned_cols=256 Identities=26% Similarity=0.304 Sum_probs=197.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh--CCCCCeeeeecccccc--CC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK--LDHPNIIKLEGLITSQ--TS 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIVkl~~~~~~~--~~ 226 (714)
..++|++++.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++||||+++++++... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 357899999999999999999976 7999999998643 33455667777777 7999999999875432 23
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhh--------hcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH--------SHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH--------~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
..+|+||||++++.|..++.. ..+++..++.++.||+.||.||| ++||+||||||+||||+.++.+||+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 458999999999877776644 47999999999999999999999 999999999999999999999999999
Q ss_pred CcccccCCCCCC---CcccccccccccCcccccCCC-----CCCccccccchhHHHHHHhhC----------CCCCCCCC
Q 005111 299 GLASFFDPKDSV---PMTSRVVTLWYRPPELLLGAS-----HYGAAVDLWSTGCILGELFSG----------KPVLPGKT 360 (714)
Q Consensus 299 Gla~~~~~~~~~---~~~~~~gT~~Y~APE~l~g~~-----~y~~~sDIWSLG~iLyeLltG----------~~pF~g~~ 360 (714)
|++......... .....+||+.|+|||++.+.. .++.++|||||||++|||++| .+||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 999876443221 123347899999999998753 245799999999999999999 88886532
Q ss_pred ----hHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 361 ----EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 361 ----~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
....+..+....+.. +..+. ......++..+.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 238 PNDPSFEDMRKVVCVDQQR-----------------PNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CSSCCHHHHHHHHTTSCCC-----------------CCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCcchhhhhHHHhccCCC-----------------CCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 223333322111100 00000 0011235678999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=377.64 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=194.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+|++.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +|||||++++++.... .+|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQ--FQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETT--EEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCC--EEE
Confidence 45799999999999999764 3467899999999865322 2356899999999 7999999999887554 489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---C--CcEEEeecCcccccC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---N--GILKIADFGLASFFD 305 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~--g~vKL~DFGla~~~~ 305 (714)
||||||++++...+......+++..++.++.||+.||.|||++||+||||||+||||+. + ..+||+|||+|..+.
T Consensus 95 lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 95 IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99999998777766666666777788999999999999999999999999999999953 2 358899999998765
Q ss_pred CCCC--CCcccccccccccCcccccC--CCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHH
Q 005111 306 PKDS--VPMTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380 (714)
Q Consensus 306 ~~~~--~~~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w 380 (714)
.... ......+||+.|+|||++.+ ...++.++||||||||+|+|++ |.+||....... ...+ .+.....
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~---~~~~~~~-- 248 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANIL---LGACSLD-- 248 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHH---TTCCCCT--
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHH---hccCCcc--
Confidence 3321 22345679999999999874 2336789999999999999999 899996554332 2221 1111100
Q ss_pred hhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 381 ~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
...+ ....+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 249 ------------~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 249 ------------CLHP--------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ------------TSCT--------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ------------ccCc--------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0000 0123566899999999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=356.44 Aligned_cols=265 Identities=24% Similarity=0.328 Sum_probs=203.4
Q ss_pred eeEEeEEeccCceEEEEEE----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 155 FEKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
|++++.||+|+||.||+|. +..+++.||||++... ......+.+.+|+.+|+.++||||+++++++.......+|
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 4999999999999998875 3457899999999765 3456677899999999999999999999998876556699
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||||++++.|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 112 lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp EEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSE
T ss_pred EEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccc
Confidence 999999987777666543 5999999999999999999999999999999999999999999999999999887543321
Q ss_pred --CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 311 --PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 311 --~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+...... ....+...
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~ 263 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQM-TVLRLTEL 263 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHHH-HHHHHHHH
T ss_pred cccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccch-hHHHHHHH
Confidence 123346788999999998765 7899999999999999999999987543211 11111111000 00000000
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.. ..........++..+.+||.+||+.||.+|||+.++++
T Consensus 264 --~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 --LE-----RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp --HH-----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --Hh-----cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00 00001122467899999999999999999999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=373.54 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=206.6
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++++||||+++++++.. . .+|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~--~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C--ceE
Confidence 35789999999999999999999764 467999999865433 3568899999999999999999998865 2 389
Q ss_pred EEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
|||||+.++.|..++.. +..+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999998777766652 3468999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........+++.|+|||++.+.. ++.++|||||||+||||++ |.+||.+.+..+.+..+......
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------- 400 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------- 400 (452)
T ss_dssp --------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred eecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 33333445688999999998765 8999999999999999999 99999998887777666431100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc--CcCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN--SEFFTTQ 442 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~--Hp~f~~~ 442 (714)
.....+|..+.+||.+||..||.+|||+.++++ ..+|+..
T Consensus 401 ---------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 401 ---------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 012357899999999999999999999999987 4676653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=362.32 Aligned_cols=275 Identities=21% Similarity=0.265 Sum_probs=205.2
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+|+.++||||+++++++..... .
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~ 102 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE--R 102 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC--C
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc--e
Confidence 3467899999999999999999974 46899999998754321 122357899999999999999999999876554 8
Q ss_pred EEEEeeccccccccccCC----CCCCCHHHHHHHHHHHHHHhhHhhhc---CeeeccCCCccEEEcCCCcEEEeecCccc
Q 005111 230 YLVFEYMEHDLVGLASLP----GMKFTESQVKCYMKQLLSGLEHCHSH---GVLHRDIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~----~~~lse~~i~~i~~QIl~aL~~LH~~---gIiHrDLKP~NILl~~~g~vKL~DFGla~ 302 (714)
++||||++++.+..++.. ...+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 999999998777655433 33599999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
..............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||....... ........|..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~ 253 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLAN--------DDDVMLLDWVK 253 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT--------TSCSBHHHHHT
T ss_pred ccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCccccccccc--------ccchhHHHHHH
Confidence 87655444455567899999999997765 7999999999999999999999996211000 00000001111
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
.............. ..........+..+.+||..||+.||.+|||+.++|+|-.-
T Consensus 254 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDV--DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCT--TCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcCh--hhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00000000000000 00001112345789999999999999999999999998654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=350.11 Aligned_cols=247 Identities=27% Similarity=0.405 Sum_probs=194.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.+.||+|+||.||+|.+ .++.||||++... ...+.+.+|+.+|++++||||+++++++.+ . +||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~--~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--P--VCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T--TEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C--cEE
Confidence 46899999999999999999976 4889999998632 345678899999999999999999998763 2 789
Q ss_pred EEeeccccccccccCCCC---CCCHHHHHHHHHHHHHHhhHhhh---cCeeeccCCCccEEEcCCCc-EEEeecCccccc
Q 005111 232 VFEYMEHDLVGLASLPGM---KFTESQVKCYMKQLLSGLEHCHS---HGVLHRDIKGSNLLLDHNGI-LKIADFGLASFF 304 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~---~lse~~i~~i~~QIl~aL~~LH~---~gIiHrDLKP~NILl~~~g~-vKL~DFGla~~~ 304 (714)
||||++++.|..++.... .+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999999877776654433 47899999999999999999999 89999999999999998886 799999999865
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh--HHHHHHHHHhhCCCChhHHhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE--VEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~--~e~l~~I~k~~G~p~~~~w~~ 382 (714)
... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ......+.. +.
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-------- 221 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT-------- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC--------
T ss_pred ccc----cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC--------
Confidence 432 23446899999999998765 89999999999999999999999975432 222211111 00
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc-----CcCCCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN-----SEFFTT 441 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~-----Hp~f~~ 441 (714)
.......+|..+.+||.+||+.||.+|||+.++++ ..+|..
T Consensus 222 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 222 ------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 01123468899999999999999999999999998 355544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=372.22 Aligned_cols=246 Identities=22% Similarity=0.354 Sum_probs=203.3
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++++.||+|+||.||+|.+ .|+.||||+++... ..+.+.+|+.+|++++|||||++++++.... ..+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT-SCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC-Cce
Confidence 3457899999999999999999976 48899999997543 3456889999999999999999999876543 248
Q ss_pred EEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 230 YLVFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
|||||||+++.|..++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 9999999987776555432 24799999999999999999999999999999999999999999999999999865322
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. ....+++.|+|||++.+.. ++.++|||||||+||||++ |..||.+.+..+.+..+.....
T Consensus 343 ~----~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------- 404 (450)
T 1k9a_A 343 Q----DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------- 404 (450)
T ss_dssp --------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------------
T ss_pred c----cCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 1 2235688999999998765 8999999999999999998 9999998776666555532110
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+|+.+.+||.+||..||.+|||+.++++
T Consensus 405 ---------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ---------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112467899999999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=356.52 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=202.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc--CCce
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ--TSCS 228 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~--~~~~ 228 (714)
..++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+.+++.++||||+++++++... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 347899999999999999999999999999999998753 346677889999999999999999999987632 2345
Q ss_pred EEEEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 229 LYLVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
+|+||||+.++.|..++. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 899999999976654443 3567999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCC--------CcccccccccccCcccccCCC--CCCccccccchhHHHHHHhhCCCCCCCCChH-HHHHHHHHhhC
Q 005111 305 DPKDSV--------PMTSRVVTLWYRPPELLLGAS--HYGAAVDLWSTGCILGELFSGKPVLPGKTEV-EQLHRIFKLCG 373 (714)
Q Consensus 305 ~~~~~~--------~~~~~~gT~~Y~APE~l~g~~--~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~-e~l~~I~k~~G 373 (714)
...... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... +.+......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 321110 012345699999999987543 2688999999999999999999999531100 000000000
Q ss_pred CCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCc
Q 005111 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSE 437 (714)
Q Consensus 374 ~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp 437 (714)
. .. ......++..+.+||.+||+.||.+|||+.+++++-
T Consensus 263 --------------~--~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 263 --------------Q--LS---------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --------------C-------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --------------c--CC---------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 0 00 001135788999999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=372.27 Aligned_cols=259 Identities=27% Similarity=0.372 Sum_probs=191.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l 229 (714)
..+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+|+++ +|||||++++++.... .+
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~--~~ 84 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDR--FL 84 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS--EE
T ss_pred hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC--eE
Confidence 34567778999999999998754 578999999998753 234577999999876 8999999999886554 49
Q ss_pred EEEEeeccccccccccCCCCC------CCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC-------------
Q 005111 230 YLVFEYMEHDLVGLASLPGMK------FTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN------------- 290 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~------lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~------------- 290 (714)
|||||||++++...+...... .++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 85 ~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 85 YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp EEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred EEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence 999999987554444332211 1333567899999999999999999999999999999754
Q ss_pred CcEEEeecCcccccCCCCCC---CcccccccccccCcccccC------CCCCCccccccchhHHHHHHhh-CCCCCCCCC
Q 005111 291 GILKIADFGLASFFDPKDSV---PMTSRVVTLWYRPPELLLG------ASHYGAAVDLWSTGCILGELFS-GKPVLPGKT 360 (714)
Q Consensus 291 g~vKL~DFGla~~~~~~~~~---~~~~~~gT~~Y~APE~l~g------~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~ 360 (714)
+.+||+|||++..+...... .....+||+.|+|||++.+ ...++.++|||||||++|||++ |.+||.+..
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999987543321 2234579999999999975 2347999999999999999999 999997665
Q ss_pred hHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 361 EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 361 ~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
..+ ..+.......+. .... ....++.++.+||.+||+.||.+|||+.++|+||||.
T Consensus 245 ~~~--~~i~~~~~~~~~-------------~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~ 300 (434)
T 2rio_A 245 SRE--SNIIRGIFSLDE-------------MKCL---------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300 (434)
T ss_dssp THH--HHHHHTCCCCCC-------------CTTC---------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred hhH--HHHhcCCCCccc-------------cccc---------ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccC
Confidence 433 223221110000 0000 0113567899999999999999999999999999997
Q ss_pred C
Q 005111 441 T 441 (714)
Q Consensus 441 ~ 441 (714)
.
T Consensus 301 ~ 301 (434)
T 2rio_A 301 P 301 (434)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=350.66 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=198.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-CC--eEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-HD--KIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-~g--~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.++|++++.||+|+||.||+|.+.. ++ ..||||+++... ......+.+.+|+.+++.++||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence 4689999999999999999998643 33 369999987653 23456778999999999999999999999887543
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+++||||+.++.+..++. ....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 789999999766654443 235699999999999999999999999999999999999999999999999999987754
Q ss_pred CCCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 307 KDSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 307 ~~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred cccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--------
Confidence 3321 122345688999999998765 7999999999999999999 999999988877776664321110
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|..+.+||.+||..||.+|||+.++++
T Consensus 245 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 245 -------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012357899999999999999999999999997
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=365.28 Aligned_cols=259 Identities=22% Similarity=0.260 Sum_probs=199.2
Q ss_pred cccCCCCCeeEEeEEeccCceEEEEEEEccCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc
Q 005111 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS 223 (714)
Q Consensus 147 ~i~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g---~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~ 223 (714)
+++.....|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.+|++++||||+++++++..
T Consensus 83 ~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp BCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 35556667999999999999999999876443 46899988653 334567789999999999999999999998654
Q ss_pred cCCceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCccc
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLAS 302 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~ 302 (714)
.. ...|+||||++++.|..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 162 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 162 SE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp CS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccc
Confidence 33 23799999999876665554 44568999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCC---CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChh
Q 005111 303 FFDPKDSV---PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSED 378 (714)
Q Consensus 303 ~~~~~~~~---~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~ 378 (714)
.+...... ......+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.... .
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--~--- 314 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--R--- 314 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--C---
T ss_pred cccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--C---
Confidence 66433221 123345688999999998765 8999999999999999999 788998776555444442210 0
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
. .....+|..+.+||.+||..||.+|||+.+++++
T Consensus 315 --------------~---------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 --------------L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp --------------C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0113578899999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=362.45 Aligned_cols=255 Identities=15% Similarity=0.166 Sum_probs=197.7
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccC--------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeee-----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIH--------DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL----- 217 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~--------g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl----- 217 (714)
..++|++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.+|++++||||+++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 357899999999999999999999874 889999998754 347799999999999999984
Q ss_pred ----------eccccccCCceEEEEEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccE
Q 005111 218 ----------EGLITSQTSCSLYLVFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNL 285 (714)
Q Consensus 218 ----------~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NI 285 (714)
++++.. ....+||||||+ ++.|..++... ..+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 113 ~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 190 (352)
T 2jii_A 113 STPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190 (352)
T ss_dssp TCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred cCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 333333 234589999999 65555554433 6799999999999999999999999999999999999
Q ss_pred EEcCCC--cEEEeecCcccccCCCCCC------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCC
Q 005111 286 LLDHNG--ILKIADFGLASFFDPKDSV------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLP 357 (714)
Q Consensus 286 Ll~~~g--~vKL~DFGla~~~~~~~~~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~ 357 (714)
||+.++ .+||+|||++..+...... ......||+.|+|||++.+.. ++.++|||||||+||+|++|..||.
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcc
Confidence 999998 9999999999876533211 123457899999999998765 8999999999999999999999998
Q ss_pred CCC-hHHHHHHHHH-hhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 358 GKT-EVEQLHRIFK-LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 358 g~~-~~e~l~~I~k-~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
+.. ..+.+..... ....+.. +. .....+..++..+.+||..||..||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~-------------~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 270 NCLPNTEDIMKQKQKFVDKPGP-------------FV-------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GGTTCHHHHHHHHHHHHHSCCC-------------EE-------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCcCHHHHHHHHHhccCChhh-------------hh-------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 764 3333332221 1111000 00 000112357899999999999999999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.36 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=195.1
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||.||+|.+ +|+.||||++.... ..+.+.+|+.++++++||||+++++++.... ..+|
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 91 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLY 91 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCE
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-CceE
Confidence 357899999999999999999976 58999999987542 4567889999999999999999999865433 2489
Q ss_pred EEEeeccccccccccCCCC--CCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGM--KFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~--~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||||++++.|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999877665554322 38999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
....+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------------- 231 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------- 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC---------------
T ss_pred ----cCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 2335688999999997765 7999999999999999998 999998876655544442110
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. ......+|+.+.+||.+||..||.+|||+.++++
T Consensus 232 ----~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ----K---------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----C---------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 0 0112467899999999999999999999999885
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=387.17 Aligned_cols=245 Identities=22% Similarity=0.297 Sum_probs=204.2
Q ss_pred eEEeccCceEEEEEEE--ccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARD--VIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d--~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
+.||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+.+|++++|||||++++++... . +|||||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~--~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-S--WMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S--EEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C--EEEEEEcc
Confidence 4899999999999954 45678999999987655556678899999999999999999999988543 2 89999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC--CCccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS--VPMTS 314 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~--~~~~~ 314 (714)
.++.|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..... .....
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9988887777677899999999999999999999999999999999999999999999999999987754332 12233
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
..+|+.|+|||++.+.. |+.++|||||||+||||++ |..||.+.+..+....+.....
T Consensus 532 ~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------------------- 590 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------------------- 590 (635)
T ss_dssp ---CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------------------
T ss_pred CCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence 45678999999998765 8999999999999999998 9999999988777666643210
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+|..+.+||..||..||++|||+.++++
T Consensus 591 --------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0112367899999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.37 Aligned_cols=250 Identities=18% Similarity=0.235 Sum_probs=191.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC------CHHHHHHHHHHHHHHHhCC---------C-----
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ------DPESVKFMAREIAILRKLD---------H----- 211 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~------~~~~~~~~~rEi~iL~~L~---------H----- 211 (714)
.++|++++.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.+|+.++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36789999999999999999987 789999999987532 2334577889999999886 4
Q ss_pred ------------CCeeeeecccccc-----------CCceEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHh
Q 005111 212 ------------PNIIKLEGLITSQ-----------TSCSLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGL 267 (714)
Q Consensus 212 ------------pnIVkl~~~~~~~-----------~~~~l~LV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL 267 (714)
|||+++++++... ....+|||||||.++ ++..+.. ..+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 5555555554431 134599999999876 5555543 5689999999999999999
Q ss_pred hHhh-hcCeeeccCCCccEEEcCCC--------------------cEEEeecCcccccCCCCCCCcccccccccccCccc
Q 005111 268 EHCH-SHGVLHRDIKGSNLLLDHNG--------------------ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326 (714)
Q Consensus 268 ~~LH-~~gIiHrDLKP~NILl~~~g--------------------~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~ 326 (714)
.||| ++||+||||||+||||+.++ .+||+|||+|+..... ..+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9999 99999999999999999887 8999999999977532 4489999999999
Q ss_pred ccCCCCCCccccccchhHH-HHHHhhCCCCCCCCChHH-HHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhh
Q 005111 327 LLGASHYGAAVDLWSTGCI-LGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAET 404 (714)
Q Consensus 327 l~g~~~y~~~sDIWSLG~i-LyeLltG~~pF~g~~~~e-~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~ 404 (714)
+.+.. +.++||||||++ ++++++|..||.+..... ....+..... +... .....
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~~~~-----~~~~~ 304 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT-----------------FKTK-----CNTPA 304 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC-----------------CSSC-----CCSHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc-----------------cCcc-----cchhh
Confidence 98764 889999998777 888999999985422111 1222221100 0000 00112
Q ss_pred ccCCcHHHHHHHHHhcccCcCCCCCHHHHH-cCcCCC
Q 005111 405 FKDFPTSALRLMETLMSIDPAHRGTATLAL-NSEFFT 440 (714)
Q Consensus 405 ~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L-~Hp~f~ 440 (714)
+..+++++.+||.+||++| ||.|+| +||||+
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 3357889999999999987 999999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=373.97 Aligned_cols=255 Identities=16% Similarity=0.195 Sum_probs=197.2
Q ss_pred cCCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCC-CCeeeee--------
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDH-PNIIKLE-------- 218 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~H-pnIVkl~-------- 218 (714)
......|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.+.| .|...+.
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 344566899999999999999999999999999999988542 233446778999999999987 3221111
Q ss_pred -------------ccccccC---CceEEEEEeeccccccccc------cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCee
Q 005111 219 -------------GLITSQT---SCSLYLVFEYMEHDLVGLA------SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276 (714)
Q Consensus 219 -------------~~~~~~~---~~~l~LV~Ey~~g~ll~~~------~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIi 276 (714)
.++.... ...++++|+++.+++...+ ......+++..+..++.||+.||+|||++|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1111111 2347889998888766554 23345688899999999999999999999999
Q ss_pred eccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccccCccccc---------CCCCCCccccccchhHHHH
Q 005111 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL---------GASHYGAAVDLWSTGCILG 347 (714)
Q Consensus 277 HrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~---------g~~~y~~~sDIWSLG~iLy 347 (714)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....|+.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999876433 345577 9999999983 3334788999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCC
Q 005111 348 ELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427 (714)
Q Consensus 348 eLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kR 427 (714)
+|++|+.||.+.+..+.... +......+|..+.+||.+||+.||.+|
T Consensus 309 elltg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHCCCCCCCcchhhhHHH---------------------------------HHhhcccCCHHHHHHHHHHccCChhhC
Confidence 99999999987653211111 111223688999999999999999999
Q ss_pred CCHHHHHcCcCCCC
Q 005111 428 GTATLALNSEFFTT 441 (714)
Q Consensus 428 pTa~e~L~Hp~f~~ 441 (714)
||+.++|+||||..
T Consensus 356 pt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 356 LLPLQAMETPEYEQ 369 (413)
T ss_dssp CCHHHHTTSHHHHH
T ss_pred cCHHHHHhCHHHHH
Confidence 99999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.56 Aligned_cols=249 Identities=16% Similarity=0.184 Sum_probs=196.4
Q ss_pred cCCCCCeeEEeEEeccCceEEEEE-----EEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeeecc
Q 005111 149 PRRANTFEKLDKIGQGTYSSVYRA-----RDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD---HPNIIKLEGL 220 (714)
Q Consensus 149 ~~~~~~Y~~~~~LG~G~fG~Vy~a-----~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIVkl~~~ 220 (714)
....++|++.+.||+|+||.||+| .+..+++.||||++... ....+.+|+.++..+. |+||+.++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344678999999999999999999 46788999999998653 2345678888888886 9999999999
Q ss_pred ccccCCceEEEEEeeccccccccccC-----CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC------
Q 005111 221 ITSQTSCSLYLVFEYMEHDLVGLASL-----PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH------ 289 (714)
Q Consensus 221 ~~~~~~~~l~LV~Ey~~g~ll~~~~~-----~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~------ 289 (714)
+..... .|||||||+++.|..++. ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 136 ~~~~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 136 HLFQNG--SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EECSSC--EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eecCCC--cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 876655 899999999877766553 4567999999999999999999999999999999999999998
Q ss_pred -----CCcEEEeecCcccccCC-CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH
Q 005111 290 -----NGILKIADFGLASFFDP-KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE 363 (714)
Q Consensus 290 -----~g~vKL~DFGla~~~~~-~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e 363 (714)
++.+||+|||+|+.+.. .........+||+.|+|||++.+.. |+.++||||||||+|||++|+.||......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~- 291 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG- 291 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC-
Confidence 89999999999976532 1222345568999999999998876 899999999999999999999998643210
Q ss_pred HHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcC
Q 005111 364 QLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438 (714)
Q Consensus 364 ~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~ 438 (714)
.|. ....+.. ...+..+.+++..||..+|.+|++..+.|.+.+
T Consensus 292 ---------------~~~-----------~~~~~~~------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 292 ---------------ECK-----------PEGLFRR------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp ---------------EEE-----------ECSCCTT------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred ---------------cee-----------echhccc------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 000 0000000 024677899999999999999977666555443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=351.08 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=201.4
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
|...+.||+|+||.||+|.+ ++..||||++.... ......+.+.+|+.+|+.++||||+++++++..... +|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD--LCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--CEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc--eEEE
Confidence 44558899999999999974 78899999987542 234567789999999999999999999999876554 8999
Q ss_pred EeeccccccccccC---CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 233 FEYMEHDLVGLASL---PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~---~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||++++.+..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 188 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence 99998876655443 235699999999999999999999999999999999999999999999999999987654322
Q ss_pred C-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC--hhHHhhhhcc
Q 005111 310 V-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS--EDYWRKSKLR 386 (714)
Q Consensus 310 ~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~--~~~w~~~~~~ 386 (714)
. ......||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+......+..+........ -..|..
T Consensus 189 ~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 262 (307)
T 2nru_A 189 TVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID---- 262 (307)
T ss_dssp CEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSC----
T ss_pred cccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcc----
Confidence 2 12334789999999988763 78999999999999999999999987654433333322111110 000000
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+.......+..+.+||.+||..||.+|||+.+++++
T Consensus 263 ------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 263 ------------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ------------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00011112346789999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=377.11 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=210.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++.++||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++|+|||||++++++.. . .+|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~--~~~ 337 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--PIY 337 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S--SCE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c--cce
Confidence 35689999999999999999999764 467999999865433 4568899999999999999999998865 2 389
Q ss_pred EEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 231 LVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
||||||.++.|..++.. +..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999998777766642 3468999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
........++..|+|||++.+.. |+.++|||||||+||||++ |..||.+.+..+.+..+......
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------- 483 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------- 483 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred eecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 11222335678999999998765 8999999999999999999 99999998887777666431100
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC--cCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS--EFFTT 441 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H--p~f~~ 441 (714)
.....++..+.+||.+||..||++|||+.++++. .+|..
T Consensus 484 ---------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 ---------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1123578999999999999999999999999874 66654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.94 Aligned_cols=279 Identities=23% Similarity=0.260 Sum_probs=193.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHH--HHHhCCCCCeeeeecccc---ccC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIA--ILRKLDHPNIIKLEGLIT---SQT 225 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~--iL~~L~HpnIVkl~~~~~---~~~ 225 (714)
..++|++++.||+|+||.||+|++ +++.||||++.... ...+..|.. .+..+.||||+++++++. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 458999999999999999999965 78999999997532 223334444 455689999999987432 233
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc---------CeeeccCCCccEEEcCCCcEEEe
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH---------GVLHRDIKGSNLLLDHNGILKIA 296 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~---------gIiHrDLKP~NILl~~~g~vKL~ 296 (714)
...+|||||||+++.|..++... .+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 34589999999987777665433 468999999999999999999999 99999999999999999999999
Q ss_pred ecCcccccCCCCC-------CCcccccccccccCcccccCC------CCCCccccccchhHHHHHHhhCCCC-CCCCChH
Q 005111 297 DFGLASFFDPKDS-------VPMTSRVVTLWYRPPELLLGA------SHYGAAVDLWSTGCILGELFSGKPV-LPGKTEV 362 (714)
Q Consensus 297 DFGla~~~~~~~~-------~~~~~~~gT~~Y~APE~l~g~------~~y~~~sDIWSLG~iLyeLltG~~p-F~g~~~~ 362 (714)
|||++..+..... ......+||+.|+|||++.+. ..++.++|||||||++|||++|..| |++....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987653221 122345789999999999763 2356789999999999999999644 4443322
Q ss_pred HHHHHHHHhhC-CCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHH------Hc
Q 005111 363 EQLHRIFKLCG-SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA------LN 435 (714)
Q Consensus 363 e~l~~I~k~~G-~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~------L~ 435 (714)
+....+....+ .+..+.+...... ....+..+ ........++..+.+||.+||..||.+|||+.++ |-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSR--EKQRPKFP---EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTT--SCCCCCCC---TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcc--cccCCCCC---cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 11111111111 1111111110000 00000000 0000011245689999999999999999999999 45
Q ss_pred CcCCCCC
Q 005111 436 SEFFTTQ 442 (714)
Q Consensus 436 Hp~f~~~ 442 (714)
++|-+..
T Consensus 318 ~~~~~~~ 324 (336)
T 3g2f_A 318 MIWERNK 324 (336)
T ss_dssp HCCCC--
T ss_pred HHHHhcc
Confidence 7777654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.08 Aligned_cols=255 Identities=22% Similarity=0.248 Sum_probs=202.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|.|++++..+.++... ....|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~-~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE-GDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE-TTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee-CCEEE
Confidence 457899999999999999999999999999999998765332 2367899999999875544444433332 23489
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE---cCCCcEEEeecCcccccCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl---~~~g~vKL~DFGla~~~~~~ 307 (714)
|||||+.+.+...+......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||++..+...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999665555554445689999999999999999999999999999999999999 58899999999999877544
Q ss_pred CCC------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCCh---HHHHHHHHHhhCCCChh
Q 005111 308 DSV------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTE---VEQLHRIFKLCGSPSED 378 (714)
Q Consensus 308 ~~~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~---~e~l~~I~k~~G~p~~~ 378 (714)
... .....+||+.|+|||++.+.. ++.++||||||||||+|++|..||.+... .+.+.++....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 232 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 232 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH------
T ss_pred ccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc------
Confidence 321 122567899999999998876 89999999999999999999999987543 33333332210
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
....+......+|.++.+||..||..||.+||++.++++
T Consensus 233 ------------------~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 233 ------------------VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ------------------HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ------------------ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011122333578999999999999999999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=350.50 Aligned_cols=270 Identities=22% Similarity=0.321 Sum_probs=204.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEE----EccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRAR----DVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~----d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
..+.|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++++++.....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 34679999999999999999998 4568999999998753 34566789999999999999999999998876554
Q ss_pred ceEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 227 CSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
..+++||||++++.|..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 45899999999876665543 33569999999999999999999999999999999999999999999999999998775
Q ss_pred CCCCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 306 PKDSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 306 ~~~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
..... ......++..|+|||++.+.. ++.++|||||||++|+|++|..||.... .. +....+......+...
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~--~~---~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPP--AE---FMRMIGNDKQGQMIVF 270 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHH--HH---HHHHHCTTCCTHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCH--HH---HHHhhccccchhhhHH
Confidence 43221 112335678899999998765 7999999999999999999998876432 11 1112222211111000
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+...... .........+|..+.+||.+||..||.+|||+.++++
T Consensus 271 ~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 271 HLIELLKN-------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHT-------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhhc-------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000000 0000112467899999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=346.39 Aligned_cols=239 Identities=22% Similarity=0.316 Sum_probs=187.1
Q ss_pred CCCeeEE-eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHH-HhCCCCCeeeeeccccc--cCCc
Q 005111 152 ANTFEKL-DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAIL-RKLDHPNIIKLEGLITS--QTSC 227 (714)
Q Consensus 152 ~~~Y~~~-~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL-~~L~HpnIVkl~~~~~~--~~~~ 227 (714)
.++|.++ +.||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4678888 7899999999999999999999999998632 3466888888 66699999999998765 2234
Q ss_pred eEEEEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCccc
Q 005111 228 SLYLVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLAS 302 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla~ 302 (714)
.+||||||++++.|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 58999999998666555433 346999999999999999999999999999999999999998 7899999999986
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
... + ..|+.++|||||||++|+|++|.+||.+.........+...
T Consensus 169 ~~~-----------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~----------- 213 (299)
T 3m2w_A 169 ETT-----------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----------- 213 (299)
T ss_dssp ECT-----------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-----------
T ss_pred ccc-----------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-----------
Confidence 542 1 23788999999999999999999999876543221111000
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
... .. .......+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 214 ------~~~-~~---~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 214 ------IRM-GQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ------SCT-TC---CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ------Hhh-cc---ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 000 00 000112235689999999999999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=378.59 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=205.2
Q ss_pred CCCeeEEe-EEeccCceEEEEEEEcc--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLD-KIGQGTYSSVYRARDVI--HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~-~LG~G~fG~Vy~a~d~~--~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.+.|.+.+ .||+|+||.||+|.+.. ++..||||+++... .....+.+.+|+.+|++++|||||++++++.. . .
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~--~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E--A 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S--S
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C--C
Confidence 34566666 89999999999998753 56789999997653 23456778999999999999999999999865 2 3
Q ss_pred EEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|||||||.++.|..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 899999999987776554 4456999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC--cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 308 DSVP--MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 308 ~~~~--~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... .....+|+.|+|||++.+.. |+.++|||||||+||||++ |..||.+.+..+.+..|.....
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~----------- 557 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------- 557 (613)
T ss_dssp ------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----------
T ss_pred CceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 2211 12224568999999998665 8999999999999999998 9999999888777766643110
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHH---cCcCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLAL---NSEFFT 440 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L---~Hp~f~ 440 (714)
......+|..+.+||..||..||.+|||+.+++ ++.|+.
T Consensus 558 -----------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 558 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 011236889999999999999999999999974 455544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.55 Aligned_cols=253 Identities=18% Similarity=0.249 Sum_probs=202.4
Q ss_pred CCCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 150 ~~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
...++|++.+.||+|+||.||+|.+.. .||+|++..........+.+.+|+.++++++||||+++++++..... +
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~ 104 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH--L 104 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC--E
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc--e
Confidence 345789999999999999999998753 49999998654444445567789999999999999999999876554 9
Q ss_pred EEEEeeccccccccccCCC-CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC-
Q 005111 230 YLVFEYMEHDLVGLASLPG-MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK- 307 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~-~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~- 307 (714)
|+||||++++.+..++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999987777666543 4799999999999999999999999999999999999998 689999999998765321
Q ss_pred ---CCCCcccccccccccCcccccC--------CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCC
Q 005111 308 ---DSVPMTSRVVTLWYRPPELLLG--------ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPS 376 (714)
Q Consensus 308 ---~~~~~~~~~gT~~Y~APE~l~g--------~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~ 376 (714)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~- 262 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN- 262 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC-
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC-
Confidence 1122334468999999999875 2347899999999999999999999999888776665553211000
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....++..+.+||..||..||.+|||+.++++
T Consensus 263 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 --------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp --------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred --------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001247889999999999999999999999997
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.90 Aligned_cols=254 Identities=26% Similarity=0.316 Sum_probs=190.4
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC--CCCCeeeeeccccccCC--ce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL--DHPNIIKLEGLITSQTS--CS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L--~HpnIVkl~~~~~~~~~--~~ 228 (714)
++|++++.||+|+||.||+|++. ++.||||++... ......+|.+++..+ +||||+++++++..... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 57999999999999999999864 999999998643 223344556665554 89999999998766532 45
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc--------CeeeccCCCccEEEcCCCcEEEeecCc
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH--------GVLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~--------gIiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
+||||||++++.|..++.. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 8999999998777766543 3699999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCC---CcccccccccccCcccccCCCCCCcc------ccccchhHHHHHHhhC----------CCCCCCCC-
Q 005111 301 ASFFDPKDSV---PMTSRVVTLWYRPPELLLGASHYGAA------VDLWSTGCILGELFSG----------KPVLPGKT- 360 (714)
Q Consensus 301 a~~~~~~~~~---~~~~~~gT~~Y~APE~l~g~~~y~~~------sDIWSLG~iLyeLltG----------~~pF~g~~- 360 (714)
+..+...... .....+||+.|+|||++.+.. +... +|||||||++|||++| ..||....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 9776433222 123457899999999998765 3443 9999999999999999 56665422
Q ss_pred ---hHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 361 ---EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 361 ---~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
....+..+....+ ..+..+. ......++..+.+||.+||+.||.+|||+.++++|
T Consensus 268 ~~~~~~~~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKK-----------------LRPSFPN----RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SSCCHHHHHHHHTTSC-----------------CCCCCCG----GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhHHHHhhhc-----------------cCccccc----cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1222222211100 0000000 00012457789999999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=389.63 Aligned_cols=280 Identities=24% Similarity=0.307 Sum_probs=209.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc----cCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS----QTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~----~~~~ 227 (714)
.++|++.+.||+|+||.||+|.+..+|+.||||+++.. ......+.+.+|+.+|+.++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 46799999999999999999999999999999998754 345667789999999999999999999998754 1134
Q ss_pred eEEEEEeeccccccccccCCC---CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc---EEEeecCcc
Q 005111 228 SLYLVFEYMEHDLVGLASLPG---MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI---LKIADFGLA 301 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~---~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~---vKL~DFGla 301 (714)
.+|||||||+++.|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 489999999887776555432 36999999999999999999999999999999999999997764 999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......+....... ....+.
T Consensus 172 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~---~~~~~~ 245 (676)
T 3qa8_A 172 KELDQGEL--CTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK---SNEHIV 245 (676)
T ss_dssp CBTTSCCC--CCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---------CC
T ss_pred cccccccc--cccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcc---cchhhh
Confidence 88754432 34568899999999998765 8999999999999999999999998765443221111000 000000
Q ss_pred -hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 382 -KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 382 -~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
.........+....+ ........++..+.+||..||..||.+|||+.++|+||||..
T Consensus 246 ~~~~l~g~~~~~~~lp---~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLP---TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCCCSSSC---CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhccccccccccC---CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000000001111001 111223457889999999999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=376.22 Aligned_cols=252 Identities=22% Similarity=0.312 Sum_probs=207.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..++|++.+.||+|+||.||+|.+..+ +..||||++... ......+.+.+|+.+|++++||||+++++++.. .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~-- 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N-- 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S--
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-C--
Confidence 346799999999999999999998653 568999998654 344566789999999999999999999998853 2
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+||||||++++.|..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 3899999999877766554 345799999999999999999999999999999999999999999999999999987754
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
..........+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~----------- 611 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------- 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC-----------
T ss_pred CcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 4433334446688999999997765 8999999999999999997 99999998888777776442100
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|+.+.+||.+||..||.+|||+.++++
T Consensus 612 -----------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 -----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112367899999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.92 Aligned_cols=255 Identities=25% Similarity=0.280 Sum_probs=197.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh--CCCCCeeeeeccccccCC--ce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK--LDHPNIIKLEGLITSQTS--CS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIVkl~~~~~~~~~--~~ 228 (714)
++|++.+.||+|+||.||+|.+ +|+.||||++... ....+.+|+.++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 5799999999999999999986 6999999998642 34567789999988 789999999998876542 25
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhh--------hcCeeeccCCCccEEEcCCCcEEEeecCc
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH--------SHGVLHRDIKGSNLLLDHNGILKIADFGL 300 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH--------~~gIiHrDLKP~NILl~~~g~vKL~DFGl 300 (714)
+|+||||++++.|..++.. ..+++.+++.++.||+.||.||| ++||+||||||+||||+.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 8999999999777666543 36999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---CcccccccccccCcccccCCCC-----CCccccccchhHHHHHHhhC----------CCCCCCCC--
Q 005111 301 ASFFDPKDSV---PMTSRVVTLWYRPPELLLGASH-----YGAAVDLWSTGCILGELFSG----------KPVLPGKT-- 360 (714)
Q Consensus 301 a~~~~~~~~~---~~~~~~gT~~Y~APE~l~g~~~-----y~~~sDIWSLG~iLyeLltG----------~~pF~g~~-- 360 (714)
+......... ......||+.|+|||++.+... ++.++|||||||++|+|++| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9876544321 2234578999999999976532 23689999999999999999 67776542
Q ss_pred --hHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 361 --EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 361 --~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
..+.+........ ..+..+. .. .....+..+.+||.+||+.||.+|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~~-----------------~~~~~~~--~~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQK-----------------LRPNIPN--RW--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSC-----------------CCCCCCG--GG--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHH-----------------hCCCCcc--cc--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1222222211000 0000000 00 011345689999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.23 Aligned_cols=229 Identities=17% Similarity=0.124 Sum_probs=187.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++..++||||+++++++...+. +|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~--~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG--GL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE--EE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc--EE
Confidence 4689999999999999999999999999999999987643 45667889999999999999999999999876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||||++|+.|..++..+ ....++..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999988887776543 4667889999999999999999999999999999999999999998543
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
|++| ++.++|||||||++|+|++|..||.+.+..+.+.. .
T Consensus 175 ----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~----------------------~ 214 (286)
T 3uqc_A 175 ----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP----------------------A 214 (286)
T ss_dssp ----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE----------------------C
T ss_pred ----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH----------------------H
Confidence 3332 68999999999999999999999987654211100 0
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.................+|..+.+||.+||+.||.+| |+.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0000000111223446789999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=371.66 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=200.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC---c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---C 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---~ 227 (714)
.++|++++.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.+|.+++|||||++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4789999999999999999999976 7999999998653 345666788999999999999999999999876443 1
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
.+||||||++|+++..+... .+++.+++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 26999999999888776544 79999999999999999999999999999999999999875 8999999999876533
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
...+||+.|+|||++.+. ++.++||||||||||+|++|.+||.+.... +.+
T Consensus 235 -----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~------------ 285 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP------------ 285 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC------------
T ss_pred -----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------ccc------------
Confidence 345789999999998764 489999999999999999999888652110 000
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
...+ ....++.+.+||.+||+.||.+||++.++|.|+|+.
T Consensus 286 -----~~~~--------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 -----EDDP--------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----TTCH--------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----cccc--------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0000 012357899999999999999999999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=317.86 Aligned_cols=188 Identities=16% Similarity=0.068 Sum_probs=137.4
Q ss_pred EEeccCceEEEEEEEccCCeEEEEEEeecCCC--------CHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCceEE
Q 005111 160 KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--------DPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 160 ~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--------~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++.|++|.+..++....|+.||+|++..+.. .....+.+.+|+.+|+++ .|+||+++++++.+... +|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~--~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS--GW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE--EE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE--EE
Confidence 46778888888888888999999999976521 123456799999999999 79999999999876654 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||||+|+.|..++..++++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... .
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~ 394 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-S 394 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----C
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-c
Confidence 999999999999888888888875 478999999999999999999999999999999999999999998765433 3
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCC
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV 355 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~p 355 (714)
...+.+||+.|+|||++.+. +..++|+||+|+++|+|+++..+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred cccCceechhhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence 45567999999999999875 57889999999999998776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-26 Score=263.48 Aligned_cols=185 Identities=18% Similarity=0.133 Sum_probs=140.8
Q ss_pred EEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC-H-----HHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 157 KLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD-P-----ESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~-~-----~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..+.||+|+||.||+| ...+..+|+|++...... . ...+.+.+|+.+|++++||||+++..++..... .|
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~~ 415 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--KR 415 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT--TE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc--cE
Confidence 3568999999999999 466888999987553221 1 124568999999999999999944333333333 69
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||||+++.|..++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++........
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence 99999998777766654 6799999999999999999999999999999998 9999999999987543211
Q ss_pred C------cccccccccccCcccccC--CCCCCccccccchhHHHHHHhhCCCCC
Q 005111 311 P------MTSRVVTLWYRPPELLLG--ASHYGAAVDLWSTGCILGELFSGKPVL 356 (714)
Q Consensus 311 ~------~~~~~gT~~Y~APE~l~g--~~~y~~~sDIWSLG~iLyeLltG~~pF 356 (714)
. ....+||+.|+|||++.+ .. |+..+|+|+..+-..+.+.++..|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~-Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEG-YKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHH-HHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHhcccc
Confidence 1 135689999999999875 33 788899999999888888776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-24 Score=224.16 Aligned_cols=149 Identities=14% Similarity=0.118 Sum_probs=120.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH----------------HHHHHHHHHHHHHHhCCCCCe
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP----------------ESVKFMAREIAILRKLDHPNI 214 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~----------------~~~~~~~rEi~iL~~L~HpnI 214 (714)
+...|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|+.++ |
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred CCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 456788889999999999999998 889999999997532111 24567889999999999 5
Q ss_pred eeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEE
Q 005111 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILK 294 (714)
Q Consensus 215 Vkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vK 294 (714)
+++++++.. . .+|+|||||+|+.|..+. ......++.||+.||.|||++||+||||||+||||+ +|.+|
T Consensus 164 ~~v~~~~~~-~--~~~lvmE~~~g~~L~~l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 164 LAVPKVYAW-E--GNAVLMELIDAKELYRVR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp SSSCCEEEE-E--TTEEEEECCCCEEGGGCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred CCcCeEEec-c--ceEEEEEecCCCcHHHcc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence 667666543 2 269999999987776532 123567999999999999999999999999999999 99999
Q ss_pred EeecCcccccCCCCCCCcccccccccccCccccc
Q 005111 295 IADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328 (714)
Q Consensus 295 L~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~ 328 (714)
|+|||+|+. +..|.|||++.
T Consensus 233 l~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 233 IIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp ECCCTTCEE--------------TTSTTHHHHHH
T ss_pred EEECCCCeE--------------CCCCCHHHHHH
Confidence 999999864 34578899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=195.13 Aligned_cols=141 Identities=15% Similarity=0.215 Sum_probs=108.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeE--EEEEEeecCCCC----------------------HHHHHHHHHHHHHHHh
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKI--VALKKVRFDNQD----------------------PESVKFMAREIAILRK 208 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~--VAiK~i~~~~~~----------------------~~~~~~~~rEi~iL~~ 208 (714)
.-|++.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+.+|..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3588999999999999999998788999 999997653211 0112367899999999
Q ss_pred CCCCCe--eeeeccccccCCceEEEEEeeccc-c----ccccccCCCCCCCHHHHHHHHHHHHHHhhHhh-hcCeeeccC
Q 005111 209 LDHPNI--IKLEGLITSQTSCSLYLVFEYMEH-D----LVGLASLPGMKFTESQVKCYMKQLLSGLEHCH-SHGVLHRDI 280 (714)
Q Consensus 209 L~HpnI--Vkl~~~~~~~~~~~l~LV~Ey~~g-~----ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDL 280 (714)
+.|+++ ..++.+ . ..+|||||+++ + .+..... .+++..+..++.||+.||.||| +.||+||||
T Consensus 127 l~~~~i~~p~~~~~----~--~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----M--KNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHHTTCCCCCEEEE----E--TTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HHhCCCCCCeEEEc----C--CCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 988764 333321 1 26899999953 2 3332221 1345678899999999999999 999999999
Q ss_pred CCccEEEcCCCcEEEeecCccccc
Q 005111 281 KGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 281 KP~NILl~~~g~vKL~DFGla~~~ 304 (714)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-17 Score=182.65 Aligned_cols=143 Identities=18% Similarity=0.202 Sum_probs=102.3
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC---------------CHHHH-----HHHHHHHHHHHhCC
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ---------------DPESV-----KFMAREIAILRKLD 210 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~---------------~~~~~-----~~~~rEi~iL~~L~ 210 (714)
+..-|++..+||.|+||.||+|.+ .+|+.||||+++.... ..... -...+|...|.+|.
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 344599999999999999999987 4799999999864210 00011 11235677777774
Q ss_pred CCCeeeeeccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC
Q 005111 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN 290 (714)
Q Consensus 211 HpnIVkl~~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~ 290 (714)
+.++. +...+.... .+|||||++|..+..+.. ...+..++.||+.+|.+||+.|||||||||.||||+++
T Consensus 172 ~~gv~-vp~p~~~~~---~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 172 EEGFP-VPEPIAQSR---HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp HTTCS-CCCEEEEET---TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred hcCCC-CCeeeeccC---ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 44332 111111111 379999999977755432 22456788999999999999999999999999999887
Q ss_pred C----------cEEEeecCccccc
Q 005111 291 G----------ILKIADFGLASFF 304 (714)
Q Consensus 291 g----------~vKL~DFGla~~~ 304 (714)
| .+.|+||+-+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 7 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1e-11 Score=127.55 Aligned_cols=140 Identities=14% Similarity=0.111 Sum_probs=106.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~L 231 (714)
..|++...++.|+++.||++.. .+..+++|+...... .....+.+|+.+|+.|. +..+.++++++... ...|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC--CceEE
Confidence 3578999999999999999963 478899999865211 11224789999999884 56677788776544 34899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh---------------------------------------
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS--------------------------------------- 272 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~--------------------------------------- 272 (714)
||||++|..+..... +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999987765421 222345788899999999998
Q ss_pred --------------------cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 --------------------HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 --------------------~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4599999999999998766667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=6.5e-11 Score=120.33 Aligned_cols=136 Identities=13% Similarity=0.112 Sum_probs=97.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeccccccCCceE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN--IIKLEGLITSQTSCSL 229 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IVkl~~~~~~~~~~~l 229 (714)
...|.+....+.|..+.||++. ..+|..+++|+.... ....+.+|+.+|+.+.+.+ +.+++.+....+ ..
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~--~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG--RD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--CE
T ss_pred cCCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC--CC
Confidence 3455665444566679999996 456788999997643 1234678999999885444 445777655443 38
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC-----------------------------------
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG----------------------------------- 274 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g----------------------------------- 274 (714)
|+||||++|..+. +. ... ...++.++...|..||+..
T Consensus 91 ~~v~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 91 WLLLGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEEEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 9999999998774 21 122 2356778888888888643
Q ss_pred -----------------------eeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 275 -----------------------VLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 275 -----------------------IiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
++|+|++|.|||++.++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=4e-10 Score=121.38 Aligned_cols=144 Identities=13% Similarity=0.228 Sum_probs=105.3
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEee--cCCCCHHHHHHHHHHHHHHHhCC--CCCeeeeeccccccCC-ceEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVR--FDNQDPESVKFMAREIAILRKLD--HPNIIKLEGLITSQTS-CSLY 230 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~--~~~~~~~~~~~~~rEi~iL~~L~--HpnIVkl~~~~~~~~~-~~l~ 230 (714)
..++.|+.|.++.||++.. .+..+++|+.. .... ......+.+|+.+|+.|. +..+.+++.++..... +..|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4577899999999999864 35678888775 3221 122346788999999996 3456777776654321 3478
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh--------------------------------------
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-------------------------------------- 272 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-------------------------------------- 272 (714)
+||||++|..+..... ..++..+...++.+++..|..||.
T Consensus 118 ~vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999999977643221 247888999999999999999997
Q ss_pred --------------------cCeeeccCCCccEEEcCCCc--EEEeecCccccc
Q 005111 273 --------------------HGVLHRDIKGSNLLLDHNGI--LKIADFGLASFF 304 (714)
Q Consensus 273 --------------------~gIiHrDLKP~NILl~~~g~--vKL~DFGla~~~ 304 (714)
..++|+|++|.|||++.++. +.|+||+.+..-
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999997753 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.9e-10 Score=121.16 Aligned_cols=183 Identities=19% Similarity=0.192 Sum_probs=120.7
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCC--eeeeeccccccC-CceEEEEE
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPN--IIKLEGLITSQT-SCSLYLVF 233 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-Hpn--IVkl~~~~~~~~-~~~l~LV~ 233 (714)
++.|+.|.+..||++. ..+++|+... ......+.+|+.+|+.+. +.. +..++.+..... ....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3458999999999873 4588898642 245667899999998883 322 223333322211 12348999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-----------------------------------------
Q 005111 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS----------------------------------------- 272 (714)
Q Consensus 234 Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~----------------------------------------- 272 (714)
+|++|..+..... ..++..+...++.|+...|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999977653221 246788888899999999888885
Q ss_pred -----------------cCeeeccCCCccEEEcC--CCcEEEeecCcccccCCCCCCCcccccccccc---cCccccc--
Q 005111 273 -----------------HGVLHRDIKGSNLLLDH--NGILKIADFGLASFFDPKDSVPMTSRVVTLWY---RPPELLL-- 328 (714)
Q Consensus 273 -----------------~gIiHrDLKP~NILl~~--~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y---~APE~l~-- 328 (714)
..++|+|++|.|||++. .+.+.|+||+.+..-++.. .......+ ..|+.+.
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHH
Confidence 13799999999999998 4568899999987643321 00111111 2332211
Q ss_pred --CCCC---------CCccccccchhHHHHHHhhCCCCC
Q 005111 329 --GASH---------YGAAVDLWSTGCILGELFSGKPVL 356 (714)
Q Consensus 329 --g~~~---------y~~~sDIWSLG~iLyeLltG~~pF 356 (714)
.... .....+.|++|.++|.+.+|.++|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000 122368999999999999998665
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.4e-06 Score=91.97 Aligned_cols=135 Identities=14% Similarity=0.194 Sum_probs=93.9
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC---CeeeeeccccccCCceEEEEEe
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP---NIIKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp---nIVkl~~~~~~~~~~~l~LV~E 234 (714)
++.++.|....||+. |..+++|+.+ .......+.+|+.+|+.|.+. .+.+++.+... ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEe
Confidence 456888999999998 5668889853 234567789999999999642 23344443322 2234789999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhc-----------------------------------------
Q 005111 235 YMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH----------------------------------------- 273 (714)
Q Consensus 235 y~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~----------------------------------------- 273 (714)
|++|..+..... ..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999977654211 1345666666666666666666642
Q ss_pred -------------------CeeeccCCCccEEEcC---CCc-EEEeecCccccc
Q 005111 274 -------------------GVLHRDIKGSNLLLDH---NGI-LKIADFGLASFF 304 (714)
Q Consensus 274 -------------------gIiHrDLKP~NILl~~---~g~-vKL~DFGla~~~ 304 (714)
.++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 455 489999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.9e-06 Score=88.35 Aligned_cols=133 Identities=17% Similarity=0.144 Sum_probs=88.3
Q ss_pred EEeccCce-EEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEEEEeecc
Q 005111 160 KIGQGTYS-SVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYLVFEYME 237 (714)
Q Consensus 160 ~LG~G~fG-~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~LV~Ey~~ 237 (714)
.+..|..+ .||+......+..+++|+-.. .....+.+|..+|+.|. +--+.+++.++...+ ..|+|||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~--~~~lvme~l~ 103 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD--DAWLLTTAIP 103 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT--EEEEEEECCC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECC--eEEEEEEeeC
Confidence 34445544 799987666778899998653 34556889999999884 222445666555443 3799999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh---------------------------------------------
Q 005111 238 HDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS--------------------------------------------- 272 (714)
Q Consensus 238 g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~--------------------------------------------- 272 (714)
|..+...... .......+..++...|..||.
T Consensus 104 G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 104 GKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp SEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred CccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8655432211 112223344445555555542
Q ss_pred -------------cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 -------------HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 -------------~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1279999999999999877778999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=4.1e-06 Score=91.24 Aligned_cols=78 Identities=19% Similarity=0.261 Sum_probs=48.6
Q ss_pred EEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC--C---HHHHHHHHHHHHHHHhCCC--CCe-eeeeccccccCCce
Q 005111 157 KLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ--D---PESVKFMAREIAILRKLDH--PNI-IKLEGLITSQTSCS 228 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~--~---~~~~~~~~rEi~iL~~L~H--pnI-Vkl~~~~~~~~~~~ 228 (714)
.++.||.|.++.||++.+..+++.|+||....... . ......+.+|+.+|+.+.. +.+ .+++.+ . ...
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d-~~~-- 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D-TEM-- 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E-TTT--
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c-CCc--
Confidence 46789999999999997655678899998653211 0 0123456779999887732 333 345443 2 222
Q ss_pred EEEEEeeccc
Q 005111 229 LYLVFEYMEH 238 (714)
Q Consensus 229 l~LV~Ey~~g 238 (714)
.+|||||+++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 5799999986
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=4.4e-05 Score=81.52 Aligned_cols=87 Identities=7% Similarity=0.058 Sum_probs=53.2
Q ss_pred eEEeEE-eccCceEEEEEEEc--c----CCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCC-C--CCeeeeecccccc
Q 005111 156 EKLDKI-GQGTYSSVYRARDV--I----HDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLD-H--PNIIKLEGLITSQ 224 (714)
Q Consensus 156 ~~~~~L-G~G~fG~Vy~a~d~--~----~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~-H--pnIVkl~~~~~~~ 224 (714)
..++.| +.|....+|+.... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.+....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 456778 88889999998643 0 267889998653210 0000134667888888773 2 2355566554432
Q ss_pred C-CceEEEEEeeccccccc
Q 005111 225 T-SCSLYLVFEYMEHDLVG 242 (714)
Q Consensus 225 ~-~~~l~LV~Ey~~g~ll~ 242 (714)
. ....|+||||++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 1 12368999999986554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.91 E-value=0.00014 Score=76.45 Aligned_cols=31 Identities=29% Similarity=0.408 Sum_probs=28.0
Q ss_pred cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00018 Score=78.98 Aligned_cols=79 Identities=9% Similarity=0.049 Sum_probs=46.7
Q ss_pred hhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccc--cccccCcccccCCC--CCCccccccchhHHH
Q 005111 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV--TLWYRPPELLLGAS--HYGAAVDLWSTGCIL 346 (714)
Q Consensus 271 H~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~g--T~~Y~APE~l~g~~--~y~~~sDIWSLG~iL 346 (714)
+...++|+|++|.|||++.++ +.|+||+.+..-.+... ...... ...|++|+...... .-....++..+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 456799999999999999877 99999999876422110 011111 23456665443111 011234444666677
Q ss_pred HHHhhC
Q 005111 347 GELFSG 352 (714)
Q Consensus 347 yeLltG 352 (714)
|+++++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 776654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00077 Score=71.34 Aligned_cols=76 Identities=18% Similarity=0.197 Sum_probs=55.2
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC---CCCeeeeeccccccCCceEEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD---HPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.-++.|+.|.+..+|+... .+..+++|+.... ....+.+|+..|+.|. ...+.+++.+.... ...|+|
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lv 109 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLL 109 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEE
Confidence 3467799999999999863 5678889987632 3556788999988873 24556666654433 348999
Q ss_pred Eeeccccc
Q 005111 233 FEYMEHDL 240 (714)
Q Consensus 233 ~Ey~~g~l 240 (714)
|||++|..
T Consensus 110 me~l~G~~ 117 (312)
T 3jr1_A 110 LEALNKSK 117 (312)
T ss_dssp EECCCCCC
T ss_pred EEeccCCC
Confidence 99999864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00073 Score=70.46 Aligned_cols=71 Identities=14% Similarity=0.063 Sum_probs=42.6
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCceEEEEEeec
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
++.|+.|....+|++ ..+++|+...... ..-...+|+.+++.+....+ .+++.+.. .. -++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~--~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVDP--AT--GVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TT--CCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEEC--CC--CEEEEeec
Confidence 677999999999998 4588898754211 11112467777776632222 34544332 22 36899999
Q ss_pred -ccccc
Q 005111 237 -EHDLV 241 (714)
Q Consensus 237 -~g~ll 241 (714)
+|..+
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 76443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00038 Score=73.01 Aligned_cols=143 Identities=13% Similarity=0.123 Sum_probs=76.7
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeccccc----cCCce
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN--IIKLEGLITS----QTSCS 228 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IVkl~~~~~~----~~~~~ 228 (714)
..-++.|+.|....||+... ..| .+++|+..... ....+..|+.++..|.... +.+++..... .....
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEEECC---EEEEEEEE-SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred ceEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34567788899999999864 334 68899886421 1223456777777663212 2233221100 01123
Q ss_pred EEEEEeecccccccc---------------cc--CCCCC------CCHHHHHHH---------------HHHHHHHhhHh
Q 005111 229 LYLVFEYMEHDLVGL---------------AS--LPGMK------FTESQVKCY---------------MKQLLSGLEHC 270 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~---------------~~--~~~~~------lse~~i~~i---------------~~QIl~aL~~L 270 (714)
.+++|+|++|..+.. +. ..... .....-... ...+...++.|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 689999999854321 00 00000 111100000 01123334444
Q ss_pred h-------hcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 271 H-------SHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 271 H-------~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
. ..+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3 24699999999999998876668999997753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0011 Score=68.69 Aligned_cols=77 Identities=14% Similarity=0.189 Sum_probs=52.8
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCC---CeeeeeccccccCCceEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP---NIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp---nIVkl~~~~~~~~~~~l~ 230 (714)
...-+..+|.|..+.||+.. ..+|+.|.+|+...... .....+.+|+..|+.|.-. .+.+++.+ .. -+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~---~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DD---RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ET---TE
T ss_pred CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEec---cC---ce
Confidence 34667889999999999997 46789999998654321 1223477899999988421 22333332 22 37
Q ss_pred EEEeecccc
Q 005111 231 LVFEYMEHD 239 (714)
Q Consensus 231 LV~Ey~~g~ 239 (714)
+||||+++.
T Consensus 87 lv~e~l~~~ 95 (288)
T 3f7w_A 87 LAMEWVDER 95 (288)
T ss_dssp EEEECCCCC
T ss_pred EEEEeeccc
Confidence 899999864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0018 Score=71.45 Aligned_cols=74 Identities=18% Similarity=0.209 Sum_probs=49.2
Q ss_pred EEeEEeccCceEEEEEEEcc-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCce
Q 005111 157 KLDKIGQGTYSSVYRARDVI-------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCS 228 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~-------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~ 228 (714)
.++.|+.|....||++.... .+..|++|+.... .. ...+.+|+.+++.|...++ .++++.+. .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~---~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFS---G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET---T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC---C--
Confidence 45678889999999997542 2578999987431 11 1345579999888843333 45665443 1
Q ss_pred EEEEEeeccccc
Q 005111 229 LYLVFEYMEHDL 240 (714)
Q Consensus 229 l~LV~Ey~~g~l 240 (714)
.+||||++|..
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 38999999743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0011 Score=72.11 Aligned_cols=137 Identities=18% Similarity=0.150 Sum_probs=81.8
Q ss_pred EeEEeccCceEEEEEEEcc-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceE
Q 005111 158 LDKIGQGTYSSVYRARDVI-------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~-------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l 229 (714)
++.|..|-...+|++.... +++.|++|+..... .....+.+|..+++.|. +.-..++++++..
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------ 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE------ 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------
Confidence 3467778888999987532 35789999853211 12345668999998884 2223456555432
Q ss_pred EEEEeeccccccccc------------------cCC----CCCC--CHHHHHHHHHHHHHH-------------------
Q 005111 230 YLVFEYMEHDLVGLA------------------SLP----GMKF--TESQVKCYMKQLLSG------------------- 266 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~------------------~~~----~~~l--se~~i~~i~~QIl~a------------------- 266 (714)
.+||||++|..+... ... .... -..++..++.++...
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 289999998554311 000 1111 245666666555321
Q ss_pred hhHhh----h----cCeeeccCCCccEEEcCC----CcEEEeecCcccc
Q 005111 267 LEHCH----S----HGVLHRDIKGSNLLLDHN----GILKIADFGLASF 303 (714)
Q Consensus 267 L~~LH----~----~gIiHrDLKP~NILl~~~----g~vKL~DFGla~~ 303 (714)
+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22222 1 359999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0011 Score=71.23 Aligned_cols=75 Identities=9% Similarity=0.042 Sum_probs=43.3
Q ss_pred EEeEEeccCceEEEEEEEcc--------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC-eeeeeccccccCCc
Q 005111 157 KLDKIGQGTYSSVYRARDVI--------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN-IIKLEGLITSQTSC 227 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~--------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-IVkl~~~~~~~~~~ 227 (714)
.+..|+.|....+|++.... .+..|++|+..... ........|+.+|+.|...+ +.++++.. .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~---~-- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF---N-- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE---T--
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec---C--
Confidence 35678888889999997543 13678899865321 11112357888888774323 33555433 1
Q ss_pred eEEEEEeeccccc
Q 005111 228 SLYLVFEYMEHDL 240 (714)
Q Consensus 228 ~l~LV~Ey~~g~l 240 (714)
-++||||++|..
T Consensus 109 -~~~v~e~i~G~~ 120 (369)
T 3c5i_A 109 -GGRIEEWLYGDP 120 (369)
T ss_dssp -TEEEEECCCSEE
T ss_pred -CcEEEEEecCCc
Confidence 268999999854
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0072 Score=63.28 Aligned_cols=137 Identities=13% Similarity=0.081 Sum_probs=77.6
Q ss_pred eEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeecccccc----CCceEEEE
Q 005111 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN--IIKLEGLITSQ----TSCSLYLV 232 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IVkl~~~~~~~----~~~~l~LV 232 (714)
..|+ |....||++.. .+|+.+++|+.+..... ...+..|+.+++.|.... +++++.. ... ..+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence 4566 88889998752 45667999998643222 334567888887773212 3334332 110 12346889
Q ss_pred Eeecccccccc---------------c---cC--C---CCCCCHHH----------------------HHHHHHHHHHHh
Q 005111 233 FEYMEHDLVGL---------------A---SL--P---GMKFTESQ----------------------VKCYMKQLLSGL 267 (714)
Q Consensus 233 ~Ey~~g~ll~~---------------~---~~--~---~~~lse~~----------------------i~~i~~QIl~aL 267 (714)
|+|++|..+.. + .. . ...++... ....+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 99999854321 0 00 0 00112111 011122222222
Q ss_pred hHh----hhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 268 EHC----HSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 268 ~~L----H~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
..+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 234689999999999999 4 899999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0074 Score=64.19 Aligned_cols=32 Identities=22% Similarity=0.313 Sum_probs=28.3
Q ss_pred cCeeeccCCCccEEEcCCCcEEEeecCccccc
Q 005111 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFF 304 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~ 304 (714)
..++|+|+.+.|||++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0069 Score=67.42 Aligned_cols=77 Identities=17% Similarity=0.152 Sum_probs=48.8
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-eeeeccccccCCceEEEEEe
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-IKLEGLITSQTSCSLYLVFE 234 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-Vkl~~~~~~~~~~~l~LV~E 234 (714)
-.++.|+.|-...+|++.....+..|++|+....... .. ...+|+.+|+.|...++ .++++++. . .+|||
T Consensus 111 ~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~--~i-dR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e 181 (458)
T 2qg7_A 111 LEFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE--II-NREREKKISCILYNKNIAKKIYVFFT---N---GRIEE 181 (458)
T ss_dssp EEEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS--CS-CHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEE
T ss_pred eEEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh--hc-CHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEE
Confidence 3467788899999999976544588999987432111 11 12579999998865444 45666552 2 25999
Q ss_pred ecccccc
Q 005111 235 YMEHDLV 241 (714)
Q Consensus 235 y~~g~ll 241 (714)
|++|..+
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9998443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0026 Score=67.04 Aligned_cols=33 Identities=27% Similarity=0.299 Sum_probs=28.4
Q ss_pred hcCeeeccCCCccEEEcCC----CcEEEeecCccccc
Q 005111 272 SHGVLHRDIKGSNLLLDHN----GILKIADFGLASFF 304 (714)
Q Consensus 272 ~~gIiHrDLKP~NILl~~~----g~vKL~DFGla~~~ 304 (714)
...++|+|+.+.|||++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3579999999999999875 68999999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.39 E-value=0.011 Score=58.97 Aligned_cols=93 Identities=15% Similarity=0.038 Sum_probs=60.3
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHhhHhh-hcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCcccccccccc
Q 005111 243 LASLPGMKFTESQVKCYMKQLLSGLEHCH-SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWY 321 (714)
Q Consensus 243 ~~~~~~~~lse~~i~~i~~QIl~aL~~LH-~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y 321 (714)
.+...+.+|+|++++.++.|.+.+|.-+- ...-..+=+.|..|+|..+|.|.+.+ +.+. .....+
T Consensus 38 IL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~~~~ 103 (229)
T 2yle_A 38 ILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGEPPP 103 (229)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------------
T ss_pred HHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------ccccCC
Confidence 33445679999999999999999987762 11112334567999999999988763 1111 112345
Q ss_pred cCcccccCCCCCCccccccchhHHHHHHhh
Q 005111 322 RPPELLLGASHYGAAVDLWSTGCILGELFS 351 (714)
Q Consensus 322 ~APE~l~g~~~y~~~sDIWSLG~iLyeLlt 351 (714)
.|||.+. ...+.+.=|||||+++|.-+-
T Consensus 104 ~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 104 VAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred CChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 6888663 224678889999999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.031 Score=61.53 Aligned_cols=137 Identities=11% Similarity=0.106 Sum_probs=81.7
Q ss_pred EEeEEeccCceEEEEEEEccC-------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCce
Q 005111 157 KLDKIGQGTYSSVYRARDVIH-------DKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~~-------g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~ 228 (714)
.++.|..|-...+|++..... +..|++++..... +..-...+|..+++.|. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~------ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP------ 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC------
Confidence 456677788889999975421 5789999864321 11112357888888774 222344554321
Q ss_pred EEEEEeeccccccccc----------------------c-----C---CCCCCCHHHHHHHHHHHHH-------------
Q 005111 229 LYLVFEYMEHDLVGLA----------------------S-----L---PGMKFTESQVKCYMKQLLS------------- 265 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~----------------------~-----~---~~~~lse~~i~~i~~QIl~------------- 265 (714)
-++||||++|..+... . . ...+.-..++..+..++-.
T Consensus 145 ~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~ 224 (424)
T 3mes_A 145 EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL 224 (424)
T ss_dssp TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence 2689999998553210 0 0 1111123444444433221
Q ss_pred ------HhhHhh------------------------hcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 266 ------GLEHCH------------------------SHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 266 ------aL~~LH------------------------~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
.+.+|. ...++|+|+.+.||| +.++.+.|+||..|..
T Consensus 225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 122221 135899999999999 7788999999999864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.41 E-value=0.2 Score=54.35 Aligned_cols=29 Identities=31% Similarity=0.537 Sum_probs=25.2
Q ss_pred eeeccCCCccEEE------cCCCcEEEeecCcccc
Q 005111 275 VLHRDIKGSNLLL------DHNGILKIADFGLASF 303 (714)
Q Consensus 275 IiHrDLKP~NILl------~~~g~vKL~DFGla~~ 303 (714)
++|+|+.+.|||+ +.++.+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567899999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 714 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-81 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-78 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-71 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-71 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-70 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-70 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-69 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-69 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-68 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-68 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-68 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-68 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-67 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-64 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-64 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-62 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-62 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-61 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-61 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-61 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-60 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-59 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-57 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-51 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-51 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-51 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-48 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-48 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-43 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-26 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (662), Expect = 3e-81
Identities = 123/311 (39%), Positives = 183/311 (58%), Gaps = 12/311 (3%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL 209
+ +EKL KIGQGT+ V++AR + VALKKV +N+ REI IL+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 210 DHPNIIKLEGLITSQTS------CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
H N++ L + ++ S S+YLVF++ EHDL GL S +KFT S++K M+ L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS---VPMTSRVVTLW 320
L+GL + H + +LHRD+K +N+L+ +G+LK+ADFGLA F + T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 321 YRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380
YRPPELLLG YG +DLW GCI+ E+++ P++ G TE QL I +LCGS + + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 381 RK-SKLRHSTVFKPVQPYRRRIAETFKDFPTS--ALRLMETLMSIDPAHRGTATLALNSE 437
+ V+ +R++ + K + AL L++ L+ +DPA R + ALN +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 438 FFTTQPLACNP 448
FF + P+ +
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (638), Expect = 4e-78
Identities = 120/301 (39%), Positives = 171/301 (56%), Gaps = 7/301 (2%)
Query: 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ---DPESVKFMAREIAILRKLDHP 212
EKLD +G+G +++VY+ARD ++IVA+KK++ ++ + REI +L++L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
NII L ++ LVF++ME DL + + T S +K YM L GLE+ H
Sbjct: 61 NIIGLLD--AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
H +LHRD+K +NLLLD NG+LK+ADFGLA F + T +VVT WYR PELL GA
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392
YG VD+W+ GCIL EL P LPG ++++QL RIF+ G+P+E+ W V
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLP 452
P + F L L++ L +P R TAT AL ++F+ +P LP
Sbjct: 238 KSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
Query: 453 K 453
+
Sbjct: 297 R 297
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 231 bits (589), Expect = 5e-71
Identities = 106/285 (37%), Positives = 156/285 (54%), Gaps = 4/285 (1%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ L+KIG+GTY VY+A++ + + ALKK+R + +D REI+IL++L H NI
Sbjct: 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
+KL +I T L LVFE+++ DL L + K ++ QLL+G+ +CH
Sbjct: 63 VKLYDVI--HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYG 334
VLHRD+K NLL++ G LKIADFGLA F T +VTLWYR P++L+G+ Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 335 AAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV 394
+D+WS GCI E+ +G P+ PG +E +QL RIF++ G+P+ W
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
K S + L+ ++ +DP R TA AL +F
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 5e-71
Identities = 103/327 (31%), Positives = 161/327 (49%), Gaps = 13/327 (3%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
+ L IG+G Y V A D ++ VA+KK+ + + REI IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 212 PNIIKLEGLITSQTSCS---LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
NII + +I + T +YLV M DL L L + + ++ Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL--LKTQHLSNDHICYFLYQILRGLK 123
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP--MTSRVVTLWYRPPEL 326
+ HS VLHRD+K SNLLL+ LKI DFGLA DP +T V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
+L + Y ++D+WS GCIL E+ S +P+ PGK ++QL+ I + GSPS++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 387 HSTVFKPVQPYRRRI--AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444
+ + P++ ++ F + + AL L++ +++ +P R AL +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY- 302
Query: 445 ACNPSNLPKYPPSKEIDAKLRDEESRR 471
+PS+ P + D +L D +
Sbjct: 303 --DPSDEPIAEAPFKFDMELDDLPKEK 327
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 1e-70
Identities = 103/326 (31%), Positives = 153/326 (46%), Gaps = 18/326 (5%)
Query: 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
++ IG G++ VY+A+ ++VA+KKV D +F RE+ I+RKLDH N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 214 IIKLEGLITS----QTSCSLYLVFEYMEHDLVGLA---SLPGMKFTESQVKCYMKQLLSG 266
I++L S + L LV +Y+ + +A S VK YM QL
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
L + HS G+ HRDIK NLLLD + +LK+ DFG A + P S + + +YR PE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPE 192
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385
L+ GA+ Y +++D+WS GC+L EL G+P+ PG + V+QL I K+ G+P+ + R+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445
++ P P A+ L L+ P R T A FF L
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELR 310
Query: 446 CNPSNLPKYPPSKEIDAKLRDEESRR 471
LP + + E S
Sbjct: 311 DPNVKLPNGRDTPALFNFTTQELSSN 336
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 1e-70
Identities = 115/293 (39%), Positives = 164/293 (55%), Gaps = 6/293 (2%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
F+K++KIG+GTY VY+AR+ + ++VALKK+R D + REI++L++L+HPNI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMK-FTESQVKCYMKQLLSGLEHCHSH 273
+KL T LYLVFE++ DL + +K Y+ QLL GL CHSH
Sbjct: 64 VKLLD--VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
VLHRD+K NLL++ G +K+ADFGLA F T VVTLWYR PE+LLG +Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYY 180
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
AVD+WS GCI E+ + + + PG +E++QL RIF+ G+P E W
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT--TQPL 444
+ R+ ++ L+ ++ DP R +A AL FF T+P+
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 3e-69
Identities = 107/326 (32%), Positives = 157/326 (48%), Gaps = 15/326 (4%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+P R ++ L +G G Y SV A D VA+KK+ Q K RE+ +L+
Sbjct: 16 VPER---YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 208 KLDHPNIIKLEGLITSQTSC----SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQL 263
+ H N+I L + T S +YLV M DL + K T+ V+ + Q+
Sbjct: 73 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQI 130
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
L GL++ HS ++HRD+K SNL ++ + LKI DFGLA D MT V T WYR
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 186
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK- 382
PE++L HY VD+WS GCI+ EL +G+ + PG ++QL I +L G+P + +K
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 383 -SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
S+ + + Q + A F A+ L+E ++ +D R TA AL +F
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 442 QPLACNPSNLPKYPPSKEIDAKLRDE 467
+ Y S E L DE
Sbjct: 307 YHDPDDEPVADPYDQSFESRDLLIDE 332
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 4e-69
Identities = 98/325 (30%), Positives = 159/325 (48%), Gaps = 13/325 (4%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ L +G G Y +V A D VA+KK+ Q K RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 213 NIIKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
N+I L + T + YLV +M DL L + K E +++ + Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL--MKHEKLGEDRIQFLVYQMLKGLR 135
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
+ H+ G++HRD+K NL ++ + LKI DFGLA D + MT VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVIL 191
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
Y VD+WS GCI+ E+ +GK + G ++QL I K+ G+P ++ ++ + +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 389 TVFKPVQPY--RRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLAC 446
+ P ++ A + A+ L+E ++ +D R TA AL +F +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 447 NPSNLPKYPPSKEIDAKLRDEESRR 471
+ + KY S + D +E +R
Sbjct: 312 DEPQVQKYDDSFD-DVDRTLDEWKR 335
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 2e-68
Identities = 71/291 (24%), Positives = 127/291 (43%), Gaps = 31/291 (10%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++ + +G+G Y V A + + ++ VA+K V + + + +EI I + L+H N+
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENV 65
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
+K G YL EY + P + E + + QL++G+ + H G
Sbjct: 66 VKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELLLGASHY 333
+ HRDIK NLLLD LKI+DFGLA+ F + + +++ TL Y PELL +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
VD+WS G +L + +G+ ++ Q + +K +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--------------- 228
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444
+K ++ L L+ ++ +P+ R T ++ +PL
Sbjct: 229 -----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY-NKPL 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 226 bits (577), Expect = 2e-68
Identities = 81/377 (21%), Positives = 147/377 (38%), Gaps = 58/377 (15%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++ L+++G G + V+R + ++ K + P + EI+I+ +L HP +
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I L + + L+ E++ +L + K +E++V YM+Q GL+H H H
Sbjct: 89 INLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 274 GVLHRDIKGSNLLLD--HNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
++H DIK N++ + +KI DFGLA+ +P + V +T T + PE++
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR-E 203
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
G D+W+ G + L SG G+ ++E L + + ED +
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF----------- 252
Query: 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNL 451
A ++ L+ +P R T AL + + SNL
Sbjct: 253 --------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG-----DHSNL 293
Query: 452 PKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLPIPAPNRDAELSIMQKRH 511
PS + + + + P PA R A S ++K
Sbjct: 294 TSRIPSSRYNKIRQ-----------------KIKEKYADWPAPQPAIGRIANFSSLRKHR 336
Query: 512 HTNSRSKNEMFISQKEA 528
+ + + +KEA
Sbjct: 337 PQEYQIYDS-YFDRKEA 352
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 2e-68
Identities = 109/287 (37%), Positives = 161/287 (56%), Gaps = 4/287 (1%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+EKL+KIG+GTY +V++A++ +IVALK+VR D+ D REI +L++L H NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
++L ++ + L LVFE+ + DL VK ++ QLL GL CHS
Sbjct: 64 VRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYG 334
VLHRD+K NLL++ NG LK+A+FGLA F ++ VVTLWYRPP++L GA Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 335 AAVDLWSTGCILGELFSGK-PVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
++D+WS GCI EL + P+ PG +QL RIF+L G+P+E+ W P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
+ P + + L++ L+ +P R +A AL +F+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 226 bits (576), Expect = 3e-68
Identities = 76/379 (20%), Positives = 137/379 (36%), Gaps = 57/379 (15%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ ++ +++G G + V+R + A K V ++ + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 83
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
++ L + +++E+M +L + K +E + YM+Q+ GL H H
Sbjct: 84 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 272 SHGVLHRDIKGSNLLL--DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
+ +H D+K N++ + LK+ DFGL + DPK S + T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEG 199
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389
G D+WS G + L SG G+ + E L + + + +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF--------- 249
Query: 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPS 449
+ L+ DP R T AL + T S
Sbjct: 250 ----------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 450 NLPKYPPSKEIDAKLRDEESRRHGVAGGRDQKGDLHRSWRKEYLPIPAPNRDAELSIMQK 509
+P +K D+ + + P+P R + S ++K
Sbjct: 294 QIPSSRYTKIRDS---------------------IKTKYDAWPEPLPPLGRISNYSSLRK 332
Query: 510 RHHTNSRSKNEMFISQKEA 528
H S + F + EA
Sbjct: 333 -HRPQEYSIRDAFWDRSEA 350
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 224 bits (572), Expect = 3e-68
Identities = 82/320 (25%), Positives = 136/320 (42%), Gaps = 39/320 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
F L +IG G++ +VY ARDV + ++VA+KK+ + Q E + + +E+ L+KL HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I+ G + + +LV EY L + E ++ L GL + HSH
Sbjct: 77 TIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH- 332
++HRD+K N+LL G++K+ DFG AS P S V T ++ PE++L
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMDEG 189
Query: 333 -YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
Y VD+WS G EL KP L + L+ I +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------------- 228
Query: 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNL 451
A + +++ + P R T+ + L F + +L
Sbjct: 229 ------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
Query: 452 PKYPPSKEIDAKLRDEESRR 471
+ +K+ +L + + R+
Sbjct: 283 IQR--TKDAVRELDNLQYRK 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 6e-67
Identities = 62/306 (20%), Positives = 115/306 (37%), Gaps = 23/306 (7%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
+ + FEK+ ++G G V++ ++A K + + P + RE+ +L + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECN 62
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
P I+ G + + + E+M+ + + E + ++ GL +
Sbjct: 63 SPYIVGFYGAF--YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 271 HS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG 329
H ++HRD+K SN+L++ G +K+ DFG++ + S V T Y PE L G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQG 177
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDYWRKSKLRHS 388
+HY D+WS G L E+ G+ +P E +L ++ G +E R
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 389 TVFKPVQPYRRRIAETFKD--------------FPTSALRLMETLMSIDPAHRGTATLAL 434
+ D F + + +PA R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 435 NSEFFT 440
F
Sbjct: 297 VHAFIK 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 2e-66
Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 37/306 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + +KIGQG +VY A DV + VA++++ Q + + EI ++R+ +PNI
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNI 79
Query: 215 IKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG 274
+ L++V EY+ + + E Q+ ++ L LE HS+
Sbjct: 80 VNYLDSY--LVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 275 VLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYG 334
V+HRDIK N+LL +G +K+ DFG + P+ S ++ V T ++ PE++ YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTR-KAYG 194
Query: 335 AAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPV 394
VD+WS G + E+ G+P + + L+ I G+P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNP-------------- 239
Query: 395 QPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF-TTQPLACNPSNLPK 453
+ + + +D RG+A L +F +PL S P
Sbjct: 240 -----------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL---SSLTPL 285
Query: 454 YPPSKE 459
+KE
Sbjct: 286 IAAAKE 291
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-65
Identities = 76/297 (25%), Positives = 124/297 (41%), Gaps = 39/297 (13%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
RA +E L IG G+Y + R KI+ K++ + + + + E+ +LR+L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYME----HDLVGLASLPGMKFTESQVKCYMKQLLSG 266
HPNI++ I +T+ +LY+V EY E ++ + E V M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 267 LEHCH-----SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWY 321
L+ CH H VLHRD+K +N+ LD +K+ DFGLA + S + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYY 180
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
PE + Y D+WS GC+L EL + P ++ E +I
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------------- 226
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
+ RRI + ++ ++++ HR + L +
Sbjct: 227 ------------REGKFRRIPY---RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 2e-64
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 36/291 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+E + ++G G + VY+A++ + A K + D + E ++ EI IL DHPNI
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMVEIDILASCDHPNI 71
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+KL + + L+++ E+ + + TESQ++ KQ L L + H +
Sbjct: 72 VKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLG---- 329
++HRD+K N+L +G +K+ADFG+++ S + T ++ PE+++
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCETSK 188
Query: 330 ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389
Y D+WS G L E+ +P + L +I K P+
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQP--------- 238
Query: 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
+ ++ ++ + + R T + L F T
Sbjct: 239 ----------------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 3e-64
Identities = 83/287 (28%), Positives = 119/287 (41%), Gaps = 36/287 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
FE +G+G + +VY AR+ I+ALK + + + RE+ I L HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
I++L G + +YL+ EY V KF E + Y+ +L + L +CHS
Sbjct: 68 ILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
V+HRDIK NLLL G LKIADFG + T+ TL Y PPE++ G +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMIEG-RMH 181
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
VDLWS G + E GKP T E RI ++ + +
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD---------------- 225
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440
A L+ L+ +P+ R L + T
Sbjct: 226 -------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 8e-64
Identities = 107/298 (35%), Positives = 161/298 (54%), Gaps = 13/298 (4%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHD-KIVALKKVRFDNQDPESVKFMAREIAILRK 208
R +E + +IG+G Y V++ARD+ + + VALK+VR + RE+A+LR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 209 L---DHPNIIKLEGLITSQTSCS---LYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMK 261
L +HPN+++L + T + L LVFE+++ D L +P +K M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 262 QLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWY 321
QLL GL+ HSH V+HRD+K N+L+ +G +K+ADFGLA + + +TS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWY 181
Query: 322 RPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
R PE+LL S Y VDLWS GCI E+F KP+ G ++V+QL +I + G P E+ W
Sbjct: 182 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
+ F + I + D L+ ++ +PA R +A AL+ +F
Sbjct: 241 RDVALPRQAFHSKSA--QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 3e-62
Identities = 70/337 (20%), Positives = 125/337 (37%), Gaps = 42/337 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + +G+G + V+R + K K V+ D VK +EI+IL H NI
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNI 63
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
+ L S L ++FE++ D+ + + E ++ Y+ Q+ L+ HSH
Sbjct: 64 LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 274 GVLHRDIKGSNLLLDH--NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
+ H DI+ N++ + +KI +FG A P D+ Y PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH-D 178
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
A D+WS G ++ L SG +T + + I + E+ +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----------- 227
Query: 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNL 451
K+ A+ ++ L+ + R TA+ AL + + + +
Sbjct: 228 --------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
Query: 452 PK------YPPSKEIDAKLRDEESRRHGVAGGRDQKG 482
Y + D + +R R QKG
Sbjct: 274 RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKG 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 208 bits (531), Expect = 4e-62
Identities = 89/300 (29%), Positives = 150/300 (50%), Gaps = 21/300 (7%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DH 211
+ ++ + K+G+G YS V+ A ++ +++ V +K ++ P K + REI IL L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
PNII L ++ S + LVFE++ + L T+ ++ YM ++L L++CH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTD--FKQLYQ-TLTDYDIRFYMYEILKALDYCH 146
Query: 272 SHGVLHRDIKGSNLLLDH-NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
S G++HRD+K N+++DH + L++ D+GLA F+ P RV + +++ PELL+
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDY 204
Query: 331 SHYGAAVDLWSTGCILGELFSGK-PVLPGKTEVEQLHRIFKLCGSPS-EDYWRKSKLRHS 388
Y ++D+WS GC+L + K P G +QL RI K+ G+ DY K +
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 389 TVFKPVQPYRRRI-------AETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441
F + R +E AL ++ L+ D R TA A+ +F T
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-61
Identities = 58/290 (20%), Positives = 115/290 (39%), Gaps = 36/290 (12%)
Query: 147 W-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAI 205
W IP +IG G++ +VY+ + VA+K + P+ ++ E+ +
Sbjct: 3 WEIPD--GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGV 57
Query: 206 LRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLL 264
LRK H NI+ G T+ L +V ++ E L + KF ++ +Q
Sbjct: 58 LRKTRHVNILLFMG---YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRP 323
G+++ H+ ++HRD+K +N+ L + +KI DFGLA+ ++ ++ +
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 324 PELLLG--ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
PE++ + Y D+++ G +L EL +G+ +Q+ +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------- 223
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
+++ + P + RLM + R
Sbjct: 224 ------------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP 261
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 5e-61
Identities = 95/334 (28%), Positives = 158/334 (47%), Gaps = 23/334 (6%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
++ L IG G V A D + D+ VA+KK+ Q+ K RE+ +++ ++H NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 215 IKLEGLITSQTSCS----LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHC 270
I L + T Q + +YLV E M+ L + M+ ++ + Q+L G++H
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 271 HSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGA 330
HS G++HRD+K SN+++ + LKI DFGLA MT VVT +YR PE++LG
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG- 192
Query: 331 SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390
Y VD+WS GCI+GE+ K + PG+ ++Q +++ + G+P ++ +K +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 391 FKPVQPYRR-------------RIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSE 437
+ Y +E K + A L+ ++ IDPA R + AL
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 438 FFTTQPLACNPSNLPKYPPSKEIDAKLRDEESRR 471
+ P K++D + E +
Sbjct: 313 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWK 346
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 5e-61
Identities = 73/296 (24%), Positives = 122/296 (41%), Gaps = 34/296 (11%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRK 208
+R F+ +G+G++S+V AR++ + A+K + + V ++ RE ++ +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
LDHP +KL Q LY Y ++ + F E+ + Y +++S LE
Sbjct: 65 LDHPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPELL 327
+ H G++HRD+K N+LL+ + ++I DFG A P+ + V T Y PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387
+ DLW+ GCI+ +L +G P E +I KL E ++ K
Sbjct: 183 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----- 236
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
A L+E L+ +D R P
Sbjct: 237 ------------------------ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 200 bits (510), Expect = 8e-60
Identities = 74/298 (24%), Positives = 123/298 (41%), Gaps = 42/298 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-------QDPESVKFMAREIAILR 207
+E + +G+G S V R K A+K + + E + +E+ ILR
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 208 KL-DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSG 266
K+ HPNII+L+ +T+ +LVF+ M+ + + +E + + M+ LL
Sbjct: 65 KVSGHPNIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 267 LEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPEL 326
+ H ++HRD+K N+LLD + +K+ DFG + DP + + T Y PE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEI 180
Query: 327 LLGA-----SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
+ + YG VD+WSTG I+ L +G P + ++ L I W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW- 239
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
D+ + L+ + + P R TA AL FF
Sbjct: 240 ------------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 1e-59
Identities = 81/321 (25%), Positives = 131/321 (40%), Gaps = 36/321 (11%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHP 212
+ ++ D +G G +S V A D K+VA+K + + + EIA+L K+ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
NI+ L+ + ++ LYL+ + + +L G +TE + Q+L +++ H
Sbjct: 68 NIVALDDIY--ESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 272 SHGVLHRDIKGSNLLL---DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
G++HRD+K NLL D + + I+DFGL+ DP +++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLA 182
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
Y AVD WS G I L G P + + + +I K YW
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW-------- 233
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNP 448
D SA + LM DP R T AL +
Sbjct: 234 -----------------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 449 SNLPKYPPSKEIDAKLRDEES 469
+ K+ AK + +++
Sbjct: 277 IHQSVSEQIKKNFAKSKWKQA 297
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-58
Identities = 67/313 (21%), Positives = 130/313 (41%), Gaps = 41/313 (13%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRK 208
+ ++ +++G G ++ V + R+ A K ++ ++ S + + RE++IL++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+ HPN+I L + ++T + L+ E + + TE + ++KQ+L+G+
Sbjct: 70 IQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGI----LKIADFGLASFFDPKDSVPMTSRVVTLWYRPP 324
+ HS + H D+K N++L + +KI DFGLA D + + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAP 185
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
E++ G D+WS G I L SG G T+ E L + + ++Y+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF---- 240
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT---T 441
+ A + L+ DP R T +L + T
Sbjct: 241 ---------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
Query: 442 QPLACNPSNLPKY 454
Q + + P++
Sbjct: 280 QQALSSAWSHPQF 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 8e-57
Identities = 58/291 (19%), Positives = 109/291 (37%), Gaps = 37/291 (12%)
Query: 155 FEKLD-KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN 213
F K D +IG+G++ +VY+ D VA +++ + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 214 IIKLEGLI--TSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
I++ T + + LV E M + ++ + +Q+L GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 272 SHG--VLHRDIKGSNLLL-DHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
+ ++HRD+K N+ + G +KI D GLA+ + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE 186
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
Y +VD+++ G + E+ + + Q++R P+
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--------- 235
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439
K ++E + + R + LN FF
Sbjct: 236 -----------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 188 bits (479), Expect = 3e-55
Identities = 59/292 (20%), Positives = 115/292 (39%), Gaps = 31/292 (10%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLD 210
++ +E + +G G S V+ ARD+ + VA+K +R D +DP RE L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 211 HPNIIKLEGLITSQTS--CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
HP I+ + ++T Y+V EY++ + T + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS--VPMTSRVVTLWYRPPEL 326
H +G++HRD+K +N+++ +K+ DFG+A + + + T Y PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 327 LLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386
G A D++S GC+L E+ +G+P G + V ++ + P
Sbjct: 186 ARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH------ 238
Query: 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEF 438
+ ++ ++ +P +R + ++
Sbjct: 239 -------------------EGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 9e-54
Identities = 63/298 (21%), Positives = 127/298 (42%), Gaps = 43/298 (14%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+PR T + ++++G G + V+ VA+K ++ + P++ E +++
Sbjct: 10 VPR--ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFL---AEANLMK 63
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVG--LASLPGMKFTESQVKCYMKQLLS 265
+L H +++L ++T + +Y++ EYME+ + L + G+K T +++ Q+
Sbjct: 64 QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
G+ +HRD++ +N+L+ KIADFGLA + + + + PE
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 326 LLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
+ + D+WS G +L E+ + G+ PG T E + + +
Sbjct: 181 AINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------------- 225
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT--LALNSEFFT 440
++ V+P + P +LM P R T ++ +FFT
Sbjct: 226 -----GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 185 bits (471), Expect = 3e-53
Identities = 85/385 (22%), Positives = 144/385 (37%), Gaps = 55/385 (14%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILRK 208
N F IG+G + VY R K+ A+K + Q ++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 209 LDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
D P I+ + T L + + M + F+E+ ++ Y +++ GLE
Sbjct: 64 GDCPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H H+ V++RD+K +N+LLD +G ++I+D GLA F K + V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQ 178
Query: 329 GASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388
Y ++ D +S GC+L +L G ++ H I ++ + + +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP-------- 229
Query: 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR-----GTATLALNSEFFTT-- 441
F L+E L+ D R A S FF +
Sbjct: 230 -----------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 442 -QPLACNPSNLPKYPPSKEIDAKLR------DEESRRHGVAGGRDQK------GDLHRSW 488
Q + P PP E++A DEE + DQ+ + W
Sbjct: 273 WQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERW 332
Query: 489 RKEYLPIPAPNRDAELSIMQKRHHT 513
++E +AE ++ R T
Sbjct: 333 QQEVAETVFDTINAETDRLEARKKT 357
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 71/318 (22%), Positives = 124/318 (38%), Gaps = 51/318 (16%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
IPR + K+GQG + V+ VA+K ++ PE+ +E +++
Sbjct: 14 IPR--ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFL---QEAQVMK 67
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL--PGMKFTESQVKCYMKQLLS 265
KL H +++L +++ + +Y+V EYM + G Q+ Q+ S
Sbjct: 68 KLRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 266 GLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
G+ + +HRD++ +N+L+ N + K+ADFGLA + + + + PE
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 326 LLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384
L + D+WS G +L EL + G+ PG E L ++ + P
Sbjct: 185 AALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP------ 237
Query: 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT--LALNSEFFTTQ 442
+ P S LM +P R T A ++FT
Sbjct: 238 ----------------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT-- 273
Query: 443 PLACNPSNLPKYPPSKEI 460
S P+Y P + +
Sbjct: 274 ------STEPQYQPGENL 285
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-52
Identities = 72/288 (25%), Positives = 116/288 (40%), Gaps = 36/288 (12%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAIL-RKLDHP 212
F +G+G++ V+ A ++ A+K ++ D + V+ E +L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 213 NIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS 272
+ + QT +L+ V EY+ + KF S+ Y +++ GL+ HS
Sbjct: 64 FLTHMFCTF--QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASH 332
G+++RD+K N+LLD +G +KIADFG+ D+ + T Y PE+LLG
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLG-QK 179
Query: 333 YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392
Y +VD WS G +L E+ G+ G+ E E H I
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--------------------DN 219
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA-LNSEFF 439
P P + A L+ L +P R F
Sbjct: 220 PFYP---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-51
Identities = 66/284 (23%), Positives = 103/284 (36%), Gaps = 37/284 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDN-QDPESVKFMAREIAILRKLD 210
L+K+G G++ V R VA+K ++ D PE++ RE+ + LD
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
H N+I+L G++ + + +V E L+ F + Y Q+ G+ +
Sbjct: 70 HRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP-KDSVPMTSRVVTLWYRPPELLL 328
S +HRD+ NLLL ++KI DFGL D M + L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 329 GASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387
+ A D W G L E+F+ G+ G + LH+I K
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----------------- 229
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
+ R E D P +M + P R T
Sbjct: 230 -------EGERLPRPE---DCPQDIYNVMVQCWAHKPEDRPTFV 263
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-51
Identities = 65/327 (19%), Positives = 122/327 (37%), Gaps = 41/327 (12%)
Query: 155 FEKLDK-IGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHP 212
++ + +G G V + + + ALK ++ RE+ + + P
Sbjct: 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCP 65
Query: 213 NIIKLEGLITSQTSC--SLYLVFEYMEH-DLVG-LASLPGMKFTESQVKCYMKQLLSGLE 268
+I+++ + + + L +V E ++ +L + FTE + MK + ++
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 269 HCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPE 325
+ HS + HRD+K NLL N ILK+ DFG A +S +T+ T +Y PE
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPE 183
Query: 326 LLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385
+L Y + D+WS G I+ L G P + +
Sbjct: 184 VLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--------- 233
Query: 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT-TQPL 444
++ P ++E K L+ L+ +P R T T +N + + +
Sbjct: 234 -----YEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281
Query: 445 ACNPSNLPKYPPSKEIDAKLRDEESRR 471
P + + + + EE
Sbjct: 282 PQTPLHTSRVLKEDKERWEDVKEEMTS 308
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 178 bits (453), Expect = 4e-51
Identities = 61/291 (20%), Positives = 115/291 (39%), Gaps = 42/291 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPN 213
F+ L +G G++ V+ R + + A+K ++ + + V+ E +L + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 214 IIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
II++ G Q + ++++ +Y+E + +F K Y ++ LE+ HS
Sbjct: 66 IIRMWGTF--QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
+++RD+K N+LLD NG +KI DFG A + + T Y PE++ Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST-KPY 178
Query: 334 GAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
++D WS G ++ E+ +G ++ +I +
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------------------AEL 218
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR-----GTATLALNSEFF 439
P F L+ L++ D + R N +F
Sbjct: 219 RFP---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 6e-51
Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 48/308 (15%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVR----FDNQDPESVKFMAREIAILR 207
+ ++ +G G + SVY V + VA+K V D + + + E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 208 KLD--HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLL 264
K+ +I+L S L+ E E + E + + Q+L
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHN-GILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
+ HCH+ GVLHRDIK N+L+D N G LK+ DFG + T T Y P
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 177
Query: 324 PELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
PE + ++G + +WS G +L ++ G E+ + F+
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------------- 224
Query: 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
+ + L+ +++ P+ R T N +
Sbjct: 225 ----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
Query: 444 LACNPSNL 451
L + +
Sbjct: 263 LPQETAEI 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 74/293 (25%), Positives = 114/293 (38%), Gaps = 39/293 (13%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDH 211
N F+ L +G+GT+ V R+ + A+K +R + + V E +L+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
P + L+ QT L V EY + FTE + + Y +++S LE+ H
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGAS 331
S V++RDIK NL+LD +G +KI DFGL + M + T Y PE+L +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLED-N 180
Query: 332 HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391
YG AVD W G ++ E+ G+ + I
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------E 220
Query: 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR-----GTATLALNSEFF 439
+ P + A L+ L+ DP R A + FF
Sbjct: 221 EIRFP---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-50
Identities = 55/290 (18%), Positives = 111/290 (38%), Gaps = 46/290 (15%)
Query: 146 GW-IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIA 204
GW + + L IG+G + V VA+K ++ + + + E +
Sbjct: 1 GWALNM--KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIK----NDATAQAFLAEAS 52
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVG--LASLPGMKFTESQVKCYMKQ 262
++ +L H N+++L G+I + LY+V EYM + L S + +
Sbjct: 53 VMTQLRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 263 LLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYR 322
+ +E+ + +HRD+ N+L+ + + K++DFGL + + + +
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWT 167
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
PE L + D+WS G +L E++S G+ P + + R+
Sbjct: 168 APEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV------------- 213
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
+ Y+ + P + +M+ +D A R +
Sbjct: 214 ------------EKGYKMDAPD---GCPPAVYEVMKNCWHLDAAMRPSFL 248
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 2e-49
Identities = 54/291 (18%), Positives = 95/291 (32%), Gaps = 36/291 (12%)
Query: 150 RRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKL 209
R N + KIG G++ +Y D+ + VA+K + P+ + E I + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
I ++ +V E + L L + KF+ V Q++S +E+
Sbjct: 60 QGGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 270 CHSHGVLHRDIKGSNLL---LDHNGILKIADFGLASFFDPKDS------VPMTSRVVTLW 320
HS +HRD+K N L ++ I DFGLA + + + T
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 321 YRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380
Y LG DL S G +L G G + + ++
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE------- 230
Query: 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
+ I K +P+ + S+ + +
Sbjct: 231 --------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-49
Identities = 57/301 (18%), Positives = 113/301 (37%), Gaps = 41/301 (13%)
Query: 147 WIPRRANTFEKLDKIGQGTYSSVYRARDVIHD--KIVALKKVRFDNQDPESVKFMAREIA 204
++ R+ T E ++G G + +V + + K VA+K ++ + DP + E
Sbjct: 2 YLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLL 264
++++LD+P I+++ G+ ++ S LV E E + + + + Q+
Sbjct: 61 VMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 265 SGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV--TLWYR 322
G+++ +HRD+ N+LL KI+DFGL+ ++ + +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 323 PPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381
PE + + + D+WS G ++ E FS G+ G E +
Sbjct: 178 APECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML------------- 223
Query: 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT---LALNSEF 438
+ R P LM + D +R L L + +
Sbjct: 224 ------------EKGERMGCPA---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
Query: 439 F 439
+
Sbjct: 269 Y 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 64/283 (22%), Positives = 109/283 (38%), Gaps = 37/283 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ +IG G + V+ ++ VA+K +R E E ++ KL HP +
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKL 62
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
++L G+ Q + LVFE+MEH L F + + G+ +
Sbjct: 63 VQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
V+HRD+ N L+ N ++K++DFG+ F T + + PE+ S Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 334 GAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392
+ D+WS G ++ E+FS GK ++ E + I ST F+
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STGFR 220
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
+P + T ++M P R + L
Sbjct: 221 LYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-49
Identities = 55/283 (19%), Positives = 110/283 (38%), Gaps = 37/283 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
L ++G G + V + VA+K ++ + + E ++ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKL 61
Query: 215 IKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSH 273
++L G+ T Q ++++ EYM + L+ +F Q+ K + +E+ S
Sbjct: 62 VQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 274 GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHY 333
LHRD+ N L++ G++K++DFGL+ + + + + PPE+L+ S +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 334 GAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392
+ D+W+ G ++ E++S GK T E I + +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-------------------GLR 219
Query: 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435
+P +M + R T + L+
Sbjct: 220 LYRP---------HLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 169 bits (429), Expect = 3e-48
Identities = 47/287 (16%), Positives = 95/287 (33%), Gaps = 38/287 (13%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
++ +IG+G++ ++ ++++++ VA+K + P+ + E + L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 59
Query: 212 PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH 271
I Q LV + + L L L G KF+ V KQ+L+ ++ H
Sbjct: 60 CTGIPNVYYF-GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 272 SHGVLHRDIKGSNLLLD-----HNGILKIADFGLASFFDPKDS------VPMTSRVVTLW 320
+++RDIK N L+ + ++ + DFG+ F+ + + T
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 321 YRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYW 380
Y LG DL + G + G G + ++
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE------- 230
Query: 381 RKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR 427
+ + E FP + M ++
Sbjct: 231 --------------KKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-48
Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 39/297 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDN--QDPESVKFMAREIAILRKL 209
FE L +G G Y V+ R + K+ A+K ++ Q ++ + E +L +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 210 DH-PNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
P ++ L QT L+L+ +Y+ + +FTE +V+ Y+ +++ LE
Sbjct: 86 RQSPFLVTLHYAF--QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLL 328
H H G+++RDIK N+LLD NG + + DFGL+ F ++ T+ Y P+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 329 GA-SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387
G S + AVD WS G ++ EL +G E I + Y
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP------- 256
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHR-----GTATLALNSEFF 439
++ A L++ L+ DP R A FF
Sbjct: 257 ------------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 1e-47
Identities = 70/333 (21%), Positives = 128/333 (38%), Gaps = 51/333 (15%)
Query: 120 PKGVEGEQVAAGWPTWLATVAGEAIKGWIPRRANT-----FEKLDKIGQGTYSSVYRARD 174
KG E E V +LA + +K W NT F+++ +G G++ V +
Sbjct: 7 KKGSEQESVK----EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 175 VIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVF 233
A+K + + ++ E IL+ ++ P ++KLE + + + +LY+V
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF--SFKDNSNLYMVM 120
Query: 234 EYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGIL 293
EY+ + +F+E + Y Q++ E+ HS +++RD+K NLL+D G +
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI 180
Query: 294 KIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK 353
++ DFG A + T PE++L Y AVD W+ G ++ E+ +G
Sbjct: 181 QVTDFGFAKRVKG----RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGY 235
Query: 354 PVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSAL 413
P ++ +I F +
Sbjct: 236 PPFFADQPIQIYEKIVSGKVRFPS-----------------------------HFSSDLK 266
Query: 414 RLMETLMSIDPAHR-----GTATLALNSEFFTT 441
L+ L+ +D R N ++F T
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 3e-47
Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 33/284 (11%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILR 207
+ R K+G G Y VY + VA+K ++ D + E +E A+++
Sbjct: 14 MER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMK 68
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
++ HPN+++L G+ T + + F + L L + + + Q+ S +
Sbjct: 69 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELL 327
E+ +HRD+ N L+ N ++K+ADFGL+ + + PE L
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387
+ + D+W+ G +L E+ + ++ Q++ + +
Sbjct: 189 AY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------------- 230
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
+ YR E P LM +P+ R +
Sbjct: 231 -------KDYRMERPE---GCPEKVYELMRACWQWNPSDRPSFA 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 4e-47
Identities = 67/308 (21%), Positives = 127/308 (41%), Gaps = 45/308 (14%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKL 209
+ + IG G + V + K VA+K ++ + + F+ E +I+ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQF 84
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
DHPN+I L S + ++ E+ME+ L +FT Q+ ++ + +G++
Sbjct: 85 DHPNVIHL--EGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV----TLWYRPP 324
+ +HRD+ N+L++ N + K++DFGL+ F + S P + + + + P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202
Query: 325 ELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383
E + + +A D+WS G ++ E+ S G+ T + ++ I
Sbjct: 203 EAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI--------------- 246
Query: 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443
Q YR D P++ +LM D HR +N T
Sbjct: 247 ----------EQDYRLPPPM---DCPSALHQLMLDCWQKDRNHRPKFGQIVN----TLDK 289
Query: 444 LACNPSNL 451
+ NP++L
Sbjct: 290 MIRNPNSL 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-46
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 40/289 (13%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIA 204
I R E IG+G + V++ + + VA+K + D KF+ +E
Sbjct: 4 IQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEAL 60
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQL 263
+R+ DHP+I+KL G+IT ++++ E +L + + + Y QL
Sbjct: 61 TMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVVTLWYRP 323
+ L + S +HRDI N+L+ N +K+ DFGL+ + + + + + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
Query: 324 PELLLGASHYGAAVDLWSTGCILGELF-SGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382
PE + + +A D+W G + E+ G G + + RI
Sbjct: 178 PESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------------ 224
Query: 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
+ P + LM + DP+ R T
Sbjct: 225 ----------------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-46
Identities = 74/297 (24%), Positives = 109/297 (36%), Gaps = 31/297 (10%)
Query: 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH 211
A T + IG+G + V+R + + VA+K + E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIF---SSREERSWFREAEIYQTVMLRH 56
Query: 212 PNIIKLEGLITS--QTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEH 269
NI+ T L+LV +Y EH + L T + SGL H
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYTVTVEGMIKLALSTASGLAH 115
Query: 270 CHSH--------GVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD---SVPMTSRVVT 318
H + HRD+K N+L+ NG IAD GLA D + RV T
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 319 LWYRPPELLLGASH-----YGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG 373
Y PE+L + + D+++ G + E+ + G E QL +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS-IGGIHEDYQLPYYDLVPS 234
Query: 374 SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
PS + RK +P P R + E + ++M + A R TA
Sbjct: 235 DPSVEEMRKVVCEQK--LRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTA 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 4e-46
Identities = 59/290 (20%), Positives = 107/290 (36%), Gaps = 42/290 (14%)
Query: 160 KIGQGTYSSVYRARDVIHDK--IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKL 217
++G G + SV + + K VA+K ++ + ++ + M RE I+ +LD+P I++L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRL 74
Query: 218 EGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVL 276
G+ + +L LV E L + S V + Q+ G+++ +
Sbjct: 75 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 277 HRDIKGSNLLLDHNGILKIADFGLASFFDPKDS--VPMTSRVVTLWYRPPELLLGASHYG 334
HRD+ N+LL + KI+DFGL+ DS ++ L + PE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190
Query: 335 AAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393
+ D+WS G + E S G+ E + I
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------------------- 225
Query: 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT---LALNSEFFT 440
Q R + P LM R + + +++
Sbjct: 226 EQGKRMECPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-46
Identities = 63/315 (20%), Positives = 105/315 (33%), Gaps = 64/315 (20%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDKI-----VALKKVRFDNQDPESVKFMARE 202
PR E +G G + V A K VA+K ++ E M E
Sbjct: 34 FPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SE 90
Query: 203 IAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH----------------------- 238
+ ++ +L H NI+ L G T +YL+FEY +
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 239 DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298
T + C+ Q+ G+E +HRD+ N+L+ H ++KI DF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 299 GLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVL 356
GLA + V + + + + PE L Y D+WS G +L E+FS G
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY 267
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
PG +++ + ++ +M
Sbjct: 268 PGIPVDANFYKLIQ------------------------NGFKMDQPF---YATEEIYIIM 300
Query: 417 ETLMSIDPAHRGTAT 431
++ + D R +
Sbjct: 301 QSCWAFDSRKRPSFP 315
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 2e-45
Identities = 69/315 (21%), Positives = 116/315 (36%), Gaps = 65/315 (20%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHD-----KIVALKKVRFDNQDPESVKFMARE 202
PR N E + IG+G + V++AR +VA+K ++ + F RE
Sbjct: 10 YPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-RE 66
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH------------------------ 238
A++ + D+PNI+KL G + L+FEYM +
Sbjct: 67 AALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 239 DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298
++S + ++ C +Q+ +G+ + +HRD+ N L+ N ++KIADF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184
Query: 299 GLASFFDPKDSVPMTSRVV-TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVL 356
GL+ D + + PPE + + Y D+W+ G +L E+FS G
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 357 PGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLM 416
G E ++ + E + P LM
Sbjct: 244 YGMAHEEVIYYV-------------------------RDGNILACPE---NCPLELYNLM 275
Query: 417 ETLMSIDPAHRGTAT 431
S PA R +
Sbjct: 276 RLCWSKLPADRPSFC 290
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 8e-45
Identities = 51/286 (17%), Positives = 96/286 (33%), Gaps = 36/286 (12%)
Query: 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALK---KVRFDNQDPESVKFMAREIAILR 207
+ F+K+ +G G + +VY+ + + V + K + P++ K + E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 208 KLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGL 267
+D+P++ +L L TS + L+ + + Q+ G+
Sbjct: 67 SVDNPHVCRL--LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 124
Query: 268 EHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSRVV-TLWYRPPEL 326
+ ++HRD+ N+L+ +KI DFGLA ++ + + E
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 327 LLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385
+L Y D+WS G + EL + G G E + K
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------------- 228
Query: 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
+ QP +M ID R
Sbjct: 229 ----GERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFR 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-43
Identities = 62/292 (21%), Positives = 107/292 (36%), Gaps = 39/292 (13%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIA 204
I + + IG+G + VY + +D A+K + E +F+ E
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGI 80
Query: 205 ILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQL 263
I++ HPN++ L G I ++ S +V YM+H DL T + + Q+
Sbjct: 81 IMKDFSHPNVLSLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 264 LSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV---PMTSRVVTLW 320
G++ S +HRD+ N +LD +K+ADFGLA K+ T + +
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 321 YRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDY 379
+ E L + D+WS G +L EL + G P P + + +
Sbjct: 200 WMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------- 249
Query: 380 WRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
+ +QP + P +M R + +
Sbjct: 250 ----------GRRLLQP---------EYCPDPLYEVMLKCWHPKAEMRPSFS 282
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (397), Expect = 5e-43
Identities = 76/341 (22%), Positives = 140/341 (41%), Gaps = 49/341 (14%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI 214
+ + K+G G +S+V+ A+D++++ VA+K VR D E+ + EI +L++++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 215 IKLEGL-----------ITSQTSCSLYLVFEYMEHDLVGLASL---PGMKFTESQVKCYM 260
K + + + +++V + LA + VK
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 261 KQLLSGLEHC-HSHGVLHRDIKGSNLLLDHNGI------LKIADFGLASFFDPKDSVPMT 313
KQLL GL++ G++H DIK N+L++ +KIAD G A ++D + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT------EVEQLHR 367
+R YR PE+LLG + +G D+WST C++ EL +G + + + + +
Sbjct: 192 TR----EYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 368 IFKLCGSPSEDYWRKSKLR-------------HSTVFKPVQPYRRRIAETFKDFPTSALR 414
I +L G R K F P++ + KD
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 415 LMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPKYP 455
+ ++ +DP R A +N + L +P
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRVPDRE 346
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-41
Identities = 67/310 (21%), Positives = 102/310 (32%), Gaps = 59/310 (19%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK-----IVALKKVRFDNQDPESVKFMARE 202
PR N +G G + V A K VA+K ++ E M E
Sbjct: 20 FPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SE 76
Query: 203 IAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH------------------DLVGL 243
+ +L L +H NI+ L G T ++ EY + +
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 244 ASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303
+ + + Q+ G+ S +HRD+ N+LL H I KI DFGLA
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 304 FDPKDSVPMTSRVV-TLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTE 361
+ + + + PE + Y D+WS G L ELFS G PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 362 VEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMS 421
+ +++ K + +R E P +M+T
Sbjct: 254 DSKFYKMIK------------------------EGFRMLSPE---HAPAEMYDIMKTCWD 286
Query: 422 IDPAHRGTAT 431
DP R T
Sbjct: 287 ADPLKRPTFK 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-40
Identities = 55/284 (19%), Positives = 116/284 (40%), Gaps = 38/284 (13%)
Query: 155 FEKLDKIGQGTYSSVYRARDVIHD----KIVALKKVRFDNQDPESVKFMAREIAILRKLD 210
+ IG G + VY+ VA+K ++ + + V F+ E I+ +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFS 67
Query: 211 HPNIIKLEGLITSQTSCSLYLVFEYMEHDLVG-LASLPGMKFTESQVKCYMKQLLSGLEH 269
H NII+LEG+I+ + ++ EYME+ + +F+ Q+ ++ + +G+++
Sbjct: 68 HHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 270 CHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFF--DPKDSVPMTSRVVTLWYRPPELL 327
+ +HRD+ N+L++ N + K++DFGL+ DP+ + + + + + PE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 328 LGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387
+ +A D+WS G ++ E+ + + ++ +
Sbjct: 186 SY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----------------- 227
Query: 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT 431
T D P++ +LM + A R
Sbjct: 228 ----------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFA 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 6e-40
Identities = 68/324 (20%), Positives = 116/324 (35%), Gaps = 56/324 (17%)
Query: 153 NTFEKLDKIGQGTYSSVYRARDVIHDKI--VALKKVRFDNQDPESVKFMAREIAILRKL- 209
N + D IG+G + V +AR A+K+++ + + + A E+ +L KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 68
Query: 210 DHPNIIKLEGLITSQTSCSLYLVFEYMEH----------------DLVGLASLPGMKFTE 253
HPNII L G + LYL EY H +A+ +
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 254 SQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMT 313
Q+ + + G+++ +HRD+ N+L+ N + KIADFGL+ + T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 314 SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLC 372
+ + + E L S Y D+WS G +L E+ S G G T E ++ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 373 GSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT- 431
++ +P + LM P R +
Sbjct: 242 -----------------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 432 -LALNSEFFTTQPLACNPSNLPKY 454
L + + N + K+
Sbjct: 276 ILVSLNRMLEERKTYVNTTLYEKF 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 64/311 (20%), Positives = 104/311 (33%), Gaps = 54/311 (17%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHD-----KIVALKKVRFDNQDPESVKFMARE 202
PR + + +G+G + V A D + VA+K ++ E M+
Sbjct: 10 FPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSEL 67
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYMEHDL----------------VGLASL 246
++ H N++ L G T + L ++ E+ + V L
Sbjct: 68 KILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 247 PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306
T + CY Q+ G+E S +HRD+ N+LL ++KI DFGLA
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 307 KDSVPMTSRVV-TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQ 364
L + PE + Y D+WS G +L E+FS PG E+
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
Query: 365 LHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDP 424
R K + R R + + M +P
Sbjct: 246 FCRRLK------------------------EGTRMRAPD---YTTPEMYQTMLDCWHGEP 278
Query: 425 AHRGTATLALN 435
+ R T + +
Sbjct: 279 SQRPTFSELVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 2e-39
Identities = 63/309 (20%), Positives = 112/309 (36%), Gaps = 58/309 (18%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARDVIHDK-------IVALKKVRFDNQDPESVKFMA 200
+PR + +G+G + V A + DK VA+K ++ D + + +
Sbjct: 10 LPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI- 66
Query: 201 REIAILRKL-DHPNIIKLEGLITSQTSCSLYLVFEYMEH----------------DLVGL 243
E+ +++ + H NII L G LY++ EY
Sbjct: 67 SEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 244 ASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303
+ P + + + Q+ G+E+ S +HRD+ N+L+ + ++KIADFGLA
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 304 FDPKDSVPMT-SRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV 362
D T + + + + PE L Y D+WS G +L E+F+ V
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 363 EQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSI 422
E+L ++ K + +R + +M
Sbjct: 244 EELFKLLK------------------------EGHRMDKPS---NCTNELYMMMRDCWHA 276
Query: 423 DPAHRGTAT 431
P+ R T
Sbjct: 277 VPSQRPTFK 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 46/306 (15%), Positives = 110/306 (35%), Gaps = 51/306 (16%)
Query: 148 IPRRANTFEKLDKIGQGTYSSVYRARD-----VIHDKIVALKKVRFDNQDPESVKFMARE 202
+ R ++GQG++ VY + VA+K V E ++F+ E
Sbjct: 17 VAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NE 73
Query: 203 IAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYME----------HDLVGLASLPGMKFT 252
+++++ + ++++L G+++ ++ E M + +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 253 ESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312
S++ ++ G+ + +++ +HRD+ N ++ + +KI DFG+ D
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 313 TSRVV-TLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFK 370
+ + + + PE L + D+WS G +L E+ + + G + + L + +
Sbjct: 192 GGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 371 LCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTA 430
+ + + P LM +P R +
Sbjct: 251 ----------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282
Query: 431 TLALNS 436
++S
Sbjct: 283 LEIISS 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (256), Expect = 7e-26
Identities = 27/198 (13%), Positives = 62/198 (31%), Gaps = 30/198 (15%)
Query: 159 DKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFM--------AREIAILRKLD 210
+G+G S+V+ +K + + + VK + + +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 211 HPNIIKLEGLITSQT--SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLE 268
+ KL+GL + ++ E ++ + + +L +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVA 117
Query: 269 HCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPMTSR---VVTLWYRPPE 325
+ G++H D+ N+L+ GI I DF + + + R + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173
Query: 326 LLLGASHYGAAVDLWSTG 343
Y D+ S
Sbjct: 174 -----RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.85 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.96 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-58 Score=485.68 Aligned_cols=293 Identities=41% Similarity=0.708 Sum_probs=245.8
Q ss_pred eEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD---PESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
|.+++||+|+||+||+|++..+|+.||||+++..... ....+.+.+|+.+|++++|||||++++++..... +|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~--~~iv 78 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN--ISLV 78 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC--CEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc--eeeh
Confidence 4688999999999999999999999999999765322 2224568899999999999999999999987655 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||||.++++..+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|........ ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-cc
Confidence 99999998888887778899999999999999999999999999999999999999999999999999987654432 33
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc-cCccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR-HSTVF 391 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~-~~~~~ 391 (714)
...+||++|+|||++.+...|+.++|||||||++|||++|.+||.+.++.+++.+|++.+|.+..+.|...... ....+
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 45689999999999987777899999999999999999999999999999999999999999998877543221 11111
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCCCCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLPK 453 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~p~ 453 (714)
.... ...+...++.+++++.+||.+||++||++||||+|+|+||||++.|.|+.++.+|+
T Consensus 238 ~~~~--~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 238 KSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp CCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred ccCC--CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 1111 11233456678999999999999999999999999999999999988877766664
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=471.83 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=219.9
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|++++.||+|+||+||+|+++.+|+.||||++..... .+..+.+.+|+.+|++++|||||++++++.+... +|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~--~~ 79 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI--QY 79 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTE--EE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce--eE
Confidence 35789999999999999999999999999999999976532 2344668899999999999999999999887654 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS- 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~- 309 (714)
||||||+++.|..++.....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999988887777778899999999999999999999999999999999999999999999999999987643322
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+||+.|+|||++.+...++.++||||||||||||++|++||.+.+.......+.......
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------------- 225 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------------- 225 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 234556899999999999887756789999999999999999999998766544333332211100
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
...+..+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 226 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 1123457899999999999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=467.17 Aligned_cols=255 Identities=33% Similarity=0.463 Sum_probs=223.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||+||+|+++.+|+.||||++..... +....+.+.+|+.+|+.++|||||++++++.+... +|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR--VY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE--EE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE--EE
Confidence 4689999999999999999999999999999999875321 12345678899999999999999999999886554 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||||+++.+..++.....+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999999888777766678999999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+||+.|+|||++.+.. |+.++|||||||+||+|++|++||.+.+..+.+..|.+.-..
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------- 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------- 222 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----------------
T ss_pred cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 234568999999999998866 899999999999999999999999999988888777542110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
....+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 223 -------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 -------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 11357899999999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=465.06 Aligned_cols=289 Identities=39% Similarity=0.692 Sum_probs=240.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|+++++||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|++++|||||++++++.+... +|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~--~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK--LYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE--EEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc--eeEE
Confidence 68999999999999999999999999999999997665444556788899999999999999999999987554 9999
Q ss_pred Eeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||.++++.... .....+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~ 158 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT 158 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BC
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-cc
Confidence 9999988766553 345679999999999999999999999999999999999999999999999999998775433 23
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+++.++++..|.+.+..|...........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 44568999999999988877778999999999999999999999999999999999999999998887765322111111
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPL 444 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~ 444 (714)
.............+..++.++.+||.+||.+||.+|||+.|+|+||||+..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 11111112234455678999999999999999999999999999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=464.59 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=214.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
+.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||++++++.+.....+|
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 45789999999999999999999999999999999988777777788899999999999999999999988765555699
Q ss_pred EEEeeccccccccccC----CCCCCCHHHHHHHHHHHHHHhhHhhhcC-----eeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 231 LVFEYMEHDLVGLASL----PGMKFTESQVKCYMKQLLSGLEHCHSHG-----VLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~----~~~~lse~~i~~i~~QIl~aL~~LH~~g-----IiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
||||||+++.|..++. .+..+++..++.++.||+.||.|||++| ||||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 9999999887776543 3457999999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHh
Q 005111 302 SFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWR 381 (714)
Q Consensus 302 ~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~ 381 (714)
+.+..... .....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+.+|.... +
T Consensus 162 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~--~------ 231 (269)
T d2java1 162 RILNHDTS-FAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK--F------ 231 (269)
T ss_dssp HHC------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--C------
T ss_pred eecccCCC-ccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C------
Confidence 98754322 334568999999999998765 8999999999999999999999999998888777775411 0
Q ss_pred hhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCC
Q 005111 382 KSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFF 439 (714)
Q Consensus 382 ~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f 439 (714)
......+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus 232 --------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 --------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 01123578999999999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-56 Score=468.83 Aligned_cols=262 Identities=28% Similarity=0.428 Sum_probs=223.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+.+|+.+|++++|||||++++++.+... +|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK--LY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE--EE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE--EE
Confidence 367999999999999999999999999999999997542 122345678999999999999999999999876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC-C
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD-S 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~-~ 309 (714)
||||||+|+.|..+......+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999998887776666789999999999999999999999999999999999999999999999999999875432 2
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
....+.+||+.|+|||++.+.. |+.++|||||||+||+|++|.+||.+.+..+.+.+|.+.-.
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------------- 227 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------------- 227 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC----------------
T ss_pred cccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC----------------
Confidence 2344568999999999998876 89999999999999999999999999999888888754211
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHH------HHcCcCCCCCCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATL------ALNSEFFTTQPLA 445 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e------~L~Hp~f~~~~~~ 445 (714)
.....+++++.+||.+||++||.+|||++| +++||||+...+.
T Consensus 228 -------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 228 -------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp -------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred -------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 011357899999999999999999999987 6889999886543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-55 Score=471.05 Aligned_cols=269 Identities=23% Similarity=0.391 Sum_probs=230.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|+++.+|+.||||++... .....+.+.+|+.+|++|+|||||++++++.+... +||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE--EEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--EEE
Confidence 35799999999999999999999999999999999754 34456788999999999999999999999886554 999
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC--CCcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH--NGILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~--~g~vKL~DFGla~~~~~~~ 308 (714)
|||||+|+.|..++ .....+++.+++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.+....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999987765544 45568999999999999999999999999999999999999964 6789999999999875433
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..|......++..
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 247 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS---------- 247 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG----------
T ss_pred --ccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 345668999999999998876 8999999999999999999999999999999888886643332221
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCCCCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLACNPSNLP 452 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~~~~~~p 452 (714)
.+..+|+++.+||.+||++||++|||++|+|+||||+....+..+..+|
T Consensus 248 ---------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~ 296 (350)
T d1koaa2 248 ---------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296 (350)
T ss_dssp ---------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCBC
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhCC
Confidence 2245889999999999999999999999999999999876554444443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=463.83 Aligned_cols=256 Identities=27% Similarity=0.476 Sum_probs=222.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+|+++++||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++..... +|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE--LWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE--EEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCE--EEEE
Confidence 5799999999999999999999999999999999865332 34678899999999999999999999887654 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||||+|+.|..+... ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... ...
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 999999888766544 479999999999999999999999999999999999999999999999999999875433 234
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
...+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+.... .+..
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~~--------------- 236 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPEL--------------- 236 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCCC---------------
T ss_pred cccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCCC---------------
Confidence 5668999999999998865 8999999999999999999999999998888777765421 1110
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
..+..+|+.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 237 ----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 237 ----------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ----------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ----------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 112357899999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-55 Score=456.87 Aligned_cols=285 Identities=37% Similarity=0.662 Sum_probs=240.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|+++++||+|+||+||+|++. +|+.||||++..........+.+.+|+.+|++++|||||++++++..... +|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR--LVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC--EEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc--eeEE
Confidence 68999999999999999999985 78999999997765444456788999999999999999999999887655 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+.++++..+......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|........ ..
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 99999999988888888999999999999999999999999999999999999999999999999999988754322 33
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFK 392 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~ 392 (714)
...++++.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.+++...|.+....|............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 45578999999999988777899999999999999999999999999999999999999999988877543221111111
Q ss_pred CCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 393 PVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 393 ~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
............+..+++.+.+||.+||++||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111112233455678999999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-55 Score=465.72 Aligned_cols=260 Identities=29% Similarity=0.427 Sum_probs=208.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||++++++.+... +||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH--LYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSE--EEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--EEE
Confidence 36699999999999999999999999999999999865432 234567899999999999999999999876544 999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc---CCCcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD---HNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~---~~g~vKL~DFGla~~~~~~~ 308 (714)
|||||+|+.|..++.....+++.+++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999888777766677899999999999999999999999999999999999995 57899999999998765433
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
...+.+||+.|+|||++.+.. |+.++|||||||+||+|++|.+||.+.+..+....|.+....++.
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 230 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS----------- 230 (307)
T ss_dssp ----------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT-----------
T ss_pred --eeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC-----------
Confidence 234568999999999998865 899999999999999999999999999988888887653222111
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
..++.+|+++.+||.+||++||++|||++|+|+||||+..
T Consensus 231 --------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 231 --------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1234689999999999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-55 Score=464.66 Aligned_cols=255 Identities=30% Similarity=0.491 Sum_probs=223.3
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.|++++.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+|++|+|||||++++++.+... +|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~--~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE--EEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE--EEEE
Confidence 49999999999999999999999999999999987643 44566789999999999999999999999876554 9999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
||||.++++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|......
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~----- 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-----
Confidence 999999988877666778999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccccCcccccCC--CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 313 TSRVVTLWYRPPELLLGA--SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~--~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
...+||+.|+|||++.+. ..|+.++|||||||++|||++|.+||.+.+..+.+.++......+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 233 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------------- 233 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 345899999999998753 348999999999999999999999999998888887775421100
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.....+|+.+.+||.+||+.||.+|||++++|+||||+..
T Consensus 234 ------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 ------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 0013578999999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=457.13 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=226.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC----CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ----DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~----~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
+.|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+|++++|||||++++++.+...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-- 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD-- 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE--
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--
Confidence 579999999999999999999999999999999976532 22346778999999999999999999999876654
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC----cEEEeecCccccc
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG----ILKIADFGLASFF 304 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g----~vKL~DFGla~~~ 304 (714)
+|||||||+++.|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999988877766667899999999999999999999999999999999999998876 5999999999887
Q ss_pred CCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 305 DPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 305 ~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.... .....+||+.|+|||++.+.. |+.++|||||||+||||++|.+||.+.+..+.+..|......++..
T Consensus 168 ~~~~--~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------ 238 (293)
T d1jksa_ 168 DFGN--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE------ 238 (293)
T ss_dssp TTSC--BCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH------
T ss_pred CCCc--cccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch------
Confidence 5433 234568899999999998765 8999999999999999999999999999999888886543333222
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.++.+|..+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 239 -------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 239 -------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp -------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred -------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 2346899999999999999999999999999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-54 Score=467.93 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=226.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.+.|++++.||+|+||.||+|++..+|+.||||+++... ....+.+.+|+.+|++|+|||||++++++.+... +||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~--~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE--MVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE--EEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--EEE
Confidence 357999999999999999999999999999999997643 3445678899999999999999999999876544 999
Q ss_pred EEeecccccccc-ccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEc--CCCcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGL-ASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLD--HNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~-~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~--~~g~vKL~DFGla~~~~~~~ 308 (714)
|||||+|+.|.. +...+.+|++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+....
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 999999877754 444556799999999999999999999999999999999999998 57899999999999876443
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....+||+.|+|||++.+.. |+.++|||||||+||+|++|.+||.+.+..+.+..|......++..
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 250 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED---------- 250 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS----------
T ss_pred --ceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 345568999999999998766 8999999999999999999999999999999988887644333222
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+..+|+++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 251 ---------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 ---------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ---------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 234689999999999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=471.95 Aligned_cols=284 Identities=23% Similarity=0.336 Sum_probs=216.8
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
..++|+++++||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++|||||+++++|.+... +|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--IS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE--EE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE--EE
Confidence 4578999999999999999999999999999999998653 33456778999999999999999999999986654 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||||+|++|..++.....+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999998888777666789999999999999999999997 59999999999999999999999999999876432
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHH-HHHHHHHhhCCCChhHHhh----hh
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVE-QLHRIFKLCGSPSEDYWRK----SK 384 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e-~l~~I~k~~G~p~~~~w~~----~~ 384 (714)
...+.+||++|+|||++.+.. |+.++||||||||+|||++|+.||.+.+..+ +...+....|.+....+.. ..
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 234568999999999999866 8999999999999999999999998765432 2333333333322211000 00
Q ss_pred c-ccCccccCCchhhh---hhh-hh-----ccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 385 L-RHSTVFKPVQPYRR---RIA-ET-----FKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 385 ~-~~~~~~~~~~p~~~---~i~-~~-----~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
. .......+...... .+. .. ...++.++.+||.+||++||.+||||+|+|+||||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 0 00000000000000 000 00 0135789999999999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=450.52 Aligned_cols=255 Identities=22% Similarity=0.292 Sum_probs=216.7
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc--cCCceEEEE
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS--QTSCSLYLV 232 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~--~~~~~l~LV 232 (714)
|++.++||+|+||+||+|++..++..||+|++..........+.+.+|+.+|++++|||||++++++.. .....+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 477789999999999999999999999999998776666777889999999999999999999998754 233458999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcC--eeeccCCCccEEEc-CCCcEEEeecCcccccCCCCC
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHG--VLHRDIKGSNLLLD-HNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~g--IiHrDLKP~NILl~-~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||+++.|..++.....+++..++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence 999999988877776678999999999999999999999998 99999999999997 578999999999986532
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......+||+.|+|||++.+ . |+.++|||||||+||||++|++||.+......+.+.+.. +..+.
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~------------ 232 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA------------ 232 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG------------
T ss_pred CccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc------------
Confidence 23456789999999998875 3 899999999999999999999999877655544333221 11111
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
.....+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 233 -------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 -------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11235788999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=461.16 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=220.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
+.|++++.||+|+||+||+|++..+|+.||||++.... ....+.+.+|+.+|++++|||||++++++..... +|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN--LWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE--EEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe--EEEE
Confidence 46999999999999999999999999999999997643 3455678899999999999999999999887654 9999
Q ss_pred EeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||++++|..++. ....+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|....... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 99999988876643 45679999999999999999999999999999999999999999999999999997653211 12
Q ss_pred cccccccccccCcccccC----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 312 MTSRVVTLWYRPPELLLG----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
....+||+.|+|||++.+ ...|+.++|||||||+||+|++|.+||.+.+..+.+.+|.+.. ++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~----------- 233 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PP----------- 233 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CC-----------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CC-----------
Confidence 335689999999999852 3347899999999999999999999999998888887775421 00
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.......+|+++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 234 -------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 234 -------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp -------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred -------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 001123578999999999999999999999999999999853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=466.60 Aligned_cols=259 Identities=27% Similarity=0.388 Sum_probs=226.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||.||+|+++.+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+... +|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~--~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR--LC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE--EE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc--cc
Confidence 4689999999999999999999999999999999975421 12345678899999999999999999999986654 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||||+|+.|..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... .
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence 999999999888777777889999999999999999999999999999999999999999999999999998764332 3
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+.+..+....-
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~----------------- 222 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred ccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-----------------
Confidence 345678999999999998876 89999999999999999999999999998888877754210
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
..+..+|+++.+||.+||++||.+|+ +++++|+||||....
T Consensus 223 ------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 11245889999999999999999999 499999999998643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=458.27 Aligned_cols=295 Identities=41% Similarity=0.700 Sum_probs=238.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccC------
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQT------ 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~------ 225 (714)
.++|+++++||+|+||+||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 57899999999999999999999999999999999776555556677889999999999999999999875422
Q ss_pred CceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccC
Q 005111 226 SCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFD 305 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~ 305 (714)
...+|+|||||.++++.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 23489999999999988888778889999999999999999999999999999999999999999999999999998765
Q ss_pred CCCC---CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 306 PKDS---VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 306 ~~~~---~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
.... ....+.+||++|+|||++.+...|+.++|||||||++|||++|++||.+.+..+.+..+.+..|.++.+.|..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 3322 2234457999999999998877789999999999999999999999999999999999999999998876644
Q ss_pred hhccc-CccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCCC
Q 005111 383 SKLRH-STVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLAC 446 (714)
Q Consensus 383 ~~~~~-~~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~~ 446 (714)
..... .............+.+.+ ...++.+++||.+||++||++||||+|+|+||||+..|.|+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 22111 001111111111111111 12467899999999999999999999999999999877653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=455.96 Aligned_cols=287 Identities=37% Similarity=0.655 Sum_probs=234.8
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccC-CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC---CCCCeeeeeccccc---c
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIH-DKIVALKKVRFDNQDPESVKFMAREIAILRKL---DHPNIIKLEGLITS---Q 224 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~-g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIVkl~~~~~~---~ 224 (714)
.++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +|||||+++++|.. .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999999765 67899999976543333334456777777665 79999999998753 2
Q ss_pred CCceEEEEEeeccccccccc-cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 225 TSCSLYLVFEYMEHDLVGLA-SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 225 ~~~~l~LV~Ey~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
....+|++||||+++++... ......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 33458999999999876533 34556799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
.... ......+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+++.+|+..+|.+....|...
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5432 2345668999999999998866 899999999999999999999999999999999999999999988877543
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.......+... ........+..+++.+.+||.+||++||++||||.|+|+||||+...
T Consensus 243 ~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 243 VALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhccc--cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 22111111111 11122344567899999999999999999999999999999998753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=460.33 Aligned_cols=289 Identities=31% Similarity=0.536 Sum_probs=236.5
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC----
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---- 226 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---- 226 (714)
..++|+++++||+|+||+||+|.+..+|+.||||+++.........+.+.+|+.+|+.++|||||+++++|.....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 4578999999999999999999999999999999998766667778889999999999999999999999875432
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
..+|||||||+..+.... . ...|++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~lv~e~~~~~l~~~~-~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLM-K-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECCSEEHHHHH-H-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecccccHHHHH-H-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 247999999965544333 2 34799999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. .+..+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....|.++.++|......
T Consensus 174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 3 345689999999999988777899999999999999999999999999999999999999999999887653221
Q ss_pred cCccccC--CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCCCC
Q 005111 387 HSTVFKP--VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQPLA 445 (714)
Q Consensus 387 ~~~~~~~--~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~~~ 445 (714)
....+.. .......+...+..+++.+.+||.+||.+||.+||||.|+|+||||+....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 1110000 0001122334556789999999999999999999999999999999976433
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-54 Score=459.39 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=225.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQ-DPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+.+|+.++|||||++++++..... +|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ--IF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE--EE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe--ee
Confidence 3679999999999999999999999999999999975421 12345778899999999999999999999876544 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
+|||||.|+++..+......+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--- 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---
Confidence 99999999998888888888999999999999999999999999999999999999999999999999999987533
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
..+.+||+.|+|||++.+.. |+.++|||||||+||+|++|.+||.+.+..+.+.+|...-.
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------------- 218 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL----------------- 218 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----------------
T ss_pred -cccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------------
Confidence 33568999999999998766 89999999999999999999999999999988888865211
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
.....+|+++.+||.+||++||.+|+ |++++|+||||+...
T Consensus 219 ------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 219 ------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 01135789999999999999999996 999999999998753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=456.77 Aligned_cols=281 Identities=35% Similarity=0.557 Sum_probs=233.2
Q ss_pred CeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccc----cCCceE
Q 005111 154 TFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITS----QTSCSL 229 (714)
Q Consensus 154 ~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~----~~~~~l 229 (714)
+|..+++||+|+||+||+|++..+|+.||||++...... +.+|+.+|++++|||||+++++|.. .+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999999999999999999765321 2479999999999999999998743 233458
Q ss_pred EEEEeeccccccccc---cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcccccC
Q 005111 230 YLVFEYMEHDLVGLA---SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFD 305 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~---~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~ 305 (714)
|||||||+++++..+ ......+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||++..+.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999998865543 34566899999999999999999999999999999999999999775 89999999998775
Q ss_pred CCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 306 PKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 306 ~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
... ...+.+||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+++..|++.+|.+..+.|.....
T Consensus 175 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 175 RGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp TTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred CCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence 433 334568999999999998877799999999999999999999999999999999999999999999988876432
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.......+..............+++++.+||.+||.+||++||||.|+|+||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 221111111111111122334689999999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-54 Score=463.19 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=224.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
++|++++.||+|+||.||+|+++.+|+.||||++.... ......+.+.+|+.+|+.++|||||++++++..... +|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~--~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--EEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc--ccc
Confidence 68999999999999999999999999999999987532 122345678899999999999999999999876554 899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
||||+.++.+..++.....+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999888777766678999999999999999999999999999999999999999999999999999987533
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+||+.|+|||++.+.. |+.++||||||||||+|++|.+||.+.+....+.+|......
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~----------------- 256 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR----------------- 256 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred cccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC-----------------
Confidence 33568999999999998866 899999999999999999999999999988888888652111
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
....+++++.+||.+||++||.+|+ |++++|+||||+...
T Consensus 257 ------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 257 ------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 1235789999999999999999995 999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-53 Score=442.20 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=224.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC-------HHHHHHHHHHHHHHHhCC-CCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD-------PESVKFMAREIAILRKLD-HPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~-------~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~ 223 (714)
.++|++++.||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999999875322 123456889999999997 9999999999986
Q ss_pred cCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
... +|||||||+++.|..++.....+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus 82 ~~~--~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSE--EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred Ccc--eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 554 999999999887777776677899999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCcccccccccccCcccccC-----CCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLG-----ASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSED 378 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g-----~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~ 378 (714)
+.... .....+||+.|+|||++.+ ...|+.++||||+||+||+|++|++||.+.+..+.+..|....-.++
T Consensus 160 ~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 235 (277)
T d1phka_ 160 LDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG-- 235 (277)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--
T ss_pred ccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC--
Confidence 76533 2345689999999999863 33478899999999999999999999999998888888765321111
Q ss_pred HHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCC
Q 005111 379 YWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTT 441 (714)
Q Consensus 379 ~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~ 441 (714)
...+..+|+++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 236 -----------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 -----------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -----------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -----------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1123468999999999999999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=440.26 Aligned_cols=287 Identities=38% Similarity=0.680 Sum_probs=246.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|+.++|||||++++++..... +++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~--~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK--LTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE--EEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc--eeEE
Confidence 58999999999999999999999999999999998876666678889999999999999999999999877655 8999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCCc
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVPM 312 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~~ 312 (714)
|||+.++++..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|........ ..
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc-cc
Confidence 99999999888877888999999999999999999999999999999999999999999999999999988754332 33
Q ss_pred ccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCC-CCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccc
Q 005111 313 TSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV-LPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVF 391 (714)
Q Consensus 313 ~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~p-F~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~ 391 (714)
....+++.|+|||++.+...++.++|||||||++|||++|..| |.+.+..+++.++....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 3456789999999998877679999999999999999998765 678888899999999999988877754322211122
Q ss_pred cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 392 KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 392 ~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
.+..+...........+++.+.+||.+||++||.+||||+|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 222233334455667789999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=452.27 Aligned_cols=258 Identities=23% Similarity=0.360 Sum_probs=225.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||+||+|.++.+|+.||||+++... .....+.+|+.+|+.++|||||++++++.+... +||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~--~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEE--LVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE--EEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE--EEE
Confidence 578999999999999999999999999999999997643 334568899999999999999999999876654 999
Q ss_pred EEeeccccccccccCC-CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC--CcEEEeecCcccccCCCC
Q 005111 232 VFEYMEHDLVGLASLP-GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN--GILKIADFGLASFFDPKD 308 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~-~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~--g~vKL~DFGla~~~~~~~ 308 (714)
|||||+|+.|..++.. +..+++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||++.......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 9999998776665544 4579999999999999999999999999999999999999854 489999999998764332
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.....++|+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+.+|......++...|
T Consensus 159 --~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------- 227 (321)
T d1tkia_ 159 --NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-------- 227 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--------
T ss_pred --cccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc--------
Confidence 344567899999999988766 899999999999999999999999999999999998775544444333
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+.+|+++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 228 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 228 -----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -----------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -----------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 4689999999999999999999999999999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.8e-53 Score=457.59 Aligned_cols=261 Identities=26% Similarity=0.363 Sum_probs=215.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC----CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN----QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~----~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
.++|++++.||+|+||.||+|+++.+|+.||||++.... ..........+|+.+++.++|||||++++++.....
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~- 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK- 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE-
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE-
Confidence 578999999999999999999999999999999986432 122223333455777788899999999999876554
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 228 SLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|||||||+|+.|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 82 -~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 82 -LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp -EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred -EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999888877776778999999999999999999999999999999999999999999999999999977543
Q ss_pred CCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 308 DSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 308 ~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
. ....+||+.|+|||++.+...|+.++|||||||+||||++|++||.+.+..+... +........
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~----------- 225 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA----------- 225 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCC-----------
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCC-----------
Confidence 2 3455899999999999766568999999999999999999999998765433222 111111000
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCC-----HHHHHcCcCCCCCC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGT-----ATLALNSEFFTTQP 443 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpT-----a~e~L~Hp~f~~~~ 443 (714)
...+..+|+++.+||.+||++||.+||| |+++|+||||+...
T Consensus 226 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 226 --------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp --------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred --------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 0112468999999999999999999999 89999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=447.68 Aligned_cols=257 Identities=27% Similarity=0.394 Sum_probs=221.7
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHH-hCCCCCeeeeeccccccCCceEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILR-KLDHPNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~-~L~HpnIVkl~~~~~~~~~~~l~ 230 (714)
++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+.++. .++|||||++++++.+... +|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~--~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN--LF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE--EE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc--ee
Confidence 68999999999999999999999999999999997542 11223455667777765 6899999999999887654 99
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
||||||+++.|..++.....+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 999999998888887777789999999999999999999999999999999999999999999999999998765433 3
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
..+..+||+.|+|||++.+.. |+.++|||||||++|+|++|++||.+.+..+.+.+|... .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~--------------- 220 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP--------------- 220 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC---------------
T ss_pred cccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC---------------
Confidence 345568999999999998876 899999999999999999999999999988888877431 11
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHH-HHHcCcCCCCC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT-LALNSEFFTTQ 442 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~-e~L~Hp~f~~~ 442 (714)
...+.+|+++.+||.+||++||.+|||+. ++++||||+..
T Consensus 221 ------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 221 ------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp ------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 01135789999999999999999999995 89999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=444.18 Aligned_cols=287 Identities=32% Similarity=0.512 Sum_probs=233.2
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC---ce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---CS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---~~ 228 (714)
.++|+++++||+|+||+||+|+++.+|+.||||+++....+....+.+.+|+.+|++++|||||++++++..... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999999999999999998776677777889999999999999999999998754221 12
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
.+++|+|+.++.|..+... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-- 173 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-- 173 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG--
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc--
Confidence 3455566666666665544 4799999999999999999999999999999999999999999999999999986542
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
...+..||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......|.+..+.+..+.+........
T Consensus 174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 234568899999999988877789999999999999999999999999999999999999999988876543211110
Q ss_pred ccc--cCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 389 TVF--KPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 389 ~~~--~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
..+ .........+...+..+++.+++||.+||++||.+||||.|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000 0000011223345567899999999999999999999999999999999764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=449.65 Aligned_cols=285 Identities=32% Similarity=0.526 Sum_probs=228.0
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeecccccc----CCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQ----TSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~----~~~~ 228 (714)
++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||+++++|... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999999999999999999987766677778899999999999999999999998654 2356
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|+|||||.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~ 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173 (355)
T ss_dssp EEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence 99999999999887664 468999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc-
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH- 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~- 387 (714)
.....++|+.|+|||++.+.. |+.++||||+||++|+|++|++||.+.+...++.+++...+.+..++|.......
T Consensus 174 --~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 174 --MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred --ccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 345568899999999998865 8999999999999999999999999999999999999999999988886421110
Q ss_pred ----CccccCCchhhh--------hhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 388 ----STVFKPVQPYRR--------RIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 388 ----~~~~~~~~p~~~--------~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
............ ........+++++.+||.+||..||++||||+|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000000000000 00111123577899999999999999999999999999999753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.6e-51 Score=435.04 Aligned_cols=283 Identities=29% Similarity=0.514 Sum_probs=229.0
Q ss_pred CCCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceE
Q 005111 151 RANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 151 ~~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l 229 (714)
..++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|+.+. ||||+++++++.......+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 347899999999999999999999999999999998643 2456789999999995 9999999999876655669
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCC-cEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNG-ILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g-~vKL~DFGla~~~~~~~ 308 (714)
|+|||||.++++..+. ..|++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|..+....
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999998876654 4699999999999999999999999999999999999998655 69999999998875443
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCC-CChHHHHHHHHHhhCCCChhHHh-hhhcc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPG-KTEVEQLHRIFKLCGSPSEDYWR-KSKLR 386 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g-~~~~e~l~~I~k~~G~p~~~~w~-~~~~~ 386 (714)
.....++|+.|+|||++.+...|+.++|||||||++|+|++|..||.. .+..++...+.+.+|.+....|. .....
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 --EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred --cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 345568899999999998877789999999999999999999998864 56677888888888876544332 22121
Q ss_pred cCcccc------CCchhhh-hhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTVFK------PVQPYRR-RIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~~~------~~~p~~~-~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
....+. ....... ........+++++.+||.+||.+||.+||||+|+|+||||++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 111111 0000111 11122345789999999999999999999999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=437.04 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=210.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhCC--CCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDP----ESVKFMAREIAILRKLD--HPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HpnIVkl~~~~~~~~ 225 (714)
.++|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|++++ |||||++++++....
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 478999999999999999999999999999999997642211 12234668999999996 899999999987655
Q ss_pred CceEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-CCcEEEeecCcccc
Q 005111 226 SCSLYLVFEYMEH-DLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-NGILKIADFGLASF 303 (714)
Q Consensus 226 ~~~l~LV~Ey~~g-~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-~g~vKL~DFGla~~ 303 (714)
. +|+||||+.+ +++..+......+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||+|..
T Consensus 83 ~--~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 83 S--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp E--EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred e--EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 4 9999999976 455555555668999999999999999999999999999999999999985 57999999999987
Q ss_pred cCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 304 FDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 304 ~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
.... ..+..+||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.+ .+.+. .
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~--------- 220 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q--------- 220 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C---------
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--c---------
Confidence 5432 34566899999999999887766888999999999999999999997642 12210 0
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
......+|+++.+||.+||++||++|||++|+|+||||+..
T Consensus 221 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 ------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01123589999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-51 Score=431.02 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=216.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC--ce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS--CS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~--~~ 228 (714)
.++|++++.||+|+||+||+|++..+|+.||||+++... .+....+.+.+|+.+|+.++|||||++++++..... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 477999999999999999999999999999999998763 356667789999999999999999999998876443 34
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+|||||||+|+.+..+......+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999998888777777789999999999999999999999999999999999999999999999999987654322
Q ss_pred C--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 309 S--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 309 ~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. ......+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+.++......++.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~--------- 235 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS--------- 235 (277)
T ss_dssp -------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG---------
T ss_pred ccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc---------
Confidence 2 2344568999999999998765 899999999999999999999999999998888877653222211
Q ss_pred cCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCC
Q 005111 387 HSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFT 440 (714)
Q Consensus 387 ~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~ 440 (714)
...+.+|+++.+||.+||++||.+||++.+.|.|+|++
T Consensus 236 ----------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ----------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 12356899999999999999999999655566677653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=438.14 Aligned_cols=289 Identities=33% Similarity=0.526 Sum_probs=229.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC---ce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS---CS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~---~~ 228 (714)
..+|++++.||+|+||+||+|.+..+|+.||||+++... .....+.+.+|+.+|++|+|||||++++++..... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 467999999999999999999999999999999997543 34566788899999999999999999998765332 23
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 229 LYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
+||+|+++++++. .++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|.......
T Consensus 86 ~~l~~~~~~g~L~-~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLVTHLMGADLY-KLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEEECCCEEHH-HHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEeecCCchh-hhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 5666665555544 44333 369999999999999999999999999999999999999999999999999998764432
Q ss_pred C--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcc
Q 005111 309 S--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLR 386 (714)
Q Consensus 309 ~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~ 386 (714)
. ......+||+.|+|||++.....|+.++||||+||++|+|++|.+||.+.+..++...+...++.+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 22345679999999999877666899999999999999999999999999999999999999888886654322111
Q ss_pred cCcc--ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCCC
Q 005111 387 HSTV--FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQP 443 (714)
Q Consensus 387 ~~~~--~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~~ 443 (714)
.... ..............++.+++.+.+||.+||++||.+||||+|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0000 00001111223345678899999999999999999999999999999999654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-52 Score=444.16 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=207.7
Q ss_pred CCCeeEEe-EEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh-CCCCCeeeeeccccc--cCCc
Q 005111 152 ANTFEKLD-KIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRK-LDHPNIIKLEGLITS--QTSC 227 (714)
Q Consensus 152 ~~~Y~~~~-~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~-L~HpnIVkl~~~~~~--~~~~ 227 (714)
.++|+++. .||+|+||+||+|++..+|+.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46899986 599999999999999999999999998632 346789998765 589999999998864 2334
Q ss_pred eEEEEEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCccc
Q 005111 228 SLYLVFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLAS 302 (714)
Q Consensus 228 ~l~LV~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla~ 302 (714)
.+|||||||+|+.|..++.. ...|++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 58999999998777655533 347999999999999999999999999999999999999985 5679999999998
Q ss_pred ccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 303 FFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 303 ~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
....... ....+||+.|+|||++.+.. |+.++||||||||||+|++|++||.+.+..+....+........
T Consensus 163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------ 233 (335)
T d2ozaa1 163 ETTSHNS--LTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 233 (335)
T ss_dssp ECCCCCC--CCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------
T ss_pred eccCCCc--cccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------
Confidence 8754433 44568999999999988765 89999999999999999999999988776555444432111000
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcCcCCCCC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNSEFFTTQ 442 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~Hp~f~~~ 442 (714)
+.. + ...+..+|+++.+||.+||+.||++|||+.|+|+||||...
T Consensus 234 --------~~~--~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 --------YEF--P-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp --------SSC--C-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred --------CCC--C-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 000 0 01123578999999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=425.11 Aligned_cols=256 Identities=22% Similarity=0.333 Sum_probs=209.4
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.+.||+|+||+||+|+. +..||||+++....+....+.+.+|+.+|++++|||||++++++.. . .+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~--~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P--QLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S--SCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c--EEEE
Confidence 47899999999999999999963 3359999998776666778889999999999999999999998754 2 3899
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC-
Q 005111 232 VFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS- 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~- 309 (714)
|||||+++.|..++ .....+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999987776655 4556799999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccccccCcccccCC--CCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 310 VPMTSRVVTLWYRPPELLLGA--SHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~--~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
.......||+.|+|||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..+......++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p----------- 229 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------- 229 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-----------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----------
Confidence 234456889999999998653 3479999999999999999999999998887766665544221111
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+......+|+++.+||.+||+.||.+|||+.+++++
T Consensus 230 ------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 ------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1122335689999999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=420.67 Aligned_cols=254 Identities=22% Similarity=0.404 Sum_probs=213.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|++. ++..||||+++..... .+.+.+|+.+|++++|||||++++++... . +||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~--~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQE-P--IYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-S--CEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeeccC-C--eEE
Confidence 368999999999999999999964 6788999999765433 45688999999999999999999987543 2 799
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||||+++.+..+... ...+++.++..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999888754433 23599999999999999999999999999999999999999999999999999998765544
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......||+.|+|||++.+.. |+.++|||||||+||||+| |.+||...+..+.+..+....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~---------------- 227 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------------- 227 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----------------
T ss_pred ccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC----------------
Confidence 4455567899999999998765 8999999999999999999 567777777777666664311
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc--CcCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN--SEFFTT 441 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~--Hp~f~~ 441 (714)
.+ .....+|+++.+||.+||+.||++|||++++++ |+||+.
T Consensus 228 ---~~---------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 ---RM---------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CC---------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 00 012357899999999999999999999999998 889863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-50 Score=424.28 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=208.7
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.+.||+|+||+||+|.+..+|+.||||+++.+.. ..+.+.+|+.+|++++|||||++++++...+. +||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--FYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--CEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe--eEE
Confidence 3689999999999999999999999999999999976543 34568899999999999999999999876654 899
Q ss_pred EEeecccccccccc--CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLAS--LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~--~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||||+++.+..++ .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999987766554 3456799999999999999999999999999999999999999999999999999998765544
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCC-CCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPV-LPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~p-F~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......||+.|+|||++.+.. |+.++|||||||++|||++|..| |.+.+.......+.. ..
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-~~--------------- 233 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DY--------------- 233 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TC---------------
T ss_pred eeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-CC---------------
Confidence 4444556899999999998766 89999999999999999996554 555554443333321 00
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
. ......+|+.+.+||.+||+.||.+|||+.++++
T Consensus 234 ---~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 234 ---R---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ---C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---C---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0 0112468899999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=414.25 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=200.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||+||+|++. ++..||||+++..... .+.+.+|+.+|++++|||||++++++..... +||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~--~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--ICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--CEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCc--eEE
Confidence 368999999999999999999975 6788999999865433 3568899999999999999999999876655 899
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC
Q 005111 232 VFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV 310 (714)
Q Consensus 232 V~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~ 310 (714)
|||||+++.|..++ .....+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++........
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999988776654 45567899999999999999999999999999999999999999999999999999887655544
Q ss_pred CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCc
Q 005111 311 PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHST 389 (714)
Q Consensus 311 ~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~ 389 (714)
......||+.|+|||++.+.. |+.++|||||||++|||+| |.+||...+..+.+..+......
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------------- 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 221 (263)
T ss_dssp -------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC---------------
T ss_pred eecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC---------------
Confidence 445567899999999998766 8999999999999999999 57888888877777766442100
Q ss_pred cccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 390 VFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 390 ~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....+|+.+.+||.+||+.||++|||++++|+|
T Consensus 222 -------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 -------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 0113468899999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=421.06 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=206.3
Q ss_pred eEEeccCceEEEEEEEc--cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEEEeec
Q 005111 159 DKIGQGTYSSVYRARDV--IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 159 ~~LG~G~fG~Vy~a~d~--~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
++||+|+||+||+|.+. .+++.||||+++....+....+.+.+|+.+|++++|||||++++++..+ . +|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~--~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-S--WMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-S--EEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-C--EEEEEEcC
Confidence 47999999999999764 4568899999986655566678899999999999999999999988543 2 78999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC--Cccc
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV--PMTS 314 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~--~~~~ 314 (714)
+++.|..+......+++.++..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+...... ....
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 99988877777778999999999999999999999999999999999999999999999999999876543322 1233
Q ss_pred ccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCccccC
Q 005111 315 RVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKP 393 (714)
Q Consensus 315 ~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~ 393 (714)
..||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+....|.+. ..
T Consensus 170 ~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~~------------------ 228 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--ER------------------ 228 (277)
T ss_dssp -CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--CC------------------
T ss_pred cCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--CC------------------
Confidence 46899999999998765 8999999999999999998 89999998887766665331 00
Q ss_pred CchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHH---HcCcCCC
Q 005111 394 VQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA---LNSEFFT 440 (714)
Q Consensus 394 ~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~---L~Hp~f~ 440 (714)
......+|+++.+||.+||+.||++|||++++ |+|+|+.
T Consensus 229 --------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 01124678999999999999999999999998 5666653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-49 Score=419.69 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=201.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDK---IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~---~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.+.|++.+.||+|+||+||+|++..+++ .||||++... ......+.+.+|+.+|++++|||||++++++.....
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-- 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-- 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS--
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE--
Confidence 3679999999999999999999887764 6888887654 345567789999999999999999999999876654
Q ss_pred EEEEEeeccccccccccC-CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLASL-PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~-~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|||||||+++.|..+.. ....+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 899999999988876444 4567999999999999999999999999999999999999999999999999999877543
Q ss_pred CCCC----cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhh
Q 005111 308 DSVP----MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRK 382 (714)
Q Consensus 308 ~~~~----~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~ 382 (714)
.... .....||+.|+|||++.+.. |+.++|||||||+||||+| |.+||.+.+..+.+..+......
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-------- 252 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL-------- 252 (299)
T ss_dssp --------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC--------
T ss_pred CCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 3221 22345789999999998765 8999999999999999998 89999999888777776432110
Q ss_pred hhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 383 SKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 383 ~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....+|..+.+||.+||+.||.+|||+.+++++
T Consensus 253 --------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 --------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0123578999999999999999999999998875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=410.73 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=215.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|+++++||+|+||+||+|++ .++..||||+++..... .+.+.+|+.++++++|||||++++++..... +|+|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~--~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP--IFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCSSS--EEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeCCc--eEEE
Confidence 6899999999999999999997 47889999999876544 3468899999999999999999999876554 9999
Q ss_pred Eeeccccccccc-cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCCC
Q 005111 233 FEYMEHDLVGLA-SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSVP 311 (714)
Q Consensus 233 ~Ey~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~~ 311 (714)
|||++++.+..+ ......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999998766554 4455679999999999999999999999999999999999999999999999999998876655555
Q ss_pred cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccCcc
Q 005111 312 MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHSTV 390 (714)
Q Consensus 312 ~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~ 390 (714)
.....+|+.|+|||++.+.. |+.++|||||||++|||+| |+.||.+.+..+...+|......+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------- 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------------
T ss_pred ecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 55668899999999998766 8999999999999999998 899999999888777775421110
Q ss_pred ccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 391 FKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 391 ~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
....+|..+.+||.+||+.||++|||+.++|+|
T Consensus 222 -------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 -------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 113578899999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=416.19 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=214.0
Q ss_pred CCCeeEEeE-EeccCceEEEEEEEcc--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDK-IGQGTYSSVYRARDVI--HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~-LG~G~fG~Vy~a~d~~--~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
.++|.+.+. ||+|+||+||+|.+.. ++..||||+++.. ......+.+.+|+.+|++++|||||++++++..+ .
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~-- 82 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A-- 82 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S--
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e--
Confidence 367888885 9999999999997754 4568999999754 3456678899999999999999999999988643 2
Q ss_pred EEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+|||||||+++.|..++ .....+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 89999999998877654 44567999999999999999999999999999999999999999999999999999987544
Q ss_pred CC--CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 308 DS--VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 308 ~~--~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
.. .......||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+.+..|.+.. .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~--~--------- 230 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--R--------- 230 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC--C---------
T ss_pred ccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence 32 2223446899999999998765 8999999999999999998 999999988877766664311 0
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHH---HcCcCCC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLA---LNSEFFT 440 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~---L~Hp~f~ 440 (714)
....+.+|+++.+||.+||+.||++|||+.++ |+|.|++
T Consensus 231 -----------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01224689999999999999999999999887 6788874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=423.51 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=207.8
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHD-----KIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTS 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g-----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~ 226 (714)
++|++.+.||+|+||+||+|++..++ ..||+|++.... .......+.+|+.+|.++ +|||||++++++.....
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 68999999999999999999987654 369999986543 234456788999999998 89999999999987655
Q ss_pred ceEEEEEeeccccccccccCCC-----------------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCc
Q 005111 227 CSLYLVFEYMEHDLVGLASLPG-----------------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGS 283 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~-----------------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~ 283 (714)
+|||||||+++.|..++... ..+++..++.|+.||+.||.|||++|||||||||+
T Consensus 116 --~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 116 --IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp --CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred --EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 89999999988776655322 35899999999999999999999999999999999
Q ss_pred cEEEcCCCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCCh
Q 005111 284 NLLLDHNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTE 361 (714)
Q Consensus 284 NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~ 361 (714)
|||++.++.+||+|||+|+........ ......||+.|+|||++.+.. |+.++|||||||+||||++ |.+||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876544332 233457899999999998765 8999999999999999997 8999998877
Q ss_pred HHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 362 VEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 362 ~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+.+.+++.....+ .....+|+++.+||.+||+.||++|||++|+++|
T Consensus 273 ~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66666665421111 1123578999999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=413.41 Aligned_cols=255 Identities=23% Similarity=0.352 Sum_probs=206.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++.+.||+|+||+||+|++..+ ..||||++...... .+.+.+|+.+|++++|||||++++++.. .. +|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~--~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP--IYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS--CEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CC--eEE
Confidence 46899999999999999999998654 57999999765443 3568899999999999999999998854 33 799
Q ss_pred EEeeccccccccccCC--CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLP--GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~--~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
|||||+++.+..+... ...+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 9999999876655432 34699999999999999999999999999999999999999999999999999988765554
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
.......||+.|+|||++.+.. ++.++|||||||+||||++| .++|.+....+.+..+......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------------- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred eeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 4455568899999999998766 89999999999999999995 6667777777776666432111
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc--CcCCCCC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN--SEFFTTQ 442 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~--Hp~f~~~ 442 (714)
.....+|+++.+||.+||+.||++|||+++++. ++||+..
T Consensus 234 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 112467899999999999999999999999988 8999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=409.24 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=200.1
Q ss_pred CCeeEEeEEeccCceEEEEEEEccC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIH---DKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~---g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l 229 (714)
++|++.+.||+|+||.||+|++..+ +..||||+++.. ......+.+.+|+.+|++++|||||++++++.. . .+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~--~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N--PV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S--SC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C--eE
Confidence 5899999999999999999998654 457889988643 345566789999999999999999999998853 2 38
Q ss_pred EEEEeeccccccccc-cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCC
Q 005111 230 YLVFEYMEHDLVGLA-SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKD 308 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~ 308 (714)
|||||||+++.+..+ ......+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999998776654 3455679999999999999999999999999999999999999999999999999999876554
Q ss_pred CCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 309 SVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 309 ~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
....+...||+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+.++.....
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-------------- 227 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------------- 227 (273)
T ss_dssp --------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------------
T ss_pred ceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 44455567899999999998765 8999999999999999998 8999999888777777643110
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
...++.+|+.+.+||.+||+.||.+|||+.++++|
T Consensus 228 --------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 --------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01234689999999999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-50 Score=426.64 Aligned_cols=264 Identities=26% Similarity=0.410 Sum_probs=218.9
Q ss_pred CCeeEEeEEeccCceEEEEEEEc---cCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhCCC-CCeeeeeccccccCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDV---IHDKIVALKKVRFDN--QDPESVKFMAREIAILRKLDH-PNIIKLEGLITSQTS 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~---~~g~~VAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~H-pnIVkl~~~~~~~~~ 226 (714)
++|++++.||+|+||+||+|++. .+|+.||||++.... .+....+.+.+|+.+|++++| |||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999874 468999999986532 122334567899999999976 899999999876654
Q ss_pred ceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
+|+||||+.++.+..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+..
T Consensus 104 --~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 104 --LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp --EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred --eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999988887777777899999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCCcccccccccccCcccccCCC-CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhc
Q 005111 307 KDSVPMTSRVVTLWYRPPELLLGAS-HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKL 385 (714)
Q Consensus 307 ~~~~~~~~~~gT~~Y~APE~l~g~~-~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~ 385 (714)
..........||+.|+|||.+.+.. .++.++|||||||+||+|++|..||.+.+..+....+.+....+
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~---------- 251 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---------- 251 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----------
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC----------
Confidence 5554455678999999999997643 46889999999999999999999998876555544443321000
Q ss_pred ccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCC-----CHHHHHcCcCCCCCC
Q 005111 386 RHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRG-----TATLALNSEFFTTQP 443 (714)
Q Consensus 386 ~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRp-----Ta~e~L~Hp~f~~~~ 443 (714)
. ...+..+++.+.+||.+||++||++|| |++|+|+||||+...
T Consensus 252 ------~---------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 252 ------E---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp ------C---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ------C---------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 0 012246899999999999999999999 599999999998643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=401.69 Aligned_cols=251 Identities=21% Similarity=0.332 Sum_probs=199.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHD----KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g----~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
+.|++.+.||+|+||.||+|.+..++ ..||||++... ........+.+|+.+|++++|||||++++++.....
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~-- 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP-- 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS--
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc--
Confidence 57999999999999999999877654 57999998754 344556678999999999999999999999876655
Q ss_pred EEEEEeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
+++|||||.++++.... .....+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 89999999998776544 34467999999999999999999999999999999999999999999999999999876543
Q ss_pred CCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 308 DSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 308 ~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
... ......||+.|+|||++.+.. |+.++|||||||+||||++| .+||.+.+..+.+..+....
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------------ 230 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------------ 230 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------
T ss_pred CccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC------------
Confidence 221 223456799999999998765 89999999999999999995 56666666665555543211
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+ ....++|..+.+||.+||..||++|||+.++++
T Consensus 231 -------~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 231 -------RL---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------CC---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------CC---------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 00 112357899999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=409.70 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=202.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDK----IVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSC 227 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~----~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~ 227 (714)
..+|++++.||+|+||+||+|.+..+|+ .||+|.++.. ......+.+.+|+.+|++++|||||++++++....
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-- 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-- 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS--
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence 3679999999999999999999988876 5888887643 23345677899999999999999999999987543
Q ss_pred eEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCC
Q 005111 228 SLYLVFEYMEHD-LVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDP 306 (714)
Q Consensus 228 ~l~LV~Ey~~g~-ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~ 306 (714)
.+++|||+.++ ++..+......+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.+..
T Consensus 85 -~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp -EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred -eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 67788888765 4455555667899999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC-cccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 307 KDSVP-MTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 307 ~~~~~-~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
..... .....||+.|+|||++.+.. |+.++|||||||+||||+| |.+||.+.+..+....+..... +
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~--------- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-L--------- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-C---------
T ss_pred ccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-C---------
Confidence 43322 23446899999999998765 8999999999999999998 8999998877665555533110 0
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.....+|+.+.+||.+||+.||.+|||+.+++.|
T Consensus 233 ------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp ------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1123578899999999999999999999999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=402.47 Aligned_cols=254 Identities=23% Similarity=0.322 Sum_probs=198.5
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCC
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTS 226 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~ 226 (714)
++|+++++||+|+||.||+|++.. +++.||||+++... .....+.+.+|+.++.++ +|+|||.+++++....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~- 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC-
Confidence 689999999999999999999754 45789999987543 344556777888888777 6899999998876544
Q ss_pred ceEEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHN 290 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~ 290 (714)
..+++|||||+++.+..++.. ...+++.+++.|+.||+.||.|||++|||||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 348999999998877665421 2358999999999999999999999999999999999999999
Q ss_pred CcEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHH
Q 005111 291 GILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRI 368 (714)
Q Consensus 291 g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I 368 (714)
+.+||+|||+|+....... ......+||+.|+|||++.+.. |+.++|||||||++|||++| .+||.+....+.+..+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987654333 2334567999999999998765 89999999999999999986 5789887665555554
Q ss_pred HHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 369 FKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 369 ~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
+.....+ .....+|+++.+||.+||+.||++|||+.++|+|
T Consensus 250 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3321111 1123578999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-47 Score=401.34 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=210.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.++|++++.||+|+||+||+|+.. .+++.||||++... ......+.+.+|+.+|++++||||+++++++.....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 467999999999999999999875 35689999998754 345567789999999999999999999999876655
Q ss_pred ceEEEEEeeccccccccccCC------------------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCC
Q 005111 227 CSLYLVFEYMEHDLVGLASLP------------------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKG 282 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~~------------------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP 282 (714)
+++||||++++.+..++.. ...|++.++..|+.||+.||+|||+++||||||||
T Consensus 91 --~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 91 --MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp --CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred --eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 8999999998776654321 23489999999999999999999999999999999
Q ss_pred ccEEEcCCCcEEEeecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCC-CCCCCCC
Q 005111 283 SNLLLDHNGILKIADFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGK-PVLPGKT 360 (714)
Q Consensus 283 ~NILl~~~g~vKL~DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~-~pF~g~~ 360 (714)
+||||+.++.+||+|||+|+.+...... ..++..||+.|+|||++.+.. |+.++|||||||++|||++|. +||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999876443322 234457899999999998766 899999999999999999984 7899998
Q ss_pred hHHHHHHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 361 EVEQLHRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 361 ~~e~l~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
..+.+..+.... .......+|+++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~e~~~~v~~~~----------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGN----------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCC----------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888777764311 01122468899999999999999999999999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=398.03 Aligned_cols=252 Identities=26% Similarity=0.362 Sum_probs=199.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEcc-CC--eEEEEEEeecCC-CCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCce
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVI-HD--KIVALKKVRFDN-QDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~-~g--~~VAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~ 228 (714)
++|++++.||+|+||.||+|+... ++ ..||||++.... ...+..+.+.+|+.+|++++|||||++++++.+. .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---P 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---c
Confidence 679999999999999999998643 33 478999987653 3445667899999999999999999999998643 2
Q ss_pred EEEEEeeccccccccc-cCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCC
Q 005111 229 LYLVFEYMEHDLVGLA-SLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPK 307 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~-~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~ 307 (714)
++||||||+++.+... ......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 7899999997665543 334457999999999999999999999999999999999999999999999999999987544
Q ss_pred CCC--CcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhh
Q 005111 308 DSV--PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSK 384 (714)
Q Consensus 308 ~~~--~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~ 384 (714)
... ......||..|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+..|.+..-.+
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--------- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---------
T ss_pred CCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC---------
Confidence 321 122346788999999998765 8999999999999999998 899999999998888775421111
Q ss_pred cccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 385 LRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 385 ~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.....+|+.+.+||.+||..||.+|||+.++++
T Consensus 235 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 ------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112468899999999999999999999999873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=390.64 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=198.1
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~L 231 (714)
.++|++++.||+|+||.||+|++ +|..||||+++.+. ..+.+.+|+.+|++++|||||++++++.+.. ..+||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEE
Confidence 46899999999999999999986 58899999997543 3456889999999999999999999875433 23899
Q ss_pred EEeeccccccccccCCC--CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCC
Q 005111 232 VFEYMEHDLVGLASLPG--MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~--~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~ 309 (714)
||||++++.+..++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999998887665432 348999999999999999999999999999999999999999999999999998764332
Q ss_pred CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHHHHHHHhhCCCChhHHhhhhcccC
Q 005111 310 VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKSKLRHS 388 (714)
Q Consensus 310 ~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~~~~~~ 388 (714)
....+|+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+.+..|...
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~----------------- 216 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG----------------- 216 (262)
T ss_dssp -------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------------
T ss_pred ---ccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2346789999999998765 8999999999999999998 79999888777666665321
Q ss_pred ccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 389 TVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 389 ~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.. .+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 217 --~~---------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 --YK---------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp --CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CC---------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00 01224578999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-46 Score=391.82 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=204.5
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCC-------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccc
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHD-------KIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITS 223 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g-------~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~ 223 (714)
.++|++.+.||+|+||.||+|++..++ ..||||+++.+. .......+.+|+..+.++ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 468999999999999999999876554 479999997653 345567788899999888 79999999999986
Q ss_pred cCCceEEEEEeeccccccccccCCC----------------CCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 224 QTSCSLYLVFEYMEHDLVGLASLPG----------------MKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 224 ~~~~~l~LV~Ey~~g~ll~~~~~~~----------------~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
... +|+|||||+++.+..++... ..+++.+++.++.||+.||.|||+++||||||||+|||+
T Consensus 91 ~~~--~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 DGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSS--CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCe--EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 554 99999999998877665322 358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l 365 (714)
+.++.+||+|||+++....... .......+|+.|+|||++.+.. |+.++|||||||++|||++ |.+||.+.+..+.+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999987754332 2234457899999999998765 8999999999999999998 79999888876655
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
..+... ..+ .....+|+.+.+||.+||+.||.+|||+.|+|+
T Consensus 248 ~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 544221 000 112367899999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=397.69 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=205.3
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeE--EEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccCCce
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKI--VALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~--VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~~~~ 228 (714)
.++|++.++||+|+||.||+|++..+|.. ||||.+.... ..+..+.+.+|+.+|.++ +|||||++++++...+.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~-- 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-- 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE--
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe--
Confidence 37899999999999999999999988875 6677765332 334566789999999999 79999999999886554
Q ss_pred EEEEEeeccccccccccCC----------------CCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCc
Q 005111 229 LYLVFEYMEHDLVGLASLP----------------GMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGI 292 (714)
Q Consensus 229 l~LV~Ey~~g~ll~~~~~~----------------~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~ 292 (714)
+||||||++++.+..++.. ...|++.++..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999998887766532 357999999999999999999999999999999999999999999
Q ss_pred EEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHHHHh
Q 005111 293 LKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFKL 371 (714)
Q Consensus 293 vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I~k~ 371 (714)
+||+|||+|+....... .....||..|+|||.+.+.. |+.++||||||||+|||++| .+||.+.+..+.+..+.+.
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999986543322 23446899999999998765 89999999999999999996 5788888877776665321
Q ss_pred hCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 372 CGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 372 ~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
. . ......+|+.+.+||.+||+.||++|||+.++|+|
T Consensus 243 ~-------------------~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 Y-------------------R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C-------------------C---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-------------------C---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 0 01124578999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=394.54 Aligned_cols=252 Identities=17% Similarity=0.244 Sum_probs=211.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEcc-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVI-----HDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS 226 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~-----~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~ 226 (714)
.++|++.+.||+|+||.||+|.+.. ++..||||+++... .......+.+|+.+|++++|||||++++++.....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 4799999999999999999998752 46789999997543 44566778999999999999999999999876655
Q ss_pred ceEEEEEeeccccccccccC----------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEe
Q 005111 227 CSLYLVFEYMEHDLVGLASL----------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIA 296 (714)
Q Consensus 227 ~~l~LV~Ey~~g~ll~~~~~----------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~ 296 (714)
++||||||.++.+..++. ....+++..+..++.||+.||.|||+++|+||||||+||||+.++++||+
T Consensus 98 --~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 98 --TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp --CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred --eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 899999999887765432 12357999999999999999999999999999999999999999999999
Q ss_pred ecCcccccCCCCCC-CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhC-CCCCCCCChHHHHHHHHHhhCC
Q 005111 297 DFGLASFFDPKDSV-PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSG-KPVLPGKTEVEQLHRIFKLCGS 374 (714)
Q Consensus 297 DFGla~~~~~~~~~-~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG-~~pF~g~~~~e~l~~I~k~~G~ 374 (714)
|||+|+.+...... .....+||+.|+|||.+.+.. |+.++|||||||+||||++| .+||.+.+..+.+..+.+...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~- 253 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-
Confidence 99999876443222 223346899999999998766 79999999999999999998 589999888887777643110
Q ss_pred CChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 375 PSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 375 p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
......+|+.+.+||.+||+.||.+|||+.++++
T Consensus 254 ---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 ---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1112467899999999999999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-45 Score=387.87 Aligned_cols=261 Identities=20% Similarity=0.236 Sum_probs=205.6
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.++|+|+|.++..+.... ...++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEG-DYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEET-TEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecC-CEEEEE
Confidence 5799999999999999999999999999999998765332 23678999999998777666554443332 348999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC---CCcEEEeecCcccccCCCCC
Q 005111 233 FEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH---NGILKIADFGLASFFDPKDS 309 (714)
Q Consensus 233 ~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~---~g~vKL~DFGla~~~~~~~~ 309 (714)
|||+++++...+......+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999999888877777778999999999999999999999999999999999999864 45799999999998754332
Q ss_pred C------CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhCCCChhHHhhh
Q 005111 310 V------PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCGSPSEDYWRKS 383 (714)
Q Consensus 310 ~------~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G~p~~~~w~~~ 383 (714)
. .....+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.........+.+... .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---------~ 231 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---------K 231 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH---------H
T ss_pred ccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc---------c
Confidence 1 234558999999999998876 89999999999999999999999988766554444322110 0
Q ss_pred hcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHH---HHHcCcCCC
Q 005111 384 KLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTAT---LALNSEFFT 440 (714)
Q Consensus 384 ~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~---e~L~Hp~f~ 440 (714)
............+|+++.+||..||..||++||++. ++|+|+|.+
T Consensus 232 ------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 232 ------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 000112233457899999999999999999999987 457787754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=391.81 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=211.0
Q ss_pred CCCeeEEeEEeccCceEEEEEEEc-----cCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhC-CCCCeeeeeccccccC
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDV-----IHDKIVALKKVRFDNQDPESVKFMAREIAILRKL-DHPNIIKLEGLITSQT 225 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~-----~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIVkl~~~~~~~~ 225 (714)
.++|++.++||+|+||.||+|++. .+++.||||+++... .......+.+|+.++..+ +|||||++++++....
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 368999999999999999999863 467899999997653 345667789999999999 6999999999987765
Q ss_pred CceEEEEEeeccccccccccC------------------CCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEE
Q 005111 226 SCSLYLVFEYMEHDLVGLASL------------------PGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLL 287 (714)
Q Consensus 226 ~~~l~LV~Ey~~g~ll~~~~~------------------~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl 287 (714)
. +|||||||+++.+..++. ....+++..+..|+.||+.||.|||++|||||||||+|||+
T Consensus 101 ~--~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 101 P--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp S--CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred E--EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 5 899999999887765543 22368999999999999999999999999999999999999
Q ss_pred cCCCcEEEeecCcccccCCCCC-CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhh-CCCCCCCCChHHHH
Q 005111 288 DHNGILKIADFGLASFFDPKDS-VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFS-GKPVLPGKTEVEQL 365 (714)
Q Consensus 288 ~~~g~vKL~DFGla~~~~~~~~-~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLlt-G~~pF~g~~~~e~l 365 (714)
+.++.+||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+....+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999997754332 2234467899999999998765 8999999999999999998 78888887777777
Q ss_pred HHHHHhhCCCChhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+++...-.+ .....+|..+.+||.+||+.||.+|||++++|+
T Consensus 258 ~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6665421111 111357899999999999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-45 Score=393.62 Aligned_cols=283 Identities=27% Similarity=0.421 Sum_probs=219.3
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-----------CCCeeeeeccc
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-----------HPNIIKLEGLI 221 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIVkl~~~~ 221 (714)
++|+++++||+|+||+||+|+++.+|+.||||+++.+ ....+.+.+|+.+|+.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4599999999999999999999999999999999743 344566788999998875 57899999888
Q ss_pred cccCCceEEEEEeeccccc---cccccCCCCCCCHHHHHHHHHHHHHHhhHhhh-cCeeeccCCCccEEEcCCC------
Q 005111 222 TSQTSCSLYLVFEYMEHDL---VGLASLPGMKFTESQVKCYMKQLLSGLEHCHS-HGVLHRDIKGSNLLLDHNG------ 291 (714)
Q Consensus 222 ~~~~~~~l~LV~Ey~~g~l---l~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~-~gIiHrDLKP~NILl~~~g------ 291 (714)
........+++|+++.... ..........+++..++.++.||+.||+|||+ +||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 7666556777777776432 22333455678999999999999999999997 8999999999999998765
Q ss_pred cEEEeecCcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCC------hHHHH
Q 005111 292 ILKIADFGLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKT------EVEQL 365 (714)
Q Consensus 292 ~vKL~DFGla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~------~~e~l 365 (714)
.++|+|||.+...... ....+||+.|+|||++.+.. |+.++|||||||++++|++|++||.+.. ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999999875432 24568999999999998766 7999999999999999999999997543 45677
Q ss_pred HHHHHhhCCCChhHHhhhhccc----------CccccCCchhhhhhhh---hccCCcHHHHHHHHHhcccCcCCCCCHHH
Q 005111 366 HRIFKLCGSPSEDYWRKSKLRH----------STVFKPVQPYRRRIAE---TFKDFPTSALRLMETLMSIDPAHRGTATL 432 (714)
Q Consensus 366 ~~I~k~~G~p~~~~w~~~~~~~----------~~~~~~~~p~~~~i~~---~~~~~p~~l~~LI~~mL~~DP~kRpTa~e 432 (714)
..++..+|.++.+.+....... ........+....+.. .....++.+.+||.+||.+||.+||||+|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 8888999998887765432211 0000011111111111 22345778999999999999999999999
Q ss_pred HHcCcCCCCCC
Q 005111 433 ALNSEFFTTQP 443 (714)
Q Consensus 433 ~L~Hp~f~~~~ 443 (714)
+|+||||+..+
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HhcCcccCCCC
Confidence 99999999643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=381.11 Aligned_cols=250 Identities=21% Similarity=0.243 Sum_probs=198.6
Q ss_pred eEEeEEeccCceEEEEEEEccCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCCceEEEE
Q 005111 156 EKLDKIGQGTYSSVYRARDVIHD---KIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTSCSLYLV 232 (714)
Q Consensus 156 ~~~~~LG~G~fG~Vy~a~d~~~g---~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~~~l~LV 232 (714)
.+-++||+|+||+||+|++..++ ..||||+++.. ......+.+.+|+.+|++++|||||++++++.... ..+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT-TEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC-CceEEE
Confidence 44678999999999999986643 36999998643 35667788999999999999999999999875433 348999
Q ss_pred Eeecccccccccc-CCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeecCcccccCCCCCC-
Q 005111 233 FEYMEHDLVGLAS-LPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADFGLASFFDPKDSV- 310 (714)
Q Consensus 233 ~Ey~~g~ll~~~~-~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~~~~~~~~- 310 (714)
||||+++++..+. .....+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999988876544 34556889999999999999999999999999999999999999999999999999876543322
Q ss_pred --CcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCC-ChHHHHHHHHHhhCCCChhHHhhhhccc
Q 005111 311 --PMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGK-TEVEQLHRIFKLCGSPSEDYWRKSKLRH 387 (714)
Q Consensus 311 --~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~-~~~e~l~~I~k~~G~p~~~~w~~~~~~~ 387 (714)
......||+.|+|||.+.+.. ++.++|||||||++|||++|..||... +..+....+... .
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~------------- 251 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R------------- 251 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--C-------------
T ss_pred ceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--C-------------
Confidence 223457899999999988765 899999999999999999976666543 333333333221 0
Q ss_pred CccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHcC
Q 005111 388 STVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALNS 436 (714)
Q Consensus 388 ~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~H 436 (714)
.+ .....+++.+.+||.+||..||++|||+.|+++|
T Consensus 252 ----~~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 252 ----RL---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CC---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00 0123578899999999999999999999999988
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-44 Score=375.90 Aligned_cols=253 Identities=19% Similarity=0.250 Sum_probs=205.6
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCC-CCeeeeeccccccCCceEE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDH-PNIIKLEGLITSQTSCSLY 230 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIVkl~~~~~~~~~~~l~ 230 (714)
.+.|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.++..|.| +|++.+++++..... .|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~--~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH--NV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE--EE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc--cE
Confidence 36899999999999999999999999999999998754322 236688999999965 899999988765544 89
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcC-----CCcEEEeecCcccccC
Q 005111 231 LVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDH-----NGILKIADFGLASFFD 305 (714)
Q Consensus 231 LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~-----~g~vKL~DFGla~~~~ 305 (714)
+||||+++++...+...+..+++..+..++.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.+.
T Consensus 78 ~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 78 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999988877777666678999999999999999999999999999999999999974 5789999999998765
Q ss_pred CCCC------CCcccccccccccCcccccCCCCCCccccccchhHHHHHHhhCCCCCCCCChH---HHHHHHHHhhCCCC
Q 005111 306 PKDS------VPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCILGELFSGKPVLPGKTEV---EQLHRIFKLCGSPS 376 (714)
Q Consensus 306 ~~~~------~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~---e~l~~I~k~~G~p~ 376 (714)
.... ......+||+.|+|||++.+.. |+.++|||||||++|||++|..||.+.... +.+.++....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK---- 232 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH----
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc----
Confidence 3321 1234568999999999998866 899999999999999999999999865433 2333332110
Q ss_pred hhHHhhhhcccCccccCCchhhhhhhhhccCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 377 EDYWRKSKLRHSTVFKPVQPYRRRIAETFKDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 377 ~~~w~~~~~~~~~~~~~~~p~~~~i~~~~~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
....+.+..+.+|+++.+||..|+..+|++||+++.+.+
T Consensus 233 --------------------~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 233 --------------------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp --------------------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 001123345678999999999999999999999776644
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=373.24 Aligned_cols=268 Identities=25% Similarity=0.268 Sum_probs=191.9
Q ss_pred CCCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCeeeeeccccccCC--ceE
Q 005111 152 ANTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNIIKLEGLITSQTS--CSL 229 (714)
Q Consensus 152 ~~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIVkl~~~~~~~~~--~~l 229 (714)
+.+|.+.+.||+|+||.||+|+. +|+.||||+++... .......+|+..+.+++|||||++++++..... ..+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 35789999999999999999974 79999999986432 222223345566667899999999999876443 358
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh--------cCeeeccCCCccEEEcCCCcEEEeecCcc
Q 005111 230 YLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS--------HGVLHRDIKGSNLLLDHNGILKIADFGLA 301 (714)
Q Consensus 230 ~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~--------~gIiHrDLKP~NILl~~~g~vKL~DFGla 301 (714)
|||||||+++.|..++... .+++.++..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999998887777543 69999999999999999999996 59999999999999999999999999999
Q ss_pred cccCCCCC---CCcccccccccccCcccccCCC-----CCCccccccchhHHHHHHhhCCCCCCCCChHHHHHHHHHhhC
Q 005111 302 SFFDPKDS---VPMTSRVVTLWYRPPELLLGAS-----HYGAAVDLWSTGCILGELFSGKPVLPGKTEVEQLHRIFKLCG 373 (714)
Q Consensus 302 ~~~~~~~~---~~~~~~~gT~~Y~APE~l~g~~-----~y~~~sDIWSLG~iLyeLltG~~pF~g~~~~e~l~~I~k~~G 373 (714)
........ ......+||+.|+|||++.+.. .++.++|||||||+||||+||.+||.......... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~--~~~~~ 233 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY--YDLVP 233 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT--TTTSC
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch--hhccc
Confidence 87754332 1234568999999999987542 25778999999999999999998875432110000 00000
Q ss_pred -CCChhHHhhhhcccCccccCCchhhhhhhhhc--cCCcHHHHHHHHHhcccCcCCCCCHHHHHc
Q 005111 374 -SPSEDYWRKSKLRHSTVFKPVQPYRRRIAETF--KDFPTSALRLMETLMSIDPAHRGTATLALN 435 (714)
Q Consensus 374 -~p~~~~w~~~~~~~~~~~~~~~p~~~~i~~~~--~~~p~~l~~LI~~mL~~DP~kRpTa~e~L~ 435 (714)
.+.......... ...+.+. +...+ ...+..+.+||.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~--~~~~~p~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 234 SDPSVEEMRKVVC--EQKLRPN------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SSCCHHHHHHHHT--TSCCCCC------CCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHh--ccccCCC------CCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 000000000000 0001110 00111 123456899999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=1.1e-24 Score=213.39 Aligned_cols=171 Identities=15% Similarity=0.130 Sum_probs=122.3
Q ss_pred eeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCC----------------HHHHHHHHHHHHHHHhCCCCCeeeee
Q 005111 155 FEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQD----------------PESVKFMAREIAILRKLDHPNIIKLE 218 (714)
Q Consensus 155 Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~----------------~~~~~~~~rEi~iL~~L~HpnIVkl~ 218 (714)
|.+.++||+|+||+||+|++ .+|+.||||+++..... ........+|+.+|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46789999999999999987 47999999998643110 11233456789999999999999887
Q ss_pred ccccccCCceEEEEEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhhcCeeeccCCCccEEEcCCCcEEEeec
Q 005111 219 GLITSQTSCSLYLVFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHSHGVLHRDIKGSNLLLDHNGILKIADF 298 (714)
Q Consensus 219 ~~~~~~~~~~l~LV~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~~gIiHrDLKP~NILl~~~g~vKL~DF 298 (714)
++. . .+|+|||+++..+.. +++..+..++.||+.+|.|||++||+||||||+|||+++++ ++|+||
T Consensus 81 ~~~---~---~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 81 AWE---G---NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp EEE---T---TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred Eec---C---CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEEC
Confidence 642 1 369999999876543 34556788999999999999999999999999999998654 899999
Q ss_pred CcccccCCCCCCCcccccccccccCcccccCCCCCCccccccchhHH
Q 005111 299 GLASFFDPKDSVPMTSRVVTLWYRPPELLLGASHYGAAVDLWSTGCI 345 (714)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gT~~Y~APE~l~g~~~y~~~sDIWSLG~i 345 (714)
|+|.............+-.+ . -.+.+. ..|+..+|+||+.--
T Consensus 147 G~a~~~~~~~~~~~l~rd~~--~-~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 147 PQSVEVGEEGWREILERDVR--N-IITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp TTCEETTSTTHHHHHHHHHH--H-HHHHHH--HHHCCCCCHHHHHHH
T ss_pred CCcccCCCCCcHHHHHHHHH--H-HHHHHc--CCCCCcccHHHHHHH
Confidence 99976542211100000000 0 012222 237899999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.13 E-value=2.1e-06 Score=85.05 Aligned_cols=140 Identities=13% Similarity=0.087 Sum_probs=86.2
Q ss_pred CCeeEEeEEeccCceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCceEEE
Q 005111 153 NTFEKLDKIGQGTYSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCSLYL 231 (714)
Q Consensus 153 ~~Y~~~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~l~L 231 (714)
..|+..+..+.++.+.||+.. ..+..++||+...... .....+.+|..+|..|. +--+.+++.+.... ...|+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEE
Confidence 456777766666667999884 4566788888754321 11224567888888773 32234455544433 34799
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHHHHHHhhHhhh---------------------------------------
Q 005111 232 VFEYMEHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCHS--------------------------------------- 272 (714)
Q Consensus 232 V~Ey~~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH~--------------------------------------- 272 (714)
||++++|..+....... .....++.++...|..||+
T Consensus 88 v~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999997664322211 1112222333333333331
Q ss_pred --------------------cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 --------------------HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 --------------------~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999876677999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=7.1e-05 Score=73.23 Aligned_cols=128 Identities=13% Similarity=0.128 Sum_probs=77.9
Q ss_pred EEeccC-ceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCC--eeeeeccccccCCceEEEEEeec
Q 005111 160 KIGQGT-YSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPN--IIKLEGLITSQTSCSLYLVFEYM 236 (714)
Q Consensus 160 ~LG~G~-fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--IVkl~~~~~~~~~~~l~LV~Ey~ 236 (714)
.+..|. -+.||+.. ...+..+++|....... ..+.+|+..|+.|.... +.+++.+..+.+ ..|+||+|+
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~--~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAG--RDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS--CEEEEEECC
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccccc--ceEEEEEee
Confidence 344454 36899986 35677788898654321 23567888887773222 445555544433 489999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHHHHHHhhHhh---------------------------------------------
Q 005111 237 EHDLVGLASLPGMKFTESQVKCYMKQLLSGLEHCH--------------------------------------------- 271 (714)
Q Consensus 237 ~g~ll~~~~~~~~~lse~~i~~i~~QIl~aL~~LH--------------------------------------------- 271 (714)
+|..+.... +..... +.++...|.-||
T Consensus 89 ~G~~~~~~~-----~~~~~~---~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 89 PGQDLLSSH-----LAPAEK---VSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp SSEETTTSC-----CCHHHH---HHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ecccccccc-----ccHHHH---HHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 986553211 111111 111222222222
Q ss_pred ------h-------cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 272 ------S-------HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 272 ------~-------~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
. ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 1379999999999999877778999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.85 E-value=1.4e-05 Score=84.76 Aligned_cols=78 Identities=19% Similarity=0.172 Sum_probs=47.8
Q ss_pred EeEEeccCceEEEEEEEccCCeEEEEEEeecC----C-CCHHHHHHHHHHHHHHHhCC-C--CCeeeeeccccccCCceE
Q 005111 158 LDKIGQGTYSSVYRARDVIHDKIVALKKVRFD----N-QDPESVKFMAREIAILRKLD-H--PNIIKLEGLITSQTSCSL 229 (714)
Q Consensus 158 ~~~LG~G~fG~Vy~a~d~~~g~~VAiK~i~~~----~-~~~~~~~~~~rEi~iL~~L~-H--pnIVkl~~~~~~~~~~~l 229 (714)
.+.||.|....||++.+..+++.|++|.-... . .-+....+...|+.+|+.+. + ..+.+++.+. ... .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~--~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEM--A 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTT--T
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCC--C
Confidence 55799999999999987777889999965321 1 11122344567888887762 2 2344555432 222 4
Q ss_pred EEEEeecccc
Q 005111 230 YLVFEYMEHD 239 (714)
Q Consensus 230 ~LV~Ey~~g~ 239 (714)
++|||++++.
T Consensus 107 ~lvmE~L~~~ 116 (392)
T d2pula1 107 VTVMEDLSHL 116 (392)
T ss_dssp EEEECCCTTS
T ss_pred EEEEeccCCc
Confidence 7899999863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.01 E-value=0.0015 Score=68.35 Aligned_cols=75 Identities=17% Similarity=0.180 Sum_probs=49.7
Q ss_pred EEeEEeccCceEEEEEEEcc-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCC-CCCeeeeeccccccCCce
Q 005111 157 KLDKIGQGTYSSVYRARDVI-------HDKIVALKKVRFDNQDPESVKFMAREIAILRKLD-HPNIIKLEGLITSQTSCS 228 (714)
Q Consensus 157 ~~~~LG~G~fG~Vy~a~d~~-------~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIVkl~~~~~~~~~~~ 228 (714)
.++.|+.|-.-.+|++.... ..+.|.+++.- .... .-...+|..+++.+. +.-..++++++. +
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T---
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch---hhHHHHHHHHHHHHHhCCCCCeEEEEcC--C---
Confidence 34678889999999997643 24567777764 2222 223568999998884 333346766653 2
Q ss_pred EEEEEeecccccc
Q 005111 229 LYLVFEYMEHDLV 241 (714)
Q Consensus 229 l~LV~Ey~~g~ll 241 (714)
.+||||++|..+
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 589999998544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.81 E-value=0.0028 Score=64.46 Aligned_cols=132 Identities=14% Similarity=0.106 Sum_probs=74.1
Q ss_pred ceEEEEEEEccCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhCCCCCe-----eeeeccccccCCceEEEEEeeccccc
Q 005111 166 YSSVYRARDVIHDKIVALKKVRFDNQDPESVKFMAREIAILRKLDHPNI-----IKLEGLITSQTSCSLYLVFEYMEHDL 240 (714)
Q Consensus 166 fG~Vy~a~d~~~g~~VAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-----Vkl~~~~~~~~~~~l~LV~Ey~~g~l 240 (714)
--.||++. ..+|..|++|+.+....+ .+.+..|+..|..|....| +..-+-.........+.++++++|..
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 35899997 467888999998765333 3446678888877742221 11111110111234788999999854
Q ss_pred cccc------------------cC----C-CCC-------------------CCH---HHHHHHHHHHHHHhhHhh----
Q 005111 241 VGLA------------------SL----P-GMK-------------------FTE---SQVKCYMKQLLSGLEHCH---- 271 (714)
Q Consensus 241 l~~~------------------~~----~-~~~-------------------lse---~~i~~i~~QIl~aL~~LH---- 271 (714)
.... .. . ... ++. ......+.+++..+.-+-
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 3210 00 0 001 111 112223333333333221
Q ss_pred hcCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 272 SHGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 272 ~~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
..++||+|+.+.|||+++ + ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 246999999999999974 3 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.96 E-value=0.0075 Score=60.47 Aligned_cols=31 Identities=26% Similarity=0.403 Sum_probs=27.7
Q ss_pred cCeeeccCCCccEEEcCCCcEEEeecCcccc
Q 005111 273 HGVLHRDIKGSNLLLDHNGILKIADFGLASF 303 (714)
Q Consensus 273 ~gIiHrDLKP~NILl~~~g~vKL~DFGla~~ 303 (714)
.||||+|+.++|||++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 5799999999999999888788999998753
|